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Steve Iliffe,1* Jane Wilcock,1 Vari Drennan,2 Claire Goodman,3
Mark Griffin,1 Martin Knapp,4 David Lowery,5 Jill Manthorpe,6
Greta Rait1 and James Warner7
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*Corresponding author s.iliffe@ucl.ac.uk
Background: The needs of people with dementia and their carers are inadequately addressed at all key
points in the illness trajectory, from diagnosis through to end-of-life care. The EVIDEM (Evidence-based
Interventions in Dementia) research and development programme (2007–12) was designed to help change
this situation within real-life settings.
Objectives: The EVIDEM projects were (1) evaluation of an educational package designed to enhance
general practitioners’ (GPs’) diagnostic and management skills; (2) evaluation of exercise as therapy for
behavioural and psychological symptoms of dementia (BPSD); (3) development of a toolkit for managing
incontinence in people with dementia living at home; (4) development of a toolkit for palliative care for
people with dementia; and (5) development of practice guidance on the use of the Mental Capacity Act
(MCA) 2005.
Design: Mixed quantitative and qualitative methods from case studies to large database analyses,
including longitudinal surveys, randomised controlled trials and research register development, with patient
and public involvement built into all projects.
Setting: General practices, community services, third-sector organisations and care homes in the area of
the North Thames Dementia and Neurodegenerative Diseases Research Network local research network.
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v
Participants: People with dementia, their family and professional carers, GPs and community mental
health team members, staff in local authority social services and third-sector bodies, and care home staff.
Main outcome measures: Dementia management reviews and case identification in general practice;
changes in behavioural and psychological symptoms measured with the Neuropsychiatric Inventory (NPI);
extent and impact of incontinence in community-dwelling people with dementia; mapping of pathways to
death of people with dementia in care homes, and testing of a model of collaborative working between
primary care and care homes; and understandings of the MCA 2005 among practitioners working with
people with dementia.
Results: An educational intervention in general practice did not alter management or case identification.
Exercise as a therapy for BPSD did not reduce NPI scores significantly, but had a significant positive effect
on carer burden. Incontinence is twice as common in community-dwelling people with dementia than their
peers, and is a hidden taboo within a stigma. Distinct trajectories of dying were identified (anticipated,
unexpected and uncertain), and collaboration between NHS primary care and care homes was improved,
with cost savings. The MCA 2005 legislation provided a useful working framework for practitioners
working with people with dementia.
Conclusions: A tailored educational intervention for general practice does not change practice, even when
incentives, policy pressure and consumer demand create a favourable environment for change; exercise
has potential as a therapy for BPSD and deserves further investigation; incontinence is a common but
unrecognised problem for people with dementia in the community; changes in relationships between care
homes and general practice can be achieved, with benefits for people with dementia at the end of life and
for the UK NHS; application of the MCA 2005 will continue to improve but educational reinforcements
will help this. Increased research capacity in dementia in the community was achieved. This study suggests
that further work is required to enhance clinical practice around dementia in general practice; investigate
the apparent beneficial effect of physical activity on BPSD and carer well-being; develop case-finding
methods for incontinence in people with dementia; optimise working relationships between NHS staff and
care homes; and reinforce practitioner understanding of the MCA 2005.
Trial registration: EVIDEM: ED-NCT00866099; EVIDEM: E-ISRCTN01423159.
Funding: This project was funded by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Glossary
Read Code This is the standard clinical terminology system used in general practice in the UK. Read
Codes are codes representing clinical terms, which are used by clinicians to record patient findings and
procedures across primary and secondary care.
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Plain English summary
The needs of people with dementia, and their carers, for information about symptom management andservice access are too often inadequately addressed in the course of the disease, from diagnosis
through to end-of-life care. With this in mind, we developed a research and development programme that
was designed to help change this situation: the EVIDEM programme – Evidence-based Interventions in
Dementia. A study of diagnosis and management in primary care (EVIDEM-ED) asked if workplace-based,
tailored education would improve medical practitioners’ recognition of, and responses to, dementia in
general practice. It concluded that education would not change practice. An exercise therapy trial (EVIDEM-E)
for behavioural and psychological symptoms in people with dementia did not reduce symptoms but had a
positive impact on carer burden. An award-winning project on continence (EVIDEM-C) established the scale
of continence problems in people with dementia living in the community, and developed new ways to
reduce the impact of incontinence on people with dementia and their families. The End of Life Care study
(EVIDEM-EoL) explored the experiences of people with dementia and their families at the end of life, and
showed how they could be improved by promoting collaboration between care homes and general practice.
How different types of practitioners working with people with dementia understood and applied the new
Mental Capacity Act (MCA) (2005) was investigated in the EVIDEM-MCA study. Finally, the programme
successfully piloted a research register for people with dementia, and their carers, who wanted to take part in
research studies.
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Scientific summary
Background
Dementia has an enormous impact on the lives of individuals and families, and on health and social care
services, and this impact is increasing as the population ages. The needs of people with dementia and their
carers for information and support are inadequately addressed at all key points in the illness trajectory. The
consequences are poor quality of life, inappropriate and costly responses to the problems that emerge
(such as avoidable admissions to hospital), prolonged inpatient stays and further disablement.
During the life of this programme there has been increasing public awareness of dementia, and growing
policy support for developing services for people with dementia and their carers. The most visible evidence
of this was the launch of the Dementia Strategy for England in 2009, and this policy momentum has
continued with the Prime Minster’s Challenge on Dementia in 2012.
Aims and objectives
The aim of this programme was to study interventions along the disease trajectory of dementia syndrome,
involving a cohort of people with dementia and their families at different stages of the disease.
Its objectives were to develop and test interventions that improve patient/user, carer and service outcomes
at different points on the disease trajectory, namely:
1. the recognition of the syndrome and the first responses to it, in primary care
2. the management of behavioural and psychological symptoms of dementia (BPSD) using exercise as
a therapy
3. the management of incontinence in people with dementia living in the community (but not in
care homes)
4. the care and support given to people with dementia at the end of life.
The programme also evaluated the impact of the Mental Capacity Act (MCA) 2005, and developed
educational interventions to support its application, specifically in relation to safeguarding.
Research plans
We aimed to assemble a cohort of people with dementia and their families, recruiting through primary and
secondary health care, social care services and voluntary organisations, and to nest five projects within it.
These projects were:
1. an educational intervention for primary care management, psychosocial interventions and shared care
of medication for people with dementia, developed and tested in an experimental study
2. a randomised trial of exercise as therapy for BPSD
3. studies of the experience of, and management strategies for, incontinence in community-dwelling
people with dementia, followed by the development and testing of evidence-based resources to reduce
the impact of incontinence on them and their carers
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4. a study of the pathway to death of older people with dementia, and the development and testing
of interventions that would enable the UK NHS, social care staff, and family members to work together
to provide end-of-life care
5. an evaluation of the impact of the MCA 2005 and the creation of practice guidance to enhance
professionals’ concordance with the MCA and with safeguarding practices.
The research team
The EVIDEM (Evidence Based Interventions for Dementia) team was multidisciplinary, with members from
the fields of medicine, nursing, social work, social science, psychology, statistics and health economics.
It drew on experiences of different methodologies, and had a track record of fruitful collaboration and
project completion and an international reputation. This programme built on successful earlier work on
dementia diagnosis and management in primary care, among other studies. We had close working
relationships with the Dementias and Neurodegenerative Diseases Research Network (DeNDRoN) and the
Primary Care Research Network-Greater London (PCRN-GL). We drew on expertise from the National
Institute for Health and Clinical Excellence/Social Care Institute for Excellence dementia clinical guidelines
development group and the National Care Home Research and Development Forum.
The research environment
Central and North West London NHS Foundation Trust hosted the EVIDEM programme. The cultural and
social diversity of London and surrounding areas provided opportunities for testing interventions in
different population groups and contexts. The trust has an energetic user forum, which played a role in
the design and management of some projects, and the research team contributed to an annual ‘school’
(continued professional development event) for trust staff on developments in dementia care, using
different methods to reach staff – day conferences, study half-days and workplace-based seminars
and workshops.
Outputs, outcomes and impact
The EVIDEM programme has produced the following:
1. An educational intervention for general practice, tested in a randomised controlled trial (RCT),
combining timely diagnosis and psychosocial support around the period of diagnosis. This includes
simple decision aids in electronic format, and shared care guidelines for medication use, to enhance the
quality of primary care practice. The records of > 1000 people with dementia were audited for this RCT,
and 161 patient–carer dyads agreed to participate in in-depth studies. The findings of the RCT,
together with literature reviews of subjective memory impairment and methods for improving primary
care’s performance with people with dementia and their carers, are outlined in Chapter 1.
2. The experience of and findings from a RCT of exercise promotion for the management of distressing or
challenging symptoms (BPSD), which involved 131 patient–carer dyads. Because of slow recruitment,
this project was granted a no-cost extension. This time extension did allow sufficient recruitment and
follow-up to conclude the study, which found that the exercise intervention did reduce carer burden
significantly; however, it made no difference to behavioural and psychological symptoms (as measured
by the Neuropsychiatric Inventory) of the patient. The intervention tested in the trial, methods used in
the study and evidence underpinning the experiment are all reported in Chapter 2.
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3. Evidence-based practice resources for the management of incontinence in people with dementia living
at home. In addition, data from a feasibility study of effectiveness and acceptability of different designs
of absorbent pads have been gathered to inform a future clinical trial. These developments, together
with an epidemiological study of incontinence in almost 114,000 people with dementia using
The Health Improvement Network (THIN) database, are reported in Chapter 3. A paper from this project
won the Royal College of General Practitioners and Novartis Research Paper of the Year Award 2011.
4. Methods for enhancing collaborative working between primary and social care to provide end-of-life
care in dementia, suitable for use in care homes without on-site nursing. The development of these
methods is summarised in Chapter 4.
5. Practice guidance on the use of the MCA 2005, including its use in adult safeguarding work. Adopting
a longitudinal approach, this study has charted changes in familiarity with, and confidence in, using the
MCA among a broad range of practitioners. It has been the first to study the MCA as a whole and to
research patient and carer decision-making experiences in this context. The development of this
guidance is reported in Chapter 5.
6. Increased research capacity in the community in the study of care for people with dementia.
The EVIDEM programme has helped create a register of people with dementia interested in research,
alongside its cohort of study participants, both of which are described in Chapter 6. The working
relationships developed across disciplines and boundaries in the programme have allowed new research
studies to be designed and funded. Two Doctor of Philosophy (PhD) studies have been nested in the
programme, which also provided a supportive environment for postdoctoral studies and academic
general practitioners. The expertise acquired by individuals in dementia research is reported in
each chapter.
7. A broad range of publications. The EVIDEM programme has, to date, published more than 30 papers
in professional and academic journals and a dozen articles in the professional press. More than
70 presentations of the programme and its findings have been made in professional, academic and
public conferences, internet seminars and meetings. This report contains further discussion of EVIDEM’s
impact in the description of each project in Chapter 7.
8. Public involvement. We have made wide use of patient and public involvement in these research
and development projects, and user and carer perspectives have contributed to project design,
implementation and analysis. The programme benefited from the interest and contribution of an
expert and enthusiastic advisory group, comprising service users, carers, patients and public
representatives, as well as professionals and academics. Each project also had its own advisory
group with similar compositions.
Finally, the implications of the main findings and some cross-cutting themes from the programme’s
projects are discussed in Chapter 7, along with a summary of what we have found and suggestions for
future research and development.
Trial registration
This trial is registered as EVIDEM: ED-NCT00866099; EVIDEM: E-ISRCTN01423159.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 EVIDEM-ED: a cluster-randomised
controlled trial to improve early diagnosis and clinical
management of dementia in primary care
Abstract
Aim To test a customised educational intervention developed for general practice, promoting both earlier
diagnosis of dementia and concordance with management guidelines.
Design/method The intervention, based on practice-based workshops, was tested in an unblinded cluster
randomised controlled trial (RCT) with a pre- and post-intervention design, with two arms: usual care
compared with the educational intervention. Twenty-three general practices participated and the records
of 1072 patients with dementia were audited. Our primary outcome was an increase in the proportion
of patients with dementia who received at least two documented dementia-specific management reviews
per year. Secondary outcomes were practitioner concordance with management guidelines in a subset of
167 patients with dementia; satisfaction and met need among 84 carers; and attitudes, knowledge and
confidence with dementia diagnosis and management in general practitioners (GPs) and practice nurses.
Findings The estimated odds ratio (OR) of having two or more reviews in the intervention group compared
with the usual care group was 0.83 [95% confidence interval (CI) 0.52 to 1.33; p= 0.44]. Case detection
rates were unaffected by the intervention. The estimated incidence rate ratio (IRR) for the intervention
group compared with the usual care group from multilevel Poisson regression modelling was 1.03 (95% CI
0.57 to 1.86, p= 0.93). Carers’ recall of advice given suggested that a large minority had not received the
information recommended by the National Institute for Health and Clinical Excellence (NICE) dementia
guidelines. Carers of patients taking cholinesterase inhibitors reported more advice on some aspects
of care.
Discussion An educational intervention customised to the needs of each practice did not appear to alter
the documentation of clinical management of patients with dementia, nor did it increase
case identification.
Background: why this study was necessary
Demography and impact
There is increasing interest in earlier diagnosis, because of:
l the ageing of the population and the rising prevalence of dementia
l the costs of care for people with dementia, and
l the perceived benefits for the person with dementia (PWD) and their carers of early intervention, with
concerns about delays in diagnosis, especially in primary care.
Dementia is one of the main causes of disability in later life; in terms of the Global Burden of Disease,
it contributes 11.2% of all years lived with disability, higher than stroke (9.5%), musculoskeletal disorders
(8.9%), heart disease (5%) and cancer (2.4%).1 The total costs of caring for people with dementia in the
UK have been estimated at between £17B and £18B per year2 – more than heart disease (£4B), stroke
(£3B) and cancer (£2B).
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Delayed recognition
Dementia syndromes are underdiagnosed and undertreated in primary care in all countries3,4 with an
estimated 50% of primary care patients of more than 65 years not diagnosed by their primary care
physicians.5,6 The complex reasons for this include patient, family, practitioner and service causes, and are
discussed in detail elsewhere.7
The evidence suggests that there are tangible benefits to earlier recognition of dementia. Early disclosure
of the diagnosis seems to be what people with dementia want to have8 and younger professionals want
to give.9 The benefits of making a diagnosis include ending uncertainty about the cause of symptoms
and behaviour change, with greater understanding of problems; giving access to appropriate support;
promoting positive coping strategies; and facilitating the planning and fulfilment of short-term goals.10,11
There is also the potential for using cholinesterase inhibitor medication to modify symptoms and delay the
need to seek care home moves among people with dementia.
Enhancing skills in primary care
The insidious nature of dementia means that it is most likely to present as a problem within primary care,
but there are obstacles to earlier recognition in this setting. Therefore, considerable efforts have been
made to provide educational programmes to enhance the diagnostic skills of primary care practitioners.
Because of the apparent time constraints in primary care consultations, much research focus has been on
the development of brief screening tests for assessing cognitive function. However, despite the availability
of user-friendly cognitive function tests, there has been little evidence of improvement in primary care
recognition of, and response to, dementia syndromes over the decade since the introduction of
cholinesterase inhibitors. The UK evidence is particularly compelling on this point, especially from early
educational interventions,12 and recent analyses by members of the EVIDEM (Evidence-based Interventions
in Dementia) programme of incidence and prevalence in a large GP data set.13
We find persuasive the argument that the problem of underdiagnosis is probably due to the interaction of
case complexity, pressure on time and the negative effects of reimbursement systems that do not reward
time commitment and systematic follow-up.14,15 However, in our view there is also considerable evidence
that the main problem is not that primary care practitioners simply lack diagnostic skills, but that they lack
the resources and management skills in both clinical management and in prioritisation of the needs of
their patients with dementia. We have presented the evidence for this elsewhere.16
The response of primary care to the needs of people with dementia may be due, in large part, to the
limited availability of support services but this does not mean that an educational intervention is unlikely to
have an effect. Improved confidence in clinical knowledge and skills is still needed to allow practitioners
to improve their performance with this patient group. It does mean that the effects of an educational
intervention would probably be weak, unless other obstacles to earlier diagnosis and better management
of dementia were reduced. Education alone does not usually change practice.
Fortuitously, three changes in UK NHS funding, in the law and in NHS priorities, created an environment
conducive to changes in practice and thereby opening an opportunity to test an educational intervention
in optimal circumstances. In 2006, the introduction of the Quality and Outcomes Framework (QOF), led to
financial incentives for primary care to establish a dementia register and carry out annual reviews of
patients. This was followed by the implementation of the Mental Capacity Act (MCA, 2005)17 in 2007,
which clarified the law on the assessment of capacity to make decisions. The third was the launch of the
National Dementia Strategy (NDS) in 2009,18 which prioritised improvements in the care of people with
dementia, along the entire disease trajectory, and introduced new resources (such as ‘dementia advisors’
in some areas). GPs came under increasing pressure from primary care trusts (PCTs) to make diagnoses
earlier, and to limit the prescription of antipsychotic drugs for behavioural and psychological symptoms of
dementia (BPSD). They also began to experience rising demand for advice about memory loss symptoms,
and to more frequently encounter situations in which they had to make difficult decisions about the best
interests of people with dementia.
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The timing for an educational intervention around dementia diagnosis and management in primary care
could hardly have been better. Practitioners were under pressure to improve the quality of the care they
gave, and were reimbursed for doing so, but knew that they lacked knowledge and skills and so were
motivated to learn.19
Components of the trial
The EVIDEM-ED trial began with literature reviews that scoped the area, followed by co-design of an
educational intervention. This was field tested for feasibility and acceptability before being tested in a
definitive cluster randomised trial.
Literature reviews
In order to inform the planned trial of an educational intervention designed to change clinical practice,
we carried out two literature reviews. The first was a rapid appraisal of the published, English language
literature on barriers to earlier diagnosis of dementia. The second was a review of interventions in primary
care designed to alter clinical practice with patients with dementia.
Review 1: Investigating Barriers to Good Practice
A full account of this review appears elsewhere.20
Method
Publications in English, up to August 2009, relating to barriers to the recognition of dementia were
identified by a broad search strategy, using electronic databases MEDLINE, EMBASE and PsycINFO.
Exclusion criteria included non-English language, studies about pharmacological interventions or screening
instruments, and settings without primary care. Figure 1 shows the selection process for papers.
Records identified through
database searching
n = 4311
Number of additional
records identified through
other sources
n = 2
Number of records removed
as duplicates, non-English,
pharmacological
intervention studies
n = 4153
Number of records
screened
n = 160
Number of records excluded
 as not accessible online
n =70
Full-text articles assessed
for eligibility
n = 90
Full-text articles excluded
(clinical reviews, guidelines,
intervention studies or
service delivery descriptions)
without exploration of barriers
n =79
Studies included in
qualitative synthesis
n =11
FIGURE 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart for EVIDEM-ED:
Review 1, Investigating Barriers to Good Practice.
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Results
Eleven empirical studies21–31 were found (see Appendix 1). The main themes from the qualitative studies
were lack of support, time constraints, financial constraints, stigma, diagnostic uncertainty and disclosing
the diagnosis. Quantitative studies yielded diverse results about knowledge, service support, time
constraints and confidence. The factors identified in qualitative and quantitative studies were grouped
into three categories: patient factors, GP factors and system characteristics. These are discussed in detail
in the published review.20
Conclusion
Much still needs to be done in service development and provision, GP training and education, and the
eradication of stigma attached to dementia to improve the early detection and management of dementia.
Implementation of dementia strategies should include attention to all three barriers, and further research
should focus on their interaction.
Review 2: Changing Service Provision and Clinical Practice
We conducted a second review of potential solutions to the problem of underperformance in primary care.
This second review aimed to identify and appraise empirical studies of interventions designed to improve
the performance of primary care practitioners. A full account appears elsewhere.32
Methods
Search strategy A rapid appraisal approach was adopted to inform the implementation of the NDS in
England,18 introduced in 2009. To avoid delays in the analysis and completion of the review, papers that
were not easily accessible were not included. Publications about the detection and management of
dementia in the community were searched for using MEDLINE, EMBASE and PsycINFO, without restricting
the date or language of publication. Searches were carried out up to February 2010. A broad search
strategy was adopted and search terms are listed in Box 1. This was executed as a two-step process with
educat* added as the second step, after all of the other search terms. Bibliographies of articles discovered
were also examined for additional relevant literature.
Search selection This search resulted in a total of 4579 articles. To prevent narrowing of the search scope
and therefore potentially reducing the search sensitivity, the terms were not refined, but instead each title
was reviewed with its abstract if available to ascertain its relevance. A number of exclusion criteria were
then applied. All studies of pharmacological interventions were excluded, as were studies of the
performance of cognitive function tests. Publications were excluded if they reported on the diagnosis or
BOX 1 Description of two-step electronic database search process
Dementia OR Cognitiv* Impair* OR Alzheimer’s Disease
AND
Primary Care OR General Practi* OR Family Pract*
AND
Diagnos* OR Manag*
AND
Educat*
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treatment of dementia in anywhere but a primary care setting (for example, the benefits of respite in
long-term care facilities); if they related to a population outside the scope of this review (for example,
interventions for caregiver health); or if they were clinical discussions about dementia diagnoses or care.
Letters were also excluded, as were publications in languages other than English. Two other relevant
articles were found, one directly from bibliographic searching, and a second was sourced following a
recommendation from an expert in the field. Figure 2 shows the search process, presented according to
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.33
After applying these criteria, 162 articles remained, but 70 of these were not readily obtainable and these
were also excluded for pragmatic reasons; 77 of the remaining 92 papers were excluded after analysis
because they were clinical reviews, guidelines, studies of barriers or studies without interventions that were
designed to change practice. References in the 92 papers were reviewed to identify other intervention studies.
Data extraction Data were extracted from each study report to allow comparison of interventions and to
assess the quality of study designs. The characteristics chosen for comparison (including location and type
of study, size, recruitment process, methodology, outcome measures, results and conclusions) and a
detailed description of each intervention can be found in the published review.32 Randomised trials were
assessed for quality using the Physiotherapy Evidence Database (PEDro) scale.34 The PEDro scale was
chosen because its assessment of blinding is very relevant to empirical studies in dementia. In quality-rating
scales that consider double-blinding as the central methodological issue, studies would lose points for
failing to be blinded. The PEDro rating scale divides blinding into participants, therapists and assessors,
recognising that although not all of the components of trials can be blinded, it is preferable that some
groups are blinded rather than none at all.35
Results
Fifteen studies were identified of which one used qualitative methods only and three were unpublished.
Of the 11 studies29–31 included in the review, 10 were RCTs (see Appendix 1). Six21–24,27,30 reported
educational interventions and five25,26,28,29,31 trialled service redesigns, either by changing the service
Records identified through
database searching
n = 4579
Number of additional records
identified through other sources
n = 2
Number of records removed as
duplicates, non-English,
pharmacological intervention
studies
n = 4419
Number of records screened
n = 162
Number of records excluded as
 not accessible online
n = 70
Full-text articles assessed
for eligibility
n = 92
Full-text articles excluded
(clinical reviews, guidelines, barrier,
diagnosis or management studies)
without empirical interventional
trials changing practice
n =77
Studies included in qualitative
synthesis
n =15
FIGURE 2 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart for EVIDEM-ED:
Review 2, Changing Service Provision and General Practice.
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pathway or by introducing case management. Educationally, only facilitated sessions and decision-support
software improved GPs’ diagnosis of dementia, as did trials of service pathway modification. Some of the
case management trials showed improved stakeholder satisfaction, decreased symptoms, and care that
was more concordant with clinical guidelines.
Conclusion
The quality of the studies varied considerably. Education interventions are effective when learners are
able to set their own educational agenda. Although modifying the service pathway and using case
management can assist in several aspects of dementia care, these would require the provision of extra
resources, and their value is yet to be tested in different health systems.
Aims and objectives of the EVIDEM-ED study
Using the insights from the two reviews, we designed an educational intervention for general practice,
combining timely diagnosis and psychosocial support around the period of diagnosis in concordance with
management guidelines.36
The objectives of the EVIDEM-ED project were to:
1. develop an educational intervention suitable for the workplace use that has the potential to change
management practice in dementia care among GPs and practice nurses
2. include shared care guidelines for medication use by patients with dementia, as part of management in
general practice
3. develop and test electronic resources that promote the above objectives.
Developing the educational intervention
The theoretical basis of the intervention is described in full elsewhere.16 In summary, the educational
intervention was constructed using the following principles:
1. Diagnosis in primary care depends upon pattern recognition and the use of ‘illness scripts’ (more or less
complex representations of diseases) in non-linear pathways to find the most probable explanations for
presenting symptoms.
2. The first stage of diagnosing is not testing, but starting to suspect the possibility that a dementia
syndrome may be emerging (the trigger phase). The doctor needs an index of suspicion to construct a
diagnosis, which is often ‘triggered’ by a symptom within the patient’s story.
3. A specific problem with dementia is that all involved – patients, families and GPs – are reluctant to
diagnose dementia, a serious and largely unmodifiable disease, which carries a huge burden of stigma.
4. The diagnostic task is complex, therefore, because the accumulating cognitive impairments are
occurring within complex personalities, themselves embedded in social relationships.
5. Any educational intervention needs to be flexible enough to correct context-specific deficits. In other
words, there is no ‘cook book’ or ‘one size fits all’ grand intervention that will alter clinical behaviour in
primary care.
A workplace approach
In primary care settings, the most effective educational methods hinge on adult learning approaches –
problem-solving, small group work, solution focus, ‘academic detailing’ (on site rather than off site) – that
permit flexibility in learning and allow adaptation of guidelines to local circumstances.
A co-design approach to the production of an Educational Needs Assessment (ENA) tool was adopted in
order to gain the insights and experiences of a range of practitioners.37 This involved an expert group of
designers and an expert panel of ‘critical friends’ working in an iterative technology development process38
to develop a prototype ENA tool for dementia diagnosis and management. The prototype was refined
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and subsequently ‘field tested’ with volunteer practices. A full description of this process can be
found elsewhere.39
The expert group
The multidisciplinary expert group was made up of three GPs, an old age psychiatrist, a carer and a
psychologist, and was attended by three members of the research team. Members of the expert group
were chosen on the basis of their expertise or experience in dementia care, or in professional education, or
both. The aim of the expert group was to decide which skills and attributes were essential for a primary
care team to possess in order to deliver effective care for patients with dementia.
The expert group was given three objectives: to (1) design a care pathway that would assist practitioners in
earlier diagnosis and enhance subsequent clinical management (the care pathway); (2) identify the
attributes a practice would need to implement the care pathway (the task matrix); and (3) use the task
matrix to derive a set of questions that would identify the practice’s learning needs (the ENA).
The expert group was also asked to frame its work in terms of adult learning approaches, in other words,
that learning would be problem-solving, case based and usable by practitioners at different points on the
spectrum from novice to expert.40,41
A modified nominal group technique was used with the expert group to develop the prototype ENA tool.
Nominal groups are potentially powerful learning and development tools.42 They have a particularly useful
role in analysing health-care problems43 and can help bridge the gap between researchers and practitioners.44
The expert group met initially to decide what the elements of a training programme designed to change
practice in dementia should be. This meant identifying what tasks were needed to be performed in order
to identify patients with dementia, and to care for them appropriately in the primary care setting.
The expert group designed a flow chart and identified elements of the diagnostic process outlining the
pathway that a clinician might follow once they suspect that a patient has dementia (see Appendix 3,
Figure 29). In addition, the elements of a training programme for primary care teams were identified
(see Appendix 4). From this, the expert group developed questions that would identify the practice’s
strengths and weaknesses in the care of people with dementia.
This cyclical process of adapting and refining ideas took place over one calendar year, and necessitated
four meetings of the expert group. The prototype ENA was sent to the expert panel after the fourth
meeting of the expert group.
The expert panel
The expert panel comprised a group of external, independent people who had registered their interest in
the EVIDEM project by subscribing to a mailing list on the website. The expert panel had 13 members
(one of whom dropped out in the course of the development process), with a mix of carers, patients, and
professionals, including two GPs, a social worker, a practice nurse and an Admiral Nurse (a community
nurse specialising in support of people with dementia and carers). Seven panel members were carers
of people with dementia.
Expert panel members were blinded to each other as well as to the expert group members. They received
and sent comments on all the documents by e-mail or post. The purpose of the panel was to review
the proposals made by the expert group to ensure that no themes were omitted and to decide how
comprehensive, valid and feasible the ENA was as a tool. They were also charged with assessing if the
development of the prototype concurred with known factors favouring the adoption of an innovation,
using literature that had been circulated to them in advance. When this had been completed the expert
panel returned their comments and suggestions to the expert group for review.
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Field-testing the Educational Needs Assessment tool
After incorporation of the feedback from the expert panel, a prototype version of the needs assessment
tool suitable for field testing was prepared. This is shown in Table 1.
This ENA template was then field tested in volunteer general practices. The practices were based in north
west and north east London, and were recruited directly by the EVIDEM programme as part of a RCT
of an educational intervention. Practices were informed about the process and asked to choose either
field-test status or RCT participation. The first five respondents wanting to join the field test were enrolled.
To carry out an ENA, two members of the research team held a group meeting at each practice. A team
member experienced in group-based learning in general practice (the expert tutor), facilitated discussion
of the needs assessment tool. The other acted as a participant observer, ensuring that all questions were
asked and clarifying points where necessary, as well as taking notes about the assessment process.
The practices were asked to invite whichever members of staff they thought should participate, including
attached staff from community services. The times of meetings were left to the practice to choose.
The research project paid for lunch when lunchtime meetings were preferred.
An educational prescription was agreed at the end of each needs assessment process, and up to three
follow-up visits were arranged to work through the themes identified for the educational prescription.
The educational prescriptions were used to collect and collate learning materials for each practice, and the
subsequent workshops were also used to revisit and revise the questions in the ENA. The research team
assembled material in written and electronic form for each of the items on the educational prescription
workshops led by the expert tutor who had facilitated the ENA process, again with a participant observer
from the research team.
Table 2 shows the characteristics of the practices in the field test, the participation of different disciplines, the
number of workshops held with each practice, and the themes identified in their ‘educational prescription’.
As a result of the field testing, the variety of learning materials used was broadened to include more
reference material for use during sessions. The timing planned for topics was also amended and the expert
tutors became more knowledgeable and aware of areas of need that were consistent across individuals
and groups. The practices involved in the field test made it clear that they did not want decision-support
software embedded in their electronic medical record systems but instead preferred simple, easily
accessible guidance in an electronic format that functioned as ‘look-up’ documents.
The educational prescriptions developed through the ENA appeared acceptable and useful in volunteer
practices. The time commitment (no more than 4 hours, spread out at the practice’s discretion) appeared
manageable. The pilot group of practices prioritised diagnosis, assessment of carers’ needs, quality markers
for dementia care in general practice, and the implications of the MCA 200517 for clinical practice. The
content of the ENA seemed to be comprehensive, in that no new topics were identified by practices in
the field trial. On the basis of this pilot, the ENA tool was used in the full trial.
Developing a learner’s manual
The themes identified by practitioners in the field test were researched by EVIDEM staff and a learner’s
manual was constructed (available via www.EVIDEM.org.uk). This manual was designed in a modular form
with Microsoft Word version 97–2004 (Microsoft Corporation, Redmond, WA, USA) documents that could
be accessed during consultations if necessary. The content of the learner’s manual was developed using
the expertise of all members of the EVIDEM team. The manual contains modules on the following:
l dementia diagnosis and cognitive assessment tools
l differential diagnosis of dementia by illness and types
l disclosure of dementia diagnosis and cultural diversity
EVIDEM-ED
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TABLE 1 Educational needs assessment for dementia care in general practice
Question What the answers tell us What we do
1. How would you rate your current
care for people with dementia
and their carers (using a simple
scale of good enough/satisfactory/
needs substantial improvement)?
Answers will indicate whether focused
educational input is needed or broader
input (this is a very subjective
assessment – the practice may be
better or worse than it thinks)
Gives the research team some sense of
scale of need and time commitment,
and may permit preliminary selection
of learning materials and resources
2. What grounds or criteria is your
rating based on?
Identifies more clearly the areas of
strength and weakness, from practice
perspective. e.g. Is the major problem
with diagnosis, or disclosure of the
diagnosis, or judging impairment, or
knowing what the appropriate
responses and resources are?
Sense of priorities for learning will
begin to emerge here
3. Does the number of people in
your practice diagnosed with
dementia correlate with the local
prevalence figures?
Reflects (1) local demography and
(2) under-recognition
GPs tend to overestimate prevalence
and likely future workload, so some
reframing possible (we need
epidemiological data)
4. How do you arrive at your
decision for diagnosis of
dementia?
Tells us about the diagnostic procedure
followed in the practice. It will also
inform us on who makes the diagnosis
Helps identify roles within the practice
team. Skill mix and experiences within
the group can then be shared between
colleagues with the opportunity for
peer-to-peer learning
5. How many older people with
suspected dementia did you refer
last year?
Reveals the practice culture (transfer of
responsibility to specialist services vs.
GP care)
We will know if we need to increase
their capacity to provide GP care or
simply reinforce existing good practice
6. After diagnosis, what follow-up
do you provide to people with
dementia and their carers?
Opens up discussion about
(1) systematisation of care within the
practice and (2) resources available to
the practice
(1) Case management methods
(2) Local (and national) directory of
resources
7. Are you using a shared care
protocol for cholinesterase
inhibitors? If ‘yes’ then (1) who
was involved in producing the
protocol, and (2) who is involved
in its implementation (e.g. hospital
consultants, community
psychiatric nurses, Care of Older
People team)?
Awareness of protocol (if it exists), and
its appropriateness for general practice
Rehearse use of (GP developed) shared
care protocol
8. How effective do you think
cholinesterase inhibitors are and
how effective have you found
them in your practice?
Awareness of realistic likely impact of
cholinesterase inhibitors
Discussion of trial data on cholinergic
drug effects
9. What non-pharmacological
alternatives do you have available
to help your patients (and their
carers)?
Will indicate extent of networking with
local services and identify practice
resources usable by people with
dementia
Provision of information about
cognitive reframing, other psychosocial
support methods
10. Based on your experience, what
do you think are the important
quality markers in caring for
people with dementia?
(What would you want for
yourself?)
Elicits both clinical and personal
experience; may provide very useful
case vignettes
Fit the practice’s conception of quality
markers to the NICE/SCIE guideline
indicators36
11. Is there anything that you would
like improve? If yes, what is it and
why would you like it to change?
Prioritisation of learning needs Highly focused educational input
SCIE, Social Care Institute for Excellence.
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l use of cholinesterase inhibitors, NICE/Social Care Institute for Excellence (SCIE) guidelines and shared
care of medication
l management of BPSD and Department of Health (DH) guidelines for using antipsychotic drugs
l non-pharmacological interventions for dementia
l medication review and dementia
l needs of people with dementia and primary care
l case studies for management of people with dementia
l carer needs and support in general practice
l end-of-life care
l holistic care in dementia – personhood approach
l MCA, advance directives and Lasting Power of Attorney (LPA)
l Independent Mental Capacity Advocates (IMCAs) and Court of Protection
l financial and legal guidance: where to go for help
l dementia and driving.
Implementing the EVIDEM-ED trial
Trial design
The effectiveness of an educational intervention combining practice-based workshops and computer-based
support was tested in a pragmatic, unblinded, cluster RCT, with a pre and post design, and with two arms:
usual care compared with educational intervention [see CONSORT (Consolidated Standards of Reporting
Trials) diagram in Figure 3]. The researchers were aware of group allocation but carers and people with
dementia were not informed. A full description of the trial design – including management structure,
participant involvement and patient and public involvement (PPI) – is available in the published protocol.45
Standard significance tests assume that random sampling has taken place, and that the behaviour or
knowledge of any one individual is not affected by others in the sample. However, this study, like many in
the health service field, is based on clusters of individuals who may influence each other – in this case
colleagues in a practice who share information or similar views, or patients who receive similar treatment.46
This ‘clustering effect’ can mean that false conclusions are drawn about relationships in the data. This
effect was controlled for by using cluster membership (i.e. respondents in each practice).
Study setting
The study took place within primary care practices in the geographical area covered by the North Thames
(NT) Dementias and Neurodegenerative Diseases Research Network (DeNDRoN) – Metropolitan North
London, Essex, Hertfordshire and Bedfordshire. Approval for the trial was received from Southampton &
South West Hampshire Research Ethics Committee (REC) (A): reference 09/H0502/77.
The educational intervention
The educational intervention consisted of practice-based workshops with a tailored curriculum designed by
a multidisciplinary expert group and supplemented by electronic resources. The educational interventions
reflected different approaches to adult learning, namely workshops directly relevant to clinical practice,
allowing learning to occur through peer reflection about real cases, and electronic resource materials
suitable for ‘real-time’ use in consultations.
Recruitment
Primary care practices
Interested general practices in the North Thames DeNDRoN were identified in collaboration with the local
Primary Care Research Networks (PCRNs): the Primary Care Research Network-Greater London (PCRN-GL) and
the Primary Care Research Network-East of England (PCRN-EoE). Practices were contacted by the trial research
team, by letter and awareness raising through general practice educational meetings, and regular newsletters.
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Inclusion criteria
The inclusion criteria for practices in this study were (1) routine data collection from clinical encounters on
electronic medical records and (2) team commitment to participate in educational workshops held in the
practice. (All staff working in the practice were eligible to participate in the study.)
Exclusion criteria
Practices that did not routinely capture clinical data in electronic records were excluded.
Patients with dementia and their carers
An in-depth study of medical care for patients with dementia was carried out in a subset of the practice
populations. Patients identified by the practice were invited by their usual GP to permit analysis of their
medical records, and their carers (where known) were invited to participate in face-to-face interviews,
with telephone follow-up 12 months later.
Practices approached (n = 200)
Expressed interest (n = 38) (19%) 
Excluded (n = 15)
Declined to participate, n = 9
Other reasons, n = 6
– (agreed then withdrew
   owing to staff changes)
New diagnosed cases (n = 129)
Newly registered cases (n = 83)
Newly registered but not diagnosed
(n = 0)
Newly registered and diagnosed (n = 28)
Workshops and electronic
guidance (11 practices)
New diagnosed cases (n = 188)
Newly registered cases (n = 87)
Newly registered but not diagnosed
(n = 2)
Newly registered and diagnosed (n = 35)  
Recruit patients with dementia for
in-depth records analysis (n = 167)
Recruit carers for interviews (n = 84)
Left the practice (n = 30)
Newly diagnosed and left (n = 16)
Newly registered and left (n = 3) 
Left the practice (n = 160)
Newly diagnosed and left
(n = 12) 
Newly registered and left
(n = 5) 
Patient data
Allocation and record
review for previous
12 months (n = 578)
Analysis
Follow-up and record
review for 12 months after
allocation/intervention
(n = 871)
Enrolment
Baseline (n = 796) 
Randomisation 
Usual care (NICE/SCIE
guidelines) (12 practices)
In-depth records analysis (n = 161)
(exclusions: one patient deceased
shortly after giving consent; five
patients had no diagnosis of dementia)
Carers interviews (n = 84)Workshops and written materials offered to usual care practices
Practices enrolled (n = 23)
FIGURE 3 EVIDEM-ED: CONSORT flow diagram.
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Inclusion criteria
Being on the QOF register with a Read Code for dementia of any type documented in their medical
records, with no lower age limit.
Exclusion criteria
Exclusion criteria were (1) participants who were unable to speak English, for whom there was no available
interpreter; (2) either the patient or carer was involved in concurrent research; (3) the key clinical professional
working with the patient felt that an approach to the person with dementia or their carer would be
inappropriate or may increase distress; and (4) any other important reason that the lead clinical professional
might have about why the person with dementia or their carer should not be contacted.
Every effort was made to include those who met the inclusion criteria and who might adequately
understand verbal explanations or written information given in English.
Outcome measurements
Primary outcome, measured in the audit sample
We derived our primary outcome measure and the effect size from discussions with practitioners in the
feasibility phase of the trial. The consensus was that the clinical tasks involved in providing good-quality
care required at least two encounters per year, and that the educational intervention would promote this
effectively in the majority of those in the intervention arm. Our hypothesis was, therefore, that the proportion
of patients receiving two dementia-specific management reviews per year would increase between the
intervention and control groups of patients by 50%, that is, 20% (usual care) compared with 70%
(intervention), after the introduction of the educational intervention. Data relating to dementia-specific
patient reviews and consultations relevant to dementia management were extracted from the practice
records, first by electronic searches and then by hand-searching by research clinicians. Read-Coded dementia
reviews were counted for each patient with dementia in the 12 months prior to intervention/randomisation
and the 12 months following intervention/randomisation. Using the same time periods, all face-to-face
consultations in which any aspect of dementia was documented as Read Code or free text were counted as
‘opportunistic reviews’, regardless of the problem triggering the consultation.
Sample size
Based on the study having 90% power to detect as significant, using a 5% two-tailed significance level,
a 50% difference in the proportion of individuals with two or more dementia-related GP visits (usual
care 20% vs. intervention 70%), the required sample size, based on individual randomisation, would be
23 per group – a total of 46 individuals. However, owing to the use of cluster randomisation, the total
required sample size needed to be inflated in order to take account of this clustering. The number of
patients recruited per practice was also inflated in order to maintain the sample sizes in the presence
of attrition.47,48 With 20 practices (10 per arm), the power to detect the differences postulated would be
maintained if the intraclass correlation coefficient were of the order ≤ 0.37. Thus the effective sample
size with 10 patients per cluster and 20 practices needed to be 200. If the expected attrition rate as
1/3 (33.3%) then 15 patients would need to be recruited per practice in order to maintain the sample size
of 10 per practice.
Secondary outcomes, measured in the subset of patients with dementia who
permitted review of their medical records
Concordance with guidelines
Documented concordance with the best practice recommendations from the intervention were assessed by
the researchers examining the medical records of the subset of patients who had agreed to participate in
the in-depth study. A medical records data extraction pro forma based on the intervention and best
practice guidelines was developed (see Appendix 7).
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Medical records at each practice were reviewed and analysed by independent clinical researchers, and
diagnostic and management actions were coded using the pro forma, noting whether or not the action
was taken in primary care.
Concordance with guidelines for diagnosis was operationalised by first identifying the index consultation.
This was taken as the first consultation, communication or other entry in the patient record which
indicated that dementia was being considered as a possible diagnosis – that is, by the use of the Read
Code and/or the recording of symptoms of dementia. Examples of symptoms included were short-term
memory loss, confusion, wandering, personality change and depression. The content of all consultations in
the 6 months prior to the index consultation were reviewed. A count of specific actions recorded as part of
the index consultation and/or in the period leading to formal diagnosis was then made. The actions were
informed by the NICE/SCIE dementia guidelines36 and agreed by the Project Management Group
(see Appendix 2) as reflecting the working definition of good practice in the diagnosis of dementia.
They were as follows:
Diagnosis in primary care
l Request for blood tests.
l Cognitive testing completed.
l Informant history taken.
l Referral to consultant, nursing or secondary care.
l Depression and/or psychosis considered.
l Carer concerns recorded.
l Behavioural and psychological symptoms related to dementia recorded (apart from depression,
elsewhere classified).
Information was given by the practice to either the carer or patient or both, on:
l signs and symptoms
l course and prognosis
l treatments
l local care and support services
l support groups
l sources of financial and legal advice and advocacy
l medicolegal issues
l local information sources, including libraries and voluntary organisations.
The following actions were coded at time of index or up to formal diagnosis:
l anti-dementia medication prescribed
l medication review undertaken
l computed tomography (CT)/magnetic resonance imaging (MRI) scan requested.
Management in primary care
l Had antipsychotic medication been prescribed?
EVIDEM-ED
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l Evidence of:
¢ consent and capacity; evidence that the provisions of the MCA 2005 have been followed and
evidence of recall, reasoning, decision-making, and, if relevant, agreement from next of kin, carers
or other consultees?
¢ care plan
¢ BPSD addressed and managed
¢ advance statements
¢ living will (advance decision to refuse treatment)
¢ LPA
¢ preferred priorities
¢ direct payments/personal budgets, functional abilities, activities of daily living (ADL) or the use of
global assessments
¢ discussion about carers’ needs.
Information was given by the practice to either the carer or patient or both, on:
l local care and support services
l sources of financial and legal advice and advocacy
l medicolegal issues.
No attempt was made to measure the number of times a particular action – for example, record of contact
with carers – was recorded, but only whether or not such contact was recorded in the pre-intervention
and/or post-intervention periods by a member of the practice.
Measurement of unmet needs in patients and carers
Unmet needs were captured using a structured interview schedule with carers, developed by the research
team in a previous trial.21
Consent
People with dementia were identified by practice managers and their lead clinician checked whether or
not they fulfilled the inclusion criteria. Before seeking consent from patients to participate in the study,
practitioners were asked for their opinion about the capacity of the person with dementia to give informed
consent to taking part in the study, using the MCA 200517 as the framework for their judgement.
For patients judged as having decision-making capacity, the following information was posted to the person
with dementia: (1) a covering letter explaining the involvement of the practice and signed by the lead
clinician; (2) a participant information sheet; and (3) a response letter and prepaid envelope to be returned
to the research team. A researcher arranged to see those patients with dementia and their carers who
expressed an interest in participating in the study. This encounter took place at the preference of the carer,
at the patient’s home, in the GP practice or at the research team’s offices at the Royal Free Hospital.
Its purpose was to seek consent from the carer and consent/assent from the person with dementia,
where possible, for their participation in the study and for allowing access to patient records.
For those judged by the lead clinician to lack capacity to give informed consent, a consultee (as defined in
the MCA 200517) was identified and consulted about possible involvement of the person with dementia
in the trial. The relevant clinician wrote to the consultee, providing full information about the trial.
Figure 4 shows the process of identifying participants and how they were approached, recruited and
consented/consulted about EVIDEM-ED.
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Randomisation and masking
Participating practices were randomised to intervention or usual care arms by an independent researcher
using a computer randomisation programme.49 Independent clinicians undertaking record reviews could
have deduced the allocation of the practices and could have become unblinded.
The process for obtaining participant informed consent was in accordance with the REC guidance,
the MCA 200517 and good clinical practice (GCP).
With the informed consent of the person with dementia or following discussion with their consultee,
members of the research team examined medical records in the GP surgery, using the pro forma to guide
data extraction. No personalised information was recorded or retained by the researcher, and each case
was allocated a unique study number for the purposes of recording data. All other information was stored
in accordance with the Data Protection Act (1998).50
Identify all primary care practices in the geographical
care covered by North Thames DeNDRoN 
Identify interested practices and contact/visit them to
explain the RCT
Primary care team recruited 
Members of clinical team screens lists to identify
potential participants using inclusion/exclusion criteria
Clinician/professional to assess whether or not appropriate
for the person with dementia to be invited to join a
RCT and if they have the capacity to give informed consent 
Administrative staff mail-merges above list with
recruitment letter onto practice letterhead (supplied in
electronic form)
Letters are checked and signed by practitioner and sent
by administrative staff along with information sheet
and response letter. Follow-up request form and prepaid
envelope sent to person with dementia and their
carer/consultee if they have one
14 days allowed for response
Consent gained from person with dementia and
carer/consultee, and opinion sought from
carer/consultee if person with dementia lacks capacity,
as appropriate. (Home visits arranged as necessary)
FIGURE 4 Flow chart of how participants were identified, approached, recruited and consented/consulted about
EVIDEM-ED (2009–10).
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Statistical analyses
Primary outcome: number of reviews
Multilevel logistic regression modelling was used to compare the proportion of patients who had two or
more reviews during the 12 months post intervention/randomisation (post period) between the usual care
and intervention arms. Two-level random-effects models were fitted in order to take account of the cluster
randomisation. The models adjusted for the proportion of patients within each practice with two or more
reviews during the 12 months pre intervention/randomisation (pre period). Separate analyses of the
dementia related reviews, opportunistic reviews and the total reviews were undertaken.
As sensitivity analyses, the above were repeated only for those patients with information available for the
full 12-month pre and post periods.
Diagnoses
Multilevel Poisson regression modelling was used to compare the diagnoses rates, in those aged ≥ 65 years,
between the intervention and usual care arms in the post period. The number of newly diagnosed patients
was used as the outcome with the practice list size of those aged ≥ 65 years used as the exposure. Two-level
random-effects models were fitted in order to take account of the cluster randomisation. The number of
diagnoses during the pre period was adjusted for in the model.
Multilevel logistic regression modelling was undertaken to compare concordance with management
guidelines in the post period between the intervention and usual care arms using two-level random-effects
models. Models were adjusted for the concordance levels in the pre period.
Findings
Of 200 practices we approached, 23 agreed to participate and provided the required level of access and
data. The practices came from 12 different primary care organisations in urban, semirural and rural areas.
Practice enrolment was from 2008 to 2010. Practices received a mean of three workshops, including the
needs assessment workshop at the beginning of the trial (range 2–4). These were staggered across the
practices and took place from 2009 to 2011.
Practice information
Eleven practices were randomised to the intervention arm and 12 to the usual care arm. The number of
patients with dementia per practice ranged from 5 to 123 in the intervention arm and from 6 to 108 in
the usual care arm. The characteristics of the practices by arm of study are shown in Table 3. There was a
slightly higher mean list size, a slightly higher mean deprivation score, and a slightly higher mean number
of GPs in the intervention practices.
Patient information
A total of 1072 (intervention 512, usual care 560) patients had information available in their medical
records at audit showing the number of reviews (dementia/opportunistic/total) in the 12 months (or a
proportion of) before intervention or randomisation and/or the 12 months (or a proportion of) after. Of
those, 61% (n= 313) were female in the intervention group and 70% (n= 382) were female in the usual
care group. The mean age for those people with dementia in the intervention group was 83 standard
deviation (SD) 8.7; minimum (min.) 33; maximum (max.) 104 years and 83 (SD 8.8; min. 55; max. 109) years
for those in the usual care group.
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Dementia management reviews
The mean total number of dementia management reviews (planned and opportunistic) for people with
dementia in the intervention group in the period before randomisation was 0.89 (SD 0.92; min. 0; median 1;
max. 4). For the period after randomisation it was 0.89 (SD 1.09; min. 0; median 1; max. 8).
For those people with dementia in the usual care group prior to the intervention, the mean total number
of dementia management reviews (planned and opportunistic) was 1.66 (SD 1.87; min. 0; median 1;
max. 12). For the period after intervention it was 1.56 (SD 1.79; min. 0; median 1; max. 11). This
difference at baseline appears to have been due to one practice in the usual care group having medical
responsibility for several care homes.
Primary outcomes
The numbers of each type of review for each patient in the pre and post periods were dichotomised for
the primary analyses. These were classified according to whether the individual had < 2 or ≥ 2 dementia
management reviews. A summary can be seen in Table 4.
TABLE 3 EVIDEM-ED: primary outcome analysis – practice characteristics by randomisation group
Variable Summary measure
Usual care
practices (n= 12)
Intervention
practices (n= 11)
No. of GPs Mean (SD) 4.6 (2.7) 5.1 (2.1)
Median 5.5 5
Min. 1 2
Max. 9 9
List size Mean (SD) 7892 (4684) 8382 (4711)
Median 9239 6849
Min. 1133 2682
Max. 14,358 19,323
Deprivation scorea Mean (SD) 19.9 (10.0) 20.4 (7.6)
Median 17.5 22.0
Min. 7 8
Max. 40 29
Care homes No. of practices with patients
residing in care homes
9 9
Min. per practice 0 0
Max. per practice 6 15
Total no. homes per group 17 30
Max., maximum; min., minimum; SD, standard deviation.
a The Index of Multiple Deprivation (IMD)51 is a standard measure of deprivation at small area level across England.
The IMD is based on seven domains: income, employment, health and disability, education and skills, barriers to housing
and services, living environment, and crime. The scores used in the indices are relative to each other and (in most cases)
do not indicate an absolute value as such. For example, an IMD score of 40 does not mean that an area is twice as
deprived as one with a score of 20, but it does mean that the area with the score of 40 is more deprived than the area
with a score of 20.
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Estimated ORs (odds of having two or more reviews in the intervention group vs. the usual care group),
along with the p-values and 95% CIs for those with a full and partial data period are presented in Table 5.
There were no significant differences in recording of dementia management reviews for patients
diagnosed by the current practice between the usual care and intervention arms.
Case detection
In order to get a realistic estimate of case identification that was comparable with studies published
elsewhere we analysed rates of diagnoses by age group.
Pre period: in the pre-intervention/randomisation 12-month period, there were 239 newly diagnosed cases
of dementia. Eleven of these (4.6%) were in people aged < 65 years. Of the 228 newly diagnosed cases in
those aged ≥ 65 years, 99 were in the usual care practices and 129 in the intervention practices.
Post period: in the post-intervention/randomisation 12-month period there was a total of 169 newly diagnosed
cases of dementia. Six of these (3.7%) were in people aged < 65 years. Of the 163 newly diagnosed cases
in those aged ≥ 65 years, 78 were in the usual care practices and 85 in the intervention practices.
TABLE 5 EVIDEM-ED: Estimated ORs, p-values and 95% CIs by classification of dementia management review
Reviews (≥ 2 vs. < 2) OR 95% CI p-value
For all cases including proportion of data collection period pre and/or post
Dementia 0.94 0.33 to 2.62 0.899
Opportunistic 0.96 0.53 to 1.74 0.890
Total 1.05 0.72 to 1.53 0.811
For full pre and post data period
Dementia 0.83 0.32 to 2.10 0.688
Opportunistic 0.62 0.25 to 1.56 0.310
Total 0.83 0.52 to 1.33 0.444
TABLE 4 EVIDEM-ED: The percentage of patients, by group, with two or more reviews for each type of review in
the pre and post periods
Variable Usual care practice patients (%) Intervention practice patients (%)
Dementia (pre) 15.1 4.9
Dementia (post) 9.6 6.1
Opportunistic (pre) 21.3 6.6
Opportunistic (post) 21.4 8.3
Total (pre) 39.0 18.2
Total (post) 35.9 19.8
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The primary analysis considered diagnosis rates in those registered with the practice list and this was used
as the denominator for the calculation of rates. For the usual care practices combined the total patient
population was 15,699 compared with 11,541 for the intervention practices.
Table 6 shows the case detection rates in the pre-intervention/randomisation and the post-intervention/
randomisation periods. These are displayed separately for the intervention practices (combined) and the
usual care practices (combined). The rates by practice were also calculated and the min. and max. rates,
across the practices, are also displayed in Table 6.
Case detection rates were unaffected by the intervention. The estimated IRR for the intervention compared
with the usual care group from the multilevel Poisson regression modelling was 1.03; the p-value was
0.927 (95% CI 0.57 to 1.86).
Secondary outcome analysis
An in-depth study of the medical records of 167 people with dementia was carried out to capture the
detail of clinical management before and after diagnosis. Nineteen of the 23 practices in the trial invited
patients with dementia and/or their carers to permit analysis of medical records; four practices were unable
to send invitations at baseline, for organisational reasons. The total number of people invited was 763, of
whom 190 expressed an interest (25%) and, after further discussion with researchers, 167 (22%) allowed
review of medical records. The medical records of some of the 167 participants were incomplete because
they had joined their practice after the index consultation, or after diagnosis, and the previous records
had not reached their new practice. One hundred and sixty-one had documentary evidence of a formal
diagnosis, and 136 had documentary evidence of the index consultation and a formal diagnosis. Figure 5
shows the characteristics of the secondary outcome sample.
Symptoms were recorded at index consultation for 101 patients, and, of those, 39% had one or
two symptoms, 45% had three or four symptoms, and 17% had five or more symptoms recorded.
TABLE 6 EVIDEM-ED: Detection rates for new cases of dementia in the pre and post periods by randomisation
Rates Usual care practices (%) Intervention practices (%)
Pre period Combined 0.63 1.12
Min. 0.00 0.17
Max. 4.40 3.45
Post period Combined 0.50 0.74
Min. 0.00 0.00
Max. 4.10 1.06
EVIDEM-ED
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One person who gave
consent died prior to
the start of the trial
and was excluded
from data collection 
Majority of
records, n = 136
Clear index
Clear diagnosis
Excluded from analysis,
n = 3
Reasons:
•  ‘Memory loss symptom’
•  Patient declined/avoided
    assessment
•  Overshadowing by
    other diagnosis
    (e.g. cancer)
Clear index
No diagnosis 
763
invitations
sent
190
responded
167 consents
for record
reviews
No evidence of cognitive impairment
at initial contact (n = 13) plus consents
received from care home managers for
the patients not in any of our
participating practices (n = 6). Four
carers declined further involvement 
Reasons, n = 25
•  ‘Memory loss
    symptom’
•  Patient very old
•  Comorbidities
•  Diagnosis
    made elsewhere
•  Diagnosis made
    for securing
    benefits
No index
Clear diagnosis
Excluded from analysis,
n = 2
Reasons:
•  ‘Confused’ and
    patient very old
•  Overshadowing by
    other symptoms
No index
No diagnosis
FIGURE 5 EVIDEM-ED: patient medical record data characteristics.
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Comorbidity and repeat medication use
Forty-two members of the subset (25.3%) had 0–3 comorbidities recorded, 64 (38.6%) had 4–6 comorbidities
and 60 (36.1%) had 7 or more comorbidities. Data on comorbidities were missing for one member of the
subset. Six members of the subset (3.6%) had no repeat medications documented in the medical record,
59 (35.5%) had 1–5 medications, 82 (49.4%) had 6–10 medications and 19 (11.4%) had more than
10 medications. Data on repeat prescription of medication were missing for one member of the subset.
Table 7 shows the characteristics of dementia type by randomisation group.
TABLE 7 Patient baseline characteristics by randomisation group
Characteristics
Randomisation group
Usual care Intervention
Age, years Mean 82 81
SD 8 8
Min. 57 60
Max. 102 97
n 97 64
n (%) n (%)
Gender Male 29 29.9 29 45.3
Female 68 70.1 35 54.7
Total 97 100.0 64 100.0
Location Community 55 59.8 40 62.5
Care home 37 40.2 24 37.5
Total 92 100.0 64 100.0
Diagnosis Senile dementia/dementia 28 28.9 12 18.8
Alzheimer’s disease 41 42.3 21 32.8
Vascular dementia 13 13.4 17 26.6
Dementia with Lewy bodies 0 0 3 4.7
Mixed dementia 8 8.2 4 6.3
Mild cognitive impairment 3 3.1 3 4.7
Other 4 4.1 4 6.3
Total 97 100.0 64 100.0
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Concordance with diagnostic and management guidelines
Table 8 shows the concordance of medical records with guidelines about the diagnostic process in the
136 people with dementia for whom we had an index consultation and a formal diagnosis. Table 9 shows
the concordance of medical records with guidelines about management after diagnosis in the same
number of cases.
Two-thirds of patients were referred for specialist assessment at the index consultation. When referral to a
specialist was documented at the index consultation, 58 (69%) were made to old age psychiatrists,
14 (17%) to memory clinics, four to neurologists (5%) and five (6%) to geriatricians. NICE guidelines for
diagnostic work-up were adhered to in the majority of patients, with documentation of the blood screen,
informant history and carer concerns, but not for cognitive function testing. Among those with cognitive
test results documented, 30 (58%) were for the Mini Mental State Examination (MMSE),52 two (4%)
were for the Six Item Cognitive Impairment Test (6CIT) and 19 (37%) were for the Abbreviated Mental
Test Score (AMTS).
A locum reading the medical records of patients in the subset for the time period between index
consultation and formal diagnosis would only occasionally learn what information had been given about
signs and symptoms of dementia, the disease course and prognosis, the resources available locally that
could provide support, and the relevant medicolegal concerns.
The number receiving cholinesterase inhibitors or memantine (Ebixa®, Lundbeck) (n= 71) was similar
to the number with a formal diagnosis of Alzheimer’s disease or mixed dementia (n= 74). Among those
receiving anti-dementia medication, 56 (82%) received donepezil (Aricept®, Eisai & Pfizer), 7 (10%)
received galantamine (Reminyl®, Janssen), 2 (3%) received rivastigmine (Excelon®, Novartis) and
one received memantine. These medications were offered but declined by two patients.
TABLE 8 Frequency and percentage of individual actions concordant with guidelines for diagnosis
(index consultation to formal diagnosis)
Diagnostic actions within primary care concordant with guidelines (N= 136) n (%)
Request for blood tests documented (full or partial screen according to NICE guidelines) 76 (56)
Results of cognitive testing 53 (39)
Informant history documented 78 (57)
Referral to specialists at index consultation 87 (64)
Depression or psychosis considered 52 (38)
Carer concerns recorded 74 (54)
BPSD considered, apart from depression 42 (31)
Documentation of information given to carer or patient or both on:
Signs and symptoms 5 (4)
Course and prognosis 0 (0)
Treatment option 18 (13)
Care and support available 20 (15)
Support groups available 7 (5)
Financial, legal and advocacy advice 11 (8)
Medicolegal matters 12 (9)
Local services (e.g. libraries, voluntary organisations) 4 (3)
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One in five were prescribed antipsychotic medication, of which the most commonly used was quetiapine
(Seroquel®, AstraZeneca) (n= 13, 52%), followed by amisulperide (patent expired 2008, multiple
manufacturers/trade names) (n= 4, 16%), haloperidol (Haldol®, Johnson & Johnson) (n= 2, 8%) and
risperidone (Risperdol®, Johnson & Johnson) (n= 2, 8%); six individuals received aripipprazole (Aripiprex®,
Otsuka and Bristol-Myers Squibb) or olanzapine (Zyprexa®, Eli Lilly and Company).
One in four records showed that mental capacity had been assessed. The majority of records showed
evidence of care planning, assessment of, and response to, BPSD and functional assessment.
A locum encountering these patients and reading their medical records would not know whether they
had considered or made any decisions about advanced statements, ‘living wills’, Power of Attorney (POA),
preferred priorities of care, use of direct payments or personal budgets, sources of support and medicolegal
concerns, such as driving.
Concordance with diagnostic guidelines at baseline differed between those patients from practices
subsequently allocated to intervention or usual care groups, as shown in Table 10.
TABLE 9 Numbers and proportions of the subset with documented management actions
Management actions (taken after formal diagnosis) n (%)
Anti-dementia drugs prescribed 71 (52)
Medication review 56 (41)
Referred for CT/MRI scan 7 (5)
Prescribed antipsychotic drugs 26 (19)
Consent and capacity; evidence that the provisions of the MCA have been followed and evidence of recall,
reasoning, decision-making and, if relevant:
33 (24)
Agreement from next of kin? 15 (11)
Care plan made 70 (52)
BPSD addressed and managed 101 (74)
Discussion of advance statements recorded 4 (3)
Discussion of living will (advance decision to refuse treatment) recorded 1 (1)
Discussion of LPA recorded 12 (9)
Preferred priorities for care (e.g. DNAR order) 12 (9)
Discussion of direct payments/personal budgets recorded 4 (3)
Functional abilities, ADL or global assessments documented 74 (54)
Discussion about carers needs 45 (33)
Evidence that information was given by the practice to either the carer or patient or both, on:
Local care and support services 5 (4)
Sources of financial and legal advice and advocacy 6 (4)
Medicolegal issues 16 (12)
Local information sources, including libraries and voluntary organisations 3 (2)
DNAR, do not attempt resuscitation.
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Concordance with management guidelines at baseline differed between those patients from practices
subsequently allocated to intervention or usual care groups, as shown in Table 11. Concordance with
management guidelines at follow-up is shown in Table 12.
Table 13 shows ORs (with 95% CIs, p-values and numbers included in each model) from models which
take into account the practice clustering and are adjusted for baseline levels of concordance. ORs
represent the odds of concordance for the intervention compared with usual care practices. There are
only two statistically significant differences, both favouring the usual care group. Participants from
practices in the intervention group were less likely to have details of valid patient consent, and of care
plans, documented in their medical records.
Professionals’ knowledge and skills analysis
Practitioners’ knowledge about dementia
Knowledge about dementia was measured by a self-completed 14-item multiple-choice quiz, for questions
which were drawn from two US instruments: the University of Alabama at Birmingham Alzheimer’s
Disease Knowledge Test53 and the Alzheimer’s Disease Knowledge Test.54 The questions reflected the
content of the educational intervention, and covered current and future prevalence, risk factors, diagnosis
(including differential diagnosis), medication and management (see Appendix 5). Where necessary,
wording was adapted to reflect development in knowledge about dementia or cultural differences.
TABLE 10 Baseline diagnostic concordance by randomisation group
Diagnostic action
Randomisation group
Usual care Intervention
n % Total n % Total
Dementia blood screen 47 81.0 58 29 69.0 42
Cognitive function test 34 58.6 58 17 39.5 43
Informant history considered 45 78.9 57 32 71.1 45
Referral made 50 87.7 57 37 84.1 44
Depression/psychosis considered 30 52.6 57 22 51.2 43
Carer concerns 47 81.0 58 26 60.5 43
BPSD recorded 27 47.4 57 15 34.9 43
Signs and symptoms 1 2.1 48 4 8.9 45
Course and prognosis 0 0.0 47 0 0.0 45
Treatment 13 27.7 47 5 11.1 45
Care and support 11 22.4 49 9 20.0 45
Support groups 3 6.1 49 4 9.1 44
Financial, legal and advocacy 7 13.7 51 4 8.9 45
Medicolegal matters 4 8.0 50 8 17.8 45
Local services 2 4.0 50 2 4.4 45
Anti-dementia drugs prescribed 40 66.7 60 31 58.5 53
Medication review 34 65.4 52 22 51.2 43
The data in this table relate to those people who received a diagnosis of dementia in the current practice. People who
received a diagnosis prior to registration were excluded.
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TABLE 11 Baseline management concordance by randomisation group
Management action
Randomisation group
Usual care Intervention
n % Total n % Total
Prescribed antipsychotic drugs 18 25.4 71 8 12.9 62
Valid patient consent 20 28.2 71 12 20.3 59
Recall and reasoning 8 11.6 69 6 10.2 59
Care plan 40 59.7 67 30 50.0 60
BPSD mentioned/managed 58 81.7 71 43 71.7 60
Advanced statements 2 2.9 70 2 3.3 60
Living will 1 1.4 69 0 0.0 60
LPA 10 14.5 69 2 3.3 60
Preferred place of care 11 15.7 70 1 1.7 60
Direct payments 3 4.3 70 1 1.7 60
Functional abilities/ADL 52 74.3 70 22 36.7 60
Carer’s needs 23 37.7 61 22 37.9 58
Care and support services 22 34.9 63 12 20.0 60
Support groups 0 0.0 64 5 8.3 60
Financial and legal advocacy 4 6.2 65 2 3.3 60
Medicolegal issues 10 15.4 65 6 10.0 60
Local services 3 4.8 63 0 0.0 60
TABLE 12 Follow-up management concordance by randomisation group
Management action
Randomisation group
Usual care Intervention
n % Total n % Total
Prescribed antipsychotic drugs 22 22.7 97 7 11.3 62
Valid patient consent 25 26.3 95 5 8.1 62
Recall and reasoning 18 20.0 90 3 4.8 62
Care plan 52 54.2 96 27 43.5 62
BPSD mentioned/managed 59 61.5 96 45 73.8 61
Advanced statements 5 5.2 96 3 4.8 62
Living will 2 2.1 95 2 3.2 62
LPA 8 8.3 96 4 6.6 61
Preferred place of care 13 13.5 96 5 8.1 62
Direct payments 3 3.2 94 2 4.0 50
Functional abilities/ADL 63 65.6 96 30 48.4 62
Carer’s needs 25 27.5 91 18 30.5 59
Care and support services 15 16.9 89 7 11.7 60
Support groups 0 0.0 93 2 3.3 60
Financial and legal advocacy 2 2.1 95 1 1.7 60
Medicolegal issues 11 11.5 96 4 6.7 60
Local services 0 0.0 93 0 0.0 48
EVIDEM-ED
NIHR Journals Library www.journalslibrary.nihr.ac.uk
26
A scoring system of ‘correct’=+ 1, ‘do not know’= 0, ‘wrong’= –1 was adopted to maximise variance and
to allow investigation of the mix of the three types of answer. These scores were transformed to give a
theoretical range of –100 to 10055 (see Appendix 5). The scores of GPs on knowledge skills and attitudes
were compared with those obtained using the same instrument in the previous trial of educational
interventions, in 2001–2.
Professional knowledge, skills and attitudes at baseline: general practitioners
Ninety-two GPs completed questionnaires at baseline, with very few missing data except for age. There
were no statistically significant differences in knowledge, skills and attitudes between GPs in the two arms
of the trial. Forty-six (50%) were women, and their age range was 26–65 years, mean= 37 years,
median= 41 years.
Sixty-six (72%) were principals, 12 were salaried (13%), six were registrars (6.5%) and four were locums or
categorised themselves as ‘other’ (8.5%). Sixty-one (66%) had worked in old age psychiatry, elderly
medicine or general psychiatry.
Eleven (12%) had discussed the implications of the NDS18 in the practice, 16 (17%) had discussed the
NDS in a professional development setting and seven (7.5%) had discussed it with specialist colleagues.
Fifteen (7.5%) had been offered training in dementia diagnosis and/or management by local specialist
services. Twenty-five (27%) had discussed the implications of the MCA 200517 with their practice,
31 (34%) had discussed it in a professional development setting, and 15 (16%) had discussed it with
a specialist colleague.
TABLE 13 Follow-up management concordance: results from multilevel modelling
Management action OR (95% CI); p-value (n)
Prescribed antipsychotic drugs 0.75 (0.20 to 2.76); 0.664 (131)
Valid patient consent 0.18 (0.03 to 0.94); 0.042 (127)
Recall and reasoning 0.08 (0.01 to 1.24); 0.071 (121)
Care plan 0.44 (0.20 to 0.98); 0.045 (125)
BPSD mentioned/managed 1.65 (0.59 to 4.59); 0.339 (128)
Advanced statements 0.49 (0.07 to 3.35); 0.470 (128)
Living will (advance decision to refuse treatment) 0.58 (0.05 to 6.55); 0.659 (127)
LPA 0.52 (0.13 to 2.14); 0.363 (126)
Preferred place of care 1.17 (0.04 to 35.94); 0.926 (128)
Direct payments/personal budgets 1.39 (0.18 to 10.77); 0.756 (116)
Functional abilities/ADL 0.65 (0.24 to 1.79); 0.407 (128)
Carer’s needs 1.10 (0.11 to 11.04); 0.938 (116)
Care and support services 0.74 (0.20 to 2.72); 0.646 (118)
Support groups 8857496 (0 to ∞); 0.995 (121)
Financial and legal advocacy 2310740 (0 to ∞); 0.995 (123)
Medicolegal issues 0.51 (0.15 to 1.81); 0.300 (123)
Local services Unable to estimate as a result of all values being zero
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Confidence in reaching a diagnosis was similar to the earlier findings, but respondents were significantly
more confident about advising on management of BPSD in 2009–10 than in 2001–2, as shown by
Table 14.
At both time periods, about one in five GPs disagreed with the statement that much can be done to
improve the quality of life of people with dementia or their carers. A similar proportion disagreed that
families would rather be told the diagnosis as soon as possible (Table 15).
Respondents were significantly more likely to agree that dementia is best diagnosed by specialist services in
2009–10 than in 2001–2, although at both time periods only a minority agreed with this proposition.
The 2009–10 respondents were significantly less familiar with management of dementia-related
symptoms, availability of services or how to access them, than respondents in 2001–2 (Table 16).
Differences between the two time points in perceived difficulties in diagnosis and management of patients
with dementia are shown in Table 17. Not all questions were the same at the two time points.
TABLE 14 General practitioners’ confidence in diagnosis and giving advice on symptom management
Confidence in: 2001–2 2009–10 p-value
Reaching a diagnosis 81 (64%) 63 (68.5%) n.s.
Advising on BPSD management 40 (32%) 41 (45%) 0.03
n.s., not significant.
TABLE 15 General practitioners’ attitudes to dementia carea
Attitude
Agreementb
p-value2001–2 2009–10
Much can be done to improve the quality of life of carers of people
with dementia
105/124 (84%) 74/92 (81%) n.s.
Families would rather be told about their relative’s dementia as soon
as possible
99/120 (83%) 76/92 (83%) n.s.
Much can be done to improve the quality of life of people with
dementia
98/124 (77%) 77/91 (84%) n.s.
Providing diagnosis is usually more helpful than harmful 79/122 (65%) 66/92 (72%) n.s.
Managing dementia is more often frustrating than rewarding 46/124 (38%) 31/92 (34%) n.s.
Dementia is best diagnosed by specialist services 41/125 (33%) 41/91 (44%) 0.03
Patients with dementia can be a drain on resources with little
positive outcome
17/118 (14%) 11/92 (12%) n.s.
It is better to talk to the patient in euphemistic terms 11/117 (9%) 15/92 (16%) n.s.
There is little point in referring families to services as they do not
want to use them
4/121 (3%) 4/92 (4%) n.s.
The primary care team has a very limited role to play in the care of
people with dementia
6/125 (5%) 9/92 (10%) n.s.
n.s., not significant.
a Ranked by level of agreement in 2001–2.
b Combined ‘strongly agree’ and ‘agree’.
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A consistent one in five respondents in 2009–10 cannot answer the questions, suggesting that they are
not engaged with patients with dementia (Table 18).
Nearly four in five GPs responding in 2009–10 thought that dementia prevalence would double by 2021,
and 41% estimated the average caseload as ≥ 21. The overestimation on both questions is consistent with
findings from 2001–2 (Table 19).
Respondents in 2009–10 were significantly less likely to answer correctly the questions about the effect on
anti-dementia drugs (cholinesterase inhibitors) and the treatment of depression in patients with dementia.
TABLE 16 General practitioners’ perceived barriers to good practice in dementia care
Perceived barrier 2001–2 2009–10 p-value
Too busy/not enough time during surgery visits 98/118 (83%) 69/92 (75%) n.s.
Lack of social service support available to practice 69/118 (58%) 54/92 (59%) n.s.
Lack of funding within the practice 54/118 (46%) 35/92 (38%) n.s.
Lack of team staff in the practice 60/118 (50%) 40/91 (44%) n.s.
Unfamiliar with advances in the management of dementia related symptoms 53/119 (45%) 61/92 (66%) < 0.001
Unfamiliar with available services to help keep patients at home 49/119 (41%) 57/92 (62%) < 0.01
Unsure how to refer patients to available services to help keep them at home 29/119 (24%) 33/92 (36%) 0.04
n.s., not significant.
TABLE 17 General practitioners’ perceptions of difficulties in dementia diagnosis and managementa
Perceived difficulty
Mean score
2001–2 (scale 1–7) 2009–10 (scale 1–6)
Responding to co-existing behaviour problems 4.6 3.7
Discussing the probable diagnosis: 4.5 3.6
With the co-ordinating support services for carers and people with
dementia
4.3 –
With the co-ordinating support services for people with dementia – 3.8
With the co-ordinating support services for carers – 3.8
Responding to the family’s concerns: 3.9 –
Getting information about support services for carers and people with
dementia
3.8 –
Getting information about support services for people with dementia – 4.1
Getting information about support services for carers – 4.2
Responding to co-existing psychiatric problems 3.8 3.9
Discussing the probable diagnosis with the family 3.5 3.3
Reaching a probable diagnosis yourself 3.4 3.3
Getting information about anti-dementia medication 3.4 3.5
Getting specialist assessment services advice by telephone 2.8 3.5
a On a score of 1 (not at all difficult) to 6/7 (very difficult), n= 123–6 (ranked).
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TABLE 19 Numbers and percentages of respondents giving correct answers on the dementia knowledge quiz
Question
Correct n (%)
p-value
2001–2,
N= 126
2009–10,
N= 92
1. A GP with a list of 1500–2000 people can expect to have the following number
of people with dementia on their list:
l 1–6
l 7–11
l 12–20
l ≥ 21
48 (38) 32 (35) n.s.
2. By 2021, the prevalence of dementia in the general population in the UK is
expected to:
l decrease slightly
l remain approximately the same
l increase slightly
l nearly double
14 (11) 16 (17) n.s.
3. One of the risk factors for the development of Alzheimer’s disease is:
l atherosclerosis
l age
l nutritional deficiencies
l exposure to aluminium
71 (58) 55 (60) n.s.
4. All of the following are potentially treatable aetiologies of dementia except:
l hypothyroidism
l normal pressure hydrocephalus
l Creutzfeldt–Jacob disease
l vitamin B12 deficiency
107 (86) 71 (77) n.s.
5. A patient suspected of having dementia should be evaluated as soon as possible as:
l prompt treatment of dementia may prevent worsening of symptoms
l prompt treatment of dementia may reverse symptoms
l it is important to rule out and treat reversible disorders
l it is best to institutionalise a dementia patient early in the course of
the disease
108 (86) 73 (79) n.s.
6. Which of the following procedures is required to definitely confirm that
symptoms are due to dementia?
l MMSE
l Post mortem
l CT scan of the brain
l Blood test
25 (21) 14 (15) n.s.
7. Which of the following is not a necessary part of the initial evaluation of a
patient with possible dementia?
l Thyroid function test
l Serum electrolytes
l Vitamin B and folate levels
l Protein electrophoresis
110 (87) 84 (91) n.s.
8. A sudden onset of confusion, disorientation and inability to sustain attention –
this presentation is most consistent with the diagnosis of:
l Alzheimer’s disease
l acute confusional state
l major depression
l vascular dementia
121 (96) 85 (92) n.s.
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Carers’ perceptions
Participants
Ninety carers of patients with dementia expressed interest in being interviewed about the quality of
dementia care. Of these, 84 gave consent for two interviews, one at baseline and then again 12 months
later. Six carers who had expressed interest did not consent to an interview, either because of the death of
the person with dementia or because they changed address and could not be contacted.
Depending on the preference of the carers, the interviews took place in the following places: the carer’s home
(n= 23, 27.4%); the patient’s home (n= 4, 4.8%); carer and patient’s home (n= 46, 54.8%); the GP practice
(n= 6, 7.1%); carer’s place of work (n= 3, 3.6%); and the research department at University College London -
Royal Free Hospital (n= 2, 2.4%). All participants received a copy of the signed and dated consent forms,
and the original was retained in the Trial Master File. A third copy was filed in the PWD’s medical notes at
their GP practice. The interviews took, on average, 98 (SD 33, range 30–205) minutes to complete.
A structured interview schedule was used, derived from the instrument used in the previous trial,56 and is
shown in Appendix 6. Interviews were tape recorded with permission, and transcribed.
TABLE 19 Numbers and percentages of respondents giving correct answers on the dementia
knowledge quiz (continued )
Question
Correct n (%)
p-value
2001–2,
N= 126
2009–10,
N= 92
9. Which of the following is nearly always present in dementia?
l Loss of memory
l Loss of memory and incontinence
l Loss of memory, incontinence and hallucinations
l None of the above
115 (92) 85 (92) n.s.
10. Which of the following clinical findings best differentiates vascular dementia
from Alzheimer’s disease?
l Word-finding problems
l Short-term (2-minute span) visual memory loss
l Stepwise disease course
l Presence of depression
89 (71) 68 (74) n.s.
11. The effect of anti-dementia drugs is to:
l temporarily halt the disease in all cases
l temporarily halt the disease in some cases
l temporarily halt the disease in some cases but often causing liver damage
l permanently halt the disease in some cases
114 (91) 72 (78) < 0.01
12. Which statement is true concerning the treatment of dementia patients who
are depressed?
l It is usually useless to treat them for depression because feelings of sadness
and inadequacy are part of the disease
l Treatments of depression may be effective in alleviating depressive symptoms
l Antidepressant medication should not be prescribed
l Proper medication may alleviate symptoms of depression and prevent further
intellectual decline
91 (72) 53 (58) 0.01
n.s., not significant.
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Results
Carer and patient characteristics
Of the 84 carers who completed interviews, 63 (75%) were women and 21 (25%) men. Their age ranged
from 36 to 88 years, with a mean age of 66 years. More than one-third were spouse carers (wives 36%,
husbands 13%) and 44% were adult children (daughters 33%, sons 11%), with the remaining 7% of
carers being sisters or daughters-in-law.
Their relatives with dementia had been diagnosed, on average, 43 months prior to interview (SD 42.9 months,
range 1–168 months) and 79 of the people with dementia (94%) lived in their own home. See Table 20 for
further sociodemographic information of dementia patients and their carers. Table 21 shows that the care
recipients had substantial functional losses and a high prevalence of BPSD.
According to carer reports, almost half of the sample taking anti-dementia medication had Alzheimer’s
disease (n= 25, 46.3%), compared with 10% (n= 3) of those not on medication.
Table 22 shows that the majority of carers recalled receiving advice or support in only 6 of 15 domains:
home adaptations, the care recipient’s driving, benefits and grants, legal concerns, respite (day care) and in
how they were coping. Despite the requirements of an annual dementia review, which should include the
assessment of carer needs, only half of the carers included in the study had been asked how they were
coping and 60% had not been asked about their fears or anxieties.
TABLE 20 Demographic information of carers and the people with dementia whom they were supporting (n= 84)
Demographic information Patient: mean (SD, range) Carer: mean (SD, range)
Age (years) 80.5 (9, 57–97) 65.7 (12.6, 36–88)
Time since diagnosis (months) 43 (42.9, 1–168) –
Age of leaving school (years) 15.3 (1.6, 11–18) 16.65 (2.5, 13–29)
Demographic information Patient: n (%) Carer: n (%)
Further education (e.g. diploma, university) 25 (29.8) 44 (52.4)
Gender
Female 44 (52.4) 63 (75)
Male 40 (47.6) 21 (25)
Marital status
Widowed 40 (47.6) –
Married/co-habiting 41 (48.8) 72 (85.7)
Single 1 (1.2) 8 (9.5)
Divorced 2 (2.4) 4 (4.8)
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TABLE 20 Demographic information of carers and the people with dementia whom they were
supporting (n= 84) (continued )
Demographic information Patient: n (%) Carer: n (%)
Ethnic status
White – UK 68 (81) 73 (86.9)
White – Irish 2 (2.4) 3 (3.6)
White – other 7 (8.3) 3 (3.6)
Black – Caribbean 1 (1.2) 1 (1.2)
Black – African 2 (2.4) –
Black – other – 1 (1.2)
Indian 3 (3.6) 3 (3.6)
Bangladeshi 1 (1.2) –
Employment status
Working full time 9 (10.7)
Working part time 12 (14.3)
Unable to work for health reasons 1 (1.2)
Homemaker 4 (4.8)
Retired 51 (60.7)
Other (e.g. freelance) 7 (8.3)
Relationship with patient
Wife 30 (35.7)
Husband 11 (13.1)
Daughter 28 (33.3)
Son 9 (10.7)
Other (e.g. sister, daughter-in-law) 6 (7.2)
Type of dementia
Alzheimer’s disease 29 (34.5)
Vascular 10 (11.9)
Lewy body 4 (4.8)
Pick’s disease 2 (2.4)
Mixed (e.g. Alzheimer’s disease and vascular) 9 (10.7)
Dementia 14 (16.7)
Other (e.g. unclear) 16 (19)
Place of residence
Own home (with or without spouse) 79 (94)
With relative 5 (6)
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TABLE 22 EVIDEM-ED: overall receipt of advice and support given to carers and people with dementia by primary
care team (n= 84)
Type of advice – been asked/given advice about: Yes, na (%) No, na (%)
How to manage verbal aggression 6 (16.2) 31 (83.8)
How to manage physical aggression 4 (26.7) 11 (73.3)
What to tell a relative re. diagnosis 6 (7.4) 75 (92.6)
Keeping a relative independent 13 (15.5) 71 (84.5)
Home adaptations and equipment 46 (58.2) 33 (41.8)
The care recipient’s driving 22 (55) 18 (45)
Benefits/grants 45 (54.2) 38 (45.8)
Costs of services 27 (32.1) 57 (67.9)
Legal aspects 44 (52.4) 40 (47.6)
Day care 44 (53) 39 (47)
Respite options 29 (37.2) 49 (62.8)
How the carer is coping 44 (52.4) 40 (47.6)
Fears and anxieties 33 (39.8) 50 (60.2)
Future care plans and expectations 13 (15.7) 70 (84.3)
Reference material 40 (48.2) 43 (51.8)
a Because of missing data/’not applicable’, not all figures add up to n= 84.
TABLE 21 Percentage of needs and/or symptoms reported by carers, among people with dementia (n= 84)
Type of disability Yes, na (%) No, na (%)
Able to manage personal care 42 (50.6) 41 (49.4)
Able to manage medication 13 (16.7) 65 (83.3)
Able to prepare food 21 (26.6) 58 (73.4)
Mobility within the house 64 (79) 17 (21)
Mobility outside the house 43 (55.1) 35 (44.9)
Able to cope with toileting 56 (67.5) 27 (32.5)
Able to do shopping 12 (14.8) 69 (85.2)
Able to do housework 20 (25) 60 (75)
Able to manage money and bills 8 (9.8) 74 (90.2)
Verbally aggressive 37 (45.1) 45 (54.9)
Physically aggressive 15 (18.3) 67 (81.7)
a Because of missing data/’not applicable’, not all figures add up to n= 84.
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Fifty-four of the 84 carers reported that the person they care for was taking cholinesterase inhibitors.
Comparison of advice and support received between the groups taking/not taking cholinesterase inhibitors
is shown in Table 23. The carers of those patients taking cholinesterase inhibitors reported significantly
more advice about the care recipient’s driving, significantly more enquiries about their own coping and
significantly more discussion about their fears and anxieties.
Qualitative results
Questions with open-ended responses were included in the interview. Box 2 displays a summary of three
themes arising; perceptions of support from primary care, expectations of primary care, and the need for
proactive care. Full analysis of the qualitative data will be reported in a separate publication.
Overall, few carers had contact with primary care and had relatively low expectations of their GP. However,
those who did have contact with the practice were generally satisfied with the care they received.
TABLE 23 EVIDEM-ED: between-group prevalence (being on or off anti-dementia medication) of being given
advice and support from health-care professionals
Been asked/given advice about:
On cholinesterase
inhibitors (N= 54),a n (%)
Off cholinesterase
inhibitors (N= 30),a n (%)
χ2; p-valueYes No Yes No
How to manage verbal aggression 5 (20.8) 19 (79.2) 1 (7) 12 (92) n.s.
How to manage physical aggression 3 (30) 7 (70) 1 (20) 4 (80) n.s.
What to tell a relative about diagnosis 6 (11.8) 45 (88.2) 0 (0) 30 (100) n.s.
Keeping a relative independent 9 (16.7) 45 (83.3) 4 (13.3) 26 (86.7) n.s.
Home adaptations and equipment 28 (57.1) 21 (42.9) 18 (60) 12 (40) n.s.
Relative driving 20 (66.7) 10 (33.3) 2 (20) 8 (80) 6.599; < 0.025
Benefits/grants 32 (60.4) 21 (36.6) 13 (43.3) 17 (56.7) n.s.
Costs of services 18 (33.3) 36 (66.7) 9 (30) 21 (70) n.s.
Legal aspects 32 (59.3) 22 (40.7) 12 (40) 18 (60) n.s.
Day care 29 (54.7) 24 (45.3) 15 (50) 15 (50) n.s.
Respite options 17 (34) 33 (66) 12 (42.9) 16 (57.1) n.s.
How the carer is doing 35 (64.8) 19 (35.2) 9 (30) 21 (70) 9.372; < 0.002
Fears and anxieties 26 (49.1) 27 (50.9) 7 (23.3) 23 (76.7) 5.292; < 0.025
Future care 8 (15.1) 45 (84.9) 5 (16.7) 25 (83.3) n.s.
Reference material 29 (54.7) 24 (45.3) 11 (36.7) 19 (63.3) n.s.
n.s., not significant.
a Because of missing data/’not applicable’; not all figures add up to n= 54; n= 30.
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BOX 2 Common themes about dementia support management and examples
Theme 1: perceptions of support from primary care
They kind of, I mean you get the proactivity in terms of coming in and have the blood tests, because she’s
got diabetes etc. But we didn’t really get any dementia help from him [the GP]. And, you know, to be
honest, when she had these water infections and we’d ring and say, ‘Oh look she’s really bad,’ they really
didn’t come and see her. They said, ‘Well there’s not a lot that we can do for her really.’ And even when
she went to hospital, they said, ‘Well why don’t you just ring 999?’
Daughter, 55, of care home resident, not on cholinesterase inhibitors
I did go and see the GP; I mean they were always very nice. And if they came to see mum here, and
they’d always, you know, sometimes they’d say to me, ‘How are you?’ you know. You know, while they,
you know, as we were showing them out etc., you know, ‘Are you okay? I know it’s hard.’ But, and then
once when I was really feeling not well myself, I did go and see the GP just to have some blood tests and
things, you know, because I was really at a bit of a low ebb. And, you know . . . we chatted about
the caring.
Daughter, 55, of care home resident, not on cholinesterase inhibitors
Wife: No, nothing at all. The bottom line is, I don’t think, then again I don’t think anybody can do
anything for us, for me. We’ll just have to help ourselves.
Interviewer (I T-B): And in terms of support then, how is that for you?
Wife: There is no support.
Wife, 66, husband living at home, on cholinesterase inhibitors
Yes we’ve been in and out of there [the practice]. And he’s brilliant, I have to say . . . Yes, he’s been a
brilliant support, you know . . . It is, I must admit, you know, a couple of times he’s said, ‘And how are
you?’ you know, and I think that’s just so nice really.
Daughter, 47, mother living in her own home, on cholinesterase inhibitors
Well it was mum’s GP that said really you do need to get this Power of Attorney done, and a couple of
times I’ve been, he’s said, ‘Have you done it yet, have you done it yet?’ And I said, ‘I will do,’ and he said,
‘Honestly,’ he said, ‘If your mum goes into hospital and I’m not around, you know, they won’t listen to
you.’ And he is lovely. He really is. But then you talk to nearly anybody in the town and he’s caring right
the way across the board, you know, right through the young . . . He’s lovely and he sits there and, you
know, he says to mum, he held her hand the other day and he said, ‘You know what’s the matter with
you,’ he said, ‘You worry too much.’ And she said, ‘I know, I’ve always been the same.’ And he said,
‘I know.’ And she just said, you know, ‘Thank you so much.’ And I thought that goes such a long way.
Daughter, 47, mother living in her own home, on cholinesterase inhibitors
Daughter-in-law: No, no. I don’t find them very helpful at all actually.
Interviewer (I T-B): And what about for you as carers, do they ever ask you if you’re okay or if you
need anything?
Daughter-in-law: No never.
Daughter-in-law, 52, mother-in-law living in her own home
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Theme 2: expectations of primary care
Well I think the GP could have put me in touch with social services a bit quicker because I was fighting to
get mum some care, because I was doing it all myself. And I think the GP could have been a bit more
sympathetic or as he’s seen her probably over the years, he could have shared the experience. But he
didn’t. He, it was just, all I ever got from him was, ‘Take her home, make her comfortable. What do you
want me to do? Do you want me to put her in a home? Do you want me to do this?’ All the things I
didn’t want him to do.
Daughter, 50, mother living in her own home, not on anti-dementia medication
Interviewer (IT-B): Is there anything else you would say to her GP that they could improve?
Daughter: Well, to take it a bit more seriously, I think. I think there is a matter of fact isn’t it? Yes, and just
to, you know, be able to help people that don’t understand dementia at all. You know, if you don’t, I
mean the first time I’d heard of it was when mum got it. And then I still didn’t understand what it was all
about. You don’t know what to ask, do you? I remember sitting in the surgery thinking, ‘Well what do I
ask next? Is she going to get better?’ They never said to me that she wasn’t going to get better.
Daughter, 50, mother living in her own home, not on anti-dementia medication
So I guess they can only do so much. And they were always very nice and we talked to them on the
phone, etc.
Daughter, 55, of care home resident, not on cholinesterase inhibitors
The bottom line is, I don’t think, there again I don’t think anybody can do anything for us, for me. We’ll
just have to help ourselves.
Wife, 66, husband living at home, on cholinesterase inhibitors
Theme 3: proactive care
Yes you’re very loathe because you’re always conscious that the doctor’s time is valuable, you know
you’ve already waited an hour to actually see them past the appointment time and you’re very grateful
you’re not being given the bum’s rush. But you don’t think to say, ‘You know, is there anything locally
that mum could go to?’ because you think it’s ‘the doctor’.
Daughter of care home resident, (carer, age unknown), no longer on cholinesterase inhibitors
I can only, I don’t know really. I mean they, they always seem quite independent of everything else. And I
know they’ve got a lot of demands on them. Again I suppose if they worked with a key worker so they,
they did their visits or they – and the idea of them looking at reviewing such a vulnerable person’s health
proactively does seem quite a good idea. I don’t know how that fits in with the opportunity cost of
resourcing and expenses.
Son, 58, mother living in own home, on cholinesterase inhibitors
So ideally that’s what I would like. I would like some sort of, I don’t know how they could do this, but
they should be, I would like them to have some sort of recognition that all people who are carers are really
under a huge strain that cannot be seen. And I mean, you know, I mean I know – I don’t want
preferential treatment for me, but I want preferential treatment for carers.
Wife, 72, husband living at home, not on cholinesterase inhibitors
BOX 2 Common themes about dementia support management and examples (continued)
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Discussion
The EVIDEM-ED trial builds on an earlier study,21 and developed and tested an intervention customised to
the educational needs of individual practices. The deliverables from this programme include an educational
intervention for general practice and practice nursing, combining timely dementia diagnosis and
psychosocial support around the period of diagnosis, with components appropriate to later stages of the
disease trajectory. It also includes electronic resources on the same themes, together with shared care
guidelines for medication use.
The English policy imperatives and financial incentives for dementia diagnosis and management have
created an ideal environment for a trial of an educational intervention designed to improve clinical practice
in primary care – the educational intervention as developed following the Medical Research Council
(MRC)’s recommendations for complex interventions,56 with strong elements of co-design to gain the
insights and experiences of a range of practitioners.37 The ENA deployed in this trial is an example of a
strategy aimed to improve quality of care by overcoming the translation block that obstructs the diffusion
of clinical guidelines and knowledge into practice.57
In this study we found no significant improvement in case identification or documentation of dementia
management reviews after an educational intervention tailored to practice educational needs. This is
despite the financial gain to practices for increasing the number of cases identified and reviewed annually.
There are several possible reasons for this.
The intervention may have been too weak to change practice. More workshops may have been needed, with
reinforcement or mentoring of practitioners over longer periods of time. This level of educational input was
not practicable in this trial, and we doubt that it would be feasible in real-world primary care organisations.
Physicians have a limited ability to accurately self-assess their competence.58 Although the ENA was
designed as a group process to offset this tendency, more external assessment may have been needed to
truly tailor the intervention to needs.
Practitioners’ knowledge, skills and attitudes in 2009–10 were similar to those recorded using the same
instrument in 2001–2. Differences in responses between the two time periods suggested that GPs were less
confident about diagnosis and overall clinical management of dementia in 2009–10 (with BPSD as
an exception).
Carers’ recall of advice given to help them manage the person with dementia suggested that a large
minority had not received the information recommended by the NICE dementia guidelines.36,59 However,
carers of patients taking cholinesterase inhibitors reported more advice on some aspects of care than those
whose care recipients did not take this medication.
Carers’ generally positive attitudes towards general practice, despite their limited contacts with the care
recipients’ GPs, is similar to findings from the earlier trial.60
Limitations of the study
It is possible that the medical records did not capture important changes in the quality of management
after the educational intervention, which were not captured in our evaluation of secondary outcomes, but
our creation of a category of ‘opportunistic dementia review’ fitted with clinical practice and allowed a
generous interpretation of clinical activity. Many patients with dementia joined or left during the pre and
post periods, truncating the data collection time so that the length of follow-up may have been too short
to capture a difference. The number of dementia management reviews was higher in the non-intervention
group at baseline; this could be the consequence of one practice in the usual care group having medical
responsibility for several care homes. Distribution of newsletters and guidelines to usual care arm practices
may have had an effect on their patients’ behaviour.
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The study took place in south east England with practices that were innovative early adopters, not typical
general practices, and local educational programmes that had been developed to implement the NDS may
have influenced practice activities, although we found no evidence of this. The volunteer practices were
probably different from others, in that they wanted to take part in a pilot educational programme about
dementia. However, the results of this study have wider implications, particularly about the value of
tailoring educational interventions.
The intervention was developed in ways consistent with current understanding of how effective
interventions are made. Nevertheless, there may have been deficiencies in the development process.
For example, the views of people with dementia and their family carers may not have had sufficient
weight. Some professional perspectives may have been too powerful; the absence of response from expert
panel members to the ENA questions themselves could be a sign of this. The expert group may not have
used the expert panel’s critical comments sufficiently, resulting in an oversimplification of the ENA. Finally,
the expert tutor may have had an effect on the use of the ENA and the ‘filling’ of the educational
prescription, even although we used a participant observer to avoid idiosyncratic interpretations of the
group discussions.
Conclusions
This study suggests that a tailored educational intervention aimed at GPs does not improve dementia case
identification or documentation of clinical management for people with dementia, even when policy
pressure encourage changes in clinical practice and the reimbursement system rewards it.
Implementation studies
There was considerable demand for the EVIDEM-ED intervention even before the results of the RCT were
available. Its use has been tested as follows:
l Thames Valley Health Innovation and Education Cluster ran sessions with 13 practices in 2011. The
sessions aimed to improve GP knowledge around dementia, and to improve care for patients and
their carers. The sessions were facilitated by a group of five postgraduate psychology students from
the University of Reading, who received 1 day of training on small group facilitation and the use of the
training tool.
l Cambridge Community Mental Health Team ran sessions, for which a consultant in old age psychiatry
acted as a group facilitator.
l Central and North West London (CNWL) NHS Foundation Trust demonstrated the approach to
specialist registrars in old age psychiatry, so that they could test it in general practices.
l NHS Wales has run two training sessions for GPs in the use of ENA.
l Two research projects using the EVIDEM-ED approach have been submitted for funding, one from
Johns Hopkins Medical School in the USA and the other from the University of Auckland in
New Zealand.
Research capacity building
Three academic GP registrars have learned research skills by working within the EVIDEM-ED project:
Dr Louise Pealing, Dr Tamar Koch and Dr Alexandra Davidson.
Dr Sarah Voss in Swindon obtained funding for a parallel project on promoting person-centred care in
general practice for people with dementia and their families. Details of this initiative are reported
elsewhere.61 This nested project was funded by the Alzheimer’s Society and its outputs have been
incorporated into EVIDEM-ED’s learners’ manual (see: www.EVIDEM.org.uk).
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Changes to protocol
No changes to the original protocol were made.
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Chapter 2 EVIDEM-E: exercise as a therapy for
behavioural and psychological symptoms of
dementia – a randomised controlled trial of clinical
effectiveness and cost-effectiveness
Abstract
Background Exercise could be beneficial for some BPSD.
Objectives To review the evidence and cost-effectiveness about exercise and BPSD, and to design and test
a simple dyadic exercise regimen.
Study overview (1) Literature review: a rapid appraisal of the literature showed that exercise programmes
for people with dementia have been poorly conceptualised. It is unclear which aspects of physical activity
produce best outcomes. (2) RCT: a pragmatic, randomised, controlled, single-blind, parallel-group trial of
12 weeks of tailored walking for community-dwelling individuals with dementia who had BPSD, and for
their carers. A total of 906 people with dementia were invited; 131 were randomised [64 treatment as
usual (TAU), 67 intervention], and 57 TAU and 59 in the intervention arm were analysed. The primary
outcome was change in the Neuropsychiatric Inventory62 (NPI) score.
Results There was no significant between-group difference in NPI score at week 12 [adjusted difference
in means (intervention minus control)= –0.41, 95% CI –7.37 to 4.32; p= 0.6]. Caregiver’s burden, as
measured by the Zarit Burden Interview (ZBI), doubled by week 12 for the TAU group but decreased in
the intervention group (OR= 0.18, 95% CI 0.05 to 0.69; p= 0.01). Average cost of the exercise
intervention was £284 per dyad. Within a subsample, the exercise intervention had a significantly higher
cost from a societal perspective (mean difference £2728.60, p= 0.05) but a non-significantly lower cost
from a health and social care (HSC) perspective.
Conclusion Regular simple exercise does not improve the BPSD but does attenuate rising caregiver burden.
Background: why this study was necessary
Dementia is associated with a cluster of non-cognitive symptoms and behaviours that are an integral part
of the syndrome. Commonly described by some clinicians as BPSD, they include disturbed perception,
thought content, mood or behaviour.63 Although recognised as core to the phenomenology of dementia in
Alzheimer’s disease seminal case studies,64 these symptoms have received relatively little attention from the
research community. This is surprising given that > 80% of people with dementia will experience BPSD at
some point during the course of their illness.65 BPSD have long been commonly associated with reduction
in the quality of life for the person as well as their carers;66 increase of caregiver stress,67 higher costs of
care;68 and premature moves to long-term care facilities.69
Although there is some evidence supporting the treatment of BPSD with antipsychotic drugs, there have
been increasing concerns over the safety of these drugs for people with dementia.70 Several studies have
indicated that there is a long-term risk of mortality in patients with dementia who take antipsychotic
medication.71,72 There are few other safe pharmacological interventions with a proven evidence base.
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Non-pharmacological alternatives that have been reported to have a positive effect include music therapy,
bright light therapy, behavioural interventions and exercise.73 As well as the obvious physical impact,
exercise has been demonstrated to have a positive effect on cognitive symptoms and mood.74,75
Interventions such as exercise may offer a safer effective alternative to pharmacological treatment, could
empower individuals with dementia and may reduce carers’ burden.
Heyn et al.76 carried out meta-analysis of exercise interventions for people with dementia and reported data
on 30 trials of exercise. The authors analysed trials that included exercise regimens promoting strength,
cardiovascular fitness or flexibility and analysed them for functional, cognitive or behavioural outcomes.
They found a positive effect of exercise on behavioural outcomes (effect size= 0.54; 95% CI 36 to 72).
However, the trials included in the meta-analysis do not provide a full picture of the effectiveness of
exercise for BPSD for a number of reasons. First, there was considerable heterogeneity among the
interventions, and exercise was often combined with other behavioural interventions; consequently, it is
difficult to isolate the impact that exercise had on behavioural outcomes. Second, some exercise regimens
were complex and required a degree of physical fitness that would preclude many older adults with
complex physical problems and moderate or significant dementia from performing them. These complex
exercise regimens were potentially unsustainable without the support of trained therapists. The relatively
high cost of delivering specialist input for such regimens may prevent such interventions being used more
widely. Finally, most trials included in the analysis were relatively small, with only two reporting samples
including > 100 participants.
Because of this limited evidence base, we designed a pragmatic, randomised, controlled, single-blind,
parallel-group trial to evaluate the effectiveness of a simple exercise regimen as a therapy for BPSD.
Research questions:
1. What is the current evidence around the effects of exercise on BPSD, and how can this evidence shape
the design of this trial?
2. Does a simple dyadic exercise regimen improve outcomes for people with BPSD and their carers?
3. What are participants’ views about, and experiences of, the dyadic exercise regimen?
Study methods and findings
Components of the study
The first question was addressed through a review of the literature; this informed the focus and design of
the clinical trial to answer the second and third research questions (ISRCTN01423159). As a consequence
of unforeseen difficulties with recruitment, a fourth question arose: Why is it difficult to recruit participants
from a seemingly large population and supportive clinical service? To answer this question we added a
small substudy that incorporated a focus group with recruiting clinicians.
Literature review
Methods
A rapid appraisal approach was adopted to inform the design and implementation of a RCT of exercise as
therapy for BPSD. This review, rather than systematically aggregating data, has adopted a critical
interpretive approach,77 the purpose of which is to construct theories grounded in research, develop an
understanding about the potential effect of exercise on BPSD and to generate practical methods to
evaluate these effects. This broad aim led to the generation of three research questions: (1) Does exercise
ameliorate BPSD?; (2) How has exercise been conceptualised and how does this relate to the findings? and
(3) What are the main limitations and methodological shortcomings of recent studies? Full details of the
methods used in this literature review were published.78
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Inclusion/exclusion criteria
Although the aim of this review was to be as inclusive as possible with the current relevant literature,
we recognised the importance of setting boundaries concerning papers to include.77 Studies and review
articles were selected that met the following criteria:
1. Individual studies must measure the efficacy of exercise as a therapy for BPSD. Exercise is defined as
physical activity that is a planned, structured and repetitive programme.
2. Review articles must examine intervention studies assessing the efficacy of exercise as a therapy
for BPSD.
3. Papers must have been published in peer-reviewed journals using relevant keywords appearing as an
important factor in the title or abstract. Studies examining combined interventions (i.e. combining
exercise with another psychosocial intervention) were excluded, as these are unable to establish the
absolute effect of exercise.
The database search was constructed using the following strategies and searched up to January 2011.
l MEDLINE, EMBASE, PsycINFO and PubMed were searched using a combination of keywords: ‘physical
activity and dementia/Alzheimer’s disease’, ‘exercise and dementia/Alzheimer’s disease’,
‘non-pharmacological interventions and dementia’, ‘exercise, sleep disturbance and dementia/
Alzheimer’s disease’, ‘exercise, apathy and dementia/Alzheimer’s disease’, ‘exercise, aggression and
dementia/Alzheimer’s disease’, ‘exercise, wandering/repetitive behaviours and dementia/Alzheimer’s
disease’, ‘exercise, depression/mood and dementia/Alzheimer’s disease’.
l Other sources were also searched including reference lists and book chapters.
Results
Seven hundred and twenty-three articles were screened, of which 16 met the inclusion criteria. Of these,
10 were review articles and six were additional papers not included in these reviews (see the PRISMA chart in
Figure 6 for the derivation of the selected papers). We examined each paper included in the reviews to assess
their inclusiveness and their contribution to answering our three questions.
1. Does exercise reduce BPSD? Using very stringent inclusion criteria, the Cochrane review by
Forbes et al.79 concluded that there is insufficient evidence of the effectiveness of physical activity
programmes on affective symptoms in older persons with dementia to warrant commissioning new
services or decommissioning existing ones. They argue that until further methodologically robust studies
are conducted and published, making firm recommendations for clinical practice about the importance,
type and duration of exercise as a therapy for BPSD will not be possible. The existing research literature,
although thin, does offer insights into potential effects of physical activity on BPSD and hints at the
impact (or not) of exercise on behavioural and psychological symptoms not included in the Cochrane
review (e.g. sleep disruptions, wandering, repetitive behaviours, anxiety and apathy).
2. How has exercise been conceptualised and how does this relate to the findings? Exercise programmes
for people with dementia have been poorly conceptualised and it is unclear which aspects of physical
activity (e.g. type and duration) provide better results than others. We need to understand further what
behavioural and psychological symptoms respond and to what type of physical activity intervention, and
how exercise may work, for whom and under what circumstances. Indeed, exercise may affect various
BPSD in different ways. The current evidence cautiously indicates that its effect on some symptoms
(e.g. agitation, anxiety) may be more rapid than on others (e.g. depression).
3. What are the main limitations and methodological shortcomings of recent studies? The methodological
shortcomings of current work in this area are substantial – very few studies have robust methodologies.
Few use randomised controlled designs and few have a sample size with enough power. In addition, many
studies have short follow-up periods, which could potentially produce a type 2 error, that is, an effect of
exercise on some symptoms may not be evident after only a short period. Many also rely on findings from
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mixed dementia groups while ignoring the potential differences between different types of dementias.
Moreover, the intervention itself was often a heterogeneous one using different modalities of exercise
(i.e. strength building, cardiovascular fitness or flexibility) and/or combined with other interventions
(e.g. carer education). In such instances it remains unclear which particular components of an intervention
are effective.
Trial objectives
Objectives
Primary objective
To determine the effectiveness of a dyadic exercise regimen delivered through a programme of
incremental walking for treating BPSD (as defined by NPI scores) compared with TAU.
Secondary objectives
To determine the effect of this dyadic exercise regimen on (1) the quality of life of people with dementia;
(2) psychotropic medication usage; (3) moving to a residential care facility (care home); (4) mortality levels;
and (5) caregivers’ perceived level of burden. We also carried out an economic evaluation of the intervention.
Number of records after
duplicates removed
(n = 513)
Number of full-text articles
assessed for eligibility
(n = 89)
Number of studies included
in the qualitative synthesis 
Reviews, n = 10
Research articles, n = 6
Number of records identified
through database search
(n = 723) 
Number of records identified
from other sources
(n = 0)
Number of records excluded
(n = 424)
Number of full-text articles excluded
(n = 73)
Reasons:
1. Articles covered in reviews, n = 71
2. Articles not published, n = 2
FIGURE 6 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart describing the search
process of finding articles examining the efficacy of exercise on BPSD.
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Method
Trial design
We conducted a pragmatic, randomised, controlled, single-blind, parallel-group trial of a dyadic exercise
regimen (tailored walking) for community-dwelling individuals with dementia who had BPSD, and for their
carers. Individuals with a diagnosis of dementia, or suspected dementia, who had a carer who was willing
and able to be a co-participant in the exercise regimen, were eligible for recruitment.
After screening and consent, participants were randomly allocated to one of two arms: the intervention
arm, which received an individually tailored regimen of walking (see below for details) in addition to TAU
or the control arm which received TAU only. TAU included home care, attendance at day-care facilities,
visits by health professionals, hospital clinic visits, receipt of medication, respite care and so on. The trial
protocol is shown in Appendix 8.
Both the intervention and TAU arms were assessed for all outcomes at weeks 6 and 12. Further telephone
contact took place at 26 weeks to assess adverse events (AEs), mortality, change in domiciliary status and
adherence to exercise regimen. The consent procedure, standard operating procedure for monitoring AEs,
risk assessment tools and risk management pathway are shown in Appendices 9–13.
An independent randomisation officer (RO) assigned participants using a computerised algorithm and
informed the participants, the participant’s GP and exercise therapist of allocation status. Other study
personnel were kept blind to randomisation status.
Recruitment and baseline assessment of participants
Participants with a clinical diagnosis of dementia or ‘suspected dementia’ with at least one significant
BPSD defined by the NPI62 (excluding the domains of delusions and hallucinations) were eligible for the
trial (Figure 7). Diagnosis of dementia was confirmed using International Classification of Diseases,
Tenth Edition (ICD-10) Diagnostic Criteria for Research (DCR-10).80 A risk assessment was performed
to assess the suitability of participants for the intervention at baseline. This assessment included
measurement for risk of falls using the Falls Risk Assessment Tool (FRAT)81 and Timed Unsupported
Steady Standing (TUSS) assessment.82
Interventions
Physical exercise was delivered as an individually tailored regimen of walking, designed to become
progressively intensive and last between 20 and 30 minutes. This was facilitated by a registered exercise
professional qualified in Instructing Physical Activity and Exercise [National Vocational Qualification (NVQ)
Level 3] and delivered to participants in the intervention arm of the trial in and around their own home.
The exercise therapist facilitated physical exercise in the participant–carer dyad with the expectation
that the dyad would perform the exercise regimen regularly and independently of the therapist at least
five times per week. In order to attempt to control for the social effects of the therapist contact, the
exercise therapist provided input for only the first 6 weeks of the trial, but participants were requested to
continue exercising for 12 weeks. The intervention protocol is shown in Appendix 16.
The intervention group dyad was asked to complete a visual analogue scale, the Rate of Perceived Exertion
(RPE).83 Perceived exertion is based on the physical sensations that a person experiences during physical
activity, including increased heart rate, increased respiration or breathing rate, increased sweating and
muscle fatigue. Although this is a subjective measure, a person’s exertion rating may provide a fairly good
estimate of the actual heart rate during physical activity.
All participants were asked to record their daily activities throughout the 12 weeks of participation using a
diary that was designed to meet the specification of this study (see Appendices 14 and 15).
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Allocation 
Follow-up week 6
Invited to participate (n = 906)
Randomised (n = 131) (dyads)
Unable to contact (n = 441) 
Excluded (n = 334)
Not meeting inlcusion criteria (n = 82)
•  no BPSD, n = 39
•  falls risk, n = 29
•  no carer, n = 8
•  GP exclusion, n = 4
•  no dementia, n = 2
Declined participation (n = 252)
•  self-exclusion, n = 106
•  no reason, n = 93
•  carers could not commit, n = 53
Follow-up week 12
n = 59 (dyads)
Lost to follow-up (n = 1)
Withdrawn (n = 4) 
Analysed (n = 57) (dyads) 
n = 57 (dyads)
Lost to follow-up (n = 2) 
Allocated to control (n = 64)
(dyads)
Received allocated intervention
(n = 64) 
Allocated to intervention (n = 67)
(dyads)
Received allocated intervention
 (n = 67)
n = 59 (dyads)
Died (n = 1)
Withdrawn (n = 2)
Analysed (n = 59) (dyads)
n = 62 (dyads)
Lost to follow-up (n = 1)
Died (n = 1)
Withdrawn (n = 3)
FIGURE 7 EVIDEM-E: CONSORT diagram.
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Setting
This study was conducted in inner city, urban and semirural locations in and around London. Recruitment
began in EVIDEM’s host trust, with approaches to memory clinic teams and community teams working
with older adults to identify and approach people with dementia who would fit the trial’s inclusion and
exclusion criteria (see below), and progressively expanded the range of potential recruitment sources,
which included:
1. North Thames DeNDRoN, which has a registry of people with dementia interested in participating in
research (DemReg).
2. GP practices working with other projects in the EVIDEM programme.
3. Memory assessment services and community mental health services in six NHS Trusts: CNWL NHS
Foundation Trust, West London Mental Health NHS Trust, East London NHS Foundation Trust, Surrey
and Borders Partnership NHS Foundation Trust, Barnet, Enfield and Haringey Mental Health NHS Trust
and South Essex Partnership University NHS Foundation Trust.
4. Self-referral in response to publicity about the trial through various media channels, including television
and radio [British Broadcasting Corporation (BBC)], websites (EVIDEM and Alzheimer’s Society), local
support groups (Housing 21 and Alzheimer’s Society’s Memory Cafés), carer information events
(‘Service user network information day’ and ‘Admiral Nurses Carer Information Day’) and newsletters,
for example the Alzheimer’s Society’s ‘Living with Dementia’.
The EVIDEM-E team held a focus group to identify barriers to recruitment, and the outcomes of these are
reported below (see Findings) and also in a research letter in the International Journal of Geriatric Psychiatry.84
Outcome measures
All outcomes were measured at baseline and after 6 and 12 weeks of participation.
The primary outcome measures were the behavioural and psychological symptom scores measured by the
NPI62 at 12 weeks’ follow-up (Table 24 provides a full description of outcome assessment).
Secondary outcome measures were:
1. participants’ mental health measured using the General Health Questionnaire (GHQ)85
2. participants’ quality of life measured using Dementia Quality of Life (DEMQOL)-Proxy86
3. carers’ burden measured using the short ZBI87
4. service use and costs, measured using the Client Service Receipt Inventory (CSRI).88
Participants’ level of physical activity and compliance with the intervention were measured by carers using
daily diaries and the RPE scale,83 and blood pressure and heart rate monitoring were carried out by the
researcher. Domiciliary change and mortality at 26 weeks was ascertained by the researcher over
the telephone.
Sample size
Assuming 80% of participants in the TAU group will have BPSD measured by the NPI at the 12-week
follow-up, and based on an anticipated between-group (TAU minus intervention) absolute risk difference
of 30% in the proportion of people with improved BPSD (defined as at least three-point improvement),
we calculated that a sample size of 146 participants would provide 90% power to detect this difference
with a 5% (two-sided) significance level, allowing for an anticipated 20% attrition rate.
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Randomisation
With consent to participation, individuals were randomly allocated to receive TAU or exercise in addition
to TAU (intervention). The randomisation ratio for the two groups was 1 : 1 (intervention : TAU).
Randomisation was performed by the central co-ordinating centre using a computer algorithm of a simple
randomisation protocol. A RO performed the randomisation and communicated notifications to
participants, carers and the therapist, but not the research worker (RW).
Concealment of individual’s group allocation was preserved until individuals had committed to the study.
The nature of the intervention rendered it impossible for participants to be blind to allocation. Although it
was difficult for the RW to be blind to the allocation of participants because of their involvement in patient
recruitment and assessments, several strategies were implemented to minimise unblinding of the RW. The
efficacy of blinding was assessed at each time point using a three-point Likert-type scale polarised by the two
arms and including a ‘not sure’ level as the centre rating. Telephone assessments were used when possible
to reduce the likelihood of the RW observing treatment. For the statistical analysis of participants’ data, the
statistician, the RW and principal investigator remained blind to the study group allocation of the participants.
Analytic methods
An analysis plan was agreed and locked before analysis began. The randomisation code was not revealed
until analysis had been completed. Descriptive statistics for the baseline demographic and the outcome
data are presented for each group. Categorical data are presented as numbers and percentages, and
continuous data as means, SDs and ranges.
Continuous outcomes were compared using analysis of covariance (ANCOVA), which included the relevant
baseline scores.
TABLE 24 Administration of outcome measures
Day Administrator Intervention/assessment
0 RW ICD-10, MMSE, NPI, demographics, CSRI, DEMQOL-Proxy, GHQ, ZBI,
medication, vital signs
0 Randomisation Allocation and diaries
1–2 Exercise therapist RPE timed walk, diarya
3–4 Exercise therapist RPE timed walka
5–8 Exercise therapist Telephone contact – advice and guidancea
6–8 Exercise therapist RPE timed walka
13–17 Exercise therapist Telephone contact – advice and guidancea
17–28 Exercise therapist Telephone contact as neededa
40–46 Independent researcher NPI, diary reminder
40–46 RW DEMQOL-Proxy, GHQ, ZBI, medication, vital signs
40–46 Exercise therapist RPE timed walka
80–88 Independent researcher NPI, diary reminder
80–88 RW DEMQOL-Proxy, GHQ, ZBI, medication, vital signs
80–88 Exercise therapist RPE timed walka
90–99 RW Collection of diaries
182–196 RW Telephone contact, check for change of status (residence and mortality)
CSRI, Client Service Receipt Inventory; DEMQOL-Proxy, Dementia Quality of Life tool; GHQ, General Health Questionnaire;
RW, research worker.
a Intervention group only.
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Participants were categorised into two groups: those who had a clinically significant reduction in BPSD
(NPI score) of three points or more, and those who did not. We used binary logistic regression to
analyse the difference in the proportions of those who had a clinically significant reduction in NPI score
between the TAU and intervention groups at 12 weeks.
All analyses were undertaken using the statistics package SPSS™ version 20 [Statistical Package for the
Social Sciences (SPSS), IBM Ltd., Armonk, NY, USA: www-01.ibm.com/software/uk/analytics/spss/] before
the breaking of the randomisation key and the analyses were carried out blindly by the RW.
Economic analysis
Resource use and cost measures
Data on utilisation of care and support services were captured through the CSRI,88 completed with the
assistance of the RW. The CSRI was completed twice (baseline and 12 weeks), on each occasion asking
about service use retrospectively over the previous 3 months. Data were collected on all HSC services,
equipment and adaptations, medication and unpaid carer inputs.
Unit costs used were drawn, where possible, from the Personal Social Services Research Unit (PSSRU)
compendium for 201189 and reflect long-run marginal opportunity costs. The British National Formulary
database was used to obtain medication costs.90 Market sources were used to estimate costs for
equipment and adaptations to homes when these were not available in the PSSRU compendium.
Although most unit costs were found at 2011 prices, in other cases available figures were adjusted to the
2011 price level. When services would continue to provide a benefit for > 1 year, costs were annuitised
using the HM Treasury recommended annual discount rate of 3.5%.91 Unpaid care costs were estimated
using an hourly rate equal to the National Minimum Wage, under the assumption that this was a potential
opportunity cost for the unpaid carers.
Cost-effectiveness analyses
Cost-effectiveness analyses were conducted from two perspectives: HSC and societal. A HSC perspective
considers those costs incurred by organisations providing HSC. A societal perspective considers costs
incurred by all members of society collectively. In this instance, the difference between the two
perspectives is the inclusion of informal (unpaid) carer costs in the societal perspective only. The main
cost-effectiveness analyses from each perspective compared the exercise regimen and control on cost and
mean difference in composite NPI score. Secondary cost-effectiveness analyses compared the exercise
regimen and control on cost and each of the following outcomes in turn: the ZARIT caregiver burden
inventory (ZBI), DEMQOL-Proxy, GHQ and a measure of quality-adjusted life-years (QALYs) generated from
DEMQOL-Proxy scores. Scores on the outcome variables for which lower scores show better outcomes
have been reversed in order to have a more intuitive interpretation for the economic analysis. For each
cost-effectiveness analysis, there were four potential outcomes.
The exercise regimen is:
i. more effective (has superior outcomes) and less expensive than usual care
ii. less effective and more expensive than usual care
iii. both less expensive and less effective than usual care, or
iv. both more expensive and more effective than usual care.
Strong dominance of one intervention over another is described in cases (i) and (ii), and the decision of
whether or not to implement the new intervention is typically straightforward, although the potential
presence of measurement error must be considered. For cases (iii) and (iv), the decision-maker must weigh up
the differences in outcomes and costs before choosing whether or not to implement the exercise regimen.
The value or weight attached to differences in outcomes will play a part in deciding whether or not to
proceed with implementing the new intervention. In such cases, the typical approach would first involve the
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calculation of the incremental cost-effectiveness ratio (ICER), ICER=ΔC/ΔE, where ΔC is the mean cost
difference between (in this case) the exercise regimen and control, and ΔE is the difference in mean outcome.
Each ICER was estimated with the Seemingly Unrelated Regression (SUR)92 model using Stata version 13
(StataCorp LP, College Station, TX, USA, http://stata.com/). Each cost and outcome measure, in turn, was
regressed on treatment allocation, controlling, respectively, for cost and outcome at baseline. In sensitivity
analysis, we controlled additionally for participant age at baseline, gender, ethnicity, marital status,
education level, whether or not living in a care home, MMSE52 score at baseline, carer’s age and gender.
Regression models were bootstrapped with 1000 replications in order to address possible data skewness.
Multiple imputation (using 10 imputed data sets) was used to deal with missing values in some outcomes
and covariates.93
The formula net benefit (NB)= λ ×ΔE –ΔC was used to calculate NBs, which, in addition to using
mean cost and outcome differences as with ICER calculations, used a range of hypothetical values of
willingness to pay (λ) for an additional unit on a given outcome measure. Cost-effectiveness acceptability
curves (CEACs) were then plotted for the primary outcome (NPI) using the NB values calculated for each
value of willingness to pay within the range of £0–10,000. This showed the probability of the exercise
regimen being cost-effective over the values of willingness to pay considered.
The economic analysis was conducted using Stata version 13.
Protocol changes
No significant protocol changes have been made to this trial (see Appendix 8).
Ethical arrangements
This study was approved by Outer North East London REC (ref. 09/H0701/67), and nine minor
amendments were requested and approved.
Findings
Description of the sample
Recruitment and follow-up began in 2010 and ended in 2012. One hundred and thirty-one participant
dyads were randomised to receive either the exercise regimen in addition to TAU (intervention) or TAU
only (control) (see Figure 7). Eighty-nine per cent of dyads completed the trial, with seven and eight dyads
lost from the TAU group and the intervention groups, respectively. The sample (people with dementia and
carers) was predominantly female (women 163: men 99). Participants with dementia were typically older
than the carer participants (78.85± 7.1 years vs. 63± 16.2 years). Most of the participants with dementia
were living at home and were being cared for by partners or adult children. Alzheimer’s disease was the
most prevalent type of dementia (n= 82, 62.6%), and most participants had been diagnosed within
the previous 2 years (n= 73, 56%). Report of a fall in the previous year was more common for people with
dementia (80%) than for carers (34%). Quality of life for people with dementia at baseline as measured
by the DEMQOL-Proxy was relatively good (101.3± 13.9). Behavioural and psychological symptoms as
measured by the NPI [30.6 (SD 17.7), range 4–80] were similar to that reported in the original validation
paper.81 Participants were dichotomised according to validated thresholds for ‘caseness’ relating to
psychological well-being (GHQ) (range 0–84, threshold ≥ 23)84 and for caregiver burden (ZBI) (range 0–28,
threshold ≥ 24).94 Thirty-six carers (27%) reached the validated threshold for ‘caseness’ relating to
psychological well-being (GHQ)84 and 25 (19%) for caregiver burden (ZBI).94 Heart rate and blood pressure
readings were generally within the normal range in our sample. Table 25 provides the descriptive analysis.
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Exercise uptake
Self-reported walking time (diary) appeared to differ between the groups. The TAU group increased walking
by just over 2 minutes at week 6 in comparison with week 1, but by week 12 their reported walking time had
decreased by almost eight minutes in comparison with week 6. Participants in receipt of the intervention
reported increasing their walking time by 6 minutes at week 6 and retained this change at week 12.
Analysis of primary outcomes
Adjusting for baseline NPI scores, there was no significant difference in NPI score at 12 weeks (β= –0.41;
p= 0.6, 95% CI –7.37 to 4.32), where ‘β’ represents the difference in mean NPI scores (intervention minus
TAU groups) at week 12. In addition, there was no significant difference in the proportions of participants
reaching a clinically significant reduction of three or more points of NPI score at week 12 compared with
baseline between the TAU and intervention groups (OR= 1.41; p= 0.36, 95% CI 0.67 to 3.01) (Table 26).
TABLE 25 Sociodemographic statistics (baseline)
Participant
Control (N= 64) Intervention (N= 67)
n
Mean± SD (range)/frequency
(percentage) n
Mean± SD (range)/frequency
(percentage)
Person with dementia
Age, years 64 78± 7.4 (58–99) 67 79± 6.8 (64–97)
Gender: female 64 39 (60.9) 67 35 (52.2)
Ethnicity: white 64 50 (78.1) 67 56 (83.6)
Marital status: married 63 45 (71.4) 67 46 (68.6)
FRAT score: ≥ 2 64 36 (56.3) 67 27 (40.3)
Living: private residence 64 57 (89.1) 67 59 (88.1)
Years’ education 60 11.92± 5.9 (0–36) 63 12.1± 4.1 (6–23)
MMSE 64 14.9± 8.7 (0–29) 67 16.3± 7.4 (0–30)
Alzheimer’s disease 59 38 (64.4) 65 44 (67.7)
Years since diagnosis: ≤ 2 years 61 38 (64.4) 59 35 (54.7)
Carer
Age, years 59 60.9± 17 (22–88) 53 65.4± 14.9 (27–89)
Gender: female 64 39 (60.9) 67 50 (74.6)
FRAT score:= 0 64 46 (71.9) 67 40 (59.7)
Relationship: ‘partner or spouse’ 64 35 (54.7) 67 42 (62.7)
Carer distress (NPI) 64 11.9± 8.1 (0–39) 67 11.8± 8.9 (0–38)
TABLE 26 EVIDEM-E: primary analysis
Control frequency (%) Intervention frequency (%) ORa 95% CI p-value
33/57 (57.9%) 39/59 (66.1%) 1.41 0.67 to 3.01 0.36
Mean± SD Mean± SD βb
25.6± 16.6 23.9± 20.6 –1.53 –7.37 to 4.32 0.60
a OR of improvement (reduction) of composite NPI score of three or more points between baseline and weeks 6 and 12.
Scoring at or above the validated threshold for ‘caseness’ at week 12.
b ANCOVA of the adjusted difference in mean NPI scores (intervention minus control) at week 12.
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Analysis of secondary outcomes
Caregiver’s burden as measured by the ZBI doubled by week 12 for the TAU group participants but
decreased from 23% to 17% for those in the intervention group (OR= 0.18; p= 0.01; 95% CI 0.05 to
0.69). There were no statistically significant differences between the groups at week 12 regarding
carers’ mental health (GHQ), carers’ distress (NPI) and quality of life of participants with dementia
(DEMQOL-Proxy) (Table 27).
Follow-up at week 26
No major changes were reported at the 26-week follow-up. Four individuals had moved from their family
homes to care homes. Three of those individuals were in the control group and one in the intervention
group (OR= 0.38; p= 0.42; 95% CI 0.04 to 3.85).
Three deaths were reported at week 26: two from the control group and one from the intervention group.
This difference was not significant (OR= 1.76; p= 0.55; 95% CI 0.28 to 11.07).
No significant difference was reported in receipt of antipsychotic medication (OR= 1.48; p= 0.68; 95% CI
0.23 to 9.52).
TABLE 27 EVIDEM-E: secondary analysis
Outcome Week
Control
frequency (%)
Intervention
frequency (%) ORa (95% CI) p-value
NPI Baseline 64 67
6 32/56 (57.1) 39/62 (62.9) 1.27a (0.61 to 2.66) 0.52
GHQ Baseline 46/63 (73) 48/67(71.6)
6 24/57 (42.1) 16/62 (25.8) 0.42b (0.18 to 1.00) 0.05
12 24/56 (43) 17/55 (31) 0.59b (0.24 to 1.43) 0.19
ZBI Baseline 52/62 (83.9) 50/65 (76.9)
6 14/55 (25.5) 14/59 (23.7) 0.48b (0.14 to 1.67 0.25
12 18/56 (32) 10/57 (17.5) 0.18b (0.05 to 0.69) 0.01
Mean± SD Mean± SD βc
NPI 6 26.6± 17.5 25.7± 20.5 –0.81 (–6.08 to 4.45) 0.76
DEMQOL-Proxy 6 101.1± 14.9 103.6± 11.9 1.27 (–2.33 to 4.86) 0.49
12 101± 13.5 104± 10 2.62 (–0.78 to 6.02) 0.09
NPI carer distress 6 11.07± 7.2 11.5± 8.5 –0.06 (–2.25 to 2.14) 0.96
12 9.98± 5.9 10.9± 9.3 1.14 (–1.31 to 3.58) 0.76
a OR of improvement (reduction) of composite NPI score of three or more points between baseline and weeks 6 and 12.
b Scoring at or above the validated threshold for ‘caseness’ at weeks 6 and 12.
c ANCOVA of the adjusted difference in means (intervention minus control) at weeks 6 and 12.
The denominator of week 6 and week 12 data varies as result of participant availability.
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Qualitative data
Diaries were returned by 90 (69%) participant dyads: 52 (78%) from the intervention group and 38 (60%)
from the TAU group. Participants in both groups reported positive and negative aspects of walking
outside, and barriers that affect this activity. Weather was reported as the main factor that affected walks.
Participants reported that during the walks they enjoyed the nature, socialisation, gaining a sense of
achievement, feeling independent and feeling less agitated (for the person with dementia). Some of the
disadvantages reported were overexertion, physical pain, feeling alone, difficult terrain and noise. Planned
walks were cancelled because of unfavourable weather conditions, poor health, carer unavailability, PWD
feeling agitated, and being busy indoors.
It was not possible to perform further detailed analyses nor draw conclusions from the diaries contents
because of variation in completion.
Recruitment
With early recruitment low and an obvious incongruity between verbal support and limited promotion of
the study, we invited clinicians (team managers, nurses, occupational therapists, physiotherapists and
psychologists) to a focus group to discuss their perceptions of research, impediments to their role as
recruiters, and potential solutions to the study’s recruitment difficulties.
The group described how clinicians are increasingly challenged by patients ‘informed about the latest research’.
The group indicated they often had to provide counter evidence in response to ‘headline’, and sometimes
‘sensationalised’ research conclusions. Together with patients’ limited understanding of varying quality in
research and the importance of clinical judgement for each individual, this could have (in the group’s view) an
adverse impact on the patient–clinician relationship. When recruiting to research, the group felt responsible – as
the source of the research invitation – for assuming a degree of accountability for the research project’s value
and conduct (Box 3, quotation a). This responsibility was experienced as unreasonable, as they often had no
part in the study’s design and administration, and so there was a risk that recruiting might be perceived as
potentially unrewarding, or worse, detrimental to patients. Although the group perceived the value of research,
they also identified several concerns about recruiting their patients to EVIDEM-E (see Box 3, quotes b–d).
BOX 3 Findings from the focus group on recruitment to the trial
a. Clinician accountability for research
What if they agree due to your relationship with them, when you’ve said this thing is going to
be great . . . ?
b. Overburdening ‘vulnerable’ individuals with voluminous Participant
Information Sheets/invitation
I was just wondering if you could take it (information pack) out and talk them (participants) through,
rather than this big pack arriving. I’d be thinking ‘wow’ I thought I was just going out on a walk . . .
c. Anxiety over the patients’ feelings after researcher withdrawal
From our perspective they have participated in research . . . but they got nothing to say: thank you very
much. I think that kind of puts people off.
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d. Concern that participants would be dissatisfied when allocated to a
control group
I’m thinking about when putting someone forward, they’ve agreed to go forward with it, only for them
not to be put in the category where they actually get the intervention. I think this maybe holds people
[professionals] back from encouraging people [clients].
We have to tell the client what is it they get out of this . . . what if they go on the control group and
get nothing?
e. Low priority in individual clinical context
A lot of people just want practical advice and support . . . if someone is, let’s say, incontinent. What can I
do, what can I put in place? It’s the practical solution to a problem that they have. And even if we say that
we bring experience, knowledge and information that doesn’t really matter because there is something
that is going on at that time that needs to be sorted.
I don’t see it as likely that patients that will be offered some sort of treatment will ask: ‘why are you saying
this is the best treatment?’ and ask for a justification. Many of our patients would be grateful because
what they are looking for is an outcome, they are not interested how we get there. They just want
positive outcome.
f. Continuation of treatment: themselves to be trained to deliver the
EVIDEM-E intervention
I think it would be really useful if we could do it (exercise intervention) ourselves and have a go. With
proper training and under you observing it, I don’t see a reason why we couldn’t.
Would it be possible, not as part of the trial, simply a form of walking with somebody who has got some
sort of behavioural problems, and we can try it out after being trained by your exercise therapist.
g. Feedback provided face to face to participants
You need to talk to people. The feedback is very important, whether it (the study) has success or not.
At the end they (participants) should be given some feedback.
h. Provision of carer respite
There is a lot going on for carers at that particular time. And I think that whilst in their heart of hearts they
might want to be involved and participate, but if the services are not going in to enable them to have a
good night sleep, or maybe incontinence worry is a primary concern . . . A lot of times carers will actually
say: I want a break. I want someone to physically do it (walking) for me. I’ve been up all night, they’ve
been going to the toilet, they are restless, agitated, they ask repetitive questions. And it will be really nice
that while the therapist takes them out the carer can put their feet up for 10, 15, 20 minutes. That’s the
expectation of the carer, that someone will do that. That’ll be the motivation.
i. Tangible rewards
What’s in it for us?
BOX 3 Findings from the focus group on recruitment to the trial (continued)
EVIDEM-E
NIHR Journals Library www.journalslibrary.nihr.ac.uk
56
Understandably, recruitment was regarded as a low priority in consultations and all too easily ‘slipped off the
radar’ (see Box 3, quote e1). However, the group did suggest ways to enhance recruitment to EVIDEM-E (see
Box 3, quotes f–i). All three suggestions aimed to enhance the participants’ experience opposed to theirs as
recruiters, and the first suggestion involved increasing clinician workload.
Recruitment to the trial improved when alternative mechanisms were tried, including recruitment from a
registry of patients and carers held by North Thames DeNDRoN Dementia Register study (DemReg). Eight
participants were recruited to the trial in the first 6 weeks of working with the DemReg registry.
Description of the economic analysis subsample
Complete CSRIs were received from 74 dyads at baseline and 67 dyads at the 12-week follow-up. However,
depending on the outcome variable, the matching sample for the economic analysis varied from 49 to
52 dyads. Using multiple imputation techniques we were able to achieve a sample size of 52 dyads
(22 control; 30 intervention). Hereafter, our findings on service use, costs and cost-effectiveness are based
on the 52 dyads in this subsample, which is just less than half of the sample available for the main outcome
analysis (116 dyads).
Table 28 presents descriptive statistics for the economic analysis subsample. We tested if the economic
analysis subsample was significantly different from the original sample of 131 dyads by using the Wilcoxon
rank-sum test for continuous variables and the Fisher’s exact test (or Pearson’s chi-squared test when
appropriate) for binary variables. We found no significant differences between the ‘economic subsample’
and the full sample at 95% level of confidence, although a p-value of 0.07 was found for the difference in
MMSE score at baseline. Using the same method we compared the intervention and control groups, and,
again, did not find any significant baseline difference at 95%, with the smallest p-value (again equal to
0.07) being associated with the ‘primary education or less’ variable, implying that people included in the
final economic analyses sample were perhaps less likely to have a limited education.
Average intervention cost per dyad
Total intervention cost was calculated by multiplying unit cost per visit (£60) or unit cost per telephone call
(£10) by the number of contacts between the exercise professional and each dyad. Average intervention
cost per dyad was £284 (range £190–320).
Cost analyses
In Table 29 we present service utilisation rates by people within the study by treatment group and overall.
At baseline, there were no significant differences in use of services by treatment group. Overall, at
baseline, 12% of people with dementia made use of accommodation services, 58% hospital services and
71% community services. Most sample members (85%) reported use of unpaid care.
At 12 weeks’ follow-up, overall proportions remained fairly similar. However, the two treatment groups
seem to have separated in terms of use of hospital services: more than 70% of the control group reported
using hospital or similar services compared with only 47% of the intervention group, although this
difference is not significant (p= 0.09). For other service categories, as at baseline, the Fisher’s exact test
did not show any significant differences.
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Table 30 displays baseline and 12-month follow-up service use costs.
The summary statistics suggest that a sizeable proportion of total HSC service costs is related to use of
accommodation services, which, at baseline, resulted in a higher cost on average for the intervention
group, although the difference was not significant (tested using an adjusted regression model with 1000
bootstrap replications).93 Apart from accommodation, hospital and community services displayed the
highest aggregate costs. Total HSC costs appeared to be higher for the intervention group (£3205) than
the control group (£2655), although this difference was not significant. At baseline, the intervention group
was found to have higher costs, on average, than the control group, even when considering the provision
of unpaid care (£6500 vs. £7800), leading to an average societal cost of £9200 for the control group and
£11,000 for the intervention group.
At follow-up, accommodation costs were more similar between the two groups than at baseline, whereas
the average cost of hospital care appeared to be higher in the control group than the intervention group,
although the difference was not significant. Interestingly, for both groups there was reduction in HSC
service costs (£1984 vs. £1838), largely due to reduction in use of paid accommodation. The only adjusted
difference found to be significant (p= 0.04) relates to the use of medications, which was higher for the
intervention group.
Provision of unpaid care was greater, and hence more costly, in the intervention than the control group
(£8400 vs. £5800). This difference may not be surprising given the nature of the intervention. Total
societal cost, including intervention and provision of unpaid care, was £10,500 for the intervention group
compared with £7800 for the control group, although after adjustment for baseline covariates this
difference was not significant.
TABLE 29 Economic analyses subsample service utilisation patterns
Variable
Treatment group: no. and percentage using services Fisher’s exact test
Control Intervention Total p-value
Pre baseline (3 months)
Residential care/accommodation 2 9 4 13 6 12 1.00
Hospital services 14 64 16 53 30 58 0.57
Community services 14 64 23 77 37 71 0.36
Equipment and adaptations 12 55 20 67 32 62 0.40
Day services 8 36 13 43 21 40 0.78
Medications 22 100 29 97 51 98 1.00
Unpaid care 19 86 24 80 43 83 0.72
n 22 100 30 100 52 100
Follow-up (1–3 months)
Residential care/accommodation 1 5 3 10 4 8 0.63
Hospital services 16 73 14 47 30 58 0.09
Community services 12 55 21 70 33 63 0.38
Equipment and adaptations 12 55 14 47 26 50 0.78
Day services 10 45 12 40 22 42 0.78
Medications 22 100 29 97 51 98 1.00
Unpaid care 18 82 26 87 44 85 0.71
n 22 100 30 100 52 100
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Cost-effectiveness analysis
In Table 31 we report the incremental costs and incremental effects for the primary and
secondary outcomes.
Incremental cost-effectiveness ratios would typically be calculated by dividing incremental costs
by incremental benefits, but these have not been presented in Table 31 because neither incremental
costs nor incremental effects were significantly different between trial arms. From a HSC perspective,
we found that incremental costs were negative, that is, the intervention group had lower costs than the
control group (about £170 less) and incremental effects were positive, that is, the intervention group
achieved better outcomes. Although none of these differences were significant at the 95% level, for
illustrative purposes we note that, from a societal perspective, the ICER for the NPI outcome measure was
£421. Figures 8 and 9 show CEACs for the primary outcome measure (NPI) from a HSC and societal
perspective, respectively.
From a HSC perspective (see Figure 8) the CEAC suggests that, at a willingness to pay of £500 per
incremental improvement in outcome (i.e. per 1-point difference in NPI score), the exercise regimen is
cost-effective with probability of > 80%. From a societal perspective (see Figure 9), the ICER was £421 per
incremental difference in NPI score. If a reduction of at least eight points in the NPI score can be
considered clinically meaningful95 then this result suggests that the cost of achieving a meaningful
improvement is £3368.
Table 32 presents results for a sensitivity analysis that, in addition to baseline costs and baseline outcomes,
also controlled for participant age at baseline, gender, ethnicity, marital status, education level, whether
living in a care home, MMSE score at baseline, carer age and gender. This analysis gave results that are
consistent with the main analysis.
TABLE 31 Incremental costs and effects (controlling for baseline costs and outcome)
Perspective
Incremental cost (£, 2010–11):
mean, 95% bootstrap CI
Incremental effect: mean,
95% bootstrap CI
ICERMean Upper CI Lower CI Mean Upper CI Lower CI
HSC: 0–12 weeks
NPI –168.6 –1232.8 895.6 4.07 –4.65 12.79 Intervention dominant
ZBI –170.8 –1234.6 893.1 1.54 –1.78 4.86
DEMQOL-Proxy –165.6 –1251.7 920.6 2.87 –1.94 7.68
QALY (DEMQOL-Proxy) –169.7 –1240.0 900.5 0.0055 –0.0031 0.0140
GHQ –173.6 –1235.8 888.6 4.19 –0.55 8.93
Societal: 0–12 weeks
NPI 1686.4 –1407.1 4780.0 4.01 –4.72 12.73 421
ZBI 1641.1 –1497.8 4780.0 1.56 –1.75 4.86 1055
DEMQOL-Proxy 1635.9 –1520.9 4792.6 2.82 –1.97 7.61 580
QALY (DEMQOL-Proxy) 1565.8 –1592.6 4724.2 0.0055 –0.0031 0.0140 286,440
GHQ 1657.3 –1471.8 4786.4 4.23 –0.50 8.97 392
Note: Positive variations in the incremental effects represent improved outcomes. Minor differences in incremental effects
between perspectives are a consequence of the incremental cost-and-effect equations being jointly estimated with the
SUR method.92
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FIGURE 8 Cost-effectiveness acceptability curve: exercise regimen vs. usual care; HSC perspective, with effectiveness
measured on the NPI scale.
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FIGURE 9 Cost-effectiveness acceptability curve: exercise regimen vs. usual care; societal perspective, with
effectiveness measured on the NPI scale.
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Discussion
Summary of the main findings
The study comprised three inter-related components: a literature review; a RCT; and some qualitative
exploration of experiences of the conduct and participation in the trial. In the literature review we
described the limited, but promising, evidence to support the use of exercise as a therapy for BPSD.
The main shortcoming in the reported literature was the limitations of the research methods in the existing
evidence base, something we sought to address with our RCT. The findings from the literature review
were used to design a methodologically robust trial of an exercise programme for the purpose of
ameliorating BPSD. Our main finding was that the exercise programme did not produce a significant
clinical benefit for BPSD in this population. Importantly, however, we did find that caregiver burden was
significantly better at the end of the trial for those in receipt of the exercise programme. Finally, significant –
and unexpected – challenges of recruiting to the trial via clinicians were explored in a focus group.
Clinicians reported significant anxieties recruiting to our relatively ‘low-risk’ trial that were most readily
overcome through the use of a well-defined systematic recruitment and feasibility tool.
Towards a research agenda: from the literature to a randomised
controlled trial
Behaviours that challenge caregivers – particularly agitation, psychosis and sleep disturbance – are often
central to predicting institutionalisation, probably because of the reported negative impact for caregivers.96–98
Research that identifies optimal physical activity modalities, frequency, intensity and duration for persons with
different types and severity of dementia has been lacking and will be important to inform commissioners of
the value of exercise programmes in this population.
Appropriateness, safety and motivation to participate are critical to the success of exercise programmes,
and may be particularly complex for older adults with dementia. For example, adherence may be influenced
TABLE 32 Incremental costs and effects (controlling for sociodemographics, baseline costs and outcome)
Perspective
Incremental cost (£, 2010–11):
mean, 95% bootstrap CI
Incremental effect: mean,
95% bootstrap CI
ICERMean Upper CI Lower CI Mean Upper CI Lower CI
HSC: 0–12 weeks
NPI –159.6 –1267.8 948.5 2.46 –7.59 12.50 Intervention dominant
ZBI –155.9 –1254.7 942.9 0.56 –3.90 5.02
DEMQOL-Proxy –156.5 –1256.3 943.3 2.55 –3.32 8.41
QALY (DEMQOL-Proxy) –156.7 –1257.4 944.1 0.0066 –0.0026 0.0157
GHQ –155.5 –1250.6 939.5 4.00 –1.92 9.91
Societal: 0–12 weeks
NPI 1,018.8 –2331.0 4368.7 2.42 –7.54 12.39 421
ZBI 992.5 –2384.6 4369.6 0.58 –3.86 5.02 1,711
DEMQOL-Proxy 978.1 –2403.7 4359.9 2.46 –3.40 8.33 397
QALY (DEMQOL-Proxy) 954.0 –2444.5 4352.4 0.0065 –0.0025 0.0155 146,437
GHQ 1,004.8 –2349.2 4358.8 4.07 –1.79 9.93 247
Note: Positive variations in the incremental effects represent improved outcomes. Minor differences in incremental effects
between perspectives are a consequence of the incremental cost-and-effect equations being jointly estimated with the
SUR method.92
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by the nature of dementia itself. Particular symptoms, such as apathy, may have a proportionally greater
impact (relative to other BPSD) on adherence, which could be further impacted upon by context76 (e.g. paid
carers often view apathy differently to unpaid carers).
Exercise appears to be beneficial in reducing some BPSD, especially depressed mood and agitation, and
may also improve sleep and reduce ‘wandering’. However, research into the efficacy of exercise with the
therapeutic aim of improving other important symptoms, such as anxiety, apathy and repetitive behaviours,
was weak. Although some studies suggest that walking for at least 30 minutes, several times per week,
may enhance outcomes, the beneficial effect of exercise type, its duration and frequency are unclear.
Indeed, studies examining the effect of daily exercise had more favourable outcomes.
Results from the trial
Although overall BPSD were lower at week 12 in the group that received the exercise in comparison with
the TAU group, this difference was not statistically significant. This is not consistent with the meta-analysis
reported by Heyn et al.76 There are three possible explanations for this: first, exercise is not a clinically
effective therapy for BPSD; second, our exercise regimen has not had sufficient intensity to effect an
impact on the participants; or, third, the effect size is smaller than we anticipated.
Importantly, our secondary analyses revealed a significant benefit for carers by attenuating burden across
the trial duration. This is important as caregiver burden is strongly linked to use of health, social and
medical services by both the person with dementia and their caregiver.65–68 Given the absence of impact on
behavioural and psychological symptoms, it is unclear why caregivers from the TAU group reported having
a significant worsening of burden in comparison with those in receipt of the intervention. The increase
may have been due to worsening burden because of BPSD, differential physical burden between the
two groups (there was a slightly higher number of physical conditions in the TAU group at baseline) or
unhappiness among carers about not being randomised to the intervention. Conversely, participation in
exercise in the intervention group may have attenuated the perception of burden.
The economic evaluation looked at costs and cost-effectiveness. At 12 weeks, average costs from a
societal perspective for the group following the exercise regimen were non-significantly higher than for
the control group getting TAU. From a HSC system perspective, costs for the exercise group were
non-significantly lower.
When considering cost-effectiveness for each outcome measure there were no significantly different
incremental costs or incremental effects. The sensitivity analysis conducted (adjusting for baseline
sociodemographic variables) generated findings that were consistent with the main analyses.
Recruitment to clinical trials
Researchers aim to work to high professional standards of GCP and require all study participants to be
consenting volunteers, who are aware of their right of refusal without fear of detriment. When people lack
capacity, ethics committees require rigorous protocols to safeguard participants’ wishes and welfare.
We believe that all people, whether they have dementia or not, should have the right to participate in
research. We recognise that people take part for many reasons, including altruism and a sense of purpose.
Within a society that often patronises and demeans older people, many clinicians and researchers are
passionate advocates of enlarging patient choice. In our experience people who are not interested in
participating in research have a range of direct and indirect ways of showing this. Despite all of these
safeguards, clinicians appear apprehensive about recruiting even for relatively low-risk studies like
EVIDEM-E. Therefore, we support recent calls to quantify clinicians’ impact on recruitment and test ways of
improving accruals.99 We also agree more is needed to understand the experience of participating as a
‘control’. The response from the teams was positive, but actual recruitment was much slower than
anticipated. Six participants were recruited to the trial through memory clinics and community mental
health teams over a 6-month period from a patient population exceeding 2000 people with dementia.
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There are several ways in which researchers can incentivise clinicians’ involvement in research. The focus
group indicated their involvement should bring tangible reward for individual clinicians and participants.
It was not enough, in the group’s view, that NHS trusts financially gain through involvement with
research – how these resources enhance frontline clinical services should be made explicit. Encouraging a
sense of ownership is a well-established tool for engendering investment, and we attempted this by
including clinicians on our advisory groups. However, it is likely that a more widespread and involved
approach is needed to improve practitioner engagement. Consulting clinicians on dissemination strategies
might help them see the pathway from project to practice more clearly. Finally, developing flexible quick
guides to recruitment may instil confidence when discussing individual projects with patients.
The approaches suggested by the focus group would all maintain clinicians at the centre of the recruitment
process. An alternative could be direct contact between researchers and patients, which could potentially
resolve many recruitment challenges for clinician and researcher while improving patient choice. In
collaboration with the North Thames DeNDRoN, we helped to develop a registry of people with dementia
who were interested in research (‘DemReg’),100 which appears to be an efficient recruitment mechanism.
This registry is discussed in detail in Chapter 6 of this report.
Strengths of the trial design
The process of designing the study was challenging to the research team. It saw the project team –
supported by an independent steering group – attempt to strike a balance between achieving a feasible
and sustainable intervention that could be widely adopted in the target population while maintaining
scientific rigour in its evaluation.
Strengths of this study include the relatively large sample size, with low attrition rates; use of well-validated
outcome measures; a pragmatic exercise programme that does not require specialist training or
equipment; and efforts to control for the impact of therapist contact.
The trial design addressed other important factors: a more homogeneous sample in terms of diagnosis,
severity of disease and mobility; a sample size with sufficient power to detect an effect (positive or
negative) of clinically significant magnitude; and blinded and objective outcome ratings.
Limitations of the study
Careful consideration was given to blinding the researcher to the allocation status of the participants.
The single-blind design left study personnel vulnerable to unmasking group allocation during data
collection with participants. To mitigate this impact we decided to include a second, independent,
researcher who collected our primary outcome data (NPI) at 6 and 12 weeks. However, a risk remained
that the dyad would divulge information about the group to which they have been allocated. The efficacy
of maintenance of blinding was assessed at each time point, by personnel collecting data who recorded
the arm to which they believed each dyad was randomised.
Separating the effect of psychosocial contact (from the exercise therapist) from the exercise intervention
has proved to be the biggest challenge in our study. We addressed this problem by introducing two
periods during the intervention: 1–6 weeks, whereby the participants in the intervention group were
trained and supported by an exercise therapist, and 6–12 weeks, when participants were encouraged to
continue exercising but had no contact with the therapist. Although we tried to control for contacts
between participants and the exercise therapist, we could not control for the social contact between the
person with dementia and their carer. Dyadic walking may have encouraged not only physical activity, but
also psychosocial support from the carer as well.
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We used outcome measures that are well validated and widely used in research with individuals with
dementia. We also gave considerable thought to the issue of measuring physical activity. Particular
consideration was given to the use of equipment by the participants to record their individual activities,
for example GPS (Global Positioning System) receivers and pedometers. However, we decided not to use such
instruments in order to avoid excessive intrusion, and to prevent the instruments affecting exercise behaviour
in their own right. Similarly, participants’ levels of physical activity was evaluated through measurements of
the participants’ self-reported RPE. The intervention delivered by the therapist centred on monitoring and
increasing activity intensity utilising the RPE, and so could be provided only to the exercise group.
Assessing physical activity with minimum intrusion to study participants is challenging and we relied on
participants’ self-reports through daily dairies. Self-report is prone to information bias, especially when
participants are not blinded to their group allocation.
The economic evaluation adopted a HSC perspective for some analyses and a societal perspective for
others to ensure that unpaid carer inputs were not overlooked. A range of outcome measures was
examined, including QALYs generated from a dementia-specific measure. A limitation of the economic
analyses was the sample size, which was 50% lower than the sample for the main outcomes analysis
because service-use data were not collected. This loss of statistical power limits the conclusions that can be
drawn. Another possible limitation is that only 85% of study participants provided information about
support received from unpaid carers, yet we know that all sample members had a carer. It is difficult to
estimate accurately the amount of time an unpaid carer spends with someone with dementia.
Conclusions
There are two key implications that we can draw from this study. First, recruitment of people with
dementia via clinical sources is resource intensive and research registers can significantly increase the
efficiency of this process. This is critical to ensure that large clinical trials are feasible. Second, regular
walking is not effective at reducing BPSD but does seem to attenuate rising caregiver burden. We cannot
be sure whether this was because of the exercise per se, increased psychosocial effect between carer and
person with dementia or a placebo effect. Neither incremental costs nor incremental effects (for any
outcome measure considered) were significantly different between the intervention and control groups,
which suggests that the exercise regimen is unlikely to be cost-effective. Further research should seek to
confirm our findings and clarify the active component.
Building research capacity
The exercise therapist (James Lee) used data from this study towards his undergraduate degree; he
received the Bob Finney Memorial prize for this work and graduated with first-class honours. The RW
(Arlinda Cerga-Pashoja) has registered for a Doctor of Philosophy (PhD) and passed her MPhil–PhD viva in
2011. In addition, David Lowery worked in a postdoctoral capacity and contributed to an expert therapy
development group of another National Institute for Health Research (NIHR)-funded research programme
(WHELD) on behalf of the EVIDEM group. The study team members have also contributed in delivering
educational programmes to the CNWL staff through summer schools.
Voluntary RWs have given an invaluable input in the EVIDEM-E study. Nine volunteers helped with data
entering, designing databases and collecting outcomes. They gained research experience and had the
opportunity to be trained in GCP.
Changes to protocol
No changes from the original protocol were made.
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Chapter 3 EVIDEM-C: promoting continence and
managing incontinence with people with dementia
living at home
Abstract
People with dementia experience persistent problems with toileting and incontinence, which are difficult to
manage, problematic for carers and one factor in the decision to move to a care home. There is little
clinical guidance for primary care professionals tailored to this population. This series of studies, shaped by
MRC framework101 for the development of complex interventions, investigated (1) the incidence of the
problems for people with dementia living in their own homes; (2) the published evidence for management;
(3) the experience; and (4) the strategies and issues faced by people with dementia, their carers and the
professionals trying to support them, as well as the feasibility of testing different designs of continence
pads and tools to aid primary care nurses in tailoring their advice, management and support.
The study has added new evidence about the incidence, experience and management of toileting
difficulties (TDs) and incontinence for this population. The reasons for the toileting and incontinence
problems are multifactorial, and a mosaic of strategies is required to both reveal the problems and manage
them in ways that are acceptable to the person with dementia and family members. This study suggests
that there are strategies and responses that primary care professionals and others can utilise to encourage
greater openness, thereby lessening the taboo of incontinence within the stigma of dementia. It remains
to be seen if these approaches, combined with more emphasis of effective containment of excreta, will
influence decisions about relocation of people with dementia to care homes.
Introduction
Dementia is one of the most disabling, distressing and burdensome diseases. Supporting people with
dementia and their family carers to live in their own homes is a major HSC policy objective in the UK102,103
and in other countries.104–106 There are many dimensions to the problems faced by people with dementia
and their family carers as the dementia progresses.107,108 Many are well understood and the strategies
required from HSC services are recognised.102,103 However, toileting problems and incontinence in people
with dementia are problems which are poorly understood and for which there is little guidance for HSC
professionals working in community settings.
Background: the overall need for the EVIDEM-C study
Family carers have reported incontinence as the most problematic symptom to manage.109 Incontinence
contributes significantly to both family and carer burden associated with supporting a person with
dementia,110 and also to the decision to seek residence in a group or care home.111
Dementia is a clinical syndrome with a trajectory of progressive loss in cognition and abilities in
undertaking ADL, including personal toileting and physical functioning.112 BPSD113 can manifest as
inappropriate voiding and toileting behaviours.114 Extrinsic factors, such as attitudes of ‘therapeutic
nihilism’ (i.e. attitudes of nothing can be done to help) by professionals and unadapted environments
compound these impairments.115
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The high prevalence of incontinence in people with dementia who are resident in care homes is well
documented,116 as are the research and guidance for managing the problems for people living in these
settings.117 However, international estimates suggest over two-thirds of all people with dementia live in
their own homes.118,119 In reviewing clinical and social care guidance for best practice in managing toileting
and incontinence problems in people with dementia living at home, and supporting their family carers,
it became evident that there was a significant knowledge deficit.
There are internationally agreed definitions of types of urinary incontinence (UI) and faecal incontinence
(FI).120 ‘Functional incontinence’ is a term sometimes used when factors outside the lower urinary tract (such
as environmental features or cognitive impairment) result in incontinence. Although internationally agreed
algorithms for assessment and treatment of UI and FI inform national clinical guidance, the guidance on
incontinence management either pointed to the evidence gaps for frail older people121 or excluded people
with cognitive impairment.122 Available guidance on primary care management of dementia did not refer to
incontinence management.123 The NICE and SCIE guidelines on supporting people with dementia and their
carers did not review evidence on incontinence management, offering the view that combined interventions
are more likely to support and maintain independence in the person with dementia.124
Against this background EVIDEM-C (2007–12) investigated the promotion of continence and management of
UI and FI in people with dementia living in their own homes. The specific research questions it addressed were:
1. What is the prevalence of different types of incontinence problems experienced by people with
dementia, living at home?
2. What is the evidence for different strategies and interventions in managing incontinence in people with
dementia living at home?
3. What are the perceived factors that support or detract from the use of different strategies and
interventions from the perspective of informal carers, people with dementia, generalist and specialist
health-care staff, social workers and social care?
4. What are the experiences, strategies, impact and cost consequences of managing incontinence
problems in people with dementia living at home, and how do they change over time?
5. What are the feasibility and acceptability of developing specific interventions to promote continence
and manage incontinence with people with dementia and their carers at home?
In addition, the study aimed to develop educational materials for those working in community and primary
care settings to assist in the promotion of continence and management of incontinence in people with
dementia living at home.
The research approach and design
The research approach was one of critical realism125 which allows an integration of both subjective and
objective research approaches. In taking this approach, the multifaceted nature of the issues and problems in
promoting continence and managing incontinence in the home, as well as the perspectives of multiple and
diverse stakeholders, was examined in the light of the evidence of effectiveness. This research approach
allowed the study to acknowledge the complexity of the issues. The EVIDEM-C study drew on the MRC
Framework101 for developing complex interventions in stepwise phases. The study had four interlinked phases:
1. Reviewing the evidence about prevalence and effective interventions (see Phase 1: reviewing the
evidence for incidence, prevalence and effective strategies, below)
2. Exploring the experiences and strategies used by people with dementia and their carers to manage
incontinence, and the impact and consequences of that incontinence (see Phase 2: exploring the
experience, strategies, impact and consequences, below)
3. Testing the feasibility of an identified intervention (see Phase 3: investigating the feasibility,
effectiveness and acceptability of an identified strategy, below)
4. Developing educational resources (see Phase 4: developing and testing resources for practice, below).
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The overall protocol can be found in Appendices 17–23 and research instruments and tools are provided in
Appendices 26–34. The study was supported by an advisory group, which brought different types of
expertise (carers, professionals – primary care, dementia specialists and continence specialists) to inform
and help shape the study. It was chaired by a former carer of a person with dementia. Patient and public
involvement representatives were present at every meeting, and performed co-production roles in shaping
the research activities, such as agreeing the intervention to be tested in Phase 3, reviewing research
materials, such as interview topic guides, and assisting in recruitment of participants.
Phase 1: reviewing the evidence for incidence, prevalence and
effective strategies
In this phase, three reviews were undertaken and a nested study of a secondary data analysis of a primary
care database was carried out to establish the prevalence and incidence of incontinence in people with
dementia. Each is presented below.
A systematic review of the evidence about prevalence
Although the presence of incontinence symptoms is well documented in people resident in care homes,116
there is currently little evidence available for clinicians, commissioners and service planners concerning the
scale of the problems in the larger population of people with dementia living at home.
Methods
Aims and objectives
To identify the prevalence of UI and FI experienced by people with dementia, living at home.
Study design: a systematic literature review
Search procedure
We searched the following electronic databases: MEDLINE, EMBASE, Cumulative Index to Nursing and
Allied Health Literature (CINAHL), PsycINFO, British Nursing Index (BNI) and The Cochrane Library [including
Database of Abstracts of Reviews of Effects (DARE) and National Technical Information Service (NTIS)],
from 1 January 1990 to 1 September 2008, and then searches were updated to 2012 week 13 (4 April).
In addition, ‘lateral searching’ techniques124 were used for key authors and cited references. Search terms
are given in Table 33.
TABLE 33 Search terms for studies of prevalence
Area Search terms (Medical Subject Headings and keywords)
Population characteristics exp Fecal Incontinence/or exp Urinary Incontinence/
exp Delirium, Dementia, Amnestic, Cognitive Disorders/or exp Dementia/
dementia.mp.
exp Aged
Setting Community dwelling.mp
Community.mp
Research field of enquiry Exp prevalence
Prevalence.mp.
Exp Needs assessment
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Screening as per the inclusion and exclusion criteria (Table 34) and data extraction were undertaken by
two researchers. Judgements of risk of bias in the studies127 used criteria recommended for prevalence
studies.128 A narrative analysis was undertaken because of the heterogeneity in the included studies.
Results
The PRISMA33 flow diagram in Figure 10 reports the results of the search. From 427 references, eight
studies129–136 met the inclusion criteria and are summarised in Table 35. No studies reported incidence.
Seven studies provided prevalence rates as findings that were incidental to their primary question.
Study populations, size of sample and assessment tools were varied, including the Care Needs Assessment
Pack for Dementia (CareNap-D),138 Cognitive Performance Score (CPS),139 the ICD-10,80 the UK Office
of Population Censuses and Surveys (OPCS) Disability Survey 1985140 and the MMSE.52 Assessment of
risk of bias found that all studies had some aspect that was judged to be a risk; this has been reported
in full elsewhere.137 The reported prevalence rates are presented in Table 36. The prevalence of UI
ranged from 1.1% in a general community population to 38% in those receiving home care services.
n = 638 duplicates removed
n = 427 records screened
n = 26 full-text papers
assessed for eligibility
n = 18 excluded
n = 12 data on care home residents or missed data for care home- and
home-dwelling population
n = 6 data on community-dwelling population with incontinence not
reported separately for those with cognitive impairment or dementia to
those without cognitive impairment dementia 
n = 8 papers included
n = 466 records identified through database searching until 2008 and n = 384 until 4 April 2012
n = 20 records identified through other sources 2008 
n = 401 records did not satisfy inclusion criteria 
FIGURE 10 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of search results for
prevalence studies.
TABLE 34 Inclusion criteria for prevalence studies
Criteria
Inclusion Community-based observational studies
Data on UI and/or FI in people with cognitive impairment or dementia
Resident in their own homes
English language
Exclusion Studies not reporting empirical data of UI and/or FI
Settings of hospital, nursing homes, cares homes, group homes
Excluded people with dementia or cognitive impairment
Data from the population of interest not identifiable in the results
Published in languages other than English
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TABLE 35 Studies with prevalence data (adapted from Drennan et al.137)
Study author,
year, location Population
No. with cognitive impairment
or dementia and method of
assessment
Method of assessment of
UI and FI
Chung,129 2006,
Hong Kong
Convenience sample recruited from
the Alzheimer’s Disease
Association, memory clinics and
outpatient clinics
n= 197
Mean age 77 years; 64% female
197 with a confirmed diagnosis
of dementia or Alzheimer’s
disease
UI/FI determined by self and
carer report to researcher
using an amended
CareNap-D138
Landi et al.,130
2003, Italy
Patients enrolled in home
health-care programmes and Silver
Network Home Care Project
n= 5372
Mean age 78.6 (SD 9.5) years;
59% female
In text, number not given but
states 30% with moderate to
severe cognitive impairment,
determined by CPS139 (CPS > 2)
UI determined by a single
self-report question with
five-point scale as part of the
enrolment assessment to the
home care service completed
by a health professional
(GP, geriatrician, nurses)
Meaney et al.,131
2005, Ireland
Patients, consecutively referred,
attending an old age psychiatry
outpatient clinic, meeting
ICD-10 criteria and living in
the community
n= 82
Mean age 76 (SD 7.8) years;
55= female, 27=male
82 with ICD-1080 diagnosis
of dementia
UI/FI determined by self and
carer report to project nurse
using (CareNap-D)138
Mohide et al.,132
1988, Canada
Patients receiving home care
services aged > 16 years
n= 2801
Mean age not given; number by
sex not given
Number not given
Method of determining cognitive
disabilities not given
UI determined by study
developed continence
assessment form completed
by health professional
(unspecified)
Nakanishi et al.,133
1997, Japan
A randomly selected (unspecified)
sample of community residing
people aged > 65 years from a
computerised sex–age register in
one city
n= 1405
Mean age not given; number by
sex not given
Number not given
Dementia determined by
intellectual functioning
subscale of OPCS Disability
Survey 1985140
UI and FI determined by
self-report using OPCS
Disability Survey 1985140
to welfare commissioners
Ouslander et al.,134
1990, USA
Community-residing patients with a
dementia diagnosis attending a
community facility whose family
carers volunteered for ‘help
with stress and burden’
n= 184
Mean age: incontinent 76.28
(SD 8.10) years; continent 75.84
(SD 7.73) years
Number by sex not given
A total of 184 with a clinical
diagnosis of dementia
UI determined by report
of carer to unspecified
researcher
Part of study developed
memory and behaviour
checklist
continued
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
73
TABLE 35 Studies with prevalence data (adapted from Drennan et al.137) (continued )
Study author,
year, location Population
No. with cognitive impairment
or dementia and method of
assessment
Method of assessment of
UI and FI
Rait et al.,135
2005, UK
General practice registered patients,
aged >75 years, approached as
part of a RCT of the methods of
assessment of older people;
computer randomised to universal or
targeted arm
n=15,051 (subjects in universal
arm) of whom 14,621 completed
MMSE52
47% aged 75–79 years,
61.5% female
n= 2682 with cognitive
impairment determined by
MMSE52 < 23/24
UI once a week or more
often single question by
self-report to research nurse
Teri et al.,136
1989, USA
Patients with diagnosis of an
Alzheimer’s disease-type dementia
attending a geriatric clinic selected
(from case notes) as meeting criteria
of diagnosis (aged between 55 and
85 years and community residing)
for the study
n=56
Mean age 71 (range 55–85) years
43% female, 57% male
56 with a clinical diagnosis of
Alzheimer’s disease-type
dementia
UI and FI determined by
report by caregivers to
trained interviewer; no tool
specified
CPS, Cognitive Performance Score; OPCS, Office of Population Censuses and Surveys.
TABLE 36 Reported prevalence rates of UI and FI (adapted from Drennan et al.137)
Study
Reported UI and FI rates
UI
FIUnspecified frequency ≥ 1 per day ≥ 1 per week Night only
Chung 2006129 – – – 21% of 197 18% of 197
Landi et al. 2003130 38% of 5372
Relative risk of UI in those
with a CPS 2–4 compared
with CPS 0–1: 2.03
(95% CI 1.88 to 2.18), and
in those with a CPS > 4
compared with CPS 0–1:
2.97 (95% CI 2.78 to 3.18)
–
–
–
–
–
–
–
–
Meaney et al. 2005131 34% of 82 – – 34% of 82 27% of 82
Mohide et al. 1988132 10% of 2801 – – – –
Nakanishi et al. 1997133 1.1% of 1405 – – – 0.9% of 1405
Ouslander et al. 1990134 – 24% of 184 11% of 184 – –
Rait et al. 2005135 –
–
–
–
8.8% of 2465
Relative risk of UI in
people with MMSE
score <24 compared
with MMSE score
≥24: 2.03 (95% CI
1.73 to 2.36)
–
–
–
–
Teri et al. 1989136 – – 11% of 56 – 7% of 56
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Prevalence of FI ranged from 0.9% in a community population to 27% in a sample attending an old age
psychiatry outpatient clinic.
Discussion
This review found no studies reporting incidence and a wide variation in reported prevalence rates of UI
and/or FI in people with dementia living in their own homes. This is explained, in part, by the variety of
populations and assessment tools, and the lack of uniformity in criteria for defining incontinence and
dementia. These methodological challenges in assessing prevalence rates have been well documented for
both incontinence116 and dementia,141 including the issues of underreporting through embarrassment
and stigma. Consequently, nearly all of the studies may have underestimated prevalence. The rates were
incidental findings in nearly all studies and the one study designed to address the prevalence question of
interest had a small population, identified through carers who identified themselves as experiencing high
levels of stress.134
To our knowledge, this is the first review addressing this question of prevalence. The greatest weakness of
the study is the search strategy, which may have overlooked other studies with incidental prevalence
findings in studies, and the exclusion of studies not reported in the English language. The study is reported
in more detail elsewhere.137
Conclusion
There is currently no definitive evidence of incidence or prevalence of UI or FI in people with dementia
living at home, and further research is required to establish population-level data.
A cohort study of the incidence and management of
incontinence in primary care
The absence of robust data on prevalence or incidence of incontinence in people with dementia living in
the community led the research team to undertake a nested study investigating these questions and
management strategies in primary care.
Methods
Aims and objectives
To investigate the incidence of UI and FI in community-dwelling people aged 60–89 years with dementia,
and management strategies in primary care.
Study design
A cohort study of patient data from The Health Improvement Network (THIN), a UK general practice
patient database.142
Procedures
We compared two cohorts: all adults with dementia aged 60–89 years with at least 6 months’ data
from 1 January 2001 to 31 December 2010, and a stratified (by age and gender) random sample
of four times as many adults without dementia. IRRs, adjusted for potential confounders (age, gender
and comorbidity), were calculated using multilevel Poisson regression.
Ethical arrangements
The NHS South-East Multicentre REC approved the scheme for THIN to obtain and provide anonymous
patient data to researchers, and scientific approval for this study was obtained from the THIN Scientific
Review Committee142 in October 2011.
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
75
Results
There were 1,246,963 eligible participants from 487 general practices, of whom 54,816 entered the
dementia cohort and 205,795 were selected for the non-dementia cohort. During the 10-year follow-up,
incontinence (urinary, faecal and double) was newly recorded for 8987 (16%) people with dementia and
23,083 (11%) without dementia. Table 37 reports the incidence of UI and FI per 1000 person-years at risk
(PYAR) in men and women with and without dementia. The IRRs, adjusted for age, sex and comorbidity,
for UI were 3.2 (95% CI 2.7 to 3.7) in men and 2.7 (2.3 to 3.2) in women. The IRRs for FI were 6.0
(95% CI 5.1 to 7.0) in men and 4.5 (3.8 to 5.2) in women.
Fifteen and 18% of people with and without dementia respectively were prescribed medication for UI.
Crude and adjusted IRRs are shown in Table 38.
The incidence of catheterisation could be analysed in 47,066 people with UI over 163,735 PYAR. The IRRs
comparing people with dementia to those without are given in Table 38. The results in full are
presented elsewhere.143
Discussion
Dementia is associated with at least a doubling in the incidence rate of incontinence (any type) in
community-dwelling primary care patients. To our knowledge this is the first report of incidence of
incontinence from the clinical records of community-dwelling people with dementia.
Patients aged 60–89 years with UI and dementia received drug treatments at more than twice the rate of
patients without dementia but of the same sex, age and comorbidity. This difference was attenuated with
age but remained evident. There is some evidence to suggest that, in general, older adults may not receive
optimum treatment for UI.144,145 Indwelling urinary catheters were recorded at more than double the rate
in women with dementia, compared with those without dementia of the same age and comorbidity.
The difference was attenuated with comorbidities but not age. Indwelling catheters are associated with
discomfort and risk of infection among other problems.146,147 The clinical reasoning for the greater use of
drug treatment and indwelling catheters in this population needs investigation.
TABLE 38 Comparison of unadjusted and adjusted IRRs and 95% CIs of drug treatment and catheterisation for
people with dementia to those without (adapted from Grant et al.143)
Incidence of action Crude IRR (95% CI)
IRR adjusted for sex, age and
comorbidity (95% CI)
Incidence of drug treatment for UI
Both sexes 1.3 (1.2 to 1.4) 2.2 (1.4 to 3.7)
Incidence of long-term catheterisation
Men 1.3 (1.2 to 1.4) 1.6 (1.3 to 1.9)
Women 1.9 (1.8 to 2.1) 2.3 (1.9 to 2.8)
TABLE 37 Incidence of UI and FI in people with and without dementia (adapted from Grant et al.143)
Type of
incontinence
Men Women
Without dementia:
rate per 1000 PYAR
(95% CI)
With dementia:
rate per 1000 PYAR
(95% CI)
Without dementia:
rate per 1000 PYAR
(95% CI)
With dementia:
rate per 1000 PYAR
(95% CI)
Urinary 19.8 (19.4 to 20.3) 42.3 (40.9 to 43.8) 18.6 (18.2 to 18.9) 33.5 (32.6 to 34.5)
Faecal 3.1 (2.9 to 3.3) 11.1 (10.4 to 11.9) 3.6 (3.5 to 3.8) 10.1(9.96 to 10.6)
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The study has a number of limitations. The data are from primary care clinical records, kept for that
purpose rather than the questions of this study. The different general practices do not record uniformly all
types of information regarding the patient, for example, treatment or non-pharmaceutical supplies from
other health-care services. Despite this the data provide insights not offered elsewhere.
Conclusions
This large cohort study establishes the incidence of incontinence among people with dementia living in the
community. The incidence of incontinence is more than double – and for some age groups treble – for
people with dementia compared with people without dementia of the same age, gender and comorbidity.
The clinical reasoning in the primary care management of UI in people with dementia requires
further investigation.
A systematic review of interventions and strategies
Urinary and faecal symptoms from underlying pathology in the genitourinary system have established
pharmacological and/or surgical treatments.120 Conservative interventions (i.e. non-pharmacological and
non-surgical86 are also important. Incontinence problems in people with dementia are multifactorial116 and
many aspects require conservative management. This review addressed the question: what is the evidence
for effectiveness of conservative interventions for the prevention or management of incontinence in
community-dwelling people with dementia or cognitive impairment?
Methods
Aims and objectives
To identify and assess the empirical evidence for the effectiveness of conservative interventions for
the prevention or management of incontinence in community-dwelling people with dementia or
cognitive impairment.
Study design
A systematic literature review.
Search procedure
We searched electronic databases: MEDLINE, EMBASE, CINAHL, PsycINFO, BNI, Care.data and The
Cochrane Library [including DARE, NTIS and System for Information on Grey Literature in Europe (SIGLE)],
Social Science Citation Index (SSCI), AgeInfo, National Research Register (NRR), PapersFirst (conference
presentations), and the specialised register of the Cochrane Effective Practice and Organisation of Care
(EPOC) Group, Dissertation Abstracts, DH and similar websites. The databases were searched from their
start date to 2012 week 13 (4 April). In addition ‘lateral searching’ techniques126 were used for key authors
and cited references. Search terms were used in combination (Box 4). Abstracts were screened by
two researchers for inclusion. For ambiguous abstracts the full text was retrieved and read. Data were
extracted against predefined categories by one researcher and confirmed by a second.
Inclusion and exclusion criteria
Inclusion Interventional studies addressing problems of incontinence (UI and/or FI) experienced in
people with dementia or cognitive problems in the setting of the person’s home, and reporting in the
English language.
Exclusion Papers not reporting empirical, observational data of interventions or strategies addressed at
problems of incontinence; settings of hospital, nursing homes, care homes or group residential homes or
populations; papers excluding people with cognitive impairment or dementia or where they were included
but not identifiable in the results; papers not published in the English language.
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BOX 4 Search terms for conservative intervention studies
FI or UI.
Delirium, dementia, amnestic, cognitive disorders or dementia.
Aged.
Elderly.
Caregivers.
Caregiver burden.
Spouses.
Family.
Significant other.
Home care services.
Housebound patients.
Community living.
Community dwelling.
Home nursing.
Ambulatory care.
Ambulatory care nursing.
Self care.
Home nursing, professional.
Home health care.
Home health agencies.
Homemaker services.
Community health services.
Social support.
Volunteer workers.
Toilet facilities.
Occupational therapy.
ADL.
ADL or adl.
Toilet.
Toilet training.
Attitude to health.
Adaptation, psychological.
Behaviour therapy.
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Results
The search results are presented in the PRISMA flow diagram (Figure 11) and three papers148–150 met
the inclusion criteria. Each study was assessed for risk of bias.127 Because of the heterogeneity of the
interventions and outcomes it was not appropriate to undertake a meta-analysis, and a narrative summary
of findings is presented. The characteristics of the three studies are presented in Table 39.
Two studies were described as exploratory and pilot studies, recruiting fewer than 20 dyads.148,150 All had a
control group, although one reported no data on these people.148 All had risk of bias to the internal
validity, presented previously in detail.150 The interventions were advice and education aimed at the family
carer, for them to act upon. Two included education for toileting: prompted voiding (PV)148 and an
individualised toileting schedule,150 together with other aspects of continence education. The interventions
involved between weekly149 and monthly150 contact with the health professional for the duration of the
study. Toileting schedule advice was the least acceptable to carers in the occupational therapist (OT)
intervention study.148 The study of individualised scheduled toileting presented statistics indicating a
significant reduction in UI in the intervention arm149 but on our re-analysis of the data provided this was
not confirmed.151 Using the intention-to-treat method the PV study found no statistical differences
between groups on any UI outcome but noted there were clinically significant reductions in episodes of UI
for some patients.150 The results in full detail have been published previously.148
n = 1201 records identified
n = 427 records screened 
n = 774 duplicates removed
n = 371 records excluded as either
referred to care home residents
or were not empirical studies
n = 56 full-text papers assessed 
n = 53 excluded as either not
empirical studies, participants were
care home residents or data for
community-dwelling people with
dementia not reported separately
n = 3 papers included  
FIGURE 11 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of the results of
search for conservative intervention studies.
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Discussion
Only three studies146–148 of conservative interventions were found, dating from over a decade ago. Two
were described as exploratory and pilot studies and all had some risk of bias to internal validity. None
provided evidence of effectiveness of the interventions. All three provided evidence as to the difficulties in
recruiting to such studies. All three provided evidence as to issues in acceptability and feasibility for some
carers in agreeing with and implementing the professional advice or instruction.
The review has limitations in that while the search was designed to be comprehensive, criteria such as
English language only may have resulted in the omission of some studies. However, to our knowledge
this is the first systematic review addressing the question of evidence of effective interventions for this
population group. Previous reviews have not differentiated between evidence from community-dwelling or
within-an-institution populations although much of the evidence relates to those within care homes,152,153
or has not drawn on a systematic approach.154 This lack of attention to the very different environments
(both physically and in availability of people to help) of an individual’s home from a care home is apparent
in many clinical guidelines.155,156
Conclusions
There is little evidence of effective interventions for managing incontinence in people with dementia living
at home. There is an urgent need for both research and clinical guidance for health professionals tailored
to the setting in which the majority of people with dementia live.
A review of English community health services continence
policies and clinical guidance
Local clinical guidelines for incontinence, produced by specialist continence services, are an important source
of evidence to guide clinical practice for primary care professionals, particularly community nurses. A major
part of district nurses’ and community nurses’ work is in supporting older people with incontinence
problems who live at home.157 Specialist continence services include nurses who work closely with a lead
medical consultant, and across primary care, acute care and in care homes, although there is wide variation
in provision.158 In the absence of nationally available clinical guidelines, as described in the introduction to
this chapter, this review sought to understand the extent to which local guidelines had been tailored to
address the needs of people with dementia or cognitive impairment. The advisory group considered this
an important review in light of the findings of the early parts of Phase 2 (see Exploring the experience,
strategies, impact and consequences, below).
Methods
Aims
To investigate if the clinical guidance for incontinence management provided by specialist continence
services in England addresses the problems and issues experienced by people with dementia living at home
and their carers.
Study design
A review by documentary analysis159 of clinical policies and guidance from a sample of at least 25% of
specialist continence services covering 152 PCT areas and distributed across the 10 Strategic Health
Authority regions of England. Documents were obtained through internet searches on public domain
NHS websites and requests to specialist continence nurses identified through a national directory.160
The framework for analysis was designed in conjunction with the advisory group.
Ethical arrangements
The NHS Research Ethics Service (NRES) advised that this was a service evaluation not requiring NHS ethics
committee review. The study followed university research ethics requirements.
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Results
Ninety-eight documents from 38 local community health service specialist continence services, located
across all 10 strategic health authority areas, were obtained and analysed.
Of the 38 local services, 19 (50%) made no mention of dementia or cognitive impairment in their
documents. Only in the documents of three services were nurses offered detailed guidance about the
management of incontinence for people with dementia at home. The remaining 16 organisations provided
guidance that mentioned dementia or cognitive impairment in assessment processes, but there was very
little evidence of any subsequent advice or mechanism for producing specifically tailored care plans, such
as a dementia care pathway. Only one organisation specified that the service user should be given any
information about the consultation, and that was a copy of the referral form for incontinence pads with
delivery information on it.
Ten (26%) of the 38 local organisations referred to a leaflet entitled Continence in the Confused Elderly
(anonymous) to be given to family carers. The carers in the advisory group reviewed this leaflet and
concluded that it had deficiencies in content, information, tone and style. People with dementia were
identified as a special case in the documentation of only one service, which warranted the provision of
additional continence products. Only one service made reference to addressing the problems of delivery
of NHS continence pads to people with dementia living alone at home.
Discussion
Fifty per cent of sampled organisations had clinical guidance on incontinence which made no mention of
dementia. A small minority provided examples of good practice. These good practice examples focused on
person-centred assessment and responsiveness to the described problems, an approach advocated for
some time in the care of people with dementia generally,115 and by gerontological nurses and dementia
specialists.161 A more detailed discussion of the results has been published previously.162
To our knowledge, this is the first study exploring the local guidance to primary care professionals in
meeting the continence needs of people with dementia living at home. The study has limitations in that
the representativeness of the documents is unknown, although the geographical spread, method of
requesting from specialist nurses and internet searches would suggest that the variety has been captured.
Conclusion
Local clinical guidance on incontinence management rarely addresses the specific needs of people
with dementia living at home or their carers. There is much room for improvement and providing
evidence-based guidance to frontline staff on the specific problems of people with dementia and their
carers. This review led the advisory group to prioritise for Phase 4: the development and testing of
dementia specific continence assessment tools and guidance for the use of primary care nurses working
with people with dementia living in their own home. The review also pointed to the importance of the
involvement of carers of people with dementia in continence service developments.
Phase 2: exploring the experience, strategies, impact
and consequences
In Phase 2, interlinked primarily qualitative studies were undertaken. All four studies were informed by the
background and rationale described in the introductory section of this chapter, and these will not be
repeated in each of the following sections. For each study therefore the details of the methods, results,
discussion and conclusion only are given here.
The views of people with dementia
We could find no accounts from the perspective of the person with dementia on issues of incontinence. The
purpose of this study was to investigate the PWD’s perceptions of managing problems of incontinence.
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Methods
The study approach was in the interpretative tradition163 and the design was of qualitative guided
conversations, a recommended research technique for use with people with dementia.164 A purposive
sample of people with dementia was recruited through primary care, specialist community mental health
services and voluntary organisations. Conversations were taperecorded with permission, transcribed and
thematically analysed,165 using NVivo™ version 8, 2008 software package (QSR International, Warrington,
UK: www.qsrinternational.com/default.aspx).
Ethics
The ethical issues we considered were capacity to consent, within the guidance of the MCA;17 assessment
of continuing consent during the conversation and non-verbal signs of wishing to finish; and preparing
researchers to manage distress and act on information that might suggest that a vulnerable adult was
being neglected or harmed. A favourable opinion was given by Camden and Islington NHS local REC
(08/H0722/60 2008) (see Appendix 24).
Results
It took a period of 1 year to recruit seven people with mild to moderate dementia and UI problems.
They described a range of problems from urgency (which they could not respond to in time) to nocturnal
enuresis. All described feelings of shame and humiliation as in this example:
There’s always the fear and sometimes I don’t get there in time and I find myself with wet pyjamas
and it’s personally very embarrassing.
Man with dementia 04
Strategies included planning activities outside the house only when they knew they could access toilets,
accepting help from their spouse (although this sometimes caused tension) and using a variety of absorbent
materials for containment, for example towels. Descriptions of the use of incontinence pads included
problems of fit and acceptability, as in this example.
I’m so small you know, and I’ve been cutting them [incontinence pads] and the whole flat is covered
in bits of, what do you call it, small pieces, fluff, every day fluff . . . they’re so big, I’ve got to cut them.
Woman with dementia 01
Strategies also included using euphemisms in describing the problems, using humour to overcome
embarrassment and trying to protect family members from spillage by clearing up or dealing with urine or
wet clothes themselves. The detailed results are reported elsewhere.158
Discussion
To our knowledge, this is the first study reporting people with dementia’s perceptions of these problems
of incontinence. The descriptions of embarrassment and shame are no different from those given by other
adults.166 The desire to protect spouses or other family members from the ‘pollution of bodily waste’167 has
not been reported before and may have two unintended consequences. The first is that it may increase
family carer stress if the person cannot appropriately deal with leakage and excreta. The second is that the
family carer may not understand the motivation for such acts and interpret these as the need to protect
their dignity by concealment from everyone, including health professionals who could potentially help.
Although the study has limitations through size and difficulty in recruitment, it does provide insights that
have not been reported previously.
Conclusion
People with dementia are able to describe in detail their experiences and management of incontinence.
Their desire to protect their own dignity, but also protect others, may lead to unintended consequences
and delays in seeking wider help for such problems.
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Views of family carers on the problems of incontinence and effective
strategies to manage them
We could find no study investigating family carers’ strategies for managing incontinence. The purpose of
this study was to investigate family carers’ perceptions of the range of incontinence problems and their
strategies for managing them.
Methods
The research approach was in the interpretative tradition.164 A purposive sample of family carers of people
with dementia, living in their own homes, was recruited through primary care, specialist community
mental health services and voluntary organisations. Qualitative semi-structured interviews (SSIs), based on
an open-ended topic guide,168 were conducted either face to face or by telephone, recorded by tape,
transcribed and thematically analysed,164 using NVivo™ version 8, 2008 software package.
Ethics
Researchers were prepared to manage participant distress appropriately, and also situations that might
suggest a vulnerable person was being neglected or harmed. A favourable review was given by Camden
and Islington NHS local REC (08/H0722/60 2008).
Results
Thirty-two carers were interviewed. They described a range of problems from supporting the person to
remain independent in toileting, through to dealing with inappropriate behaviours, to containing and
managing incontinence. Key themes were identified: active problem-solving, protecting the dignity of the
person with dementia, problematic responses from health services and unintended consequences.
All carers actively used problem-solving strategies but sometimes these were not acceptable or understood
by the person with dementia, particularly as the dementia progressed. Most carers reported protecting the
person’s dignity by not seeking health professionals’ help, often until the point of crisis.
I didn’t want people to know about her not managing and incontinence . . . I felt her dignity, you
know . . . She was so in herself a very dignified lady . . . If she’d have known she’d have been horrified.
Husband c6
Once the carer had decided to seek help, the responses from health professionals were reported to be often
less than helpful, and carers reported local health service policies on access to continence products to be
inconsistent and often inappropriate to their circumstances. A few carers reported strategies for managing
toileting and incontinence that had the potential for distress and harm to the person with dementia.
These findings are reported in full elsewhere169 in a paper that was awarded the Royal College of
General Practitioners’ Research Paper of the Year 2011, in the category of dementias and
neurodegenerative diseases.
Discussion
The reluctance to seek help for toileting and incontinence problems by carers of people with dementia
as they seek to preserve their dignity and personhood115 has not been reported before, although the low
rate of seeking help for incontinence symptoms is well documented in older adults.170 The variability
and sometimes inappropriate responses of primary care professionals has not been reported previously, to
our knowledge. Management strategies were mediated by their acceptability to both the PWD, the carer
and other family members. A key influence in carers’ management strategies was to ensure that excreta
were well contained, an important goal identified by expert panels for incontinence management in
frail older people.117 Although the study has limitations because of its sample size, the diversity of the
population and the sampling until saturation in data ensured depth and breadth in the findings.
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Conclusions
There is a wide range of types of incontinence problems that change over time, and carers managing
them are often poorly supported by primary care professionals. Primary care professionals could be more
proactive in enquiry, repeated over time, about toileting and incontinence problems; alert to strategies that
have the potential for negative effects; and develop their repertoire of referrals, advice and information to
reduce crisis and problems.
Views of primary care, social care and specialist mental health staff in
community settings on effective strategies
We could find no studies reporting HSC professionals’ perceptions of effective strategies for the
management of incontinence in this population. The aim of this study was to investigate the perceived
range of problems and effective strategies.
Method
The study design was in the interpretative tradition using qualitative individual and group interviews,171
with HSC professionals purposively sampled to ensure a range of generalist and specialist community
services, disciplines, grades of staff and those with qualifications regulated through legislation and those
without. Participants were approached through organisations that had agreed to participate in the EVIDEM
programme and at EVIDEM educational events; these were mainly in north and central London and
Hertfordshire. Data were recorded in field notes and in flip charts kept as part of the group discussions,
transcribed to electronic documents and thematically analysed.
Ethics
The NRES advised us that the study did not require review as it was a service evaluation. The study followed
university research ethics requirements.
Results
We recruited 140 participants from a wide range of staff groups (Table 40), and they took part in
30 individual interviews and group interviews. Collectively, they described a wide range of toileting and
incontinence problems, with a wide range in the number of problems reported. Some informants
mentioned only one or two types of problems, whereas dementia specialist staff, such as the Admiral
Nurses, described greater numbers of both physical problems and dementia-related problems.
TABLE 40 Staff participating in interview by professional groups
Staff group No.
Dementia specialist social care staff 40
LA social workers and care managers 14
Continence nurse specialists 9
GPs 3
Admiral Nurses (specialist dementia care nurses) 10
Consultant old age psychiatrists and medical team 6
Community mental health services for older people and memory service team members (nurses, assistants,
psychologists managers)
33
Occupational therapists 6
District and community nurses 3
Voluntary organisations advice and carers support staff 15
Total 139
LA, local authority.
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Collectively, they reported a wide repertoire of strategies but many offered only one or two strategies that
reflected their type of service. A commonly reported strategy was to refer the patient to another service,
in many cases the district nursing service. The small number of district nurse informants focused mainly on
using continence pads as a containment strategy. Many informants considered that the local NHS provision
of incontinence advice and absorbent products did not address the needs of people with dementia and
their carers; in some instances these deficiencies were seen as contributing directly to decisions to move
the person to a care home. Other system-level problems were identified, such as the lack of acknowledgement
of toileting support in social care assessments.
Discussion and conclusion
To our knowledge there are no other published studies exploring multidisciplinary and multiagency perspectives
on managing incontinence for people with dementia living at home, although there are some that have
considered the issue from the perspective of care home staff.172 The study has limitations in that views offered
by a small number of informants may not be representative of others throughout England. However, the
intention was not to undertake a representative survey but to understand the breadth of issues and strategies.
The findings suggest that many staff groups have relatively limited knowledge of the range of problems that
can be experienced with a concomitant limited repertoire of responsive strategies. However, the cumulative
responses also point to a mosaic of practical, psychological, behavioural, biomedical, environmental and
supportive strategies that can be utilised. One question is whether knowledge alone of this mosaic of strategies
can influence primary care professional practice in addressing these types of problems. The respondents also
pointed to failures of publicly funded systems in addressing these problems, which raises the question of
whether or not new commissioning processes and initiatives, such as personal budgets, will be better able to
address them.
Experience, including impact and consequences, of people with dementia
and their family carers over time
Dementia follows a course of progressive disablement over a number of years.173 The experience, impact,
cost and consequences over time are poorly described in relation to incontinence and TDs (defined as a
range of problems associated with loss of independence in toileting or behavioural symptoms, sometimes
resulting in soiled clothing or excreta uncontained in pads or voiding inappropriately). This study
investigated the experiences, impacts, costs and consequences of incontinence in people with dementia
and their family carers over a period of up to 3 years.
Method
This was a longitudinal mixed-methods174 study investigating the experience of a purposive sample of people
with dementia with continence problems living at home, and of their carers. Personal and general invitations to
participate were distributed via community organisations, social care organisations, specialist community mental
health services for older adults in five London boroughs, and GPs in eight PCT areas. Data collection was by
serial qualitative interviews.175 In addition, validated instruments were used to characterise the person with
dementia who met the criteria of the ICD-10.80 Their mental state and abilities were described by the MMSE,52
the NPI62 and the Disability Assessment for Dementia (DAD),176 their TDs and incontinence by an adapted
International Incontinence Modular Questionnaire [International Consultation on Incontinence Questionnaire
(ICIQ)]177 and their health-related quality of life using the DEMQOL.86 Also recorded were the service use and
cost consequences using the CSRI Parts 1 and 2,88 as well as the carers’ health-related quality of life [EuroQol:
European Quality of Life-5 Dimensions (EQ-5D)],178 and burden (ZBI87 and NPI Caregiver Distress Scale179).
Analysis of the qualitative data was thematic,165 through comparisons over time and between cases using the
NVivo 8 software package and longitudinal charting. Statistical analyses of quantitative data were undertaken
using SPSS version 20 and Stata version 13 software. Costs were derived from the PSSRU Unit Costs of Health
and Social Care 201189 and estimates using the Office for National Statistics 2011 Annual Earnings Survey.180
Ethics
Ethical considerations included those described above (see p. 84). The study was given a favourable review
by the Camden and Islington NHS local REC 08/HO722/77 in 2008.
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Results
Thirty-four people with dementia and 29 family carers were recruited over 2 years (1 December 2008 to
31 December 2010). During the period of the study, 10 people with dementia died, six moved to care
homes and one withdrew. Because of the long recruitment period the remaining participants were in the
study for different lengths of time (see Figure 12) but many family carers provided retrospective data on
entering the study to describe their experiences over a longer period of time (Table 41). The characteristics
of participants at the first interview are provided in Table 42.
The types of toileting and incontinence problems are described in Table 43.
Consented, n = 34
Baseline: 0 months
Died, n = 1 Follow-up: 4 months
Follow-up: 8 months
Participants, n = 34
Participants, n = 33
Participants, n = 29
Follow-up: 12 months
Moved to RH/NH, n = 1
Participants, n = 27
Follow-up: 16 months
Follow-up: 20 months
Participants, n = 21
Participants, n = 19
Recruitment period
1 December 2008–
31 December 2010
Follow-up: 24 months Participants, n = 13Participants unable to
follow-up due to time scale, n = 6
Participants unable to
follow-up due to time scale, n = 1
Follow-up: 28 months
Follow-up: 32 months
Follow-up: 36 months
Participants unable to
follow-up due to time scale, n = 7
Participants unable to
follow-up due to time scale, n = 1
Participants, n = 6
Participants, n = 3
Participants, n = 2
Moved to RH/NH, n = 4
Moved to RH/NH, n = 1
Died, n = 1 
Died, n = 2
Withdrawn from study
(risk to researcher), n = 1
Died, n = 2
Died, n = 1
Died, n = 3
FIGURE 12 Flow diagram of participants over time.
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TABLE 41 Length of time of reported data
Months of reported data No. of participants
0–12 2
13–24 11
25–36 15
37+ 6
TABLE 42 Characteristics of the person with dementia and their carer at first interview
Characteristics Person with dementia (N= 34) Carer (N= 29)
Male, n (%) 10 (29.4) 13 (44.8)
Female, n (%) 24 (70.6) 16 (55.2)
Age, years (mean/range) 81.9 (62–98) 68.1 (44–88)
Relationship to carer (N= 29), n (%)
Spouse 17 (58.6) –
Adult–child 11 (37.9) –
Sibling 1 (3.5) –
Ethnicity, n (%)
White British 24 (70.6) 21 (72.4)
White other 4 (11.8) 1 (3.4)
White Irish 3 (8.8) 3 (10.3)
Black British 1 (2.9) 1 (3.4)
Black Caribbean 1 (2.9) 1 (3.4)
Black African 1 (2.9) 1 (3.4)
Chinese 0 (0) 1 (3.4)
English not first language 6 (17.6) 2 (6.9)
Person with dementia living alone 8 (23.5) –
Person with dementia median measure scores (range)
MMSE52 (possible score 0–30) (n= 14) 18 (2–26) –
DAD176 (possible score 0–100%) (n= 33) 15 (0–95) –
DEMQOL86 (possible score 28–116) (n= 8) 87 (52–101) –
NPI62 (possible score 0–120) (n= 24) 18 (0–69) –
Carer measure scores (mean/range)
EQ-5D178 (possible score 0–100) (n= 24) – 75 (40–95)
NPI carer distress179 (possible score 0–50) (n= 24) – 10 (0–32)
ZBI87 (possible score 0–88) (n= 27) – 30 (11–60)
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The progression of the dementia was evident in participants and was reflected in the DAD scores, which
showed a significant reduction over time in ability from a median score of 15 to 10 (p= 0.003 by Wilcoxon
signed-rank test). A series of basic regression models were fitted to the data. Inter-participant variability
was allowed for by random-effect parameter, and bootstrap CIs were used to account for floor and ceiling
effects in the outcomes. The effects on each of the carers’ measures were adjusted for the person with
dementia’s NPI measure (Table 44). The carers’ health-related quality of life scores were significantly
negatively affected by the presence of FI (–5.3, CI –10.4 to –0.1, significant at the 5% level) but not by
TDs or UI. The carers’ distress scores (in response to BPSD) were significantly negatively affected in the
presence of TDs (6.5, CI 0.6 to 12.3, significant at the 5% level) and UI (5.2, CI 2.7 to 7.6, significant at
the 5% level) but not in the presence of FI.
A number of themes were identified: changes in problems over time; the processes of normalisation, both
in managing toileting changes over time and also in managing excreta out of place; the iatrogenic effects
of hospital inpatient stays and respite stays in care homes on both the PWD’s toileting abilities and physical
health (e.g. the development of pressure ulcers); the interplay of decreased mobility and incontinence;
and the perceived positive impact of both paid help in personal care, which the carer controlled, and good
excreta containment on reducing carer stress. Figure 13 illustrates some of these themes through the
changes and experiences over time of one person with dementia and their family carer. The presence
of double incontinence (UI and FI) compared with one type of problem only (TD, UI or FI) was found to
significantly increase the costs by 89% from a HSC perspective and by 69% from a societal perspective
(Table 45). The HSC perspective includes costs both provided by the NHS or government and also privately
purchased. Societal costs include costs of the time of the informal or family carers.
TABLE 43 Types of problems reporteda
Problem Baseline 12 months 24 months 36 months
TDs 44.1% (15/34) 21% (4/19) 11% (1/9) 0% (0/2)
Urinary (UI) 29% (10/34) 31% (6/19) 11% (1/9) 0% (0/2)
Faecal (FI) 9% (3/34) 5% (1/19) 0% (0/9) 0% (0/2)
Double (UI plus FI) 56% (19/34) 53% (10/19) 89% (8/9) 100% (2/2)
a Individuals may have had TDs plus incontinence.
TABLE 44 Mean association of TDs with carer measures, with 95% CI
Carer
measure
Presence of
TDs (95% CI)
TDs adjusted
for NPI (95% CI)
Presence of
UI (95% CI)
UI adjusted for
NPI (95% CI)
Presence of FI
(95% CI)
FI adjusted for
NPI (95% CI)
EQ-5D178 0.1
(–5.6 to 5.7)
3.6
(–4.0 to 11.2)
–0.8
(–12.0 to 10.5)
–2.8
(–18.0 to 12.4)
–5.3a
(–10.4 to –0.1)
–5.1
(–12.4 to 2.3)
Caregiver
Distress
Scale179
6.5a
(0.6 to 12.3)
N/A 5.2a
(2.7 to 7.6)
N/A 1.8
(–2.2 to 5.8)
N/A
ZBI87 4.9
(–0.7 to 10.4)
2.4
(–6.0 to 10.8)
0.1
(–11.3 to 11.5)
–4.1
(–19.6 to 11.4)
–0.1
(–4.8 to 4.6)
–2.9
(–9.0 to 3.3)
N/A, not applicable.
a Significant at the 5% level.
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Discussion and conclusion
To our knowledge this is the first study reporting experiences of incontinence over time, and impacts upon
this patient population and their carers. The small sample is a limitation but provides insights into the
experience, types, costs and impact of incontinence that are not provided elsewhere. The results in full are
discussed elsewhere.169 The negative impact of the presence of FI on carer quality of life warrants further
investigation. The perceived positive impact of assistance in personal care tasks, which are within the
control of the carer, and effective containment of excreta require further investigation, in particular
whether or not it influences or defers decisions about moving to a care home.
Phase 3: investigating the feasibility, effectiveness and
acceptability of an identified strategy
Effective containment of excreta was identified as very important to family carers, both in discussing their
experiences and also in its impact on factors such as reported burden (Phases 2 and 3). Carers within
and outwith the advisory group prioritised the investigation of designs of incontinence pads to meet the
needs of people with dementia and their carers. The one previous study of acceptability and effectiveness
of different pad design did not include people with dementia living at home.181 The study aimed to
investigate the feasibility of ascertaining acceptability, effectiveness and associated costs of different types
of incontinence pad designs as used by people with dementia living at home and also to provide data to
inform both future research design and also service providers.
Method
This was an observational study based on the methods of a previous clinical trial with cognitively intact
adults181 and informed by the family carers in the advisory group. The study aimed to recruit a sample
of 40 family carers, diverse in their, and the PWD’s, characteristics, for example age, gender, stage of
dementia. Family carers were recruited through voluntary organisations across Greater London, specialist
mental health services for older people in North West London, and general practices and a community
continence service in South West London. At time point 1, the family carers were instructed in
observational and diary data collection. They were asked to complete the diary sheets for 1 week. Data
characterising the person with dementia (DAD,176 NPI62) and the family carer burden176 and the type of
incontinence (ICIQ)177 were also collected. At time point 2, the family carers were interviewed about the
experience of data collection and their diaries retrieved. Analysis of quantitative data was undertaken using
the SPSS version 20 software package. Analysis of the qualitative data was undertaken thematically.165
Ethics
Ethical issues were as outlined previously (see p. 84). The study was given a favourable review by the NHS
South East REC (10/H1102/34) in 2010.
TABLE 45 The 3-month mean costs by number of incontinence problems
Issue present, and significance
3-month mean costs in pounds sterling (SD): n= 34
HSC (SD) Societal (SD) n
One type only (TDs or UI or FI) 4200.9 (4110.8) 7464.6 (4885.1) 15
Double incontinence (UI and FI) 8207.5 (6722.2) 12431.3 (7163.7) 19
p-value (2 > 0 or 1) 0.03 0.01
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Results
Twenty-five family carers of people with dementia living at home were recruited to the study over
18 months. There was diversity in the sample of family carers, the person they cared for and the toileting
and incontinence problems (Table 46).
The range and funding source of aids and adaptations used are described in Table 47.
TABLE 46 Characteristics of participants
Characteristics Family carer (N= 25) Person with dementia (N= 25)
Female, n (%) 19 (76) 17 (68)
Male, n (%) 6 (24) 8 (32)
Age, years (median/range) 63 (32–89) 84 (64–90)
Relationship, n (%):
Spouse 11 (44)
Adult–child 11 (44)
Sibling and other 3 (12)
Ethnicity, n (%):
White British 19 (76) 22 (88)
White other 4 (16) 2 (8)
White Irish 1 (4) 0 (0)
Black Caribbean 3 (12) 1 (4)
English not first language, n (%) 3 (12)
ZBI87 possible score 0–88: median (range) 45 (8–60)
DAD176 possible score 0–100%: median (range) 23 (0–83)
NPI62 possible score 0–120: median (range) 21 (0–72)
TDs only 1 (4%)
UI only 4 (16%)
FI only 1(4%)
TDs+UI 3 (12%)
UI+ FI 8 (32%)
TDs+UI+ FI 8 (32%)
TABLE 47 The range of aids, equipment, adaptations and funding source
Items used
Provided by or funding source (n= 24)
Own NHS LA NHS+own LA+NHS+own
Incontinence pads 8 (33%) 10 (42%) 0 (0%) 5 (21%) 1 (4%)
Equipment (e.g. commodes) 5 (21%) 6 (25%) 0 (0%) 13 (54%)
Adaptation of home (17 had no adaptations) 6 (25%) 1 (4%)
LA, local authority.
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There was also diversity in the designs of incontinence pads used, which changed for some individuals
when outside the home and between day and night-time (Table 48).
Those who were recruited demonstrated high levels of commitment to the study’s aims. Twenty (80%)
of the carers were able to complete some days of the diary sheets (mean number of days 8, range
2–16 days). Carers entered data about each change of pads; the number of times they entered data
ranged from 4 to 56. One aspect was leakage of excreta outside the pad, for example onto clothes.
The rate of leakage by pad design is reported in Table 49.
Analysis of data on the acceptability and effectiveness of different designs of incontinence pads revealed
several important factors. Designs of pads were acceptable to the carer when they could safely and efficiently
be changed by the carer (and others such as day centre staff). Safety factors related to designs that allowed
the carer to change the pad and hold the person steady if necessary (i.e. to minimise risks of a fall). Efficiency
factors related to speed in changing, to cause least disturbance to the person and with minimal effort on the
part of the carer. Effectiveness related to the ability of the design to ensure containment of excreta.
It was evident that the required specifications of pads changed according to location (e.g. the use of public
toilets or at home), the availability of the carer or others to change the pad and whether a pad was to be
used in the day or at night. At night, 40% of the sample (n= 10) used either a more absorbent pad than
in the day, a different design or two designs in combination. The results are described in full elsewhere.169
TABLE 48 Types of design of incontinence pad used day and night
Time period
Design of incontinence pad used (n= 27a/n= 25 nightb)a
Large shaped
inserts Pull-ups Small inserts Nappy T-shaped nappy
Combination of
two types at once
Daytimec 10 10 4 1 0 2
Night-time 8 8 1 1 1 5
a Missing data from one person and two used two designs.
b One used no pad at night, and one alternated between two designs.
c Two participants changed when outside of the home to a higher level of absorbency (n= 1) and securing the pad to
different type of underpants.
TABLE 49 Frequency of leakage events by design of incontinence pad
Design No. of pad changes No. of leakage events (%)
Large shaped insert pads 201 51 (24)
Pull-ups 218 41 (19)
Nappy 19 4 (21)
T-shaped nappy 8 2 (25)
Small insert pad 19 1 (0.05)
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Discussion and conclusion
To our knowledge this is the first study exploring preferences and effectiveness of incontinence pad design
when used by people with dementia living at home and their family carers. Considerable endeavour and
resources went into the recruitment process, which was much slower than anticipated, and we were unable
to recruit the planned numbers: future studies will need to take great care with recruitment strategies.
There are limitations due to the sample size but the study provides data that will be used to inform the
development of a clinical trial protocol. It also provides insights into the specifications in effectiveness and
acceptability of different pad designs for people with dementia living at home not provided elsewhere.
Phase 4: developing and testing resources for practice
Drawing on the evidence of the earlier studies, a priority for the family carers in the advisory group was
practical resources to assist primary care professionals to both recognise the range of problems faced by
people with dementia and their carers and promote a variety of strategies that would be helpful.
This phase of the study therefore undertook the development and testing of a continence assessment tool
for people with dementia, to be used by primary care professionals, primarily community nurses. It also
undertook the development and testing of supporting educational materials.
Developing and testing a continence assessment tool and resources
The aim of this study was to develop and test a continence assessment tool and supporting resources for
people with dementia, to be used by primary care professionals, primarily community nurses.
Methods
An adapted three-stage Delphi consultation study182 was used. Stage 1 brought together an expert group
of carers, dementia specialist workers from the voluntary sector and health professionals. This group
examined commonly used continence assessment tools, and discussions were facilitated to describe a
broad range of principles and issues that would underpin an assessment tool designed to address the
needs of people with dementia. At stage 2 a prototype dementia-focused continence assessment tool was
developed using the data generated in stage 1, asking for agreement or disagreement to items plus
suggestions for further items. This was used to consult, in writing, both the expert group in stage 1 and
also a further group of carers and specialist continence professionals. The prototype was further adapted.
At stage 3 a different, wider group of experts (carers and professionals) was consulted in writing. They
were sent the draft dementia-focused assessment tool (Figure 14) together with a questionnaire to test its
face and content validity. Recipients were asked (1) whether or not the tool would improve recognition of
the problems (face validity) and (b) to rate each item for importance and identify missing or unnecessary
items (content validity). It was emphasised that the tool’s remit was a supplement to the continence
assessment tools and guidance currently used, hence it was called an add-on tool. Participants were also
sent supporting resource materials on which to comment (Table 50).
Ethics
The NHS research ethics service advised the researchers that the study did not require NHS research ethics
review. The study adhered to university ethical conduct of research requirements.
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TABLE 50 Resource material to accompany the EVIDEM-C add-on continence assessment tool
Toileting/continence issue
Examples of suggested actions/strategies
Techniques/knowledge/
activities Environmental/aids
Further professional
assessment or source of
advice
1 Recognising the need to
void but unable to act on
it in a timely way
Awareness of aspects of the
person’s behaviour that may
signal the need to void, for
example unexplained
restlessness, tugging at
clothes
Map usual voiding patterns
and plan support accordingly
PV if acceptable
2 Apathetic or not acting
on the need to void
Map usual voiding patterns
and plan support accordingly
PV if acceptable
Consider assessment by
another professional for
other problems, such as
depression, e.g. GP, CPN
3 Difficulty in locating the
toilet in the home
Map usual voiding patterns
and plan support accordingly
PV if acceptable
Toilet signage Occupational therapist
PromoCon
4 Difficulty in recognising
the toilet
Map usual voiding patterns
and plan support accordingly
PV if acceptable
Contrast and lighting,
e.g. different coloured toilet
set to toilet bowl
Declutter the bathroom
Occupational therapist
PromoCon
5 Unable to perform all
difference of actions to
void in the right place
Map usual voiding patterns
and plan support accordingly
Assist men to sit to urinate
Family carer of opposite sex
may need advice/explanation
on how to assist in this
Consider ways in which the
task could be simplified,
e.g. pull-up trousers/jogging
bottoms rather than zips
Occupational therapist
PromoCon
6 Unable to perform all
personal hygiene
afterwards
Map usual voiding patterns
and plan support accordingly
Family carer of opposite sex
may need advice/explanation
on how to assist in this
Consider wipes rather than
toilet paper
Advice from:
Continence specialist nurse
Occupational therapist
PromoCon
7 Physically unable to get
to/use the toilet in a
timely way and/or has
dexterity problems which
make it difficult to
manage clothes and
personal hygiene
Grab rails
Raised toilet seats
Commodes
Urine bottles
Extended wipers
Easier clothing
(Velcro® closures/elasticated
waists)
Consider potential for
assessment by other
professional, e.g. GP and/
or physiotherapist and/or
occupational therapist
PromoCon
Disabled Living Foundation
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TABLE 50 Resource material to accompany the EVIDEM-C add-on continence assessment tool (continued )
Toileting/continence issue
Examples of suggested actions/strategies
Techniques/knowledge/
activities Environmental/aids
Further professional
assessment or source of
advice
8 Locks toilet door and
is then unable to
comprehend how to
unlock it
Remove or disable the toilet
door lock
Occupational therapist
PromoCon
9 Uses inappropriate places
or receptacles
Use behavioural management
techniques, e.g. the ABC
approach (Antecedents,
Behaviour and Consequences)
to then decide appropriate
strategies:
What happened, when?
In what circumstances?
With what consequences?
Plan strategies based on this
information
Consider strategies to make
it easier to locate a toilet
Place appropriate receptacle
in the place used (if
appropriate)
Advice from:
CPN
Occupational therapist
PromoCona
10 Aids not acceptable or
not helpful
Consider different designs Advice from:
Occupational therapist
PromoCona
Disabled Living Foundation
11 Resists assistance in
toileting
Check awareness of good
communication techniques
for people with dementia to
reduce anxiety/fear/
embarrassment/reluctance
Use behavioural
management techniques to
problem solve
Consider potential for
assessment and advice
by other professional,
e.g. GP, CPN, clinical
psychologist
12 Restlessness/does not
remain on/at the toilet
long enough to void
Check awareness of good
communication techniques
for people with dementia to
reduce anxiety/fear/
embarrassment/reluctance
(Information Sheet 5)
Use behavioural
management techniques to
problem solve
Consider other reasons for
restlessness, e.g. pain
Consider potential for
assessment and advice
by other professional,
e.g. GP, CPN
13 Resists changing of
body-worn pads
Check awareness of good
communication techniques
for people with dementia
to reduce anxiety/fear/
embarrassment/reluctance
(Info. Sheet 5)
Use behavioural
management techniques to
problem solve
Consider a different design
of body-worn pads
Advice from:
Continence specialist nurse
PromoCona
Disabled Living Foundation
Consider potential for
assessment and advice by
other professional, e.g. GP,
CPN, clinical psychologist
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TABLE 50 Resource material to accompany the EVIDEM-C add-on continence assessment tool (continued )
Toileting/continence issue
Examples of suggested actions/strategies
Techniques/knowledge/
activities Environmental/aids
Further professional
assessment or source of
advice
14 Removes all body-worn
pads (dry and/or wet)
Use behavioural
management techniques to
problem solve (Information
Sheet 4)
Consider a different design of
body-worn pads, e.g. pull-up
pant designs
Advice from:
Continence specialist nurse
PromoCona
15 Leakage from
body-worn pads
Ensure the product is being
used correctly
Ensure other issues are not
interfering with the
product’s effectiveness,
e.g. over-liberal use of
barrier creams
Consider a different design or
absorbency of body-worn
pads (Information Sheet 6)
Information about, and
opportunities to test different
designs of pads
Advice from:
Continence specialist nurse
PromoCona
16 Problems voiding at night Consider pattern of fluid
intake, aiming for 1.5 l per
day but reducing intake and
type in the evening (cross
reference to fluids and diet
information in local
assessment tools)
Night-time lights with motion
sensors
Consider commode/urine
bottles for night-time use
Consider whether
medications contributing
to nocturia and refer for
review as appropriate
Consider potential for
other professional to
address any causes of
nocturia, e.g. GP
Advice from:
OT
17 Problems in managing
outside the home
Consider carrying a change
of lower garments in case of
‘accidents’
Provide information on
RADARb keys
18 Concerns about ‘smells’ Awareness of smell-
neutralising products
Consider removing items
where accidental spills may
not be noticed, e.g. toilet
mats
Advice from:
Continence specialist nurse
PromoCona
19 Problems in faecal matter
in the wrong place
(smearing, clearing up
inappropriately and
concealment of faeces)
Consider whether there are
problems of constipation
which can be addressed
(local guidance applies) NB.
The innate response of
curiosity can mean people
investigate (feel for) the
‘problem’ which often
results in faeces on hands
Use behavioural management
techniques to problem solve
Toilet signage Consider potential for
assessment and advice
by other professional,
e.g. GP, CPN, clinical
psychologist, continence
specialist nurse
PromoCona
20 Problems in that the
person takes multiple
doses of laxatives, having
forgotten taking them
before, resulting in
diarrhoea
Consider the use of
medication aids such as
dosette boxes
Advise on medication storage
Consider potential for
assessment and advice by
other professional, e.g. GP
continued
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Results
The three stages of the Delphi consultation involved 46 carers and professionals (Figure 15).
At stage 1, the key principle agreed by the group was that the typical NHS continence assessment tools
should be turned ‘upside down’, and that the first question in the tool should be an enquiry about
the problem and its impact as defined by the person (if able) and their carer. At stage 3, 26 experts, of the
50 invited, returned the questionnaire (Table 51).
The majority of respondents (87%) perceived the tool as being likely to improve primary care professionals’
recognition of the toileting and incontinence problems experienced by people with dementia and their family
carers. The GPs could see the value of the tool as an educational rather than a practice aid. All agreed that the
first two questions, on the problem and the impact, were important. Most agreed on the importance of the
items within the tool, although not all items were supported equally. For example, the carers did not rank the
question regarding awareness of benefits as important. Caveats to the value of the tool on its own were
added, such as the need for training. The results in full are described elsewhere.183
TABLE 50 Resource material to accompany the EVIDEM-C add-on continence assessment tool (continued )
Toileting/continence issue
Examples of suggested actions/strategies
Techniques/knowledge/
activities Environmental/aids
Further professional
assessment or source of
advice
21 Problems of disposal of
used body-worn pads
Awareness of principles of
hygiene and waste disposal
22 Problems of concealment
of soiled clothing or pads
Use behavioural management
techniques to problem solve
Consider potential for
assessment and advice by
other professional, e.g.
GP, CPN, clinical
psychologist
CPN, community psychiatric nurse.
a PromoCon provides a national service to improve the life for all people with bladder or bowel problems by offering
product information, advice and practical solutions to both.
b RADAR is a National Key Scheme, which offers disabled people independent access to locked public toilets around
the country.
Stage 1
Stage 2
Stage 3
Face to face. Carers and
professionals (n = 10)
Postal. Stage 1 group (n = 10)
plus specialist continence
professionals (n = 10)
Postal. Carers and a variety of
professionals (n = 26/50)
FIGURE 15 The three-stage Delphi consultation and participants.
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Discussion and conclusion
The face and content validity of the dementia-focused continence assessment tool were established.
The study had limitations in the response rate from some groups but provides a breadth of opinion not
provided elsewhere on such an assessment tool. The involvement of family carers (i.e. experts by
experience) in the first two stages ensured that the perspective of service users was present. Continence
services in the UK have been repeatedly criticised for the absence of service user involvement.158 To our
knowledge there have been no other studies developing continence assessment tools tailored to people
with dementia. Using a three-stage adapted Delphi consultation technique we created a tool (see
Figure 14) along with supporting resources (Table 50) that is person centred120 rather than constructed
from a biomedical perspective. The challenge, as pointed out by a number of participants, is how to ensure
that those using the tool also adopt a person-centred approach and have a repertoire of strategies to
address the problems identified.
Summary of the main findings
This study investigated ways in which toileting and incontinence problems could be addressed for people
with dementia living in their own homes. The study design drew on the MRC framework for the
development of complex interventions.101
The first phase was of one of review. Little evidence was found on prevalence, effective conservative
interventions or local clinical guidance or provision of NHS-funded incontinence products tailored to the
needs of this population. Our nested cohort study provides data on incidence of incontinence in this
population for the first time.
The second phase explored the experiences and strategies of people with dementia, their family carers –
including longitudinally – and of HSC professionals. People with dementia and their family carers
experienced multiple impacts, including humiliation, distress, quality of life, and financial and iatrogenic
consequences from some care services. The carer strategies emphasised preservation of dignity and
effective containment of excreta. Decision-making balanced both the needs of the person with dementia
and the family members. Some solutions had the potential to have unintended, negative consequences for
the person with dementia. HSC professionals varied in the extent to which they recognised the range of
problems and, consequently, in their repertoire of possible strategies.
The third phase explored the feasibility of investigating the effectiveness and acceptability of different
designs of incontinence pads with people with dementia. Although there were significant problems in
recruitment, those who volunteered were committed to the study. The study also revealed the types of
TABLE 51 Respondents to Delphi stage 3
Respondents’ area of expertise No. of responses
Carer 8
GP 2
Geriatrician/psychogeriatrician 1
Continence nurse specialist 3
District nurse/community nurse 7
OT 2
Other 3
Total 26
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criteria family carers used in assessing designs of incontinence pads. This included safety and efficiency in
changing pads as well as effective containment of excreta. These specifications changed in different
settings, for example outside the home and at night-time.
In the fourth phase, a continence assessment tool (Figure 14) and supporting resource (see Table 50) were
designed with an expert group and bench tested through a Delphi process. This used a person-centred
approach and was tailored to the needs of people with dementia living at home. It was found to
have good face and content validity, although it raised questions regarding whether or not it and the
supporting materials alone could change professional practice. In addition, material from this and other
phases were used to provide continuing professional development education materials for GPs,184
community nurses185 and social care staff.
Strengths and limitations
These have been described at each phase. In overview, the study strengths were the presentation of new
knowledge not previously reported in each phase. The iterative processes between the phases allowed for
greater reflexivity and responsiveness to both findings and the input from carers of people with dementia
as well as professionals. The main weakness lies in the failure to always achieve the planned sample size,
and the consequences of this for external validity. However, dementia and incontinence are both
stigmatised conditions and the discussion of excreta, particularly faeces, is often a taboo subject in all
societies.167 This study was successful in engaging people with dementia and family carers in research on
incontinence, and is a strength in both the research approaches and findings. The failure to always engage
practitioners in studies indicates that this population and these types of problems are not necessarily
perceived as a priority.
Interpretation of the findings
The study has addressed all of the research questions presented at the beginning of the chapter.
First, each phase of the study was able to add to the body of knowledge that primary care practitioners
and commissioners can draw upon, because there is very little other evidence or guidance available
tailored to this population.117,118 Toileting and incontinence problems are neglected among those who have
been, until relatively recently, an overlooked population: people with dementia living at home.
Second, the depth and breadth of the description of the problem of incontinence and its impact, provided
in this study, expand and illuminate accounts of people with dementia in care homes186 and studies of
older adults with incontinence but without cognitive impairment.166,170
Third, a key message from this study for primary care professionals was to proactively enquire at each
contact about toileting/bladder and bowel problems. The range of problems (from those amenable to
medical treatment such as urinary tract infections through to voiding in inappropriate places) suggested a
stepwise approach to identifying suitable and acceptable management strategies. The findings indicated
that primary care professionals need a repertoire of strategies that draws on knowledge of cultural,
psychological, behavioural, biomedical, technical and environmental aspects, as well as local systems,
in order to help solve practical problems. This study has been able to develop resources for primary care
practitioners that take cognisance of all factors (see Figure 14 and Table 50). There is little other research
detailing this mosaic of interlocking incontinence problems, although it is evident in the report of eight
case studies in Australia.187 Expert opinion tends to focus on physical practicalities117 or behavioural
techniques188 as solutions. It has highlighted for the first time that some strategies adopted by carers
(family and paid care workers) may be unintentionally detrimental to the person and that health-care
professionals need to be alert to this possibility.
Fourth, the study has developed and tested the first person-centred tool for continence assessment by
primary care nurses, tailored to people with dementia living at home. This requires further field testing
and evaluation.
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Fifth, the study has demonstrated the high priority that family carers place on adequate containment
of excreta, and its link with carer quality of life. The evidence of less-than-helpful responses from some
NHS continence services supports other accounts from service users about variation in service quality and
lack of professional help.145 This study provides further evidence to support a continence paradigm shift
from cure and prevention to very good containment as proposed by the International Continence Society
expert group on UI in frail elders.117 A pilot study has been conducted that investigated the acceptability
and effectiveness of different continence pad designs with people with dementia living at home and their
carers. The results indicate that a clinical trial of designs of pads is feasible, although with caveats on
recruitment, as discussed below.
Sixth, the study highlighted the difficulties in recruiting people with dementia and their family carers to
observational studies that address issues of incontinence. This has also been reported in studies attempting
investigations of interventions in the USA149,150 and Australia.187 The influence of embarrassment and
stigma on clinical practice and research for both dementia and incontinence is well documented.4,116
Conclusions
Incontinence has been described as a ‘geriatric giant’,189 a significant problem among older adults,
and the evidence from this study suggests that it is yet to be ‘tamed’ for those with dementia living at
home. The reasons are multifactorial and a mosaic of strategies is required to both reveal the problems
and manage them in ways that are acceptable to the person with dementia and their family members.
This study suggests that there are strategies and responses that primary care professionals and others can
use to encourage greater openness that may reduce the taboo of incontinence within the stigma of
dementia. It remains to be seen if these approaches, combined with more emphasis on effective
containment of excreta, influence the point at which decisions are made for a person with dementia
to move to a care home.
Impact
In addition to the impact through the presentations at events attended by HSC professionals, people with
dementia and their family carers (see Tables 70 and 71), the study can point to two other types of impact.
The first was the award to the study by the Royal College of General Practitioners for Research Paper
of the Year 2011 in the category of dementias and neurodegenerative diseases.169 The second relates
to the invitations to provide materials on incontinence and dementia for the continuing professional
development of:
l GPs by the British Medical Journal Quality group184
l nurses by the Royal College of Nursing-published Nursing Standard185
l adult care staff by the South East England DH and the Social Care & Local Partnerships Programme.
Building research capacity
Laura Cole, research associate, has undertaken part-time doctoral study registered at St George’s University
of London.
Changes to protocol
Owing to recruitment problems, the continence element of the programme did not undertake a
longitudinal cohort study. Instead, a longitudinal qualitative study was agreed and undertaken. (Agreed by
the Programme Director, December 2010.)
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Appendix 33 Chapter 3: Data collection tools for examining feasibility and acceptability in the absorbent
pads study.
Appendix 34 Chapter 3: Additional Table in the Client Service Receipt Inventory (part 1) for the absorbent
pads study.
a This includes the overall EVIDEM-C protocol as written in 2007, plus the subsequent protocols written for
individual elements. Study tools and instruments are in Appendices 26–34. Appendix 24 lists the applications
made for study adoption, research governance permissions and NHS service support costs for research.
Details of research ethics review are given with each study in the main report.
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Chapter 4 EVIDEM-EoL: quality of care at the end
of life
Abstract
Timely and appropriate agreements between visiting health-care professionals and care home staff
regarding end-of-life care for older people with dementia (OPWD) are difficult to reach. This study tracked
care received by 133 OPWD over 18 months in six residential care homes, including medication review
and economic evaluation. Interviews with residents, care home and visiting NHS staff focused on their
views of end-of-life care for OPWD and ways of working. Just over 20% of the resident cohort died. There
were no significant differences between those who died and those still alive in terms of sex, age, care
home, duration of prior residence or a formal diagnosis of dementia. Sedative load was not significant but
inappropriate prescribing was. Providing end-of-life care to OPWD was characterised by three types of
uncertainty: treatment uncertainty related to difficulties in prognostication and how to interpret and
manage key events and symptoms; relational uncertainty related to roles, responsibilities and relationships
among those involved; and service uncertainty related to service capability.
Phase 2 used a co-design approach [Appreciative Inquiry (AI)] with three of the six care homes that built on
existing relationships and expertise and, when appropriate, end-of-life care tools. The intervention was
evaluated in terms of its ability to address the different types of uncertainty. AI did not increase resource
use and there was a reduction in hospital costs. The intervention supported a shift in care home culture
that could mitigate uncertainties inherent to end-of-life care of OPWD and different ways of working
between NHS and care home staff.
Introduction
Background: the need for this study
People with dementia have a limited life expectancy and the type of end-of-life care that they need has
been widely discussed.190–193 These discussions focus particularly on the place of care and on the adaptation
of existing end-of-life care pathways, but people with dementia experience different trajectories of
functional decline and have different needs.194,195
Communication problems, confusion, functional loss, nutritional deficiencies and complications, such as
infections and incontinence, can compound the distress of a person who is dying, challenge clinicians’
knowledge and expertise,196 and result in inappropriate medical interventions and referral to hospital.197–199
There are significant methodological challenges in researching end-of-life care for people with
dementia.200,201 Most research in this area tends to rely on proxy or retrospective accounts of particular
symptoms and events. Fewer studies have addressed the environment and organisation of care, or
decisions by different practitioners on individual patient outcomes.
In the UK, the quality of care of people with dementia in care homes is variable.202–204 The cognitive ability
and dependency of residents vary between care homes, and there is a considerable overlap in residents’
needs between homes with on-site nursing and those without.205 Many factors influence how care homes
work with primary health-care services. These include ownership, staff turnover, the qualifications of the
care home manager, access to specialist palliative care, financial incentives offered to GPs, and the history
of innovation within the home.206–210 There is little evidence that care home residents, relatives and staff
are involved in identifying priorities for end-of-life care for people with dementia, or in developing models
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of care that go beyond the individual patient-focused encounter. There is a need to develop and test
dementia-specific approaches to end-of-life care for this often marginalised population.211,212
The NHS End of Life Care Programme for care homes209 seeks to ensure that when residents are dying they
can avoid emergency hospital admissions and be supported by care home and NHS staff who are skilled in
providing end-of-life care. Care homes are being encouraged to use end-of-life care support tools, such as
the Gold Standards Framework (GSF),213 Preferred Priorities for Care,214 and the Liverpool Care Pathway
(LCP).215 These interventions increase staff confidence and knowledge, reduce unplanned hospital
admissions, and allow more people to die in their preferred place of care.216,217
Research questions
This study had two phases. In the first phase the research question was, what are the pathways to death
of OPWD living in a care home? In the second phase the research question was, can an intervention be
developed to promote integrated working between primary care and care home providers, to improve
end-of-life care for OPWD?
Methods
The methodology used in Phases 1 and 2 of the study is detailed in the study protocols shown in
Appendices 35 and 36.
Phase 1 objectives
Phase 1 objectives were to:
l characterise OPWD living in care homes and describe their respective pathways to death, including a
survival analysis to identify indicators of the end of life
l describe the care and support needs of this population, and of their carers
l establish how care home staff and NHS primary care practitioners define, assess and provide end-of-life
care for this population
l describe how different contexts and models of care in care home environments influence experiences
of end-of-life care
l identify the treatments and interventions received (including medication and potentially inappropriate
prescribing), and services and resources used, leading up to death.
Study design
Phase 1 used a prospective, mixed-methods design including case notes analysis, interviews, mapping of
service use and economic evaluation. Data from residents’ care notes were extracted at three time points
(Table 52). Care notes of residents who had either died or left the home before the end of the data
collection period were reviewed to the date of death or leaving the home.
TABLE 52 Phase 1 care notes review periods
Time point Dates
Baseline March 2009 to July 2009
Time point 2 July 2009 to November 2009
Time point 3 December 2009 to April 2010
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Unstructured conversational interviews were undertaken with a purposively selected sample of older care
home residents with dementia. The manager and, where possible, deputy manager, as well as two NHS
professionals (e.g. GP and district nurse) with ongoing involvement with each home were interviewed.
Emergency care practitioners and paramedics were also interviewed to establish how they interpreted their
responsibilities when called to an older person with dementia in a care home. Care home notes of older
people who died during Phase 1 were reviewed to document services received prior to death, the place of
death and the care provided. These reviews were complemented by interviews with care home staff.
Interview schedules and data extraction forms are shown in Appendices 37–46. Interview information
sheets are shown in Appendices 49–51.
Inclusion and exclusion criteria
Inclusion and exclusion criteria for care homes and OPWD are detailed in Appendix 35. Inclusion criteria for
care home residents were age ≥ 65 years, and a documented diagnosis of dementia or an assessment by the
senior care worker that their level of cognitive impairment and behaviour were consistent with a diagnosis of
dementia. Exclusion criteria were people with dementia who did not speak English, those whom the care
home manager thought it inappropriate to approach (e.g. people in the terminal stage of the disease) and
individuals who lacked capacity to consent and for whom a consultee could not be identified.
Information sources
Care home characteristics were collected using Annual Quality Assurance Assessment (AQAA) forms
completed for the study by the care home managers (Table 53). Missing data were obtained through Care
Quality Commission (CQC) listings and care home managers’ interviews.
Sample
Details of the recruitment process used for both the care homes and the OPWD are reported elsewhere210
(see also Appendix 35). A total of 214 residents were eligible for participation in the study across the
six care homes. Care homes were identified using the CQC (previously known as the Commission for Social
Care Inspection) directory of care homes. Inclusion criteria were that the care home was for older people,
provided personal care and specialist support in dementia care, had a minimum of 20 beds and there was
no onsite nursing provision. To optimise the opportunities for participation, a further inclusion criterion was
that the last CQC inspection report was favourable and that care home staff considered that they have a
good working relationship with their local primary care services. Of the 10 care homes approached,
six agreed to participate. The six care homes had a mix of ownership and geographical location.
A staged approach to the recruitment of OPWD was adopted, involving separate meetings with staff,
residents and relatives. Individual consent was secured with residents with dementia who could consent in
the moment and for those without capacity, through letters and follow-up contact with consultees.
Minimum data set
Areas of data collection are detailed in Appendix 35. Participants’ health and care needs over time
were documented, as well as service utilisation (using an adapted version of the CSRI).88 Additional
data on residents were obtained using the DAD,176 the Barthel ADL Index,218 the Cohen–Mansfield
Agitation Inventory (CMAI),219 and the Cornell Scale for Depression in Dementia,220 completed by home
managers and senior carers.
TABLE 53 Annual Quality Assurance Assessments dates
Care home
CH1 CH2 CH3 CH4 CH5 CH6
April 2007 July 2008 March 2009 June 2008 March 2009 March 2009
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Analytic methods
Case notes review and interviews
Data extracted from residents’ care notes were analysed using SPSS version 20. Interviews were digitally
recorded, anonymised and analysed thematically using NVivo version 8. Two researchers undertook the
analysis and discussion of key themes and issues.
Review of resident deaths
Health events and care received in the month preceding death were extracted from care notes and
through interviews with care home managers and/or senior care workers. Data were summarised in
timelines depicting deceased residents’ end-of-life trajectories, using Microsoft Visio™ software
version 2010 (Microsoft Corporation, Redmond, WA, USA). Two researchers were involved in defining
dying trajectories, using an inductive approach to classification of Visio timelines.
Medication review
Residents’ medical administration records were reviewed to (1) determine the sedative load and use of
sedative and psychotropic medications and (2) estimate the prevalence of potentially inappropriate
prescribing (PIP) among OPWD in care homes. To determine the sedative load and use of sedative and
psychotropic medications, regular medications were classified using the Anatomical Therapeutic Chemical
classification system and individual sedative loads were calculated using a model to quantify the cumulative
effect of taking multiple drugs with sedative properties (see Parsons et al.221 for further detail). The
prevalence of PIP was determined using 31 of the 65 Screening Tool of Older Persons’ potentially
inappropriate Prescriptions (STOPP) criteria (see Parsons et al.221 for further detail).222
Characteristics of older people who died compared with those alive
Examination of characteristics of older people who died compared with those alive using Kaplan–Meier
methods (significance values where quoted are for the log-rank test) was undertaken to examine if there
were indicators that residents were reaching end of life. The analysis was restricted to residents who
met the following criteria: (1) residents who were alive and resident in the care home at the date of the
baseline data collection and (2) residents who had a valid date at which their survival time was censored
(at date of either death or transfer, or recorded alive at date of last data collection).
Costing analysis
Objectives
l To compare the resource utilisation patterns between residents who were alive and dead by the
end of Phase 1.
l To establish the estimated costs for supporting end-of-life care for OPWD in care homes.
Descriptive statistics derived using SPSS version 20 were used to report estimated service use and costs.
The Wilcoxon rank-sum test (two independent samples test) was used to detect differences in service
utilisation and costs between residents who were alive and who had died by the end of Phase 1. HSC unit
costs estimates were taken from the Unit Costs of Health and Social Care 2010.223 Medication costs were
estimated using information from the British National Formulary.224 The monthly accommodation cost
per resident was based on the average of the accommodation costs between the two time points.
For those residents with missing records, the overall average accommodation cost was used.
Ethical considerations
The protocol of Phase 1 of the EVIDEM-EoL study entitled ‘Changing practice in dementia care in care
homes: developing and testing evidence-based interventions at the end of life’ (REC reference: 08/H0502/74)
received a favourable ethical opinion from the Southampton & South West Hampshire REC (A) on
14 July 2008.
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Public involvement
Two members of the Public Involvement in Research Group (PIRG) based at the University of Hertfordshire
provided support to the study. Both were recruited because of their particular expertise and experience of
dementia and mental health services. One member of PIRG was a member of the project advisory group,
attended coffee mornings at the care homes to explain the study to residents, was involved in some of the
qualitative analysis, including the interviews with residents, and commented on the final report. Both
members commented on various study materials throughout the project, including care home newsletters.
The steering group was chaired by a member of the PIRG who had been a carer of someone with
dementia and three other members of the group were PPI representatives, all of whom had been carers of
people with dementia who had died in a care home.
Phase 2: Intervention objectives
The intervention phase objectives were to:
l identify interventions/ways of working to support integrated working between care home staff and
primary health-care services
l test ways that primary health-care services and care home staff can work together to reflect the
priorities, experiences and concerns of OPWD living in care homes at the end of life
l consider how available end-of-life care frameworks help primary care and care home staff to manage
uncertainty at the end of life
l identify facilitators and barriers to sustaining effective end-of-life care for people with dementia living in
care homes.
Study design
Phase 2 used a co-design approach (AI)225,226 to bring together care home and visiting NHS staff to identify
what worked well in end-of-life care for people with dementia, and to use that as a basis to plan and
implement change. The exploration and enhancement of what is working well in an organisation is often
framed as a ‘4-D cycle’ (Box 5). The cycle is often conceptualised as discrete steps, although the process is
non-linear, iterative and ongoing.
The 4-D cycle was implemented over three facilitated hour-long AI sessions over 6 months. The AI method
and session design are detailed in Appendix 47 (for further detail regarding the design of the intervention,
see Nicholson et al.227). Phase 2 tracked the events and care experienced by OPWD living in the care
homes who participated in the intervention phase. Data were extracted from residents’ care notes at two
time points, staggered over 7 months of data collection that ran from January to July 2011.
Baseline data extraction coincided with the start of the intervention (Table 54). Researchers reviewed
participating residents’ care notes over the 3 months prior to the start of the intervention or closely thereafter
and again in July 2011 after the third and final round of intervention sessions in the care homes. Baseline
data were collected in this way for 90% of the study sample. Baseline data for the remaining residents
(n= 8) were collected between mid-March and mid-April 2011 owing to delays in obtaining consent.
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Impact of the Appreciative Inquiry intervention
The impact of the AI intervention on integrated working in end-of-life care was evaluated through analysis
of resident deaths following the intervention and resource use before and after the intervention.
Resident deaths were examined through care note reviews, complemented by interviews with care home
staff, for changes in services received prior to death, place of death and care provided following
the intervention.
Resource use was examined among residents who participated in both phases of the study (see Costing
Analysis, below, for further details).
Finally, postintervention interviews with all participants following the third and final AI session (see
Appendix 47, interview schedule) were undertaken to examine perceived changes in working practices.
BOX 5 Appreciative Inquiry ‘4-D cycle’
Discovery phase
Appreciating the best of what is Conversations between participants (within the chosen topic area) reveal
stories of people working at their best. In the EVIDEM-EoL study the topic was the best experience of
collaborative working in caring for a resident dying with dementia in a care home.
Dream
Envisaging what might be The stories are collectively discussed in order to generate new ideas, understanding
and agreeing a shared future image of the future. This shared future is often summed up in a statement of
intent. For example, in the EVIDEM-EoL study, one care home created the future ideal: ‘All residents who wish
to can live and die here, their home’.
Design
Together, create innovative ways to make it happen Participants choose and prioritise what needs to change to
enable participants to move towards the agreed future and identify resources to enable these changes to occur.
Within the EVIDEM-EoL study the design phase focused on one context-specific innovation per site.
Destiny
Sustaining the change Together, participants think about how to involve the wider organisation and systems
necessary to ensure changes are sustained and spread.
TABLE 54 Phase 2 intervention: AI session dates
Session
Care home
CH1 CH5 CH6
1 25 January 2011 3 February 2011 19 January 2011
2 15 March 2011 24 March 2011 14 March 2011
3 28 June 2011 29 June 2011 20 June 2011
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Minimum data set
A minimum data set of information was generated, as in Phase 1. Additional data on residents were
obtained using the Clinical Dementia Rating Scale,228 completed by care home managers and senior carers.
Sample
Care home and resident samples
The six care homes that participated in Phase 1 received feedback and summaries of the Phase 1 findings,
and all care homes were then invited to participate in Phase 2. Three of the six homes agreed to join the
intervention phase, with a total of 154 residents eligible for participation.
Intervention sample
The GP practices and district nurses approached in Phase 2 were the same as those recommended to
researchers in Phase 1. In two of the practices [attached to care homes 5 and 6 (CH5, CH6)] the GPs who
had participated in Phase 1 both suggested other GPs at the practice to interview. Only the district nurse
associated to CH6 participated in both phases of the study.
Care homes involved staff as they were able, with interviews being completed with all of the managers.
The manager of CH5 attended two sessions before leaving her post. This manager had not yet been
replaced by the third AI session, which was held with the GP and deputy manager only.
Relatives sample
A significant amendment was made to the Phase 2 protocol in 2011 following a recommendation from
the study’s advisory group to include relatives of care home residents both living and deceased. Relatives
were recruited via study information leaflets left in the care homes, and through care home managers.
Researchers also approached potential participants at relative group meetings normally held in the care
home. Five participants were recruited in this way, including one relative living at the care home with
his/her partner.
Analytic methods
Interviews and care note data were analysed as in Phase 1. The facilitated meetings were digitally
recorded, anonymised and analysed thematically using NVivo version 8 to organise and manage the
analysis. Two researchers were involved in the analysis and discussion of key themes and issues.
Costing analysis
Objectives
l To establish the estimated costs for supporting end-of-life care for OPWD in care homes for Phase 2.
l To compare the resource utilisation patterns between the same residents who were in both phases.
Patterns of service utilisation and estimation of costs were carried out as in Phase 1.
Ethical considerations
The intervention phase of the EVIDEM-EoL study entitled ‘EVIDEM-End of Life: Changing practice
in dementia care in care homes: developing and testing evidence-based interventions at the end of
life – Phase 2’ (REC reference: 10/H0502/55) received a favourable ethical opinion from the
Southampton & South West Hampshire REC (A) on 10 August 2010.
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Results from Phase 1
Care home characteristics
Care homes were a mix of provider type, size, location, building structure and religious affiliation
(Table 55).
Resident funding status and care home fees, as well as staff numbers, working patterns and qualifications
are shown in Tables 56–58.
TABLE 55 Care home size, environment and affiliationa
Characteristic
Care home
CH1 CH2 CH3 CH4 CH5 CH6
Provider type Private not for
profit
Private not for
profit
Private not for
profit
Voluntary Private Private
No. of places 46 62 60b 66 67 57
No. of dementia
places
46 61 60 66 67 57
Location Suburban Urban Suburban Urban Rural Rural
Building Former LA Purpose built Purpose built Purpose built Conversion Purpose built
Religious affiliation No No No Yes No No
LA, local authority.
a Source: CQC listings.
b One place for learning disability.
TABLE 56 Care home provider type and resident funding statusa
Characteristic
Care home
CH1
(n= 44)
CH2
(n= 58)
CH3
(n= 57)
CH4
(n= 62)
CH5
(n= 66)
CH6
(n= 54)
Total
N (%)
Provider type Private not
for profit
Private not
for profit
Private not
for profit
Voluntary Private Private
Privately funded 7 (15.9%) 0 (0%) 32 (56.1%) 47 (75.8%) 17 (25.8%) 27 (50.0%) 130 (38.1%)
Publicly funded 37 (84.1%) 58 (100%) 25 (43.9%) 15 (24.2%) 49 (74.2%) 27 (50.0%) 211 (61.9%)
a Source: AQAA data.
TABLE 57 Care home fees (2009–10)a
Characteristic
Care home
CH1 CH2 CH3 CH4 CH5 CH6 Average
Min. cost per
week (£)
Unavailable 495 595 525 500 420 507
Max. cost per
week (£)
Unavailable 580 695 640 660 600 635
Cost range (£) Unavailable 85 100 115 160 180 128
a Source: CQC listings.
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Organisation of care
All of the care homes operated a key worker system with a named care worker. Most operated teams
headed by a senior care worker/team leader and tried to keep the same teams for continuity of care.
Only one care home had permanent night staff. Training in most care homes was ongoing and in-house
(see Appendix 55, Table 106). Frameworks for structured end-of-life care, such as the LCP215 or GSF213 for
Care Homes, appeared rarely, if ever used (see Appendix 55, Table 107).
Resident needs
Resident needs are shown in Appendix 56, Table 108. Overall, care home 1 is characterised by the highest
concentration of dependent older people with advanced dementia. Residents at care homes 3 and 4 had
similar levels of dependency but less of dementia-related dysfunction. Residents in care homes 5 and 6
were more heterogeneous, evidenced by wider ranges of cognitive and functional ability.
Reported number and location of resident deaths in the year prior to the study are shown in Table 59.
Between 30% and 50% of residents who had died in the year prior to the study died in hospital or
in a hospice.
Access to primary and specialist palliative care
General practitioners
Care homes arrangements with GPs differed considerably (see Appendix 57, Table 109). For example,
some GPs had set days to visit (but would also visit at other times if necessary), whereas others visited on
request only.
TABLE 58 Care home staff numbers, working patterns and qualificationsa
Characteristic
Care home
CH1 CH2 CH3 CH4 CH5 CH6
Total no. of caring staff 41 52 43 42a 40 41
Full time, n (%) 5 (12.2) 14 (26.9) 20 (46.5) 23 (54.8)a (59)c 26 (63.4)
Part time, n (%) 36 (87.8) 38 (73.1) 23 (53.5) 19 (45.2)a (41)c 15 (36.6)
Agency (temporary) care staff 0 –b –b 1a –b –b
Full-time direct care workers to
residents
0.89 0.9 0.75 0.68 0.61 0.76
Non-caring staff members 21 11 32 –b 11 22
Direct care workers holding
NVQ at Level 2 or above, n (%)
14 (34.1) 31 (59.6) 19 (44.2) 19 (47.5) 26% (exact
number
unavailable)
29 (70.7)
Direct care workers turnover in
past 12 months
13 (1FT;
12 PT)
25 (FT/PT
not specified)
5 (FT/PT
not specified)
4 in past
6 monthsa
6 (FT/PT
not specified)
8 (FT/PT
not specified)
Manager’s time in post, years 4.5 2 3 3 3 6
Manager dementia traininga Yes Yes Yes Yes Yes Yes
Manager end-of-life traininga Yes No No Yes Yes Yes
Volunteersa Yes No Yes Yes No No
FT, full time; PT, part time.
a Source: care home manager interviews.
b AQAA data collection procedure modification (information no longer extracted).
c Source: Care Homes’ Minimum data set.
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District nurses
All the care homes had frequent visits from district nurses. These nurses also provided diabetes care,
wound and continence care, as well as ordering equipment from medical loans or equipment services, for
example pressure-relieving mattresses. Their involvement in end-of-life care was variable and in one care
home the district nursing team had no history of such involvement.
Out-of-hours general practitioners and emergency ambulance services
Care homes frequently called on the services of out-of-hours (OOH) GPs. The decision to call the
emergency services for distressing symptoms was often linked to staff confidence in managing
end-of-life care.
Specialist care
None of the care homes had Admiral Nurse support or used night-sitter services. Counsellor services for
staff were available on request via GP referral for only two of the six care homes. Only three of the care
homes received any kind of regular support from a Community Mental Health Team. Three out of the
six care homes reported never receiving support from palliative care specialists. The care homes that had
access to specialist services reported variable patterns of contact, and in one home the service was
restricted to residents with cancer.
Phase 1 resident baseline characteristics (n = 133)
Recruitment and retention
One hundred and thirty-three OPWD were recruited, representing 62% of the population (see
Appendix 58, Table 110).
Resident age, length of stay, admission route into the home
Appendix 58 (Tables 111 and 112) shows resident characteristics, including age, length of stay and
admission route into the home. Median age at admission ranged from 82.7 years in CH5 to 87.5 years in
CH3. Length of residency ranged from 0.2 years in CH6 to 3.4 years in CH2. A total of 43% of residents
were admitted to the care home from their own home; 6% were admitted from a relative’s home;
29% from hospital; 11% from another care home; and 11% from sheltered/warden-controlled housing.
Cognitive function, activities of daily living, behavioural status,
distressing behaviour
Over one-quarter 26.3% (n= 35) of the sample did not have a formal diagnosis of dementia recorded
(see Appendix 58, Table 113) but were identified by care home staff as having memory problems and/or
behaviours consistent with a diagnosis of dementia (e.g. memory lapses, disorientation to time and place,
lack of ability to problem solve, needing help/prompts for personal care). Of those who had a formal
diagnosis of dementia, 70% did not have the source of their dementia diagnosis recorded.
TABLE 59 Deaths in year prior to studya
No. of deaths in year prior to study
Care home
CH1: 12 CH2: 12 CH3: 16 CH4: 14 CH5: 10 CH6: 3
At home, n (%) 7 (58.3) 7 (58.3) 11 (68.8) 7 (50.0) 7 (70.0) 2 (66.6)
At hospital or hospice, n (%) 5 (41.6) 5 (41.6) 5 (31.3) 7 (50.0) 3 (30.0) 1 (33.3)
Short-term/temporary residents in last 12 months
before completion of AQAA
51 63 73 1 12 3
a Source: AQAA data.
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Resident needs in relation to ADL were documented in the areas of continence, personal care, maintaining
a safe environment, and eating and drinking, and are shown (see Appendix 58, Tables 114 and 115).
Assessment of all residents using validated tools including the DAD scale,176 CMAI219 and Cornell Scale for
Depression in Dementia220 confirmed the presence of symptoms that were consistent with a diagnosis of
dementia (Tables 60 and 61). Care home 1 was characterised by a high concentration of dementia-related
disability, as evidenced as by DAD scores ranging from 0% to 20% (see Table 61). Care homes 5 and 6
are characterised by wide ranges of disability levels as evidenced by DAD scores ranging from 2.5%
(i.e. more dysfunction) to 100% (no disability).
Around 15% of the overall sample displayed aggressive behaviour and around 50% of the sample
displayed both physically non-aggressive and verbally agitated behaviour. Only 12% of the overall sample
was assessed on the Cornell Scale for Depression in Dementia scale as exhibiting symptoms of depression
(see Table 61).
TABLE 60 Resident function within care homes (DAD; N= 101a)
DAD
Care home
CH1 CH2 CH3 CH4 CH5 CH6 Total
n 18 –b 15 22 32 14 101
Median 11.25 –b 12.5 10 29.14 40 17.5
Mean (SD) 10.42 (6.26) –b 17.50 (15.50) 16.88 (16.90) 32.88 (25.54) 35.50 (24.77) 23.47 (21.83)
Range 0–20.00 –b 0–42.50 0–48.72 2.50–100.00 2.50–100.00 0–100.00
a Source: DAD176 completed by care home managers and/or senior care workers. Total score out of 100. Higher scores
represent less disability in ADL, whereas lower scores indicate more dysfunction.
b Care home staff unable to administer assessments because of time constraints.
TABLE 61 Distressing or challenging behaviour in care homes reported by staffa (N= 133)
Characteristic
Care home
CH1 (n= 19) CH2 CH3 (n= 15) CH4 (n= 22) CH5 (n= 32) CH6 (n= 14)
% of total
N= 102
CMAI219 (n = 102)
Aggressive
behaviour, n (%)
3 (15.8) –b 2 (13.3) 4 (18.2) 6 (18.8) 1 (7.1) 16 (15.7)
Physically
non-aggressive
behaviour, n (%)
8 (42.1) –b 6 (40.0) 12 (54.5) 15 (46.9) 11 (78.6) 52 (51.0)
Verbally agitated
behaviour, n (%)
11 (57.9) –b 9 (60.0) 11 (50.0) 14 (43.8) 7 (50.0) 52 (51.0)
Cornell Scale for Depression in Dementia220 (n = 101)
Indicating probable
depression
(i.e. score of ≥ 12),
n (%)
5 (27.8) –b 0 (0) 0 (0) 5 (15.6) 2 (14.3) 12 (11.9)
a Source: CMAI and Cornell Scale for Depression in Dementia completed by care home managers and/or senior
care workers.
b Care home staff unable to administer assessments because of time constraints.
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Average number of comorbidities and prescribed medications
Residents had a wide range of documented conditions and symptoms, with just under half experiencing
three or more comorbidities (Table 62). Residents were prescribed a median of seven medications,
with a range of 0–17 (Table 63).
Sedative load of medications
Analysis of sedative load and use of sedative and psychotropic medications among participating residents
showed that approximately one-third of residents were not taking any medications with sedative properties
at each time point, whereas a significant proportion of residents had a low sedative load score of 1 or 2
(54.8%, 59.0% and 57.1% at baseline and time points 2 and 3, respectively). Sedative load scores were
similar throughout the study period for residents with dementia in each of the care homes, and lower than
previously reported in studies conducted in long-term care (for further details, see Parsons et al.222).
Evaluation of potentially inappropriate prescribing
Analysis of the prevalence of PIP using STOPP criteria shows that 46.2% and 40.9% of the sample were
prescribed at least one potentially inappropriate medication (PIM) at time points 2 and 3, respectively.
Long-term (i.e. > 1 month) use of neuroleptic drugs, non-steroidal anti-inflammatory drug use for
> 3 months and proton pump inhibitors use at maximum therapeutic dosage for > 8 weeks were the
most prevalent PIMs in this study population (for further details, see Parsons et al.222).
Health events
Range of health events
Health-related events recorded in care notes were reviewed in order to capture possible signs of physical
decline (see Appendix 58, Table 116). The proportion of residents for whom an event was recorded at
each time point over the course of Phase 1 is shown in Appendix 58, Table 117. Problems relating to
eating, drinking and falls were among the most frequent events, whereas pain, distress and decreased
mobility were documented relatively less often. The number of falls across care homes per time point is
shown in Appendix 58, Table 118. Across homes, 22%, 31% and 30% of residents had sustained a fall in
the 3 months preceding data extraction at baseline, time point 2 and time point 3, respectively.
TABLE 62 Comorbidities per care homea
Comorbidities
Care home
CH1 CH2 CH3 CH4 CH5 CH6 Total
≥ 3, n (%) 9 (45) 13 (52) 3 (18.8) 7 (30.4) 22 (64.7) 4 (26.7) 58 (43.6)
a Source: care notes.
TABLE 63 Prescribed medicationa
Characteristic
Care home
CH1 CH2 CH3 CH4 CH5 CH6 Total
Mean no.
medications (SD)
7.60 (3.35) 7.70 (4.19) 7.07 (4.73) 6.87 (2.88) 7.91 (2.87) 6.67 (4.13) 7.40 (3.56)
Median no.
medications
6.5 7 6 7 8 6 7
Range 3.0–15.0 2.0–17.0 0.0–17.0 1.0–13.0 2.0–14.0 2.0–15.0 0.0–17.0
a Source: Medical Administration Record sheets.
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Advance Care Planning
Documented involvement in end-of-life discussions is shown in Appendix 58 (see Table 119). Forty per cent
of residents had no evidence of end-of-life discussions recorded in their care notes. It is worth noting that
end-of-life discussions as recorded in the care notes pertained for the most part to decisions regarding
faith-based and post-death arrangements (e.g. religion and funeral arrangements) rather than care-related
preferences (i.e. resuscitation status; significant carers, family members whom the resident would want to
be present at the end of life) (Table 64).
Deaths over the course of Phase 1
Just over 20% (n= 27) of the sample died over the course of Phase 1, including 15 residents in the care
homes and 12 in, or on their way to, hospital (see Appendix 58, Table 120). A further six residents (n= 5)
were discharged from the care home into a care home with nursing over the course of the study.
Health events and service utilisation in the month leading up to death
The most widely reported symptoms among residents in the month preceding death were problems with
eating and drinking (18 of the 22 residents for whom data were available), perceived general deterioration
(14 out of 22), breathing problems (13 out of 22), infection (9 out of 22) and increased sleepiness (9 out
of 22). These mirror events and symptoms as they were recorded in the care notes across the sample
(i.e. residents both alive and dead at the end of Phase 1) and over the 12-month period (see Appendix 58,
Tables 114 and 115), and suggest that care home staff do not perceive any significant differences in
symptoms between residents who are close to death and those who are not, nor any sudden changes
in symptoms in the month preceding death. Only 3 out of 22 deaths reportedly involved any pain
management. Examination of service utilisation in the month preceding death reveals that only 2 out of
the 22 resident deaths, for which data was available, reportedly had received specialist services support
(i.e. hospice nurse and Twilight Nurse). Both cases involved a resident with a cancer diagnosis.
Characteristics of older people who died compared with those still alive
The typical illness trajectory of OPWD is one of progressive functional decline over a prolonged period.
Among the 127 residents with available data there were 17 deaths. Six residents had moved from the care
home and 104 residents were alive at end of the study. There were no evident differences in survival
comparing 80- to 89-year-olds with those aged ≥ 90 years. Survival rates appeared slightly lower for males
but this difference was not significant (p= 0.096). The absence or presence of a formal diagnosis of
dementia (p= 0.67) was not a relevant indicator for impending death. The mortality rate was highest in
care home 6, but the 98% CIs indicate the relative imprecision of these estimates, given the small number
of deaths per care home. Our results suggest that for care home staff and visiting health-care practitioners,
it is difficult to predict how long this period will last or to differentiate even in hindsight between residents
who are dying and those who are not.
TABLE 64 Evidence of discussion regarding resuscitation statusa
No evidence of resuscitation discussions, n (%) 56 (42.11)
Evidence of resuscitation discussions, n (%) 22 (16.54)
No evidence of discussions on end-of-life wishes, n (%) 53 (39.85)
Unavailable, n (%) 2 (1.50)
a Source: care notes.
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Dying trajectories
Residents’ trajectories to death were examined in depth, and summarised from care home notes and staff
accounts in the form of Visio timelines. Classification of Visio summary timelines resulted in three distinct
end-of-life trajectories: anticipated, unexpected and uncertain dying.
Trajectory A, anticipated dying Anticipated death with planned end-of-life care in the care home.
These residents were recognised to be approaching death and decisions were made about providing for
end-of-life care in the care home (Figure 16). In all cases, care continued in the home up to death; none
were transferred to hospital or hospice. Twelve cases fitted into this model – the majority of the deaths.
Trajectory B, unexpected dying Acute illness or sudden event leading to death in the care home or
emergency admission to hospital where the resident subsequently died. Only two deaths were classified as
‘unexpected’. In both cases, residents had been stable in the care home and then suffered an unexpected
acute event (i.e. pulmonary embolus and breathing difficulties), which led to unexpected death in the care
home or emergency admission to hospital (Figure 17).
Trajectory C, uncertain dying Diagnostic uncertainty or disagreement as to the best course of action that
led to hospital admission and death in hospital. For these residents the period before death appeared to be
a time of diagnostic uncertainty. They were unwell but it was not evident to the care home staff that they
were close to the end of life. Resident deaths that fit into this category were further classified into
treatment uncertainty (n= 5) and service uncertainty (n= 3).
Treatment uncertainty These residents died in hospital following admittance for reasons such as treatment
of infection, not responding to oral antibiotics or for further investigation of an illness for which the cause
was not clear (Figure 18). Equally, there were residents who were still alive at the end of data collection,
whose experience of episodes of ill health did not signal their impending death within the next 6 months
(Figure 19).
Service uncertainty Three deaths occurred in the midst of disagreement as to where the resident should be
cared for and by whom, leading to prolonged stays in hospital awaiting placement in a care home with
nursing, and in one case to discharge from the hospital back to the care home just 1 day before death
(Figure 20). Finally, in four of the cases it was not possible to categorise the death because of
limited information.
Living and working with uncertainty
This section synthesises the qualitative data from Phase 1 interviews with OPWD (n= 18), care home staff
(n= 33), GPs (n= 5), district nurses (n= 5) and emergency ambulance services staff (n= 3), which focused
on the experience of providing and receiving care. Interviews illustrated the issues and decisions that led
up to the events observed in the resident dying trajectories outlined above, and made explicit how the
experience of dying with dementia is shaped by multiple factors and not just symptom-related issues.
Interview data indicate that care home staff members were more likely than NHS staff to have undertaken
dementia training (see Appendix 60, Tables 124 and 125). Only two GPs (out of five) and two district
nurses (also out of five) reported having received some form of training in dementia care. All but one
member of care home managerial staff had received dementia training. None of the GPs had undergone
any further specialist training in geriatric or end-of-life care.
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Residents’ interviews
When discussing end-of-life priorities and needs, the recurrent and overarching theme was one of
uncertainty about their future and how they would be involved in decision-making. Among older people,
important themes were uncertainty about the progression of their disease, how they understood living in a
care home and who they identified as the person(s) who understood them. Place of death was not
necessarily a meaningful measure of effective end-of-life care. Preferences and expectations about
end-of-life care were blurred with the everyday experiences of care. Findings demonstrated the importance
of ongoing review and discussion with people whose dementia might wrongly be seen as precluding
meaningful discussion. Residents’ uncertainty about the future and being in the care homes is discussed in
detail by Goodman et al.229
Care home and NHS staff interviews
Uncertainty was also a dominant theme in the staff interviews. It was expressed in terms of diagnostic
uncertainty and clinical decision-making at different time points, and staff uncertainty about roles
and responsibilities within care homes and NHS services, including questions about workforce capacity and
uncertainty when accessing primary and community care services.
Uncertainty in the resident trajectory
Knowing when someone with dementia was actively dying was very difficult. Although care home and
NHS staff knew signs of deterioration such as weight loss, reduced function, chest infections and increased
apathy were significant indicators, these were often not documented, were diffuse, and could either be
present for long periods of time, or, with treatment, might resolve. This variable path to death was
recognisable after death but not always in the moment. Treatment uncertainty affected decision-making
about withdrawal of treatments and referral to hospital, and how information about the person with
dementia was communicated to family members and within/across organisations.
Clinical decision-making in care homes was not seen as the work of one person and had to take multiple
perspectives into account. For care home staff, decision-making about quality of life related to the
responsiveness of the resident, their ability to still interact and take an interest in their surroundings.
For clinical staff it was whether the treatment was unduly prolonging a life that was naturally coming to an
end (and one that they themselves would not want to live). When the dying period was protracted it was
difficult to maintain both communication – between clinicians, care home staff and family members – and
responsiveness in times of crisis.
Examples of when staff had worked together well suggested that there had been time to discuss
symptoms and involve relatives, and that the pathway to death had been clear. NHS staff seem to have
had very little input to the care of some residents who died, and it was unclear if this was because it
was not required or because their needs were not obvious and they had been overlooked.
Uncertainty in roles, relationships and responsibilities
At the outset of the study, NHS and care home staff believed that they had good working relationships
but communication and responsibility for decision-making were often unclear. To provide end-of-life
care NHS staff relied on care home staff to describe what was normal for the older person, and to inform
decisions to visit, treat, liaise with family and involve other services. Interviews highlighted persistent
themes of uncertainty in how these roles and relationships were negotiated. When it was clear that
someone was terminally ill, and in the last days of life, some (but not all) care home staff wanted
something, such as the LCP,215 to give them permission to talk about dying, liaise with NHS staff and help
structure their activities. However, two managers commented that the LCP meant that primary care staff
‘took over’ end-of-life care, which ‘medicalised’ dying, excluded the involvement of staff and complicated
communication between them.
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Paramedics interviewed in this phase reported that they were sometimes used as a ‘go-between’, and the
‘easy option’ when a GP was unavailable to attend or when an inexperienced care worker was unsure
what to do. This was an area that was also raised during post-death analysis interviews by some care
home managers. It suggested a sense that these two participant groups lacked the authority and
opportunity to discuss and debate the choices and decisions that staff make in emergency situations.230
Uncertainty about access to, and capacity of, services
There was uncertainty within and across groups about the value of focusing on end of life, and whether
or not care homes were the best place to die. Only GPs were convinced that end of life for people with
dementia should be in the care homes. District nurses and care home managers, for different reasons,
were unsure.
For care home managers, it was because their focus was on the living; consequently, talking about dying
was often felt to be inappropriate. District nurses, regular visitors to care homes and some paramedics
were concerned that neither they nor the care home staff had the capacity to care for people at the end of
life. This view was supported by examples of care home staff working unpaid overtime when a resident
was dying because there was limited cover at night. GPs also hinted at the possibility that some OPWD
were overlooked because reviewing their care would generate more work for their already full caseloads.
Uncertainty about access to, and capacity of, services to provide end-of-life care was related to the limited
responsiveness of primary care services and the eligibility of residents for specialist palliative care services
and equipment (even if they could be provided in time). Similarly, there was evidence of people dying
in hospital while waiting for a placement to a care home with nursing because the hospital staff were
uncertain if the care home could provide end-of-life care.
Service utilisation and associated costs
Distribution of service use per month
All care homes residents are entitled to the full range of NHS primary, community and hospital-based care
support but were found to access only a limited number of services on a regular basis. Three main
categories of service were defined:
l Hospital services were limited to emergency (ambulance), accident and emergency (A&E), inpatient and
outpatient services.
l Community health services included district nursing as well as OOH GP services.
l GP services.
Use of these services was examined among all residents for whom data were available. There were no
significant differences between residents who were alive at the end of the study period and those
who had died, in terms of age on admission, gender, reason for admission, admission route and number
of long-term conditions (Table 65).
Service use for the whole sample is shown in Appendix 59, Table 121, and for those alive at the end of
12 months plus those who had died. In accordance with other research that has found that costs are
usually highest for people 1 year before death,231 service use was significantly greater among those
individuals who had died in all three categories of service.
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Distribution of costs
The distribution of health-care costs for the overall sample is shown in Appendix 59 (see Table 122),
and for those alive at 12 months compared with those individuals who died. Generally, each care home
resident in Phase 1 incurred about £2549 per month in terms of accommodation, health service use
and medication consumption. Given the significant differences in service use, it was not surprising to
observe that primary care, hospital and community health-care costs were significantly greater for those
individuals who died than those alive at the end of 12 months. Including the costs of accommodation and
medicines did not alter this finding, despite accommodation costs being much greater than all of the other
health-care cost components.
Multivariate analysis of total costs
Table 66 presents the results of a multivariate analysis of total costs (including accommodation and
medication costs). A generalised linear model was used to estimate the relative effects of individual
characteristics on total costs. Death significantly increased total costs. The marginal effect of death on
total costs was a £379 increase (other characteristics at their average values). Results also suggest that
individuals admitted from a relative’s home or from another care home incurred significantly lower total
costs than those admitted from their own home. Further investigation regarding route of admission
of older people into care homes may be warranted.
TABLE 65 Distribution of baseline characteristics
Characteristic Overall (n= 133) Alive (n= 116) Dead (n= 17) p-valuea
Age on admission (years): mean (SD) 84.0 (6.7) 84.0 (6.9) 84.4 (5.5) 0.984
Gender: % female 77.4 79.3 64.7 0.178
Reason for admission (%) 0.513
Isolation 5.7 6.8 0.0
Not coping 44.3 43.2 50.0
Bad health 18.2 16.2 28.6
Needs not being met 25.0 25.7 21.4
Other (note: missing for 45 individuals) 6.8 8.1 0.0
Admitted from (%) 0.0.728
Own home 43.3 42.9 46.7
Relative’s home 5.8 6.7 0.0
Hospital 29.2 29.5 26.7
Other care home 10.8 10.5 13.3
Sheltered housing/warden controlled 10.8 10.5 13.3
No. of long-term conditions: mean (SD) 2.4 (1.5) 2.4 (1.5) 2.4 (1.5) 0.844
a Based on Wilcoxon rank-sum test for continuous variables and chi-squared test for categorical variables.
EVIDEM-EOL: QUALITY OF CARE AT THE END OF LIFE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
128
Results from Phase 2
Phase 1 identified uncertainty at all levels as a potential barrier to the delivery of effective end-of-life care
for OPWD in residential care homes. This analysis led us to design an intervention that could address
these different but overlapping levels of uncertainty by building on existing relationships, strengths and
achievements and, when appropriate, end-of-life care resources. This section considers how AI (and the
tools that emerged in the process of implementing it) was effective in addressing the different types of
uncertainty experienced by care home and NHS staff. The findings from Phase 2 are organised and
discussed under three headings.
How AI addressed uncertainty:
l in interpersonal and interprofessional relationships (Relational uncertainty)
l in identification and management of end-of-life care for people with dementia and resource use
(Treatment uncertainty)
l around the knowledge and skills required to provide end-of-life care for people with dementia and
the capacity of NHS and care home staff and services to provide this (Service uncertainty).
Relational uncertainty
Creating communicative space
Appreciative Inquiry sessions were protected, non-hierarchical meetings and were held in the care home.
The starting point was discussion of the participants’ strengths in end-of-life care; it was a space in
which care home staff heard first hand (and in most cases for the first time), from visiting NHS staff, that
their experience in dementia care and knowledge of the resident was valued and ‘fundamental’ to
end-of-life care.
A persistent theme in Phase 1 was concerns about the accountability of care home staff to the regulator
(CQC), and, for NHS staff, their personal liability. The AI processes meant that practitioners were able
to admit their own fears and concerns, and acknowledge their co-dependency. At the end of the
intervention, one GP commented to the care home manager that he used to dread coming to the care
home but this was no longer the case.
TABLE 66 Multivariate analysis of total costs: generalised linear model (n= 113) – marginal effects, 95% CI of
marginal effects and p-values
Characteristic Marginal effect 95% CI p-value
Age at admission, years –56.2 –111.1 to –1.3 0.05
Gender: male –478.6 –1336.4 to 379.3 0.27
Admitted from:
Relative’s home –1527.3 –2333.5 to –721.3 0.00
Hospital –330.4 –1037.4 to 376.7 0.36
Other care home –377.7 –1154.0 to 398.5 0.34
Other/sheltered housing/warden controlled . . . –346.4 –1145.9 to 453.0 0.40
No. of long-term conditions 90.5 –138.2 to 319.3 0.44
Died 2592.7 432.1 to 4753.2 0.02
Notes
R2= 0.31.
Kurtosis= 3.12.
Marginal effect of death on total cost (£) (95% CI)= 379 (57 to 702).
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Participants perceived the most important outcome as appreciating colleagues’ roles in end-of-life care.
The GP linked to care home 1 recognised that post AI there was a greater shared understanding of what
they were trying to achieve.
It’s (. . .) important to share that we actually have the same goals, that we think the same things are
important, it enables easier conversations on a daily basis, because we know where we are all
coming from
GP-CH1
Out-of-hours checklist
These discussions demonstrated how important it was for NHS staff to value the knowledge that care
home staff had about their residents and dementia. It highlighted why this valuing was less evident when
contacting OOH services. Care home staff did not know what information the OOH GP needed. OOH GPs
would tell care home staff to call an ambulance when the information received seemed insufficient to
make an assessment of the urgency of the problem. It was through ‘appreciating’ the challenges of their
respective roles that the development of the OOH checklist arose. The checklist provided sufficient
information for the GP and it could be left by the phone ready for OOH call-back. It was a tool developed
together that addressed a shared frustration.
Do Not Attempt Cardiopulmonary Resuscitation audit
The AI intervention gave care home staff the confidence to share information and initiate conversations
with the primary health-care staff. In care home 5, the GP carried out an audit of Do Not Attempt
Cardiopulmonary Resuscitation (DNACPR) forms in April 2011, which revealed only one out of 53 residents
(i.e. the total number of residents in the care home, including those not consented to the study) or others
on their behalf had completed such a form, but by July 2011 there were seven, and, by March 2012, 25 out
of 55 residents (45.5%) had a DNACPR form. Residents identified as nearing the end of life were more
likely to be included on the practice palliative care register and have their situation discussed with family
members. The process of the DNACPR audit, and the involvement of the GP, triggered conversations across
the care home about anticipating end of life, and normalised talking about dying. All three senior care
workers interviewed in this care home following the intervention described how they initiated discussions
with the GP regarding possible signs of deterioration and transitions to end-of-life care. Indeed, the
proportion of care home staff involved in discussions around of life care of residents was observed to have
doubled after the intervention (see Appendix 61, Table 126).The GP interviewed after the intervention
recognised this change:
The communication (. . .) is no longer doctor–carer, ‘you do this, I’ll do that’ (. . .) there’s an improved
confidence with the staff to be able to say, ‘doctor, we’re concerned that this patient is deteriorating,
what do you think we should do?’ (. . .) or ‘his family are here’, and then I say, ‘OK, fine, I think we
should all come together’.
GP-CH5
Prompt sheet
The explicit focus on end-of-life care started a discussion about care homes as places for living and dying.
In care home 1 participants worked together to develop a prompt sheet that could help staff initiate a
conversation about preferences and priorities for end-of-life care with residents, using a range of resources
including information from the Dying Matters coalition.232 The AI sessions had sharpened the organisation’s
focus on providing end-of-life care:
We do talk about [end of life] (. . .) [but] I think the meetings really helped us to focus a bit more on
that (. . .) helps to focus on what we are doing. People are coming here [and] we know that they will
eventually pass away (. . .) that is what we should be planning for.
Deputy Care Home Manager-CH1
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There was evidence this had made her more receptive to the subject of end-of-life wishes when carrying
out care reviews with residents, thus allowing residents to raise and discuss end-of-life topics.
Treatment uncertainty
Symptom management
Uncertainty about symptom management, such as breathlessness, repeated falls and difficulty eating and
drinking had been documented in Phase 1, as triggers for admission to hospital or calls to emergency
services. During the final AI session, one care home manager expressed concern over ‘eating and drinking’
issues at end of life and personal liability, suggesting that AI was an intervention that could accommodate
and address underlying concerns about responsibility alongside clinical decisions. Post intervention there
was evidence of consultation with specialist palliative care services and improved understanding about
situations when supplementary and enteral nutrition would not be appropriate.
Post-death analysis and use of Visios
Phase 1 made it explicit that NHS staff lacked confidence in their knowledge about dementia, and care
home staff their lack of clinical knowledge. The use of Visios in Phase 2 enabled an exploration of what
‘normal’ looks like for the resident with dementia and what symptoms were significant (see Appendix 51).
AI balanced a focus on an unplanned hospital admission and death with a discussion of what had been
achieved leading up to the resident’s death. It encouraged reflexivity and review, and enabled participants
to ‘hold’ situations when it was unclear what the best decision would be, for example when a resident
was well in between increasing episodes of ill health. It enabled them to identify and reinforce what
had worked well, how to improve care but also accept that in some of the deaths it was only with
hindsight that the situations were clear, which led to discussion on how to negotiate uncertainty across
organisations and between practitioners.
Documentation change
Finally, the AI intervention addressed treatment uncertainty by making the challenges participants
encountered explicit, and by the co-development of documentation that helped bridge the gap between
social and medical views of care. This included care plans that used language and instructions that made
clear to care staff the medical decisions that had been reached with the GP. End-of-life care tools
were being appropriated by care home staff to make explicit the impact that medical decisions had on
end-of-life care practices, especially in times of crisis and exacerbation:
Yeah basically he (family member) doesn’t want his mum to go to hospital so it’s not so much a
‘Do Not Resuscitate’ [as a] ‘Don’t Call Paramedics – call GP’
Deputy Care Home Manager-CH6
Service uncertainty
Appreciative Inquiry focused on the capacity and assets of the workforce and the evidence for what
was achievable and appreciated. Among care home staff there was evidence of increased confidence
that primary health-care services would respond when needed:
That is something that we are really promoting here [with the doctors]. Instead of going to hospital . . .
lately quite a few deaths that we had, they passed away in the home. [T]hrough this research, I think
we have [discovered] what we can [provide] here in the home with the help of the doctors, rather
than have to send someone to hospital for treatment (. . .) now, having the GP involved and everything
we know that they can stay here, they can be looked after and cared for here.
Deputy Care Home Manager-CH5
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Increased district nurse involvement
Finally, a change brought about through the AI intervention in care home 6 included ‘coffee mornings’
between care home staff and the wider district nursing team to introduce incoming members of staff and
discuss any issues (an innovation that was still in place 18 months after the end of data collection). Family
members interviewed after a relative’s deaths in this care home also noticed how district nurse involvement
had been instrumental in enabling their mother to die in the care home:
They knew my mother didn’t want to go into hospital, they knew what the situation was, um and
they . . . the home felt . . . When she spoke to me about, when [Deputy Manager] spoke to me about
mother going to hospital, I said can you care for her in the home? Have you got enough you know . . .
and she said yes, we have, with the District Nurses coming in
Family member-CH6
Overall, the numbers of primary health-care staff involved in the resident deaths increased. For example
the district nurses working with care home 1 who had not been involved in end-of-life care in Phase 1
were consulted for advice, nursing support and reassurance in Phase 2 (Figure 21).
Costing analysis
Comparison of resource utilisation and associated costs was undertaken between the overall sample in
Phases 1 and 2. Table 67 shows the costs incurred per resident per month for each category of costs.
As the sample size of this study is relatively small, only median values are presented. Each care home
resident in Phase 2 incurred about £2633 per month in terms of accommodation, health service use and
medication consumption compared with £2549 in Phase 1. Accommodation costs (including care home
staff and food and so on) accounted for around 90% of the total costs per month. There was a decrease
in community health costs (–83%) and hospital costs (–52%). Medication costs however nearly doubled.
Overall, total service costs incurred dropped by 15% from Phase 1 to Phase 2.
One of the most commonly used quantitative means for measuring end-of-life care has been place of
death.233 This study saw similar proportions of residents dying in hospital (55%) and in the care home
(45%) in Phase 1 (15 out of 27 deaths in care homes) and Phase 2 (five out of nine deaths in care
homes). However, we observed a decrease in the length of inpatient stays and emergency ambulance
use specifically, which was found to significantly reduce hospital costs overall.
Costs before and after the intervention were further examined among residents who had participated in
both phases of the study. Results are similar to those derived from comparisons between the wider
samples and were subject to significance testing. Among residents who participated in both phases of the
study (n= 28), hospital and community care costs were significantly lower in Phase 2 than in Phase 1
(p= 0.0456 and p= 0.0001, respectively). However, there was no significant difference between primary
care costs between the two phases (p= 0.8376).234
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Discussion
Summary and discussion of Phase 1 findings
Prognostication is difficult for people with dementia.200,201 Key symptoms and events among OPWD can
sometimes be indicative of a transition from living to dying.235
There were no significant differences between residents who were alive at the end of the study period
and those who had died, in terms of age on admission, formal dementia diagnosis, gender, reason for
admission, admission route and number of long-term conditions.
There was considerable heterogeneity, however, in the resident population across care homes in terms of
length of stay, function, residents with a dementia diagnosis, and individual resident’s use of resources.
Future research on end-of-life care for people with dementia needs to consider how the diversity of the
care home population affects the experience and knowledge of care home staff about end-of-life care.
Phase 1 showed that in care homes with no on-site nursing there were different pathways to death. Not
all residents had advanced dementia and dementia was not always the cause of death. However, dementia
did complicate decision-making. There was evidence of attempts to use Advance Care Planning but there
was considerable variation in how this was documented, who was involved in the decision-making and
whether or not this information was used. Interviews with residents demonstrated that residents’ accounts
of care preferences and identification of key care staff had the potential to inform future decision-making
and augment the completion of an Advance Care Plan.
In the care home environment, dying with a dementia could be a ‘contested’ process,236 complicated by
uncertainty at the individual, service and organisational levels of care. Different participants had
considerable discretion about how they engaged in providing end-of-life care for people with dementia,
both in the care home and between services. Patterns of working could either foster discussion of
residents’ needs or limit opportunities for it.
Access to services was inextricably linked to uncertainty about roles, responsibilities, capacity and
knowledge of the workforce, and whether the person with dementia was approaching the end of life.
From an organisational perspective, however, there was an additional lack of clarity. This was uncertainty
about the appropriateness of service requests, the capacity of the primary care workforce to provide
ongoing support, entitlement to specialist services and whether hospital and emergency services believed
that care homes were able to provide end-of-life care.
TABLE 67 Estimated costs: Phase 1 vs. Phase 2
Costs (£) per resident per month
Median
Percentage change in
terms of median costsPhase 1 Phase 2
Accommodation 2243.35 2380.49 6
Medication 56.54 81.17 44
Primary care 76.31 83.90 10
Hospital 38.98 18.52 –52
Community health 45.46 7.82 –83
Total service 193.98 164.52 –15
Total service and accommodation 2488.17 2539.47 2
Total (service, accommodation, medication) 2548.53 2632.61 3
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The co-dependency between NHS and care home staff and the examples of when collaborative working
mitigated some of the challenges described suggested an intervention that would require the engagement
of all those involved, incorporate the residents’ views and preferences and build on relationships that were
already in place. It had the potential to address and ‘hold’ the uncertainty experienced when staff are
reliant on input from (multiple) external services, as well as answerable for decision-making to family
members and the regulator.
Summary and discussion of Phase 2 findings
Although ‘clear care pathways’ for people with dementia at the end of life were desirable, they were
often unattainable. AI sought solutions from among those already involved in providing care. As a
context-sensitive intervention it addressed the participants’ interests and concerns, and created a process
of working that, using Fisher and Ridley’s terms,237 could foster ‘practical certainty’ in situations when
uncertainty was an intrinsic and enduring feature. AI’s effectiveness is judged by its ability to create an
environment in which participants were able to safely acknowledge their co-dependency and appreciate
each other’s role in end-of-life care (i.e. Discovery Phase), imagine the best end-of-life care for people with
dementia within the home (i.e. the Dream Phase) and work together to design end-of-life care tools that
would help them to attain their ideal (i.e. Design Phase).
The relocation of a person with dementia to a care home can signal a reduction in, or even the end of, the
involvement and responsibility of NHS professionals. This study demonstrated the value of an intervention
that sustained ongoing negotiated involvement of NHS staff.
Appreciative Inquiry focused on the practical delivery and expectation of care by taking into account the
assets of the organisations involved and the capacity of the participants to build on previous achievements.
It complemented approaches to dementia care that emphasise what a person retains and has capacity to
do. A deficit model of care that starts with failure (e.g. breakdown in communication, knowledge deficits,
inappropriate admission and uncontrolled symptoms) can identify service shortcomings, but is less likely to
engage with the complex uncertainties that NHS and care home staff encounter, which Phase 1 findings
demonstrated. AI did not preclude the use and refinement of existing Advance Care Plans, end-of-life
care frameworks and extra training in end-of-life care, all of which aim to address the same issues.238–240
AI led to their increased use (DNACPR, palliative care register, LCP215). However, its context-specific,
non-hierarchical approach to co-design was arguably more flexible and better suited to working across
organisations and between public and independent providers. Implementation of AI in Phase 2 helped
reduce the use of health services and corresponding costs, and these results were corroborated by the
qualitative findings. The total costs incurred by residents were lower in Phase 2 than in Phase 1.
Appreciative Inquiry was an intervention that could accommodate and address underlying concerns about
responsibility and liability alongside clinical decisions. The difference between using AI and introducing an
established end-of-life tool such as the GSF213 was that AI led to the use and development of end-of-life
resources that arose from a change in working relationships. A decision to use a particular tool did not
change how care was organised, but rather was itself a result of a change in care practices and working
relationships initiated by the AI intervention.
Relative interviews in conjunction with care home notes demonstrated the importance of involving relatives
in end-of-life discussions and medical decisions concerning residents and keeping relatives informed of
any changes and/or deterioration. The reasons why some relatives wanted more rather than less medical
intervention and encouraged hospital admission needs further investigation. One relative interview
highlighted the importance of viewing a resident’s death within the context of their life before admission
to the care home.
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Finally, findings related to medication use in Phase 1 were not explored or challenged in Phase 2, but
suggest that sedative load was not as significant as anticipated. Inappropriate prescribing does appear,
however, to be an issue among older people both living and dying with dementia, which may warrant
further research.
Limitations
The EVIDEM-EoL study is an exploratory study. The results are tentative. AI appears to improve and change
working relationships with promising outcomes. It is an approach that fits with others that emphasise
relational approaches to care.241,242 Nevertheless, more research is needed to test these findings further and
with more robust controls.
The small sample of care homes and care home residents is a limitation affecting generalisability, although
the resident characteristics and size of care homes were consistent with other studies in care homes
without on-site nursing.243–245 Care home notes from which resident baseline characteristics were extracted
could be inconsistent across time points. Residents’ long-term conditions are likely to be under-reported as
a result. Phase 2 was shorter, which might lead to an underestimate of the impact of the interventions
introduced in Phase 2 on resource utilisation. There could also be potential underestimation of the costs of
resources to support the care home residents. Outcome measures for end-of-life care were captured in the
study but were limited to place of death and evidence of documentation. This made it more difficult to
assess the association between resource utilisation (i.e. costs) and the quality of life of the residents in
this study.
Conclusion
Dying with, or from, dementia is invariably ‘protracted, unglamorous and ordinary’.211 The everyday
realities of living in a care home, the impact of dementia and other health problems, and the physical
and practical isolation from NHS services further complicated that process. Appreciative Inquiry addressed
these context-specific challenges, emphasised the capacity and assets of the organisations and services
involved, provided a basis from which to co-design new tools and use existing end-of-life care resources.
An important output of this study is the development of a framework that defines the different
manifestations or levels of uncertainty, and that can be used to test the comprehensiveness and strengths
of future interventions designed to improve end-of-life care for people with dementia in care homes.
As Seymour et al.246 have observed, for the vast majority of those who die, the promise of hospice and
palliative care has never been fulfilled. The rapidly changing demography of ageing and dying requires
solutions that are grounded in a reality that can carry the vision of hospice and palliative care into settings
with limited access to specialist palliative care. Kellehear and Young247 have argued for a ‘public health
of dying’ in as much as care homes are small communities of care, reliant on unqualified staff, family
members and a varying range of support services; this study provides a model of relational working that
arguably reflects some of those goals and realities. From an economic perspective, the findings have
highlighted that there is greater scope for more efficient use of resources. However, further and
continuing research on the costing and economic analysis of different end-of-life care models for OPWD
in care homes is needed.
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Changes to protocol
Phase 1
Phase 1 of the EVIDEM-EoL study entitled ‘Changing practice in dementia care in care homes: developing
and testing evidence-based interventions at the end of life’ (REC reference: 08/H0502/74) received a
favourable ethical opinion from the Southampton & South West Hampshire REC (A) on 14 July 2008.
The Phase 1 protocol was subject to three significant amendments.
l Amendment 1 sought to offer anonymous resident data to the EVIDEM registry study (see Chapter 6)
(approved 30 June 2008). Amendment 1 (REC reference: 08/H0502/74) was approved by the
Southampton & South West Hampshire REC (A) on 5 March 2009.
l Amendment 2 sought to refine the process of consultee engagement. Amendment 2 (REC reference:
08/H0502/74) was approved by the Southampton & South West Hampshire REC (A) on 5 March 2009.
l Amendment 3 sought to include ambulance staff from the London Ambulance and Paramedic Service
and the Bedfordshire and Hertfordshire Paramedic Service in the research study. Amendment 3
(REC reference: 08/H0502/74) was approved by the Southampton & South West Hampshire REC (A) on
11 August 2009.
Phase 2: Intervention phase
Phase 2 of the EVIDEM-EoL study entitled ‘EVIDEM-End of Life: Changing practice in dementia care in care
homes: developing and testing evidence-based interventions at the end of life – Phase 2’ (REC reference:
10/H0502/55) received a favourable ethical opinion from the Southampton & South West Hampshire REC
(A) on 10 August 2010. Phase 2 of the study was subject to one amendment that sought to include
relatives of residents living in participating care homes in the study. Amendment 1 (REC reference:
10/H0502/55) was approved by NRES Committee South Central – Southampton (A) on 27 May 2011.
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Chapter 5 EVIDEM-MCA: implementing the
Mental Capacity Act 2005
Abstract
The MCA 200517 safeguards the rights of people with dementia and carers, enshrining principles of
capacity, decision-making and best interests. Our study, designed in four phases (pre diagnosis, immediately
after diagnosis, living with dementia, end of life), explored the MCA’s implementation and impact.
We interviewed practitioners from agencies working with people with dementia (n= 272), ‘well’ older
people about approaches to long-term planning (n= 37), OPWD (n= 16) and carers (n= 15) about views
and experiences of using the MCA to make plans and everyday decisions, and many of these were
followed up 9–12 months later. Framework methods were used to analyse and categorise themes.
Baseline interviews indicated limited awareness, knowledge and understanding of the MCA but by
follow-up these had grown. The need for training to be a continuous process informed by supervision,
rather than one-off events was identified. An ‘information merry-go-round’ for people seeking advice and
information was found. Some ‘well’ older people had made financial plans but appeared reluctant to think
about HSC preferences and choices. Principles of the MCA, such as ‘best interests’ decision-making, were
useful for carers to apply when deciding for their relatives. Few professionals are aware of offences under
the MCA and lack confidence in distinguishing criminal acts (ill treatment and wilful neglect) from
poor care.
Practitioners working with people with dementia may be uniquely placed to address decision-making and
longer-term planning. Specific information and advice can empower people with dementia and carers
and minimise risks of abuse and neglect. Implementation of major legal changes, such as the MCA, needs
to be managed in all settings and needs long-term commitment.
Introduction
This study investigated one of the major changes affecting day-to-day practice in dementia care in England,
a change that also fundamentally enhanced the rights of people with dementia and their carers. The MCA
200517 in England and Wales, implemented in 2007, enshrines much of the practice already established
under case law.248,249 It safeguards people who lack ability to make specific decisions, enhances personal
autonomy and enables people to make advance decisions about their care and finances and to refuse
treatment. It introduced new proxy decision-making roles to address health, welfare and financial matters,
and specialist advocacy when major health and welfare decisions are being considered for people who do
not have family or friends. The implications of the MCA for HSC practitioners were initially unclear.250,251
It had been estimated that over two million people in England and Wales were likely to be personally
affected by the provisions of the new MCA.252 These were expected to include many people with dementia
and their carers, their representatives or service providers.253 The MCA now provides a statutory framework
to empower and protect people, notably those who fear cognitive impairment, those who have newly
received a diagnosis of dementia, or those who have advancing symptoms who may not be able to make
specific decisions at specific times (www.dca.gov.uk).254 It clarifies who can make decisions, in which
situations, and the steps that should be taken when considering these decisions (see Mental Health
Foundation, 2012 for a review on the topic).255 It also enables people to plan ahead in the event of loss
of their capacity to make particular decisions.256
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
139
The ability to make choices about future care and treatment decisions led to predictions that the MCA
would have great potential to enhance practice and thus contribute to better outcomes for people with
dementia and their carers.257 People with dementia may require specialist advice sensitive to their particular
values and circumstances to formulate and communicate their wishes and preferences about care and
treatment. However, there are likely to be key transitions or times when advice and assistance may be
most pertinent.258 These include professional encounters, such as the communication of a diagnosis of
dementia, transitional periods when planning and setting up care packages, or when facing the end
of life. It was predicted that professionals would need to devote time to assisting people with dementia
and their carers to benefit from the MCA, and to make sure that they were ready to explain and debate its
implications within teams and across agencies.259 Although savings of professional time were envisaged,
there were concerns that practitioners might feel compromised by work pressures or be unable to provide
the necessary expertise and support.260 Furthermore, proactive promotion of the MCA by service managers
and professionals may be required if people with dementia are able to maximise their opportunities for
planning their care and making their wishes known.
Essentially, the MCA offered people with dementia a crucial opportunity to influence professional
decision-making. It confirmed that professionals should presume capacity to make decisions unless proven
otherwise and that best interests should be the basis for action if a person is not able to make a specific
decision. It has the potential to enhance the confidence of people with dementia and their carers that they
are able to shape their current and future care and treatment. Lastly, the new criminal offences of ill
treatment and wilful neglect defined by the MCA were designed to strengthen adult protection systems,
to the benefit of people with dementia and others who may have particular difficulty in reporting abuse
and providing evidence. The full implementation of the MCA in late 2007 provided a unique opportunity
to explore the early, then ongoing implementation and impact of the MCA with a focus on its
incorporation into practice and service cultures.
Methods
Aims and objectives
Two overarching aims of the study informed the initial study design (see Appendix 62 for the study
protocol). These aims were to:
1. identify the implementation issues arising from the introduction of the MCA in the services working
with people with dementia and their carers over a 5-year period, in community settings (including
care homes)
2. explore and make recommendations about continued professional development programmes about the
MCA, and their links to adult safeguarding training and practice.
Study design
The study was designed as four phases to reflect the trajectory of the dementia syndrome: (1) pre
diagnosis; (2) post diagnosis; (3) living with dementia after diagnosis; and (4) towards the end of life.
Distinct research questions were developed for each phase, incorporating the overarching aims of the
study. Participants for each phase were recruited accordingly. The phases, research questions and
participants are summarised in Table 68 and details can be found in Appendix 63.
To capture the element of change over time in the implementation of the MCA, we incorporated a
longitudinal element in our study by interviewing most practitioners at two time points: time 1 and time 2
(and some groups at time 3). As our intention was to investigate how the MCA was becoming embedded
in practice settings, the study was designed in order to elicit practitioners’ own experiences over time as
a way of capturing changes in their understanding and experiences.
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Settings
Participants were interviewed at their convenience. For the majority of practitioners, interviews took
place in work hours in a private office or staff room at their place of work, although a small minority opted
for telephone interviews. ‘Well’ older people, people with dementia and their carers all preferred interviews
to be conducted in their own homes. Three participants offered to be interviewed in the researchers’
office, as they were in the area and their offices were unsuitable (e.g. open plan).
Inclusion and exclusion criteria
No exclusion criteria applied to staff interviews as we sought responses from staff in each service, at
all grades and undertaking a range of work with people with dementia. Because of time constraints
and work pressures, some staff declined the opportunity to participate. As participation was voluntary,
no further invitations were extended.
TABLE 68 Phase classification of research questions and participant groups
Phase Pre diagnosis
Immediately post
diagnosis
Living with dementia
after diagnosis End of life
Characteristics
of phase
Before diagnosis
Possibly before contact
with specialist HSC
services
Early planning
Capacity not likely to
be greatly impaired
Capacity may be
impaired
Safeguarding against
abuse is priority
Attitudes towards
Advance Care Plans
Proxy decision-making
may be needed
Research
questions
RQ1: How do ‘well’
older people
conceptualise and
consider future care
needs?
RQ2: What support is
there for older people
and how is it
conceptualised by
staff?
RQ3: What are the
knowledge, views,
experiences and
expectations of the
MCA among staff
supporting ‘well’ older
people living in the
community, who may
wish to consider
planning for their
possible futures?
RQ4: What are the
knowledge, views,
experiences and
expectations of the
MCA among staff
supporting people in
the early stages of
dementia? How does
this change over time?
RQ5: What advice,
information and support
are available to those
keen to plan soon after
receiving a diagnosis?
RQ6: What framework
does the MCA provide
for people with
dementia and carers
living in their own
homes when making
everyday decisions?
RQ7: What are the
knowledge, views,
experiences and
expectations of the
MCA among staff
supporting people in
the later stages of
dementia, when
capacity may be
impaired? How does
this change over time?
RQ8: What advice,
information and support
are available to those
whose relatives with
dementia lack capacity?
RQ9: What frameworks
can be put in place
so that people with
dementia – with and
without capacity – are
safeguarded against
abuse? Does the MCA
help?
RQ10: What are the
knowledge, views,
experiences and
expectations of the
MCA among staff who
work with people with
dementia at the end of
their lives and their
carers regarding
Advance Care Plans?
RQ11: How does the
MCA help them make
proxy decisions?
Research
participants
Older people interviews
Age Concern (now Age
UK)
Safeguarding Adult
Coordinators
Alzheimer’s Society
Carers’ Centres
Safeguarding Adult
Coordinators
People with dementia
plus carers
Social workers
Admiral Nurses
People with dementia
plus carers
Safeguarding Adult
Coordinators
Alzheimer’s Society
staff survey
Care home staff and
managers
Care home staff and
managers
RQ, research question.
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Inclusion criteria for interviews with ‘well’ older people were that participants had to be aged > 50 years
(to explore how people possibly plan ahead as they approach later life) and the ability to participate in an
interview in English. No other exclusion criteria were applied.
For interviews with dyads of people with dementia and their carers, the inclusion criteria were the presence
of a formal diagnosis of dementia, and the presence of a carer whom they either lived with or saw for more
than half the week. An ability to speak English was also necessary. No other exclusion criteria were applied.
Sources
In order to access the wide range of participants needed, different community-based groups were asked to
publicise this study as a recruitment strategy. These included advocacy groups, social clubs and social groups,
lunch clubs, support groups, Carers’ Centres, Alzheimer’s Society groups, Age Concern (now Age UK), Greater
London Forum for Older People, University of the Third Age, local authority (LA) social services/adult services
departments, and a selection of care homes in the private and not-for-profit sectors. We were keen to access as
diverse a range of participants as possible, and hence recruited from different areas in and around London
along with agencies that worked with diverse client groups. As Robson125 suggests, we adopted flexibility in our
sampling framework, for instance, although we started with a quota sampling frame, that is, aiming to speak
to people with varying job roles and experiences, we also adopted a ‘snowballing’ approach – the practice of
asking interview participants for suggestions of other potential participants.
Recruitment and sampling strategy
For all phases of the study, a quota sampling strategy125 was designed to recruit participants who would
be willing to share their views with the research team. An invitation letter and details of the study were
provided for those who expressed interest. In some cases, contact was initiated by a presentation by a
member of the research team on a related topic, at the end of which recruitment was discussed and
participants were invited to participate. This proved an effective way to make contact, as it engaged the
group or agency from the start and fostered a relationship based on mutual trust. Once permission
from senior management had been obtained, invitation letters were cascaded to all staff via e-mails or in
hard copy. Voluntary participation, confidentiality and anonymity of responses were emphasised. As noted
above, ‘snowballing’ was a further means to recruitment.
Data collection
All who expressed interest were approached, the study was described to them, implications of taking part
were explained, assurances of confidentiality were made and consent was obtained. For the analytical
method chosen (see Analytic methods, below), SSIs within a structured format are considered most
appropriate. For this reason, structured questioning was seen as too restrictive for participants to talk in detail
about individual experiences, and open-ended questioning was seen as too broad and reflexive, which could
have diluted the focus of this study. SSIs were conducted using topic guides developed in light of the study
aims and emerging knowledge about the MCA in practice. Most interviews lasted 30–45 minutes.
To achieve maximum consistency, a similar methodology was applied to interviews with ‘well’ older
people, people with dementia and carers. However, the researcher (KS) conducting the interviews adopted
a more exploratory approach to the interview when talking with people with dementia and probed where
relevant. Her experience in other phenomenological research studies was helpful in engagement and
conducting interviews on sensitive subjects.
For the subsample of Alzheimer’s Society staff, the Society had chosen an electronic survey as being the
most efficient way to collect information from busy staff, and questions were developed accordingly.
This contained as many questions from other interview topic guides as relevant and feasible.
In view of the potential sensitivity and personal nature of the interviews, participants were reassured
that their anonymity would be maintained and, therefore, all identifying personal details have been
changed or replaced with ellipses and ‘their’ has been used to replace his/her. Participants who requested
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information about the MCA following the interview were provided with sources of information and
specific material that was relevant to their role or interest. Following some interviews, the research team
provided training on the MCA to care home staff or information to older people’s groups.
Interview topic guides
Tailored, semi-structured topic guides were developed to explore the research questions at each phase. Topic
guides were piloted and discussed with members of the study advisory group. For practitioners this was tailored
to activities of the specific agency or professional group being interviewed. The topics covered included:
l Training The model and effectiveness of training received (if any), the nature of the training, the
effectiveness of training in developing expertise and confidence.
l Roles and activities Any impact of the MCA on specific roles and activities, matters raised by people
with dementia and/or carers.
l Looking ahead Predictions about use and uptake of the MCA and its impact.
l Personal perspectives Any documents that participants had drawn up for themselves or others,
exploring the reasons why/why not.
A longitudinal element was captured in two ways. First, participants were asked to reflect on changes in
their practice, and how these may have affected their knowledge and experiences when using and abiding
by the MCA. Second, questions were specifically framed to ask participants to describe ‘new’ or ‘recent’
procedures, frameworks, structures and processes encountered following the first interview. Although
time 1 and time 2 interviews were not always directly compared, an understanding of findings from time 1
interviews informed the development of the time 2 topic guide, thus further capturing the longitudinal
element of this study.
The topic guides for ‘well’ older people in Phase 1, and people with dementia and carers in Phases 2 and
3, incorporated questions around planning (financial, HSC – referred to as ‘welfare’ in the MCA), everyday
decision-making, proxy decision-making and sources of support they would consider or had used, or were
unknown or unavailable. Appendix 64 includes all topic guides used in the study.
Sample size
Because we used a qualitative methodology, no sample size was determined in advance. Instead, members
of staff in participating organisations were approached and the importance of the study explained to
them. For qualitative interviews with ‘well’ older people, recruiting and data collection ceased when
thematic saturation was achieved, that is, when no new themes appeared to be emerging from the data.
The same principles of thematic saturation were followed for interviews with dyads of people with
dementia and carers. For this group we anticipated recruiting 12 dyads, allowing for around two dyads
to drop out over the course of the longitudinal element of the study.
Analytic methods
All interviews were digitally recorded and transcribed verbatim by an experienced transcriber. All transcripts
were checked for clarity, verified by the interviewer for consistencies and subjected to framework
analysis.261,262 Framework analysis is appropriate for this type of evidence-based practice study, as it enables
the delineation of themes in relation to prespecified research questions. This enables a priori questions to
be answered through the use of qualitative research and is particularly useful in HSC services research.262
More details of the five main stages in framework analysis can be found in Appendix 65.
Ethical permissions
Ethical requirements were maintained across all phases. Appropriate permissions from senior managers were
obtained for interviews with their staff. Local government bodies’ requirements for research governance
approvals were met. All participants were approached through staff e-mails or written invitations but
voluntary participation was emphasised and confidentiality was assured. We were keen to assure participants
that the interview was not a test of them or their service, but simply an exploration of their views.
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All data collected were stored in password-protected computers, accessible to only the research team.
When reporting findings, any identifying data were removed and only the interviewer who collected the
data was able to identify a participant. For interviews with ‘well’ older people, ethical approval was
obtained from King’s College London REC (REP(GGS)/08/09–29). For interviews with dyads of people
with dementia and carers, ethical approval was obtained from the Social Care REC (09/IEC08/17). For the
survey of Alzheimer’s Society staff, relevant data sharing agreements were exchanged and signed.
Results
In order to obtain a multidimensional perspective on the implementation of the MCA, the study data were
analysed as a complete data set. Principles of framework analysis enabled the identification of themes in
relation to questions from the interview topic guides. Significant cross-cutting themes were delineated
from transcripts rather than from each phase. Although the phases helped with designing the study and
data collection, we judged this would be a more holistic means of presenting the findings, understanding
the data and addressing the overall aims of the study.
Sample characteristics
Overall, semi-structured interviews conducted included: 272 interviews with practitioners over all time
points; 37 interviews with ‘well’ older people; 16 interviews with people with dementia; and 15 interviews
with carers of people with dementia. We further conducted analyses of 84 responses to a survey of carers
undertaken by the EVIDEM-ED team and of 86 survey responses by staff working for the Alzheimer’s
Society. See Table 69 for description of the interviews.
TABLE 69 Participant interviews along the phases of EVIDEM-MCA
Phase Pre diagnosis
Post diagnosis
(just received)
Post diagnosis
(later in trajectory)
Towards end-of-life
care
Characteristics
of phase
Before diagnosis
Possibly before contact
with HSC services
Early planning
Capacity still likely to not
be impaired too much
Capacity may be
impaired
Safeguarding against
abuse is priority
Attitudes towards
Advance Care Planning
Proxy decision-making
may need to be made
Research
participants
Older adult
interviews= 37
Age Concern
(now Age UK)= 10
Safeguarding Adult
Coordinators
(time 1)= 13
Alzheimer’s Society= 10
Staff from voluntary
associations and Carers’
Centres= 15
Safeguarding Adult
Coordinators
(time 2)= 12
People with dementia and
carers= 12
EVIDEM-ED questionnaire
survey of carers= 84
Social services staff
(time 1)= 10
Admiral Nurses
(time 1)= 15
Admiral Nurses
(time 2)= 15
Safeguarding Adult
Coordinators= 15
Alzheimer’s Society
staff survey= 86
Care home staff
(time 1)= 43
Care home staff
(time 2)= 28
Total 272 interviews with practitioners over all time points
37 interviews with ‘well’ older people
16 interviews with people with dementia
15 interviews with carers of people with dementia plus 84 responses to questionnaire
86 survey responses (Alzheimer’s Society)
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Detailed breakdowns of sample characteristics are presented in each of the published papers. In summary,
these comprised 10 staff from Age Concern (now Age UK) groups;258 15 staff from Carers’ Centres and
other voluntary associations and nine staff from Alzheimer’s Society branches;263 13 Safeguarding Adult
Coordinators (SACs) at time 1,264 12 at time 2;265 and 15 at time 3;266,267 28 care home managers and senior
care staff and 15 care workers in care homes at time 1;268 and 28 care home staff at time 2 (in preparation);
15 specialist dementia community nurses (Admiral Nurses) at time 1;269 and 15 again at time 2;270 10 social
services’ staff at time 1 (in preparation). We also analysed the views of 86 Alzheimer’s Society staff who
contributed to a survey about responding to financial abuse of people with dementia and carers.271
Additionally, 37 ‘well’ older people were interviewed for Phase 1;272 a survey captured responses from
84 carers for Phase 2; and 15 dyads were interviewed comprising a person with dementia and their carer for
Phases 2 and 3.
Thematic findings: overall
A number of themes were derived from transcripts. For the purposes of this report, overarching themes
are presented (for an overview see Table 70) and between-group differences are highlighted.
Detailed findings are reported in the study’s publications. Please refer to Appendix 66 for a narrative
description of each theme.
TABLE 70 Overall thematic findings from all transcripts
3.2.1. Universal
appeal of MCA 3.2.2. Training 3.2.3. Implementation
3.2.4. Everyday
decision-making
3.2.5. Long-term
planning 3.2.6. Safeguarding
3.2.1.1. Beneficial 3.2.2.1. Frequency
and format of
training offered
3.2.3.1. Quickly and
easily adapted into
adult safeguarding
practices and
procedures
3.2.4.1.
Negotiated on
regular basis
between person
with dementia
and carer
3.2.5.1. Planning
influenced by
personal factors
3.2.6.1. Inherent
safeguarding value
of MCA
3.2.1.2. Dignity
and rights
protected
3.2.2.2. Challenge
of translating
training into
practice
3.2.3.2. Confidence
and expertise
3.2.4.2. Past
preferences and
best interests
principal key to
making proxy
decisions
3.2.5.2. Financial
plans and funeral
plans common,
less so HSC plans
3.2.6.2. Financial
management and
safeguarding
against financial
abuse is a significant
area of concern as
capacity deteriorates
3.2.1.3.
Familiarity with
details not
widespread but
growing
3.2.3.3. Risk of
information
‘merry-go-round’
3.2.4.3.
Challenges remain
in understanding
how best interests
can be weighed
up – i.e. whose
best interest if the
well-being of one
depends on
well-being of the
other?
3.2.5.3. Most
patients and
carers did not
know where
to turn –
conceptualising
debilitating
conditions is a
good way to start
these discussions
3.2.6.3. Warning
signs of financial
abuse need to be
publicised more to
raise awareness
among practitioners,
community support
networks, financial
bodies and society
in general
3.2.3.4. MCA expertise
at all levels unlikely,
but central expertise
required
3.2.4.4.
Inequalities in
information access
remained, in terms
of those who had
access to family
solicitors and
knowledgeable
family members
compared with
those who did not
3.2.6.4. Role of
banks and other
community support
networks
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Universal appeal of the Mental Capacity Act
One of the most important themes to emerge from the study was the wide appeal of the values and
principles of the MCA to practitioners working in HSC services, to ‘well’ older people, and to people with
dementia and carers. Most of those who knew about it or had experience of using it were strongly positive
about the MCA. This wide appeal contained the following three subthemes.
1. Beneficial to range of health, social care and voluntary sector practitioners.
2. Dignity and rights protected of people with dementia and carers.
The second of these two subthemes was illustrated in one of our early interviews with a participant
working for a local Age UK group (see below). Although Age UK is not a specialist dementia-focused
organisation, its branches and national organisation play a substantial part in advice-giving to older people.
This illustrates the value of taking a broad system perspective to dementia care and support. It also
highlighted the dimension to the MCA of enhancing the rights of people with dementia rather than
seeing it as a professional burden.
I think it would be that it maybe just allowed people to have more rights, be supported in terms of
making their decisions, and so I think that is the key thing, and that people are able to retain rights
more than they have been able to, and I think the Act is around the best interest of the individual
more and something about it being less restrictive in terms of the intervention on behalf of people, so
I think it is really about broadening people’s rights.
Age Concern (now Age UK) staff member, CO 02
3. Awareness not widespread but growing.
This third subtheme is illustrated by a short extract from a specialist community nurse working with people
with dementia (an Admiral Nurse). This practitioner had yet to call on specialist support but, in practice,
her decision-making appeared to rest comfortably on principles of thinking about decisions on the basis of
what was in the person’s best interests.
I think the only way really that it has been useful in terms of practising is that it’s at the back of my
mind now. When I come into contact with people and decisions have to be made, I am thinking
‘is that something that is in that person’s best interests or is this case where somebody else should be
called in?’ So I am more aware but in actual fact there hasn’t been any actual incident where I felt
that I have actually put it into practice.
Admiral Nurse 03
Training
We systematically asked all practitioner groups about the training they had received in order to explore
the sources of their understanding and knowledge. The frequency and format of training and the
challenge of translating training into practice were two subthemes that emerged. The first exposed
professionals’ variable introductions to the MCA and ways in which didactic training was not always seen
as useful. Those who had missed initial training were not often offered opportunities to remedy this. In
services with very high turnover this is a particular problem, as there is little opportunity for peer education.
Some participants spoke of the problem of translating training into practice and we found few reports of
the MCA being used in supervision. Staff within local authorities with responsibilities for safeguarding, and
for the MCA Deprivation of Liberty Safeguards, emerged as valued sources of local knowledge
and support.
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Implementation
At the level of implementation, most practitioner groups found the MCA easy to apply in everyday
practice. Principles of the MCA were universally accepted, and seen as reflecting the values of the Human
Rights Act.273 Most practitioners felt that the MCA generally clarified their thinking around matters such
as capacity and making best-interests decisions. Recording decision-making processes was proving
relatively straightforward. The following four subthemes emerged.
Quick and easy incorporation into safeguarding practices and procedures
There was strong evidence from interviews that the MCA had made a difference to the safeguarding of
people with dementia from abuse and neglect. Prior to the MCA this had been seen as difficult as
intervention powers were unclear and individuals’ refusal of support seemed hard to override. Those
working in safeguarding services were unanimous that people with dementia were better safeguarded,
as the extract below from one interview shows.
I think it gives a framework for evidence decision-making on behalf of someone. I think it also gives us
a framework to discuss with families their responsibilities under the MCA framework. It gives people
who don’t have capacity a level of protection – capacity has to be made in a particular systematic way
and it gives us protection as to why that decision has been made in their best interests.
Safeguarding Adult Coordinator 04
Confidence and expertise
We asked all practitioners to report on their own levels of confidence and expertise in the MCA. Our
analysis is reported by professional group. Generally, those working in adult safeguarding scored highest,
whereas care home staff were less confident but recognised their own limited expertise, as the quotation
below illustrates. This finding has major implications for the wider system of support for people with
dementia as lack of familiarity with legal powers and safeguards in one setting may mean that
communication between different practitioners is not based on similar understandings. For example, we
found that advance statements in a care home might be known to a manager but not other staff and
the decision-making authority of a person who had been granted LPA might not be understood by care
home staff. These findings chime with some of the findings of EVIDEM-EoL.
My knowledge on a standard basis would be around 2 (out of a possible 5), but if I were to do
research for my clients then I would delve into it and on that specific issue, then I would be confident
in getting the information. We just offer general advice and up to a level of 2 I would know general
advice, and we could research if we don’t know, that is more than adequate [for] my post.
Care home worker 01
Risk of information ‘merry-go-round’
Taking a system-wide approach, this study also found that people with dementia and their carers remain
poorly served by some agencies and professionals. The advice and information they seek may not be easily
accessible and they run the risk of being passed from agency to agency. Advice to find information online
seems particularly inappropriate for many people with dementia: ‘Frustration that people are referred to
numerous sources of information which are not able to give them advice or address their specific concerns’.
Mental Capacity Act expertise at all levels is unlikely, but central expertise
is required
We noted above that local sources of expertise were emerging but did not always have explicit roles in
being the main source of local knowledge. Our linked study, which audited MCA knowledge and practice
in an acute hospital,274 also observed the limits of MCA expertise within the hospital and in its own policies
and procedures. We do not suspect that this hospital is unique.
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Everyday decision-making
The MCA contains principles that support everyday decision-making. However, there was limited evidence
of their formal application and operation with respect to people with dementia living in their own homes
and their carers. Our interviews with these individuals revealed a number of subthemes that throw light on
how decisions are made within such close relationships: negotiated decisions, past preferences, weighing
best interests and inequities in access to knowledge. This area had not been investigated previously. Our
interviews were with people with early dementia and these themes may not necessarily apply to people
whose symptoms are more severe. Four subthemes were identified, the first three of which are illustrated
by a quotation from a participant.
Everyday negotiation
I like retirement. I like being at home. We [wife and myself] have breakfast together and decide what
we’re going to do all day. Mostly we’re together but if she has one of her Ramblers’ outings, I don’t
stop her. I’m not that kind of husband! But mostly we do things together.
Man with dementia
Past preferences being key to making proxy decisions
Oh I don’t ask her what she wants any more. I know what she’ll say anyway – ‘anything you like, you
decide’. So I just do what’s best for us both. She has never had sugar in her tea. Never! And lately,
she seems to like it! So I let her be, let her have it if that’s what makes her happy. When the sugar
runs out, I’ll get some more but I’m not going to break my back getting the sugar for her because
she’s never had it before, you know?
Spouse carer of woman with dementia
Weighing best interest decisions
I need to make sure that my health does not suffer. I know I should be doing anything that’s good for
him, and I would. But I get so tired these days and I worry . . . if I go what will happen to him? So
sometimes I need to force myself to rest . . . for his benefit, if you see what I mean?
Spouse carer of man with dementia
Inequalities in access to information
This subtheme arose in these interviews as well as in those with professional participants. In particular,
there appear to be inequalities of access to information among those who do not have close family
members or friends, and those who are not familiar with making financial plans and arrangements. Such
people may never have consulted a solicitor and may regard themselves as being able to rely on continuity
of care – for example, presuming that they will be able to retain their ‘family’ GP if they move to a
care home.
Long-term planning
We asked a diverse group of people with dementia, their carers and ‘well’ older people to discuss
their thoughts about long-term care needs and planning. They described personal perspectives and
circumstances, talked of different types of plans, and some acknowledged not knowing where to turn.
Three main subthemes were identified which are illustrated in the quotations below:
Planning influenced by personal perspectives and circumstances
I live for today, tomorrow you die. It has been successful for me so far, I am 79 . . . I enjoy good health
and I go away every year and everything.
OA 021, male, age 79 years, black Caribbean
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I don’t care if I am dying tomorrow, I said to people ‘look, if it is my turn that God said I should come
and join Him’, I said ‘I am prepared, what is the use of worrying?’
OA 035, female, age 65 years, black Caribbean
What the Government have to realise is as I get older my friends get older, so at the moment I am
waiting to find out if one friend is going to be buried, another friend has Alzheimer’s and so it goes
on and on and on and on, no way can I ask a friend my age. Younger friends lead very busy lives and
they have got family problems of their own.
OA 012, female, age 84 years, white British
Financial and funeral plans common, less so health and social care plans
Participant: I am hoping that I won’t be looked after [in a care home], but yes I will wait until I cross
that bridge, I think.
Interviewer: Is there a reason you have avoided thinking about it now?
Participant: No, I have not thought about it, perhaps I need to think about it, I was just interested in
getting the money sorted, but you are right, I do need to think about it, haven’t heard about it before.
(OA 016, female, age 59, British Indian)
Participant: Hopefully I will probably die [in own home] because I don’t want to go into a home,
unless I have to, or into an old people’s bed-sit with a warden.
Interviewer: Have you made any written formal plans to ensure this?
Participant: No, I think that automatically would happen with the council.
Interviewer: Have you made any provisions to prevent being moved into a home?
Participant: No, I don’t know how I can.
OA 023, female, age 68 years, white British
Limited support with knowing where to turn
No (not sure where to seek help around care), I have a financial adviser so he keeps up to date with
everything, and, you know, he is very good – like certain policies that I used to have that he felt that I
should cash them in, you know, because I have become ill, he said it is no use carrying on with them,
so he has advised me to keep a certain life[style], car, and things like that – but certain policies I was
paying in monthly and that and he said it is not worth it at the moment so that is very good.
OA 037, female, age 53 years, British Indian
If I made plans in the future, well I could think of an event immediately that would save me the
trouble, if my doctor tells me I have only six months to live, something like that. But I think if a doctor
told me that I had dementia, then yes, I would be making plans in that case, but I cannot think of
anything else which would precipitate that. Well it is all I can think of at the moment, there may well
be others you know, or if I have a sudden debilitating illness I suppose, like muscular dystrophy.
OA 010, male, age 70 years, white British
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Safeguarding
As noted above, a significant element of the MCA is the safeguards it provides for vulnerable people
such as those with dementia. Almost all practitioners noted this in their accounts of everyday practice.
Alongside this central tenet, three subthemes emerged, which are illustrated in the quotations below:
Inherent safeguarding ethos
I think it has shifted the relationship between the people who receive services and those who provide
services if it’s being implemented properly. And it can be challenged in law. It keeps us in our place.
We provide support and expertise but in the end it’s their decision. And in our care management
procedures it’s about positive risk taking. Life is about risk and adventure. When I first came into
safeguarding it was about protection. If they are being empowered and feeling in control the chances
of them being victimised are less.
Safeguarding Adult Coordinator 08
Need for help with financial management and safeguarding
Financial abuse is one of the second biggest abuse (types) that occurs in (area), it’s the second biggest
of our alerts. There are a substantial amount of people with memory impairment which leads people
to believe that they can get away with it.
Safeguarding Adult Coordinator 07
Warning signs of financial abuse should be publicised
We’ve done one (referral to the Police concerning a person who had gained) Power of Attorney. He
befriended a couple when they had capacity. The husband died and the wife gave him Power of
Attorney. He moved into the property and he moved her into a small room. The (person granted)
Power of Attorney was not willing to spend money on her – for nightdresses and things when these
were asked for. We’ve gone to the Court – the Office of Public Guardian has asked for bank
statements. We’ve moved the lady to a place of safety; he doesn’t know where she is, while
investigations are going on.
Safeguarding Adult Coordinator 019
Role of banks and community support networks in risk reduction
Many of those who had encountered people with dementia (whom they thought were at risk of financial
abuse) thought that more could be done to reduce these risks if banks and other financial bodies were
more engaged with safeguarding services so that that they could draw attention to emerging concerns
about a customer’s vulnerability. Our investigation of this subject was extended by a partnership with
the national Alzheimer’s Society in which we offered support in the devolvement of their national staff
survey and shared data from our interviews with Adult Safeguarding Coordinators. This partnership
established the extent of carers’ concerns about financial exploitation of their relative with dementia and,
for the first time, highlighted the growing risks of internet and telephone scams.
Discussion
Strengths of the study
There are two main strengths of this study: (1) the range of practitioner groups that shared their views of
understanding and using the MCA in their work and permitted us to see this from a systems perspective
and (2) the longitudinal nature of the study that enabled us to explore change in perceptions among
the same groups of practitioners, their successors, and among people with dementia and their carers.
Together, these contributed to a form of triangulation of data that provided us with a holistic perspective
on how the MCA is being implemented and incorporated into practice and everyday decision-making.
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We gained insight into a breadth of experience, as well as depth over time. Our familiarity with the
emerging literature on the MCA led to an invitation to produce an integrative review of the MCA evidence
for dementia practitioners.275,276
An additional strength of this study is its predominant use of qualitative methods, which gave participants
the opportunity to discuss their experiences in greater depth than might have been possible from any
other method, such as a survey. Qualitative interviews further enabled us to probe appropriately according
to the responses given. We also drew on survey methodology when we wanted to obtain a greater
number of responses and a broader (rather than deeper) perspective, as in the survey of Alzheimer’s
Society practitioners’ views of managing money, and by conducting secondary analysis of the EVIDEM-ED
survey of carers’ satisfaction with legal and financial advice, planning and referrals. We drew on national
and local media for examples of criminal prosecutions under the MCA (as these are not collected
nationally). We also mined our research unit’s unique collection of Serious Case Reviews to investigate
their coverage of MCA practice.
Methodologically, the rigour or trustworthiness of the study can be established by three criteria: credibility
or validity of study findings, confirmability or dependability of study findings, and transferability or
generalisability of the interpretations:
(a) Credibility or validity was sought through obtaining a wide range of perspective, over time, on
the issue, ensuring that a broad holistic view of the research question was obtained in our data.
A commitment to iterative collection and analysis also supported this.
(b) Confirmability or dependability of interpretations was established through clear description of analytical
methods, peer analysis of data, rigorous paper trails and reflexive thinking on the parts
of the researchers.
(c) Generalisability or transferability to other settings was sought through detailed discussion with research
peers, through the multidisciplinary advisory groups of the MCA study and the research programme as
a whole, who offered insights in the transferable elements of our study in various settings.
Limitations of the study
Our study is limited in that participants were not always the same between time 1 and time 2 due to staff
changes and differences in availability. We were unable to observe practice and everyday decision-making
and relied on participants’ accounts. Our interviews with people with dementia and their carers were
undertaken with a group in which dementia symptoms were not severe. Planning and decision-making
may change as severity and disability increase.
Interpretation of the study findings in light of previous research
Interviews conducted during time 1 revealed interesting trends related to early implementation and
expectations of using the MCA. The value of the MCA in supporting carers was a development first
identified in this study during early interviews with Alzheimer’s Society staff.263 These staff reported that
the framework of the MCA was very useful to carers, particularly around long-term care planning and the
‘best interests’ principle. Challenges in proxy decision-making have been recorded277 and, based on this
understanding, we investigated how proxy decision-making by carers was developing and changing over
time. Although a person with dementia and their carer may require separate advice,278 we found that
many of our dyads presented themselves as a unit and talked of the importance of getting advice together
so they could discuss the implications with each other ‘there and then’. We found that, if approached
sensitively, some dyads welcomed the opportunity to discuss long-term care planning. However, some did
not and in many cases, it falls to a skilful practitioner to gauge individuals’ needs and wishes. We also have
drawn attention to the potential to think about advance planning and arrangements among people who
do not have family or friends who are willing and able to take on such roles.
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Safeguarding Adult Coordinators appeared to find the MCA easy to incorporate into their systems of
work.264 Most were well informed about it and acted as sources of expertise locally. Prior to the MCA,
many SACs considered there had been a legal vacuum around decision-making.279 We cautioned at time 1
if this concentration on MCA work could mean that safeguarding work was in danger of being sidelined,
further contributing to demands on SACs’ time and resources. By time 2, most SACs continued to be well
informed and had greater experience in using the MCA.265
There is a need, however, for continuous training to be sustained over time, given the high rate of staff
turnover in social care settings,280 and even among SACs as our participant groups showed. The extensive
investment by the DH in developing training and publicity at the time the MCA was implemented in
2007281 will not be repeated. Having the confidence to use and refer to the MCA also grew, alongside
knowledge and experience with using the MCA, but it is unclear how case law and other developments
are being fed into practice. At the time of writing (April 2014) Parliament has been debating the new
Care Act 2014, as proposed by the White Paper Caring for our Future: Reforming Care and Support,282
and the experiences of the MCA implementation have lessons for how new law can be incorporated into
professional transfer training. We have discussed these lessons with stakeholders in Ireland where a new
Mental Capacity Bill, similar to the MCA, is shortly to be published and with dementia researchers and
gerontologists in Australia, including policy-makers in the state of South Australia.
Our study also highlighted how voluntary sector organisations often served as valuable sources of support
and advice to people living in the community but their knowledge varied. Staff from Age Concern (now
Age UK) and carers’ organisations were not always specifically trained about the MCA, and tended to rely
on signposting to other organisations that they felt would be more knowledgeable about legal matters.258
Signposting is an important part of any local information strategy and the need for it may be greatest
among people lacking confidence, having mixed experiences with ‘officialdom’ and those who are on their
own in later life. Age UK at the local level was a major resource for some older people who were keen to
discuss and consider long-term care planning.272 However, our interviews with ‘well’ older people revealed
that attitudes to planning could also be based on personal inclinations and long-term habits, as well as
preferences. Approaching GPs or primary care services was not generally considered appropriate unless
there were health concerns. Professionals working with people with dementia and their carers may need
to offer time and a listening ear in order to support people who are feeling that matters are slipping out of
their control at many levels.
By time 2, community nurses’ and adult safeguarding staff’s understanding of the MCA was generally
more sophisticated. However, specifics of the MCA remained blurred among some and memories of
training were dim. Some community nurses, initially themselves often lacking confidence, expressed
concern about a lack of understanding of the MCA among other professionals.270 One exception to this
was that many participants at time 2 were aware of the importance of financial planning and that they
could promote understanding of this among their clients or service users.265–267 This confidence was
obvious about end-of-life care planning, except among care home managers who described undertaking
such discussion with residents on moving into the home, but largely without reference to the MCA.
This study has highlighted that many professionals have experience of family members with dementia, an
observation that has not previously been evidenced. At a personal level, some reported finding family
decision-making and planning potentially easier under the MCA, but loss of decision-making capacity or
family disputes were sources of tension. We note the value of building upon the personal experience of
practitioners to promote empathy with family carers in the provision of timely information and advice.263,268
There have been surprisingly few investigations of the overlap of professional and personal experiences of
dementia caring and so this study has added to the literature.
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The offences of ill treatment and neglect created by the MCA were poorly understood and their
implications have not been reported widely in professional or research-based literature.39 Understanding
among practitioner groups was minimal, as reported in our papers.269,270 Accounts given appeared to be
based on ‘common sense’ rather than legal definitions and thus potentially erroneously downgrading the
offence of ill treatment and wilful neglect as poor practice. We therefore investigated this subject more
thoroughly through the use of a consensus group. This group recognised the importance of highlighting
that poor practice could be addressed by legal sanctions but were unsure how to access emerging case
law and to promote learning from it. In conjunction with our understanding that some MCA training has
been reported to be didactic and piecemeal, or needs to better reflect practice dilemmas and uncertainties,
we have developed resources on this facet of the MCA reflecting the findings of our interviews. These
include overviews for dementia practitioners283 and for the care home sector.284
Conclusions and implications
There are three main lessons to be drawn from this study. For HSC practitioners it is evident that this
legislation met a need in practice and that the legislation has largely been easy to work with, that
professional values are in accordance with the values and principles of the MCA, and that it has promoted
interdisciplinary and interagency working. This is possibly a result of the consensus that shaped the
legislation: the involvement of practitioners in the implementation of the MCA and the devising of its
Code of Practice. Engagement with practitioners and with stakeholders from patient/user and carer groups
may be a valuable consideration for other change processes.
Second, this study has gleaned information about training transfer, the process by which professionals and
non-qualified staff (the majority of practitioners working in dementia care) are provided with training while
in post and change their practice. One advantage of a longitudinal study is that we were able to discuss
training at various intervals, to talk to practitioners about what seemed to work well and whether or not
they were able to refresh their knowledge and skills. We found that training was not always welcome or
seen as relevant if it was didactic in nature, that there seem to be gaps among hospital-based staff in
particular, and that few employers are explicitly checking that their new staff are familiar with the MCA.
There was surprisingly little use of the MCA in supervision among professionals. Many practitioners were
reliant on local expertise but this ran the risks of overloading certain sources. In light of the high levels of
concern about financial abuse of people with dementia expressed by many participants, there may be
scope to highlight this among all practitioners – especially to alert them to the targeting of people with
dementia by strangers and by electronic or telephone contacts.
The third lesson lies in the potential inequalities of information. Providing information online may
be acceptable to professionals but it is not welcomed by many older people or carers. Those with
knowledgeable family members or those who have legal advisers are better off in this regard. Information
was also not always shared among services, with one particular gap in social care – where some care
home staff are not familiar with the implications of the MCA and the legal documents that their residents
may have drawn up but which the residents are no longer able to bring to staff’s attention. The key
professional here is the person’s GP but the sharing of MCA details with the GP and consequent passing
to new care providers was not commonly encountered. We further noted the potential of an ‘information
merry-go-round’ locally, as not all voluntary sector staff offering information and advice were confident
in their knowledge of the MCA and potentially re-referred people making enquiries. A similar lack of
expertise and confidence was also found among some professionals, such as some community nurses,
who were otherwise likely to be seen as highly informed about dementia.
We do not suggest that everyone needs to have legal expertise in dementia services. The implication of
this study is that it should be available and that information, advice and assistance are not the same.
Commissioners may wish to ensure that these three areas are covered. Although memory services,
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for example, may give early information, some people with dementia and carers do not wish to take this
up at the time of diagnosis but when these issues do arise they may not have contact with staff from a
memory service. Advice to look ‘online’ may not be adequate or person centred.
Conclusion
This study broke new ground in investigating legislation that has fundamentally altered dementia practice
and the experiences of many people with dementia and their carers. Although many people with
dementia and carers will not encounter the MCA directly, it has great salience for them and its principles
are widely supported by practitioners. Our research has outlined how new law is transferred to services
and professionals. It has learned about changes in experience and confidence over time. It has focused on
day-to-day decisions, as these are at the heart of human relationships. We are most grateful to all those
who have allowed us to hear directly of their practice, plans, decisions and experiences.
Impacts
l The research team has engaged with members of staff working with CNWL NHS Foundation Trust at
events such as the annual summer schools across the study period, providing updates and workshops
on aspects of the MCA (see Acknowledgements, EVIDEM-MCA publications and presentations).
Discussions have been held with different professional groups and feedback provided to the Trust on
MCA staff training.
l A Dementia E-Learning Package (2012) was commissioned by King’s College School of Nursing and
Midwifery and has subsequently been delivered to staff across the NHS South West. This educational
package comprises the following modules: Introduction to Legal, Ethical and Cultural Issues in
Dementia Care; Developing Competence in Social, Legal and Cultural Context; and Advanced
Competence in Social, Legal and Ethical Context of Dementia. These are continuing professional
development courses that a range of staff can undertake.
l The research team was invited to undertake a literature review for the Joseph Rowntree Foundation on
improving practice in communication with older people living in housing with care schemes, which
made use of the EVIDEM-MCA study’s findings. This was published by the Joseph Rowntree
Foundation285 and revised for a peer-reviewed publication.286
l The research team worked with Dr Mareeni Raymond on the development of a toolbox for GPs on
dementia for BMJ Quality during 2011 to 2012.
l This study team provided assistance to staff of the Mental Health Foundation as members of its
advisory groups on the Mental Capacity Advocates study and Proxy Decision-Making (INDIPS study).
The study is represented on the Advisory Group of the NIHR School for Social Care Research
(SSCR)-funded study of the MCA Deprivation of Liberty Safeguards.
l Membership of the Dementia Action Alliance (DAA) was awarded to the Social Care Workforce
Research Unit. The DAA is a national consortium of over 100 organisations committed to transforming
the quality of life of people living with dementia in the UK and people who care for them. Our
application drew attention to work on the EVIDEM programme and other studies. In our application
we drew up an action plan to outline how we remain actively committed to involving people with
dementia and carers in current and future research (www.dementiaaction.org.uk/info/2/action_plans/
117/social_care_workforce_research_unit_kings_college_london).
l The study contributed to the Alzheimer’s Society’s policy and communications work on safeguarding
people with dementia from financial abuse287 (http://alzheimers.org.uk/site/scripts/documents_info.php?
documentID= 1770). The research team provided expert review of three of the Society’s fact sheets on
Financial Abuse and Making Decisions, which are available to members of the public.
l The research team has informed student and professional development studies in several UK
universities by discussing study proposals and details (e.g. at University of Bedfordshire).
l The MCA lead at the DH has requested all outputs from this study and pre-publication copies have
been sent to her.
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Building on research capacity
Nested within the EVIDEM-MCA study was a further NIHR Service Delivery and Organisation-funded
research study, ‘The transition from cognitive impairment to dementia: older people’s experiences’.288 This
study complemented the EVIDEM-MCA study by providing the opportunity to investigate the dementia
diagnosis transition from the perspective of people receiving this diagnosis and their carers. It highlighted
the nuances of providing ‘information’ and the need to think about what information is wanted,
understood and retained. The literature review confirmed the professional focus on care and treatment
at the end of life (Advance Care Planning), and less so on day-to-day decision-making in dementia.289
Implications for commissioners and primary care teams were published in the British Journal of General
Practice in 2013.290
A second study was also nested in the EVIDEM-MCA study. Although the EVIDEM-MCA study protocol
explained that the focus on the research would be community based, the opportunity arose to work
on the findings of an audit covering policy and practice about the MCA in one teaching hospital. This
audit provided valuable insight into the implementation of the MCA in this setting, where reasonability
appeared to have been diluted and procedural documents were incomplete and overlapping, and where
training had been partial and not reflective of the needs of adult learners.274
Research capacity was further built by the involvement of new and junior staff in the study. This included
assistance with interviewing, when senior staff mentored researchers who were new to dementia research,
and help with study outputs (from Nigel Charles, now of University of Plymouth, and Jess Harris of King’s
College London). The EVIDEM-MCA study has also provided illustrative case examples of approaches to
research with care homes as published in the ENRICH Research in Care Homes resources (www.DeNDRoN.
nihr.ac.uk/enrich/#.UEcmZcEiaHc).
Changes to protocol
The original protocol aimed to recruit a range of staff from HSC services. This included IMCAs and medical
staff using the MCA. We subsequently learned that the DH and others had commissioned studies with
IMCAs291,292 and in the field of health care, with patients293 and with health-care practitioners.254,294,295
There was a clear evidence gap in the views, experiences and expectations of social care staff when
using the MCA. Social care practitioners were also those who were most likely to come into contact with
people with dementia and carers living in the community. Following guidance from our advisory group,
we focused on this particular and diverse group of practitioners, as this was, and remains, the
under-researched population and sector.
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Chapter 6 EVIDEM: from cohort to research
register
Abstract
The EVIDEM programme aimed to develop a cohort of up to 2000 people with dementia and their carers
in order to recruit along the dementia disease trajectory, from diagnosis to end of life. The EVIDEM
programme’s position in an NHS Trust allowed the research team to work closely with the North Thames
DeNDRoN to create a register for people with dementia and their carers who wanted to become involved
in research. The register contributed participants to EVIDEM studies, facilitated other dementia studies in
the North Thames DeNDRoN area and provided a model for register development more widely.
A technology development methodology was used to develop the register. The construction and
population of a dementia research register was feasible but its initial phase of development was complex
because of ethical and organisational difficulties. Recruitment from primary care was particularly costly
in staff time and identified only a small number of people with dementia who were not already known
to specialist services. Recruiting people with dementia through secondary care was more effective but
was also a resource intensive process.
In 21 months of operation across four NHS trusts, clinical researchers invited 1400 people with dementia
or their carers to enrol in the register, gained consent from just over 800 and recruited around 230 to
studies. To achieve the upper target of 2000, cohort members would take, we estimate, about 4–5 years
of consistent recruitment through the existing register.
Background
UK government policy is to maintain people with dementia syndromes in their own homes for as long as
possible.18 However, the needs of people with dementia and their carers are inadequately addressed at all
key points in the illness trajectory, from diagnosis through to end-of-life care.296 Further research is
required to understand the barriers to the timely recognition of dementia syndromes in primary care,7
the support needed by people with dementia and their families after diagnosis, the factors predicting
relocation of people with dementia syndromes to care homes, the best methods of managing incontinence
and challenging symptoms297 and the therapeutic options available to clinicians, which are currently
sparse and insufficiently evaluated.298
Some treatments for people with Alzheimer’s disease have been shown in trials to be modestly effective
in modifying symptoms299 and emerging therapies – both pharmacological and psychosocial – will need
rigorous evaluation in large-scale trials. The design of these trials will raise many questions, including
which populations should be studied, for how long and with which principal and secondary end points?300
These questions may be difficult to answer. Difficulties in ensuring that samples are representative have
meant that people with dementia who are recruited to clinical research have been younger than the
general population of people with dementia, whereas women, the oldest old and ethnic minorities have
been under-represented in study populations. Such under-representation may not always affect the
external validity of relative effect estimates, but measures of absolute effectiveness, absolute harm
and cost-effectiveness are associated with underlying risk levels in different sociodemographic groups and
under-representation of subgroups will bias absolute effect estimates.301 Research on dementia could gain
much from the study of patient populations that more appropriately reflect the population at risk.302
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Age is particularly important given the potential for delays in dementia diagnosis, the inexorable
progression of dementia and the diminishing capacity of people with dementia to give informed consent
to participate in research.
In theory, primary care-based studies could address these problems of representativeness because of the
heterogeneity of the community-dwelling population but, in practice, we know from recent trials that
recruitment to studies on dementia through general practice is problematic.303,304
Promoting dementia research
One of the barriers to recruiting people with dementia to clinical trials is the lack of a suitable tool that
would facilitate identification of potential participants with the desired baseline characteristics. Registers for
patients with motor neurone disease and Huntington’s disease have been long established but to date there is
no equivalent register in the UK for those with dementia syndrome. This situation prompted North Thames
DeNDRoN to test the concept of a research register of people with dementia who would express an interest
in participating in dementia and cognitive impairment research in general, rather than specific studies.
North Thames DeNDRoN was one of the seven regional DeNDRoN networks and was a collaboration between
three universities [Imperial College London (ICL), Queen Mary’s University of London (QMUL) and University
College London (UCL)] and 36 NHS trusts covering all North London boroughs plus areas of Essex,
Hertfordshire and Bedfordshire (26 acute trusts, 10 mental health trusts). It is hosted by one NHS trust.
The EVIDEM programme needed to recruit to five specific studies but also had an interest in creating a
cohort of people with dementia to allow studies to take place along the entire trajectory of dementia,
from diagnosis to end of life. A joint approach to creating a register and deriving a cohort was a
logical way to combine researcher expertise with the research facilitation objectives of DeNDRoN.
A full description of the early stages of this project is reported elsewhere,100 and this chapter is based
substantially on that account.
Research registers
There is now considerable experience of developing research registers, particularly in North America. Many
registers have been developed to facilitate epidemiological studies305 but can also offer an organised and
systematic way to maintain contact with participants from previous research and recruit an even more
diverse pool of subjects interested in participating in future studies.306
Research registers have been used in dementia research to study the clinical expression of Alzheimer’s
disease307 and to improve the flow of information in order to increase research participation.308 The US
Consortium to Establish a Registry for Alzheimer’s Disease (CERAD)309 has functioned as a vehicle for a
wide range of studies and as a mechanism for developing and testing dementia-specific instruments.
In 2008, the Leon Thal Symposium proposed the development of a US National Registry and Database to
meet the multiple needs of the research field, including the development of a research programme on
prevention.310 Similarly, the European Alzheimer’s Disease Consortium, in 2010, proposed the construction
of international research registries for studies of familial Alzheimer’s disease and for therapeutic trials.311
However, there are difficulties in developing research registries. Although registries based on routinely
collected data can offer opportunities for research, they pose problems of data organisation and accuracy
for researchers.312 Prospective collection of additional data requires organised outreach from the registry to
patients, providers and staff, integration of the register into pre-existing clinical routines and addition of
reminder systems to clinical workstations.313 Unique challenges in recruiting and retaining participants with
neurological disorders for research studies include the cognitive deficits of the participants and the complex
ways in which many neurological conditions present.314
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The perceived advantages of a research register were that it could allow prescreening of research-ready
populations for different types of study, allow more accurate assessments of study feasibility (because the
potential research population would be known), and create the basis for longitudinal studies.
Construction and contents
The research and development questions we asked in the joint EVIDEM and North Thames DeNDRoN project were:
1. Is it feasible to develop and sustain a research register for people with dementia?
2. What are the actions and resources required to develop and implement a dementia research register?
3. What are the clinical requirements for a dementia register for the purpose of clinical trials recruitment?
4. What are the likely recruitment rates to a dementia research register?
Register design
The development of the register was based on a standard technology development methodology,
originally derived from the construction of decision support systems.38 This involves phases of modelling
and prototype creation, ‘bench testing’ and refining of the prototype with experts, and then ‘field testing’
of the refined prototype register in exemplar sites. We have used this methodology elsewhere in the
EVIDEM programme (see Chapter 1).
A co-design approach was taken,37 bringing together researchers (in the EVIDEM programme), research
network developers (in DeNDRoN) and people with dementia and carers, through the PPI arm of
DeNDRoN. Expert advisors from the Centre for Health Informatics at University College London were
recruited to the design team to develop the electronic database for the register.
The design team met on six occasions during 2008–9 and held monthly teleconferences to review
progress. The design team consisted of five members from the EVIDEM programme (Iliffe, Lowery, Rait,
Walters, Kharicha) and two from North Thames DeNDRoN, bringing together academic, clinical and
research network expertise. The design team developed a prototype register, ‘bench tested’ it with other
experts in the field, and then initiated recruitment to it, initially in one specialist pilot site but also in
selected general practices.
The proposals for the register were discussed with DeNDRoN’s PPI working group (made up of DeNDRoN
regional workers and members of third-sector organisations) and its PPI forum (made up of people with
neurodegenerative diseases and their carers).
Modelling, ‘bench testing’ and prototype development
The objectives agreed by the joint design team were to:
(a) identify people with dementia and their carers through primary and secondary health care, social care,
community care and voluntary sector organisations in the North Thames DeNDRoN region
(b) invite patients to join a research register
(c) gain consent for a minimum data set of information about patients to be held on the research register
(d) enable clinical research staff and registered research staff to search for patients relevant to a set of
user-defined parameters, and then use that retrieval set as the basis for making contact (through the
patients’ clinicians)
(e) enable the register staff to maintain a list of studies to which the patient has been invited, is deciding
about, has consented to or is participating in
(f) enable appropriate matching of register members to research projects and further anonymised analyses
(g) manage all such data securely, using role-based access and maintaining an audit log.
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Recruitment to the registry would occur in the geographical area covered by the North Thames DeNDRoN
(North London, and parts of Essex, Buckinghamshire and Hertfordshire). Recruitment would be tested in
primary care, secondary care, and if possible in social care (e.g. care homes), community health care
(e.g. community nursing services, Admiral Nurses) and third-sector (voluntary) organisations (e.g.
Alzheimer’s Society).
The target population was defined as people of any age, with any form of dementia, residing in the
community or residential care within the defined geographical area.
The inclusion criteria chosen were people with either a formal specialist (imaging/neuropsychological) or
informal generalist diagnosis of dementia, as well as participants with cognitive impairment presumed
secondary to an underlying neurodegenerative disease. The case definition includes different types of
dementia syndrome and people with dementia of differing severity (from early to late dementia as well as
mild cognitive impairment). We agreed to include non-ICD-10 Diagnostic and statistical Manual of Mental
Disorders-Fourth Edition (DSM-IV) diagnoses but the source of, and basis for, the diagnosis would be a field
within the register to allow prospective filtering to match the quality needs of future research projects.
The exclusion criteria we selected were (1) people who do not speak English, for whom an interpreter could
not be located and (2) those whose clinician believed would be inappropriate to approach, for specific
reasons like receiving end-of-life care, treatment for severe comorbidity or major behaviour disturbance.
Ethical approval
Although the primary aim of the register was to support research, the design team felt that it was essential
to seek ethical approval, in part because diminishing capacity to consent to participation in research is a
feature of dementia syndrome. In addition, the Data Protection Act50 requires that all patients who are
identified for research projects have given their consent to be identified in this way. Although other
disease research registers had not sought approval from ethics committees, the design team believed that
an ethics committee would provide another layer of expert opinion about how best to explain the purpose
of the register. In addition, the rigorous and well-documented consenting process that has to be applied
following an ethics committee’s approval provides a clear, auditable and defensible pathway documenting
dissemination of information about the register, the assessment of capacity and the storage of clinical
documents, should challenges arise. Approval for the trial was received from Southampton & South West
Hampshire REC (A): reference 08/H0502/34.
It was also clear that recruitment of large numbers of people with dementia and their carers would require
Research Management and Governance approvals across multiple sites and sectors, and information
management approvals for data storage. In addition, the joint team had to develop a minimum data set
and database, and devise mechanisms for capturing data in primary and secondary care, and through
other routes, such as care homes and third-sector organisations.
Constructing the minimum data set
A minimum data set was developed in three stages. In the first stage, comments on the secondary care
requirements of the data set were gathered from the North Thames DeNDRoN’s executive board,
supplemented by individual discussions with researchers within the local network. In the second stage,
face-to-face interviews with 39 GPs were conducted to discuss the potential for using data from the general
practice reimbursement mechanism (the ‘QOF’) for dementia. In the third stage, members of North Thames
DeNDRoN gave feedback on the minimum data set fields generated in the previous two stages, and the
data set was refined based on this feedback. Box 6 shows the contents and data fields of the minimum data
set. The design group intended that the minimum data set would evolve over time to be consistent among
collaborating centres, as far as pragmatically possible.
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We were aware that information recorded in notes would be variable across services and sites. This
minimum data set was based on data known to be routinely collected in secondary care clinics assessing
patients with cognitive disorders, but its applicability to primary care was unclear.
We therefore invited 25 GPs from 10 practices known to be both interested in dementia and engaged
in research, to assist us with a study of the data content of the records of patients with dementia.
Five accepted the invitation and four (all from different practices) were able to commit time to it. In each
practice the electronic medical records were searched by the GPs for patients with dementia, and
individual records were scrutinised (‘hand-searched’) for information in the data fields shown in Box 6.
Figure 22 shows how information that could be used to prescreen patients with dementia is distributed
across codes, free-text and scanned documents, and which categories (e.g. functional abilities) are
commonly missing. This demonstrates the amount of additional work that would be required to use
existing GP electronic records as the source of data for a registry. This finding, together with a pilot
recruitment study in general practice (see below and Appendix 67) convinced the joint team that the
research register should be built primarily from patient populations that were already engaged with
specialist services.
Three aspects of the minimum data set were seen as important by both researchers and PPI experts, and
confirmed as such by an ethics committee: confidentiality, duplication of information and access.
BOX 6 The minimum data set
Data to be included on the registry
l For all primary care practices we recorded location (PCT) and deprivation index score.
l For all clinics we recorded specialist and clinic location.
l For other services we recorded location, e.g. care home, supported accommodation, elderly mentally infirm
home, and key worker details.
l For all participants in the register the following information (extracted from practice or clinic notes) is
recorded where possible:
¢ demographic details (name, date of birth, gender, marital status, first language, ethnicity, address,
postcode, housing status, NHS number)
¢ carer information (name, date of birth, gender, address, postcode, relationship to person with dementia)
¢ practice details (name, address)
¢ specialist details (name, clinic details)
¢ cognitive status (date of most recent test and score)
¢ functional status (date of most recent test and score)
¢ behavioural/neuropsychiatric status
¢ investigations (imaging and dates)
¢ specific dementia medication
¢ comorbidity (e.g. depression, cardiovascular disease, diabetes)
¢ history of participation in trials/studies.
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Confidentiality
A unique identifier is assigned to all participants on the register so that data are held anonymously.
A file linking name and unique identifier is stored separately and securely, and in accordance with the
Data Protection Act.50 This will be held until the participant indicates that s/he no longer wishes her/his data
to be included on the register, and 6-monthly reviews will allow reaffirmation of register status. Six-monthly
reviews were chosen because of the relatively rapid health status changes that can occur in dementia
syndrome. It is intended for the register to be comprehensive and to be able to include all patients seen in
the North Thames DeNDRoN region in order to be representative of the patient population.
Duplication
Information on whether or not the patient has been/is currently participating in research studies will be
included on the register to avoid patients being approached for participation in multiple projects, and
register managers will cross check key identifiers (name, date of birth, NHS number) of potential new
participants to ensure that people with dementia and their carers are not approached repeatedly.
Access
National and regional researchers wanting to access the registry would need to approach North Thames
DeNDRoN in the first instance. Prioritisation of studies within the North Thames DeNDRoN portfolio by
local researchers was anticipated and access to the register would reflect this prioritisation. Governance of
the registry would be managed through DeNDRoN’s national co-ordinating centre, in the first instance.
Computer search/audit Hand search/audit
Diagnosis
Exclude: psychiatric
morbidity
Exclude: opioid
dependency
Include: comorbidities 
Include: medicationsa
Age
Sex
Address
Dementia symptoms in
free text
Alcohol dependency not
coded
MMSE score or equivalent
often in letters or free text
Housing status poorly
recorded
Carer details variably
recorded
Contact with other
professionals can be hard
to identify
Medical imaging results
may be in letters
Characterised 
population 
Dementia symptoms
unreliable (too many
other conditions)
No linkage to carer’s
records is possible unless
they live at same address
No measure of
functional status 
FIGURE 22 Prescreening from GP record. a, Medications may not be accurate in all cases.
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Constructing the register
Physical construction of the research register and its use at the first sites provided experience of the
practical problems involved in recruiting people with dementia to a research register. These included
identification and invitation of potential participants, judgement of capacity, and obtaining both official
permission and actual support from practitioners and administrators to recruit through NHS services.
Identification of people with dementia
This was undertaken using medical records complied with the then-current recommendations from the
Patient Information Advisory Group. These recommendations allowed only members of the patient’s usual
clinical care team to identify patients suitable for the register. The lead clinician (or other member of the
normal clinical team responsible for the patient’s care) would then make the first contact with the patients
identified, either in a face-to-face meeting or by letter/telephone. This contact would be only to inform the
individual or their family about the register; enrolment would usually take place separately from the clinical
encounter in which the information about the register was given. There were, in practice, exceptions to
this, as some people were keen to enrol immediately rather than wait until their next appointment. In
cases when people feel they have had sufficient time to consider their decision, their consent can be taken
on the same day as they receive the information. Figure 23 shows the recruitment path that we developed
for an individual enrolled through a memory clinic. This process is likely to vary slightly to reflect differing
care pathways in different memory clinic services.
Judgement of capacity
To ensure that people at all stages of the disease process were able to join the register requires
judgements about decision-making capacity. (This proved particularly difficult in primary care – see below.)
A recent analysis of ability to consent to research in a therapeutic trial of Ginkgo biloba found
approximately 70% of individuals with mild-moderate dementia could not give valid consent to research
participation.315 In the case of individuals who are not able to give informed consent, UK MRC and
European Union-GCP guidelines and the principles of the MCA 200517 (England and Wales) were
followed, and opinion sought from a relevant consultee. This is also in accord with internationally accepted
guidelines on research involving human subjects with dementia.316
Seeking permissions
Research Management and Governance offices at each NHS trust where researchers were interested
in setting up the research register were approached for permission to involve trust staff. Seeking multiple
permissions across provider organisations in primary and secondary care proved to be a lengthy process,
taking up to 5 months per organisation. This process was not made easier by high staff turnover rates in
the DeNDRoN research network itself and the time needed for training, Criminal Research Bureau checks
and research passport applications for new study officers. The steps required to engage a new clinical site
as a recruitment site for the register are summed up in Box 7.
Recruitment in secondary care
Recruitment began in the first mental health trust in early March 2009, and three other trusts began
patient recruitment in the following 12 months, with four more initiating involvement. Figure 24 shows
the gender distribution of those joining the research register, and Figure 25 shows the age distribution.
The self-reported ethnicity of those enrolled is shown in Figure 26; about 20% were non-white.
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BOX 7 The steps to engage a new clinical recruitment site
Getting a new specialist site to recruitment stage requires:
l A Principal Investigator to act as champion for that site.
l Local Research Management and Governance approval.
l Resources for a local co-ordinator, who initially carries out and then co-ordinates data entry, acts as contact
person for data queries, and liaises with site staff about recruiting patients. To date, the financial resources
have come from different streams of research network funding. New staff may need to be recruited, or
honorary contracts established, for those already in other posts.
l Agreement from local information technology departments who need to give new staff access to electronic
databases, and to set up shared drives where none existed previously. The local information governance
manager needs to be satisfied about data security.
l Service manager agreement to provide office space, promote the use of the register to front line clinical
staff, allow computer use and staff involvement in seeking consent, as well as facilitating best working
practices for each site.
l Site team involvement in supporting the lead clinician in identification of patients to inform about
the study.
The initial phase of recruitment of patients and carers to the research register yielded important lessons about
where best to recruit, and about data governance.
59%
41%
Females
Males
FIGURE 24 Gender distribution of enrollees in the dementia register.
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Figure 27 shows the rates of invitation and recruitment to the register, and the numbers engaged through
the register in trials, from the end of March 2009 to the end of December 2011. Acceptance of the
invitation was high, at over 90%, but the rate of recruitment was determined by the pattern of clinic
attendances, with a gap of 3–6 months between the invitation to join the register and acceptance for the
majority of participants. Figure 28 shows the recruitment to DemReg and to studies across four NHS trusts
at the end of February 2012 (when EVIDEM’s involvement in the register’s development process ended).
2%
7%
11%
15%
28%
25%
12%
< 65 years
65–69 years
70–74 years
75–79 years
80–84 years
85–90 years
> 90 years
FIGURE 25 Age distribution of enrollees in the dementia register.
White British
White other
Indian
White Irish
Other ethnic group
Black Caribbean
Not stated
Asian other
Black British
Pakistani
Black African
Austrian
Bangladeshi
Black other
Chinese
Mixed
Portuguese
Sri Lankan
63%
1%
1%1%
2%
3%
3%
4%
6%
6%
10%
FIGURE 26 Ethnicity of enrollees in the dementia register.
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Recruitment in primary care
Tests of recruitment began with five practices that were already part of the EVIDEM programme in autumn
2009. Of 72 people with dementia identified from these five general practices, who were sent information
by post about the research register, three people responded that they were not interested in research
or finding out more, and 18 people expressed interest and asked for more information. Fifty-one people
did not respond to the invitation.
Among those expressing interest in the research register, 10 people were already attending specialist
clinics operating the research register, and their details were passed on to the appropriate clinic. Three
lived in care homes, and an assistant psychologist obtained the carer’s agreement to gather data for one
of them. She did not meet the resident to assess decision-making capacity, but both the GP and the care
home manager judged that the resident lacked capacity for this decision but said that the person would
have wanted to have participated in the study. The data gathered did not contain information about
medication or MMSE score, and for one potential recruit the psychologist extracting the data was unsure
which of two documented diagnoses was correct. For the other two individuals the assistant psychologist
had to meet relatives (in their role as consultees), as the care home staff did not feel able to give an
opinion about participation in research (which they are not able to do under the MCA).
The assistant psychologist also arranged a meeting, at a hospital site, with two of the three people with
dementia who were not seen in any other NHS service. The remaining person not seen by any other
service lived in an area distant from any facility that the psychologist could invite them to, and the
psychologist was reluctant to make home visits, so this individual’s expression of interest was not pursued.
Testing the process of recruitment in general practice was undertaken by the EVIDEM team and in
specialist clinics by North Thames DeNDRoN but responsibility for subsequent 6-monthly follow-up and
review did not clearly belong to either party and had to be decided through discussion. The situation was
complicated by the organisation of research infrastructure in England, where three research networks may
be involved in dementia research: DeNDRoN; the PCRN, which recruits GPs for research projects; and the
Comprehensive Local Research Network, which funds the involvement of practitioners in research work.
These three types of network do not have the same boundaries, so trilateral negotiations were necessary in
some locations to allow the EVIDEM team to test recruitment to the register through general practice.
For these reasons, the prototype register was developed first in specialist services (particularly memory
clinics), leaving recruitment in primary care (and other settings – see above) to be explored at a later stage.
Invited
Consented
Declined
Identified for studies
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Accrual to studies
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FIGURE 28 Recruitment to DemReg and accrual to studies across four trusts, February 2012.
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Data governance
A decision had to be made about who would ultimately hold and be responsible for the data collected in
this way. The project information sheets stated that documents and register data would be stored by the
register team at North Thames DeNDRoN but, as North Thames DeNDRoN is not a legal entity, documents
and register data are stored by West London Mental Health Trust and were accessible by only the clinical
and research staff within the involved NHS trust’s boundaries.
In a later development which was not part of the joint EVIDEM/North Thames DeNDRoN project, the
register’s software was adapted to fit within clinical systems, to facilitate recruitment and avoid duplicating
data entry.
Discussion
Feasibility
The North Thames DeNDRoN dementia register was a pioneering project in the UK. This case study
suggests that construction and population of a dementia research register is feasible, but that the initial
development is complex because of the ethical safeguards in dementia research and the organisational
difficulties in embedding research projects in NHS clinical services. Recruitment from primary care has
proved problematic; enrolment of patients is particularly costly in terms of staff time, especially given the
very small number of people with dementia identified who were not already known to specialist services.
The logistics of recruitment in memory clinics were better because of the concentration of patients and
staff as well as the use of care pathways into which the register’s recruitment process could be embedded.
Even then, given the time scale of clinic attendance and the restrictions on obtaining informed consent,
the recruitment process may take up to 6 months.
Resource issues
Recruiting people with dementia to the register through secondary care is still a resource intensive process.
Potential register members need to be identified as suitable, informed about the register, met again to
obtain consent and to capture information for the minimum data set, and reviewed every 6 months
to confirm their continued interest and update their data.
The preliminary steps in gaining the necessary permissions and resources to establish the register at a new
site require effort (a manager able to devote sufficient time) and up to 5 months of preparatory work
(decreasing as time and experience informs the process). However, early investment of effort will ensure
that not only will local clinical teams be invested in the process, but also that it ensures that data collected
thereafter will be both accurate and complete. The costs of developing and running the register were seen
as core service support costs and were therefore borne by the NIHR Clinical Research Network. DeNDRoN
funded the register’s development in the short term but it is also part of DeNDRoN’s 5-year strategy
(2010–15) to develop a broad coalition to secure appropriate funding arrangements for research registers
in the longer term.
Clinical data requirements
Identifying the components of a minimum data set was an early achievement of the design team, which is
being tested as researchers begin to use the register to recruit to studies. The effectiveness of the register’s
minimum data set (as currently designed) as a device for prescreening potential research populations is
under investigation.
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Recruitment
Acceptance rates are very high in the first clinic to recruit to the register but this may reflect the efforts of
register ‘champions’. We have monitored recruitment in more recently recruited clinics, for which there
may be less ‘ownership’ and hence less commitment to register development; this gives us an estimate of
the likely growth of a dementia research register within usual NHS clinical practice. Easier recruitment may
perpetuate potential selection biases and we are not yet able to assess the representativeness of the
research-ready population recruited to the register; this is an issue that needs to be revisited as register use
becomes a normal process for researchers. We know from analysis of participants in the first site to start
recruitment to the register that the register included more women than men, and a substantial number of
people from minority ethnic groups and from the ≥ 75 years age group. Ways of increasing recruitment
through primary care, and through care homes and social care services, to offset biases inherent in clinic
recruitment, need further investigation.
Conclusions
Between them the EVIDEM projects recruited 704 people with dementia to studies, along with 292 carers;
EVIDEM-ED’s audit of general practice included 1072 people with dementia at baseline, and at the end of
the EVIDEM programme the dementia register held an additional 500 people who were not involved with
EVIDEM but who have expressed an interest in being involved in dementia research.
We believe that the register will assist in connecting people with dementia and their carers with
high-quality research studies that will help us answer important questions regarding the pathology,
clinical pathways, aetiology, experiences of, and best treatments for, neurodegenerative disease.
The primary obstacle to the development of the register has been the complexity of permission processes
within the NHS, an experience noted by others.317 This may change, as the register is adopted by research
sites that are not part of the designer group; in new sites, negative staff attitudes and competing clinical
priorities may become more salient and more limiting, as found in other registries.313 A number of
important characteristics of the register are awaiting evaluation, including the utility to researchers of the
minimum data set and the cost per person recruited to studies through the register.
The success of this prototype will be measured by the proportion of people from the register who
participate in research studies and the impact over time that the register has on overall accrual to
portfolio studies.
Appendix
Appendix 67 Chapter 6: Proposed data capture fields with definitions for primary care.
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Chapter 7 Implications for research, policy
and practice
What are the implications of the EVIDEM programme for research, policy and practice? We will attemptto answer these questions in terms of new knowledge and knowledge application, products arising
from EVIDEM projects, methodology development in EVIDEM and the implications of the programme for
research. We will also illustrate how the programme organisation added value to the individual projects,
describing the synergies in the research process, EVIDEM’s ‘offspring’, and research capacity building
within the programme.
Diagnosis and management in primary care
New knowledge and knowledge application The EVIDEM-ED trial has shown that a high-intensity, tailored
educational intervention in a context of increasing policy pressure (NDS 2009,18 the review of antipsychotic
use in 2011), growing resources in some areas (e.g. pilot schemes of dementia advisors, dementia
champions in general practice) and financial incentives for general practices (within the QOF reimbursement
system) does not increase dementia case recognition or improve the amount or content of clinical
management of people with dementia in general practice. Our view is that the less-intense, less-tailored
educational activities currently being promoted as part of the NDS are unlikely to change clinical practice in
primary care.
EVIDEM-ED products Although the educational intervention proved ineffective in changing documented
practice, it was popular with practitioners and researchers. By the end of the EVIDEM programme the
methods for carrying out learning needs assessment and the writing of educational prescriptions used in
the EVIDEM-ED project had been taken up by practitioners in the English and Welsh NHS, and Ireland,
and by researchers in Germany (University of Düsseldorf), the USA (at Johns Hopkins Medical School) and
New Zealand (University of Auckland). The clinical themes identified by GPs as priorities for learning in
EVIDEM-ED were used in the evaluation of e-learning packages on dementia, funded by the Alzheimer’s
Society (see www.alzheimers.org.uk/site/scripts/documents_info.php?document ID= 367).
Methodology development The implementation of ENA and educational prescriptions in general practice
(EVIDEM-ED) has tested this approach to learning on a scale that is unusual in educational research,
and takes these methods beyond theoretical discussion into practical application.
Implications for research Educational interventions in settings in which a co-ordinated system of dementia
case management operated have shown positive effects,318 so the effective change may need to include
the additional resource of case management as well as focused education. Future research may need to
refocus on the additional resources needed in primary care, as in the CAREDEM study,319 rather than in the
acquisition of new skills by the existing workforce.
Exercise as therapy for behavioural and psychological
symptoms of dementia
New knowledge and knowledge application The EVIDEM-E trial has demonstrated that exercise as a form
of therapy for BPSD is acceptable to people with dementia and their families, and feasible for use by the
NHS, but its effectiveness in reducing behavioural and psychological symptoms in people with dementia is
not yet established. The secondary, but important, finding of EVIDEM-E is that the exercise intervention
seemed to have a strong positive effect on carer’s burden. This is important, as carer’s burden is strongly
associated with increased likelihood of relocation to a care home. It does not appear likely to be
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cost-effective, however, showing no significant cost or effect differences for any of the outcome
measures considered.
EVIDEM-E products The EVIDEM-E project has made a video about exercise as therapy in dementia,
accessible via www.EVIDEM.org.uk.
Methodology development EVIDEM-E is one of the largest RCTs of exercise for BPSD. This trial has
contributed to the debate about designing trials for non-pharmacological studies. Predictably, recruitment
has been one of the main challenges encountered. The EVIDEM-E team largely solved the recruitment
problems, and, as a consequence, learned lessons that have been reported to the wider research and
clinical communities.
Implications for research The walking intervention developed and tested in EVIDEM-E is safe, simple to
apply and does not need special training or equipment. Further research should focus on the mechanisms
by which exercise affects carers’ burden, the feasibility of deploying this tailored intervention on a wide
scale without loss of fidelity, and its long-term impact on BPSD, carer burden and relocation.
Managing incontinence in community-dwelling people
with dementia
New knowledge and knowledge application The EVIDEM-C project has found that the incidence of
incontinence (urinary and/or faecal) in community-dwelling people with dementia is at least double that
in populations matched by age, gender and comorbidity. The use of indwelling urinary catheters, a
management strategy discouraged by international and national clinical guidelines, was found to be double
the rate in people with dementia compared with a matched population without dementia. It has shown
that incontinence in people with dementia is a deeply hidden problem, a taboo concealed within a stigma.
Family carers often sought to preserve the person’s dignity by not seeking help, often to the point of crisis.
Professional and continence service responses to incontinence often omitted any specific consideration of
the effects of dementia. Family carer management strategies emphasised the effective containment of
excreta and some solutions had unintended, negative consequences for the person with dementia. FI was
shown to be less common than UI among people with dementia, but found to have a greater negative
effect on the carer’s quality of life. The presence of FI was found to significantly increase the costs, by
almost two-thirds, from both a HSC perspective and a societal perspective, compared with the costs of
managing UI. This project made recommendations for practice (routine enquiry by professionals about
continence problems at each encounter with carers) and developed an assessment tool for
community nurses.
EVIDEM-C products The EVIDEM-C project provides tools and supporting materials for practitioners
working with people with dementia and their families, and insights that require further testing and
investigation by researchers.
Methodology development The analysis of a GP records database (THIN142) by the EVIDEM-C project has
clarified the methods needed to study the epidemiology of incontinence, especially when using routinely
collected clinical data. The EVIDEM-C project also developed innovative analyses of costs incurred in the
management of incontinence in people with dementia.
Implications for research Strategies and responses that primary care professionals and others can use to
encourage greater openness, and which may reduce the taboo of incontinence within the stigma of
dementia, need testing in further studies. Similarly, dementia-specific continence assessment tools and
guidance for the use of primary care nurses produced by this project need evaluation for their utility
and impact.
IMPLICATIONS FOR RESEARCH, POLICY AND PRACTICE
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End-of-life care in dementia
New knowledge and knowledge application The EVIDEM-EoL project showed that the trajectories of the
end-of-life in people with dementia are often unclear to care home staff, family members and visiting
health-care practitioners. The transition from living to dying with or from dementia is often characterised
by uncertainty in three key areas:
1. how different groups should work together and across the health and social (independent) care
2. whether or not a person with dementia is actively dying and how to manage the process and its
related symptoms
3. whether or not the resources and services needed to support the person in the care home will always
be accessible.
In settings in which there are no on-site clinical practitioners, decision-making in these three areas is a
complex process reliant on how roles and relationships are negotiated between family, residents and NHS
and care home staff. An intervention such as AI was able to help address ‘relational uncertainties’ about
who does what and for whom and to develop productive working relationships between care home
practitioners, family members and NHS staff. It fostered rapid and sustained engagement between care
homes staff and GPs, did not increase resource use, reduced the use of emergency services and appeared
to improve the management of unexpected events, crisis management and unplanned hospital admissions.
This has direct implications for practice.
EVIDEM-EoL products The EVIDEM-EoL project has field-tested AI in care homes and developed a
framework for the evaluation of end-of-life care interventions for people with dementia in long-term care
settings, which is currently being used in a Train the Trainer evaluation funded by East of England
Multi-Professional Deanery.
Methodology development The application of AI methods in care homes and primary care (in the
EVIDEM-EoL project) is one of the few examples of the practical use of this quality improvement technique.
The methodological testing of consent processes for people with dementia in long-term care in the
EVIDEM-EoL project adds to our understanding of how to conduct research with people with impaired
cognition, and contributed to the NIHR SSCR-commissioned review of research methods for end-of-life
care research in social care settings. The evaluation framework for end-of-life interventions in long-term care
settings is a novel development. Collaboration with Belfast University in analysis of medication use in
care homes (EVIDEM-EoL) is also innovative – see Chapter 4 for details and outputs from this collaboration.
Implications for research AI appears to improve working relationships between NHS professionals and care
home staff, with promising outcomes. It is an approach that fits with others which emphasise relational
approaches to care. Nevertheless, more research is needed to test these findings further and with more
robust controls.
Evaluating the Mental Capacity Act 2005
New knowledge and knowledge application The EVIDEM-MCA project found that dementia care services
and practitioners have traditionally not conceptualised their practice as being framed by legal rules.
The MCA 200517 was a major challenge to this and the dementia care sector has had to adapt to this
fundamental shift. There are lessons here for future changes being proposed for social care law, such as
those outlined in the Care and Support White Paper of July 2012.282
EVIDEM-MCA products The EVIDEM-ED learners’ manual included brief advice for practitioners on capacity
assessment and the requirements of the MCA 2005,17 derived from the MCA project. Forty-four tailored
learning resources have been prepared by the EVIDEM-MCA project.
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Methodology development The longitudinal element of the programme enabled repeat interviews with
practitioners and people with dementia and carers; this is a novel approach among some practitioner
groups. EVIDEM-MCA for example, interviewed SACs four times, many of whom participated in all rounds.
In contrast, on returning to care homes for repeat interviews, few staff interviewed initially were still in
post at time 2. Learning from this study has contributed to the NIHR SSCR-commissioned overview of
qualitative research with people with dementia.
Implications for research We need to study MCA offences and their role in providing assurance that
people with dementia have access to justice and are safeguarded. It is difficult to know if the media
coverage of prosecutions under the MCA is having the effect of reducing ill treatment and wilful neglect,
but research might establish if emerging case law was facilitating cultural change within care services, by
demonstrating that ill treatment is not simply a matter of poor practice, but potentially subject to criminal
sanctions. Much dementia care has focused on efforts to improve services, support carers, promote good
practice and encourage staff. We do not know if an approach that is more punitive leads to greater
intolerance of abuse. We do not know the effects on services such as hospitals and care homes if cases are
brought against staff or family carers, or on staff and team dynamics.
A final area for research is that of bridging the gap between professionals and carers. Our finding that
many professionals have experience of dementia among family members is probably of no surprise to
readers of this report. However, it has not been commented upon or its implications explored. Research
might investigate the interface between care work and family care. In relation to the MCA, such personal
and professional experiences appear mutually informative.
A dementia cohort
New knowledge and knowledge application The COHORT/REGISTER project, developed jointly with North
Thames DeNDRoN, demonstrated that it is feasible to develop, populate and use an ethically acceptable
dementia register, housed within a NHS clinical record system. However, we also showed that recruitment
to such a register through primary care is costly and yields small numbers of participants, making
recruitment through specialist services more cost-effective. The further development of research registers
was taken up by DeNDRoN.
COHORT/REGISTER products The North Thames Dementia register (NT DemReg) was adopted and used by
five NHS trusts.
Methodology development The development of the North Thames DeNDRoN research register has
influenced debates within DeNDRoN about the configuration of recruitment and feasibility assessment
tools for neurodegenerative diseases research.
Implications for research The pioneering work of the dementia registry has led to the development of a
specification of a national registry by DeNDRoN; this work is under way. There is potential for using the
registry not only to identify and recruit research interested people with dementia and their carers, but also
as a research database in its own right.
The benefits of programme funding
The EVIDEM programme has had a rich research output because of its multidisciplinary nature and its
connectedness to the host NHS trust, CNWL NHS Foundation Trust. Combining the expertise of different
organisations and disciplines created synergies in the research programme, allowed EVIDEM to produce
‘offspring’ studies, and contributed to the expansion of research capacity in dementia studies.
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Synergies in the research process
The interaction between projects was critical to the success of the EVIDEM programme. Some of the
cross-fertilisation was about specific topics, problems and techniques. For example, the EVIDEM-ED project
benefited from the knowledge of BPSD within the trial of exercise as therapy, and drew its training
materials on the MCA 200517 from EVIDEM-MCA. In turn, EVIDEM-ED provided data from interviews with
carers about the experience of managing incontinence for EVIDEM-C, and about sources of legal advice
provided to family carers from EVIDEM-MCA. Similarly, EVIDEM-EoL, EVIDEM-C and EVIDEM-MCA shared
ethics protocols and supporting consent documents.
All projects benefited from iterative face-to-face debate within the EVIDEM programme about recruitment
methods. All projects experienced challenges in recruiting people with dementia and their carers to the
EVIDEM studies. The process of recruitment from where there was no on-site research presence or input
was both time-consuming and resource intensive. The projects noted how recruitment could be experienced
as an additional burden by practitioners, how the stigma of the diagnosis impeded recruitment, how
professionals acted as gatekeepers to research in some services, and how among some NHS staff there
were concerns about the ownership of research.
We also noted the variable appetite of some professionals to improve care for people with dementia.
Although there were some enthusiasts among the generalists (especially GPs and community nurses), these
individuals were not necessarily typical of their entire professional groups, which, although not averse to
improving care, were not necessarily willing to put in any additional effort into a research activity designed
to achieve this.
Nevertheless, the EVIDEM projects recruited 704 people with dementia to studies, along with 292 carers;
EVIDEM-ED’s audit of general practice included > 1000 people with dementia, and, at the end of the
EVIDEM programme, the dementia register held an additional 500 people who were not involved
with EVIDEM but who have expressed an interest in being involved in dementia research. Over
500 professionals – ranging from part-time care home staff and volunteer carer support workers to highly
trained psychiatrists and dementia care nurses – were interviewed, took part in group discussions or
participated in the research in other ways (e.g. in a Delphi process).
Sharing ideas within the EVIDEM programme also prompted new research initiatives within the
programme, such as the use of the THIN database,142 a primary care data set, to gather epidemiological
evidence about continence in EVIDEM-C.
The EVIDEM programme has run annual ‘summer schools’ with CNWL NHS Foundation Trust staff using
the project themes to update practitioners and managers and using different styles of dissemination events
and opportunities, some in the workplace and others organised centrally. Large numbers of practitioners
have attended other EVIDEM presentations and new media, such as free online journals and professional
outlets, webinars, tweets and blogs, have been used as communication tools.
Offspring from the EVIDEM programme
The EVIDEM programme generated further studies, as shown below.
l The Transitions study on how people with dementia experienced the process of diagnosis (NIHR Service
Delivery and Organisation programme funded; project number 08/1809/229). See www.netscc.ac.uk/
hsdr/files/project/SDO_FR_08–1809–229_V01.pdf.
l A person-centred primary care training package, developed and field-tested in Avon and Wiltshire NHS
Trust by Sarah Voss and Rachel Edwards (and funded by the Alzheimer’s Society). See Chapter 1 for
details of this project or: www.alzheimers.org.uk/site/scripts/documents_info.php?documentID = 1475&
pageNumber= 3.
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l The Optimal study (funded by the NIHR Health Services and Delivery Research programme; project
number 11/1021/02) on ways of optimising NHS working with care homes.
l The EVIDEM-MCA team worked with the Alzheimer’s Society in devising data collection instruments,
augmentation of interview data and secondary analysis of findings in its study of Financial Abuse in
dementia (The ‘Short Changed’ report:287 see www.alzheimers.org.uk/site/scripts/news_article.
php?newsID= 1127).
Research capacity building
The EVIDEM programme has created a fruitful postdoctoral research environment allowing the further
development of dementia researchers (Samsi, Thune-Boylé, Lowery). Two new researchers have
undertaken PhDs within EVIDEM: (Cerga-Pashoja, Cole), and four early-career GPs have acquired research
and writing skills within EVIDEM (Koch, Pealing, Davidson, Venavadem) with another experienced social
scientist (Charles) participating in EVIDEM-MCA prior to moving to health services research. One exercise
therapist (Lee) used his experience of working on EVIDEM-E for his Bachelor of Science dissertation. One
postgraduate (Ng) secured her Master of Science in International Health Policy under the direction of
Professor Martin Knapp at the London School of Economics based on her economic evaluation of the
end-of-life intervention. Embedding the EVIDEM programme in the CNWL NHS Trust has assisted the trust
to increase its research activity and focus it more on older adults. The NT DemReg is a powerful tool for
recruiting people with dementia and their carers to studies. The EVIDEM-MCA research team has acted as
research advisors on projects covering Mental Capacity Advocates, Indirect or Proxy Holding Personal
Budget Arrangements, and the Deprivation of Liberty Safeguards, at the Mental Health Foundation and
University of Bristol.
Conclusions
The EVIDEM programme is an addition to the small number of longitudinal studies of the dementia
trajectory, and leaves behind a mechanism (the register) for recruiting further cohorts. It has shown the
benefits of interdisciplinarity in dementia research, and demonstrated the value of mixed methodologies in
addressing complex problems. Grounding the EVIDEM programme in an NHS trust allowed the research
teams to work with the diversity of the population and the range of providers operating in dementia services.
The longitudinal element of the programme enabled repeat interviews with practitioners and people with
dementia and carers, as described above in the review of EVIDEM-MCA. Both EVIDEM-C and EVIDEM-EoL
had longitudinal elements in which they interviewed and followed up people with dementia and family
carers for up to 3 (EVIDEM-C) and 4 (EVIDEM-EoL) years.
As discussed above, the testing of recruitment from primary and secondary care has been a feature of all
projects, with different methods being used in different settings. The EVIDEM-E project, which experienced
slow recruitment initially, benefited most from using the research register. In contrast, and to meet the
aims of part of its study, EVIDEM-MCA gained the trust of community and voluntary groups of older
people to access ‘well’ older people. EVIDEM-EoL developed and tested recruitment within the care home
settings, providing learning which contributed to the DeNDRoN ENRICH research initiative
(www.DeNDRoN.org.uk/enrich/).
Finally, the extensive involvement of lay experts at the levels of individual projects as well as in the steering
group for the whole programme has shaped the development of methods and had a decisive role in the
evolution of projects such as EVIDEM-C and EVIDEM-EoL.
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EVIDEM-E publications and presentations
Papers have been published (Table 75) and presentations (Table 76) made throughout the study.
In addition, there are papers accepted for publication but not yet published, and others under review.
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Authors Title Journal
Lowery D, Warner J Behavioural and psychological symptoms of
dementia (BPSD): the personal and practical
costs of dementia
J Integ Care 2009;17:13–19
Lowery D Exercise and dementia Alzheimer’s Society Newsletter, Living with
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Cerga-Pashoja A,
Lowery D, Bhattacharya R,
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controlled trial
Trials 2010;11:53
Lowery D, Warner J,
Cerga-Pashoja A,
Thuné-Boyle I, Iliffe S
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lessons from the EVIDEM-E project
Int J Geriatr Psychiatry 2011;26:765–9
Iliffe S, Curry L, Kharicha K,
Rait G, Wilcock J,
Lowery D, et al.
Developing a Dementia Registry: a
descriptive case study from North Thames
DeNDRoN and the EVIDEM programme
BMC Med Res Methodol 2011;11:9
Thuné-Boyle, I, Iliffe, S,
Cerga-Pashoja A,
Lowery D, Warner J
The effect of exercise on behavioral and
psychological symptoms in dementia:
towards a research agenda
Int Psychogeriatr 2012. URL: http://dx.doi.org/
10.1017/S1041610211002365
Lowery D, Cerga-Pashoja A,
Iliffe S, Thuné-Boyle I,
Griffin M, et al.
The effect of exercise on behavioural and
psychological symptoms of dementia and
caregiver’s perceived burden: the EVIDEM-E
randomised controlled clinical trial
Int J Geriatr Psychiatry 2014;29:819–27
TABLE 76 EVIDEM-E: presentations (until April 2014)
Presenter Title Location and date
Warner J The use of Anti-Psychotic Medications in
People with Dementia
EVIDEM Summer School, London, UK, 2008
Warner J Exercising your Mind Enfield over-50s Group, London, UK, 2009
Warner J Behavioural and psychological symptoms of
dementia and their management
EVIDEM Summer School, CNWL NHS Trust,
UK, 2009
Lowery D EVIDEM-E: A randomised controlled evaluation
of a tailored exercise package for individuals
with dementia and their carers: the impact on
sleep, behaviour and quality of life
Dementia Services Development Centre’s 3rd
International Conference, York, UK, 2009
Warner J The motion: people in the terminal stages of
dementia are wasting their families’ lives and
the resources of the NHS, as opposer
Dementia Care Congress, Harrogate, UK,
2009
Cerga-Pashoja A Evaluation of exercise on individuals and their
carers: a randomised controlled trial
PRIMENT Clinical Trials Unit, University
College London, UK, 2010
Lowery D Challenging behaviour: meaning and (care)
management. The National Dementia Strategy
Practice Perspectives: one year on
King’s College London, London, 2010
Lowery D Evidenced based interventions in dementia:
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in dementia care in the community
Hillingdon Carers Information Day, Hillingdon
Civic Centre, 2010, UK
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psychological symptoms of dementia and a
possible therapy: an invitation to participate in
EVIDEM-E
Hillingdon Admiral Nurse Service Carers
Information Day, Hillingdon Civic Centre, UK,
2010
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TABLE 76 EVIDEM-E: presentations (until April 2014) (continued )
Presenter Title Location and date
Warner J Managing Behavioural and Psychological
Symptoms of Dementia: training our
colleagues to identify causes and
consequences
EVIDEM Summer School, CNWL NHS Trust, UK,
2011
Lowery D Taking a stroll beyond memory lane: Can
walking help with symptoms of dementia?
Alzheimer’s Society Memory Lane Café,
London, UK, 2011
Lowery D and Lee J Providing people with dementia and their
carers with tools to improve their levels of
physical activity
Dementia Care Congress, Liverpool, UK,
2011
Lowery D Scientists assess whether exercise helps
combat dementia
BBC One/Radio 4 Breakfast News, 2011
Lowery D Physical Activity: A tool for improving
outcomes for people with dementia
Chartered Society of Physiotherapy Annual
Congress, Liverpool, UK, 2011
Cerga-Pashoja A Evaluation of exercise on individuals with
dementia and their carers: a randomised
controlled trial
Presentation for conversion to PhD. Research
Department of Primary Care & Population
Health, University College London, UK, 2011
Cerga-Pashoja A Methodological challenges of conducting
research in the NHS
Society for Academic Primary Care Regional
Meeting, Cambridge, UK, 2011
Lowery D Factors affecting clinician engagement in
recruitment for dementia trials
Gerontological Society of America Annual
Scientific Meeting, Boston, USA, 2011
Lee J The role of applied health research:
experiences of implementing an intervention
within a trial of exercise therapy for symptoms
of dementia
University of Brighton, UK, 2011
Thuné-Boyle I The effect of exercise on behavioural and
psychological symptoms in dementia
Alzheimer’s Disease International, London, UK,
2012
Lowery D Reducing caregiver burden: a curious corollary
of asking a caregiver to do more! In ‘The real
dementia challenge: using research to change
practice for older people with dementia’,
symposium
The British Society of Gerontologists, Oxford, UK,
AutumnMeeting, 2013
Lowery D Reducing caregiver burden: a curious corollary
of asking a caregiver to do more!
Dementia Care Congress, Nottingham, UK,
2013
Lowery D EVIDEM Exercise In ‘Evidence-Based Interventions
in Dementia (EVIDEM): Research Across the
Dementia Trajectory’, symposium
Gerontological Society of America Annual
Scientific Meeting, New Orleans, USA, 2013
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
183
Chapter 3: EVIDEM-C
The authors all contributed and agreed on the final version of this chapter as shown in Table 77.
In addition, we would like to thank others who were involved in individual studies as identified in
Table 78.
TABLE 77 EVIDEM-C: acknowledgements of contributors (Faculty of Health and Social Care Sciences, Kingston
University and St George’s, University of London)
Name and role Study element to which they contributed
Vari Drennan Professor of Health Policy
and Service Delivery
Chief Investigator
Conceived, designed, organised the overall and individual elements of the
study, including data collection, analysis and interpretation, and drafted
this report
Laura Cole Research Associate Made a contribution to the design of individual elements, the
organisation of the study, data collection, analysis and interpretation of
the study. In addition, helped to draft and critique the output for
important intellectual content
Sheila Donovan Research Fellow Made a contribution to the design of individual elements, the
organisation of the study, data collection, analysis and interpretation of
the study. In addition, helped to draft and critique the output for
important intellectual content
Robert Grant Senior Research Fellow in
quantitative methods
Provided statistical analysis and interpretation, and, in addition, helped to
draft this output for important intellectual content
TABLE 78 EVIDEM C: acknowledgements of additional contributors
Name Role Study element contributed to
Francesco D’Amico Research Officer, PSSRU London School of Economics Health economics
Anna El-Jouzi Librarian, St George’s University of London Systematic review
Mandy Fader Professor of Continence Technology, Faculty of Health Sciences,
Southampton University
Systematic review and advisory
group member
Nan Greenwood Senior Research Fellow, Faculty of Health and Social Care Sciences,
St George’s University of London and Kingston University
Systematic review
Steve Iliffe Professor of Primary Care for Older People, Research Department
of Primary Care & Population Health, University College London,
London
Chief investigator for the
programme
Martin Knapp Director and Professor of Social Policy PSSRU, London School of
Economics
Health economics
Mary Murrell Former family carer Member of advisory group
Caroline Norrie Research Associate, Faculty of Health and Social Care Sciences,
St George’s University of London and Kingston University
Survey
Irene Peterson Principal Research Associate, Research Department of Primary
Care & Population Health, University College London, London
Cohort study
Greta Rait Senior Lecturer in Primary Care, PRIMENT Clinical Trials Unit,
Research Department of Primary Care & Population Health,
University College London, London
Systematic review, cohort study
and advisory group member
Amritpal Redhill Researcher, PSSRU London School of Economics Health economics
Jacqui Woods Former family carer Chair of advisory group
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EVIDEM-C publications and presentations
Papers have been published (Table 79) and presentations [oral (Table 80) and poster (Table 81)] made
throughout the study. In addition, there are papers accepted for publication but not yet published, and
others under review.
TABLE 79 EVIDEM-C: published papers (until April 2014)
Authors Title Journal
Drennan V, Cole L Promoting continence and managing incontinence with
people with dementia living at home: one more challenge
for integration
J Integ Care 2009;17:15–25
Drennan V, Cole L Dealing with incontinence Alzheimer’s Society Magazine 2009:14
Drennan V, Cole L Exploring Issues and solutions in promoting continence
with people with dementia living at home
J Clin Nurs 2010;19(Suppl. 1):100
Drennan VM, Cole L,
Iliffe S
A taboo within a stigma? A qualitative study of managing
continence in people with dementia living at home
BMC Geriatr 2011;11:75
Drennan VM,
Norrie C, Cole L,
Donovan S
Addressing incontinence for people with dementia living
at home: a documentary analysis of local English
community nursing service continence policies and clinical
guidance
J Clin Nurs 2012;22:339–46
Drennan V, Rait G,
Cole L, Grant R,
Iliffe S
The prevalence of incontinence in people with cognitive
impairment or dementia living at home: a systematic review
Neurol Urodyn 2013;32:314–24
TABLE 80 EVIDEM-C: oral presentations (until April 2014)
Title Event Date Location
Management of Incontinence in the
Community: Workshop
London Centre for Dementia Care:
State of Art in Dementia Care
Summer School and Stakeholders
event
1 July 2008 London
Workshop on incontinence as part of
Dignity and dementia: where do the
problems and solutions lie?
Dementia Congress 28–30 October 2008 Bournemouth
An overview of the EVIDEM programme
and the EVIDEM-C study
Academic Primary Care Seminar
St George’s University of London
4 November 2008 London
Exploring issues and solutions in
promoting continence and managing
incontinence with people with memory
problems and dementia living at home
Faculty of Health and Social Care
Sciences Seminar, St George’s
University of London
14 May 2009 London
Comparing the views of people with
dementia and their carers with health
and social care staff on managing toilet
difficulties and incontinence
British Society of Gerontology
Annual Conference
2–4 September 2009 Bristol
Exploring issues and solutions in
promoting continence and managing
incontinence with people with memory
loss and cognitive problems living at
home and their carers
Dementia Services Development
Centre’s International Conference
14–16 September
2009
York
continued
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TABLE 80 EVIDEM-C: oral presentations (until April 2014) (continued )
Title Event Date Location
Exploring issues of toileting problems
and continence promotion for people
living at home
EVIDEM Summer School, CNWL
NHS Foundation Trust
11 September 2009 Hillingdon
EVIDEM-C: Exploring issues and solutions
in promoting continence and managing
incontinence with people with memory
problems and dementia living at home
Annual Meeting of the North West
of England Annual Association of
Continence Advisors
9 December 2009 Preston
Research Support: EVIDEM-C Association for Continence Advice
(ACA) North East Thames
Continence Advisors Group
22 January 2010 London
The Last Taboo? Managing toileting
problems and incontinence with people
with dementia living in their own homes
Making Research Count in Social
Work and Social Care Practice:
The National Dementia Strategy.
King’s College London
1 March 2010 London
Exploring issues and solutions in
promoting continence and managing
incontinence with people with memory
loss and cognitive problems living at
home and their carers
Royal College of Nursing
International Nursing Research
Conference
11–13 May 2010 Newcastle
The last taboo? Managing toileting
problems and incontinence with people
with dementia living in their own homes
Dementia Care Conference,
Hertfordshire Adult Care Services
22 June 2010 Hertfordshire
Promoting continence and managing
incontinence with people with memory
problems living at home
Hillingdon Admiral Nurse Service
Carers’ Information Day
8 July 2010 Hillingdon
Exploring issues and solutions in
promoting continence with people with
dementia living at home
Fourth European Nursing Congress:
Older Persons: The Future Of Care
4–7 July 2010 Rotterdam
Issues in managing continence problems
with people with dementia living at
home: the EVIDEM-C study
Faculty of Health and Social Care
Sciences Seminar, St George’s
University of London
28 October 2010 London
Managing incontinence and dementia at
home: a feasibility study of preferences
and effectiveness of different types of
absorbent products
Royal College of Nursing
Continence Conference
2–3 November 2010 York
Managing incontinence and dementia at
home: a feasibility study of preferences
and effectiveness of different types of
absorbent products
Royal College of Nursing
International Nursing Research
Conference
16–18 May 2011 Harrogate
Issues in managing continence problems
with people with dementia living at
home: the EVIDEM-C study
CNWL NHS Foundation Trust
Occupational Therapists Study Day
1 September 2011 London
Issues in managing continence problems
with people with dementia living at
home: the EVIDEM-C study
EVIDEM Summer School and
Central and North West London
NHS Foundation Trust
7 October 2011 London
Developing a continence assessment tool
for use by district nursing services
sensitive to the needs of people with
dementia
Royal College of Nursing
International Research Conference
22–24 April 2012 London
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Chapter 4: EVIDEM-EoL
A large number of people have contributed to this project. We are very grateful to all of the older people
in the care homes, and their relatives, who participated in the study. Hosting a research study in a care
home is time-consuming and often inconvenient. We are particularly grateful to the care home managers
and staff who welcomed us as a research team, facilitated our work and engaged enthusiastically with all
the demands of the project.
We are also grateful to the primary care professionals who were involved with us throughout the study.
Their participation, and continued interest made Phase 2 possible.
The study received support from North Thames DeNDRoN and Hertfordshire NHS Community Trust with
FSF support.
We are grateful to members of the study advisory group (for membership, see Appendix 54) for their
commitment over the 4 years of the study. Their experience, robust views, input and guidance
were invaluable.
In addition, others were involved as identified in Tables 82 and 83.
TABLE 81 EVIDEM-C: poster presentations (until April 2014)
Title Event Date Location
EVIDEM-C Promoting continence and managing
incontinence with people with dementia and
their carers living at home: A review of Evidence
DeNDRoN Conference 14 October 2008 Newcastle
Promoting continence and managing
incontinence with people with dementia and
their carers living at home: EVIDEM-C
St George’s University of London
Research Conference
3 December 2008 London
Exploring issues and solutions in promoting
continence and managing incontinence with
people with dementia living at home and their
family carers
St George’s University of London
Research Conference
2 December 2009 London
Managing incontinence at home: preferences,
effectiveness and ease of use of different types
of absorbent products
The Dementia Services
Development Centre’s 4th
International Conference: Coming
of Age
19–21 October 2010 London
Managing incontinence at home: preferences,
effectiveness and ease of use of different types
of absorbent products
St George’s University of London
Research Day
30 November 2011 London
Developing a continence assessment tool
sensitive to the needs of people with dementia
living at home and their family carers
Alzheimer’s Disease International
Conference
13 April 2012 London
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EVIDEM-EoL publications and presentations
Papers have been published (Tables 84–87). A Master’s thesis has been submitted (Table 88). In addition,
study newsletters (Table 89), presentations (Table 90) and posters (Table 91) have been made throughout
the study.
TABLE 82 EVIDEM-EoL: acknowledgements of contributors
Name and role Study element they contributed to
Claire Goodman Professor of Health Care Research,
CRIPACC, University of Hertfordshire
Chief Investigator. Conceived the idea of the study,
provided clinical oversight and wrote the first draft of
this chapter
Sarah Amador Research Fellow, CRIPACC, University of
Hertfordshire
Made a significant contribution to the organisation,
data collection, analysis and interpretation of Phase 2.
In addition, helped draft and critique the output for
important intellectual content
Elspeth Mathie Research Fellow, CRIPACC, University of
Hertfordshire
Made a significant contribution to the development of
the AI intervention, the organisation of the study, data
collection, analysis and interpretation of Phase 2
Natasha Baron Research Assistant, Cambridge Centre
for Health Services Research, University
of Cambridge
Made a significant contribution to the organisation,
data collection, analysis and interpretation of Phase 1
Ina Machen Research Fellow, CRIPACC, University of
Hertfordshire
Made a significant contribution to the organisation,
data collection, analysis and interpretation of Phase 1
CRIPACC, Centre for Research in Primary and Community Care.
TABLE 83 EVIDEM-EoL: acknowledgements of additional contributors
Name and role Study element to which they contributed
Catherine Evans NIHR Clinical Lecturer in Palliative Care,
Cicely Saunders Institute, King’s College
London
Review study set-up and care home recruitment, and
member of advisory group
Carole Parsons Lecturer in Pharmacy Practice, School of
Pharmacy, Queen’s University Belfast
Analysis of sedative load and potentially inappropriate
prescribing
Yi Ting Ng Postgraduate student, London School of
Economics
Economic analysis
Derek King Research Fellow, PSSRU, London School
of Economics
Economic analysis
Caroline Nicholson Postdoctoral Research Fellow, Florence
Nightingale School of Nursing and
Midwifery, King’s College London
Development and facilitation of AI intervention
Liz Stevenson Research assistant, CRIPACC, University
of Hertfordshire
Data collection in care homes
David Stott CLiCIR, University of Hertfordshire Survival analysis
CLiCIR, Centre for Lifespan and Chronic Illness Research; CRIPACC, Centre for Research in Primary and Community Care.
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TABLE 84 EVIDEM-EoL: published papers (until April 2014)
Authors Title Journal
Evans C, Goodman C End-of-life care for people with dementia
living in a care home
J Integ Care 2008;16:15–25
Iliffe S, Manthorpe J, Drennan V, Goodman C,
Warner J
The EVIDEM programme a test for primary
care research in London
London J Prim Care
2008;1:69–73
Robinson L, Iliffe S, Brayne C, Goodman C,
Rait G, Manthorpe J, et al.
Primary care and dementia: 1. diagnosis,
screening and disclosure
Int J Geriatr Psychiatry
2009;24:9895–901
Goodman C, Evans C Innovation section: changing practice in
dementia care for people in care homes
towards the end of life
Dementia 2009;8:424–31
Goodman C, Evans C, Wilcock J, Froggatt K,
Sampson E, Drennan V, et al.
End-of-life care for community-dwelling
older people with dementia: an integrated
review
Int J Geriatr Psychiatry
2010;25:329–37
Robinson L, Iliffe S, Brayne C, Goodman C,
Rait G, Manthorpe J, et al., for the
DeNDRoN Primary Care Clinical Studies
Group
Long-term care at home: psychosocial
interventions, information provision, carer
support and case management
Int J Geriatr Psychiatry
2010;25:657–64
Manthorpe J, Iliffe S, Samsi K, Cole L,
Goodman C, Drennan V, et al.
Dementia, dignity and quality of life:
nursing practice and its dilemmas
Int J Older People Nurs
2010;5:235–44
Goodman C, Baron NL, Machen I, Stevenson E,
Evans C, Davies SL, et al.
Culture, consent, costs and care homes:
enabling older people with dementia to
participate in research
Aging Ment Health
2011;15:475–81
Parsons C, Haydock J, Mathie E, Baron N,
Machen I, Stevenson E, et al.
Sedative load of medications prescribed
for older people with dementia in care
homes
BMC Geriatr 2011;11:56
Goodman C The organisational culture of nursing staff
providing long-term dementia care is
related to quality of care
Evid Based Nurs
2011;14:88–9
Davies SL, Goodman C, Bunn F, Victor C,
Dickinson A, Illiffe S, et al.
A systematic review of integrated working
between care homes and health-care
services
BMC Health Serv Res
2011;11:320
(highly accessed)
McMurdo MET, Roberts H, Parker S, Wyatt N,
May H, Goodman C, et al. on behalf of
the Age and Ageing Specialty Group, NIHR,
Comprehensive Clinical Research Network
Improving recruitment of older people to
research through good practice
Age Aging
2011;40:659–65
Goodman C, Davies S ENRICH: an initiative to facilitate dementia
research in care homes
Br J Community Nurs
2012;17:277
Parsons C, Johnston S, Mathie E, Baron N,
Machen I, Stevenson I, et al.
Potentially inappropriate prescribing in
older people with dementia in care
homes: a retrospective analysis
Drugs Aging
2012;29:143–55
Siegel EO, Anderson R, Calkin J, Chu C,
Corazzini K, Dellefield ME, et al.
Supporting and promoting personhood in
long term care settings: contextual factors
Int J Older People Nurs
2012;7:295–302
Goodman C, Amador S, Elmore N, Machen I,
Mathie E
Preferences and priorities for end-of-life
care: A qualitative study of older people
with dementia resident in care homes.
Int J Nurs Studies
2013;50:1639–74
Amador S, Goodman C, King D, Ng YT,
Elmore N, Machen I, et al.
Exploring resource use and associated
costs in end-of-life care for older people
with dementia in residential care homes
Int J Geriatr Psychiatry
2014;29:758–66
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TABLE 85 EVIDEM-EoL: forthcoming papers at January 2014
Authors Chapter title Book title/editors
Amador S, Goodman C,
King D, Machen I, Elmore N,
Mathie E, et al.
Emergency ambulance service involvement with
residential care homes in the support of older
people with dementia: an observational study
BMC Geriatr (under review)
Goodman C, Amador S,
Elmore N, Machen I,
Mathie E
A framework for the evaluation of interventions
and future research in end-of-life care of older
people with dementia
In preparation
Amador S, Goodman C,
Elmore N, Mathie E,
Machen I
A modified Appreciative Inquiry in care homes:
promoting cooperative working for end-of-life
care of older people with dementia
In preparation
TABLE 86 EVIDEM-EoL: chapters (until April 2014)
Authors Chapter title Book title/editors
Wilcock J, Frogatt K,
Goodman C
End-of-life care for people with dementia In Downs M, Bowers B, editors. Excellence
in dementia care: Research in to practice.
Maidenhead: Open University Press; 2008
Goodman C, Davies S,
Leyshon S, Fader M,
Norton C, Gage H, et al.
Collaborating with Primary Care: promoting
shared working between district nurses and care
home staff
In Froggatt K, et al., editors. Understanding
Care Homes: A Research and Development
Perspective. London: Jessica Kingsley
Publishers; 2009
Goodman C, Davies SL Good practice outside the care homes In Dening T, Milne A, editors.Mental
Health in Care Homes. Oxford: Oxford
University Press; 2011
TABLE 87 EVIDEM-EoL: monographs (until April 2014)
Authors Chapter title Book title/editors
Goodman C, Froggatt K,
Mathie E
End of life research methods in social care.
Research Methods in Social Care series
NIHR School for Social Care Research.
2012. URL: www2.lse.ac.uk/LSEHealth
AndSocialCare/pdf/SSCR-Methods-
Review_12_web.pdf
TABLE 89 EVIDEM-EoL: newsletters (until April 2014)
Authors Title Newsletter
Evans C, Goodman C Spotlight on the End of Life Project Alzheimer’s Society magazine, 2008.
URL: http://alzheimers.org.uk/site/scripts/
documents_info.php?documentID= 809
&pageNumber= 3
Evans C, Goodman C Spotlight on the End of Life Project EVIDEM Newsletter 2:5
Baron N, Goodman C An update on the End of Life study EVIDEM Newsletter 5:3–4
TABLE 88 EVIDEM-EoL: master thesis/unpublished manuscripts (until April 2014)
Authors Title
Ng YT Resource implications of supporting end-of-life
care for older persons with dementia in the care
homes in England
Unpublished Master’s Thesis. London:
Department of Social Policy, London
School of Economics
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TABLE 90 EVIDEM-EoL: presentations (until April 2014)
Authors Title Event
Goodman C, Wilcock J,
Bisset M, Froggatt K,
Drennan V, Blanchard M, et al.
Integrative review of end-of-life care for
community-dwelling older people with
dementia
Royal Society of Medicine, London, 2008
Goodman C, Evans C Setting the scene: introduction to
providing care in NHS care homes
Royal Society of Medicine, London, 2008
Goodman C, Evans C EVIDEM-EoL: changing practice in
dementia care in care homes: developing
and testing evidence based interventions
at the end of life
Symposium Presentation King’s College
London, London, 2008
Evans C, Goodman C,
Davies SL
Research in care homes. Bulletin issue 11 PCRN_GL Masterclass, 2008
Goodman C Understanding the experience of living
and dying in a care home
Presentation to Quantum Homes, Herts,
2008
Goodman C Research in end-of-life care in care homes Dementia and end-of-life care study day
St Nicholas Hospice, Ipswich, 2008
Iliffe S, Manthorpe J,
Goodman C, Drennan V,
Warner J
Dignity and dementia: where do the
problems and solutions lie?
Dementia Care Congress, Bournemouth,
2008
Goodman C Supporting people with dementia and
their carers at the end of life in care
homes and primary care
EVIDEM Summer School, CNWL NHS
Foundation Trust, London 2009
Goodman C, Baron N Living and dying with dementia in care
homes: the EVIDEM-End of Life study
The Dementia Service Development Centre
3rd International Conference, York, 2009
Goodman C, Baron N,
Stevenson E, Machen I
Culture consent and care home: enabling
older people with dementia to participate
in research
British Society of Gerontology Annual
Conference, Bristol, 2009
Goodman C Addressing uncertainty: end-of-life care in
residential settings
The National Dementia Strategy Practice
Perspectives: One Year On, King’s College
London, London, 2010
Goodman C End-of-life care for people with dementia DeNDRoN, 2010
Goodman C EVIDEM-End of Life: recognising and
supporting end-of-life care for people with
dementia living in care homes
Delivering Better Health Services: The
Health Services Research Network,
Manchester, 2010
Mathie E, Goodman C Living and dying in residential care homes:
views of residents: ‘a good death’
NHS Luton and Bedfordshire Quality
Summit – Care Homes, Flitwick, 2011
Goodman C The role of care homes in HSC integration Navigating the Future: Partnership and
Integration in a Changing World. Seminar
of ADASS and BGS, London, 2011
Goodman C Dementia research in care homes Presentation at Dementia Research:
Knowledge into Care. NIHR CLAHRC,
Cambridge, 2011
Nicholson C Good gossip: using appreciative inquiry to
further end-of-life care in care homes
Presentation at the Margaret Butterworth
Care Home Forum, London, 2011
Goodman C The role of care homes in HSC integration Workshop session at Navigating the
future: Partnership and Integration in a
Changing World. Seminar of ADASS and
BGS, London, 2011
Goodman C New research into partnership working
with dementia
Presentation at the Hertfordshire Care
Providers Association Members Meeting,
Welwyn Garden City, 2011
continued
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TABLE 90 EVIDEM-EoL: presentations (until April 2014) (continued )
Authors Title Event
Mathie E, Goodman C,
Nicholson C, Amador S
End of life care in residential care homes –
an appreciative inquiry
Presentation at the Assets for Health and
Wellbeing Across the Life Course
International Conference, British Library
Conference Centre, London, 2011
Goodman C Dementia research in care homes Presentation at Dementia Research:
Knowledge into Care, NIHR CLAHRC,
Cambridge, 2011
Goodman C, Mathie E,
Nicholson C, Amador S
Dealing with uncertainty at the end of life
for people with dementia: appreciative
inquiry as an intervention to improve
working between primary healthcare and
care homes
Presentation at the UK Dementia Congress
Liverpool, 2011
Goodman C, Mathie E,
Nicholson C, Amador S
Using what we do well to improve end of
life care for older people with dementia
Presentation at the Hertfordshire County
Council Good Practice in Dementia Care
Conference, Hatfield, 2011
Mathie E EVIDEM-End of Life: working with primary
healthcare supporting people with
dementia living and dying in care homes
Presentation at Working Together: Valuing
Each Other. New Approaches to Working
Between Care Homes and Primary Care.
Hertfordshire AGENET meeting, Hatfield,
2012
Nicholson C An appreciative inquiry: end of life care in
residential care
Presentation at Working Together: Valuing
Each Other. New Approaches to Working
Between Care Homes and Primary Care
Hertfordshire AGENET meeting, Hatfield,
2012
Mathie E Supporting people with dementia: living
and dying in residential care homes
Community Care Conference, London,
2012
Goodman C, Nicholson C,
Mathie E, Amador S
End-of-life care for people with dementia:
an intervention to promote integrated
working between care home staff and
healthcare practitioners
Presentation at the Alzheimer’s Disease
International Conference London, 2012
Nicholson C, Mathie E,
Machen I, Amador S,
Goodman C
Working appreciatively in end-of-life care:
an intervention to promote collaborative
working between care home staff and
healthcare practitioners
Presentation at the RCN UK’s International
Nursing Research Conference London,
2012
Goodman C Care homes: working with and working
for the NHS
Presentation at the BGS Community
Geriatrics Meeting, The Met Hotel, Leeds,
2012
Goodman C An intervention to promote integrated
working between care homes and
healthcare practitioners for end-of-life care
of older people with dementia
Presentation at Delivering Better Health
Services HSRN symposium, Manchester
Central, 2012
Goodman C Maximising quality in residential care Presentation at the New Dynamics of
Ageing/My Home Life workshop, RIBA,
London, 2012
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Chapter 5: EVIDEM-MCA
A number of people have contributed to this project. We are extremely grateful to all of the participants for
their time and for sharing their views. We are most grateful to Joan Rapaport, Hazel Heath, Jess Harris,
Philip Rapaport, Tayavnie Nagendran, Nigel Charles and Lynn Phair who conducted a number of interviews
and assisted with data analysis. We thank Karishma Chandaria for the opportunity to work with the
Alzheimer’s Society and for contributing to our linked study of financial abuse among people with dementia.
We are grateful to members of the study advisory group and of the Social Care Workforce Research Unit
advisory group for sharing their views on various aspects. Thanks are also due to Steve Chamberlain,
Maria Grey, Priya Jain and Frances Lefford for their contributions to a consensus group meeting.
The authors all contributed and agreed on the final version of this chapter as shown in Table 92.
TABLE 90 EVIDEM-EoL: presentations (until April 2014) (continued )
Authors Title Event
Amador S, Mathie E,
Nicholson C, Goodman C
End of life care for people with dementia:
researching uncertainty
Presentation at Developing a Research
Culture, CLCH NHS Trust Annual Conference,
Mary Ward House, London, 2012
Amador S, Mathie E,
Nicholson C, Goodman C
Participatory research in care homes:
promoting collaborative working between
care homes and healthcare professionals
for end-of-life care of older people with
dementia
Presentation in Conducting Healthcare
Research with Care Homes: Residents,
Researchers and Healthcare Professional’s
Perspectives Symposium, BSG Annual
Conference, Keele, 2012
ADASS, Association of Directors of Adult Social Services; BGS, British Geriatrics Society; BSG, British Society of Gerontology;
CLAHRC, Collaborations for Leadership in Applied Health Research and Care; CLCH, Central London Community
Healthcare; HSRN, Health Services Research Network; RCN, Royal College of Nursing; RIBA, Royal Institute of
British Architects.
TABLE 91 EVIDEM-EoL: posters (until April 2014)
Authors Title Event
Goodman C, Evans C EVIDEM-End of Life (EoL): changing
practice in dementia care in care homes –
developing and testing interventions
towards the end of life
Poster session at the DeNDRoN Annual
Conference, Newcastle upon Tyne, 2008
Goodman C, Baron N,
Machen I, Stevenson L
EVIDEM-EoL: living and dying with
dementia in care homes
Poster session at the DeNDRoN Annual
Conference, 2009
Goodman C, Baron N Ensuring equity of participation for people
with dementia: strategies to support
inclusionary research
Poster session at the Biennial symposium
of ICCHNR, Edmonton, Canada, 2011
GoodmanC,NicholsonC End-of-life care in residential care homes:
an Appreciative Inquiry
Poster session at the fourth National Care
Homes Congress, Birmingham, 2011
NicholsonC,GoodmanC,
MathieE,AmadorS,BaronN,
Machen I
End of life care for people with dementia:
an intervention to promote collaborative
working between care home staff and
healthcare practitioners
Poster session at the 9th Palliative Care
Congress, The Sage Gateshead,
Gateshead, UK, 2012. URL: http://spcare.
bmj.com/content/2/Suppl_1/A23.1
Nicholson C, Mathie E,
Machen I, Amador S,
Goodman C
Working appreciatively in end-of-life care:
an intervention to promote collaborative
working between care home staff and
healthcare practitioners
Poster session at the RCN UK, 2012.
The 2012 International Nursing Research
Conference
ICCHNR, International Conferences in Community Health Nursing Research; RCN, Royal College of Nursing.
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EVIDEM-MCA publications and presentations
Papers have been published (Table 93) throughout the study. In addition, there are papers accepted for
publication not yet published and under review (Table 94). Please see Table 95 for a list of all of the
presentations at seminars, events and conferences.
TABLE 92 EVIDEM-MCA: acknowledgements of contributors (Social Care Workforce Research Unit,
King’s College London)
Name and role Study element to which they contributed
Jill Manthorpe Professor of
Social Work
Chief Investigator. Conceived the idea of the study, conducted interviews, report
writer, member of EVIDEM project team, data analysis and dissemination lead;
drafted final report
Jessica Harris Research
Associate
Assistance with interviewing at initial stage of the study
Kritika Samsi Lecturer Project researcher and co-investigator. Interviews, analysis and project manager,
assisted with drafting of final report and all study outputs
TABLE 93 EVIDEM-MCA: published papers (until April 2014)
Authors Title Journal
Manthorpe J, Rapaport J,
Harris J, Samsi K
Realising the safeguarding potential of the
Mental Capacity Act 2005: early reports from
adult safeguarding staff
J Adult Protect 2009;11:13–24
Manthorpe J, Samsi K Implementing the Mental Capacity Act 2005:
challenges for commissioners
J Integ Care 2009;17:39–47
Manthorpe J, Iliffe S,
Samsi K, Cole L,
Goodman C, Drennan V,
et al.
Dementia, dignity and quality of life: nursing
practice and its dilemmas
Int J Older People Nurs 2010;5:235–44
Manthorpe J, Samsi K,
Heath H, Charles N
‘Early days’: Knowledge and use of the
Mental Capacity Act 2005 by care home
managers and staff
Dementia 2011;10:283–98
Manthorpe J, Samsi K Improving practice in communication with
older people and support networks living in
housing with care schemes: aspirations and
ambitions
Br J Soc Work 2012;42:1495–512
Samsi K, Manthorpe J,
Rapaport P
‘As people get to know it more’: Experiences
and expectations of the Mental Capacity Act
2005 amongst local information, advice and
advocacy services
Soc Pol Soc 2011;10:41–54
Samsi K, Manthorpe J ‘I live for today’: A qualitative study
investigating older people’s attitudes to
advance planning
Health Soc Care Community 2011;19:52–9
Samsi K, Manthorpe J,
Nagendaran T, Heath H
Challenges and expectations of the Mental
Capacity Act 2005: The perspectives of
community-based specialist nurses working in
dementia care
J Clin Nurs 2012;21:1697–705
Phair L, Manthorpe J The use of the Mental Capacity Act among
hospital patients: findings from a case study
of one Acute Hospital Trust in England
J Adult Protect 2012;14:259–70
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TABLE 93 EVIDEM-MCA: published papers (until April 2014) (continued )
Authors Title Journal
Manthorpe J, Samsi K,
Rapaport J
When the profession becomes personal:
dementia care practitioners as family
caregivers
Int Psychogeriatr 2012;24:902–10
Manthorpe J, Samsi K,
Rapaport J
‘More of a leg to stand on’: Views and usage
of the Mental Capacity Act 2005 among local
Alzheimer’s Society and Caregiver groups:
findings from the EVIDEM MCA project
Aging Ment Health 2012;16:102–9
Manthorpe J, Samsi K Mental capacity: the force of law J Dementia Care 2012;20:12–13
Manthorpe J, Samsi K,
Rapaport J
Dementia nurses’ experience of the Mental
Capacity Act 2005; a follow-up-study
Dementia 2014;13:131–43
Manthorpe J, Samsi K Inherently risky? Personal budgets for people
with dementia and the risks of financial
abuse: findings from an interview-based study
with Adult Safeguarding Coordinators
Br J Soc Work 2013;43:889–903
Manthorpe J, Samsi K,
Rapaport J
Responding to the financial abuse of people
with dementia: a qualitative study of
safeguarding experiences in England
Int Psychogeriatr 2012;1–11. doi:10.1017/
S1041610212000348
Manthorpe J, Samsi K Mental Capacity and dementia: A review, Part 1 J Dementia Care 2012;20:35–8
Manthorpe J, Samsi K Making Decisions in Dementia Care: Has the
Mental Capacity Act Helped Social Work
Practice in England and Wales?
Community Care, 28 November 2012.
URL: www.communitycare.co.uk/articles/28/
11/2012/118730/making-decisions-in-
dementia-care-has-the-mental-capacity-act-
helped-social-work-practice-in-england-and-
wales.htm)
Manthorpe J, Samsi K Mental Capacity and dementia: A review, Part 2 J Dementia Care 2013;21:35–8
Manthorpe J, Samsi K,
Rapaport J
‘Capacity is the key’: Investigating new legal
provisions in England and Wales for adult
safeguarding
J Elder Abuse Negl 2013;25:355–73
Samsi K, Manthorpe J Everyday decision-making amongst people
with dementia and carers: findings from a
longitudinal interview study of people with
dementia and family carers
Int Psychogeriatr 2013;25:949–61
Manthorpe J, Samsi K Changing practice: adapting to the Mental
Capacity Act 2005
Soc Care Neurodisabil 2013;4:124–33
Manthorpe J, Iliffe S,
Goodman C, Drennan V,
Warner J
Working together in dementia research:
reflections on the EVIDEM programme
Working with Older People 2013;17:138–45
Samsi K, Manthorpe J,
Chandaria K
Risks of financial abuse of older people with
dementia: findings from a survey of UK
voluntary sector dementia community services
staff
Journal Adult Protect 2014;16:3
Manthorpe J, Samsi K Care professionals’ understanding of the new
criminal offences created by the Mental
Capacity Act 2005
Int J Geriatr Psychiatry 2014; doi:10.1002/
gps.4147
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TABLE 94 EVIDEM-MCA: forthcoming papers at April 2014
Authors Title Journal
Manthorpe J,
Samsi K
Care homes and the Mental Capacity Act 2005:
changes in understanding and practice over time
Dementia [being revised]
Samsi K Negotiating capacity and consent in substance
misuse
In Crome I, Wu L-T, Rao R, Crome P, editors.
Substance Use and Older People. Chichester,
West Sussex: John Wiley & Sons Inc.; 2014
Manthorpe J,
Samsi K
Briefing note on MCA offences for care homes National Care Home Forum (in press 2015)
TABLE 95 EVIDEM-MCA: presentations and posters (until April 2014)
Author Title Event
Manthorpe J,
Samsi K
Early views of local Alzheimer’s Society staff
regarding the Mental Capacity Act 2005
Dementia Congress, Harrogate, November, 2009
Manthorpe J,
Samsi K
‘Can you help me think about my future?’:
Exploring the role of information and advice
organisations
Dementia Services Development Centre Annual
Conference, York, July, 2009
Samsi K,
Manthorpe J,
Heath H
Early findings from interviews with care home staff Care Home Congress, Birmingham, July, 2009
Manthorpe J,
Samsi K.
Putting the Mental Capacity Act into practice
in care homes: emerging findings and research
challenges
National Care Home Research and Development
Forum, London, April, 2009
Samsi K,
Manthorpe J
Making plans for the unknown: transitions in
cognitive impairment Alzheimer’s disease and other
dementias
Annual Gerontological Society of America
Conference, Atlanta, GA, November, 2009
Manthorpe J,
Seminar Series
Money management and the Mental Capacity Act Centre for Policy on Ageing, London, 2010
Samsi K,
Manthorpe J
Planning for retirement and later life: ‘Hope
nothing is going to happen and we carry on as
long as we can’
Annual Conference of BSG, London, 5 July, 2010
Samsi K,
Manthorpe J
‘It helps us to give people something concrete that
they can work with’: early views of local
Alzheimer’s Society staff or the Mental Capacity
Act 2005
North East London NHS Foundation Trust Older
People’s Conference, July 2010
Samsi K,
Manthorpe J
Futurescopes: older people’s attitudes and
knowledge of making plans
Annual Conference of Dementia Services and
Development Centre, London, May 2010
Manthorpe J,
Samsi K
Developmental steps in building a toolkit to
challenge wilful neglect and ill-treatment under the
Mental Capacity Act
Dementia Congress, Liverpool, 10 November 2011
(poster)
Samsi K,
Manthorpe J
Wilful neglect and ill-treatment under the Mental
Capacity Act 2005: identifying thresholds and
safeguarding pathways
Annual Conference of International
Psychogeriatrics Association, Den Haag,
Netherlands, 5 September 2011
Samsi K,
Manthorpe J
Use and views of the Mental Capacity Act 2005 Annual Conference of British Society of
Gerontology, Plymouth, 10 July 2011
Manthorpe J,
Samsi K
Developing a toolkit to understand the offences of
wilful neglect and ill-treatment under the Mental
Capacity Act
Annual Conference of Gerontological Society of
America, Boston, November 2011
Manthorpe J,
Samsi K,
Chandaria K
Safeguarding people with dementia from financial
abuse
Alzheimer’s Disease International Conference,
London, 7–9 March 2012 (poster)
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TABLE 95 EVIDEM-MCA: presentations and posters (until April 2014) (continued )
Author Title Event
Manthorpe J,
Samsi K
When psychosocial interventions go wrong INTERDEM meeting, Alzheimer’s Disease
International Conference, London, 7 March 2012
Samsi K Championing dementia Addressing equalities in older people’s social care,
A Joint Conference of Making Research Count,
Age UK London and the Social Care Workforce
Research Unit, 26 January 2012
Manthorpe J Lessons from England on mental capacity working International conference on Squalor and Neglect,
Sydney, Australia, 22 February 2012
Manthorpe J Making decisions in dementia care: how new law
helped practice in England and messages for social
work practice in other jurisdictions
European Social Work Research Conference,
Basle, 23 March 2012
Manthorpe J Elder abuse and mental capacity (pod broadcast
and audience)
Age UK staff group seminar, London, 11 April 2012
Manthorpe J Care and Control: Mental Health, Mental Capacity
and Social Care Futures
Manchester Metropolitan University Social Work
Conference, 26 April 2012
Manthorpe J Interventions in elder abuse International Elder Abuse Day, National Centre for
the study of Elder Abuse, Dublin, 24 June 2012
Manthorpe J,
Samsi K
Crime against residents with dementia Margaret Butterworth Care Home Forum, London,
10 July 2012
Manthorpe J,
Samsi K
Everyday independent and joint decision-making by
people with dementia and carers
British Society of Gerontology Annual Conference,
University of Keele, Stoke, 12 July 2012
Manthorpe J,
Samsi K
Preventing financial abuse among people with
dementia
British Society of Gerontology Annual Conference,
University of Keele, Stoke, 11 July 2012
Manthorpe J,
Samsi K
Everyday decision-making among people with
dementia and carers
Gerontological Society of America’s 65th Annual
Scientific Meeting, San Diego, 14 November 2012
Manthorpe J,
Samsi K
Planning in advance for long-term care needs 2nd International Conference on Evidence-based
Policy in Long-term Care, London, September 2012
Manthorpe J,
Samsi K,
Chandaria K
Who should protect people with dementia from
financial abuse?
Alzheimer Europe, Vienna, 6 October 2012
(poster)
Samsi K,
Manthorpe J
‘How do carers decide for their relatives with
dementia?’
Alzheimer Europe, Vienna, 6 October 2012
Manthorpe J,
Samsi K,
Chandaria K
‘Protecting people with dementia from financial
abuse’ (poster)
7th UK Dementia Congress, Brighton, 30 October
to 1 November, 2012
Samsi K,
Manthorpe J
Everyday decision-making among people with
dementia and carers
Gerontological Society of America’s 65th Annual
Scientific Meeting, San Diego, CA, 14 November 2012
Manthorpe J,
Samsi K
Use and views of the Mental Capacity Act 2005 Evidence Based Interventions in Dementia:
Findings, London, 16 April 2013
Manthorpe J Leaning about Lasting Powers of Attorney Making Research Count, London, 22 September 2013
Manthorpe J,
Samsi K
Understanding the new criminal offences created
by the Mental Capacity Act 2005
Annual Conference of the British Society of
Gerontology, University of Oxford, 11 September 2013
continued
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Chapter 6: EVIDEM: from cohort to research register
The authors all contributed and agreed on the final version of this chapter as shown in Table 96.
EVIDEM: from cohort to research register – publications and presentations
The following peer-reviewed papers have been published (Table 97).
Additional publications on behalf of the EVIDEM group: publications
and presentations
The following peer-reviewed papers have been published (Table 98).
TABLE 95 EVIDEM-MCA: presentations and posters (until April 2014) (continued )
Author Title Event
Manthorpe J,
Samsi K
The mistreatment and neglect of people with
dementia
Alzheimer Europe, Malta, 12 October 2013
Manthorpe J,
Samsi K
From professional to the personal dementia care
practitioners as family carers
INTERDEM/Alzheimer Europe, Malta, 10 October
2013
Manthorpe J,
Samsi K
Making decisions in dementia care Gerontological Society of America, New Orleans,
26 November 2013
Manthorpe J The relevance of the MCA for audiologists in
practice
University College London Audiology Masterclass,
London, 5 December 2013
BSC, British Society of Gerontology.
TABLE 96 EVIDEM, from cohort to research register: acknowledgements of contributors
Name and role Study element to which they contributed
Steve Iliffe Research Department of Primary Care & Population
Health, University College London
Project development, management committee
member
Lisa Curry West London Mental Health Trust Cohort manager
Jane Wilcock Research Department of Primary Care & Population
Health, University College London
Project development, field research and
management committee member
Greta Rait Research Department of Primary Care & Population
Health, University College London
Project development, management committee
member
David Lowery CNWL NHS Foundation Trust Management committee member
Kalpa Kharicha Research Department of Primary Care & Population
Health, University College London
Management committee member
Archana Tapuria Centre for Health Informatics and Multiprofessional
Education, University College London, London
Information technology development
Dipak Kalra Centre for Health Informatics and Multiprofessional
Education, University College London, London
Information Technology Development
Craig Ritchie West London Mental Health Trust Project leader
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TABLE 97 EVIDEM-COHORT: published papers (until April 2014)
Authors Title Journal
Iliffe S, Curry L, Kharicha K, Rait G,
Wilcock J, Lowery D, et al.
Developing a Dementia Research Registry:
a descriptive case study from North Thames
DeNDRoN and the EVIDEM programme
BMC Med Res Methodol 2011;11:9
TABLE 98 EVIDEM: published papers (until April 2014)
Authors Title Journal
Iliffe S, Manthorpe J, Warner J,
Drennan V, Goodman C, Rait G, et al.
Making progress in psychosocial research
in dementia
Dementia 2008;7:167–74
Iliffe S, Manthorpe J, Drennan V,
Goodman C, Warner J
The EVIDEM programme: a test for primary
care research in London?
London J Prim Care 2008;1:69–73
Manthorpe J, Iliffe S The Mental Health of Older People: Taking
a Long View
J Integr Care 2008;16:4–13
Manthorpe J Mental Health in Later Life: Better
Outcomes through Wise Commissioning
J Integr Care 2009;17:15–22
Manthorpe J, Iliffe S, Rait G,
Goodman C, Drennan V, Warner J
Keeping on Track Sign post 2009;14:26–30
Manthorpe J, Iliffe S, Samsi K, Cole L,
Goodman C, Drennan V, et al.
Dementia, dignity and quality of life:
nursing practice and its dilemmas
Int J Older People Nurs
2010;5:235–44
Manthorpe J, Iliffe S, Goodman C,
Drennan V, Warner J
Working together in dementia research:
reflections on the EVIDEM programme
Working With Older People
2013;17:1–8
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Appendix 2 Chapter 1: Advisory and steering
group membership
EVIDEM-ED: expert group members
First name Role
Professor Steve Iliffe Research team, University College London
Ms Jane Wilcock Research team, University College London
Ms Priya Jain Research team, University College London
Dr Geoff Wong GP with educational role, Queen Mary, University of London,
Centre for Health Sciences
Dr Frances Lefford GP with educational role, University College London
Dr Alex Warner GP without educational role, University College London
Dr Susham Gupta Specialist registrar in adult and old age psychiatry,
Chelsea and Westminster Hospital
Mr Mark Griffin Statistician, University College London
Mr Andrew Kingston Social worker
Mr Horton Kennedy Carer
Ms Kate Wolfe Dementia and mental health advocate
Dr Alexandra Davidson Clinical research associate
Ms Anna Dowrick Campaigns officer, Alzheimer’s Society
EVIDEM-ED: expert panel members
First name Category
Dr James Hickling GP, Alzheimer’s Society
Dr Peter O’Brien GP without educational role
Dr Lucy Farley GP without educational role
Ms Sally Murnaghan Practice nurse
Ms Clare Morris Admiral Nurse
Ms Jane Langton Social worker
Professor John Keady Educationalist
Mr Peter Ashley Person with dementia
Mrs Deborah Stone Carer
Mrs Karen Weech Carer
Mrs Stephanie Palmer Carer
Ms Karen Thompson Carer
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Appendix 3 Chapter 1: Diagnostic and
management processes identified by the expert team
Early signs: memory loss, executive
function changes, behaviour changes 
Patient concern about memory
(probably depressed)
Family concern about memory
(more likely to have dementia) 
Receptionist or practice
nurse notes change in
prescription use
Arrange time to discuss and
to use cognitive function
tests if appropriate
Informant history
Cognitive assessment
How much impairment?
What do they think is happening?
Are they depressed?
‘Reversible dementias’ probably
do not exist, but check Hb for
macrocytosis (B12 deficiency),
TSH, renal function and calcium
Global assessment
is useful here,
test can help
If impaired, or if symptoms do
not fit the pattern, refer for:
• cognitive function review
• CT scan
• consultant opinion 
General practice follow-up,
behaviour and psychological
symptoms of dementia, carer’s needs
FIGURE 29 Diagnosis of dementia; care pathway for community-dwelling patients. Hb, haemoglobin;
TSH, thyroid-stimulating hormone.
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
241

Appendix 4 Chapter 1: Changing clinical practice
in dementia: elements of a training programme –
for primary care team
TABLE 102 Changing clinical practice in dementia: elements of a training programme – for primary care teams
The task Objectives How to achieve
Pattern recognition
[interpreting the meaning of
accumulating symptom(s)]
Growing personal awareness/knowledge
of members of the public, as well as
professional experience among
practitioners
l Personal experiences offer a lot of
lessons; see the other side: professional
who is also a carer/relative/friend
l Producing a video for professionals about
the life of people with dementia at home
Understanding the difficulties of the
diagnostic process
l Recognition of complexity/uncertainty
l Listening to carers and family members
A raised profile for dementia in the GP’s
work environment (increasing
‘receptiveness’)
l The professional and organisational
culture of the practice is important;
create a learning environment
l Include reminders and templates in
electronic medical records
l Greater understanding of cognitive
symptoms and their effects on patient
l Should be tailored to individual practice
team’s needs
Practice team awareness of the issues l Partners need to allow and encourage
nurses and receptionists to attend
training; doctors also need to be
prepared to learn from non-medical
professionals
l Non-clinical staff need to be empowered
to alert clinicians to changes in individuals’
behaviour (e.g. repeated requests for
regular medication, repeated defaults
from consultations)
l Involvement of whole team in clinical
meetings
Practice systems for intelligence gathering,
collation of information and knowledge of
individual’s family circumstances and
social networks, and responsibility for
acting on that gathered knowledge
l ’Key worker’ roles in bigger practices
l Having ‘at risk’ registers
l In smaller practices, all team members
meet with the patient and carer at some
point of time
l Named family or carer main contact
important, especially for those living alone
l Establishing relationships with patient’s
neighbours/milkman, etc.
Continuity of care for individuals, which
deepens knowledge, allows observation
over time and permits trust to develop
l Systems for maintaining continuity of
care need to be discussed explicitly,
especially in large group practices
l Needs active management by the practice
Managing expectations of patients and
carers by Primary Care Team
l Promote their role in early diagnosis by
explaining their roles in a simple language
l Promote a message for those attending
for a first consultation that they will be
taken seriously and their needs listened to
continued
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TABLE 102 Changing clinical practice in dementia: elements of a training programme – for primary
care teams (continued )
The task Objectives How to achieve
l Promote understanding that presenting
for this initial consultation may be at
the end of a hard road/decision for
individuals/families and that ‘we’ are
there to promote the interests and care
to all parties caught up in this process
Assessing the degree of
impairment
Getting all sides of the story: patient,
carer, others (including own team and
local social services in case known to
them)
l Experience matters here, so exchanging
experience may be a mechanism
l If known to allied health professionals,
they can provide useful insights
l Role of key worker is important as it may
be difficult to collate information from
many people
l Visit at home and seeing patients in
typical environment with typical others
Assess the risks and challenges l Think about the level of concern of
patients/carers and others
l What is patient like in out of ‘normal’
environment, for example on holiday,
in hospital – provides insight into level
of impairment
Consider other long-term conditions and
their relationship to the symptoms of
dementia and other functional abilities
(hearing or visual impairments, mobility
problems)
l Information and explanation crucial but
with many people having an information
cascade is useful
Using locally preferred (standardised)
assessment tools, knowing their limits
l There is guidance on the usefulness of
the different tools (for reference see
NICE guidelines36 and Culverwell et al.323)
l Agreement between psychiatrists about
what they use and then information
to GPs
Using tacit knowledge (instincts, hunches,
acquired experience)
l Acknowledge that tacit knowledge
is useful
Self-awareness of changes in thinking
abilities (planning, calculating) and
recognition of compensatory adaptations
by other people (someone else takes over
the bill paying)
l Ask about the methods that they are
using to cope with their disabilities
Discussing possible
diagnoses
Disclosure – who, when and to whom?
(This is no different from breaking bad
news for any other condition.)
l Attention to context when giving
diagnosis – where it should be done,
who is present, how will they get
home/be spending the rest of the day;
involving/initiating support network
can greatly help future management
¢ For example:
(i) A support package should be
given, with names and addresses
of the various bodies, etc., who
may provide help in any shape or
form can be given
(ii) A follow-up visit should be
arranged with a support nurse in a
week or two to enable questions
to be asked when patients and
their families have had a little time
to think things through
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TABLE 102 Changing clinical practice in dementia: elements of a training programme – for primary
care teams (continued )
The task Objectives How to achieve
l Consider patient’s confidentiality. Think
about when to regard the patient as
dependent, as in the case of a dependant
child
l A mechanism for communications
between specialists is required to take
the responsibility of follow-up after
disclosure
Negotiate disclosure of the diagnosis with
patient/carer
l This could be tied up with end of care
and ACP – breaking bad news and
discussing options for the future
Responding Maintain a positive attitude about
dementia: ‘something can be done’ –
based on awareness of local resources
l Wider understanding about differential
diagnosis (Alzheimer’s disease/vascular
dementia/Lewy body dementia, etc.),
which means different treatment and
management issues
l Awareness of range of possible
interventions than just medical
treatment, e.g. training packages for
improving communication and use of
activities, such as Sonas training
l Forming closer links between GP
surgeries and local dementia specialist
support services
Getting support and involvement of
secondary care
l Specialist services offer assessment and
diagnostic services. Having a responsive
local specialist service makes a difference
to GP behaviour
l May be useful if special services could
provide a summary of how their
cognitive symptoms translate into ADL
and some strategies of dealing with
them
l Lack of accessibility and approachability
of the resources could lead GPs to feel
unsupported and frustrated. Training of
psychogeriatricians and improved
communication could help
Phase in responses involving resources/
services
l Professional requires clear understanding
of what is available
l Requires an assessment of that person’s
needs and those of their family or
other supporters
Locate services and assess if they make a
difference
l Think in terms of advanced support
systems, care packages, alarm systems,
simple behavioural strategies for carers
l Map local and national services,
including voluntary organisations
Medication for dementia and ‘shared
care’ systems
l Take cultural factors of the practice and
local specialist services into consideration
Support for carers (practical, information,
psychological support) means
understanding how and why family
members respond differently to dementia
l Liaise with local carers’ group, for
example names and addresses of other
patients at a similar stage of the illness
made available (if there is consent) for
perhaps a ‘buddy’ system
continued
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TABLE 102 Changing clinical practice in dementia: elements of a training programme – for primary
care teams (continued )
The task Objectives How to achieve
l Be aware that stigma applies to services
as well as dementia itself; this may
influence your source of advice
l Assess capacity and affect of the
MCA/importance of discussing POA early
on, while the patient still has capacity
l Record patient’s views early on in the
disease process so that can use this as a
guide later
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Appendix 5 Chapter 1: General practitioner
questionnaire
General practitioner questionnaire
Thank you for agreeing to complete this questionnaire.
Most responses involve you only circling a number, and we have avoided questions which might require
you to refer to your records.
We would ask that when the questionnaires are completed that colleagues do not confer, or cross-check
textbooks for responses, because it is very important that we get an accurate picture of any change in
knowledge as a consequence of the interventions. The responses will not be divulged to anyone.
Please return to your practice manager or a member of the research team
www.EVIDEM.org.uk
Jane Wilcock and Steve Iliffe
Research Department of Primary Care & Population Health
Royal Free Campus, Rowland Hill Street, London NW3 2PF
NIHR: Programme Grant for Applied Research for the EVIDEM Research & Development programme
Hosted by Central and North West London NHS Foundation Trust in Collaboration with UCL,
King’s College London, St George’s University of London, Kingston University London and the
University of Hertfordshire.
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 Part A: Current practice 
Date…………..    Name……………………………………………………   
(We ask your name so that we can follow-up in twelve months time. You will be given a unique alphanumeric 
code for the purposes of data entry and your responses will remain confidential).     
 
1. Gender: Male 1 Female  2  Age     Year qualified        
2. Are you a: (please circle one) 
Principal GP 1  Locum  2  GP Registrar 3  
Salaried GP 4 Other (specify) ………………………….  5 
3. Are you: Full time (over 30 hours per week) 1 Part time 2  (state hrs/wk)   
4. What relevant Postgraduate training have you had? (Please circle all that apply)  
Elderly medicine 1  Old Age Psychiatry 2  General Psychiatry 3 
None of these 4  
5. Have you discussed the implications of the National Dementia Strategy (2009) for your patients: 
a) In your practice?     Yes 1 No 2 Don’t know 88 
b) In another professional development arena? Yes 1 No 2 Don’t know 88 
c) With your specialist colleagues?  Yes 1 No 2 Don’t know 88 
6. Have your local specialist services offered you training in dementia diagnosis and management in the last 3 
years? 
Yes 1 No 2 Don’t know 88 
7. Could you estimate the number of consultations for any problem that you have in a typical month with 
patients with dementia?  
Enter number    Don’t know 88 
 
8. In a typical month, how many consultations (incl. Telephone consultations) with carers of people with 
dementia do you have for any health problem? 
Enter number    Don’t know 88 
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9a. How confident are you about reaching a diagnosis of dementia? 
Very 1 Somewhat 2 A little  3 Not at all 4  
9b. How confident are you about the advice you usually give about managing dementia-related symptoms? 
Very  1 Somewhat 2 A little  3 Not at all 4  
10. From your experience, please rate the difficulty of these aspects of dementia care, from 1 (not at all difficult) 
to 6 (extremely difficult) by circling the appropriate number on the scale. 
Reaching a probable diagnosis yourself  1 2 3 4 5 6  88 
Discussing the probable diagnosis with the patient 1 2 3 4 5 6  88 
Discussing the probable diagnosis with the family 1 2 3 4 5 6  88 
Responding to behaviour or psychological symptoms 1 2 3 4 5 6  88 
Responding to co-existing behaviour problems 1 2 3 4 5 6  88
  
Responding to any psychiatric symptoms   1 2 3 4 5 6  88 
Getting information about support services 
for people with dementia     
1 2 3 4 5 6   88
 
Getting information about support services for carers 1 2 3 4 5 6   88 
Co-ordinating support services for people with dementia  
      1 2 3 4 5 6  88 
Co-ordinating support services for carers  1 2 3 4 5 6  88 
Getting specialist advice by telephone  1 2 3 4 5 6  88 
Getting information about anti-dementia medication 1 2 3 4 5 6  88 
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11. How do you rate the following in regard to dementia care in your area? 
     Available and  Available but     Needed, but           Not
 
Can’t  
    satisfactory   not satisfactory     not available          needed  say 
       
Information about what old age  
psychiatry services offer   1    2  3   4  99 
 
Protocol for assessment and investigation 
of a patient with possible dementia  1    2  3   4  99 
 
Brief screening instrument for early   
identification     1    2  3   4  99 
 
Nurse with mental health training working 
in association with the practice  1    2  3   4  99 
 
Shared care protocol for cholinesterase 1   2  3  4  99 
inhibitors 
 
Information about benefits (attendance  
allowance, council tax, etc.  1    2  3   4  99 
 
  
APPENDIX 5
NIHR Journals Library www.journalslibrary.nihr.ac.uk
250
12. Please indicate on the scale below your responses to the following statements regarding dementia in primary 
care 
 
     Strongly  Agree  Neither  Disagree   Strongly   Can’t 
        Agree    Agree nor  Disagree  Say 
        Disagree 
Providing a patient with a diagnosis is 
usually more helpful than harmful  1  2  3  4 5   99 
 
Managing dementia is more often  
frustrating than rewarding   1  2   3  4 5   99 
 
Much can be done to improve the quality 
of life for people with dementia   1  2   3  4 5   99 
 
Dementia is best diagnosed  
by specialist services rather 
than by the primary care team  1  2  3  4 5   99 
 
It’s better to talk in euphemistic terms 
when discussing the condition with 
someone with dementia   1  2  3  4 5   99 
 
Families would rather be told about 
their relative’s dementia as early as possible 1  2  3  4 5   99 
 
The primary care team has a very 
limited role to play in the ongoing 
care of people with dementia  1  2  3  4 5   99 
 
Much can be done to improve the quality 
of life of carers of people with dementia 1  2  3  4 5   99  
 
Patients with dementia can be a drain on 
resources with little positive outcome 1  2  3  4 5   99 
 
There is little point in referring  
families to services as they don’t  
want to use them    1  2  3  4 5   99 
 
13. Have you discussed the implications of the Mental Capacity Act 2005 for your patients with dementia: 
a) In your practice?    Yes 1 No 2 Not relevant  77 
b) In your professional development?  Yes 1 No 2 Not relevant  77 
c) With your specialist colleagues?  Yes 1 No 2 Not relevant  77 
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 14. Which of the following prevent you from doing as much as you would like for people  
with dementia and their carers? 
        YES   NO  
 
DON’T 
      PREVENTS DOES NOT 
 
KNOW
  
Too busy: not enough time during consultations   1   2    88 
 
Unfamiliar with advances in the management of  1   2    88 
dementia-related symptoms 
 
Unfamiliar with available services to help keep   1   2   88 
patients at home 
 
Unsure how to refer patients to available services  1   2   88 
to help keep them at home  
 
Lack of team staff in the practice    1   2    88 
 
Lack of funding within the practice     1   2    88 
 
Lack of Social Service support available to the practice  1   2    88 
 
Other (Please specify)…………………………………………………………………………...  3 
 
15. How would you rate your own current knowledge, on a scale of 1–10, about diagnosis and care of people 
with dementia and their families? (1 = insufficient, 10 = up to date in all aspects).   
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Part B. Pre-training knowledge quiz 
Please answer the following questions from your current knowledge without consulting 
colleagues or reference materials. Indicate your answer to each question by circling only 
one of the responses. 
1. A GP with a list of 1,500 – 2,000 patients can expect to have the following number of people with 
dementia on their list: 
A. 1-6     1 
B. 7-11     2 
C. 12-20     3 
D. 21 or more    4 
E. I don’t know    5 
 
2. By 2021, the prevalence of dementia in the general population in the UK is expected to: 
A. Decrease slightly   1 
B. Remain approximately the same  2 
C. Increase slightly   3 
D. Nearly double     4 
E. I don’t know    5 
 
3. One of the risk factors for the development of Alzheimer’s disease is: 
A. Atherosclerosis    1 
B. Age     2 
C. Nutritional deficiencies   3 
D. Exposure to aluminium   4 
E. I don’t know    5 
 
4. All of the following are potentially treatable aetiologies of dementia except: 
A. Hypothyroidism   1 
B. Normal pressure hydrocephalus  2 
C. Creutzfeldt-Jacob disease  3 
D. Vitamin B12 deficiency   4 
E. I don’t know    5 
 
  
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
253
5. A patient suspected of having dementia should be evaluated as soon as possible as: 
A. Prompt treatment of dementia prevents worsening of symptoms in the majority of cases 1 
B. Prompt treatment of dementia may reverse symptoms     2 
C. It is important to rule out and treat reversible disorders     3 
D. It is best to engage social services early in the course of the disease   4 
E. I don’t know          5 
 
6. Which one of the following procedures is required to definitely confirm that symptoms are due to 
dementia?  
A. Cognitive test score    1 
B. Post mortem     2 
C. CAT scan of the brain    3 
D. Blood test for biomarkers   4 
E. I don’t know     5 
 
7. Which of the following is not a necessary part of the initial evaluation of someone with possible 
dementia? 
A. Thyroid function test    1 
B. Serum electrolytes    2 
C. Vitamin B and folate levels   3 
D. Protein electrophoresis    4 
E. I don’t know     5 
 
8. Which of the following sometimes resembles dementia? 
A. Depression     1 
B. Acute confusional state    2 
C. Stroke      3 
D. All of the above    4 
E. I don’t know     5 
 
9. When a patient develops a sudden onset of confusion, disorientation, and inability to sustain 
attention, this presentation is most consistent with the diagnosis of: 
A. Alzheimer’s disease    1 
B. Acute confusional state    2 
C. Major depression    3 
D. Vascular dementia    4 
E. I don’t know     5 
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A. Loss of memory     1 
B. Loss of memory and incontinence   2 
C. Loss of memory and hallucinations   3 
D. None of the above     4 
E. I don’t know      5 
 
11. Which of the following clinical findings best differentiates vascular dementia from Alzheimer’s?  
A. Word finding problems     1 
B. Short term (2 minute span) visual memory loss  2 
C. Stepwise disease course     3 
D. Presence of depression     4 
E. I don’t know      5 
 
12. The effect of cholinesterase inhibitors is to: 
A. Temporarily halt the disease in all cases      1 
B. Temporarily halt the disease in some cases     2 
C. Temporarily halt the disease in some cases but often causing liver damage 3 
D. Permanently halt the disease in some cases     4 
E. I don’t know         5 
 
13. Which statement is true concerning the treatment of people with dementia who are depressed? 
A. It is usually useless to treat them for depression because feelings of sadness  
and inadequacy are part of the disease       1 
B. Treatments may be effective in alleviating depressive symptoms   2 
C. Anti-depressant medication should not be prescribed    3 
D. Anti-depressant medication may alleviate symptoms of depression and  
also prevent further intellectual decline      4 
E. I don’t know         5 
 
  
10. Which of the following is nearly always present in dementia? 
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14. The NICE/SCIE guidelines on dementia (2006) recommend: 
A. CT scanning for all patients with suspected dementia    1  
B. Treatment of patients with Alzheimer’s disease whilst their MMSE score  
is between 10 and 20        2 
C. Treatment of patients with Alzheimer’s disease who have significant  
impairment         3 
D. All of the above         4 
E. I don’t know         5 
 
__________________________________________________________________________________
Thank you for completing this questionnaire 
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Appendix 6 Chapter 1: Carer semi-structured
interview schedule
EVIDEM-ED: carer schedule
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 Interview information 
Carer study number  ED_RT _C  
General practice ref number  ED_RT _T  
Interviewer (tick)  I T-B  PJ   JW   TG    Other  
Interview date       
 
Interview time   1  Baseline  2  Follow-up 
 
Location of interview with carer  
1  Patient’s home   2  Carer’s home   3  GP surgery 
4  Hospital   5  Residential home  6  Nursing 
home 
7  Day centre   8  Carer’s workplace 
9  Other……………………………… 
10  Patient and Carer’s home 
 
Interview start time        Interview end time   
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Introduction 
Thank you for seeing me today.  
Points to cover with carer pre interview: 
1. I’ll just go over what the study is about again. We plan to talk to families who are 
registered with twenty GP practices in the area, all with a relative with memory 
problems (or who have been diagnosed with dementia). This involves asking about 
the time you first became concerned something was wrong with your relative, about 
when and how the diagnosis was made, and what’s happened since.  
 
2. A lot of the questions are about any contact you have had with your GP 
practice……We ask these questions because we are working with some of practices to 
try and improve their service to people with these problems. Then we plan to talk to 
the families again to see if they have noticed any difference. 
 
3. As we said in the letter…..  
 
Your involvement is VOLUNTARY 
Information is kept confidential, and nothing will be passed on to the 
practice. So no one at the practice will know what you have said and there 
will be no detrimental effect on the care you or your relative gets from the 
doctor.  
Please say if I ask a question you don’t understand or feel unhappy about: 
I’ll try to explain why we are asking it, but we can always skip a question 
if you are still not happy with it.  
Please let me know if you would like to take a break or continue the 
interview at another time. 
4. Any questions or things not understood? Yes  No  Can we start? 
 
I’d like to start by asking you some background questions about you and your family. This will 
help us understand the differences between people in the study. 
1a). Could you tell me how you are related to (name)? 
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Carer is :  Wife    1 Son    5 
  Husband   2 Other relative ……………… 6 
  Daughter   3  Other (specify ………………) 7 
  Daughter-in-law  4   
    
b). Record carer gender   Male 1  Female  2  
   
  
 c). Record patient gender  Male 1  Female  2 
 
 
2 a). Could you tell me whether you are: 
Married/Co-habiting    1  Divorced  4 
Single      2   Separated  5 
Widowed     3      
 
b). Is your (relative): 
Widowed     1  Divorced  4 
Married/Co-habiting    2   Separated  5 
Single      3      
 
3 a). Do you have any children under 18 living at home? RECORD NUMBER ………. 
 
 b). Are you responsible for looking after anyone else other than (your relative)(and your 
children)? 
Yes (details …………………………………) 1   No 2 NA 99 
 
4. Are you: 
Working full time (30hrs/wk or more) 1  Family commitments/homemaker  5 
Part time (29 hrs/wk or less)  2 Retired (when …………………………) 6 
Unemployed    3 Studying/training    7  
Unable to work for health reasons 4 Other (specify) ………………………… 8 
 
  
 
5 a). Could you tell me your date of birth?    ¨¨¨¨¨¨¨¨  
 b). How old were you when you finished education?   ¨¨¨¨¨¨¨¨  
 c). Did you do any further studies after you left school? …………….…………….  
 d).How old was your relative when they finished school?  …………………………. DK  88 
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 e). And did your relative go into further education?  …………….…………….  DK  88 
 
6 a). To which of these ethnic groups do you consider you belong?  
 
    Carer    Relative     Carer         Relative 
 White UK   1  1 Indian    7 7 
 White Irish   2 2 Pakistani   8 8 
 White other ……………….. 3 3 Bangladeshi   9 9 
 Black - Caribbean  4 4 Chinese   10 10 
 Black - African   5 5 Asian other …………… 11 11 
 Black - Other   6 6 Any other ethnic group   12 12 
       Refused to say   13 13 
 
 b). And your (relative)? (CODE ABOVE) 
 
7 a). Does your (relative) live in her own home?   Yes 1 No 2 
 
IF NO: b). How long is it since she left her own home?   ……. yrs …....mths  
DK 88 NA 99 
 
 c). Who does your relative live with? (RECORD ALL HOUSHOLD MEMBERS) 
  ………………………………………………………………………………………………………. 
  ………………………………………………………………………………………………………. 
  …………………………………………………………………………………………………NA 99 
     
 IF LIVES WITH CARER: GO TO Q8 
 
IF NOT WITH CARER: 
 d). In an average week, how many times do you see your relative?     
How long, on average, do you stay each visit?   mins 
 e). In an average week, how many times do you talk on the phone?    
  How long, on average, do you spend on each call?  mins 
         NA   99 
 
  
8 a). Does anyone else – family, friends or neighbours – give your relative any help? 
 
Yes 1 No 2 DK 88  NA 99  
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IF NO: GO TO Q9 
 
 b). IF YES: Who? …………………………………………………………………………………….. 
  …...…………………………………………………………………………………………………. 
  ……………………………………………………………………………………………NA 99…. 
  
 
 c). After you, who helps the most? ……………………………………………………………….….. 
  ……………………………………………………………………………………………………… 
  …………………………………………………………………………………………… NA 99… 
    
 
These next questions are about how it first became noticed (your relative) might be having 
problems with their memory or getting confused: 
 
9 a). First, can I just check, has (your relative) been with the same doctors’ practice since the time 
these problems    were first noticed?  Yes 1 No 2 DK 88 
 
 b). And with same GP?    
Yes, same GP throughout    1 Same practice, any GP  2 
Same practice, changed GP  3 No, changed practice    4   
Can’t remember   77 Don’t know   88 
 
IF CHANGED: 
 c). Why did (your relative) change GP/Practice? 
When moved address    1 
Other ..................................................... 2 
Can’t remember   77 
DK     88 
NA     99 
 
 d). When did (your relative) change practice?    
Before diagnosis of d. made  1       
After diagnosis made   2 
Other ..................................................... 3 
Can’t remember   77 
DK  88 
NA     99 
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IF CHANGED PRACTICE AFTER DIAGNOSIS- GO TO Q23 
 
10 a). Can you tell me how long ago it was first noticed that something was wrong?  
mths ago    Can’t remember  77 DK  88 
 
 b). Who noticed it?  
Main Carer   1 GP    4  
Other Relative   2 Nurse    5  
Friend/Neighbour  3 Social Services   6  
Other (who) ………………… 7 
        
  
 c). What was it that was noticed? ……………………………………………………………………….. 
  ………………………………………………………………………………………………………… 
  ………………………………………………………………………………………………………… 
 
 d). What did you think was causing it? 
Dementia 1     Age   2  
Other    3 GO TO (e) Can’t remember  77 Don’t know 88  
           
IF OTHER: 
 e). (Detail) ……………………………………………………………………………………………… 
  ………………………………………………………………………………………………… NA 99 
 
11 a). Was anyone at the practice contacted about it when you first noticed it? 
Yes  1  No  2 IF NO: GO to 11(f)  
Can’t Remember  77 DK 88 
            
IF YES: 
 b). Who contacted them?  
Interviewee  1  Social Services   5 
Other Relative  2  Other (who) ………………… 6 
Friend   3  Can’t remember  77  
Neighbour  4  DK    88 
NA   99 
   
 c). Who was contacted?  
GP   1  Practice  nurse   2  
Other………..    3  Other nurse   4  
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Can’t Remember 77  DK      88 
NA   99       
 
 d). What did she say? ……………………………………………………………………………………. 
   ..……………………………………………………………………………………………………….. 
Can’t remember  77    DK 88   NA 99 
 
 e). What did she do? 
………………………………………………………………………………….….. 
   …………………………………………………………………………………………………………. 
Can’t remember  77    DK 88   NA 99 
   
IF NO: 
 f). How long was it after you noticed something was wrong before someone talked to the GP about it? 
mths later  Can’t remember  77   DK 88 NA 99 
 
 g). Who contacted the GP at this time?  
Interviewee  1 Social Services   5 
Other Relative  2 Other (who)…………………  6 
Friend   3 Can’t remember    77    
Neighbour  4  DK    88 
NA   99 
 
 h). What did she say? 
……………………………………..…………………………………………….… 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
Can’t remember  77    DK  88  NA  99 
            
 i). What did she do? 
………………………………………………………………………………………. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
Can’t remember  77    DK  88  NA  99 
   
 
12 a). What did you think of the way the GP responded to the concern about (your relative)? (CARD 
A) 
Very poor 1 Poor  2 Fair  3  
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Good   4  Very good 5 Excellent 6 
Can’t say 77  NA  99 
 
 b). Why do you say that? ……………………………………………………………………………….. 
  ………………………………………………………………………………………………………… 
  ………………………………………………………………………………………………………… 
        
 c). What did you think of the way the practice team as a whole responded? (CARD A) 
 
Very poor 1 Poor  2 Fair  3  
Good   4  Very good 5 Excellent 6 
Can’t say 77  NA  99 
 
    
 d). Why do you say that? 
………………………………………………………………………………… 
  
…………………………………………………………………………………………………………. 
  
…………………………………………………………………………………………………………. 
  
13 a). How long was it after it was noticed something was wrong before Social Services /The Council 
were contacted?  
mths later   
Straight away  1  Already in contact 2 Not contacted 3   
Can’t remember 77 DK   88 
 
IF NOT CONTACTED: GO TO Q14 
 
IF CONTACTED: 
 b). Did anyone contact them for you? 
   
Yes 1 No 2 Can’t remember  77   DK 88 NA 99 
 
IF NO: GO TO 13d 
 
IF YES: 
 c). Who contacted Social Services? 
GP     1 Practice  nurse  2   Other nurse   3  
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other(who) ……….…….  4 Can’t remember 77   DK  88  
NA     99   
 
 d). What did Social Services say when they were contacted about your relative? 
…………………………………………………………………………………………………………… 
…………………………………………………………………………………………………… NA 99 
 e). What did they do? 
…………………………………………………………………………………….................................... 
  ………………………………………………………………………………………………… NA 99 
 
  
 
f). What did you think of Social Services’ response? (CARD A)  
Very poor 1 Poor  2 Fair  3  
Good   4  Very good 5 Excellent 6 
Can’t say 77  NA  99 
 
 g). Why do you say that? 
……………………………………………………………………………………………………….. 
…………..……………………………………………………………………………………… NA 99 
 
These next questions are about what was done to establish what was wrong: 
 
14 a). What was done by the GP to establish what was wrong?  
 
GP did something 1 GP did something- DK what  2  
GP did nothing 3 DK if GP did anything   88 
 
CODE BELOW  
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b). Did anyone else do anything to establish what was wrong?  
 
Yes  1 No   2   Can’t remember 77 DK 88 NA  99
            
IF YES, 1: 
CODE BELOW (PROMPT)  
      Done Done by   Done but  Not  Can’t  
     By GP other (who)   DK by   done  remember 
who   
Took a blood sample   1 2 ……………  3  77 88 
Took a urine sample   1 2 ……………  3  77 88  
Took blood pressure   1 2 ……………  3  77  88 
Did a physical examination  1 2 ……………  3  77 88 
Arranged a brain scan   1 2 ……………  3  77 88 
Tested your relative’s memory  1 2 ……………  3  77 88 
Prescribed medicine for depression 1 2 ……………  3  77 88 
Referred to a specialist/hospital/unit 1 2 ……………  3  77 88 
Told you about help and   1 2 ……………  3  77 88 
support organisations, i.e.  
the Alzheimer’s Society? 
Other ………………………………… 1 2 ……………  3  77 88 
 
 
15 a). All in all, how would you rate the way the problem was investigated? (CARD A)  
 
Very poor 1 Poor  2 Fair  3  
Good   4  Very good 5 Excellent 6 
Can’t say 77  NA  99 
    
 b). Why do you say that?  
  
……………………………………………………………………………………………………………. 
  
…………………………………………………………………………………………………… NA 99 
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Now I’d like to ask about how you were told what the problem was:  
 
 
16 a). Can you remember who first gave you a diagnosis for your relative’s problem? 
   
GP      1 GO TO (c)    
Other prof  (title …..……………)   2 GO TO (d)  
Not given by anyone   3 GO TO (b)   
Other   (…..……………)   4    
Can’t remember   77   
DK     88  
 
IF 3 (Not given): CHECK 
 b). So how did you find out what the problem was? 
……………………………………………………………………………………………………………
…………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………… 
 
IF CLEAR NO DISCLOSURE OCCURRED, SKIP TO Q18  
 
IF GP: 
 c). Which GP was that? ………………………………………..   NA 99 
 
 
 d). How long ago was that?  mths  Can’t remember  77   NA  99 
 
 
 e). What was the diagnosis you were given? (What did you find out the diagnosis to be?) 
 
AD    1  Senile dementia 3   Mixed type       5 DK   88 
Vascular  2  Dementia     4   Other ……………….  6  NA   99 
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 f). Apart from the diagnosis, were you told (did you find out) anything else at that time?  
   
 PROMPT 
     Yes No Can’t rem.  DK NA 
Course, prognosis   1 2  77  88 99 
Tranqu/sedative medication  1 2  77  88 99  
Available services   1 2  77  88 99 
Prim care team support  1 2  77  88 99  
Anti-dem medication   1 2  77  88 99 
Carer support    1 2  77  88 99 
Cause     1 2  77  88 99  
Other ………………..   1 2  77  88 99 
Other ………………..   1 2  77  88 99 
 
17 a). All in all, how would you rate the way you were told (found out about) the diagnosis? (CARD 
A) 
Very poor 1 Poor  2 Fair  3  
Good   4  Very good 5 Excellent 6 
Can’t say 77  NA  99 
    
  
 b). Why do you say that?  
   ………………………………………………………………………………………………………… 
   ………………………………………………………………………………………………………… 
  ………………………………………………………………………………………………… NA 99 
 
IF NO DISCLOSURE OCCURRED, SKIP TO Q18 
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The next questions are about how things are now. The first ones are about your relative’s usual 
doctor. If you don’t feel she has a usual doctor just think about the doctor in the practice who 
you feel knows your relative best. IF NONE OF THE DOCTORS KNOWS BEST ASK ABOUT 
THE DOCTORS AT THE PRACTICE IN GENERAL. 
 
 
18 a). In the last 12 months, how many different doctors from the practice has she seen? …………
  DK 88 
 
 b). IF DOESN’T SEE OWN OR SAME GP CONSISTENTLY: Can you tell me why not?  
  ……………………………………………………………………………………………………….. 
  …………………………………………………………………………………………………NA 99 
 
 
 c). Are you with the same practice yourself?  Yes   1   No   2 
    
 
19. In the past 12 months, how many times have you seen a doctor from the practice about your 
relative?  
 times  Don’t know 88 
20. In the past 12 months, has your relative seen a doctor from the practice on her own? 
 
Yes  1 No  2  Don’t know 88 
 
IF YES: 
 
 b). How many times?    times   Don’t know 88 NA 99 
 
21. Overall, how satisfied are you with the? (CARD D) 
 
     Very Satis- Dis- Very No  Can’t  DK 
     Satis- fied satis- Dissat- Contact Say 
     fied  fied isfied  
     
 a). Doctor’s care for your relative?   1  2  3  4  5  77 88 
 b). Help the Doctor gives you to  
   care for your relative?    1  2  3  4  5  77 88 
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22.      Def. Prob.  Prob.  Def.  Not  DK 
     not  not  yes  yes  Sure  
Would you recommend your    
  relative’s usual doctor to someone  1   2   3   4  5  88 
  else looking after someone with  
  dementia? (CARD F) 
 
 
I’d like to ask now about the practice as a whole – nurses, receptionists and so on who work with 
the GPs. 
 
23 a). Can I just check: have you talked to any of these people at your relative’s practice about her 
care? 
 
FOR EACH SEEN: 
 b). How helpful did you find the? (Card E) 
 
                             Seen     Not       Very      Quite    Neither Notvery Notatall  Madethings     Does 
                                          seen     Helpful   helpful  helpful helpful  worse          not apply 
Practice nurse            1   2       1 2 3 4 5 6   99 
Practice manager      1   2       1  2 3 4 5 6   99 
Community nurse     1      2       1 2 3 4 5 6   99 
Health Visitor            1      2       1 2 3 4 5 6   99 
CPN                            1      2       1 2 3 4 5 6   99 
Nurse (unspecific)     1      2       1 2 3 4 5 6   99 
Receptionist               1      2       1 2 3 4 5 6   99 
Other………………  1      2       1 2 3 4 5 6   99 
 
 
24. Would you recommend your relative’s practice as a whole to someone else looking after a person 
with dementia? (CARD F) 
 
  1  2  3  4  5  88 
   Definitely   Probably   Probably   Definitely      Not  DK 
    Not     Not     Yes     Yes  Sure 
These next questions are about what your relative can and can’t do for herself, and whether they get or 
want extra help, advice or information. The help might be from your GP or someone else at the 
practice, from social services, from a voluntary agency or just someone that you know. For each sort, 
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I’d like you to tell me how helpful it’s been for you, using this scale, with 1 for very helpful to 6 for 
makes things worse. (CARD E) 
 
 
25 a). First, is she able to manage her own personal care by herself – washing and dressing? 
    1   2   88  
   Yes  No  DK   IF YES: GO TO Q26 
 
IF NO: 
 b). Does she get any help with that? 
    1   2   88  99 
   Yes  No  DK  NA  IF NO: GO TO 
Q25f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
…………………………………………………………………… NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel this is enough help?   1   2   88   99 
      Yes  No  DK   NA 
IF NO AT (b): 
 f). Do you feel she needs help with that?   1   2   88   99 
      Yes  No  DK   NA 
  
 
26 a). Is she able to manage her medication by herself ?  
    1   2  88  
   Yes  No  DK   IF YES: GO TO Q27 
 
IF NO: 
 b). Does she get any help with that? 
    1   2   88  99 
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   Yes  No  DK  NA  IF NO: GO TO 
Q26f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
………………………………………………………………….. NA 99 
 
IF NOT FAMILY MEMBERS (CARD E) 
 d). How helpful would you say that was? 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel this is enough help?   1  2   88  99  
      Yes  No   DK  NA 
 
 
IF NO AT (b): 
 f). Do you feel she needs help with that ? 1  2 88  99  
      Yes  No DK  NA  
 
 
 
27 a). Is she able to prepare her food by herself? 
 
   1  2  88  
   Yes  No  DK   IF YES: GO TO Q28 
 
IF NO: 
 b). Does she get any help with that? 
 
   1  2  88  99  
   Yes  No  DK  NA  IF NO: GO TO 
Q27f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
…………………………………………………………………… NA 99 
 
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
273
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
  
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel this is enough help?   1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (b): 
 f). Do you feel she needs help with that?  1  2  88  99 
      Yes  No  DK  NA 
 
 
 
28 a). Is she able to get around the house safely by herself? 
 
   1  2  88  
   Yes  No  DK   IF YES: GO TO Q29 
 
IF NO: 
 b). Does she get any help with that? 
 
   1  2  88  99  
   Yes  No  DK  NA  IF NO: GO TO 
Q28f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
……………………………………………………………………NA 99 
 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
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  e.) Do you feel this is enough help?   1  2  88  99
  
      Yes  No  DK  NA 
IF NO AT (b): 
 f). Do you feel she needs help with that?  1  2  88  99
  
      Yes  No  DK  NA
  
   
 
 
29 a). Is she able to go to the toilet by herself? (ie. stay continent) (toileting problems) (any accidents?) 
 
   1  2  88  
   Yes  No  DK   IF YES: GO TO Q30 
 
IF NO: 
 b). Does she get any help with that? 
 
   1  2  88  99  
   Yes  No  DK  NA  IF NO: GO TO 
Q29f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
………………………………………………………………….. NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel this is enough help?   1  2  88  99
  
      Yes  No  DK  NA 
IF NO AT (b): 
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 f). Do you feel she needs help with that?  1  2  88  99
  
      Yes  No  DK  NA
  
 
 
30 a). Is she able to do the shopping for herself? 
   1  2  88  
   Yes  No  DK   IF YES: GO TO Q31 
 
IF NO: 
 b). Does she get any help with that? 
   1  2  88  99  
   Yes  No  DK  NA   IF NO: GO 
TO Q30f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
……………………………………………………………………. NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel this is enough help?   1  2  88  99
  
      Yes  No  DK  NA 
IF NO AT (b): 
 f). Do you feel she needs help with that?  1  2  88  99
  
      Yes  No  DK  NA
  
 
 
 
31 a). Is she able to get around outside the house? 
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   1  2  88  
   Yes  No  DK   IF YES: GO TO Q32 
 
IF NO: 
 b). Does she get any help with that? 
 
   1  2  88  99  
   Yes  No  DK  NA   IF NO: GO 
TO Q31f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
……………………………………………………………….……. NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel this is enough help?   1  2  88  99
  
      Yes  No  DK  NA 
IF NO AT (b): 
 f). Do you feel she needs help with that?  1  2  88  99
  
      Yes  No  DK  NA
  
 
 
 
32 a). Is she able to do the housework? 
 
   1  2  88  
   Yes  No  DK   IF YES: GO TO Q33 
 
IF NO: 
 b). Does she get any help with that? 
   1  2  88  99  
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   Yes  No  DK  NA   IF NO: GO 
TO Q32f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
………………………………………………………………… NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 
 e). Do you feel this is enough help?   1  2  88  99
  
      Yes  No  DK  NA 
IF NO AT (b): 
 f). Do you feel she needs help with that? 1  2  88  99
  
      Yes  No  DK  NA
  
 
33. Is she able to manage her money and bills? 
   1  2  88  
   Yes  No  DK   IF YES: GO TO Q34 
 
IF NO: 
 b). Does she get any help with that? 
   1  2  88  99  
   Yes  No  DK  NA   IF NO: GO 
TO Q33f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
…………………………………………………………………. NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
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Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel this is enough help?   1  2  88  99
  
      Yes  No  DK  NA 
IF NO AT (b): 
 f). Do you feel she needs help with that? 1  2  88  99
  
      Yes  No  DK  NA
  
 
 
34 a). Does she ever become aggressive verbally? (eg. threatening to harm you, swearing) 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q35 
 
IF YES: 
 b). Do you get any advice on how to manage that? 
   1  2  88  99  
   Yes  No  DK  NA   IF NO: GO 
TO Q34f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
………………………………………………………………… NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you get enough advice?  .1  2  88  99 
      Yes  No  DK  NA 
    
IF NO AT (b): 
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 f). Do you feel you need more advice?   1  2  88  99
      Yes  No  DK  NA
  
 
35 a). Does she ever become aggressive physically? (eg. hitting out, spitting, kicking) 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q36 
 
IF YES: 
 b). Do you get any advice on how to manage that? 
   1  2  88  99  
   Yes  No  DK  NA   IF NO: GO 
TO Q35f 
 
IF YES AT (b): 
 c). Who from? (identify prof if possible) 
…………………………………………………………………. NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you get enough advice?  1  2  88  99 
      Yes  No  DK  NA 
    
IF NO AT (b): 
 f). Do you feel you need more advice?   1  2  88  99
      Yes  No  DK  NA 
 
36 a). So, can I just check what help from outside the family your relative is getting at the moment? 
  (circle all services/ sources of help named by carer in list below) 
      Yes No 
1 District nurse/Health visitor  1 2  
2 Community Psychiatric Nurse  1 2  
3 Memory clinic    1 2  
4 Social Services worker   1 2  
5 Befriending service   1 2  
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6 Support group    1 2  
7 Residential/nursing home respite care 1 2  
8 Sitting service    1 2 Hrs/week  NA 99 
9 Meals on Wheels   1 2 Hrs/week  NA 99 
10  Home care    1 2 Hrs/week  NA 99 
11 Day Care    1 2 Hrs/week  NA 99 
12 Lunch club    1 2 Hrs/week  NA 99 
13 Privately funded carer   1 2 Hrs/week  NA 99 
 
 
37. Is there anyone else who helps your relative that I haven’t already mentioned? 
    1  2  88 
    YES  NO  DK  IF NO: GO TO Q38 
IFYES: 
Who? 
………………………………………………………………………………………………………… 
   ………………………………………………………………………………………………….NA 99 
 
 
 
Now I’d like to ask about different issues or questions that might have come up in relation to 
your relative’s care. Can you tell me for each one if its something that’s come up for you – by 
that I mean you might have worried about it or got advice or help about it from someone. 
 
38 a). Have you had any advice about what to tell your relative (about their diagnosis)?  
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q38f 
 
IF YES: 
 b). Who from? (identify prof if possible) 
………………………………………………………………… NA 99 
 
 c). What advice? 
…………………………………………………………………………….……………. NA 99 
 
IF NOT FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
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1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99
      Yes  No  DK  NA 
 
 
39 a). Have you had any advice about how to keep your relative as independent as possible? 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q39f 
 
IF YES: 
 b). Who from? (identify prof if possible) ………………………………………………………….……. 
NA 99 
 
 c). What advice? 
………………………………………………………………………………………… NA 99 
 
IF NOT FROM FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
  f). Do you feel you needed advice about that?  1 2  88  99
  
       Yes No  DK  NA 
 
40 a). Have you had any advice about equipment and adaptations for the home? 
 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q40f 
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IF YES: 
 b). Who from? (identify prof if possible) 
………………………………………………………………… NA 99 
 
 c). What advice? 
………………………………………………………………………………………….. NA 99 
 
IF NOT FROM FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99 
      Yes  No  DK  NA 
 
 
41 a). Have you had any advice about your relative driving?  
   1  2  88  99 
   Yes  No  DK  NA   IF NO: GO 
TO Q41f 
 
IF YES: 
 b). Who from? (identify prof if possible) 
………………………………………………………………… NA 99 
 
 c). What advice? 
…………………………………………………………………………………………. NA 99 
 
IF NOT FROM FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 e). Do you feel that you got enough advice?  1  2  88  99 
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      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99 
      Yes  No  DK  NA 
 
42 a). Have you had any advice about pensions and 'social security benefits' and grants? 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q42f 
 
IF YES: 
 b). Who from? (identify prof if possible) ……………………………………………………………….. 
NA 99 
 
 c). What advice? 
………………………………………………………………………………………… NA 99 
 
IF NOT FROM FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99 
      Yes  No  DK  NA 
 
 
43 a). Have you had any advice about costs of services? 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q43f 
 
IF YES: 
 b). Who from? (identify prof if possible) ……………………………………………………………….. 
NA 99 
 
 c). What advice? 
………………………………………………………………………………………… NA 99 
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IF NOT FROM FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99 
      Yes  No  DK  NA 
 
44 a). Have you had any advice about legal aspects like Enduring Power of Attorney (prompt 
regarding making decisions about future care and wishes and note specifics)? 
 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q44f 
 
IF YES: 
 b). Who from? (identify prof if possible) ……………………………………………………………….. 
NA 99 
 
 c). What advice? 
………………………………………………………………………………………… NA 99 
 
IF NOT FROM FAMILY MEMBERS 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99 
      Yes  No  DK  NA 
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45 a). Have you had any advice about day care?  
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q45f 
 
IF YES: 
 b). Who from? (identify prof if possible) ………………………………………………………………. 
NA 99 
 
 c). What advice? ………………………………………………………………………………………... 
NA 99 
 
IF NOT FROM FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99 
      Yes  No  DK  NA 
  
 
46 a). Have you had any advice about how to get a break? 
   1  2  88  
   Yes  No  DK   IF NO: GO TO Q46f 
 
IF YES 
 b). Who from? (identify prof if possible) ……………………………………………………………….. 
NA 99 
 
 c). What advice? ……………………………………………………………………………………….... 
NA 99 
 
IF NOT FROM FAMILY MEMBERS: 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
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1  2  3  4  5  6  99 
 
 e). Do you feel that you got enough advice?  1  2  88  99 
      Yes  No  DK  NA 
IF NO AT (a): 
 f). Do you feel you needed advice about that?  1  2  88  99 
      Yes  No  DK  NA 
 
Now I’d like to ask you a few questions about your own needs as a carer. 
 
47 a). Has anyone asked you how you were doing in the care of your relative? 
 
    Yes 1  No 2  DK 88 IF NO: GO TO 47d 
IF YES: 
 b). Who? …………………………..…………………………………………………………………….. 
NA 99 
 
 c). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
 
IF NO: 
 d). Would you have liked to be asked   1  2  88  99 
   how you were doing?   Yes  No  DK  NA 
 
 
48 a). Has anyone given you a chance to talk about your fears or anxieties about your relative? 
 
    Yes 1  No 2  DK 88 IF NO: GO TO 48d 
IF YES: 
 b). Who? …………………………..……………………………………………………………………. 
NA 99 
 
  
 c). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
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1  2  3  4  5  6  99 
 
IF NO: 
 d). Have you wanted a chance to do that? 1  2  88  99 
      Yes  No  DK  NA 
 
 
49 a). Has anyone given you a chance to talk about what to expect in the future care of your relative?
   
 
    Yes 1  No 2  DK 88 IF NO: GO TO 49d 
IF YES: 
 b). Who? …………………………..…………………………………………………………………….. 
NA 99 
 
 c). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
1  2  3  4  5  6  99 
IF NO: 
 d). Do you feel you needed to talk about that?  1  2  88  99 
      Yes  No  DK  NA 
 
50 a). Has anyone given you any reference materials containing information or advice about dementia, 
such as books, leaflets, information sheets, videos? 
 
    Yes 1  No 2  DK 88 IF NO: GO TO 50e 
 
IF YES: 
 b). What were you given? 
………………………………………………………………………………… NA 99 
 
 c). Who gave that to you? 
………………………………………………………………………………… NA 99 
 
 d). How helpful would you say that was? (CARD E) 
Very      Quite     Neither Not very  Not at all   Makes things   NA 
helpful  helpful   helpful    helpful  helpful  worse  
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1  2  3  4  5  6  99 
 
IF NO: 
 e). Do you feel you needed things like that 1  2  88  99 
      Yes  No  DK  NA 
 
Finally, one or two more background questions 
 
51. How is your health in general?   
  Would you say it was: (CARD A)      
Very poor 1 Poor  2 Fair  3  
Good   4  Very good 5 Excellent 6 
Can’t say 77  NA  99 
 
52. Have you had any long-standing illness, disability or infirmity? By long-standing I mean 
anything that has troubled you over a period of time or that is likely to affect you over a period of time.  
     Yes (specify)  1 No 2 Can’t say 77 
  
…………………………………………………………………………………………………………… 
  
…………………………………………………………………………………………………………… 
  …………………………………………………………………………………………… NA 99 
 
 
53. Is your accommodation:    1) Owner-occupied? 
      2) Rented from local authority/housing association? 
      3) Rented from a private landlord? 
      4) Or is it under other arrangements? 
      If so, please describe: 
…………………………………….. 
     
 ……………………………………………………………… 
 
54 a). Is there a car or van normally available for use by you?  Yes  1 No  2 
 
 b). If yes, how many are normally available? One   1 Two or more   2 NA 99 
 
55. I’d like to end by asking you a question about the future. 
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 a). What do you feel your relative needs to give her the best possible life in, say, 12 months time? 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
 
 b). And what about for yourself: what do you think would help you over the next 12 months ? 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
 
 
 
56. What advice would you give to someone else who has started caring for their relative? 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
  ………………………………………………………………………………………………………….. 
 
I’ve finished, thank you very much for all your help. I would like to come back in a year’s time 
and talk to you again, to see how things have changed. Do you think that would be OK? I’ll 
contact you again nearer the time. (Check morale) 
 
Again, thank you very much for your help. 
 
Interview end time  
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Appendix 7 Chapter 1: Medical records data
extraction tool – baseline (time 1)
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Abbreviations
AE Adverse event
CNWL NHS Central & North West London NHS Foundation Trust
CRF Case Report Form
DAP Data Analysis Plan
DeNDRoN Dementia & Neuro-Degenerative Diseases Research Network
DMG Data Monitoring Group
EOT End of Trial
ET Exercise Therapist
GCP Good Clinical Practice
ICF Informed Consent Form
TAU Treatment as Usual
NHS National Health Service
PCT Primary Care Trust
PI Principal Investigator
PIS Participant Information Sheet
IR Independent Researcher
RW Research Worker
REC Research Ethics Committee
R&D Research and Development Department
SAE Serious Adverse Event
TSC Trial Steering Committee
Summary
Background
Over 700,000 people in the UK have dementia. The deterioration associated with dementia is distressing for
patient and carer alike and often leads to institutionalisation. Behavioural and Psychological Symptoms of
Dementia (BPSD) are common and are core symptoms of the disease. However, research on interventions has
traditionally focused on treating the cognitive components of dementia. Over 80% of people suffering from
dementia experience BPSD including symptoms such as agitation and aggression. These symptoms cause
considerable distress to the person with dementia and their carers and predict early institutionalisation and
death. Historically, BPSD has been managed with medication, typically anti-psychotic drugs. Though effective
in symptom control, recent data show that anti-psychotic medications increase mortality and the risk of stroke
in people with dementia. Consequently, there is a need to evaluate the impact that non-pharmacological
interventions such as physical exercise have on BPSD.
Design
A pragmatic, randomised, single-blind controlled trial. The two arms of the trail are: a graded programme
of dyadic exercise (walking) in addition to treatment as usual (TAU) in the intervention arm and treatment
as usual alone as the control arm.
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Setting
The study will be conducted in a community cohort in the UK nested within the EVIDEM
research programme.
Sample
Participants with a clinical diagnosis of dementia or ‘suspected dementia’ (age related difficulty with
thinking or memory loss not related to an acute confusional episode) with at least one significant BPSD
symptom defined by the Neuropsychiatric Inventory (NPI) (excluding the domains of delusions and
hallucinations) will be eligible for the trial. Diagnosis of dementia will be confirmed in accordance with
ICD-10 Diagnostic Criteria for Research (DCR-10).
Participants will be recruited directly through the North Thames DeNDRoN’s registry of participants with
Dementia, as well as primary and secondary care, carer homes and self-referrals.
Interventions
A 6-week supervised incremental course of walking outside, at a pace and distance to suit the participant
and carer for at least 5 days per week. Walking is a useful exercise which is considered acceptable by
participants, and is easily delivered and measured (in terms of time and distance) but rarely incorporated in
a daily routine. A physiotherapist or exercise therapist will oversee the delivery of the exercise programme.
The sustainability of this intervention will be assessed by evaluating adherence and impact during an
unsupervised interval (weeks 6–12) and by further telephone contact at 6 months.
Treatment as usual includes attendance at day care facilities, visits by health professionals, receipt
of medication.
Outcome assessment
The primary outcome measure will be behavioural and psychological symptoms measured by the
Neuropsychiatric Inventory (NPI).
Secondary outcome measures will be:
1. participants’ mental health (GHQ)85
2. participants’ quality of life (DEMQOL-Proxy)86
3. caregivers’ burden of caring (short ZBI)87
4. participants’ level of physical activity and compliance with the intervention (diaries, blood pressure and
heart rate monitors)
5. economic evaluation (Client Service Receipt Inventory)88
6. participants’ and carers’ views about the intervention (Diaries and semi-structured questionnaires).
Aims and objectives of the project
Primary objective
To determine the effectiveness of physical exercise delivered through a programme of incremental walking
for treating behavioural and psychological symptoms of dementia compared with treatment as usual (TAU).
Secondary objectives
1. To determine the impact of physical exercise (involving the carer) on the carers’ assessment of
participant’s functioning and their quality of life.
2. To determine the effect of a dyadic walking programme on caregivers’ perceived level of burden.
3. To explore participants’ views about the intervention and barriers to treatment.
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Background
Dementia and BPSD
Dementia is defined as ‘progressive brain atrophy due to nerve cell loss leading to a characteristic
worsening of memory and global intellectual deterioration without impairment of consciousness’.331 The
increase in degenerative diseases through the inversion of the age pyramid in industrialised societies has
brought about an increase in the prevalence of dementia. Approximately 5% of people aged over 65 years
have some form of dementia, with the population prevalence rising to 20% in those aged over 80 years.332
Over 80% of people with dementia will experience related changes of personality and behaviour, including
apathy, aberrant motor behaviour, disinhibition, verbal and physical aggression.65 Behavioural symptoms
sometimes cause distress for people with dementia and their carers, and can often contribute to the
breakdown in care at home leading to institutional care.333
Conventional treatments for BPSD
Conventional treatment for dementia involves the use of cholinesterase inhibiting drugs (such as donepezil,
rivastigmine or galantamine). However these drugs are expensive,90 have limited efficacy,334 minimal impact
for participant related quality of life335 and the evidence base for impact on BPSD is weak. Though there is
some evidence base in treating BPSD with antipsychotics (e.g. haloperidol, risperidone and olanzapine),
there has been increasing concerns over the safety of these drugs for people with dementia. In the UK the
Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning about the increased
risk of cerebro-vascular events for people taking a course of risperidone and olanzapine. In the US, the
Food and Drug Administration (FDA) has issued a warning against the use of all anti-psychotics in
dementia. Therefore, in the absence of effective and safe pharmacological options, non-pharmacological
alternatives should be explored and appraised more thoroughly.
Health and social care professionals are faced with a significant challenge in managing BPSD, which is
critical in enabling participants to continue to live in their own homes. This is made all the more important
by the demographical changes of our future. There is insufficient evidence for non-pharmacological
interventions in managing BPSD sustainably, and supporting the participant and carer with a degree of
safety in such a situation. The use of pharmacological interventions often poses a dilemma in balancing
risk and benefit. Interventions such as the exercise dyad may offer a safer alternative, which if effective
may not only have all the benefits of an effective intervention, it could also be empowering to the
participant and carer due to its dyad modality of delivery.
Exercise as treatment for BPSD
Physical Exercise is defined by the American Diabetes Association as ‘physical activity or anything that gets
you moving’.336 Exercise has an impact on the cardio-vascular and musculo-skeletal systems and has been
shown to have a modest positive impact on mood,74 including for those with dementia.75
There has been some research on non-pharmacological interventions in the treatment of BPSD, mainly
in the US.337 Impact of exercise on cognitive symptoms has also been studied particularly in residential
home settings in Australia338 and France.339 Heyn et al. carried out meta-analysis of exercise in dementia
and reported data on 30 trials of exercise.76 The authors reported on trials that included strength,
cardiovascular or flexibility regimes; and analysed for functional, cognitive or behavioural outcomes. The
authors reported a significant positive effect size of exercise on behavioural outcomes. However, most trials
included in the analysis on behavioural outcomes were relatively small (n< 65), and only two of eight
reported on samples that included in excess of 100 participants. Further, exercise interventions were often
combined with behavioural interventions and so it is difficult to isolate the impact that exercise has had on
behavioural outcomes.
Perhaps, of greater importance, is the feasibility and sustainability of any exercise regime. Many of the
trials reported in Heyn et al.’s meta-analysis were relatively complex, required equipment or sustained
interaction with a trained therapist and so are potentially not suitable for the community setting. We are
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aware of one trial of tailored walking for community-dwelling people with dementia–carer dyads340 that
has demonstrated a significant reduction of the frequency of ‘aggressive incidents’ within the dyad.
However, this trial was restricted to a relatively small sample and the impact on other important BPSD
was not captured. Therefore, we propose a simple walking regime, provided it is of sufficient pace and
distance, meets the criteria for exercise yet is more likely to be acceptable and sustainable in a community
setting. We believe there is a need to assess the impact of a regular regime of walking on a wide range of
behavioural domains by means of a randomised controlled trial.
Experimental design and methods
Study design
We will undertake a pragmatic, randomised, controlled, single-blind, parallel-group trial. Individuals with a
diagnosis of dementia or suspected dementia (age related difficulty with thinking or memory loss not
related to an acute confusional episode), which will be confirmed with ICD-10 criteria using the DCR-10,
will be recruited to the study. In order to be eligible, participants will present with at least one behavioural
and psychological symptom in one of the sub-scales of the Neuropsychiatric Inventory (NPI) (except
hallucinations or delusions occurring in isolation); and will score at least 2 for severity (‘causes distress’) and
2 for frequency (‘often- about once a week’) in the NPI rating sub-scale. Suitability for inclusion into the
trial is assessed, based on availability of an identified carer and ability to perform exercise regime safely.
Community-dwelling individuals including those living in residential and care facilities will be recruited
through the EVIDEM network, CNWL NHS Foundation Trust and North Thames DeNDRoN.
Risk assessment will be performed to assess the suitability of participants for the intervention at baseline.
Assessment will include measurement for risk of falls through Falls Risk Assessment Tool (FRAT)81 and
Timed Unsupported Steady Standing (TUSS)82 If the person has neurological, mobility related or sensory
impairment, which might limit their ability to involve in walking regime, attempts will be made to modify
their exercise regime with advice from the Association of Chartered Physiotherapists in Exercise Therapy
(UK). Acute confusional state will be assessed by The Confusion Assessment Method (CAM).341
After confirming eligibility and obtaining patient and carer consent to treatment, initial baseline
assessments will be carried out. Participants will then be randomised into one of two arms: the treatment
arm which includes receipt of the intervention in addition to treatment as usual (TAU) or the control arm
which receives TAU only. Both the treatment and control arms will be re-assessed for all outcomes at week
6 and week 12. At 18 weeks, qualitative data will be gathered from a smaller sample of participants using
semi-structured questionnaires. Further telephone contact will occur at 26 weeks to assess adverse events
and mortality, change in domiciliary status and adherence to exercise regime.
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Is there presence of dementia and BPSD (+ one BSPD symptom in NPI except delusions
or hallucinations) and identified carer?
Risk falls assessed in both patient and carer using:
•  Falls Risk Assessment Tool (FRAT)
•  Timed Unsupported Steady Standing (TUSS) 
Exclude participants
Low falls risk
Patient and carer give consent or assent to participate
in the study
High falls risk
 
No
Carer asked – does the patient or you have any
cardiorespiratory conditions impairment of mobility,
hearing or vision that would prevent them/you from
taking part?
Letter sent to GP requesting that they inform us if there
are any conditions compromising patient’s or carer’s
ability to participate in a programme of regular walking
GP excludes
 
Yes 
Yes
Does the patient have acute confusional state
assessed by Confusion Assessment Method (CAM)?
No 
No
Yes
Yes
Yes
RANDOMISED TO TREATMENT OR CONTROL GROUP 
Baseline data collection 
Repeat assessments at weeks 6 and 12  
FIGURE 30 Study design: Recruitment protocol of subjects for structured exercise as an intervention for dementia
with BPSD.
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Participant randomised to ‘treatment’ arm of trial
Week 1 – visit 1 – exercise therapist: 
•
•
•
•
•
Explains exercise regime
Explains diary including the use of a visual analogue scale for RPE (Borg)
Assess RPE and extend exercise to 60–70%, or 12–14 on 20-point scale
Joins carer–participant dyad on first walk of approximately 20–30 minutes
(depending on ability) and notes time and distance
Supports completion of diary and facilitates participants’ completion of RPE
Week 1 – visits 2 and 3 – exercise therapist three visits over 10 days;
visits at days 3–5 and days 8–10 
•
•
•
Assesses RPE and re-explains exercise programme
Assesses and re-explains diary
Joins carer–participant dyad on walk  
Weeks 2 and 4 – exercise therapist
•
•
Telephone contact to encourage compliance and adherence
Respond to participant–carer dyad on an ‘as-needs basis’ for
information about exercise programme only 
Weeks 6 and 12 – visits 4 and 5 – exercise therapist
•
•
Joins carer–participant dyad on walk of approximately 20–30 minutes (depending on ability)
and notes time and distance
Supports completion of diary and facilitates participants’ completion of RPE 
FIGURE 30 Study design: Recruitment protocol of subjects for structured exercise as an intervention for dementia
with BPSD.
Safety variables and end points
Safety variables will include falls’ risk assessments and functional abilities. Safety endpoints will be falls and
significant adverse events (AEs) spontaneously reported during the study and discontinuations due to AEs.
Stopping rules and discontinuation
If there is a significant statistical difference (p< 0.05) between the number of reported AE/SAE by the
intervention and control groups the TSC and PI will consider the discontinuation of the trial. See risk
management procedures (section below).
Interventions
Physical Exercise will be delivered as an individually tailored regime of walking designed to become
progressively intensive. This will be facilitated by a qualified exercise therapist or physiotherapist and
delivered to participants in the treatment arm of the trial. The exercise therapist would facilitate physical
exercise in the participant–carer dyad with the expectation that the participant–carer dyad would perform
the exercise regime regularly and independently of the therapist.
(continued)
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Participant involvement
People with a clinician’s diagnosis of dementia or ‘suspected dementia’ (age related difficulty with thinking
or memory loss not related to an acute confusional episode) with at least one significant BSPD symptom
defined by the Neuropsychiatric Inventory (NPI) (excluding the domains of delusions and hallucinations)
would be eligible for the trial. Diagnosis of dementia will be confirmed in accordance with the ICD-10
Diagnostic Criteria for Research (DCR-10).
We will recruit participants with dementia with an identified carer. The carer can be a family member or a
professional. We shall ensure about their level of physical health and their ability to support the participant
with dementia in the trial.
Recruitment base
Participant recruitment will be both retrospective and prospective: individuals with dementia known to the
GP or secondary care will be identified and suspected new cases would be further investigated to confirm
diagnosis. Regular reminders about the study will be sent to participating practices and secondary care
teams with the network catchments area. A central register of all referrals will be maintained.
There are four potential sources of recruitment:
l North Thames Dementia & Neuro-Degenerative Diseases Research Network (DeNDRoN) – Registry of
people with dementia interested in participating in research (DemReg)
l GP practices that are affiliated to the EVIDEM Research Group – Practices will be asked to interrogate
their lists for people with a diagnosis of dementia or memory impairment
l Memory assessment services and community mental health services, (e.g. Admiral Nurses) will be
recruited via CNWL NHS Foundation Trust
l Self-referral.
Recruitment process
An assigned clinical support officer (CSO) from DeNDRoN will inspect their registry for people that are
eligible to participate in our study. This worker will identify lists of people with dementia who are eligible
to participate in our study and post the following information to the person with dementia and the carer:
l a covering letter signed by the clinical lead for North Thames DeNDRoN
l a participant information sheet
l a response letter and stamped addressed envelope.
The clinical support officer from DeNDRoN will contact participants by phone 1 week after the date of the
mail-out to confirm interest, presence of BPSD and carer availability. The clinical support officer will ask for
permission to pass on their contact details to the research worker. The CSO will provide the trial manager
and research worker with details of the interested individuals within 24 hours.
GP practices recruited through the EVIDEM Research Group will be asked to inspect their patient lists using
QoF (quality outcomes framework) data and READ codes to identify patients with dementia. Lists of people
with dementia identified by practices, Memory Clinics and Community Mental Health Teams will be
checked by their lead clinician. Practitioners will be asked for their opinion about the capacity of the
person with dementia to give informed consent, using the Mental Capacity Act 2005 as the framework for
their judgement.
The practices will post the following information to the person with dementia and/or the carer:
l a covering letter signed by the lead clinician
l a participant information sheet
l a response letter and stamped addressed envelope.
APPENDIX 8
NIHR Journals Library www.journalslibrary.nihr.ac.uk
322
Participants will be directed to return letters to the research team or contact the research team by phone
or e-mail. A researcher will arrange to see those people with dementia and their carers who express an
interest in participating in the study. During the meeting the researcher will explain the study, respond to
any queries, screen for eligibility and seek consent/assent for participation in the study.
For those judged as lacking capacity to consent, a consultee will be identified and consulted about
involvement in the trial. In the event that a consultee cannot be identified, the person with dementia will
be excluded from participation in the trial.
The researcher will undertake an initial telephone screen to confirm interest, and likelihood of at least one
BPSD symptom and then arrange an initial interview at a time and venue convenient to the participants
(ideally their home). The potential participants will receive a written and verbal explanation of the trial
(appendix 1). If the participant meets inclusion and exclusion criteria we will seek consent from both
participant and carer, using the consent protocol. Once obtained (or in the case of an individual who is not
capable of giving informed consent, the assent of the participant with agreement of carer in accordance
with accepted guidelines),316 participants will proceed to the baseline interview/assessment and then be
randomised. As the NPI score is an outcome this will be administered at the baseline interview once
consent has been obtained along with the DEMQOL-Proxy, CSRI, GHQ, ZBI and vital signs (i.e. blood
pressure and heart rate).
Inclusion criteria
l Diagnosis of:
¢ dementia in primary or secondary care or
¢ suspected dementia confirmed by the researcher to ensure the DCR-10 criteria are met.
l Presence of a carer (professional, friend or family member, who does not necessarily have to live with
the participant).
l NPI score in any one sub-set except only hallucination or delusion more than or equal to 2 in severity
and more than or equal to 2 in frequency.
l Consent of participant, or in the case of an individual who is not capable of giving informed consent,
the assent of the participant with agreement of carer.
l Consent of carer.
Exclusion criteria
l Cardio-respiratory condition, neurological or musculo-skeletal condition of a degree that prevents
participation to even the modified exercise regime unsafe or not possible.
l Three or more falls in the previous year (‘frequent fallers’) assessed by FRAT or high falls risk defined
by TUSS.
l Uncontrolled medical problems, which the GP considers would exclude participants from undertaking
the exercise programme; for example, acute systemic illness’ such as pneumonia, poorly controlled
angina, acute rheumatoid arthritis, unstable or acute heart failure.
l Sensory impairment to an extent that prevents dyad facilitated exercise.
l Participant or carer dissent to engage in the exercise programme.
l Acute confusional state assessed by The Confusion Assessment Method (CAM).
Informed consent
All participants and their carers will provide written informed consent. The Informed Consent Form
(appendix 2 & 3) will be signed and dated by both the patient and carer before they enter the trial. The
research worker (RW) will explain the details of the trial and provide a Participant Information Sheet, then
allow the patient and carer a minimum of 72 hours to consider whether they would like to be involved in
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the trial. The research worker will encourage the patient/carer to ask any questions that might help them
make a decision on their potential involvement in the trial.
Informed consent will be collected from each participant before they undergo any interventions (including
history taking) related to the study. One copy of the Informed Consent Form will be kept by the
participant, one will be kept by the research worker, and a third will be retained in the participant’s
general practice records.
Where a participant who appeared to be eligible and signed a consent form is subsequently found not to
be eligible (e.g. the GP considers they fulfil one of the exclusion criteria) they will not be considered
to have entered the study.
Should there be any subsequent amendment to the final protocol, which might affect a participant’s
participation in the trial, continuing consent will be obtained using an amended consent form which will
be signed by the participant.
Compliance
Compliance will be defined as continuation with the exercise programme. This will be recorded though
diarised entries, blood pressure and heart rate monitoring from carers and participants (see Section 4.7.2).
Randomisation
Patient/carer dyads will be randomly allocated to receive treatment as usual (TAU) or exercise therapy in
addition to treatment as usual (ET). The randomisation ratio for the two groups will be 1 : 1 (ET : TAU). A
computer algorithm will be used to perform the randomisation centrally by an Independent Researcher
after the initial interview, who will communicate the results to the participant and carer, and to the
exercise therapist; but not the research worker or IR.
Concealment and blinding
In order to maintain blinding, randomisation will be performed independently of the research worker (RW)
following baseline evaluation. The exercise programme will be initiated and supervised by an ‘Exercise
Therapist’ (ETh). Baseline and subsequent evaluations will be undertaken by RW. An independent
researcher (IR) will collect the primary outcome data (NPI) at weeks 6 and 12, which will be completed by
telephone with the aim of minimising the risk of un-blinding participants.
Outcome assessment
Assessments will be conducted according to Table 103. Participants will be visited in either their own
homes, or a mutually acceptable convenient location (e.g. GP’s surgery), by a trained research worker (RW)
masked to arm allocation. All possible measures will be taken to ensure that blinding will be uncompromised
and the efficacy of this will be assessed at each time point using a 5 point Likert Scale. Both the IR and RW
will complete the scale indicating to which arm they believe each individual dyad is randomised to. The scale
will be polarised by the two arms and include a ‘not sure’ level as the centre rating. However, there remains a
risk that the dyad will divulge information about the group they have been allocated to. The IR will collect the
primary outcome measure (NPI) by telephone. This strategy has been adopted so as to minimise the risk of
conversation with the dyad that might un-blind the randomisation.
Baseline assessment
In addition to the protocol, socio-demographic data and illness characteristics, including medication, will be
sought at recruitment (see Table 103). Confirmation of clinical diagnosis of dementia will be ascertained at
the beginning of recruitment into the trial using the ICD-10 criteria, using the DCR manual.
All participant–carer dyads will be provided with diaries to record the level of their physical activity i.e.
walking and any difficulties they encountered when walking (see appendix 2.4.1 & 2.4.2). Diaries for the
intervention group will differ slightly from the control group. Thus, the dyad on intervention group will also
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TABLE 103 Assessment Schedule: delineation of responsibility
Exercise
therapist (ET)
Research
worker (RW)
Independent
researcher 1 (IR1) Independent researcher 2 (IR2)
Exercise group
only All participants All participants All participants
Baseline Screens for
eligibility;
Obtains consent;
Outcomes
assessed;
BP & HR at rest
assessed
T –1 Randomisation & mails diaries and phone
contact to provide instruction about diary
completion
Week 1 RPE, walk,
support to
complete diary
RPE, walk,
support to
complete diary
RPE, walk,
support to
complete diary
Week 2 Telephone
contact
Week 4 Telephone
contact
Week 6 RPE, walk,
support to
complete diary
Visits: outcomes;
Adverse events;
BP & HR at rest
assessed
Telephone to complete
NPI, remind diary
completion
Week 12 RPE, walk,
support to
complete diary
Visits: outcomes;
Adverse events;
BP & HR at rest
assessed
Telephone to complete
NPI, remind diary
completion
Week 13 Collects sealed
diaries
Week 16 Qualitative
interviews
Week 26 Telephone
contact:
CSRI
Change in
domicile?
Still exercising?
Mortality
assessment
BP, blood pressure; HR, heart rate.
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be asked to complete a visual analogue scale (Rating of Perceived Exertion)83 to which they will be trained
by the exercise therapist.
Follow-up assessments
The primary outcome assessments include change of behavioural and psychological functioning measured
using the NPI.62 This tool can also be used to derive a score which pertains to the distress caused by each
behavioural domain). We can not think of any plausible mechanism by which our intervention might effect
psychotic behavioural domains and so we will exclude the domains of delusions and hallucinations from
our analysis.
An assessment of caregiver-rated quality of life (DEMQOL-Proxy);86 assessment of general health (GHQ)84
and a caregiver assessment of the burden of caring (short version of the ZBI)94 will also be administered.
Participants general level of fitness will also be assessed as heart rate at rest and blood pressure readings.
At week 6 and 12 the NPI, GHQ, DEMQOL-Proxy, ZBI and measurement of vital signs will be repeated in
both groups.
In carrying out the NPI assessment we will focus on eight of the ten domains. We will measure the
difference between the treatment and control groups in agitation/aggression, dysphoria, anxiety, euphoria,
apathy, disinhibition, irritability/ability and aberrant motor behaviour. We do not expect physical exercise to
impact on hallucinations and delusions. The summative mean of the 8 sub-scales is 8.08 (if hallucinations
and delusions are included the figure is 8.25). In studies where NPI was measured in the placebo group a
mean reduction of 2.2 was observed.339
The phenomenology of participants’ and cares’ perspectives of exercise and barriers to treatment will be
examined with open-ended, in-depth interviews. The interviews will be carried out by the research worker
after the quantitative data has been analysed and the randomisation code has been breached. Theoretical
sampling will be used to ensure that an initial sample is drawn to include as many as possible of the
factors that might affect variability of behaviour. It is anticipated that saturation will be reached after
15–20 interviews.
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TABLE 104 Administration of outcome measures
Day Administrator
Assessment schedule
Exercise dyad group Treatment as usual group
Measure Subject Measure Subject
0 Researcher ICD-10 Participant+
Carer
Participant
Participant
Carer
Carer
Participant+
Carer
Carer
Participant
Participant+
Carer
ICD-10 Participant+
Carer
Participant
Participant
Carer
Carer
Participant+
Carer
Carer
Participant
Participant+
Carer
MMSE MMSE
NPI NPI
Demographics Demographics
CSRI CSRI
DEMQOL-Proxy DEMQOL-Proxy
GHQ GHQ
ZBI ZBI
Medication Medication
Vital signs (BP&HR) Vital signs (BP&HR)
0 Independent
Researcher 2
RANDOMISATION and SEND DIARIES TO ALL
1–2 Exercise therapist RPE Participant+
Carer
Timed walk
Diary
3–4 Exercise therapist RPE Participant+
Carer
Participant+
Carer
Timed walk
Diary
6–8 Exercise therapist RPE Participant+
Carer
Timed walk
Diary
40–46 Independent
Researcher 1
(telephone
contact)
NPI Carer
Participant+
Carer
NPI Carer
Participant+
Carer
Remind completion of
diaries
Remind completion of
diaries
40–46 Researcher DEMQOL-Proxy Carer
Participant+
Carer
Carer
Participant
Participant+
Carer
Participant+
Carer
DEMQOL-Proxy Carer
Participant+
Carer
Carer
Participant
Participant+
Carer
Participant+
Carer
GHQ GHQ
ZBI ZBI
Medication Medication
Adverse events Adverse events
Vital signs (BP&HR) Vital signs (BP&HR)
continued
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TABLE 104 Administration of outcome measures (continued )
Day Administrator
Assessment schedule
Exercise dyad group Treatment as usual group
Measure Subject Measure Subject
40–46 Exercise therapist RPE Participant+
Carer
Timed walk
Diary
80–88 Independent
Researcher 1
(telephone
contact)
NPI
Remind completion of
diaries
Participant
Participant+
Carer
NPI
Remind completion of
diaries
Carer
Participant+
Carer
80–88 Researcher DEMQOL-Proxy Carer
Participant+
Carer
Carer
Participant
Participant+
Carer
Participant+
Carer
DEMQOL-Proxy Carer
Participant+
Carer
Carer
Participant
Participant+
Carer
Participant+
Carer
GHQ GHQ
ZBI ZBI
Medication Medication
Adverse events Adverse events
Vital signs (BP&HR) Vital signs (BP&HR)
80–88 Exercise therapist RPE
Timed walk
Diary
Participant+
Carer
90–98 Researcher Collection of diaries Participant+
Carer
Collection of diaries Participant+
Carer
112–120 Researcher Qualitative interviews Participant+
Carer
182–196 Researcher Telephone contact: Participant+
Carer
Telephone contact: Participant+
Carer
CSRI CSRI
Change in domicile?
(hospitalisation)
Change in domicile?
(hospitalisation)
Still exercising? Still exercising?
Mortality assessment Mortality assessment
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Statistical methods
Sample size
Based on observing a meaningful clinical difference between the groups (0.3) on the primary outcome
measure (NPI), using a statistical cut off of p< 0.05 with a two tailed test, a sample size of 146 participants
will give 90% power to detect this difference. (calculated by URL: http://www.stat.ubc.ca/∼rollin/stats/ssize/
b2.html)
Intervention Difference N (including compensation for 20% attrition)
0.4 0.4 70 (88)
0.5 0.3 116 (145)
0.6 0.2 238 (298)
Therefore, we aim to recruit 146 persons with dementia and their carers in this trial, 73 dyads on each arm.
Data entry
Double entry of data provided in paper form will be undertaken using automated consistency and logical
checks. Data will be stored encrypted and password-protected on local drive with weekly backup. The
central database will be maintained at CNWL NHS Foundation Trust head quarters. A log will be kept of
data amendments. A research diary will be maintained by the researchers, which will be counter-signed
monthly by the Principal Investigator.
Data protection
We will be fully compliant with the provisions of the Data Protection Act.50 All records will be kept in a
locked filing cabinet at the study centre. Confidentiality of electronic records will be ensured by password
protection. The databases will be designed so that participant names are not shown on screen. Participant
names and contact addresses will be deleted from the database at the earliest opportunity (for example,
if a participant withdraws from the trial).
Data analysis
Baseline demographic and outcome data will be compared between the two randomisation groups.
Categorical data will be analysed using the chi-square test. Continuous data will be analysed using the
t-test or, if the data is found to be non-normally distributed, the Wilcoxon Rank-Sum test.
Outcomes at 6 and 12 weeks will be compared between randomisation groups using ANCOVA for
continuous data. The relevant baseline scores will be included as the co-variate in order to adjust for any
potential baseline differences in the respective outcome. Categorical outcomes will be compared using the
chi-square test.
All data will be analysed on an intention-to-treat basis. Where appropriate imputation of missing data will
be implemented. Under the assumption that data are missing at random (MAR) multiple imputation
will be used.
All analyses will be completed using the statistics package STATA before the breaking of the
randomisation key and the blinded analyses will be sent to a third party.
Qualitative data will be simultaneously collected and analysed. In order to enhance reliability, the analysis
and coding will be carried out independently and simultaneously by two independent researchers. The
analysis will be aided by the use of the NVivo™ computer software package. Line-by-line initial descriptive
open coding will be carried out. Low-level categories will emerge from the data, which will be integrated
into meaningful units to form higher-level categories, which will be grounded in the data. A coding
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paradigm will be applied to link categories with one another and create themes. The process of data
collection and analysis will continue until theoretical saturation has been achieved.
Adverse events and risk management
Attrition will be carefully monitored to determine its effects on the power of the study. If a dyad withdraw
from the exercise component of the trial permission would be sought to continue monitoring outcomes.
Definitions
An adverse event is any unfavourable and unintended sign, symptom, syndrome or illness that develops or
worsens during the period of observation in the trial.
An AE does include a/an:
1. exacerbation of a pre-existing illness
2. increase in frequency or intensity of a pre-existing episodic event or condition
3. condition detected or diagnosed after intervention even though it may have been present prior to the
start of the trial
4. continuous persistent disease or symptoms present at baseline that worsen following the start of
the trial.
An AE does not include a/an:
1. medical or surgical procedure (e.g. surgery, endoscopy, tooth extraction, transfusion); but the condition
that leads to the procedure is an AE
2. pre-existing disease or conditions present or detected at the start of the trial that did not worsen
3. situations where an untoward medical occurrence has not occurred (e.g. hospitalisations for cosmetic
elective surgery, social and/or convenience admissions).
A Serious Adverse Event (SAE) is any adverse event occurring following study mandated procedures,
having received exercise intervention or usual treatment that results in any of the following outcomes:
1. death
2. a life-threatening adverse event
3. inpatient hospitalisation for non elective procedures
4. sudden or rapidly progressive major disablement
5. an event that caused the participant to seek non-routine medical treatment.
Important medical events that may not result in death, be life-threatening, or require hospitalisation may
be considered a serious adverse event when, based upon appropriate medical judgement, they may
jeopardise the patient or participant and may require medical or surgical intervention to prevent one of the
outcomes listed in this definition.
All adverse events will be assessed for seriousness, expectedness and causality.
A distinction is drawn between serious and severe AEs. Severity is a measure of intensity whereas
seriousness is defined using the criteria above. Hence, a severe AE need not necessarily be serious.
APPENDIX 8
NIHR Journals Library www.journalslibrary.nihr.ac.uk
330
Reporting of adverse events
All treatment related serious adverse events will be recorded and reported to the TSC and REC as part of
the annual reports. Unexpected serious adverse events will be reported within the timeframes to the REC
as stated below. The Principal Investigator shall be responsible for all adverse event reporting.
During the trial we will conduct monitoring of adverse events. Participants will be asked to contact the trial
site immediately in the event of any serious adverse event. Adverse Events (AEs) will be brought to the
attention of the study team by either:
l Return of AE card Participants will be instructed to complete a coded, Freepost postcard each time
they experience an AE, which they have not previously reported to the study centre.
l Telephone call to the study team Participants will be encouraged to call the study team if they
experience any adverse effects during the study.
l Notification by GP Participant’s doctors will be encouraged to contact the study team of any AEs they
are made aware of.
l Notification by carer The participant’s carer will be encouraged to contact the study team, either by
returning the AE postcard or by telephoning the study team, if they observe any AEs in the participant
or themselves.
On notification of an AE at the study centre, the Principal Investigator will call the subject and carer for
further information. The Principal Investigator shall determine seriousness and causality in conjunction with
any treating medical practitioners.
All adverse events will be recorded and closely monitored until resolution, stabilisation, or it has been
demonstrated that the study treatment is not the cause.
Risk management
To ensure the safety of the researchers the GP will be asked if there is a history of violence with any
participants to be interviewed. In case of participants recruited from residential or nursing homes, staff will
be approached for history of violence. Where participants are recruited from secondary care, similar
information will be obtained from the secondary care team or CMHT. Falls risk will be minimised by
assessment prior to randomisation
Risk issues:
l inadvertent disclosure of dementia [disclosure of diagnosis rests with lead clinician (GP)]
l carer suffering from undiagnosed dementia
l falls (exclude high falls risk; exercise therapist to monitor; adverse event reporting)
l cardiovascular events (exclude high risk, exercise therapist to monitor; adverse event reporting)
l worsening of BPSD (exercise therapist to monitor; adverse event reporting)
l accidents – exercise therapist to assess road sense and undertake location risk assessment (for exercise
location) (e.g. traffic density, kerb height, risk of mugging/assault), ability of carer to manage the
person with dementia safely in the streets.
Trial intervention related SAEs
A serious adverse event that is deemed directly related to or suspected to be related to the trial intervention
shall be reported to the TSC and ethics committee. The reporting form for SAEs is shown in the Appendix 4.
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The event shall be reported immediately of knowledge of its occurrence to the Principal Investigator.
The Principal Investigator will:
l Assess the event for seriousness, expectedness and relatedness to the trial treatment.
l Take appropriate medical action, which may include halting the trial and inform the sponsor of
such action.
l If the event is deemed related to the trial treatment, shall inform the REC using the reporting form
found on the NRES web page within 7 days of knowledge of the event.
l Within a further 8 days send any follow-up information and reports to the REC.
l Make any amendments as required to the trial protocol and inform the REC as required.
Removal of participants from interventions, assessments or the trial
Participants may be withdrawn from the trial either at their own request or at the discretion of the
Investigator. The participants will be made aware that this will not affect their future care.
The research team will advise discontinuation of exercise intervention or withdrawal from the trial if the
exercise intervention poses a hazard to the safety of a participant, or if the participant poses a hazard to
the safety of his carer or someone else.
Those who withdraw from the trial or follow-up will not be replaced. Participants should not be accepted
as lost to follow-up unless 2 phone calls, letters or visits to the participant and carer have been fruitless.
Feasibility
The design allows for a total recruitment period of 24 months. We have obtained funds to recruit and
employ one researcher who is based at CNWL FT HQ. Taking into account leave, sickness we expect
44 working weeks per year from the researcher. On this basis, there are 440 days for recruitment and
follow-up. We believe it is possible to undertake an average of two participant contacts per day depending
on location and complexity (in addition to other duties such as data entry). We estimate a maximum of
435 face-to-face participant contacts by the researcher in this trial. There will be a maximum of 725 visits by
the exercise therapist.
Stopping rule
The stopping rule will be as follows: once all participants have been randomised any recruitment interviews
that have been arranged will be honoured. Participants yet to be contacted, as well as those subsequently
expressing an interest in the trial, will be sent a letter thanking for their interest but explaining that
recruitment for the trial is now closed.
End of trial notifications
Once the trial is completed a summary of the results will be sent to the participants and to their GPs.
Ethical and regulatory aspects
Full ethical approval for the study will be sought from IRAS.
This research will be conducted in accordance with the Declaration of Helsinki.342 Informed consent will be
sought from all participants. However, due to the nature of this study, we anticipate some participants
will be unable to give real consent. In the case of subjects who are not able to give informed consent,
guidance from the Mental Capacity Act will be followed, and consent sought from the responsible carer.
Specifically, as in all biomedical research involving human subjects, the investigators will need to obtain the
informed consent of the prospective subject or, in the case of an individual who is not capable of giving
informed consent, the proxy agreement of a representative, having given due consideration to advance
decisions. This is also in accord with internationally accepted guidelines on research involving human
subjects with dementia.
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The participants’ GPs will have clinical responsibility for the participant throughout the trial. Study
personnel will inform the GP of any adverse events and any significant clinical problems that are brought
to the investigators’ attention.
All study records will be securely stored for 10 years after the completion of the study.
We will make every effort to maintain confidentiality of data supplied by participants. Participants will be
free to withdraw from the study at any time and will be reassured that doing so will not affect their
medical care.
Informed consent and participant information
The process for obtaining participant informed consent will be in accordance with the REC guidance, and
GCP and any other regulatory requirements that might be introduced. The researcher and the participant
or other legally authorised representative shall both sign and date the Informed Consent Form before the
participant can participate in the trial.
The participant will receive a copy of the signed and dated forms and the original will be retained in the
Trial Master File. A second copy will be filed in the participant’s medical notes and a signed and dated
note made in the notes that informed consent was obtained for the trial.
The decision regarding participation in the study is entirely voluntary. The research worker shall emphasise
to them that consent regarding study participation may be withdrawn at any time without penalty or
affecting the quality or quantity of their future medical care, or loss of benefits to which the participant is
otherwise entitled. No trial-specific interventions will be done before informed consent has been obtained.
The research worker will inform the participant of any relevant information that becomes available during
the course of the trial, and will discuss with them, whether they wish to continue with the trial. If
applicable they will be asked to sign revised consent forms.
If the Informed Consent Form is amended during the trial, the investigator shall follow all applicable
regulatory requirements pertaining to approval of the amended Informed Consent Form by the REC and
use of the amended form (including for ongoing participants).
Records
Case report forms
Each participant will be assigned a unique Participant Identification Number for use on CRFs, other trial
documents and the electronic database. CRFs will be treated as confidential documents and held securely
in accordance with regulations. The investigator will make a separate Trial Recruitment Log (TRL) to record
confidential participant information including, name, date of birth and Participant Identification Number.
This permits identification of all participants enrolled in the trial, in case additional follow-up is required.
CRFs shall be restricted to those personnel approved by the Principal Investigator and recorded on the ‘Trial
Delegation Log.’
All paper forms shall be filled in using black ballpoint pen. Errors shall be lined out but not obliterated by
using correction fluid and the correction inserted, initialled and dated.
The Principal Investigator shall sign a declaration ensuring accuracy of data recorded in the CRF.
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Source documents
Source documents shall be filed at the investigator’s site and may include but are not limited to consent
forms and questionnaires. A CRF may also completely serve as its own source data. Only trial staff as listed
on the Delegation Log shall have access to trial documentation other than the regulatory requirements
listed below.
Direct access to source data/documents
The CRF and all source documents shall be made available at all times for review by the Principal
Investigator, and inspection by the sponsor [Central and North West London NHS Foundation Trust] and
relevant regulatory authorities, including the R&D departments.
Ethical issues
It is possible some participants have not been formally diagnosed with dementia or have been diagnosed
but have not been told, or have forgotten the diagnosis.
Quality assurance and audit
Research staff training
The researcher conducting the recruitment and outcome interviews will undergo training in administering
the relevant questionnaires. In addition researcher will be trained in participant risk assessment.
Monitoring and audit
The Principal Investigator will conduct an internal audit at the study centre every 3 months to ensure:
confidentiality and integrity of databases; effectiveness of database backup systems; confidentiality and
integrity of paper records; reconciliation of enquiries with enquiry outcome; data entry procedures;
numbers allocated to each treatment group; comparison of paper records and electronic records. Each
month, the Principal Investigator, together with the study team will review the progress of recruitment by
recording number of letters sent, number of enquiries received, number of calls made, number of
participants entered, number of participants randomised.
The study team will comply fully with any request for external audit by the sponsors or funding body.
Indemnity arrangements
This project will be indemnified through Central North West London NHS Foundation Trust. This covers
participants in the event of negligent or non-negligent harm. Standard NHS indemnities apply.
User and public involvement
User representatives will be involved in the development, implementation and interpretation of the study.
This involvement will include: advice on recruiting patients, invitation letters, the design of information
leaflets, and research instruments, piloting assessments, helping to assess progress, and contributing to the
evaluation of the project, the interpretation of findings and the dissemination of results. User representatives
will be invited to trial steering committee meetings and also provide assistance to the study.
Trial Steering Committee
The Trial Steering Committee (TSC) will provide a critical overview of the trial, and will meet at the
beginning of the trial and then 6-monthly, unless the Principal Investigator needs to seek its advice on
risk management, in which case a special meeting will be convened. The TSC will include the Principal
Investigator (JW), the project lead (DL), researchers (RB and AP), independent representatives of relevant
voluntary organisations, individuals with expertise in exercise promotion and falls prevention, a statistician,
and nominees of the funding body. It will be chaired by an independent investigator with expertise in
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exercise promotion. Because no medicinal products are being tested and the risks of the kind of exercise
that are being promoted are low, a separate data management and ethics committee will not be
convened, but responsibility for overview of the risks of the trial will rest with the TSC.
Independent members
Chair – Dr Craig Ritchie, Senior Lecturer, Imperial College
Vice Chair – Clare Leonard, Physiotherapist
l James Lee, Exercise Therapist
l Sue Ricketts, Carer
l Timothy Shore, Assistant Clinical Psychologist
l Lyn Strother, Carer and EVIDEM advisory group member
l Fiona Walters, OT
l Lay representative
EVIDEM members
l Dr Rahul Bhattacharya. SpR Charing Cross Psychiatric Training Scheme
l Sandra Brookes, Lead of the Old Age Directorate in CNWL FT
l Prof Steve Iliffe, Professor of Primary Care for Older People at UCL, and co-director of the Centre for
Ageing Population Studies in the Research Department of Primary Care
l Mark Griffin, Lecturer Medical Statistical Department, UCL
l Dr David Lowery, EVIDEM Research Programme Manager, CNWL NHS FT
l Dr James Warner, Consultant Psychiatrist CNWL NHS FT and Senior Lecturer Imperial College School
of Medicine
l Arlinda Cerga-Pashoja, Research Worker
Non-participant observers
l Jane Wilcock, Senior Research Fellow and EVIDEM Research Programme Manager UCL
The steering group will meet 6-monthly (or more often if necessary).
Methods for disseminating and implementing research results
The systematic review will be forwarded to The Cochrane Library, as will the write-up of the trial for
inclusion in their clinical trials register.
The trial will be published in a peer-reviewed medical journal.
Abstracts will be submitted to identified relevant conferences to inform other researchers of the work.
The support of the National Institute for Health Research (NIHR) will be credited in all publications that
arise from this project in accordance with the acknowledgment and disclaimer agreed between NIHR and
the EVIDEM Consortium.
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Project timetable
Year Month
General
administrative
tasks Milestones
Participant
management tasks
Target recruitment
(cumulative)
2009 March Steering Group Researcher starts, ethics
submissions
April
May
June
July Ethics and R&D
approvals
August Recruitment begins 0
September Steering Group 8
October 16
November Final follow-up begins 24
December 30
2010 January 38
February 46
March Steering Group 54
April 62
May 70
June 78
July 86
August 92
September Steering Group 100
October 108
November 116
December 124
2011 January 132
February Recruitment ends 146
March
April Steering Group
May Final follow-up ends
June Analysis and writing up
July
August
September
October
November
December
2012 January Steering Group
February Final report/publications
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Appendix 9 Chapter 2: Consenting protocol –
standard operating procedures
I t is important to establish if the potential participant and their carer have the capacity to provideinformed consent at each interview. It is vital that the carer can provide informed consent. If the
potential participant does not have the capacity to provide informed consent, they must still provide their
assent (agree to participate) alongside the informed consent of their carer.
Assessment of capacity is based on current case law applicable in England. To determine if the individual is
capable of providing informed consent, it is important to test whether pertinent information about the trial
and the alternative (i.e. no trial) can be understood; if it can be retained for a sufficient amount of time to
weigh in the balance and reach a decision about participation; and that the person can communicate their
decision to participate free from coercion. The process for doing this is as follows:
1. Understanding the trial As well as providing written information sheets, the main points of the trial and
the alternative (i.e. no trial) should be provided (and discussed) verbally in a way that the potential
participant can understand. These points are:
i. Dementia causes problems with memory and thinking as well as changes in mood and behaviour.
ii. Problems with mood and behaviour are usually treated with drugs, which can sometimes have a
negative impact on the person taking them.
iii. There is some evidence that exercising may be a safe, alternative treatment to BPSD.
iv. Walking is a safe way of exercising.
v. Participants will be randomly allocated into two groups: to receive either exercise therapy or care as
usual for 12 weeks. There is an equal chance (50 : 50) of receiving either of these two allocations.
This is because we do not know for sure if exercise works.
vi. A few participants and their carers will be allocated to one further follow-up, at which they will be
asked questions about their experiences of the trial. This interview will be audio-recorded.
vii. A final telephone contact will occur at week 26, where all participants from the exercise therapy
group will be asked a few questions about their current activity levels.
viii. Participation is for 12–26 weeks but participants can withdraw at any time without having to give
a reason.
ix. Participants at risk of falling or who have other physical health problems that may unable them to
carry out a walking programme will not be included in the study.
x. An exercise therapist will visit participants at home and establish a programme of walking outside
for the participant–carer dyad.
xi. The walking programme will be at a pace and distance to suit both the participant and his/her carer.
xii. The exercise therapist will visit participants on five occasions. Each visit will last approximately
1–2 hours and will take place in the home of either the participant or their carer.
xiii. A RW will visit participants on three or four occasions. At each visit, we will complete
various questionnaires.
xiv. All information held about them will be strictly confidential and it will not be possible to identify
them from published project data.
xv. They do not have to take part and if they do not, the medical care they receive will in no way be
altered. They can withdraw at any time.
2. Retain and weigh in the balance of the information The length of time they need to retain this information
for depends on the individual. If they are happy to give a decision immediately then they need to retain
only the information for that amount of time. Similarly, if they ask to think about it and say that they will
decide the next day then they need to retain the information until the next day. The best way to test belief
and retention of information is to ask the participant to repeat back the relevant information.
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3. Communicate a decision free from coercion The individual needs to communicate their decision on
participation without any pressure from the carer (if applicable) or the researcher attempting to obtain
informed consent.
Once this procedure is followed, the researcher can then assess whether or not she/he feels that the
individual has the capacity to give informed consent. If it is decided that they are not so capable then
the potential participant may be able to participate but still needs to give their assent to the study
(confirmation that they are happy to participate in the absence of full capacity). Therefore, an Assent Form
will be completed. Three copies of the Assent Form are then made: one to go to the participant’s GP; one
to go to the carer; and one to be kept at the study centre.
Participants with established capacity to consent will complete the Participant’s Consent Form. One copy of
the form will go to the participant’s GP; one to the participant; and one to be kept at the study centre.
The carer will complete a Participant–Carer Consent Form, at all occasions. One copy will be kept by the
carer and one will be kept at the study centre.
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Appendix 10 Chapter 2: Standard operating
procedure for monitoring of adverse events
Classification of event
All adverse events will be classified by the Principal Investigator as either:
l Adverse event (AE) Any unfavourable and unintended sign, symptom or disease temporarily associated
with the use of an investigational product, whether or not considered related to the
investigational product.
l Serious adverse event (SAE) An AE that results in death, or is life threatening, or required in-participant
hospitalisation, or results in persistent or significant disability or incapacity.
Classification of intensity
Regardless of the classification of AEs as serious/non-serious, the maximal intensity of the event is to be
evaluated by the responsible clinician, after consultation with the participant, carer and participant’s GP:
l Mild no impairment of normal daily activities
l Moderate impairment of normal daily activities
l Severe unable to perform normal daily activities.
Classification of causal relationship
Each AE must be classified on the basis of the available data with regard to the presumed causal
relationship to one of the following categories:
1 = probable
l Rational relationship to the time of intake of the investigational medication.
l AE is already known to be a side effect of the investigational medication or may be expected.
l Regression or disappearance of the AE after discontinuation of investigational medication or
dose reduction.
l Reappearance of the AE after repeated exposure.
l AE cannot be explained in a reasonable manner by the clinical state of the participant.
2 = possible
l Rational relationship to the time of intake of the investigational medication.
l AE is already known as a side effect of the investigational medication or may be expected.
l AE could be explained by numerous other factors.
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3 = improbable
l Rational relationship to the time of intake of the investigational medication.
l AE has not been reported so far as a side effect of the investigational medication or cannot
be expected.
l AE persists after discontinuation of the investigational medication or dose reduction.
l Repeated exposure does not lead to reappearance of the AE.
l AE could be explained by numerous other factors.
4 = no relationship
l No rational relationship to the time of intake of the investigational medication.
l AE is evidently caused by other factors, for example symptom of a concomitant disease.
5 = unable to evaluate
l Amount and content of data do not permit a judgement of the relationship to the
investigational medication.
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Appendix 11 Chapter 2: Risk assessment and
management tool
INCIDENT REPORT FORM 
 
Name : 
 
 
Date of Incident : 
 
Member of Staff Incident reported to : 
Details of the Incident 
 
 
 
 
 
 
 
Action Taken 
 
 
 
 
 
Witness Name and Role in Trial 
 
 
 
Outcome 
 
 
 
 
 
 
 
 
 
 Name of Member of Staff 
…………………………. 
 
Witness Signature  
……………………………….. 
 
Signed ……………………………………………... 
 
Dated …………………………………… 
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Appendix 12 Chapter 2: Serious adverse event
reporting form
Patient ID: _ _ _    Patient Initials: _ _ _ 
Patient Date of Birth: _ _/_ _/_ _  Allocation Group: Intervention/Control 
Date form completed: _ _/_ _/_ _ 
 
Death (any cause):        Yes  No  
Description:   ____________________________________________________  
  ____________________________________________________ 
 
Date of occurrence _ _/_ _/_ _      
 
Hospital Admission:        Yes  No   
Description: ____________________________________________________  
  ____________________________________________________  
 
Was the admission as a result of a fall?     Yes  No  
 
Injurious fall without Admission:      Yes  No   
Description: ____________________________________________________  
  ____________________________________________________  
  ____________________________________________________  
 
Fall During the exercise sessions: 
 
Did a fall or medical event occur during an actual exercise session, requiring medical 
attention?         Yes  No  
 
Form completed by: 
______________ (Print name)  Date_ _/_ _/_ _____________ (Signature) 
 
Form reviewed by 
______________ (Print name) Date_ _/_ _/_ _ _____________ (Signature) 
 
For Principal Investigator 
Is this event an SAE relating to patient safety in the trial? 
  Yes – inform TSC, convene meeting to discuss trial safety  
  No – no further action required 
 
Signed by Chair of TSC      Date 
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Appendix 13 Chapter 2: Risk management
pathway
Research participant,
carer or GP reports
falls or other AEs to 
research team
Research participant or
carer experience falls 
or other AE during
exercise therapist visit
Exercise therapist
takes immediate
remedial action
Inform GPComplete incident or falls report
form, pass to trial manager/or 
Principal Investigator
Trial manager/or Principal 
Investigator reviews and
classifies event, taking medical
advice if needed
AESAE (injurious fall, 
hospital admission, 
disablement, death, etc.)
Complete SAE report, and
decide if linked to trial
Yes No
Th
e 
p
ro
ce
ss
 t
o
 b
e 
co
m
p
le
te
d
 w
it
h
in
 2
4 
h
o
u
rs
Inform TSC
for review
Update risk log
Review participant’s status and make decision with him/her about
continued participation
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Appendix 14 Chapter 2: Diary – intervention
group, example page
 
Date Did you go out for a 
walk today? Yes/No 
How many 
times? 
 
How long was each of your walks? (in 
minutes)  
[e.g. walk1=10mins; walk2=20mins, 
etc] 
 
What RPE did you achieve? Rating of Perceived Exertion (Please circle below) 
 
___6___7___8___9___10___11___12___13___14___15___16___17___18___19___20___ 
              no exertion   very light  light  somewhat hard  hard   very hard  extremely hard maximal exertion 
What did you enjoy about your 
walk/s? 
What did you NOT enjoy 
about walk/s? 
Did you complete the course set by 
the exercise therapist?  
Yes/No 
If you did NOT go out, why not? Please circle below  
Didn’t feel like it / Something stopped me (i.e. pain, agitation, weather conditions)/ Carer unavailable/ 
Other (please describe below) 
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Appendix 15 Chapter 2: Diary – control group,
example page
 
Week 1 
Date Did you go out for a walk today?  
Yes/No 
 
How many 
times? 
 
How long was each of your 
walks? (in minutes)       
[e.g. walk1=10mins; 
walk2=20mins, etc] 
 
What did you enjoy about your walk/s? What did you NOT enjoy about 
walk/s? 
 
 
If you did NOT go out, why not? Please circle below  
Didn’t feel like it / Something stopped me (i.e. pain, agitation, weather conditions)/ Carer unavailable/ 
Other (please describe below). 
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Appendix 16 Chapter 2: Intervention protocol
W ithin 5 working days of randomisation, the consultant is to visit the participant in the participantsown home at a time that is convenient to the participant and carer (Visit 1):
l explain the exercise regime to carer and patient
l explain diary including the use of a visual analogue scale for Rating of Perceived Exertion (RPE) (Borg)83
l carry out local risk assessment for Carer–Patient dyad performing walking independently of
study personnel
¢ where risk is identified, the consultant agrees to record and report such risks to the Trial Manager
within 24 hours
l join Carer–Patient dyad on walk of approximately 20–30 minutes (depending on ability) and record
time and distance
l assess RPE and extend exercise to 60–70%, or 12–14 on 20-point scale
l support completion of diary and facilitate participant completion of RPE
l inform the Randomisation Officer when the first visit has been completed.
At Visits 2 (must be between 3 and 5 days of first visit) and 3 (must be within 8–10 days of first visit) – the
consultant will:
l inquire and document the dyads’ compliance with the exercise regime, and re-explain the regime/diary/
RPE where required
l identify any barriers to adherence and suggest solutions where possible
l give general encouragement to maintain the exercise regime.
Up to 28 days from the first visit the consultant will respond to the participant–carer dyad by telephone on
an ‘as needs basis’ for information about the exercise programme only.
l Where participants’ requests extend beyond the exercise regime or the 28-day time period, the
consultant will provide them with the contact details of the Trial Manager and log the contact with the
Trial Manager within 48 hours.
l The Consultant will respond to any carer/patient telephone call within 48 hours.
At Visits 4 (must be within 41–45 days of first visit) and 5 (must be within 82–86 days of first visit) – the
consultant will:
l join carer–participant dyad on walk of approximately 20–30 minutes (depending on ability) and record
time and distance
l support completion of diary and facilitate participant’s completion of RPE.
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Appendix 17 Chapter 3: Overall EVIDEM-C
protocol 2007
Introduction
Urinary and faecal incontinence in people with dementia is a major challenge for carers and professionals
in supporting a person with dementia in their own home and a common trigger for admission to
long-term care. Continence research and evidence-based guidance either explicitly excludes people
with dementia (see for example NICE 2006)122 or addresses those in care home settings (see for example
Ouslander et al. 2005).343 Current evidence-based guidelines on primary care management of dementia
does not address incontinence management or its contribution to carer burden.344 This study is part of a
wider programme of research and has the ultimate goal of developing and field testing evidence-based
tool kit for the management of urinary and faecal incontinence with carers, community nurses, social care
workers and home care staff. The elements within this study include: an investigation into the prevalence
of incontinence problems in people with dementia living at home, the identification and testing of feasible
and acceptable interventions for continence management in the home, and the development of
educational packages tailored to informal carers and different groups of specialist and generalist health
and social care professionals.
Background and rationale
Dementia affects over 4% of the people over 60, increasing to 13% for those over the age of 80 in
Western Europe with significant projected increases in the next 20 years.345 Dementia has enormous
impact not only for the individual and their family but also for the health and social care system.346 The
median length of survival from diagnosis to death is 8 years, with a trajectory of progressive deterioration
in cognition, abilities and physical functioning. In the later stages of the condition, people with dementia
can present with complex and challenging problems including aggressive behaviour, restlessness and
‘wandering’, eating problems, incontinence, delusions and hallucinations, and mobility difficulties. Urinary
and faecal incontinence are frequent symptoms as the disease progresses. Incontinence is the involuntary
leakage of urine or stool or both.347,348
The prevalence of any type of urinary incontinence in all older adults is between 6% and 10%, with
increasing rates associated with old age.349 It is estimated that 2–5% of adults experience faecal
incontinence.350 Incontinence lowers quality of life and impacts negatively on mental health351,352 as well
as creates significant practical and financial problems. There is evidence that incontinence contributes
significantly to other major health issues for older people such as falls.353 Incontinence has been identified
by professional and older people as an issue of unmet need in primary care.354–356
A United Kingdom (UK) population-based study of 15,000 home-dwelling people aged over 75 identified
that 18.3% had cognitive impairment and of these 31% had urinary incontinence problems.135 A national
general practice audit of 999 older patients with faecal incontinence identified that 27% had a diagnosis
of dementia.357 Estimates suggest that about 60% of people with cognitive impairment live in their own
homes.358 For this group, there are no data on the prevalence over time of faecal incontinence or urinary
incontinence problems to aid in service planning for the support of continence management or estimating
cost consequences for households or primary care organisations.
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Incontinence problems have been identified as a significant factor in increasing informal carer burden and
triggering the admission of people with dementias to care homes.110,134,356 There is little literature that
explores the nature and impact of managing bladder and bowel problems in people with dementia at
home by informal carers. Two small scale qualitative investigations into informal carers views (n= 12) on
managing frail spouses’ incontinence suggested individual problem solving strategies359,360 that contributed
further to carer stress such as decreasing their outside social contact. There is an absence of information
that identifies both those aspects of incontinence problems and also the carer and service contexts that
contribute to the admission to care homes. Anecdotal evidence suggests that faecal incontinence is the
tipping point as far as carers are concerned whether they are able to continue supporting the person with
dementia.361 Evidence from care home settings suggest that carers had difficulty interpreting what the
person with dementia wanted and therefore how best to manage their continence e.g. repeated requests
to be taken to the toilet and refusal of medication to ease constipation.362
Assisting older people remain in their own homes, improving continence care and addressing carer burden
are priorities for the health and social care improvement and service frameworks.363–365 People with
dementia receive services from both generalist primary care services and specialist mental health care of
older people. They may also receive support from social workers (generalist or specialist) and publicly
funded social care assistance. Incontinence is a clinical issue that often has low priority in generalist
primary care services and specialist mental health care services. Specialist continence services are not
currently available in all areas of the UK.366,367 However, there is no current evidence-based guidance for
addressing problems of incontinence in people with dementia living at home. Evidence-based guidance in
continence management has been developed by a number of agencies111,122,156,365,368 however, these either
point to the evidence gaps in treatment and management for frail older people (e.g. SIGN 2004)121 or
exclude people with cognitive impairment (e.g. NICE 2006).122 Current evidence-based guidelines on
primary care management of dementia does not address incontinence management or its contribution to
carer burden.344
Aims and research questions
The aims of this study are to:
1. identify the prevalence of different types of incontinence problems experienced by people with
dementia and the associated cost consequences over a 3-year period
2. identify and test feasible and acceptable interventions for continence management in the home.
The specific research questions are:
1. What is the prevalence of different types of incontinence problems experienced by people with
dementia, living at home, and their carers, over a 3-year period?
2. What is the evidence for different strategies and interventions in managing incontinence in people with
dementia living at home?
3. What are the perceived factors that support or detract from the use of different interventions (identified
in question 2) from the perspective of informal carers, generalist and specialist health-care staff, social
workers and social care?
4. Are the interventions (identified in questions 2 and 3) feasible, acceptable, effective and appropriate in
the home setting from the perspective of the person, their carer(s), professionals and public
service delivery?
APPENDIX 17
NIHR Journals Library www.journalslibrary.nihr.ac.uk
354
Method
The overall research approach is one of critical realism369 which allows an integration of both subjective
and objective research approaches and makes explicit the interrelationships between context, process,
interventions (mechanisms) and outcomes.370 In taking this approach, the multifaceted nature of the issues
and problems in managing incontinence in the home, as well as the perspectives of multiple and diverse
stakeholders can be examined in the light of the evidence of effectiveness. This research approach allows
the study to acknowledge the complexity of the issues. The study therefore draws on more than one
methodology for generating evidence and knowledge. There are three elements leading to the fourth
element of producing and field testing educational packages tailored to informal and formal carers and
different groups of specialist and generalist health and social care professionals. The three elements are:
Element 1 The establishment of period prevalence of different types of incontinence problems in a
community-dwelling cohort through interview survey at three points during the 5-year programme span.
This data will be obtained as part of the broader set of enquiries on ‘transitions’ undertaken with a sample
of people and their carers enrolled in the parent cohort study.
Element 2 The development of feasible and acceptable interventions for incontinence
management through:
1. A systematic review of the evidence, which integrates evidence from both quantitative and qualitative,
approaches (Dixon–Woods et al. 2004).371
2. Qualitative exploration of people with dementia, carers and professionals views of problems and
potential interventions through:
i. Up to 25 (or until saturation is reached) semi-structured individual interviews and four group
interviews with informal care givers using adapted structured focus group techniques134 to explore
perceptions of the problems and acceptability or consequences of different types of interventions.
ii. Up to 10 exploratory discussions (rather than semi-structured interviews) with people with dementia
regarding their perceptions of problems with going to the toilet or lack of control.
iii. Up to eight group interviews with health and social care professionals employing adapted structured
focus group techniques125 on their perceptions of the problems and acceptability or consequences of
different types of interventions.
Element 3 The testing of the identified interventions for feasibility, acceptability and cost consequences372
with up to 40 people with dementia (the exact number to be determined following the evidence revealed
by one and their carers over 12 months). The detailed methods for element 3 are dependent on results
from element 2. A subsequent protocol will be developed for this.
Element 1 method
This element addresses research question 1. The research design for this element is a repeated descriptive
survey. It is a nested study within the broader cohort ‘longitudinal study of transitions’, which addresses a
broader range of health and social topics. The survey questions are repeated annually over 3 years. The
rationale for embedding this element in a broader study is that most adults find discussion of bowel and
bladder problems deeply embarrassing and often shameful. Adults are unlikely to volunteer to participate
in a study that focuses on this issue in isolation; however, they are likely to be more willing to discuss it in
the wider contexts of their daily life.
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The sample
The sample will be people with cognitive impairment, living at home, and their carers within the cohort
who have agreed to participate in the ‘longitudinal study of transitions’. The recruitment for this
longitudinal study will be recruited via health, social work and social care professionals. Recruitment and
consent processes are in line with the overall EVIDEM programme principles.
The data collection and tools
There are no data collection tools on incontinence specifically validated for a population of cognitively
impaired people. The study advisory group and user group will provide expert opinion on drawing together
the most appropriate and acceptable validated tools (e.g. Leicester Urinary Symptom Questionnaire)373
plus additional questions to describe symptoms, severity, impact, causes and contributing factors
e.g. motor/mobility deficits, behavioural problems, management strategies and associated costs. While
population-based surveys of incontinence problems have found that postal methods are acceptable
(Perry et al. 2002350) it is unlikely to be feasible with this group of people and their carers. It is anticipated
that this will be an interviewer delivered survey and that the interviewer will proceed with the interview in
conversational ways rather than as a checklist set of questions which are more likely to distress and agitate
people with dementia. The survey questions on this topic will be piloted as part of the wider longitudinal
survey and amended as necessary. The survey interviews will be undertaken at three points in time over
3 years. The feasibility of carer completed diaries of continence related problems will also be explored as
these have been used successfully in some other studies. It is possible that after the first survey, some carer
informants may prefer and be willing to complete a postal survey.
Data analysis
The data will be entered on to a SPSS™ software programme and analysed descriptively in the first
instance and subsequently for correlates between types of incontinence, management strategies and
demographic and mental and physical condition factors.
Timetable
Year 1 Year 2 Year 3 Year 4
Advisory group and user group ✗ ✗ ✗ ✗
Developing data collection tools ✗
Ethics and research governance (linked to broader study) ✗
Recruitment and piloting (linked to broader study) ✗
Recruitment and data collection and analysis time period 1 ✗
Data collection and analysis time period 2 ✗
Data collection and analysis time period 3 ✗
Overall data analysis and report writing ✗
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Element 2 method
This element addresses research questions 2 and 3.
The systematic literature search
A systematic review of the published and unpublished literature on continence management community-
dwelling older people with dementia and their carers will be undertaken using methods developed by the
Cochrane Collaboration374 and the Social Care Institute for Excellence,375 incorporating both qualitative and
quantitative evidence. The scope of the review will include:
l studies that offer continence care, management and educational-based interventions with people with
dementia and their carers in primary care settings including patients’ own home
l studies that consider services operated within developed health economies and focus on research
undertaken in the UK, Europe, Australasia and North America where there is a similarity in the age
distribution of the populations and comparable methods of health-care delivery.
Excluded from the review will be:
l Studies that are hospital based and nursing home based. It is not within the scope of this review to
include foreign language papers.
The review will then proceed in stages:
1. Search the literature across a wide range of health and social care electronic databases including
MEDLINE, EMBASE, CINAHL, PsycINFO BNI, CAREDATA, Cochrane Library (including DARE, NTIS,
SIGLE), Social Science Citation index, Age Info, National Research register, Papers First (conference
presentations) and the specialised register of the Cochrane Effective Practice and Organisation of Care
Group (EPOC), Dissertation Abstracts, Department of Health and similar websites. Preliminary searching
will begin with a strategy based on keyword/index (MeSH) terms. The two main themes will be
dementia and incontinence. In addition ‘lateral searching’ techniques will be used such as checking
reference lists of relevant papers, and using the ‘Cited by’ option on WoS, Google Scholar and Scopus,
and the ‘Related articles’ option on PubMed and WoS, as recommended in searching for studies of
complex interventions.126 In addition, leading researchers and expert practitioners in the field will be
contacted to help identify unpublished research. Key publications linked to dementia care and
incontinence management that are not indexed on databases will be hand searched.
2. Abstracts and brief records from databases will be screened by two researchers for relevance to the
research questions 2 and 3 and filed in a bibliographic management package (RefMan 10).
3. A common data extraction sheet will be developed for study quality appraisal and evidence relevant
to research questions 2 and 3 (above). Each retrieved study will be assessed by two researchers
independently. The initial aim will be to identify and classify interventions to incontinence care for
community-dwelling older people with dementia.
4. The evidence will be synthesised and a report produced.
The findings from the review will inform the second element of this phase.
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Method: the exploration of perceptions of feasible and
acceptable interventions for continence management
(the qualitative interview studies)
This stage uses qualitative methods to explore perceptions of feasibility and acceptability of different types
of strategies for incontinence management from the perspectives of the three groups of key stakeholders:
the people with dementia, the informal carers of people with dementia and professionals (generalist
and specialists) providing services to people with dementia in their own home. Three data collection
methodologies will be used by:
1. up to 25 (or until saturation is reached) semi-structured individual interviews and four group interviews
with informal care givers using adapted structured focus group techniques125 to explore perceptions of
the problems and acceptability or consequences of different types of interventions
2. up to 10 exploratory discussions (rather than semi-structured interviews) with people with dementia
regarding their perceptions of problems with going to the toilet or lack of control
3. up to eight group interviews with health and social care professionals’ employing adapted structured
focus group techniques125 on their perceptions of the problems and acceptability or consequences of
different types of interventions.
Sample recruitment
The study user advisory group will be consulted on suitable wording for recruitment materials and data
collection tools. Recruitment for carers and people with dementia will take place via local Alzheimer’s
Society branches. Recruitment of professionals will take place through local service generalist and specialist
services. Each structured focus group will have between 8 and 12 participants.
Data collection and analysis
The structured focus group interviews will be led by an experienced researcher, with another researcher
present to take research field notes.376 The lead researcher will record the key issues and views on flip
chart, using some of the techniques of nominal group technique (NGT)43 to focus the discussions on the
key research questions. With permission the group discussion will be taped as an aide to the record of
the group which will be typed up from the flip charts and the filed notes. The record of the groups
interviews will be analysed in NVivo™ software using a template methodology,377 derived from a priori
theories derived from the literature review but also allowing new themes and issues to be identified. The
semi-structured interviews will be guided by an aide-memoire125 developed from the literature in the first
phase. Interviews will be recorded with permission, transcribed (tapes destroyed) and analysed with the
same template framework as used for the NGT groups using NVivo™ software. The exploratory discussions
with people with dementia are forms of semi-structured interviews that are much more flexible in their
approach, using conversational techniques rather than lists of questions,378 to assist participation by people
with dementia. The exploratory discussions will focus around views and feelings related to bladder, bowel
and toilet problems rather than questions that require detailed recall.379 With permission the discussions
will be recorded, transcribed (recording destroyed) into the NVivo™ software package and analysed as
described above. The findings between the different stakeholders will be compared and contrasted and
the evidence used with that of the findings from the systematic review to design element 3.
Ethical considerations
Participants’ information sheets will be developed in consultation with the research advisory and study user
reference group. Participants will be recruited having been provided with full information about the study,
its processes and data uses. The consenting process for people with dementia will conform to that agreed
for the EVIDEM research programme and for all participants researchers will make it clear that individuals
will be free to withdraw at any point in the research process. The Individuals in interview process will be
assured confidentiality and anonymity in data processing (through assignment of a study identification
number) and subsequent reporting. Participants in group interviews will be known to each other and
each interview will start with group agreements on the level of confidentiality those participants feel
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comfortable with. Quotations from participants may be used but in a way that will not reveal identities.
All data will be kept on password protected computers and locked filing cabinets. Each participant will
be made aware that the researchers have a duty of care should any information be revealed that suggests
a vulnerable adult is being neglected or abused in any way.
Timescale
Year 1 Year 2 Year 3 Year 4
Advisory group and user group ✗ ✗ ✗ ✗
Systematic literature review ✗
Ethics and research governance for element 2b ✗
Data collection 2b interviews and focus groups ✗
Data analysis and report writing ✗ ✗
Development of protocols for element 3 ✗ ✗
Establishment of research and user advisory group
It is anticipated that a group of professionals with interests in the care of people with dementia and
incontinence and service users/carers will be formed to advise on the conduct of this work stream.
It is anticipated that there will be an initial and annual meeting but most work will be undertaken
by e-communication.
Dissemination
The disseminations strategy is part of the overall EVIDEM strategy to submit material for lay and
professional audiences, participate in Central and North West London NHS Foundation Trust research
events and submit to present orally in relevant conferences.
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Appendix 18 Chapter 3: Protocol – exploring
issues and solutions in promoting continence and
managing incontinence with people with memory
problems living at home and their carers, 2008
Introduction
Urinary or faecal incontinence are distressing symptoms for any adult that impact on many facets of an
individual’s health and quality of life. Professional knowledge and public awareness is increasing the
availability of an evidence base in treatment and best practice.121,362,380 However, people with memory
problems and dementia living at home are one group for whom there is little guidance on promoting
continence or managing incontinence. Incontinence problems are a common element in the decisions to
move into a care home.134,356 Continence research and evidence-based guidance either explicitly excludes
people with dementia (see for example National Institute of Clinical Excellence 2006)122 or more commonly
includes only those people living in care home settings (see for example Ostaszkiewicz et al. 2004).368
Evidence-based guidelines produced in 1998 for primary care staff on supporting people with dementia
and their carers did not address incontinence management.123 The recent NICE–SCIE guideline on
supporting people with dementia and their carers124 does not review evidence in relation to continence
promotion but offers the view that combined interventions are more likely to support and maintain
independence in the person with dementia.
EVIDEM C is a part of the NIHR funded programme of research (Principal Investigator Professor Steve Iliffe,
University College London). It has the ultimate goal of developing and field testing an evidence-based
resource for the promotion of continence and management of urinary and faecal incontinence with carers,
community nurses, and social care staff.
Background and rationale
Dementia affects over 4% of the people over 60, increasing to 13% for those over the age of 80 in
Western Europe with significant projected increases in the next 20 years.345 Dementia has enormous
impact not only for the individual and their family but also for the health and social care system.119,296,346
The median length of time from diagnosis to death is 10 years for those under 65 at diagnosis and 4 years
for those over 80 years.173 The clinical syndrome of dementia has a trajectory of progressive deterioration
in cognition, abilities, and physical functioning. The impairment experienced by the individual is often
compounded by extrinsic factors such as attitudes of ‘therapeutic nihilism’115 in professionals, unadapted
environments, and social exclusion. As the condition progresses problems may arise in maintaining
independence in going to the toilet, in avoiding constipation, and in managing incontinence problems
that cannot be resolved. Estimates suggest that there are 500,000 people with dementia in England and
two-thirds live at home.119
Incontinence is the involuntary leakage of urine or stool or both.347,349 The prevalence of any type of urinary
incontinence in all older adults is between 6% and 10%, with increasing rates associated with old age.349
It is estimated that 2–5% of adults experience faecal incontinence.350 Incontinence lowers quality of life
and impacts negatively on mental health351,352 as well as creates significant practical and financial problems.
There is evidence that incontinence contributes significantly to other major health issues for older people
such as falls.353 Incontinence has been identified by professionals and older people as an issue of unmet
need in primary care.354,355,366
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A UK population-based study of 15,000 home-dwelling people aged over 75 identified that 18.3% had
cognitive impairment and of these 31% had urinary incontinence problems.135 A national general practice
audit of 999 older patients with faecal incontinence identified that 27% had a diagnosis of dementia.381
Estimates suggest that about 60% of people with cognitive impairment live in their own homes.358
For this group, there are no data on the changes over time in continence status to aid in service planning
for the support of continence management or estimating cost consequences for households or primary
care organisations.
Incontinence problems have been identified as a significant factor in increasing informal carer burden and
triggering the admission of people with dementias to care homes.110,134,356 There is little literature that
explores the nature and impact of managing bladder and bowel problems in people with dementia at
home by informal carers. Two small scale qualitative investigations into informal carers views (total n= 12)
on managing frail spouses’ incontinence359,360 suggested that individual problem solving strategies might
contribute further to carer stress through decreasing their outside social contact. There is an absence of
information that identifies both those aspects of incontinence problems and also the carer and service
contexts that contribute to the admission to care homes. Anecdotal evidence suggests that faecal
incontinence is the tipping point as far as carers are concerned whether they are able to continue
supporting the person with dementia.361 Evidence from care home settings suggest that formal carers had
difficulty interpreting what the person with dementia wanted and therefore how best to manage their
continence, e.g. repeated requests to be taken to the toilet and refusal of medication to ease constipation.362
Assisting older people to remain in their own homes, improving continence care and addressing carer
burden are priorities for the health and social care improvement and service frameworks (DOH 1998,
2000, 2001).363–365 People with dementia receive services from both generalist primary care services and
specialist mental health care of older people. They may also receive support from social workers (generalist
or specialist) and publicly funded social care assistance. Incontinence is a clinical issue that often has low
priority in generalist primary care services and specialist mental health care services. Specialist continence
services are not currently available in all areas of the UK.356 Evidence-based practice guidance is not
currently available to assist professionals and staff in generalist services in their support of people with
dementia living at home and their carers.
Study aim and research approach
This study draws on the Medical Research Council (MRC 2000)56 Framework for developing complex
interventions in using stepwise phases. The study has a number of linked phases commencing with an
integrative review of the literature,367 which is currently in progress. The research approach is one of critical
realism369 which allows an integration of both subjective and objective research approaches and makes
explicit the interrelationships between context, process, interventions (mechanisms) and outcomes.370 In
taking this approach, the multifaceted nature of the issues and problems in promoting continence and
managing incontinence in the home, as well as the perspectives of multiple and diverse stakeholders can
be examined in the light of the evidence of effectiveness. This research approach allows the study to
acknowledge the complexity of the issues.
The research questions for this phase of the study are:
1. What is the evidence for different strategies and interventions in promoting continence and managing
incontinence in people with dementia living at home? (Addressed by the integrative review of
the literature.)
2. What is the experience and perceptions of people with dementia and their close carers regarding the
problems and successful strategies for promoting continence and managing incontinence at home?
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The results from this phase will then be used to develop feasibility studies of potential interventions, which
will be submitted for peer and ethical review.
The development of this protocol has been informed by the EVIDEM and EVIDEM-C advisory group, which
involves service users and carers.
Method
The methodology is qualitative, in the interpretive tradition, using individual and group interviews.
The sample and recruitment
Informal carers and people with dementia (up to 55 people) will be recruited through (a) invitation letters
in local North London Alzheimer’s Society branch newsletters and (b) invitation letters being distributed
to service users with memory problems and their carers, who might be interested in participating,
by professional staff in the day and community services for older people with mental health problems
(primarily those provided by Central and North West London NHS Trust). It is anticipated that people
with dementia likely to be willing to participate would be at the mild to moderate stage of the
disease progression.
Those individuals willing to participate will make contact with the researcher who will send them the
participant information leaflet and arrange a time to meet at their home or another community service
venue convenient for them. At the meeting the research will be explained and consent sought to
participate (see section below on detailed ethical considerations and mental capacity).
Data collection and analysis
Data will be gathered through:
l Up to 25 (or until saturation is reached) semi-structured individual interviews with close care givers to
explore perceptions of the problems, their criteria for success in promoting continence and managing
incontinence, and their experience of successful strategies in promoting continence and managing
incontinence. These will be face to face or by telephone as the person chooses.
l Up to four group interviews (approximately five per group) with close care givers using adapted
structured focus group techniques369 to gain their views on the feasibility and acceptability of different
types of strategies/interventions identified from the literature. From the data gathered, individual
interviews will be undertaken with carers and professionals. If group interviews are not feasible
logistically or in terms of numbers then individual interviews (face to face or by telephone as the person
chooses) will be conducted.
l Up to 10 exploratory discussions164 with people with mild to moderate dementia regarding their
feelings and experience of problems with going to the toilet and different types of help.
Semi-structured interviews with individuals will use an aide memoire to ensure key themes are explored.
Interviews will be taped, with permission, transcribed and the tapes deleted. Each transcription will only be
known by an identifying number not the person’s name and all items that might identify the informant,
such as names, will be made anonymous. The transcriptions will be entered into a software programme,
NVivo™, to aid data management. Content analysis370 will be undertaken by two researchers,
independently and compared, to aid validation of the analysis.
Small group interviews will be conducted by two researchers. One will lead the discussion using the
same topics as in the aide memoire and the other will take notes. The group’s discussion points will be
summarised on flip chart to aid verification from the group of the issues raised and views expressed.
The notes and flip chart will be transcribed into word documents and entered into NVivo™ for cross
comparison and analysis between groups and themes from individual interviews.
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Exploratory discussions with individuals with dementia will be much more conversational and centre on
two questions:
l What sort of problems do you have with going to the toilet? and
l What helps you when you have these problems?
It is anticipated that the conversation is likely to be in the presence of the person’s spouse/close carer if
they have one. The emphasis in the exploratory discussion will be on experiences and feelings not ‘facts’.
Exploration on views of different types of help will only be explored if the person is comfortable with the
discussion and willing to continue. The conversation will be taped, with permission. If permission is not
given, permission for taking notes will be sought. The tapes or notes will then be treated in the same way
as the transcriptions of the semi-structured interview as above.
Ethical considerations
The research questions under consideration are directly relevant to people who have dementia and it is
important to incorporate views of those people experiencing the problems not just the professional views
or their family members.382 People who have dementia may lack capacity to consent. Only those people
with dementia with the capacity to make the decision to participate in the research will be included. The
procedure for establishing the ability to make the decision will proceed in accordance with the guidance
for the Mental Capacity Act 2005. People with dementia will only be approached after their close family
carer or a professional who knows them well enough to judge their ability to consent to participation
in the study, has discussed the research first and asked whether they would be willing to meet the
researcher. This person will explain about the research and the exploratory discussion process using the
information leaflet which has been adapted to provide key points in straight forward language. After
consent to approach the person has been gained, the researcher will arrange to meet them with their
carer or supporting person of their choice. She will repeat the explanations, using the leaflet and check the
person is able to consent at that point in time. Key elements in checking will be: whether the person has
general understanding of what they are consenting to and why they are being asked to make it, whether
the person understands what will happen if they agree to participate in the study, whether they are they
able to understand the verbal and/or written information relevant to making a decision whether to
participate in the study. A consent form for signing will be offered, although if the informant is unwilling
to sign (writing may be difficult) this will not be pursued and verbal consent will be noted. Any sign
(verbally or in body language) that the individual is not happy about taking part or continuing to take part
in the research will be interpreted as withholding consent, or a desire to withdraw. The researcher will
end the conversation, thanking the person for their time and involvement. The researcher will check
throughout the discussion that the informant is willing to continue and cease if the person indicates they
wish the discussion to end.
Urinary or faecal incontinence are distressing symptoms that are embarrassing to discuss for any adult.
Undertaking intimate care associated with incontinence for an adult spouse, relative or loved one is a
sensitive issue. All interviews will be conducted by researchers aware of the potential socially problematic
nature of the issues that are being discussed. Interviewers will use language understandable and
acceptable to the interviewee and make all efforts to lessen any discomfort in discussing the issues.
Should an individual become distressed then the interviewer will pause, be sympathetic, and check
whether the person wishes to discontinue the interview. The researcher will encourage informants to
share their problems and distress with their key health professional, or family doctor as appropriate.
All researchers will have contact information on key support agencies to leave with informants.
All informants will be assured of anonymity and confidentiality in the transcription, analysis and reporting
of their interview. Any direct quotations used in the report will be non-attributable. At the start of the
group interviews, informants will be asked to respect that views and opinions expressed in the interview
are held confidential to the group.
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Informants will be made aware that if any information is shared that suggests that a vulnerable older adult
is suffering neglect or abuse then the researcher has a responsibility to share that information with the
service manager (in case of abuse or neglect from a service provider) or in the case of individuals gain their
consent to share that information with the named Local Authority Officer for vulnerable adults.
Data protection considerations
All participants will be assigned a code number and this with their contact details will be kept separately
and securely from any data collected in the process of the research. This file will be registered with the
University data manager. All research data will be identifiable by code number alone. Audiotapes will be
transcribed and deleted. The transcribed interviews will be entered stored on a password protected
computer, accessible only to the researchers in locked offices the University. Hard copies of data will be
stored in locked filing cabinets in the same offices. Research data will be archived for 5 years and
then destroyed.
Timescale
Interviews – July and August 2008
Analysis – August and September 2008
Report writing – September 2008
Feedback to participants – end of September 2008
Reports and dissemination
The findings will be written up as a brief report for circulation to participants. A full report will be used as
the basis for papers and articles to be submitted to a professional journal and local and national voluntary
organisation’s newsletters. An abstract will be submitted for presentation at a service users and professional
conference, such as Dementia Congress.
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Appendix 19 Chapter 3: Protocol – professional
views of current issues and solutions in promoting
continence and managing incontinence with people
with memory and cognition problems living at home
This protocol concerns the investigation of the views of health and social care professionals and staff ofcurrent issues and solutions in promoting continence and managing incontinence with people with
memory and cognition problems, and their carers, living at home. (NB. The views of people with these
problems and their carers are also being investigated under a separate study protocol.)
Introduction
Urinary or faecal incontinence are distressing symptoms for any adult that impact on many facets of an
individual’s health and quality of life. Professional knowledge and public awareness is increasing the
availability of an evidence base in treatment and best practice.119,124,362 However, people with memory
problems and dementia living at home are one group for whom there is little guidance on promoting
continence or managing incontinence. Incontinence problems are a common element in the decisions to
move into a care home.343,356 Continence research and evidence-based guidance either explicitly excludes
people with dementia (see for example National Institute of Clinical Excellence 2006)122 or more commonly
includes only those people living in care home settings (see for example Ostaszkiewicz et al. 2004).368
Evidence-based guidelines produced in 1998 for primary care staff on supporting people with dementia
and their carers did not address incontinence management.123 The recent NICE–SCIE guideline on
supporting people with dementia and their carers380 does not review evidence in relation to continence
promotion but offers the view that combined interventions are more likely to support and maintain
independence in the person with dementia.
This investigation of professional views is part of a larger study (EVIDEM-C) which has the ultimate goal of
developing and field testing an evidence-based resource for the promotion of continence and management
of urinary and faecal incontinence with carers, community nurses and social care staff. EVIDEM-C is a part
of the NIHR funded programme of research (Principal Investigator Professor Steve Iliffe, University College
London website: www.evidem.org.uk).
Background and rationale
Dementia affects over 4% of the people over 60, increasing to 13% for those over the age of 80 in
Western Europe with significant projected increases in the next 20 years.345 Dementia has enormous
impact not only for the individual and their family but also for the health and social care system.119,296,346
The median length of time from diagnosis to death is 10 years for those under 65 at diagnosis and 4 years
for those over 80 years.173 The clinical syndrome of dementia has a trajectory of progressive deterioration
in cognition, abilities, and physical functioning. The impairment experienced by the individual is often
compounded by extrinsic factors such as attitudes of ‘therapeutic nihilism’115 in professionals, un-adapted
environments, and social exclusion. As the condition progresses problems may arise in maintaining
independence in going to the toilet, in avoiding constipation, and in managing incontinence problems
that cannot be resolved. Estimates suggest that there are 500,000 people with dementia in England and
two-thirds live at home.119
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Incontinence is the involuntary leakage of urine or stool or both.347,349 The prevalence of any type of urinary
incontinence in all older adults is between 6% and 10%, with increasing rates associated with old age.349
It is estimated that 2–5% of adults experience faecal incontinence. Incontinence lowers quality of life and
impacts negatively on mental health351,352 as well as creates significant practical and financial problems.
There is evidence that incontinence contributes significantly to other major health issues for older people
such as falls.353 Incontinence has been identified by professionals and older people as an issue of unmet
need in primary care.354,355,381
A UK population-based study of 15,000 home-dwelling people aged over 75 identified that 18.3% had
cognitive impairment and of these 31% had urinary incontinence problems.135 A national general practice
audit of 999 older patients with faecal incontinence identified that 27% had a diagnosis of dementia.367
Estimates suggest that about 60% of people with cognitive impairment live in their own homes.356 For this
group, there are no data on the changes over time in continence status to aid in service planning for
the support of continence management or estimating cost consequences for households or primary
care organisations.
Incontinence problems have been identified as a significant factor in increasing informal carer burden and
triggering the admission of people with dementias to care homes.110,134 There is little literature that
explores the nature and impact of managing bladder and bowel problems in people with dementia at
home by informal carers. Two small-scale qualitative investigations into informal carers views (total n= 12)
on managing frail spouses’ incontinence359,360 suggested that individual problem solving strategies might
contribute further to carer stress through decreasing their outside social contact. There is an absence of
information that identifies both those aspects of incontinence problems and also the carer and service
contexts that contribute to the admission to care homes. Anecdotal evidence suggests that faecal
incontinence is the tipping point as far as carers are concerned whether they are able to continue
supporting the person with dementia.361 Evidence from care home settings suggest that formal carers had
difficulty interpreting what the person with dementia wanted and therefore how best to manage their
continence, e.g. repeated requests to be taken to the toilet and refusal of medication to ease constipation.362
Assisting older people to remain in their own homes, improving continence care and addressing carer
burden are priorities for the health and social care improvement and service frameworks (DOH 1998,363
2000,365 2001364). People with dementia receive services from both generalist primary care services and
specialist mental health care of older people. They may also receive support from social workers (generalist
or specialist) and publicly funded social care assistance. Incontinence is a clinical issue that often has low
priority in generalist primary care services and specialist mental health care services. Specialist continence
services are not currently available in all areas of the UK.367 Evidence-based practice guidance is not
currently available to assist professionals and staff in generalist services in their support of people with
dementia living at home and their carers.
Aims
This investigation is part of a larger study (EVIDEM-C), which has the ultimate goal of developing and field
testing evidence-based resources for the promotion of continence and management of urinary and faecal
incontinence with people with dementia, close carers, primary care professionals, social care and home
care staff. EVIDEM-C draws on the Medical Research Council (MRC 2000)56 Framework for developing
complex interventions in using stepwise phases. The research approach is one of critical realism369 which
allows an integration of both subjective and objective research approaches and makes explicit the
interrelationships between context, interventions (mechanisms) and outcomes.370 In taking this approach,
the multifaceted nature of the issues and problems in promoting continence and managing incontinence
in the home, as well as the perspectives of diverse stakeholders can be explored.
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This investigation asks the questions:
l What are the views of health and social care professionals and staff of (a) current issues and
(b) currently employed solutions in promoting continence and managing incontinence with people with
memory and cognition problems, and their carers, living at home?
l From professional and clinical experience, are there strategies/advice/interventions/aids/support/
technology that appear to be more acceptable and effective in supporting people living at home?
l From professional and clinical experience, are there gaps in the knowledge and/or provision to
appropriately support people and their carers in dealing with these issues?
The results from this investigation will be both fed to local participating services and used to develop
feasibility studies of potential interventions, which will be submitted for peer and ethical review.
The development of this protocol has been informed by the EVIDEM-C advisory group, which involves
service users and carers.
Methods
The methodology is qualitative, in the interpretative tradition, using small group and individual interviews.
The sample is purposive to capture views from a diverse range of professional and staff groups across
health and social care services in different inner urban and urban areas within the North Thames DeNDRoN
research network area (URL: http://www.dendron.org.uk/rn/north_thames.html).
Professional groups include:
l staff in older people mental health services providing day, outreach, and domiciliary services (likely staff
groups include community mental health nurses, social workers, occupational therapists,
admiral nurses)
l staff in Primary Care Trust Provider Services providing domiciliary services to older people (likely staff
groups include district nursing, community nursing, physiotherapists) and continence/bowel and
bladder services
l staff in independent service providers of home care and day centres for older people (likely staff groups
include home care organisers, day centre managers)
l staff in Local Authority Adult Service Departments (likely staff groups include social workers, in house
home care managers and carers)
l general practitioners and practice nurses (approached via the Greater London Primary Care
Research Network).
The initial approach will be to a senior manager of the organisation to explain the investigation and seek
permission to approach staff to volunteer. Requests for volunteers and participation information sheets
will be circulated to staff. If it is not possible to organise small groups in convenient work locations then
face-to-face or telephone interviews will be conducted as preferred.
Data will be gathered through:
l Group interviews (approximately 5–8 per group) using adapted structured focus group techniques
(Robson 2004)369 based on the research questions outlined above or
l Individual semi-structured interviews based on the research questions outlined above. These will be
face to face or by telephone as the person chooses.
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Small group interviews will be conducted by two researchers. One will lead the discussion using the
same topics as in the aide memoire and the other will take notes. The group’s discussion points will be
summarised on flip chart to aid verification from the group of the issues raised and views expressed.
The notes and flip chart will be transcribed into word documents and entered into NVivo™ for cross
comparison and analysis between groups and themes from individual interviews. Semi-structured
interviews with individuals will be recorded in field notes to be comparable with the data gathered in
the group interviews. These will be entered into MS Word documents and treated as above. Content
analysis370 will be undertaken by two researchers, independently, and compared to aid validation of
the analysis.
Ethical and data protection considerations
All informants will be assured of anonymity and confidentiality in the transcription, analysis and reporting
of their interview. Any direct quotations used in the report will be non-attributable. At the start of the
group interviews, informants will be asked to respect that views and opinions expressed in the interview
are held confidential to the group.
Informants will be made aware that if any information is shared that suggests that a vulnerable older adult
is suffering abuse from a service provider then the researcher has a responsibility to share that information
with the service manager.
All participants will be assigned a code number and this with their contact details will be kept separately
and securely from any data collected in the process of the research. All data will be identifiable by code
number alone. Data collected in group interviews will not have any identifying information on it. Data will
be stored on a password protected computer, accessible only to the researchers in locked offices of the
University. Hard copies of data will be stored in locked filing cabinets in the same offices and destroyed
after the investigation is completed.
This protocol is deemed as service evaluation by the NHS Research Ethics Service and does not require an
NHS ethics committee review. The protocol complies with the ethical review procedures of the
host University.
Reports and dissemination
The findings will be written up as a brief report for circulation to participants. A full report will be used
as the basis for papers and articles to be submitted to professional and service orientated journals.
The findings will be used to develop feasibility studies of possible interventions/services and develop
an evidence-based resource for the promotion of continence and management of urinary and faecal
incontinence with people with dementia, close carers, primary care professionals, social care and home
care staff.
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Appendix 20 Chapter 3: Protocol – investigating
the experience of managing continence problems over
time, version 2, 2010
This study protocol originally had greater emphasis on quantitative elements of a cohort study.Unfortunately the difficulties in recruiting people into the study led to an amendment with greater
emphasis on the qualitative elements.
Introduction
Urinary or faecal incontinence are distressing symptoms for any adult that impact on many facets of an
individual’s health and quality of life. It is estimated that up to a third of people with memory problems
living at home have incontinence problems. Incontinence is known to be a significant factor in the decision
for people with memory problems and dementias to take up residence in a care home. This is an aspect
of the health and well-being of people with memory loss that is poorly described both in its trajectory and
the factors that promote the maintenance of continence and the management of incontinence at home.
This lack of detailed knowledge of the issues and effective management strategies is reflected in the lack
of guidance for people with dementia, their carers and health and social care professionals to address
these problems.
This study aims to prospectively follow a group of people with dementia with continence problems and
their carers for up to 3 years to describe the type of problems, the management strategies, the lived
experience of the family carers and the person with dementia and the impact and cost of managing
these problems.
This is one study in a group of studies known as EVIDEM-C which has the ultimate goal of developing
and field testing an evidence-based resource for the promotion of continence and management of
urinary and faecal incontinence with people with dementia, close carers, community nurses, social care
workers and home care staff. In addition data from this study will assist in the planning of future studies
which test interventions to help manage incontinence. EVIDEM-C is a part of the NIHR funded programme
of research ‘Changing practice in dementia care in the community: developing and testing evidence-based
interventions, from timely diagnosis to end of life’. The chief investigator is Professor Steve Iliffe, University
College London.
Background and rationale
Dementia affects over 4% of the people over 60, increasing to 13% for those over the age of 80 in
Western Europe with significant projected increases in the next 20 years.345 Dementia has enormous
impact not only for the individual and their family but also for the health and social care system.119,296,346
The median length of time from diagnosis to death is 10 years for those under 65 at diagnosis and 4 years
for those over 80 years.173 The clinical syndrome of dementia has a trajectory of progressive deterioration
in cognition, abilities, and physical functioning. The impairment experienced by the individual is often
compounded by extrinsic factors such as attitudes of ‘therapeutic nihilism’115 in professionals, unadapted
environments, and social exclusion. As the condition progresses problems may arise in maintaining
independence in going to the toilet, in avoiding constipation, and in managing incontinence problems that
cannot be resolved. In addition, there can be behavioural and psychological problems such as disinhibition,
apathy, and faecal smearing. Estimates suggest that there are 500,000 people with dementia in England
and two-thirds live at home.119
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Incontinence is the involuntary leakage of urine or stool or both.347,349 The prevalence of any type of urinary
incontinence in all older adults is between 6% and 10%, with increasing rates associated with old age.349
It is estimated that 2–5% of adults experience faecal incontinence. Incontinence lowers quality of life and
impacts negatively on mental health351,352 as well as creates significant practical and financial problems.
There is evidence that incontinence contributes significantly to other major health issues for older people
such as falls.353 Incontinence has been identified by professionals and older people as an issue of unmet
need in primary care.354,355,381
A UK population-based study of 15,000 home-dwelling people aged over 75 identified that 18.3% had
cognitive impairment and of these 31% had urinary incontinence problems.135 A national general practice
audit of 999 older patients with faecal incontinence identified that 27% had a diagnosis of dementia.367
Evidence on prevalence of problems is invariably provided at a single time point. However, for a
progressive degenerative disorder such as the dementia syndromes the experience from the affected
person and their family is one of ongoing changes and adaptations. There are no studies that describe
changes over time. As a consequence there are no data on the changes over time in continence status and
associated issues to aid in service planning for the support of incontinence management or estimating cost
consequences for households or primary care organisations.
Incontinence problems have been identified as a significant factor in increasing informal carer burden and
triggering the admission of people with dementias to care homes.110,134 There is little literature that
explores the nature and impact of managing bladder and bowel problems in people with dementia at
home by informal carers. Two small scale qualitative investigations into informal carers views (total n= 12)
on managing frail spouses’ incontinence359,360 suggested that individual problem solving strategies might
contribute further to carer stress through decreasing their outside social contact. There is an absence of
information that identifies both those aspects of incontinence problems and also the carer and service
contexts that contribute to the admission to care homes. Anecdotal evidence suggests that faecal
incontinence is the tipping point as far as carers are concerned whether they are able to continue
supporting the person with dementia.361 Evidence from care home settings suggest that formal carers had
difficulty interpreting what the person with dementia wanted and therefore how best to manage their
continence e.g. repeated requests to be taken to the toilet and refusal of medication to ease constipation.362
Assisting older people to remain in their own homes, improving continence care and addressing carer
burden are priorities for the health and social care improvement and service frameworks (DOH 1998,363
2000,365 2001364). People with dementia receive services from both generalist primary care services and
specialist mental health care of older people. They may also receive support from social workers (generalist
or specialist) and publicly funded social care assistance. Incontinence is a clinical issue that often has low
priority in generalist primary care services and specialist mental health care services. Specialist continence
services are not currently available in all areas of the UK.367 Evidence-based practice guidance is not
currently available to assist professionals and staff in generalist services in their support of people with
dementia living at home and their carers.
Professional knowledge and public awareness is increasing the availability of an evidence base in treatment
and best practice.121,380,383 However, people with memory problems and dementia living at home are one
group for whom there is little guidance on promoting continence or managing incontinence. Continence
research and evidence-based guidance either explicitly excludes people with dementia (see for example
National Institute of Clinical Excellence 2006)122 or more commonly includes only those people living
in care home settings (see for example Ostaszkiewicz et al. 2004).369 A recent review of a sample of
English Primary Care Trust continence assessment and management policies for primary care nurses162
demonstrated that little guidance was available for this group of patients beyond offering a general leaflet
(Continence Foundation undated). Evidence-based guidelines produced in 1998 for primary care staff on
supporting people with dementia and their carers did not address incontinence management.123 The recent
NICE–SCIE guideline on supporting people with dementia and their carers124 does not review evidence in
relation to continence promotion but offers the view that combined interventions are more likely to
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support and maintain independence in the person with dementia. International experts in incontinence
have reviewed the research evidence concerned with frail elderly people and concluded that there is a
paucity of research that specifically consider frail elderly people, including those with cognitive impairment.
They recommended that further research is required that considers the prevalence and natural history of
urinary incontinence and faecal incontinence, the management and cost consequences.384
Our earlier study interviewing people with dementia, family carers and health and social care professionals as
to effective continence management strategies385 suggested a number of social and contextual factors that
may be significant in the experience over time. These factors include access to health and social care services,
access to finance to pay for additional continence aids, the gender of the family carer in relation to the
gender of the person with dementia as well as the type of relationships e.g. spousal or child. Some of these
factors reflect the broader literature on the nature and impact of informal care giving.56,386–390
Our review of evidence391 has found no studies that explore the experience or impact of managing
toileting and incontinence problems in people with dementia living at home and their family carers over
time. This study aims to investigate aspects of these questions specifically in a community-dwelling sample
of people with dementia and their family carers.
Study aim and research approach
This study aims to prospectively investigate and describe the experience of people with memory loss and
continence problems living at home and their family carers over a time period of up to 3 years. The
purpose is to inform the development of an education resource, inform the planning of future intervention
studies and inform the commissioning and provision of services for people with dementia and their carers
at home. The research questions it addresses are:
l What types of continence promotion problems and incontinence problems are experienced by people
with memory loss and dementia living at home over time?
l What is the range of continence promotion and incontinence management strategies?
l Which strategies are viewed as most effective?
l What is the impact and cost consequences of incontinence management for the individuals, their carers
and services supporting them? In particular what is the lived experience of managing intimate care
involving excreta and what factors influences the ability of the family carer(s) to offer care in these
circumstances or decide that alternative caring options must be found?
l What is the sequence of continence related events that contribute to decisions to seek residential
placement for the person with dementia?
The overall EVIDEM-C study draws on the Medical Research Council56,392 Framework for developing
complex interventions in using stepwise phases. The study has a number of linked phases commencing
with an integrative review of the literature,367 which is currently in progress. The research approach is one
of critical realism369 which allows an integration of both subjective and objective research approaches
and makes explicit the interrelationships between context, process, interventions (mechanisms) and
outcomes.370 In taking this approach, the multifaceted nature of the issues and problems in promoting
continence and managing incontinence in the home, as well as the perspectives of multiple and diverse
stakeholders can be examined in the light of the evidence of effectiveness. This research approach allows
the study to acknowledge the complexity of the issues.
The EVIDEM research group have assisted in the development of this protocol. This includes:
Professor Steve Iliffe (UCL, primary care)
Dr James Warner (Imperial College, old age psychiatry)
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Professor Claire Goodman (University of Hertfordshire, health services research)
Professor Jill Manthorpe (King’s College London, social work and social care)
Dr Greta Rait (UCL, primary care)
Professor Martin Knapp (LSE, economics)
Dr Mark Griffin (UCL, statistics)
Kalpa Kharicha (UCL, health service research and primary care)
David Lowery (CNWL NHS Trust, research management)
Members of the EVIDEM-C advisory group, which involves service users and carers, have also assisted in
the development of the protocol.
Methods
This is a prospective longitudinal, descriptive study investigating the experience of up to 30 people
with dementia with continence problems, living at home and their carers through qualitative serial
interviews.175,393 The use of qualitative, serial interviews allows the in-depth exploration of the patient
with dementia and the family carer experience as it changes over time rather than as a snapshot at
one point in time. The relationship and trust between the participant(s) and researcher builds over time,
allowing the time for sensitive or complex information to be disclosed in depth. Serial qualitative
interviewing yields a detailed and contextualised account of the experience of change and decline in
chronic illness, relationships between the cared for and the family carers as they develop strategies to
manage distressing and stigmatising symptoms and the response and impact of health and social care
services and professionals as the disease progresses and the symptoms change. Longitudinal qualitative
studies allow for the exploration of transitions, adaptations and trajectories.394
The study will be through face-to-face and telephone interviews, repeated at 4-monthly intervals. The
initial interview and those at yearly intervals will gather data that characterises the participants using
validated tools. At the first interviews carers will be asked to provide retrospective information for the
preceding year.
The sample and recruitment
Sample size in qualitative longitudinal research is influenced by the research questions, the population
under consideration, the theoretical framing and available resources.395,396 Examples can be found of
studies with samples of 12 or less397 to those with cohorts of 500.398 The Department of Health funded
Bangor Longitudinal study of ageing included a qualitative study of a sub set of 30 people visited
2–4 times a year over 3 years.399 The sample size in this study has been based on a number of factors.
These are (a) the theoretical framing and findings revealed in the earlier study (referred to above), (b) the
resources and timescales of the broader EVIDEM-C study and c) experience of the difficulties of trying to
recruit participants, who are often already burdened by coping with their day-to-day lives, to a study
investigating sensitive, embarrassing and often felt to be stigmatising aspects of their condition.
The aim is to have a sample of up to 30 men and women with dementia and continence problems living
at home and their family carers to try and capture diversity in dementia conditions, socio-demographic
characteristics, and health and social care service contexts. The sample is intended to be purposive, with a
sampling framework informed by theory and earlier research findings, to ensure the greatest diversity in
experience. The sample is intended to be selected to include both men and women, people in a range of
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age bands (age 65–74, 75–84, 85 and over), people from majority and minority ethnic groups, people
from a range of socio-economic circumstances (i.e. those on income support and those not) and from a
range of service and contextual factors (from deprived inner city areas to wealthier suburban areas). The
experience to date is that the sample is one of convenience in that it includes those that volunteer rather
than those selected for specific characteristics. In the sample recruited to date (August 2010) there are
male and female participants with dementia, in age bands 75–84, and 85 and over, from majority and
minority ethnic groups, people from a range of socio-economic circumstances (i.e. those on income
support and those not) and from a range of service and contextual factors (from deprived inner city areas
to wealthier suburban areas). Participants are living alone, living with spouses and living with daughters as
their main family carers.
Inclusion criteria
The person has mild to moderate memory problems and cognition problems (not all people have formal
dementia diagnosis) and problems with managing the toilet, remaining continent or incontinence problems.
The person and/or their carer are able to communicate in English.
Exclusion criteria
Neither the person nor their carer can communicate in English.
Recruitment
People with dementia (up to 30 people) and their carers living at home, will be recruited through the
following multiple routes:
l through initial approaches from their general practice (in the London PCTs of Westminster, Kensington
& Chelsea, Brent and Harrow, Hounslow, Hillingdon, Hammersmith and Fulham)
l through initial approaches from their specialist secondary services in Central and North West London
NHS Trust older people services e.g. memory clinics, and community mental health teams and services
such as Admiral Nurses
l through the individuals volunteering, having seen the wider EVIDEM publicity or joined the wider
EVIDEM cohort of people willing to consider involvement in community-based research studies and the
North Thames DemReg
l through specialist dementia social care services such as Housing 21 in North West London
l through advertisements and contacts in local Alzheimer’s Associations, Age Concern and Carer groups
in North London.
The clinical support officers from the Greater London Primary Care Research Network and the North
Thames Dementias & Neurodegenerative Diseases Research Network will assist in general practice and in
secondary care services in identifying patients with dementia and continence problems to be approached.
Individuals will either be asked in the first instance by their clinician at the end of a consultation whether
they would be willing to be approached to learn more about the study or their clinician will write to them
asking whether they are willing to be approached to learn more about the study.
It is anticipated that people with dementia likely to be willing to participate would be at the mild to
moderate stage of the disease progression. Those individuals willing to participate will make contact with
the researcher who will send them the participant information leaflet and arrange a time to meet. At the
meeting the research will be explained and consent sought to participate (see section on detailed ethical
considerations and mental capacity).
After the first interview, the family carer will be asked if they would be willing to be interviewed again in
4 months time to discuss their experience in the intervening period. If they decline then they will be asked
if they are willing to continue in the study by brief telephone contact at 4 and 8 months, followed by
being asked to undertake a full interview at 12 months, repeated the following year. Participants are able
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to decline and drop out of the study at any point without needing to give a reason. Those happy to
continue in the qualitative element will be interviewed at 4 and 8 and 12 months of each year they are in
the study. After the first interview, the interview can be with the carer alone if the person with dementia
decides not to continue or their condition is such that their communication abilities preclude an interview.
If an individual moves to a care home then a final interview will be undertaken with the carer and if
appropriate, consent sought for a final interview with the affected person.
The data collection and tools
The interviewer will proceed with the interview in conversational ways rather than as a checklist set of
questions which are more likely to distress people with dementia. If the interview is proving too long
for the individual, the interviewer will arrange, with permission, to return at another time to compete
the interview.
Data collection for the person with dementia and as appropriate their carer will include:
l demographic data
l medical information, including current other medical conditions, number of births for women, weight
and medications
l characterisation of their mental condition and levels of ability (Mini-Mental State Examination,52
Disability Assessment for Dementia,176 Neuropsychiatric Inventory Questionnaire,62 Cornell Scale for
depression in dementia220)
l characterisation of their continence promotion activities and incontinence problems (ICIQ short form
ICIQ-Noctururia,177 additional questions regarding bowel symptoms and management)
l characterisation of their home and its adaptation to any impairments (adapted Home Environment
Assessment Protocol400)
l characterisation of their quality of Life (DEMQOL, Smith et al. 2005)86
l characterisation of service use and cost consequences (Client Service Receipt Inventory part 1).401
Data collection for the qualitative element with the person with dementia descriptive will be by guided
conversation as to any views on what helps in dealing with continence problems.
For the carer alone:
l demographic data
l characterisation of their level of support to their family member, service use and cost consequences
(Client Service Receipt Inventory part 2, Howard et al. 2007)401
l characterisation of the impact of caring and their quality of life, (caregivers burden scale,402
health-related quality of life EQ-5D, EuroQol 2008)
l perceptions of the effectiveness of strategies that are most helpful with current problems.
The qualitative element included at the annual and 4-monthly interviews will be undertaken using an aide
memoire. This will cover the following topics, explored through open ended, semi-structured questions.
l The experience of living with someone with toileting problems and incontinence due to dementia.
l The experiencing of developing strategies in managing the current toileting problems and incontinence
problems, including sources of information, advice and practical help.
l The experience of developing a caring role in providing intimate care that involves managing excreta.
l Any critical or significant events related to incontinence that have occurred since the last interview and
the impact of those events e.g. hospital admission.
l The extent to which providing intimate care involving excreta influences their view of their ability to
continue in a caring role or whether alternatives are being sought.
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Data analysis
Descriptive techniques will be used to characterise the participants, summarising information collected
through the validated tools.
The analysis of longitudinal qualitative data requires specific techniques to ensure that the temporal nature
at the individual and group level is captured.403 This analysis will be based on methods suggested by
Pettigrew (1990)394 Saldana (2003)396 and Lewis (2005)404 and previous experience as part of a NIHR Service
Delivery and Organisation study of older adults experience of nurse case management overtime.405 Data
will be entered onto the NVivo™ software package and the organisation of the cases and multiple
interviews undertaken as recommended by Saldana (2003).396 In addition a schematic representation of the
individual case narrative overtime will be prepared as recommended by Pettigrew (1990)394 and Lewis
(2005)404 and undertaken in a previous study.405 The analysis will be undertaken at five different levels as
described by Lewis (2005)404 and framed by the research questions above:
l Individual case narratives to capture the trajectory over time, i.e. the course of events, the adaptations,
transitions as well any re-interpretations of events and decisions over time.
l Cross-sectional analysis between cases at specific time points.
l Identification of themes using the constant comparative method406 and analysis of linkages between
themes and participant characteristics over time.
l Cross-case comparisons of narratives and themes.
l Between-group comparisons for example by sub groups defined by gender.
Final interpretations will address the research questions as well as generalise the findings at a
theoretical level.
Ethical considerations
The research questions under consideration are directly relevant to people who have dementia and it is
important to incorporate views of those people experiencing the problems not just the professional views
or their family members.382 People who have dementia may lack capacity to consent. Only those people
with dementia with the capacity to make the decision to participate in the research will be included at the
first point. The procedure for establishing the ability to make the decision will proceed in accordance with
the guidance for the Mental Capacity Act 2005. People with dementia will only be approached after their
close family carer or a professional who knows them well enough to judge their ability to consent to
participation in the study, has discussed the research first and asked whether they would be willing to
meet the researcher. This person will explain about the research and the exploratory discussion process
using the information leaflet which has been adapted to provide key points in straight forward language.
After consent to approach the person has been gained, the researcher will arrange to meet them with
their carer or supporting person of their choice. She will repeat the explanations, using the leaflet and
check the person is able to consent at that point in time. Key elements in checking will be: whether the
person has general understanding of what they are consenting to and why they are being asked to make
it, whether the person understands what will happen if they agree to participate in the study, whether
they are they able to understand the verbal and/or written information relevant to making a decision
whether to participate in the study. A consent form for signing will be offered, although if the informant is
unwilling to sign (writing may be difficult) this will not be pursued and verbal consent will be noted. Any
sign (verbally or in body language) that the individual is not happy about taking part or continuing to take
part in the research will be interpreted as withholding consent, or a desire to withdraw. The research will
end the conversation, thanking the person for their time and involvement. The researcher will check
throughout the discussion that the informant is willing to continue and cease if the person indicates they
wish the discussion to end.
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As this is a study over time the consent process will be repeated before each subsequent contact. Consent
will be at subsequent contacts over the 3 years, the person with dementia may have lost the capacity to
make a decision to consent, i.e. understand information about the decision to be made, retain that
information in their mind, use or weigh that information as part of the decision-making process, or
communicate their decision (by talking, using sign language or any other means). In these instances the
researcher will consult the family carer (the consultee) in accordance with the code of practice of the
Mental Capacity Act 2005 whether the person would want to take part in this further stage of the
research. With their agreement in writing, the interviewer would continue. However, the interviewer would
stop at any sign that the person wishes to withdraw, as described as above. The interviews in this study
offer minimal risk to the person and minimal intrusion (see next paragraph) or interference to their rights.
Urinary or faecal incontinence are distressing symptoms that are embarrassing to discuss for any adult.
Undertaking intimate care associated with incontinence for an adult spouse, relative or loved one is a
sensitive issue. All interviews will be conducted by researchers aware of the potential socially problematic
nature of the issues that are being discussed. Interviewers will use language understandable and
acceptable to the interviewee and make all efforts to lessen any discomfort in discussing the issues. Should
an individual become distressed then the interviewer will pause, be sympathetic, and check whether the
person wishes to discontinue the interview. The researcher will encourage informants to share their
problems and distress with their key health professional, or family doctor as appropriate. All researchers
will have contact information on key support agencies to leave with informants.
All informants will be assured of anonymity and confidentiality in the transcription, analysis and reporting
of their interview. Any direct quotations used in the report will be non-attributable.
Informants will be made aware that if any information is shared that suggests that a vulnerable older adult
is suffering neglect or abuse then the researcher has a responsibility to share that information with the
service manager (in case of abuse or neglect from a service provider) or in the case of individuals gain their
consent to share that information with the named Local Authority Officer for vulnerable adults.
Data protection considerations
All participants will be assigned a code number and this with their contact details will be kept separately
and securely from any data collected in the process of the research. All research data will be identifiable by
code number alone. The interview data will be entered and stored on a password protected computer,
accessible only to the researchers in locked offices of the University. Hard copies of data will be stored in
locked filing cabinets in the same offices. Research data will be archived for 5 years and then destroyed.
Timescale
Recruitment will commence in October 2008 and end in December 2010.
Data analysis will be ongoing and completed by January 2012.
A final report will be made in 2012.
Reports and dissemination
The findings will be written up as a brief report for circulation to participants. The full report will be used
as the basis for papers and articles to be submitted to a professional journal and local and national
voluntary organisation’s newsletters. An abstract will be submitted for presentation at a service users and
professional conference, such as Dementia Congress.
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Appendix 21 Chapter 3: Protocol – incidence and
management of incontinence in general practice
patients with dementia: an analysis of THIN data, 2011
Incontinence problems have been identified as a significant factor in increasing carer ‘burden’ andtriggering the entry of people with dementias to care homes.110,134,356 Supporting people with dementia
to live at home is a major policy objective. There are currently no primary care-based data available in the
UK or elsewhere to provide clinicians or commissioners services with data on the incidence and current
management of people with dementia living at home who also have problems with urinary and/or faecal
incontinence. This protocol addresses this absence of data through an analysis of general practice records
held in the THIN database.
Background
Dementia affects over 4% of the people over 60, increasing to 13% for those over the age of 80 in
Western Europe with significant projected increases in the next 20 years.345 Dementia has enormous
impact not only for the individual and their family but also for the health and social care system.119,296,346
The median length of time from diagnosis to death is 10 years for those under 65 at diagnosis and 4 years
for those over 80 years.173 The clinical syndrome of dementia has a trajectory of progressive deterioration
in cognition, abilities, and physical functioning. The impairment experienced by the individual is often
compounded by extrinsic factors such as attitudes of ‘therapeutic nihilism’115 in professionals, un-adapted
environments, and social exclusion. As the condition progresses problems may arise in maintaining
independence in going to the toilet, in avoiding constipation, and in managing incontinence problems
that cannot be resolved. Estimates suggest that there are 500,000 people with dementia in England and
two-thirds live at home.119
Incontinence is the involuntary leakage of urine or stool or both.347,349 The prevalence of any type of urinary
incontinence in all older adults is between 6% and 10%, with increasing rates associated with old age.349
It is estimated that 2–5% of adults experience faecal incontinence. Incontinence lowers quality of life and
impacts negatively on mental health351,352 as well as creates significant practical and financial problems.
There is evidence that incontinence contributes significantly to other major health issues for older people
such as falls.353 Incontinence has been identified by professionals and older people as an issue of unmet
need in primary care.354,355,381
There are no population surveys that identify the incidence of people with dementia and continence
problems living at home. However, there are some indications that they may be a substantial minority.
A UK population-based study of 15,000 home-dwelling people aged over 75 identified that 18.3% had
cognitive impairment and of these 31% had urinary incontinence problems.135 A national general practice
audit of 999 older patients with faecal incontinence identified that 27% had a diagnosis of dementia.367
There are some indications that people with dementia and incontinence symptoms are not investigated
and managed proactively.407
There are currently no primary care-based data available in the UK or elsewhere to provide clinicians or
commissioners services with data on incidence and the characteristics of people with dementia living at
home who also have problems with urinary and/or faecal incontinence.
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The experience of people with dementia and their family carers interviewed in a related ongoing study
by the authors suggests that:
l Like the general population408 most delay consulting general practice or any health professional about
incontinence problems as they feel embarrassed and humiliated.
l Family members report avoiding talking to their general practitioner about these issues as they seek to
protect the person with dementia’s dignity and public persona.354 However, as the dementia progresses
this becomes unsustainable and the family carers insist on seeking help in order to cope with the wider
burden of supporting their family member. This is sometimes reported as part of a crisis situation in
which hospitalisation or temporary residence in a care home occurs.
l Family carers report a variety of responses from general practice when they do seek help: some indicate
they get little assessment or help other than the referral for continence pads, others indicate a more
detailed investigative approach to identify or discount possible treatable causes of these symptoms,
such as urinary tract infections or prostate hypertrophy problems, and then more active management
of the problems.
Purpose
This cohort study will describe current practice in continence care for people with dementia, and quantify
the burden of disease. It will also examine whether this differs with demographics or health status, or
between general practices in ways not explained by patient characteristics.
Hypotheses
The background described above suggests a number of hypotheses:
1. The general practice reported incidence of incontinence problems is higher in the dementia population
than in the general population of similar age registered with a GP. This relationship may be confounded
by other factors such as age or mobility.
2. The general practice response to people with dementia consulting for incontinence problems, compared
to people of similar demographics without dementia, is more likely to be prescription of continence
pads, and less likely to be investigation and referral for tractable problems, including surgery, or it may
take longer to get referred.
Research questions
1. What is the incidence rate of urinary and/or faecal incontinence, stratified by age and sex, recorded in
general practice patients aged over 60:
a. overall
b. with a diagnosis of dementia and
c. without a diagnosis of dementia?
Which covariates affect this relationship (co-morbidity, restricted mobility, Townsend deprivation score)?
2. What is the incidence of recorded treatments, management and referrals made for incontinence in
patients with and without dementia, stratified by sex and age?
Which covariates affect this relationship (polypharmacy, restricted mobility, Townsend
deprivation score)?
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Methods
Study design
A cohort study
Data source
Data will be taken from THIN (URL: http://www.epic-uk.org/thin.htm) covering general practices in the
United Kingdom (UK) providing data during the period 1 January 2000 – 31 December 2009. This
electronic recording scheme is one of the largest UK sources of continuous primary care data on patients’
consultations and prescribing data. It has been widely used for epidemiological studies, including a study
of dementia and survival.13 Anonymised patient data are pre-collected from participating practices.
Practices are broadly representative of UK general practices in terms of patients’ age and sex, practice size
and geographical distribution. GPs enter medical diagnoses and symptoms using Read codes, a hierarchical
recording system used to record clinical summary information. The age, sex, medical diagnosis and
symptom records, health promotion activity, referrals to secondary care, prescriptions and quintiles of
Townsend deprivation score are recorded for each registered individual.
Inclusion/exclusion criteria
In order to examine the incidence of incontinence (research question 1) we will first identify an ‘exposed
cohort’ of individuals aged 60 or above with data available for at least 6 months between 1 January 2000
and 31 December 2009. Any patients with Read codes indicating learning disabilities and specifically
Down’s syndrome will be excluded as this is a known risk factor for both dementia and incontinence.
Based on the overall age and gender distribution in this cohort we will identify a comparison ‘unexposed
cohort’ stratified by age, sex and practice, by randomly selecting from patients over the age of 60 without
a record of dementia.
For all research questions, data will be taken from each practice after they have achieved an acceptable
level of data quality as defined by the Acceptable Mortality Rate (AMR) date.409 We will use established
methods to identify and exclude likely prevalent cases of incontinence or dementia recorded within
120 days of registration. This cut-off has been established by analysing THIN using the method of
Lewis et al., specifically for incontinence and dementia.403 Pre-existing incontinence and/or dementia will
be identified from any time point in the patient’s data, except for ‘incontinence’ codes prior to age 16.
Study variables
Dementia and incontinence will be identified from Read codes and drug codes, excluding single isolated
drug codes and any codes flagged on THIN as having errors. Learning disabilities, Down’s syndrome and
restricted mobility will similarly be identified from Read codes. Lists of Read codes have been developed in
order to identify patients with these conditions. Codes were identified by searching the code dictionary for
relevant terms (e.g. continen*, faecal, urin*, dement*, alzheimer*, memor*), then adjacent codes were
examined and searches run on other keywords which are suggested by the dictionary definitions. This
process has been used on a number of studies using THIN data.410 Drug/device codes were identified in the
same way. All these lists were checked by two clinicians for relevance and completeness.
The first date against a code for dementia, incontinence and restricted mobility will be stored, allowing
dementia and mobility to be modelled as time-varying predictors. The first date of each of various types of
treatment/referral for incontinence will also be stored for use in research question 2.
We will use drugs prescribed as a proxy index for co-morbidity, calculated from the therapy records by
counting the number of distinct BNF sections prescribed within the 6 months preceding the first
incontinence code. For those without incontinence, a random date will be selected within their time at risk
(uniformly distributed) and 6 months of prescriptions taken prior to that point. These calculations will apply
to both exposed and unexposed cohorts.
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
381
Year of birth and sex will be extracted from the patient data files. Townsend deprivation scores
(in quintiles) will be extracted from the postcode variable information (PVI) file for each practice.
Other variables to be extracted include:
l practice and patient ID
l indicator variables for the presence of dementia, incontinence (including pre-existing codes), and
different types of treatments or referrals
l the AMR date for the practice
l year of birth, registration date, transfer date and death date.
Analysis
For research question 1 (incidence of incontinence in dementia compared to no dementia), incidence rates
will be derived for incontinence in people with and without pre-existing dementia, and stratified by age,
gender and deprivation. Epidemiological calculations of rate ratios will be used for the stratified analysis.
Continuous covariates and inter-practice variation will be accounted for in a multilevel Poisson regression
model. Incontinence will be the outcome, dementia the exposure, potential covariates are age, sex,
deprivation, polypharmacy, and calendar period, and in a Poisson model time at risk will be an offset
variable. This will allow us to find the adjusted relationships between dementia and incontinence and to
consider whether the covariates interact (are effect modifiers) with dementia. We will account for variation
between practices by modelling this as a random effect in the Poisson regression. Results will be compared
with published statistics that are representative of current practice.116
For research question 2 (access to, and timeliness of, treatment for incontinence in dementia compared
to no dementia), another multilevel regression model will be constructed with treatment options for
incontinence as the outcomes, dementia as the exposure, and covariates defined as for question 1. A
multilevel Poisson regression will be used and the offset and random effect will be defined as above. This
will allow us to quantify any differences in access to treatment between those with and without dementia.
Limitations
The data are limited to consultations recorded in general practice and there may be differences in coding
by different GPs, which we will investigate where possible. Because the data are drawn from GP
consultations, there could be a Berkson’s bias inflating associations between morbidities. This will be
minimised by looking over long time periods and measuring the time to first recording (incidence) of a
diagnosis or treatment.411 We also know that people with continence problems can delay seeking help,
sometimes by years, so there may be a bias toward earlier recording of incident incontinence in patients
with dementia. We will cross-check diagnostic codes against prescriptions and free-text comments for
under-recording or delayed recording of diagnoses.
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Appendix 22 Chapter 3: Protocol – investigating
the acceptability, effectiveness and associated costs
of different types of absorbent products used for
incontinence by people with memory problems living
at home, 2010
Aim
The aim of this study is:
(a) to investigate the feasibility of the research methods to ascertain the acceptability, effectiveness and
associated costs of different types of absorbent products used for incontinence by people with memory
problems living at home
(b) to provide preliminary data on the acceptability, effectiveness and associated costs of different types of
absorbent products used for incontinence by people with memory problems living at home to inform
both future research design and also service providers.
Background and rationale
Urinary or faecal incontinence are distressing symptoms for any adult. Incontinence lowers quality of life
and impacts negatively on mental health351,352 as well as creates significant practical and financial problems.
Incontinence can lead to social embarrassment, restriction of leisure activity, creation of extra laundry and
replacement costs for clothing and bedding, and it can be a source of conflict between individuals and
their family (Continence Foundation, undated).
There is no firm evidence of the numbers of people with memory problems living at home who have
continence problems. Evidence suggests that up to a third of people with memory problems and dementia
living at home experience incontinence problems.135,381 Dementia affects over 4% of the people over 60,
increasing to 13% for those over the age of 80 in Western Europe with significant projected increases in
the next 20 years.345 Dementia has enormous impact not only for the individual and their family but also
for the health and social care system.119,296,346 The clinical syndrome of dementia has a trajectory of
progressive deterioration in cognition, abilities, and physical functioning. As the condition progresses
problems may arise in maintaining independence in going to the toilet, in avoiding constipation, and in
managing incontinence problems that cannot be resolved. In addition, there can be behavioural and
psychological problems such as disinhibition, apathy and faecal smearing.114 Estimates suggest that there
are 500,000 people with dementia in England, two-thirds of whom live at home.119 Incontinence is known
to be a significant factor in the decision for people with memory problems and dementias to take up
residence in a care home.110,134,359 There is an absence of information exploring incontinence problems
combined with the carer and service contexts that contribute to the admission to care homes.
Incontinence is the involuntary leakage of urine or stool or both.347,349 There are a number of internationally
agreed algorithms for the assessing and treating incontinence symptoms, with the term ‘functional’
incontinence used to describe that which has no physiological basis.348 UK surveys suggest that even though
individuals find their urinary symptoms bothersome and socially disabling, some older people consider them
as an inevitable part of ageing and too humiliating to seek help,166 while others view the treatments as
cumbersome and too invasive.412 There is also evidence that health professionals have a nihilistic view of
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incontinence in older adults, thinking that nothing can be done, and rather than thorough assessment
and treatment of the underlying causes they resort to provision of containment devices e.g. pads,
as the first option.407 The International Continence Society suggests that for frail, elderly people (which
include people with moderate to severe dementia) the aim of professional input may be to have well
contained incontinence.117
There are no UK estimates of the total public expenditure associated with treating or managing
incontinence. There are some indications of the scale of the direct expenditure. It was estimated that the
NHS spent £536 million at 1999/2000 prices in treating clinically significant urinary incontinence symptoms
in community-dwelling adults.354 In 2007 nearly 1.5 million NHS prescriptions were filled for incontinence
appliances in England at a cost of £33 million.413 Absorbent incontinence products account for the majority
of this spending.181 They come in a wide range of designs and absorbencies (see table below). Reviews of
NHS provision of continence services357,365,382 have suggested that:
l There are significant geographical variations in eligibility criteria to receive NHS continence services, in
access to specialist continence services, and in the range and quantities of treatment provided in
primary and secondary care.
l In addition, a national survey found variations, inflexibility, and arbitrary ceilings on the NHS provision
of continence aids e.g. disposable and washable pads, and bed pads.414
Our recent research involving interviewing people with dementia living at home, their family carers and
health and social care staff closely supporting them162 suggested that:
(a) Carers and people with dementia often stated preferences for certain types of continence pad designs;
this was often but not always for ‘pull-up’ pants.
(b) Preferences might be affected by: different degrees of incapacity, different types of behavioural
problems and ease of use at night or during the day in the home or ease of use outside the home.
(c) Ineffective containment pads increased the financial costs and stress of supporting someone with these
problems at home.
There are only currently studies looking at absorbent incontinence products and preferences, ease of use
and effectiveness with people living at home who do not have dementias.169 The following chart indicates
the range of products available.
Types of absorbent pad designs
Designs of body-worn
containment pads
Used for which type
of incontinence Design details
Inserts Light/moderate/heavy Disposable inserts for light incontinence often held in place in
underwear by an adhesive strip
Other types held in place by close fitting underwear or stretch
mesh briefs
Sometimes have wetness indicator to signal the need for a
pad change
Sometimes have elasticised gathers of hydrophobic material
which are intended to impede lateral leakage
Nappies Moderate/heavy Adult-sized versions of babies’ nappies (nappies)
Disposable nappies usually have elasticated waist and legs and
self-adhesive tabs (usually resealable), and often a wetness
indicator and standing gathers
Washable nappies are fixed with Velcro or press-studs and
usually elasticated at the waist and legs
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Designs of body-worn
containment pads
Used for which type
of incontinence Design details
T-shaped nappies Moderate/heavy To enable users to apply the nappy while the person is standing
Fastens round the waist before the pad is pulled through
between the legs into position and secured
Pull-up disposable pants Moderate/heavy Similar in construction to trainer pants for toddlers
Those for light incontinence are often know as pants with
integral pad
Menstrual pads (W)
(disposable only)
Light Have an adhesive strip to adhere to underpants
Leafs (M) and pouches (M) Light Leafs designed to fit over the penis, pouches designed to fit over
the scrotum also
Worn with close-fitting underwear or stretch mesh briefs
Disposables have an adhesive strip to adhere to underpants
(W) and (M) denote products specifically designed for women and men, respectively.
All designs have disposable and washable variants.
Research questions
1. Do the research questionnaires capture all aspects of the acceptability, effectiveness, and associated
costs of different types of absorbent products used for incontinence by people with memory problems
living at home?
2. Is there evidence from this pilot study of the extent to which different types of absorbent products used
for incontinence by people with memory problems living at home are acceptable, and effective in
dealing with different types of continence in different social situations?
3. Are people with memory problems, their family carers and/or their paid carers willing to participate in
this type of research and try different types of absorbent incontinence products?
4. Is it feasible to ask people with memory problems, their family carers and/or paid carers to collect this
amount of data?
Method
This pilot study design is informed by the Medical Research Council recommendations for assessing
feasibility in developing and testing complex interventions.56 The design aims to examine key uncertainties
as outlined in the questions above and may be refined for future studies. This is a pilot study using
primarily quantitative methods but also capturing participants’ views with qualitative methods.
We aim to recruit up to 40 family carers of people with memory problems living at home and using
absorbent incontinence products. We also aim to recruit the person with memory problems if they have
capacity to consent. We aim for the sample to have a wide variation of demographic characteristics,
co-morbidities and health status as a result of recruiting through a NHS continence services and voluntary
organisations across London. Interested NHS continence services will be identified through presentations at
the London Association of Continence Advisors and then permissions sought with the employing NHS
organisation as required under NHS research governance requirements.
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The sample
The sample will be a purposive sample of up to 40 family carers, who are supporting their family member
in managing continence problems with absorbent pads. In addition those people with memory problems
who have capacity to consent will be recruited. The purposive sample will include family carers of people
with memory problems who have been using pads for different amounts of time and people who had
incontinence problems that pre-dated symptoms of dementia.
Inclusion criteria:
l The person is a family carer who is supporting their family member with memory problems in
managing incontinence with absorbent pads.
l They are able to communicate in English.
l The person using the absorbent pads has capacity to give consent.
Exclusion criteria:
l The family carer cannot communicate in English.
l The person with memory problems does not have capacity to consent.
Recruitment
Participants will be recruited using several approaches as it is anticipated people will be slow to come
forward due to the sensitive nature of the topic. We will ask local (in up to four different areas of London
Strategic Health Authority) community service and primary care staff such as district nurses, continence
nurses and GPs to identify and initially approach family carers of people with dementia living at home
with incontinence and in receipt of absorbent pads from local NHS services. In addition we will place
information in local Alzheimer’s Society branch newsletters and in the Dementia Research Network
Registry (DemReg) asking people to contact us directly who might be interested in participating. Those
individuals willing to participate will make contact with the researchers who will send them the participant
information leaflet and arrange a time to meet them in their home. At the meeting the research will be
explained and consent sought to participate (see below on detailed ethical considerations and
mental capacity).
Data collection
Participants (family carers and people with memory problems) will be seen in their own home and
information collected at two points:
l Time point 1: initial meeting in the person’s home.
l Time point 2: 8–10 days after time point 1 as suits the participant.
Data collection at time point 1
The following data will be collected using these tools. If the person with dementia has consented then the
data will be collected in an interview supported by the family carer. If the person with dementia is unable
to consent then the information will be collected from the family carer alone.
l demographic data about the person with dementia
l medical information about the person with dementia, including current other medical conditions,
weight and medications
l Disability Assessment for Dementia176
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l characterisation of continence promotion activities and incontinence problems (ICIQ short form
ICIQ-Nocturia,177 additional questions regarding bowel symptoms and management)
l characterisation of service receipt and cost consequences (Client Service Receipt Inventory part 1
section C)401
l characterisation of mental condition and levels of ability (Mini-Mental State Examination)52 only used if
the person with dementia is able to consent.
For the family carer alone:
l demographic data about the family carer
l characterisation of the impact of caring and their quality of life (caregivers burden scale)94
l NPI (Neuropsychiatric Inventory).62
The researcher will also:
l introduce the pilot study diaries and recording tools (Pad and leakage diary sheet, and opinion sheet)
to be kept for the next seven days (including for night-time); these have been adapted with permission
from the research tools used by Dr M Fader et al.181 for the NIHR Health Technology funded project.
l enquire whether the family carer would be willing to try pad weighing scales and record the weight
(indicates the volume of contents); for those willing, scales will be left alongside the study diaries.
Data collection at time point 2
The researcher will collect the study diaries and recording sheets. The researcher will also ask about the
acceptability, ease of completion, level of completion and any other relevant views regarding the study
data collection tools (topic guide for evaluation of study research methods).
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Flow chart of the study
Professionals identify and approach 
suitable participants. Those that agree are 
put in touch with the researchers who 
arrange to visit and explain the study in 
more detail and arrange a future contact to 
consent and proceed 
 
Interview: time point 1  
Interview in the home in two parts:  
i) Structured interview measures to 
characterise the person with dementia, the 
family carer, the incontinence, its 
management and the impact  
ii) Introduce the diary sheets and opinion 
sheet, leaving pad weighing scales if 
agreeable  
 
Interview: time point 2  
(between 1 week to 2 weeks’ later, as  
convenient) 
· Collection of diary sheets and opinion 
sheet 
· Semi-structured interviews on views 
about the data collection tools and 
completing them  
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Data analysis
Quantitative data will be managed through SPSS™ and analysed descriptively to address the research
questions. Qualitative data from the second interview will be managed and thematically analysed through
a software system such as NVivo™.
Ethical considerations
There are ethical issues related to capacity to consent, distress, confidentiality and safeguarding
vulnerable adults.
The research questions under consideration are directly relevant to people who have memory problems
and it is important to incorporate views of those people experiencing the problems if possible (Department
of Health 2005).415 People who have memory problems may lack capacity to consent. Only those people
with memory problems with the capacity to make the decision to participate in the research will
be included.
The procedure for establishing the ability to make the decision will proceed in accordance with the
guidance for the Mental Capacity Act 2005. People with memory problems will only be approached after
their close family carer or a professional who knows them well enough to judge their ability to consent to
participation in the study, has discussed the research first and asked whether they would be willing to
meet the researcher. This person will explain about the research and the exploratory discussion process
using the information leaflet which has been adapted to provide key points in straight forward language.
After consent to approach the person has been gained, the researcher will arrange to meet them with
their carer or supporting person of their choice. She will repeat the explanations, using the leaflet and
check the person is able to consent at that point in time. Key elements in checking will be: whether the
person has general understanding of what they are consenting to and why they are being asked to give it,
whether the person understands what will happen if they agree to participate in the study, whether they
are they able to understand the verbal and/or written information relevant to making a decision whether
to participate in the study. A consent form for signing will be offered, although if the informant is
unwilling to sign (writing may be difficult) this will not be pursued and verbal consent will be noted.
Any sign (verbally or in body language) that the individual is not happy about taking part or continuing to
take part in the research will be interpreted as withholding consent, or a desire to withdraw. The research
will end the conversation, thanking the person for their time and involvement. The researcher will check
throughout the discussion that the informant is willing to continue and cease if the person indicates they
wish the discussion to end.
The interviews in this study offer minimal risk to the person and minimal intrusion (see next paragraph) or
interference to their rights. Urinary or faecal incontinence are distressing symptoms that are embarrassing
to discuss for any adult. Undertaking intimate care associated with incontinence for an adult spouse,
relative or loved one is a sensitive issue. All interviews will be conducted by researchers aware of the
potential socially problematic nature of the issues that are being discussed. Interviewers will use language
understandable and acceptable to the interviewee and make all efforts to lessen any discomfort in
discussing the issues. Should an individual become distressed then the interviewer will pause, be
sympathetic, and check whether the person wishes to discontinue the interview. The researcher will
encourage informants to share their problems and distress with their key health professional, or family
doctor as appropriate. All researchers will have information on key support agencies to leave
with informants.
All informants will be assured of anonymity and confidentiality in the transcription, analysis and reporting
of their interview. Any direct quotations used in the report will be non-attributable.
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Informants will be made aware that if any information is shared that suggests that a vulnerable older adult
is suffering neglect or abuse then the researcher has a responsibility to share that information with the
service manager (in case of abuse or neglect from a service provider) or in the case of individuals gain their
consent to share that information with the named Local Authority Officer for adult safeguarding.
Data protection considerations
All participants will be assigned a code number and this with their contact details will be kept separately
and securely from any data collected in the process of the research. All research data will be identifiable by
code number alone. The data will be entered and stored on a password protected computer, accessible
only to the researchers in locked offices of the University. Hard copies of data will be stored in locked filing
cabinets in the same offices. Research data will be archived for 5 years and then destroyed.
Timescale
The timescale for the project is 1 year. Recruitment will commence in June/July 2010 (determined by
ethical review and governance procedures). Our experience to date suggests that recruitment will be slow
for such a sensitive subject and we anticipate that it may take up to 6 months to recruit. A final report will
be written in 2012.
Reports and dissemination
The findings will be written up as a brief report for circulation to participants and in the EVIDEM final
report. Papers and articles to be submitted to a professional journal and local and national voluntary
organisation’s newsletters. An abstract will be submitted for presentation at a service users and
professional conference, such as Dementia Congress.
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Appendix 23 Chapter 3: Protocol – a modified
Delphi consultation to develop a dementia-focused
continence assessment tool for use with people with
dementia living at home, 2010
This protocol describes the process for developing and establishing the face and content validity of theEVIDEM-C continence assessment tool to be used with people with dementia living at home and their
family carers. (NB. It draws on the background from previous protocols and does not repeat it here.)
Background
EVIDEM-C is a research study investigating issues of continence promotion and incontinence management
for people with dementia living at home and their family carers with the ultimate aim of developing
resources to assist those working in primary care. Our earlier studies revealed that:
l people with dementia and their family carers often only sought professional help in toileting and
incontinence problems at points for crisis169
l people with dementia and their family carers often reported difficulties with health professionals
recognising and advising on their problems170
l local NHS continence policies and assessment tools, primarily used by primary care nurses, rarely
directly explored the problems of people with dementia in toileting and incontinence or outlined
appropriate care pathways.162
Aim
The aim is to develop and test the face and content validity of a prototype dementia specific assessment
tool to be used in tandem with locally agreed continence assessment tools.
Method
To undertake a three-stage adapted Delphi consultation.182
Stage one will bring together a group of experts in a facilitated series of group activities to review current
examples of local continence assessment tools and agree the range of principles to be incorporated in a
dementia specific continence assessment tool.
Stage two will consult those in stage one and a wider group of experts by post (or e-mail) on a prototype
dementia specific tool for views on whether it addresses the principles and issues identified in stage one
plus views on any omitted items.
Stage three will undertake a postal consultation of family carers and professional experts to address the
following questions:
l Is this additional assessment tool likely to improve primary care professionals’ recognition of the
toileting and incontinence problems experienced by people with dementia and their family carers?
(face validity)
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l Have all the important items associated with toileting problems and incontinence experienced by
people with dementia and their family carers, been included? And are there any items which are not
important and should not be included? (content validity)
Stage three
The diversity of the sample is important rather than its size to capture the widest variation in views.183
The aim is for at least five participants in each of eight categories as listed described below:
Stage three proposed participants
Expert group No. Route to approach
Family carers 5–10 EVIDEM-C family carer e-network
Voluntary organisations with knowledge and expertise
in bladder and bowel problems and dementia carers
supporting people with dementia
5–10 Members of EVIDEM steering group from these
organisations plus direct approaches to Bladder and
Bowel Foundation
General practitioners 5–10 Identified as either published about an aspect of
dementia or incontinence
Psychogeriatricians 5–10 Identified as having published about an aspect
incontinence
Nurses in the community 5–10 Identified as either published about aspects of
dementia or incontinence. Also through the e-network
of the Queens Nursing Institute
Continence nurse specialists 5–10 Identified through the Association of Continence
Advisors local branches in London and the North West
of England
Community mental health nurses and Admiral Nurses 5–10 Identified through Community Psychiatric Nursing
Association, For Dementia and also publishing on
aspects of care for people with dementia living at
home
Others with specific e.g. occupational therapists, Disable
Living Advice Centres, PromoCon social workers, social
care providers
5–10 EVIDEM–C network of advisers and contacts
Individual experts will be identified through publications in this field, from the advice of the wider EVIDEM
team, the EVIDEM-C advisory group and events held in the host NHS Trust. Each identified person will be
sent the draft assessment tool and a data collection form. Analysis will be by descriptive statistics for the
quantitative elements. Thematic analysis165 of any text received in the comments section.
Ethics
NHS research ethics query service advised that this is not within the domain of the NHS ethics committee.
University requirements will be followed. Anonymity and confidentiality of participants will be kept by the
use of participant identifying numbers. Data will be kept in locked filing cabinets and on password
protected University computers.
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Timescale
Stage one will commence in the Autumn 2010.
Stage two, early Winter 2010.
Stage three, Spring 2011.
Reports and dissemination
The findings will be written up as a brief report for circulation to participants and in the EVIDEM final
report. Papers and articles to be submitted to a professional journal and local and national voluntary
organisation’s newsletters. An abstract will be submitted for presentation at professional conferences.
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Appendix 24 Chapter 3: Adoption by research
networks and research permissions
The EVIDEM-C study was adopted onto the portfolio of the UK Clinical Research Network (UKCRN) andby the associated research networks for primary care and dementia and neurodegenerative diseases.
Individual study elements required permissions from each organisation through which participants were
approached. In addition, application and agreement for payment of NHS support to research costs to GPs
was required for some elements. This is summarised below in Table 105. Most of these processes required
completion of forms specific to that organisation and then correspondence, monitoring returns (from
monthly to completions of data collection to annual) and often reports on study completion. Throughout
the period of the EVIDEM-C study the research governance processes and the organisations responsible for
them repeatedly altered.
TABLE 105 Research network adoption, research governance, NHS service support costs to research and
access permissions
Study
element
Research
network
adoption
UKCRN
Portfolio ID
Body/bodies agreeing research
access permissions
Body/bodies agreeing
NHS service support costs
Qualitative
interviews
study
UKCRN 4938
(EVIDEM-C-1)
West London Mental Health
Research & Development
Consortium
DeNDRoN Brent PCT for 6 North West
London PCTs
Brent PCT for North West
London PCTs
Westminster PCT
NIHR PCRN London Borough of Westminster
Social Care Services
Housing 21
For Dementia
Age Concern (Westminster)
Four local branches of Alzheimer’s
Society
Longitudinal
study
UKCRN 8928
(EVIDEM-C-2)
West London Mental Health
Research & Development
Consortium
PCRN– Greater London as above Brent PCT for 6 North West
London PCTs
Brent PCT for North West
London PCTs
Hounslow PCT
Westminster PCT
London Borough of Westminster
Social Care Services
Housing 21
For Dementia
Age Concern (Westminster)
Four local branches of Alzheimer’s
Society
continued
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TABLE 105 Research network adoption, research governance, NHS service support costs to research and
access permissions (continued )
Study
element
Research
network
adoption
UKCRN
Portfolio ID
Body/bodies agreeing research
access permissions
Body/bodies agreeing
NHS service support costs
Absorbent
pads study
UKCRN 10058
(EVIDEM-C-3)
DeNDRoN as above
PCRN-Greater London as above South East London NHS
Research & Development Centre
South East London NHS
R&D Centre
South West London Primary &
Community Care
South West London Primary
& Community Care
West London Mental Health Trust
CNWL NHS Foundation Trust
Age Concern (Westminster)
Eight local branches of the
Alzheimer’s Society
UKCRN, UK Clinical Research Network.
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Appendix 25 Chapter 3: EVIDEM-CL1 March
2011 – briefing for Local Authority Adult Services
managers and social workers
Meeting the needs of frail and cognitively impaired older people with incontinence in order to maintainindependence and minimise the consequences for the person, their family and health and social
care services.
Prepared by Vari Drennan, Jill Manthorpe and Steve Iliffe.
Background
Incontinence is leakage of urine or faeces or both. It is a symptom of a bladder or bowel problem. The
prevalence of incontinence rises with age, with estimates of up to 15% of older women and 2–11% for
older men experiencing daily urinary incontinence (UI).116 Among people living in care settings the rates are
even higher. The risk of women having UI increases with factors such as having three or more children
(although this diminishes with increasing age), obesity, diabetes and moderate to severe dementia.116
We know less about factors that predispose men to UI but these include urinary tract infections, disability
and cognitive impairment, brain disorders and prostate problems. Among people aged over 60, rates of
faecal incontinence are 5.1% in men and 6.2% in women116 and these increase with age. It can be caused
by problems in the gastrointestinal or nervous systems as well as food intolerances, infections and the
interplay between loss of mobility and cognition.416 For some people with physical and/or cognitive
impairments incontinence is the result of a lack of aids, unadapted environments, or a lack of timely
assistance rather than a bladder or bowel problem.
Incontinence lowers a person’s quality of life and adversely affects mental health.351 It can be socially
embarrassing, restricts social activity, creates extra work, such as laundry, and can mean much money has
to be spent on replacement clothing and bedding. It can cause conflict between individuals and their
family417 and can make caring harder. Other health problems may get even worse, and it can lead to
events such as falls.353
There are no UK estimates of the total public expenditure associated with treating or managing
incontinence. There are some indications of the scale of the direct health service expenditure. It was
estimated that the NHS spent £536 million at 1999/2000 prices in treating clinically significant urinary
incontinence symptoms in community-dwelling adults.418 In 2007 nearly 1.5 million NHS prescriptions
were filled for incontinence appliances in England at a cost of £33 million.413 Absorbent products for
incontinence account for the majority of this spending.181
This briefing highlights the key actions in six areas that Local Authority staff and funded services can take
in helping to promote continence and manage incontinence to minimise the consequences for the service
user, the family carers and the health and social care services. Each action point is elaborated by a brief
explanation and followed by a range of questions raising key points for adult service managers and social
workers to consider.
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Key action points
Assessment before assumptions
In many cases incontinence can be treated and the symptoms stop or lessen but treatment can only start if
the person seeks help, usually from their GP or community nurse, who should conduct a thorough
assessment. Assumptions that these symptoms should just be managed by absorbent products i.e.
incontinence pads, are demoralising for the person and costly to them, their families and any health and
social care services.
Key points for social care: many bowel and bladder problems can be treated
or the consequences reduced
Are care planners and social care staff actively encouraging and helping service users to consult their GP or
community nurse for an assessment if they have these bladder or bowel symptoms or the symptoms
change? Do they encourage family carers to seek help? Is this information available to personal assistants?
Do the local authority and NHS publish information about this? Is this information given to people in
frontline, information, signposting and other community-facing roles? Do social care workers, older people
and families have confidence that these problems are addressed by GPs and not seen as ones where
nothing can be done because of a person’s age? How are the experiences of those making referrals
audited or collated? What is done with any concerns?
Are positive stories about the point of consulting NHS professionals available to social care staff? Are these
promoted among staff who may not encounter many professionals or who are worried of being seen as
interfering? Are such messages as ‘requests for assessment are welcome’ promoted among families,
volunteers and housing support staff?
Promoting continence
The likelihood of bladder and bowel problems increases with age and having other medical problems.
Simple steps can help avoid some bladder and bowel problems and associated incontinence.
These include:
l a balanced diet, with sufficient fibre, e.g. five portions of fruit and vegetables a day, 6–8 glasses of
fluids a day (approximately 1.2 litres or 2–3 pints) – more in hot weather.
l general exercise of up to 30 minutes five times a week (adapted exercise for those with disabilities)
l a toilet routine that allows privacy, dignity and adequate time for their bowels to open; and
l in the case of those with impaired mobility or dexterity (skill in using hands), adaptations, aids or
assistance (such as raised toilet seats, grab rails, elastic waist trousers rather than zips, etc.).
Key points for social care: there are basic steps to promote continence and
prevent incontinence
Are basic prevention factors understood, in place in support plans, and promoted in social care contacts
with users of services, particularly older people?
Are these subjects covered in reviews? What evidence is available that they are covered in self- or
facilitated assessments, support planning and reviews? Would an audit of support plans show that these
subjects are being addressed? What outcomes are recorded in this area?
Needing the help of other people with managing toileting
Many older people with health problems and disabilities have limited mobility and reduced dexterity.
They may need support in acquiring the best adaptations, aids or assistance to maintain independence
in toileting. For some people this will mean that they can only remain continent if they are supported by
other people.117 This has implications for family and other carers and social care supporters. Extensive
help will very likely be needed if a person becomes seriously cognitively impaired, for example with
Alzheimer’s disease.
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Key points for social care: some people will only remain continent with aids,
adaptations and assistance
Is publicly funded social care focused on maintaining continence rather than just relying on the premature
use of continence pads which lower self esteem and are costly? Can re-ablement and other prevention
services be called upon and what are the referral routes? What importance does the Resource Allocation
System (RAS) give to these outcomes and what sums are allocated? What information is given about
sources of equipment to people paying for all their social care as well as those receiving some support
through personal budgets or help with paying care home fees?
Do carers and social care providers have access to training and support to enable them to help people
remain continent? What is the access point for carers and social care workers if they have questions? What
are the training opportunities for carers and care workers around subjects such as ‘prompted voiding’ (the
reminding or helping someone to use the toilet regularly of a person with dementia)? Are these training
opportunities available to personal assistants and to carers?
What is the local source of advice for care managers and care staff on aids and adaptations and what is
provided through publicly funded joint (NHS and local government) equipment stores? How are such
services audited in terms of access and acceptability? Are local older people engaged in activities such as
‘mystery shopping’ to see if such services are accessible and informative? Are charges and payments
systems clear and fair?
Are frontline staff well equipped to inform people about sources of information and advice, particularly
those not meeting publicly funded social care eligibility criteria? Are information, brokerage and navigation
services audited to ensure that they are giving the best support?
Do care managers, brokers, dementia advisers and others supporting people with dementia and their
carers consider specifically what assistance with continence might be needed and who is responsible for
this? How and where is this recorded?
Do planners and providers consider the needs of people with dementia in the design of day centres and
care homes, e.g. toilet signage, adequate lighting, contrasting colours for toilet seats? Are aspects of good
design part of neighbourhood and community planning and regeneration?
Managing incontinence
Some people’s incontinence cannot be treated or the underlying condition means they are unable to
regain continence e.g. teaching pelvic floor exercises may not work for a person with dementia. The aim
then is to manage and contain incontinence and minimise distress to all concerned. It may be possible to
manage urinary incontinence and maintain bowel continence by assisting the person to sit on the toilet or
commode after a meal (often breakfast), or at the time they usually open their bowels.
Key points for social care: many people who have urinary incontinence
contained by pads are able to sit on a toilet or commode to open
their bowels
Has the extent of support or aids required to assist someone to open their bowels on a toilet or commode
been considered by those supporting people with assessments and in support planning? Is this part of
desired outcomes for people affected, including carers? Are the costs of meeting these outcomes included
in the Resource Allocation System (RAS)? Is information about help with equipment such as dryers and
washing machines from the Social Fund or the voluntary sector clearly signposted to older people, carers
and advice sources?
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Absorbent products
The aim for the person, their family carers and for health and social care staff is to ensure that the use of
incontinence pads leads to the best possible outcomes. Points to consider include ensuring that they:
l adequately contain the urine and/or faeces without leakage (both during the day and at night)
l are changed in ways to preserve dignity and as required to avoid skin damage
l are a design that is acceptable to, and manageable by, the person who is changing the pads
l are used according to the manufacturers’ instructions
l are disposed of safely.
Chair and mattress protection may help meet outcomes such as promoting hygiene, in the context other
issues such difficulty in pad design or in the case of a person with cognitive impairment who may be
unwilling to use pads (dry or wet) or who may disturb or take them off.
The Department of Health has stated that the NHS supplies absorbent continence products according to
clinical need364 and has developed standards and criteria for continence services.365 Social care services
managers may wish to consult these if there are disagreements about responsibilities. The Royal College of
Physicians’ national audits show great variation in provision and policies.158
Key points for social care: incontinence products
Are care managers and social care managers aware of local community health services/NHS policies
on the provision of NHS-funded continence pads including any eligibility criteria? Has there been
discussion of how these are operationalised at a local level, e.g. at Health and Wellbeing Boards or
Overview and Scrutiny Committees? Do social care services staff in all sectors know how to refer
people for an assessment for these products? Are care managers and care providers aware of other
sources of information about these products such as the web-based PromoCon (part of the Disabled
Living Foundation), the Disabled Living Foundation and the Bladder and Bowel Foundation Charity?
Is information about these readily accessible on the internet and other public information services?
Are care managers and social care providers aware of the local contacts for altering or stopping deliveries
of NHS funded pads when the need changes, or the person moves or dies?
How are people given choice and control over the products that are supplied by the NHS?
Do social care staff receive education and training in the correct use of different designs of pads and how
to maintain modesty and dignity while changing pads? Do they receive training in hygienic practices and
correct disposal? How is this audited? How do complaints about this lead to improvement? How are NHS
services informed by local feedback on the quality of the service as well as the quality of the product?
Challenging behaviour and ‘matter’ out of place
Assistance in toileting and intimate, personal care can seem particularly insulting or threatening for
someone with dementia and may be a flash point for the person to resist help or become aggressive.
Other challenges for carers and staff may include faecal smearing, and lack of hygiene. Visitors may
misinterpret care practices and the issue may lead to conflict between carers and care staff. Both older
people and care workers may have cultural preferences that need to be considered. The Mental Capacity
Act 2005 provides a framework for acting legally and in a person’s best interests in this area of making
decisions, as it does in others when a person lacks capacity to make decisions. Some situations may give
rise to concerns about safeguarding and advice should be sought on these from safeguarding staff in
accordance with local policy and procedures.
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Key points for social care: challenging behaviour in toileting and intimate
personal care
Have social care providers received training in working with people with dementia and are they
knowledgeable about communicating with people with dementia to reduce fear, anxiety and resistance?
What support is available to staff and carers in written but also face-to-face learning? Are there
opportunities for staff to discuss intimate care in group or personal supervision? How well are
interventions, information and support meeting the needs of diverse groups of older people, carers and
care workers? Is care informed by the principles and guidance of the Mental Capacity Act when carers
and care workers are making decisions about supporting people lacking capacity when they are acting in
their best interests, e.g. carrying out care when a person is refusing this?
Are social care staff aware of behavioural management techniques that may help to identify potential
causes of challenging behaviours? Are social care staff aware of who to either refer the person to, or
encourage the person and their family to approach for assessment and strategies to manage or lessen
behavioural and psychological disturbances? What is the referral pathway in the locality and is there
evidence that it leads to positive outcomes? Are there any examples that can be used to assure care staff
and carers that this is worth the trouble?
Incontinence is humiliating, distressing and embarrassing for any adult. Denial and concealing this problem
from others is a common response. In people with dementia this can sometimes mean inappropriate
activities, e.g. hiding soiled clothing and forgetting it, wrapping up faeces and hiding them. As the
dementia progresses, identifying the correct place to urinate or defecate can also become a problem, as
can apathy, and both can result in urine or faeces spillage. Attempts to clear up leakage and ‘matter’ out
of place can also be ineffective or make matters worse from a carer’s or care worker’s point of view. If a
person has faeces on their hands and tries to remove them (also known as faecal smearing) this can cause
great distress. This can occur when the person can no longer manage personal hygiene after defecating or
the person has tried to manipulate the pelvic floor or rectum to help defecation, or in severe dementia as
an innate response of curiosity to the sensation of faeces exiting the body. These types of behaviours can
place additional stress and distress on family carers and care workers, as well as visitors and others living in
close proximity.
Key points for social care: when urine and faeces is out of place
Are care managers and care providers aware of contact points for obtaining assessment and advice in
preventing and managing these situations? Is access to advice timely and useful? Are people who are not
eligible for publicly funded social care services fully included in information and advice resources?
Are carers and social care workers provided with accessible and realistic information on managing spillage
and leakage hygienically? Who is responsible for ensuring this information is useful and how is it audited?
What is the involvement of carers and frontline staff in the construction of referral pathways and in the
production of information? What records are kept to ensure that care practices are lawful and that staff
are protected from unfair allegations that they are acting unlawfully? Are risk assessments used to support
good practice and decision-making? Are safeguarding staff able to access expertise when responding to
referrals or enquiries in this area?
Questions to address in the overall commissioning and provision
What do older people say about local information and services? What information is available to carers
and to direct care workers, and is this accurate, sufficient and accessible?
How are local responsibilities for information, equipment, advice and professional interventions divided or
managed jointly?
What should be the responses to an actual or future audit of assessments, support plans and reviews
covering continence and incontinence?
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If managing continence and incontinence is to be part of the outcomes framework in local commissioning,
what needs to happen locally for this to be successful?
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Research instruments and tools
These appendices provide examples of the research instruments and tools used in the different
EVIDEM-C studies.
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Appendix 26 Chapter 3: Aide-memoire for
guided conversations with the person with dementia
Instructions to researcher
Repeat rationale for the study and the process of this data collection. Confirm confidentiality and
anonymity in reporting. Confirm that they are willing to carry on with the discussion. Confirm permission
to record or not. Confirm that the exploratory discussion can be stopped at any time.
The discussion will start with general enquires of health and well-being to start establishing a
non-threatening rapport and set the tone for the conversation about the more sensitive issues.
Discussion should centre around these themes:
1. Some people like you sometimes experience problems with not being able to get to the toilet in time,
do you ever have those sort of problems?
i. Conversational probes for types of problems – urge/stress urinary incontinence, nocturia, finding the
toilet, managing clothes, etc.
2. What helps you when you have that . . . INSERT . . . problems? How do you manage?
i. Conversational probes for types of strategies for addressing those problems and preferences,
e.g. containment pads/pants, commode/urinal by bed, manageable clothes.
ii. Conversational probes on preferences and feelings about different strategies. How do you feel about
managing in that way?
3. Some people like you sometimes experience problems with their bowels, getting constipated and then
sometimes very loose motions, do you ever have those sorts of problems?
i. Conversational probes for types of problems with bowels.
4. What helps you when you have those sorts of problems?
i. Conversational probes for types of strategies and preferences.
5. Some people discuss these sorts of problems with their family doctor or with a district or continence
nurse? Have you discussed these problems with your doctor or any other professional?
Probes for any views on experience of discussing or receiving help for these problems.
Confirm demographic information:
l age band, e.g. sixties, seventies, etc.
l living arrangements, e.g. living with family or alone.
Check whether uses any other health and social care services not mentioned above.
Closure by thanking for their contribution and confirm arrangements for summary of all research findings
to be shared.
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Appendix 27 Chapter 3: Aide-memoire in the
qualitative interview study with family carers
Instructions for researcher
Repeat rationale for the study and the process of this data collection. Confirm confidentiality and
anonymity in reporting. Confirm permission to record or not. Repeat that the interview can stop at
any time.
The interview will start with general enquires of health and well-being of the close carer and the types of
support and help they give to the person with dementia they care for. The interview then moves to the
more sensitive issues.
1. Can you describe any problems your (insert – husband/wife, partner, parent, etc.) has with going to the
toilet or being incontinent? Probes into:
i. urinary and faecal
ii. origin of problems
iii. impact of different types of incontinence
2. What types of interventions/strategies/support help you in helping support your loved one (a) stay
continent and (b) manage their incontinence? Probe:
i. explore strategies for different problems, for day and night-time or for changing circumstances
ii. explore whether strategies ideas worked out alone or from suggestions/help from professionals/
other carers
3. Are there problems/situations that are more difficult to cope with than others? Probe:
i. emotional issues in relation to dealing with adult urine/faeces, intimate tasks
ii. successful strategies but with other consequences like restricting outside activities
4. Have your discussed these sorts of problems with your family doctor or with continence nurse or any
other professional?
5. Are you currently using services/aids/equipment to help manage these problems? If yes what sort, how
acquired and what has that experience been like?
6. Confirm demographic information
i. age band, e.g. sixties, seventies
ii. record gender
iii. ask whether has had a carer’s assessment of need by social services
iv. ask whether in receipt of additional financial benefits, e.g. attendance allowance.
Closure by thanking for their contribution and confirm arrangements for summary for findings to
be shared.
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Appendix 28 Chapter 3: Interview tools to
characterise the person with dementia and the carer
in the longitudinal study and absorbent pads study
ID number:  
Date: / /  
Carer details 
(also on CSRI) 
 
We would like to know some things about you. Please tick as appropriate. 
What is your year of birth?  
 
 
Are you….?  Male     Female  
 
 
Is the person with memory problems your….?        
Spouse/Partner   Parent              
Sibling    Other family member            
Friend/Neighbour  
 
 
Is English your 1st language? Yes    No  
If no, please state first language: ______________________________ 
Interpreter required?   Yes    No  
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Current Medical Conditions 
 
Are you currently seeing your GP for treatment for a medical (physical) 
condition?   Yes    No  
 
Are you currently seeing your GP for treatment for a mental health problem? 
   Yes    No  
 
Are you currently seeing hospital specialists for a medical (physical) condition? 
   Yes    No  
 
Are you currently seeing hospital specialists for a mental health problem? 
   Yes    No  
 
Decline     
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ID number:  
Date: / /  
 
 
Carer Ethnicity Categories 
 
What ethnic background are you? (Categories are taken from the Census) 
 
White         
British 
Irish 
Any other White background 
 
Mixed         
White and Black Caribbean 
White and Black African 
White and Asian 
Any other Mixed background 
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Asian or Asian British       
Indian  
Pakistani 
Bangladeshi 
Any other Asian background 
 
Black or Black British       
Caribbean 
African 
Any other Black background 
 
 
Chinese or other ethnic group     
Chinese 
Any other background 
 
 Decline         
 
 
ID number:  
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Date: / /  
 
PWD Demographic details (also on CSRI) 
 
Year of birth    
 
 
Gender  Male        Female  
 
 
Carers relationship     
Spouse/Partner    
Daughter/son            Sibling    
Other family member         Friend/Neighbour  
 
 
English 1st language?  Yes        No  
If no, please state first language: _______________________________________ 
Interpreter required?   Yes        No  
 
 
 
Medical information 
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 GP Details 
Name: ____________________________________________________________________ 
Surgery: ___________________________________________________________________ 
Address: ___________________________________________________________________ 
__________________________________________________________________________ 
Telephone number: __________________________________________________________ 
 
 
Current Medical Conditions 
Please give details: 
1) __________________________________________________________________________ 
2) __________________________________________________________________________ 
3) __________________________________________________________________________ 
4) __________________________________________________________________________ 
5) __________________________________________________________________________ 
6) __________________________________________________________________________ 
 
 
Height (estimated)  feet and  inches   OR   
centimetres 
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Weight (estimated)  stone and  pounds  BMI (calculated later) 
  
OR   kilos      
 
 
Number of births (women only) 
1   2   3   4   5   6+  
 
 
Past surgical procedures? (NB probe for surgery related to gynae. and urinary system) 
 No      Yes  
If yes, please give details: _________________________________________________________ 
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ID number:  
Date: / /  
 
 
PWD Ethnicity Categories: Census 
(Self assigned at end of interview) 
 
 
White         
British 
Irish 
Any other White background 
 
Mixed         
White and Black Caribbean 
White and Black African 
White and Asian 
Any other Mixed background 
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Asian or Asian British      
Indian  
Pakistani 
Bangladeshi 
Any other Asian background 
 
Black or Black British      
Caribbean 
African 
Any other Black background 
 
Chinese or other ethnic group    
Chinese 
Any other background 
 
Decline         
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Appendix 29 Chapter 3: Validated tools used in
the longitudinal study and the absorbent pads study
Measures References Permissions
Neuropsychiatric Inventory (NPI) Cummings JL, Mega M, Grey K, Rosenberg-Thompson S,
Carusi DA, Gornbein J. The Neuropsychiatric Inventory:
comprehensive assessment of psychopathology in
dementia. Neurology 1994;44:2308–14
Permission
obtained
Health-related quality of life for people with
dementia (DEMQOL)
Smith SC, Lamping DL, Banerjee S, Harwood R,
Foley B, et al. Measurement of health-related quality of
life for people with dementia: development of a new
instrument (DEMQOL) and an evaluation of current
methodology. Health Technol Assess 2005:9(10).
URL: www.iop.kcl.ac.uk/departments/?locator= 330&
context= 773
Publicly
available
Mini Mental State Examination (MMSE) Folstein MF, Folstein SE, McHugh PR. Mini-Mental
State. A practical method for grading the cognitive
state of patients for the clinician. J Psychiatr Res
1975;12:189–98
Publicly
available
International Consultation on Incontinence
Questionnaire: Urinary Incontinence (ICIQ-UI)
and Nocturia (ICIQ-N)
Avery K, Donovan J, Peters T, Shaw C, Gotoh M,
Abrams P. ICIQ: a brief and robust measure for
evaluating the symptoms and impact of urinary
incontinence. Neurourol Urodyn 2004;23:322–30.
Permissions
obtained
Disability Assessment for Dementia (DAD) Gelinas I, Gauthier L, McIntyre M. Development of a
functional measure for persons with Alzheimer’s
disease: the Disability Assessment for Dementia.
Am J Occupat Ther 1999;53:471–81
Permissions
obtained
International Statistical Classification of Diseases
and Related Health Problems: dementia (ICD-10)
URL: www.who.int/classifications/icd/en/ Publicly
available
Health outcomes/quality of life (EQ-5D) URL: www.euroqol.org/ Permission
obtained
Zarit Burden Inventory (ZBI) Zarit SH, Reever KE, Bach-Peterson J. Relatives of the
impaired elderly: correlates of feelings of burden.
Gerontologist 1980;20:649–55
Permission
obtained
Census ethnicity categories Office for National Statistics (ONS) Publicly
available
Client Service Receipt Inventory (CSRI) Reference for CALM study: Howard RJ, Juszczak E,
Ballard CG, Bentham P, Brown RG, Bullock R, et al.
Donezepil for the Treatment of Agitation in Alzheimer’s
Disease. N Engl J Med 2007;357:1382–92
Schneider J, Murray J, Banerjee S, Mann A.
EUROCARE: A cross-national study of co-resident
spouse carers for people with Alzheimer’s Disease:
I factors associated with carer burden. Int J Geriatr
Psychiatry 1999;14:651–61
Permission
obtained
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Appendix 30 Chapter 3: Toileting difficulties
and incontinence questions used in addition to the
ICIQ-UI and ICIQ-N, for the longitudinal study and
the absorbent pads study
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Answered by: PWD / Carer        ID number: 
 
(Please delete as appropriate)        Date: /
/  
1. Problems with going to the toilet 
 
a) Toileting difficulties? (e.g. finding the toilet)   
Yes  (go to Q.2)  No  
 
b) Any problems with your bladder / passing water?   
Yes  (do to Q.3)   No  
 
c) Any problems with your bowels?    
Yes  (go to Q.4)   No  
 
d) Any problems with both bladder and bowels?   
Yes  (go to Q.3 AND Q4) No  
 
 
2) Toileting difficulties 
 
a) What happens?    
Can’t find the toilet   Uses inappropriate receptacle / place   
Finds the toilet but can’t use it  Can’t manage clothing     
Hides evidence of accidents  Faecal smearing     
Won’t sit on the toilet   Not recognising the urge or desire to act on it  
Screaming    Other (please give details): ____________________ 
APPENDIX 30
NIHR Journals Library www.journalslibrary.nihr.ac.uk
420
 b) How frequently? 
All the time    Two or three times a week    
Several times a day    About once a week or less often    
About once a day   Never       
 
c) How much does this bother you (PWD)? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
d) Overall, how much do the toileting difficulties that you (PWD) experience interfere with your 
(PWD) everyday life? Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
e) What helps you to deal with that? 
Active – doing something before   Passive – after (e.g. pads)   
Please explain: ______________________________________________________________ 
 
f) Are the strategies bothersome? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
g) Have you sought advice or help on this from any professional?  
Yes  (e.g. continence nurse) No  
 i) Who? ___________________________________________________ 
 ii) What help was offered/ did you gain? _________________________ 
3) Problems with your bladder / passing water 
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 3) ICIQ-UI 
a) How often do you leak urine? (Tick one box) 
All the time     Two or three times a week   
Several times a day     About once a week or less often   
About once a day    Never      
 
b) We would like to know how much urine you think leaks. 
How much urine do you usually leak (whether you wear protection or not)? (Tick one box) 
 A large amount     A small amount    
 A moderate amount    None     
 
c) Overall, how much does leaking urine interfere with your everyday life? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
d) When does urine leak? (Please tick all that apply to you / PWD) 
Leaks all the time      
Leaks when you are asleep     
Leak for no obvious reason     
Leaks when you cough or sneeze    
Leaks when you have finished urinating & are dressed  
Leaks before you can get to the toilet    
Leaks when you are physically active/exercising   
Never – urine does not leak     
 
ICIQ-N 
e) How often do you pass urine during the day? 
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13 times or more   11 to 12 times   9 to 10 times   7 to 8 times   1 to 6 times  
 
i) How much does this bother you? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
f) During the night, how many times do you have to get up to urinate, on average? 
 Four or more  Three  Two  One   None  
 
i) How much does this bother you? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
Additional 
g) Overall, how much does leaking urine interfere with your everyday life? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
h) What helps you to deal with that?   
Active – doing something before   Passive - after (e.g. pads)   
Please explain: ______________________________________________________________ 
 
i) Are the strategies bothersome? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
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 j) Have you sought advice or help on this from any professional?   
Yes  (e.g. continence nurse) No  
 i) Who? ___________________________________________________ 
 ii) What help was offered/ did you gain? __________________________ 
 
 
4) Problems with your bowel 
 
a) Do you have problems with your bowels?   
Yes  (please go to Q.4b)  No  
 
b) What type of problem? 
 i) Constipation      
Yes  (please go to Q.5)  No  
 ii) Leakage / incontinence    
Yes  (please go to Q.6)  No  
 iii) Both      
Yes  (please go to Q.5 then Q.6) No  
 iv) Other e.g. uncontrollable wind (flatus):  
Yes  (please give details below) No  
Details: 
___________________________________________________________________________ 
 
5) Constipation 
 
a) How often do you feel constipated? 
All the time     Two or three times a week   
Several times a day     About once a week or less often   
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About once a day    Never      
 
b) How much does this bother you? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
c) Overall, how much does constipation interfere with your everyday life? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
d) What helps you to deal with that?   
Active – doing something before     
Please explain: ______________________________________________________________ 
___________________________________________________________________________ 
 
e) Are the strategies bothersome? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
f) Have you sought advice or help on this from any professional?  Yes  (e.g. continence 
nurse) No  
 i) Who? ___________________________________________________ 
 ii) What help was offered/ did you gain? _________________________ 
 
6) Leakage / incontinence of faeces 
 
a) How often are you incontinent of faeces? 
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All the time     Two or three times a week   
Several times a day     About once a week or less often   
About once a day    Never      
 
b) What type of stool is it? Liquid   Solid  `Other  (please give 
details below) 
Details: ______________________________________________________________ 
 
c) When does it happen? 
Small amounts leaking all the time    
Occurs when you are asleep    
Occurs when you are passive, just sitting   
Occurs before you can get to the toilet   
Occurs at particular points e.g. after meals (please give details): 
________________________________________ 
 
c) How much does this bother you? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
d) Overall, how much does faecal incontinence interfere with your everyday life? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
e) What helps you to deal with that?   
Active – ding something before    Passive - after (e.g. pads)   
Please explain: ______________________________________________________________ 
___________________________________________________________________________ 
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 f) Are the strategies bothersome? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
g) Have you sought advice or help on this from any professional?  Yes  (e.g. continence 
nurse) No  
 i) Who? ___________________________________________________ 
 ii) What help was offered/ did you gain? __________________________ 
 
ID number:  
Date: / /  
7) Carer 
 
a) How much does the person you care for’s incontinence bother you? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
b) Overall, how much does this interfere with your everyday life? 
Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
c) Are the strategies bothersome? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
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 d) Have you sought advice or help on this from any professional?   
Yes  (e.g. admiral nurse) No  
 i) Who? ___________________________________________________ 
 ii) What help was offered/ did you gain? __________________________ 
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Appendix 31 Chapter 3: Further incontinence
questions about pad usage for the longitudinal study
ADDITIONAL QUESTIONS - for person with dementia using pads  
3) ICIQ-UI 
a) How often do you leak urine (outside of the pad)? (Tick one box) 
All the time     Two or three times a week   
Several times a day     About once a week or less often   
About once a day    Never      
 
b) We would like to know how much urine you think leaks (outside of the pad). 
How much urine do you usually leak? (Tick one box) 
A large amount     A small amount     
A moderate amount    None      
 
c) Overall, how much does leaking urine (outside of the pad) interfere with your everyday life? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
d) When does urine leak (outside of the pad?) (Please tick all that apply to you / PWD) 
Leaks all the time       
Leaks when you are asleep     
Leak for no obvious reason      
Leaks when you cough or sneeze    
Leaks when you have finished urinating & are dressed   
Leaks before you can get to the toilet    
Leaks when you are physically active/exercising    
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Never – urine does not leak     
Other         
Please explain: 
_______________________________________________________________________ 
 
h) What helps you to deal with that?   
Active – doing something before  Passive - after   (e.g. pads)       
Please explain:   ______________________________________________________________ 
 
i) Are the strategies bothersome? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
 
j) Have you sought advice or help on this from any professional?   
Yes    (e.g. continence nurse)  No    
 i) Who? ___________________________________________________ 
 ii) What help was offered/ did you gain? __________________________ 
 
 
 
ADDITIONAL QUESTIONS - for person with dementia wearing pads 
ICIQ-N 
f) During the night, how many times do you leak urine INTO the pad, on average? 
Four or more   Three   Two   One   None   
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 i) How much does this bother you? 
(Please ring a number between 0 (not at all) and 10 (a great deal) 
0 1 2 3 4 5 6 7 8 9 10 
not at all           a great deal 
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Appendix 32 Chapter 3: Additional table in the
Client Service Receipt Inventory (part 1) longitudinal
and absorbent pads study
Adaptations, equipment and products Tick if yes
Type of adaptation
or equipment
(list all)
Who supplied
this?
Who/what
organisation
paid for this?
Changes to service user’s home (e.g. putting in
shower cubicle, stair lift)
Special equipment (e.g. for mobility, bathing, etc.)
Continence products (e.g. pads, pull-up pants)
Aids to getting to and using the toilet or
protecting bedding/furniture (e.g. grab rails,
raised toilet, urinal bottles)
Furniture, clothing, bedding or household
goods replaced because of incontinence
problems
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Appendix 33 Chapter 3: Data collection tools for
examining feasibility and acceptability in the
absorbent pads study
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Appendix 34 Chapter 3: Additional table in
the Client Service Receipt Inventory (part 1) for the
absorbent pads study
Absorbent products
Brand Size Teardrops Amount/frequency Source, e.g. NHS/internet Cost (if applicable) Notes
Other continence productsa
Name Source, e.g. NHS/internet Cost (if applicable) Notes
a For example, disposable bed/chair sheets, disposable bags, gloves, sprays, etc.
EVIDEM C Investigating absorbent products CSRI Version 1 29032010
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Appendix 35 Chapter 4: Phase 1 protocol
REC REF 08/H0502/74
Changing practice in dementia care in care homes: developing
and testing evidence-based interventions at the end of life
PI: Professor Claire Goodman, University of Hertfordshire, c.goodman@herts.ac.uk
Background
How people with dementia die, and the type of end-of-life interventions they should receive, has been
widely discussed and partially introduced across the NHS and care home sector.191–193 These discussions
focus particularly on place of care and the adaptation of existing approaches to provide palliative care for
people with dementia. There remains, however, a limited understanding of how this population experience
the end of life and if the recognition of an end stage of life in dementia can improve service provision and
influence place of care.
Older people with dementia have a limited life expectancy from the time they receive a diagnosis, and
particularly on entry to a care home. Cox and Cook190 identify three ways in which people with dementia
can die:
l People who have a diagnosis of dementia at the end of life, but whose death is caused by another
medical condition, for example, cancer, or heart disease.
l People who die due to a complex interplay of mental and physical problems, where the dementia has
not impacted greatly on their functioning.
l People who are described as having end-stage dementia, where the associated consequences of the
dementia impact upon all domains of their life and they ultimately die of the complications that go
with progressive neurodegeneration.
Each of these different ways will directly influence the place and experience of death for an individual and
his/her family members. Death for people with dementia is not a single trajectory, rather patients and
carers live with dementia for years often with different trajectories of functional decline and needs.194,195
Practitioners experience many difficulties in recognising and responding to older people’s needs with
dementia at the end of life. Practitioners of all disciplines lack confidence in discussing advance care
planning with patients and their families, and find the recognition of when someone is dying, and
identification of the kind of support needed, problematic.197,199 The range of health needs experienced at
the end of life by people with dementia is many. Communication problems, confusion, functional loss,
nutrition and complications, such as, infections and incontinence, can compound the distress of a person
who is dying and challenge clinicians’ knowledge and expertise.419 Attempting to manage these challenges
can result in inappropriate medical interventions and referral to acute care.198
Few diagnostic and support tools have been developed for primary care, or take into account the range
of community-based professionals and support workers that can be involved in caring for people with
dementia in a care home. In the United Kingdom, over 13,000 care homes offer personal care and
approximately 405,000 older people receive care in these settings. The average care home providing
personal care has between 26 and 36 places depending on ownership.420 Twenty-three per cent of older
people over 65 will die in a care home, the majority of whom will die with dementia. It is often assumed
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that most people with dementia die in a care home with nursing care (a nursing home), but homes with
personal care only (a residential home) care for a significant number of older people who have some
degree of dementia, which may be unrecognised.193 Care homes without on-site nursing provision are
wholly reliant on primary care services for first contact, referral and access to health-care and end-of-life
services. This makes end-of-life care an important issue for a wide, primary care-based workforce.
An integrative review of qualitative and quantitative research on palliative care interventions for
community-dwelling older people with dementia (including older people in care homes), demonstrates that
research on end-of-life care for people with dementia poses significant methodological challenges.200 The
North American context of care heavily influences this literature where a focus on prognostication is linked
to decisions about reimbursement for medical costs and use of more ‘aggressive’ interventions for people
with advanced symptoms of dementia, for example, management of pneumonia with intravenous
antibiotics. Moreover, the majority of research on end-of-life care for people with dementia tends to rely
on proxy or retrospective accounts of particular symptoms and events in the illness. Few studies have
addressed the environment and organisation of care, or the affect of different care decisions on
patient outcomes.
It is important to recognise that the organisation and context of care home provision for people with
dementia is highly variable and heterogeneous.202,203 This affects individuals’ access to care and experience
of support at the end of their lives. The care home sector is a mixed economy of care operating with
different patterns of ownership (local authority, private, charitable and voluntary) and size of organisation
(e.g. a single independent care home/a commercial chain). The cognitive ability and dependency of
residents in care homes also varies by care home, and there is a considerable overlap in residents’ needs
between settings with on-site nursing and those without.205 Despite a requirement by the National
Minimum Care Standards for Care Homes that 50% of care staff within a home are trained to NVQ level 2
by 2005,421,422 there is a wide variation in the levels of staff training that care homes offer and expect from
their care staff. Many factors influence how care homes work with primary health-care services, and the
degree a care home is likely to engage with end-of-life care for their residents. These include factors both
within a care home, such as, ownership, care staff turnover, and qualifications held by a care home
manager (e.g. a nursing qualification), and service provision to a care home, for example, GP attachment,
the payment of a GP retainer, a locality’s (LA/PCT) organisational history of innovation with care homes.198,199
This study, the EVIDEM-end of life project, has two phases. This protocol addresses Phase 1 of the study.
In Phase 1 we aim to establish the different possible pathways to death for older people with dementia
living in a care home. The second phase will use these findings to develop and test dementia specific
interventions that support health-care professionals, community workers and care home staff in palliative
care for older people with dementia in care homes. The Phase 1 findings will directly inform Phase 2
that intends to develop a toolkit for providing end-of-life care for people with dementia resident in a
care home.
Aim
To explore and document the need for support and end-of-life care of older people with dementia living in
a care home environment.
Objectives
1. To describe the different characteristics of older people with dementia residing in a care home and their
respective pathways to death.
2. To describe the care and support needs of older people with dementia living in a care home and
their carers.
APPENDIX 35
NIHR Journals Library www.journalslibrary.nihr.ac.uk
442
3. To establish how care staff, and NHS primary care practitioners define, assess and provide end-of-life
care for older people with dementia resident in a care home.
4. To describe how different contexts and models of care in care home environments influence an older
person with dementia’s experience of end-of-life care.
5. To identify the treatments and interventions received, and services and resources used, leading up to an
older person’s death.
6. To establish if dementia specific educational support and assessment tools can improve experiences and
outcomes for older people with dementia dying in care homes (this applies to Phase 2 of the study).
Definitions of end-of-life care
End-of-life care is a contested term423 and consequent inconsistencies in understanding can lead to
different emphasis in care provision. End-of-life care as a type of service provision is closely related to the
palliative care speciality. Palliative care focuses upon the support of people as they live and die with a life
limiting illness. The World Health Organization (WHO) defines palliative care as:
An approach that improves the quality of life of patients and their families facing the problems
associated with life-threatening illness, through the prevention and relief of suffering by means of
early identification and impeccable assessment and treatment of pain and other problems,
physical, psychosocial and spiritual.420
This WHO stance on palliative care adopts a public health perspective with emphasis on early identification
to prevent symptoms and ensure optimal disease management.420 There is a distinction between generalist
and specialist palliative care services:424,425
l Generalist palliative care services are provided by health and social care practitioners to individuals in
whatever care setting they reside.
l Specialist palliative care services support these generalist services and provide care for people with
unresolved symptoms, or complex psychosocial, end-of-life or bereavement issues. Specialist palliative
care may be provided in dedicated settings such as hospices, but also in hospitals, people’s homes, and
long-term care facilities.
End-of-life care is a broader term than ‘terminal care’. Terminal care is usually associated with the last few
days and hours of life, and is based upon the knowledge that an individual is dying, while end-of-life
care encompasses more than the terminal care phase. The term ‘end of life’ originates from North America
and is particularly used in the context of the care of older people.
End of life care for seniors requires an active, compassionate approach that treats, comforts
and supports older individuals who are living with, or dying from, progressive or chronic
life-threatening conditions. Such care is sensitive to personal, cultural and spiritual values, beliefs
and practices and encompasses support for families and friends up to and including the period
of bereavement.426
Phase I study design
The project uses a two-phase prospective study design to explore and document needs for support and
end-of-life care for people with dementia in care homes to develop care practices at the end of life. This
proposal refers to Phase 1 only. Phase 1 intends to use documentary review and interviews to prospectively
track care needs and service use for people with dementia in care homes over a 2-year period at
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4-monthly intervals. The study will involve older people with dementia resident in care homes, care staff,
NHS primary care practitioners and social service personnel. The Phase 1 findings will inform Phase 2,
developing and evaluating care practices at the end of life for people with dementia in care homes.
A separate NRES submission will be made for Phase 2.
Study settings
Six care homes in a range of possible sites within the North Thames DeNDRoN area (i.e. Camden, Barnet,
Enfield, Haringey, Islington, Barking and Dagenham, City and Hackney, Havering, Newham, Redbridge,
Tower Hamlets, Waltham Forrest, Brent, Hammersmith and Fulham, Ealing Kensington and Chelsea,
Harrow, Hillingdon, Hounslow, Westminster, Hertfordshire, Bedfordshire and Essex) and registered with the
Commission for Social Care and Inspection (CSCI) as offering personal care and specialist support in
dementia care, with up to 50 beds (the median size of a care home in England offering personal care is
35 beds)427 and which, in recent inspections by CSCI, have been assessed as meeting National Minimum
Standards.422 To reflect the diversity of care home provision within England, and London in particular,
requires the selection and identification of care homes that reflect a range of providers (e.g. private,
voluntary/charitable and national chain), staffing expertise and history of working with NHS services
(e.g. use of integrated care pathways, adoption of palliative care frameworks, etc.). The participating care
home settings will therefore reflect a mix of ownership to include care homes that are part of a large
commercial chain, private, voluntary, charitable and faith-based providers.
Recruitment
In the UK there are over 13,000 care homes that offer personal care and approximately 405,000 older
people receiving care in residential settings.428 Older people in care homes with personal care represent the
majority of residents in long-term care. For this population, access to health and palliative care services is
mediated wholly through primary care services. This group are the focus of the study.
The care homes
The sensitivity of the focus of the study on end-of-life care for people with dementia, and the need to
maintain a relationship with the care home staff over a 2-year period, requires that the recruitment of care
homes and participants is undertaken in three stages, namely:
Stage 1: identification of possible care homes
The intrinsic heterogeneity (culture of care, population, staff turnover, income, ownership) of care homes
makes identifying representative care homes problematic. The median size of a care home with personal
care is 35 places.427 Using the CSCI Directory of Care Homes and Care services, we will identify eligible
care homes from the range of possible sites in the North DeNDRoN area and Sussex on the basis that:
l The care home is for older people, offering personal care and specialist support in dementia care.
l The care home does not have on-site nursing care (care homes with mixed provision can be included
in the study, we will recruit participants who have been assessed as not requiring nursing care).
l Has between 20 and 50 places.
l The most recent CSCI inspection report is favourable, with no ongoing problems or issues identified
requiring action.
l The care homes’ ‘typicality’ is comparable with findings from other national studies and similar to
one another.
l Care home staff consider they have a good working relationship with their local primary care services.
l The final sample has a mix of ownership (e.g. charity, voluntary, private, corporate).
Stage 2: invitation to express an interest in participation
We will write to the managers of the identified care homes, introducing the study and asking if we can
telephone to arrange a meeting at a mutually convenient time with the manager/senior management team
to discuss the study’s aim, and what participation will involve. Where several care homes are represented
by one provider, we will first approach the owner organisation to gauge their interest and willingness for
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their care homes to participate, and then write to the relevant care home managers. Managers and liaison
staff within a Primary Care Trust (and Local Authority) where a care home has signalled an interest to
participate will inform NHS professionals and social service personnel about the study taking place within
their respective organisations.
Stage 3: discussion with older people, care staff, NHS and social
service personnel
Having met with the care home manager, we will arrange meetings with the different participant groups
to introduce ourselves and the study. This will include a care home’s residents’ forum, care home staff
(preferably without the care home manager being present) and the relevant primary health care teams,
and social service personnel. These will be informal meetings to gauge the different groups’ level of
interest and engagement with the study, and identify possible reasons for a care home or NHS staff not
taking part (e.g. staff sickness, reorganisation within the care home). We will host coffee mornings/
afternoon tea events in interested care homes to encourage discussion and questions about the study.
Once it has been established which six care homes will participate in the study, we will provide all the
potential participants (older people, care staff within a care home, and NHS and social service staff
providing services to a care home) with information booklets about the study. We will ask to display a
poster about the study in each care home to inform visitors that a research study is taking place. All
participants will have a minimum of 48 hours to consider information provided about the study before
further contact by the researcher to gauge interest or not in the study. To enable the older people (and/or
their consultee) to discuss the older person’s participation with family and trusted friends, we will allow a
week for them to consider if they would like to take part. It will be made clear from the start that a
decision whether to take part in the study or not is entirely voluntary and that their decision will not affect
care or working in the care home or PCT in any way. At no stage will care home or NHS staff be involved
in providing detailed information about the study to the older people, or in the consenting process.
Older people with dementia
A recent study found that the numbers of older people with a recorded diagnosis of dementia account for
46% of older people resident in care homes with no on-site nursing care.429 This is consistent with larger
surveys of residents of care homes with personal care. The PSSRU report that 22% of residents’ experience
severe cognitive impairment430 and 48% mild/moderate impairment. Similarly, a secondary analysis of the
Health Survey for England 2000 indicates 24% of residents experience severe impairment,431 but 30% of
residents were considered unable to complete a cognitive function test, indicating likely under reporting.
In the PSSRU study, most individuals with severe impairment on admission had no documented diagnosis
of dementia.206
To address objectives one, two and five, and capture the range of characteristics, episodes of ill health,
care needs and service use experienced by older people with dementia, we will purposively recruit a
minimum of 120, and up to 250, older people resident in 10 care homes with personal care and no
on-site nursing. The older people approached to participate will either have a recorded diagnosis of
dementia in their care notes, or following discussion with their care staff, be identified as having symptoms
and behaviour that is consistent with a diagnosis of dementia. Older people will be recruited by project
staff using a separate information and consent process, and in discussion with their consultee when a
person with dementia lacks capacity to give (informed) consent. Respective inclusion and exclusion
criteria comprise:
l Inclusion criteria Older people aged 65 years and over with a formal diagnosis of dementia
(documented medical assessment) or informal diagnosis (considered by care home staff and/or in care
notes as having dementia) and a validated measure of cognitive function impairment (undertaken by
the researcher), resident in a care home registered to provide personal care only and specialist support
in dementia care.
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l Exclusion criteria People who do not speak English for whom an interpreter cannot be located, those
whose care home manager considers it inappropriate to approach, and individuals who lack capacity
to give an (informed) consent where a consultee cannot be identified to support (or not) the
individual’s participation.
Recruitment of the older people will involve a three stage process previously used in care home
research431,432 that intends to minimise pressure on individuals to take part and provide opportunities for
discussion with others:
l Stage 1 The respective care home managers will give each older person (and/or their consultee) within
the sampling frame a letter of invitation to participate in the study and an information booklet.
l Stage 2 A member of the care home staff (e.g. the care home manager) will introduce a member of
the project staff (e.g. the research fellow) to each older person (and/or their consultee) who has
indicated they may wish to participate in the study. A time is agreed with each older person (and/or
consultee) and when available, an intermediary, to discuss the study.
l Stage 3 Meeting with an older person, and an intermediary (if available), such as a care worker or
family carer, with whom the older person particularly relates to explain the research study and if in
agreement, begin initial consenting. The researcher will ensure that the intermediary is present and
able to explain and, if necessary to interpret any areas of concern of lack of understanding. The
researcher will ensure that the participant is given full opportunity to have the study explained to them
in a way that best meets their individual needs.
In situations where an older person has been formally assessed, and it is documented that they do not
have the capacity to consent or take part in an interview, we will ask the older person’s consultee (e.g. a
relative) if, based on their knowledge of the older person, allowing a researcher to review his/her care
notes would upset or distress them. The care home manager will be asked to write to the consultee about
the study and they will be asked to assent to enrolment of the person with dementia. The researcher will
arrange to see the person with dementia and his/her consultee to seek their written support for the older
person’s participation in the study. In the event that a consultee cannot be identified, then the person with
dementia will be excluded from the study.
Amendment – submitted Southampton REC November 2008
The process of engaging consultees in the research study required amendment following a low consultee
response rate in the EPOCH-ExPeriences of Older People in Care Homes research study (PI, Claire Goodman).
In the event that a nominated consultee does not respond to a care home manager’s letter, additional
processes have been put in place to ensure that we have consulted appropriately, comprising:
1. The letter of invitation, sent by the care home manager, requests that the consultee response form is
returned (in the SAE) within 2 weeks of receipt.
2. The letter details that if we do not hear from the consultee after 2 weeks we will follow up their
response with a telephone call, asking them, if, based on their knowledge of the older person they
think they would be interested or not in participating in the study, and allow the researchers to review
their medical and nursing notes, and to share anonymous patient data with the EVIDEM Registry.
In the event of still not being able to obtain a response from the nominated consultee, we propose to
approach the GP, District Nurse or Social Worker, who knows the older person best.
3. If the consultee at any point expresses the opinion that the older person would not wish to take part,
that person must be excluded from the study, unless another consultee can be identified.
4. We will then write to consultees who felt the older person would wish to take part, to inform them
that the researchers have begun to extract data from the person’s medical and nursing notes.
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These additional processes are in keeping with the Mental Capacity Act (2005)17 expectation that
‘reasonable steps’ have been take to identify others who could be consulted about what a prospective
participant’s wishes and feelings about participation in the project would be if they had capacity. These
changes reflect the British Psychological Society’s recommendations for undertaking research with people
who do not have the capacity to consent.433
The above amendment was approved by the Southampton and South West Hampshire Research Ethics
Committee on 6 March 2009, reference no. 08/H0502/74.
Care workers, NHS and social care staff
To address objectives three, four and five (above) we will recruit up to five care home staff from each care
home including the care home manager, and up to three NHS professionals (e.g. general practitioner,
district nurse and Macmillan nurse) who have ongoing involvement with a care home participating in the
study. This will establish how care home, NHS and MHS care staff define end-of-life care for older people
with dementia, the assessment and care tools they use, approaches to care, current service provision,
access to specialist services and level of training and expertise.
Amendment – submitted Southampton REC July 2009
In addition, early results are indicating that ambulance staff called to the care home will automatically start
resuscitation procedures even if a do not resuscitate agreement is in place for the person concerned.
We would therefore like to include data from the ambulance service about how they interpret their
responsibilities in these situations.
Ethical review and approval for the above amendment has been obtained. The Southampton and South
West Hampshire Research Ethics Committee A approved the amendment on 11 August 2009, reference
no. 08/H0502/74.
Data collection
In keeping with the study’s aim and objectives, data collection focuses on five main areas, summarised as:
l Baseline characteristics of the older people with dementia participating in the study, including: age,
gender, ethnicity, funding support, level of cognitive and physical function, medical conditions,
function and length of stay in the care home.
l How older people with dementia’s health and care needs change over time, the services they receive,
and key events in their lives over the 2 years that affect their health and use of services.
l Training and experience of care home and NHS staff to provide care to older people with dementia
and understanding of older people’s care needs at the end of life.
l Current assessment and management strategies for people with dementia within the care homes
(e.g. assessment tools, care protocols and end-of-life care frameworks).
l The physical environment, resources, and current access to health-care services of each participating
care home.
Older people with dementia: characteristics and change over time
A pilot of the tool to extract data from residents’ care home notes and care plans will be undertaken
within two care homes. The development of the tool is informed in particular by previous research projects
undertaken in care homes by members of the research team,429,430 the broader EVIDEM research
programme, and a further study lead by Professor Claire Goodman; EPOCH-ExPeriences of Older People in
Care Homes, examining experiences of living and dying in a care home.
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To address objectives one, two and five (above) we will record a baseline for all participants, where
possible, the following minimum data set of information (extracted from care home notes and care plans):
(a) Demographic details (name, date of birth, gender, marital status, first language, ethnicity).
(b) When appropriate: carer information (name, date of birth, gender, address, postcode, relationship to
person with dementia).
(c) GP and practice details (name, address).
(d) Cognitive status: if available, date of most recent test and score. In instances when unavailable, and an
individual is considered by care staff to exhibit symptoms likely indicative of dementia, a validated
measure of cognitive function will be undertaken.
(e) Functional status (date of most recent test and score) and Barthel score in discussion with the older
person’s key care worker.
(f) Behavioural/neuropsychiatric status.
(g) Medication.
(h) Co-morbidity (e.g. depression, CVD, diabetes).
We will review existing care plans (including details of advanced advance care plans, and other support
tools for end-of-life care and current medication, specifically the use of pain relief and sedatives, and
(if held in the care home) residents’ medical notes. These reviews will be repeated every four months over
2 years. Data extraction will focus particularly upon those areas of care that are most significant for
end-of-life care. These will include, for example, episodes of ill health, physical care needs, cognition,
discussion of advanced care plans, access and use of primary care and specialist services, out of hours
services, and bereavement/deaths in each care home. Particular attention will be given to those care needs
of older people with dementia that are modifiable and likely to respond to palliative care interventions
(e.g. evidence of experiencing pain, agitation, constipation, low mood, confusion, loss of appetite, fatigue).
Where possible, to complement the notes review, brief unstructured interviews are planned with a small
purposively selected sample of the older people participating in the study to explore their health, and
experiences of living in a care home. Events, reported by care staff, or documented in the notes, that occur
during the 4-monthly data collection intervals will inform the purposive selection. Events are those likely
indicative of a change in health status and care needs, for example, episodes of ill health, advance care
planning. We will also seek interviews in instances of incomplete documentation or an older person’s
expression of interest in the study. The interviews with the older participants will help to validate the note
review process and identify any changes over time in the older person’s function and cognition that may
not have been documented. This will also ensure that as far as is possible the person with dementia’s
experience of living and dying in a care home is acknowledged and documented. To facilitate older
people’s participation in an interview, we will draw upon different media, for example, ‘talking mats’ used
in previous research involving older people with dementia.434 The media used will inform how interviews
are recorded, for example, notes, audio tape.
For those older people who die during the study, care home and GP notes will be retrospectively reviewed,
with permission from the respective GP, to establish what services the older person received prior to death,
place of death and the care provided. A case study analysis of this group will combine the different data
sources for each person (interviews with older people and staff, case notes, field notes, services received)
collected over time and allow thematic and outcomes related analysis of the care these older
people received.
Amendment – submitted Southampton REC November 2008
Anonymous data from the reviews of residents’ care home notes and care plans (part of the study’s
dataset) will be shared with the EVIDEM Registry research study, entitled; ‘A registry of people with
dementia using services in the North Thames Dementia and Neurodegenerative Research Network
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(North Thames DeNDRoN) Region’. The EVIDEM Registry study intends to develop a unique and
comprehensive minimum dataset (MDS) of individuals with dementia (or symptoms likely indicative of
dementia) at differing stages in the disease trajectory (from diagnosis to nearing the end of life).
Recruitment to the Registry is intended through inclusion of anonymous patient data from the four
EVIDEM research studies and direct recruitment to the registry (e.g. via general practices).
Ethical review and approval for the EVIDEM Registry has been obtained. The Southampton and
South West Hampshire Research Ethics Committee A approved the EVIDEM Registry research study
on 30 June 2008, reference no. 08/H0502/34. Ethical approval has also been given for the EVIDEM
research study ‘Promoting Continence and Managing Incontinence at Home’ that includes sharing of
anonymous patient data with the EVIDEM Registry study. Ethical approval was obtained from Camden
and Islington Community Local Ethics Committee on 29 September 2008.
The above amendment was approved by the Southampton and South West Hampshire Research Ethics
Committee on 6 March 2009, reference no. 08/H0502/74.
Care home and NHS staff training and experience
To address objectives three, four and five (above), and understand how care home and NHS primary
care staff conceptualise, recognise and provide end-of-life care for older people with dementia, we
will undertake audio recordings of semi-structured interviews with the care home managers from the
participating care homes, and up to five care workers (sampled to reflect the range of experiences
and seniority within a care home), up to three NHS staff (i.e. GP, district nurse and palliative care
specialist). Semi-structured interviews will cover participants’ length of employment, training, knowledge
on end-of-life care and use of relevant tools for the assessment and care of people with dementia,
experience and attitudes towards providing end-of-life care for people with dementia, and working with
generalist and specialist palliative care services.
Practitioners will be asked to provide up to three examples of where they have provided end-of-life care to
an older person with dementia in the study care homes. These examples will help to illustrate what
supports and inhibits good end-of-life care for people with dementia.
Emergency care staff
The focus of the interviews was the impact dementia had on the treatment, and care that was provided
and the decision-making processes, as well as the policies and protocols used at the end of life. Particular
attention was given to the use of Do Not Resuscitate orders and the challenges of adhering to patient
wishes, and other challenges that may arise when treating someone who is at the end of life. Finally, two
scenarios were described and participants were asked how they would respond to these fictional scenarios
and why, if they received the call out. This helped the researchers understand the circumstances and
decision-making process when placed in difficult situations.
The care home environment
To inform objectives three and four, in each of the participating care homes we will review care home
documentation and policies for evidence of end-of-life care training, use of frameworks and support
tools, and guidance on end-of-life care and evidence of the involvement of older people and relatives
in end-of-life decision-making.435 This will include the review of support materials used for training
programmes on working with people with dementia and end-of-life care implementing the Mental
Capacity Act 2005.
We will also review shared documentation, such as, integrated care pathways, e.g. continence
management, and notes that show evidence of older people with dementia’s use of related services, for
example, specialist palliative care, hospice support and out of hours services, as well as documenting
informal support available to the home (e.g. volunteers, older people advocates and faith organisations).
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Analysis of data
Quantitative data
This is a prospective study that aims to describe the symptoms, health needs, care received and
experiences of older people with dementia resident in a care home, and their pathway to death. Analysis
will focus on physical and mental care needs, social relationships, care interventions, access to support,
documented hopes and expectations about death, and access and use of primary care, specialist palliative
and psychogeriatric services. Quantitative analysis will include descriptive statistics to summarise the
attributes and key events in the lives of the older people over time. This data will provide information
about the frequency and pattern of death in the care homes, services that were available to the older
people, and the place of death. To ensure the volume of data is managed appropriately, the data will be
specifically analysed to consider what it reveals about living in a care home with a diagnosis of dementia
and the pathway to death, including:
l mapping key events
l episodes of ill health and related prescribing
l care provision within the care home
l access to generalist and specialist NHS services
l place of death, evidence of use and implementation of advance care planning, and care home staff’s
expectation (or not) of death and impact on the care provided.
Where older people have received palliative care, analysis will draw on Corner et al.’s436 matrix of evidence
for making judgements about the type of palliative care interventions received.
Qualitative data
Summaries of documentary reviews and interview transcripts will be thematically analysed using computer
software for qualitative analysis (N7) to facilitate storage, retrieval, and analysis of the data. Data analysis
will follow a process of data reduction and data complication to identify prominent themes and their
interrelationships.437 The analysis will involve three stages:
1. a process of familiarisation and categorisation by reviewing and segmenting data into separate and
defined categories that are close to the participants’ and documents’ own categories
2. categorical and thematic comparisons within and between groups (e.g. care staff, NHS staff, older
people) and the identification of preoccupations, differences and themes
3. data interpretation and recontextualisation to identify thematic relationships and working hypotheses
on, for example, pathways to death for people with dementia in care homes.
Credibility of analysis will be achieved through comprehensive data analysis, such as, searching for rival
explanations for emergent themes, and peer debriefing with the research team and the steering group.
Economic analysis
The resource implications of providing end-of-life care for people with dementia resident in a care home will
be documented and cost calculated. This will include the health and social care services provided by care
home staff, and NHS generalist and specialist practitioners. The skill mix and relative contribution of
different services will be compared across the different care homes in a cost–consequence framework.438
This will incorporate the perspectives of health and social care services, older people with dementia, care
home staff and other practitioners providing services to the care home.
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Ethical issues arising from the study
There are ethical issues about researching sensitive issues and ensuring voluntary and informed consent in
a closed community such as a care home. We propose a framework for participatory and inclusionary
consent compatible with the Mental Capacity Act 2005. Consent will be seen as an ongoing and context
specific process. We will aim whenever possible to include people with dementia or confusion in every
stage of the study. It will be stressed throughout the negotiation for access, and within the consent
process, that this study is about living in a care home and approaching the end of life. We will also ensure
that in each care home processes are in place that support the older person and can address any issues
that may arise from participation.
The researchers are very experienced with professional, personal and research experience of working with
older people that are vulnerable. Dr Evans as the research fellow is an experienced academic and primary
care nurse, who has specialised in the area of gerontology completing a doctoral study that involved
working closely with care home staff and interviewing older people in care homes. The researchers will
work closely with the senior members of the research team to provide continual supervision, support and
guidance. Specific ethical issues arising from this study are:
l Anonymity and confidentiality All participants will have a unique identification code. No names, or
identifying details, will appear on any data collection forms, analysis or draft and final reports. During
data collection, access to the names and contact details of participants will be restricted and these will
be kept in a password protected computer at the University of Hertfordshire. Those with access will be
the research fellow, and members of the research team. All participants will be guaranteed anonymity
in written reports, summaries of data analysis and a summary of the findings will be sent out to
participants for their comments prior to publication and dissemination. The care homes will not be
identifiable and if necessary distinguishing details that are not central to the study will be changed to
ensure they are not recognised
l Consent Care home staff, NHS staff and the older people, may feel they are obliged to take part in the
study because either their manager or care worker has identified them as possible participants. They
may feel that refusal to participate could adversely affect either their relationships with their employer,
or their care worker. In introducing the study to the managers and care home staff, care will be taken
to ensure no one feels coerced or obliged to take part. The information sheets stress that participation
(or not) in the study will not affect the care they receive or their relations with other people in the care
home or primary care services. At each stage of the recruitment process, the researchers will re-iterate
that participation is voluntary.
l People with cognitive impairment/limited understanding The research team in this study have over
10 years experience of working with people who find consent and participation in research difficult,
arising from problems of dementia, confusion or illness and fatigue. For people with cognitive
impairment, the approach will be informed by the principles of the Mental Capacity Act 2005 that
assumes that all adults are capable of giving or refusing consent unless proven otherwise, and that the
best interests of the person who lacks capacity are paramount. It is therefore an assumption of
the study that older people who may experience short term memory and cognition problems can
nevertheless consent in the moment, and that it is the responsibility of the researcher on each occasion
to review the study aims, confirm with the participant that they are willing to participate in the study
and ensure that they are not alarmed or distressed by the experience.439,440 At the stage of initial
consenting, the researcher will ensure that the participant is given full opportunity to have the study
explained to them in a way that best meets their individual needs. If there is an intermediary, such as a
care worker or family carer, with whom the older person particularly relates, the researcher will ensure
that this intermediary is present and able to explain and, if necessary to interpret any areas of concern
of lack of understanding.
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In situations where an older person has been formally assessed, and it is documented that they do not
have the capacity to consent or take part in an interview, we will ask the older person’s consultee
(e.g. a relative) if, based on their knowledge of the older person allowing a researcher to review his/her
care notes would upset or distress them (see below).
l People judged by the practitioner/professional who works most closely with them as lacking capacity to
give (informed) consent For those judged by the care worker/care home manager who works most
closely with them as lacking the capacity to give consent, or when an older person during the course
of the study loses the capacity to consent, a consultee (as outlined in the Mental Capacity Act 2005)
will be consulted about the older person’s care notes being reviewed for the purpose of the study.
The care home manager will be asked to write to the consultee about the study and they will be asked
to assent to enrolment of the person with dementia. The researcher will arrange to see the person
with dementia and his/her consultee to seek their written support for the older person’s participation in
the study. In the event that a consultee cannot be identified, then the person with dementia will be
excluded from the study.
l Risk There is some risk that involvement in this study may affect an older person’s care by an individual
providing or expressing information of which care home and NHS staff were unaware, or through the
disclosure of risk. At all stages the researcher will make clear that they cannot be involved in an older
person’s care in any way. However, failure to disclose information about observed or reported poor
practice may harm an individual particularly if a researcher chooses not to intervene in a potentially
damaging situation.441 If any risk (e.g. evidence of elder abuse, inadequate care, an acute health need)
is disclosed or observed, procedures are in place to address this as part of the study protocol and
reflect CSCI, PCT and university guidance and procedures. This will be discussed with the care home
staff and NHS staff prior to the commencement of data collection.
l A vulnerable group This research will be conducted with a group of people who are ill, easily tired and
who may be vulnerable for a number of reasons. The older people will be treated with dignity and
respect at all times, and the researchers who will have contact with the participants are experienced in
working with people of very advanced age. Data collection procedures, and participants’ responses, will
be carefully monitored and reviewed by the research team throughout the study. The wellbeing and
support of the participants in the study are study priorities.
l Emotional support and supervision for researchers and members of the Public Involvement Group This
kind of research is challenging. The contact with the older people and their care workers over time
means that the researchers will know some of the older people in the study quite well and be affected
if they should die during the study. The research team will meet weekly to debrief and review issues
together and meet with their respective research manager (CG) every 2 weeks to ensure
adequate support.
Project management and governance
This research will operate under the Research Governance Framework, and the University of Hertfordshire
will be the sponsor. As the study involves older people in care homes, and care home staff, we shall also
apply for ethical permissions from the relevant social services’ research governance group within the Local
Authority departments of social care who work with the participating PCTs.
User and service involvement
An expert advisory panel of representatives from service and the Public Involvement in Research group has
been commenting on and influencing the research process throughout, and will continue to do so. There
is a heavy reliance on collaboration and co-operation between the research team and service partners.
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Dissemination and development of Phase 2
Throughout this study, the identity of all participants and the care homes will be protected and will remain
confidential to the study team. All findings will be reported in a way that ensures that no individual,
or the study settings, can be identified. A number of dissemination strategies, in partnership with key
stakeholders and representative organisations, will be used to ensure the findings inform policy and
practice development in end-of-life care for people with dementia. In addition to the traditional methods
of dissemination through peer reviewed and professional publication and conference presentations, we
propose to disseminate findings through:
l Presentations to staff, residents and their relatives in the participating care homes and key professional
service and user representative groups.
l Workshops for community and palliative care nurses providing end-of-life care to people with dementia
in care homes.
l Sending a summary report of findings to all participants who wish to receive this.
l Organisations that the research team have strong links with will be included in a planned process of
dissemination, including e-alerts, seminars and publications e.g. Royal College of Nursing, Alzheimer’s
Society, National Care Homes Research and Development Forum, DeNDRoN, Dementia Care, Royal
Society of Medicine (geriatrics and specialist gerontology section), Queens Nursing Institute, Better
Government for Older People, Social services’ research group ‘Making Research Count’, Help the Aged
and Age Concern. The planned process will include, for example:
¢ Production of summary findings and briefing papers, in collaboration with ‘My Home Life
Programme’ for dissemination and discussion with their care home partners (English Community
Care Association; National Care Association; National Care Forum), and relative and patient
representative organisations.
¢ Academic and professional conference presentations (including Dementia and Care Home
Congress, and Palliative Care Congress).
¢ Links with initiatives by the National Palliative Care Council, Marie Curie, and Alzheimer’s Society
for end-of-life care for people with dementia in care homes.
The findings from Phase 1 will be fed back to the participants for comment and review. Four care homes
from Phase 1 will be involved in Phase 2 of the study. These will be homes interested in developing and
testing a toolkit for supporting people with dementia at the end of life. Findings from Phase 1 will inform
the development of a protocol to develop and test the toolkit. A separate NRES submission will be made
for Phase 2.
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Appendix 36 Chapter 4: Phase 2 protocol
REC Ref: 10/H0502/55
EVIDEM-End of Life: Changing practice in dementia care in care homes: developing and testing evidence-
based interventions at the end of life – Phase 2.
Introduction
Approximately two-thirds of people living in care homes have limited mental capacity119 and it is estimated
that 54% of people with dementia are living in care homes.2 Research consistently shows that it is very
difficult to identify when someone is no longer living with dementia but dying from or with it.406
Consequently, decisions about when to withhold treatment and how to provide palliative care are often
influenced by the context of care, professional, and family beliefs and values. To date, research on
end-of-life care for people with dementia has been dominated by US-based research and on prognosis and
studies on decision-making on withdrawal of particular treatments (e.g. use of antibiotics and artificial
feeding), and interventions to reduce unplanned hospital admissions.241,442 The majority of research has
been conducted in nursing homes rather than residential care homes and the research questions reflect
the priorities and concerns of health-care professionals and services.
There is minimal evidence of residents, relatives and care home staff being involved in discussing and
identifying research priorities for end-of-life care for people with dementia, or models of care that go
beyond the individual patient-focused encounter There is a need to develop and test dementia-specific
approaches to providing comfort and avoidance of distress for this vulnerable and often marginalised
population that are grounded in the everyday experience of residents and care home life.211
An emphasis on improving the quality of end-of-life care for older people living in care homes is the focus
of the NHS End of Life Care programme for care homes.209 Within this programme there is a commitment
to providing patients with more choice in how they are cared for at the end of their life and where they
die. It aims to extend the boundaries of palliative care provision to ensure that when residents in care
homes are dying they can avoid emergency hospital admissions and be supported by care home and NHS
staff skilled in providing end-of-life care.
Care homes at the time of writing were being encouraged, in collaboration with NHS staff, to use
palliative care support tools such as the Gold Standards Framework,213 the Preferred Priorities for Care,443
and the Liverpool Care Pathway.215 Studies that have evaluated these interventions report an increase in
staff confidence and knowledge, a reduction in unplanned hospital admissions, and an increase in people
being able to die in their care home as the preferred place of care.216,217 However, other commentators and
researchers have asked whether equivalent improvements can be achieved with the use of alternative
approaches to joint working between health-care and care home staff, and if, with these tools, there is a
danger of medicalising the dying process.444 Care homes are a sector that are already under-resourced and
the assumption that they can accept end-of-life care responsibilities without appropriate support and
resources could have unintended consequences for the overall focus and quality of care that care home
staff can provide.246
This protocol is informed by the NHS End of Life Care Programme and builds upon longitudinal research
on how people with dementia live and die in care homes. It will be informed by a participatory research
approach that will support collaboration between researchers, care home staff and NHS staff that visit the
care homes.
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It aims to develop and refine an intervention that encourages integrated working between primary care
health services and care home providers, to provide end-of-life care for older people with dementia and
develop a resource that can inform future service development and research for people with dementia
living and dying in care homes. It builds on initiatives and practice development work that have focused on
improving/changing the organisation and quality of end-of-life care within care home settings (for example
Hewison et al.239).
Study aims and objectives:
Aims and objectives:
1. To identify with care home and primary care staff, and relatives, strategies to support integrated
working between care home staff and primary health care services for end-of-life care for people
with dementia.
2. To test ways that primary health-care services and care home staff can work together to identify
resident and organisational aims/outcomes to support end-of-life care that reflect the priorities,
experiences and concerns of older people with dementia living in care homes and support required at
end of life.
3. To consider how available palliative care support tools and frameworks act as a resource for primary
health care services and care home staff, to manage uncertainty at the end of life.
4. To identify facilitators and barriers to collaborative working to support and sustain effective end-of-life
care for people with dementia living in care homes.
Background
Phase 1 of EVIDEM-end of life tracked the care received by 133 people with dementia living in six different
care homes (residential) during the 18 months of data collection. Twenty-seven (20%) people died. In the
event of a person dying, the research team, where possible, conducted post-death analyses, consisting of a
final care note review and a brief interview with an appropriate carer or care home manager about the
circumstances of the death. Of the 26 post-death analyses complete, 11 (42%) died in hospital. A further
six (4.5%) people were lost to follow-up after being transferred to other care homes or nursing homes.
How people died was very variable, shaped by which NHS services were involved, and whether it had been
formally recognised that they were dying. The most commonly recorded symptoms at the point of death
were decreased appetite, increased sleepiness, decreased mobility, and shortness of breath or breathing
difficulties. The majority of the people that died saw the GP and/or the district nurse at least once when
approaching end of life. Interestingly, 10 of the 27 deaths were recorded as dying out of hours (when out
of hours was defined as from 6.30 p.m. to 8.00 a.m. on weekdays and all day at weekends and on bank
holidays), and for a further 10, the time of death was unknown. Furthermore, 16 were recorded as being
admitted to hospital at least once during the previous year before death, with seven of these returning
to the care home, where they later died. It was also found that there were often discrepancies between
what was recorded in the care home notes and what the researchers were told at the point of interview,
particularly in relation to wishes surrounding preferred place of care.
Interviews with care home staff, district nurses, GPs and paramedics revealed a commitment to providing
high quality, end-of-life care that ensured the person with dementia’s symptoms were palliated and they
were able to die in their place of choice. However, findings also suggest a lack of confidence and
knowledge when supporting people with dementia at the end of life. This was in part because of the
heterogeneity of the dying experience for people with dementia and the disconnect between the espoused
principles of good end-of-life care and staff’s ability to apply them to particular events and situations
within the care homes.
APPENDIX 36
NIHR Journals Library www.journalslibrary.nihr.ac.uk
456
Tools to support assessment and recognition of the need for palliative care were known and valued
(mainly by NHS staff), but participants expressed uncertainty about how to use them to support people
with dementia at the end of life. Staff struggled to provide examples of how the tools had supported
end-of-life care for a person with dementia except in one instance where a palliative care register was
cited as having improved communication between GPs and out of hours services.
Health service staff definitions of when someone was approaching the end of life varied, and did not
necessarily reflect how older people and care home staff identified their needs for support and their
priorities for end-of-life care. For NHS staff there was a proscribed amount of time when they were likely
to become involved in providing end-of-life care. Despite recognising dying could be a prolonged process,
and their belief in the importance of building relationships, their involvement invariably was during the last
week and days of life. Furthermore, whilst there was recognition from all participants that providing
end-of-life care for people with dementia was difficult and required extra training and knowledge, there
was no consensus as to who had (or should have) this knowledge, or more importantly, should lead and
co-ordinate the care. However, GPs were most frequently the person suggested. For care home staff it
could be a difficult transition to move from providing every day care to someone with dementia to
providing end-of-life care.
NHS staff were regular visitors to the participating care homes and there were frequently occurring
opportunities to meet with care home staff to talk about residents. However, these encounters were
largely unstructured and specific to particular residents in the care home. Findings suggested that
participants would welcome strategies that helped primary health care services and care home staff
develop ways of collaborating that could be mutually supportive, address their uncertainties about how to
support people with dementia, promote shared learning and incorporate regular review of the care needs
of the residents.
The majority of NHS primary care staff, (in particular the district nurses and GPs but not the paramedics)
were familiar with palliative care support tools such as the Gold Standards Framework,213 Preferred
Priorities for Care443 and the Liverpool Care Pathway,215 but only a minority had used/were using these
resources for people with dementia living in care homes. Many were unsure how to take this forward, or if
it was their role to do so. An assumption of many of the palliative care tools that care notes can support
and guide how practitioners review care together, and document decisions and future plans was not
supported by the review of residents’ notes. Phase 1 highlighted that care homes would mainly use notes
to record care and past events, and not as a tool to plan and review care with the different services and
practitioners involved in the individual’s end-of-life care.
Interviews with older people with dementia demonstrated that they were able to articulate their opinions,
preferences and concerns about living in a care home, and for some, anxieties and unmet spiritual needs
about approaching the end of life. What they appeared to value was having the time to reflect and talk
with someone about their end of life as one element and expression of having meaningful relationships
with staff and family members. This was linked to the need to find meaning and purpose to their life in
the care home and some resolution of past losses and events that had led to them being admitted. For
many, what happened in the future was not as important as how they felt now about living in the care
home, or the events that had led to their admission to a care home. Older people were not sure with
whom, in the care home or from the primary health care staff that visited the care home, they would or
could talk to about their preferences and priorities for care. Longitudinal data did, however, demonstrate
that for the majority of residents, there was enough time (at least a year) to initiate and sustain these
conversations and, where appropriate to involve relatives in discussions before a crisis or event occurred.
The findings indicate that there is a need to review and develop existing resources and palliative care
support tools in two ways. Firstly, to contextualise any intervention to support end-of-life care for people
with dementia, as one aspect of care that assumes older people with dementia have the opportunity to
discuss and express what is important to them about living in a care home. Secondly, to develop or modify
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interventions and tools that equips NHS and care home staff, residents and their relatives, to live and work
with the uncertainties of providing end-of-life care to people with dementia, and that can be incorporated
into, or developed from existing patterns of working and collaboration.
Phase 2 aims to begin to address these issues and develop a model of collaborative working for end-of-life
care for people with dementia through working in partnership with care home and primary care staff in
three care homes.
Method
Research approach
Phase 2 will use a participatory research approach that is informed by the principles of action research. This
is an approach that emphasises shared objective setting, review, and development as part of the research
process, and refinement of the intervention.445 It offers an opportunity to use the findings from Phase 1 to
inform problem identification and problem solving, as an activity shared and negotiated between the care
home and NHS staff, the research team, and the residents and their families; a process that will aim
to develop an intervention that reflects the preoccupations and context of care which is relevant and
grounded in everyday practice.
In three care homes that have already participated in Phase 1 of the study we will facilitate regular
meetings over 1 year to:
l review and discuss the findings from Phase 1 of the study together, and their implications for the
residents with dementia living in the care home
l identify from a suggested list of changes (drawn from the findings of Phase 1) an aspect of end-of-life
care they would want to focus on
l agree study objectives and a strategy for change that can be jointly implemented during the data
collection period
l implement, review and refine the intervention
l evaluate the change against the objectives and desired outcomes.
In the three participating residential care homes, care home staff (including the manager or deputy
manager), and the NHS staff that work most closely with them to provide end-of-life care for people with
dementia (GPs and district nurses) will meet with the research team.
In the first 3 months of the study, (following ethical and governance approvals and recruitment of residents
and staff) at a series of meetings (up to four per care home) facilitated by the researchers, we will discuss the
proposed approach, the level of commitment required participants’ preferences for structuring shared working
and discussions into existing patterns of contact between primary care and care home staff.
Months 3–6 The participants will review with the research team the findings from Phase 1 and discuss
what the findings reveal about how care is provided within the care home and in collaboration with NHS
services, key assumptions about what end-of-life care involves and what the priorities are for the different
participants. The purpose of the discussions will be to discover how care home and NHS staff interpret
the findings, discuss priorities and agree together an aspect of working together that can be improved.
Based on the findings we anticipate that the areas they could choose to focus on will be on strategies/
interventions that:
l enable NHS staff and care home staff to better work to create opportunities over time for discussion
with the older person, and where appropriate their family, their priorities for end of life and review
together the implications this has for how they work together, what tools they use and how they can
maintain communication
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l support NHS and care home staff to review and plan together the care of people with dementia who
are not well/showing signs of deterioration, but it is unclear if they are dying
l develop shared approaches when key decisions are needed that involve NHS staff for example need for
extra care, management of symptoms experienced by people with dementia as they approach the end
of life
l develop strategies that enable care home and NHS staff to incorporate end-of-life care into every day
practice, and to manage uncertainty.
As part of this process, and facilitated by the research team, participants will work together to discuss and
refine research questions/objectives, plan achievable change, and evaluate the outcomes and effectiveness
of the intervention(s).
Months 5–10 The participants will develop with the research team (and where appropriate, experts in
end-of-life care and care of people with dementia), the chosen area of end-of-life care they want to work
on together. It is anticipated this will be an iterative process of discussion and review facilitated by
the researchers.
Months 10–12 The participants will review progress against the stated objectives and desired outcomes.
In order to understand the impact of the intervention on resident experience over time, and ensure their
experience is central to the study, we will track the care received by residents with dementia from each of
the participating care homes. This will involve approximately 75 residents in total. We will document their
access to and use of health-care services continuity of care and involvement in decision-making. Where
possible and appropriate we will conduct discussions with up to five older people with dementia in each
care home for up to two times over the year, and their key care workers (including health-care staff),
review their case notes to identify any key events, assessment and support tools used, frequency of contact
with health care and service uptake.
This data will be compared with equivalent data collected in Phase 1 and show if integrated working
to plan for and support end-of-life care makes a difference to the process of care, residents’ health needs,
their quality of life, and use of services including unplanned hospital admissions, length of hospital stay
and transfers to nursing home care.
We will carefully monitor the resources involved, and estimate the costs of the chosen interventions. We
will use interviews, focus groups and documentary review to complement the older person’s experience,
and obtain a detailed understanding of the context of the care homes and services that work with them.
In addition to the development of the interventions and the related documenting of the process,
participants’ views and contributions at each of the three care homes, we will undertake the following:
l interviews with family carers/relatives (n= 5–8)
l documentary review of care home and PCT related documentation (e.g. shared protocols/assessment/
care planning, joint funding agreements, integrated pathways and service level agreements)
l interviews with key stakeholders (e.g. PCT manager, palliative care specialist services, paramedic/
ambulance services).
Anonymous data from the reviews of residents’ care home notes and care plans (part of the study’s
dataset) will be shared with the EVIDEM Registry research study, entitled ‘A registry of people with
dementia using services in the North Thames Dementia and Neurodegenerative Research Network
(North Thames DeNDRoN) Region’. The EVIDEM Registry study intends to develop a unique and
comprehensive minimum dataset (MDS) of individuals with dementia (or symptoms likely indicative of
dementia) at differing stages in the disease trajectory (from diagnosis to nearing the end of life).
Recruitment to the Registry is intended through inclusion of anonymous patient data from the four
EVIDEM research studies and direct recruitment to the registry (e.g. via general practices).
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Ethical review and approval for the EVIDEM Registry has been obtained. The Southampton and South West
Hampshire Research Ethics Committee A approved the EVIDEM Registry research study on 30 June 2008,
reference no. 08/H0502/34. Ethical approval has also been given for the EVIDEM research study ‘Promoting
Continence and Managing Incontinence at Home’ that includes sharing of anonymous patient data with
the EVIDEM Registry study. Ethical approval was obtained from Camden and Islington Community Local
Ethics Committee on 29 September 2008.
Data analysis will establish how the findings from Phase 1 impact on how participants set priorities for
end-of-life care and work together and whether the chosen interventions and their implementation
influence the process and networks of care available to the older person with dementia.
We anticipate that resident and organisational outcome measures will focus on how older peoples’ views,
priorities needs and choices are supported through the chosen interventions, their effect on quality
of life and wellbeing, continuity of care, staff satisfaction, use of resources, services, and the costs of
implementation. The cross case comparison of how the three care homes implement shared working to
improve end-of-life care for people with dementia will enable us to establish how priorities and outcomes
are defined, key achievements, and distinguish between those processes of negotiation and development
that are common to all settings, and those that are context specific. It will also enable a comparison of the
costs and effectiveness of different approaches to end-of-life care.
Recruitment
We will recruit three care homes from the six care homes that participated in Phase 1 of the EVIDEM-End
of Life study. All six care homes will receive a summary of the findings from Phase 1 and the proposal for
Phase 2. Recruitment will be primarily based on interest and willingness of NHS and care home staff to
participate in Phase 2 of the study and commit to a further 18 months of data collection.
If more than three care homes and their partner NHS primary care teams express an interest in
participating, we will purposively select three care homes that represent diversity of approaches to
end-of-life care and expertise in palliative and dementia care.
The findings from Phase 1 highlighted that the majority of care homes could provide some examples of
providing end-of-life care at the patient level. However, even at the individual patient level of care there
was a wide range of how dying was defined, how decisions were made about keeping the older person in
the care home and the actual intensity and involvement of NHS staff. For example, in terms of the level of
care home contact with primary care services, use of support tools such as the Liverpool Care Pathway,
involvement of relatives in decision-making, etc.
Inclusion criteria would be:
l perceived good working relationship between NHS and care home staff and willingness to commit to
work together on EVIDEM-EoL
l ability to commit to a minimum of four face-to-face meetings over the year’s data collection
l methods of sharing information and some documentation about patients in particular aspects of care
for end-of-life care between the care home and primary care staff (GPs, district nurses, specialist
palliative care support) linked to the care home.
Exclusion criteria would be:
l only one of the participant groups (NHS or care home staff) are interested in the study.
APPENDIX 36
NIHR Journals Library www.journalslibrary.nihr.ac.uk
460
Recruitment of health-care professionals
The research team will meet with possible participants, either as a group or as individuals, to discuss the
study and answer any questions. The research team will then wait a minimum of a week before
seeking practitioners’ individual written consent to participate. All health-care professionals will fit
the following criteria:
l act as the main contact for the care home they work with (where more than one General Practice and
attached community nursing team visits the care home we will recruit the team that has the most
frequently occurring contact)
l have been going into the care home in question for at least a year
l be able to commit to a minimum number (i.e. four) of meetings at the study care home.
Recruitment of care homes
Care homes will be recruited on the basis that:
l The care home is for older people offering personal care including specialist support for dementia.
l Can identify NHS primary care staff that they would be able to work with.
l Be able to commit to a minimum number of meetings at the care home and support staff in their
participation (e.g. agree to release them from other duties for the period of the intervention).
l Regardless of how they are identified initially, recruitment will follow the same process. After an initial
meeting between the care home manager and members of the study team, for interested care homes,
separate meetings will be set up with care home staff and residents to outline the study, what it
involves, give them information sheets and answer any queries. Following these meetings the care
home manager will be asked to confirm whether or not the care home has decided to participate.
Permission may also need to be sought from the care home organisation it belongs to.
Recruitment of care home staff
Following the initial meeting to explain the study to the staff as a group, give out information sheets and
answer queries, those staff who have expressed an interest will be approached individually so they can be
given further information and voice any questions. Those agreeing to participate will be given at least
48 hours to decide whether or not they want to participate. They will be asked to sign a consent form
endorsing their agreement to take part. It will be emphasised that participation is purely voluntary and that
they can change their mind at any time without giving a reason. Where some members of the group do
not agree to the interview being recorded, only notes will be taken. Researchers will reiterate to all staff
that their participation is voluntary and that they can leave the study at any time.
Recruitment of older people
The older people who will be recruited will fit the following criteria.
Inclusion criteria
l Resident in care home for a minimum of 4 weeks.
l Have a diagnosis of dementia and/or be perceived by staff as having dementia.
l Have the capacity to understand and consent to participate in the study, or have a nominated
consultee who could provide an opinion whether the older person, if they had the capacity, would
have wanted to take part in the study.
l Anticipated to be resident in the care home for the coming year.
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Exclusion criteria
l Has a mental health problem (not caused by the ageing process).
l Does not have capacity to consent in the moment or an identifiable consultee (see above) who can be
approached for their opinion.
l Cannot speak English and an interpreter not available in the participant’s language.
Following the initial meeting, the older person will be provided with an information sheet and consent
form and given at least 48 hours to consider the information before further contact by the researcher.
For those who are agreeable, a meeting will be set up with a member of the study team to explain what
involvement in the study means for them, and answer any questions they may have. All residents will be
given at least 48 hours to consider their participation before a member of the research team revisits them
to answer any further queries and confirm whether or not they would like to take part. It will be made
clear from the start that a decision to take part in the study is entirely voluntary and a decision not to take
part will not affect their care in any way.
All of the older people in this study have complex needs, and will include people who are in difficult
circumstances, who may be vulnerable, have communication or recall difficulties and may tire easily.
At every stage verbal consent to continue will be obtained and the opportunity offered to defer or shorten
the time of involvement in the study. Those who have special communication needs will be interviewed
using communication aids if appropriate.
Recruitment of family/relatives
Family members and relatives of older people will be invited to attend the initial meeting with residents to
give them information about the study, and will also be given an information sheet outlining the study.
At the end of the study we will invite by letter family members of residents who have died during the
study to ask if they would be willing to take part in an interview to gain insight into their perspective on
their thoughts and views about end-of-life care. Those who express an interest will be asked to contact the
researchers for further information. A member of the research team will meet with relatives individually to
discuss the study and answer any queries. They will be given at least 48 hours to consider whether or
not they would like to participate, after which they will be consented individually. However, it will be
impressed upon them that taking part is voluntary and that they may withdraw from the study at any
time without giving a reason. The interview will be held in a private room within the care home, the
participant’s home, or the host university, depending on which is more convenient for the participants. It is
possible that taking part in an interview could trigger distress. The possibility of this will be discussed with
participants prior to the interview and what might help to reduce the impact of talking about a recent
bereavement. Participants will be offered the option of writing down their thoughts or being interviewed
with a friend or relative present if that is preferable to a one-on-one interview. Contact with relatives will
not be made before a minimum of 8 weeks has elapsed since the resident has died.
Amendment submitted NRES Committee South Central – Southampton A
(May 2011)
Preliminary findings from Phase 2 have demonstrated how influential the relative can be in decision-making
around end-of-life care. Following discussion with the EVIDEM-EoL steering group it was agreed that it
was important to include the views of relatives of residents living in the care home.
It is proposed to extend the study to include views of all relatives, and not restrict data collection to
capture only the views of relatives who have had a relative die in the care home (as stated in the original
proposal). The same protocol as before (consenting, information, etc.) will be followed. We will recruit to
up to 15 relatives, who will be approached in the first instance by the care staff to see if they are willing
to talk. Some of the relatives will have a family member who is taking part in the study and others may not.
They will be given at least 48 hours to consider whether or not they would like to participate, after which
they will be consented individually. However, it will be impressed upon them that taking part is voluntary
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and that they may withdraw from the study at any time without giving a reason. The interview will be held
in a private room within the care home, the participant’s home, or the host university, depending on which
is more convenient for the participants.
The above amendment was approved by the South Central – Southampton A
Committee on 27 May 2011 (REC reference 10/H05002/55 – amendment number 1)
Interviews with stakeholders
Semi-structured interviews with NHS health-care professionals and up to three stake holders (e.g. Care
Quality Commission, PCT Commissioners, Directors of Primary Care Services) at the end of the study to
establish how they understand end-of-life care is provided, how the older person is identified as needing
the service, how the older person’s needs are assessed and care is planned, and to what extent the care
home staff are involved with this, and the time different team members spend in discussing and planning
care/end-of-life intervention, the skills and knowledge needed and range of activities this involves.
Data collection
General
Multiple sources of evidence are needed to provide a full picture of how the different end-of-life care
related interventions are implemented and experienced across the three study sites by care home staff,
health-care professionals and older people resident in the care homes. By triangulating a range of data
sources, it will be possible to demonstrate which characteristics of integrated working are specific to
certain circumstances, and which are transferable and can be shown to achieve different types of
outcomes for older people. This phase of the study will use mainly qualitative data collection methods
including face-to-face interviews; care notes reviews, documentary review and field notes.
Data collection will be undertaken as follows:
(a) Where feasible discussions with a number of older people with dementia per care home, over the
period of 1 year to establish their views and perspectives of living and dying in the care home and if
this changes over the period of the study, if appropriate to the chosen intervention.
(b) Two reviews of each older person’s care home case notes including, demographic information, care
plans and ongoing updates, at 6-monthly intervals, over the period of 1 year to establish their care,
planned and ongoing, health-care services received including any hospitalisations and any changes in
their health status and needs.
(c) Field notes and observation documenting the detail and outcomes of meetings between the care home
and NHS staff and the researchers and the implementation process in the care homes of the
chosen interventions.
(d) Review of key documents and tools that are shared by the care home staff and health-care
professionals such as care pathways, shared notes and assessment tools, to establish the structural and
organisational context of end-of-life care.
(e) Semi-structured interviews with care home staff at the beginning and end of the study to establish, the
support they consider the older person needs when they are dying, how they define end-of-life care,
how often they see the health-care professional and where, how the health-care professional and the
care home staff work together, and any support and training received from health-care
staff, or they would like to receive, and what facilitates and or hinders integrated working with the
health-care professional.
(f) One focus group will be conducted with up to 10 care home staff of differing levels of experience and
seniority. This will be facilitated by two members of the research team and will be recorded if the
group consents to this unanimously, otherwise only notes will be taken. The interview will be
conducted in a private room in the care home at the convenience of the staff, using a semi-structured
format that will focus on their experiences of the implementation of the chosen intervention and
working with health-care professionals to provide end-of-life care. It will explore the level of contact
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they have, how they communicate and feed back information about the older people receiving care,
and perceived facilitators and barriers to integrated working with health-care professionals.
(g) Semi-structured interviews with NHS health-care professionals and up to three stakeholders (e.g. Care
Quality Commission, PCT Commissioners, Directors of Primary Care Services) at the beginning and end
of the study to establish how the older person is identified as needing the service, how the older
people’s needs are assessed and care is planned, and to what extent the care home staff are involved
with this, and the time different team members spend in discussing and planning care/end-of-life
intervention, the skills and knowledge needed and range of activities this involves.
(h) Interviews (either face to face, or over the telephone) with relatives of older people who have died will
be conducted where the relative is able. Contact will not be made before a minimum of 8 weeks has
elapsed since the resident has died. Interviews will last up to 30 minutes, and will explore the relatives’
experience of the end-of-life care the older person received, including services and communication with
the care home and NHS. Alternatively, the relatives will be given the option to write their thoughts
down in the event that they feel an interview may be too distressing.
Data collection: older people
For those older people with dementia, who have the capacity to consent in the moment, they will be
interviewed up to two times over the study in a private room within the care home. As the research
is being conducted with frail older people who may tire easily, the interviews will last for a maximum of
30 minutes or less if it is apparent that that the older person is tiring. These semi-structured interviews
will focus on:
l their experience of living in a care home and thoughts about end of life
l the amount of support they need from the care home staff
l the health-care services they have received
l how they define their priorities for end of life
l what indicators/measures they use to assess if care received is effective
l how they think that care home staff and health-care professionals work together.
For those residents who consent, their care home notes will be reviewed twice, over the period of a year,
to coincide with their interviews. The following data will be collected:
l demographic information
l health conditions
l medication
l use of equipment
l hospital admissions
l health-care professionals involved in their care, for which condition, frequency of contact, planned
care, location of consultation (i.e. care home or hospital outpatients)
l care plans
l any shared assessments/care planning between care home staff and health-care professionals in use
l activities of daily living – level of support residents need with these
l evidence of planning for end-of-life care, records of decisions made and where appropriate after death
analysis, consisting of a brief interview with a care worker or the care home manager who was
involved in the person’s death and a final review of the care plan for that person.
These data will reveal the range and intensity of activities undertaken to support residents’ care, and
where relevant, how effective the integrated working for end-of-life care is over time, as measured by
outcomes and by the older people themselves, the care home staff and health-care professionals
(outcomes are likely to include quality of life, continuity of care, access to, and satisfaction with care,
involvement in decision-making on treatments, opportunities to discuss their uncertainties, priorities and
preferences and place of care). The data will also identify preferred practitioners and key drivers for the
different types of chosen interventions.
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Data collection: care home staff
Care home staff who participate in the research and the shared discussions with NHS staff will be
interviewed at the beginning and end of the study. The aim of these semi-structured interviews
is to establish:
l the support they consider the older person needs when they are dying
l how they define end-of-life care
l how often they see the health-care professional concerned and where
l how the health-care professional and the care home staff work together, and any support and training
received from health-care staff, or they would like to receive
l what facilitates and or hinders integrated working with the health-care professional.
At the end of the study, one focus group will be conducted with up to 10 care home staff of differing levels
of experience and seniority. This will be facilitated by two members of the research team and will be
recorded if the group consents to this unanimously otherwise only notes will be taken. The interview will be
conducted in a private room in the care home at the convenience of the staff, using a semi-structured
format that will focus on their experiences of the implementation of the chosen intervention and working
with health-care professionals to provide end-of-life care. It will explore the level of contact that they have,
how they communicate and feed back information about the older people receiving care, and perceived
facilitators and barriers to integrated working with health-care professionals.
Data collection: health-care professionals and stakeholders
Individual health-care professionals who participate in the group discussions and the development and
implementation of the chosen intervention to support end-of-life care will be interviewed at the beginning,
and end of the study.
The interview will establish their professional backgrounds, training, workload, funding, and how they
work together with the care home. We will investigate their perception of the focus of their activities with
the older person and the extent and mechanisms of their integrated working with the care home staff to
achieve their care, support or treatment objectives for the older people. In addition we will investigate how
they evaluate and reflect on their experience of integrated working to promote end-of-life care for people
with dementia through interviews, care plans and notes review, we will aim to establish:
l how the older person is identified as needing the service
l how the older person’s needs are assessed and care is planned, and to what extent the care home staff
are involved with this
l the time different team members spend in discussing and planning care/end-of-life intervention, the
skills and knowledge needed and range of activities this involves.
Data collection: relatives of residents that have died during Phase 2 and
family members of residents who are living in the care home
Based on the findings from Phase 1 we anticipate 20% of residents recruited to the study will die over the
data collection period. A minimum of 8 weeks after the death of the older person with dementia (and
following discussion with the care home manager to ensure that there are no reasons not to contact the
relative) we will invite by letter a family member or significant other, to take part in an interview to gain
insight into their perspective on their thoughts and views about end-of-life care. Those that indicate they
are willing to take part in an interview will be contacted by phone and their possible participation will
be discussed further.
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The interview will be semi-structured and seek to explore their experience as a relative visiting the care
home what they thought was significant about the last months of the person’s life. As already noted it is
possible that the interview will cause distress because of the memories and feelings talking about the
deceased person may generate. Every attempt to ameliorate the impact of the interview will be made and
participants will be offered the option of writing down their thoughts or being interviewed with a friend or
relative present if that is preferable to a one-on-one interview.
Amendment submitted NRES Committee South Central: Southampton A
(May 2011)
Interviews with family members of residents who are living in the care home will be open and discursive
and ask about their views about living and dying in a care home. We know from securing consultees’
opinions about their relatives’ possible participation in the study that some relatives will want to talk
about their regret and guilt about placing a relative in a care home. We will be careful to ensure that
participation does not create any further distress and will ensure that sufficient time is allowed in the
interview for relatives to express their views and feelings about a range of issues. It is likely that past
experiences will influence how they think about end-of-life care for people with dementia. Once we have
explained the purpose of the study very few prompts will be used to ensure participant priorities and views
are shared. If any issues are raised that cannot be addressed or resolved in the interview that relate to the
care home or the care of their relative the researcher will ensure an appropriate person is identified for
the relative to talk further with (e.g. care home manager, Age UK advocate).
The above amendment was approved by the South Central: Southampton A Committee on 27 May 2011
(REC reference 10/H05002/55 – amendment number 1).
Analytical synthesis
All interviews will be recorded, transcribed and analysed using NVivo™ software. Organisational,
operational and quality review documents will be analysed through the same framework and using the
same software. Statistical data from validated assessment tools, and information on the older persons’
use of services, and the professional diaries on service activities will be entered onto an SPSS™ database.
The findings generated from the integrated working in the three study sites will be brought together in
two units of analysis:
1. the individual care homes
2. cross-case comparisons looking at how the different contexts and mechanisms affect the outcomes for
the older person.
To enable comparison and the development of an explanatory model, analysis will then be undertaken
within and across sites. Qualitative data analysis will be undertaken using NVivo™ and thematic content
analysis to identify key themes and common experiences and priorities of care. Data from the case studies
will be analysed to describe the features and impact of end-of-life care on the outcomes. The analysis of
outcomes will be guided by the findings of Phase 1 but is likely to be categorised as outcomes for the
older person, the care home staff, and the health-care practitioners’ roles, and include the older person’s
understanding of their care, access to services, clinical outcomes. Outcomes for the health-care system will
include: transparency of care, service utilisation, and staff resources used as a result of working together to
develop end-of-life care interventions that are dementia specific.
Economic evaluation
The resource implications of different approaches supporting end-of-life care with care homes will be
documented and costed, including the resource implications of developing an intervention this way,
the health and social care services delivered, hospitalisations. The contribution of care home staff and
health-care professionals will be compared across models and sites in a cost consequences framework.438
This will incorporate the perspectives of the health-care services, older people, and care home staff.
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Ethical issues
Intrusion
Participatory approaches to research are by definition intrusive. There is a risk that individuals participating
in the study may feel that their right to self determination is compromised if during the course of the study
they do want to participate in the planned change agreed by their peers. For the residents too, the impact
of the chosen intervention on the care they receive may be intrusive in an environment that is their home.
Integral to the research questions asked, the design of the study, the role of the facilitator and the stages
of data collection methods is a consciousness of the need to be encouraging reflection at each stage of
the study and be responsive to the participants and the context of care. To this end, ongoing opportunities
will be created for individuals to reflect on the study and withdraw from participation and/or highlight if
participation in the research is disruptive and intrusive for residents, care home staff and primary care staff.
It is a potential finding of the study that certain interventions are judged too intrusive on staff time and
responsibilities and the everyday life of residents.
Anonymity and confidentiality
All participants and study sites will have a code number and no names or identifying details will appear on
any data collection forms, analysis or draft and final reports. During data collection only the research team
will have access to the names and contact details of participants and these will be kept in a password
protected computer and double locked filing cabinet, to which only the research team will have access to.
All participants will be guaranteed anonymity in written reports and summaries of data analysis.
A summary of the findings will be sent out to participants for their comments prior to publication
and dissemination.
Consent
It is possible that health-care professionals, older people and care home staff may feel obliged to take part.
They may feel that refusal to participate may adversely affect their relationships with their employer or the
services involved in providing their care. In introducing the study to the possible participants, care will
be taken to ensure no one feels coerced or obliged to take part. The information sheets stress that
participation (or not) in the study will not affect the care they receive or their relations with other people
in their organisations. At each stage of the recruitment process, the researchers will re-iterate that
participation is voluntary.
People with cognitive impairment/limited capacity
The research team has extensive experience of working with people who find consent and participation in
research difficult, perhaps because of problems of cognition, confusion, illness or fatigue. For people with
dementia whose level of cognitive impairment means they will not be able to consent to participation, the
approach taken will be informed by the key principles set out in the Mental Capacity Act17 that assumes
that all adults are capable of giving or refusing consent unless proven otherwise, and that the best
interests of the person who lacks capacity are paramount. It is, therefore, an assumption of the study that
patients who experience short term memory and cognition problems can consent in the moment. It is the
responsibility of the researcher on each occasion to review the study aims with the participant, and confirm
that they are still willing to participate in the study, ensuring that they are not alarmed or distressed by the
experience.439,440 The study is informed by the principles of inclusionary research whereby every effort
will be made to enable people that wish to, to participate, even if that means alternative methods of
communication and data collection need to be found.
At the stage of initial consenting the researcher will ensure that the participant is given full and
appropriate opportunity to have the study explained to them in a way that best meets their individual
needs. If there is an intermediary, such as a family member or key worker, with whom the older person
particularly relates, the researcher will ensure that this intermediary is present and able to explain and, if
necessary, to interpret any areas of concern or lack of understanding. Where older people are unable to
give written consent because of poor vision or if they are unable to write, verbal consent will be recorded
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by the researcher with a care home staff member as a witness. If the older person is unable to consent in
the moment, or loses capacity over the period of the data collection, their consultee will be approached for
their opinion on whether this study is something that the older person would have participated in or
would wish to continue participating in, if they had the capacity.
Risk
The focus of the study is end-of-life care for older people with dementia. Discussing such sensitive issues
may cause distress for the people involved. There is a risk that by expressing their needs and experiences
some older people may become distressed, confused or concerned. If this should happen any serious issues
will be communicated to the professional whom they identify as knowing them best, and being most
involved in their care. There is some risk that involvement in this study may affect residents’ care and
outcomes, by older people providing or expressing information of which care home staff were not
previously aware. At all stages, the researcher will make clear that they cannot be involved in providing
care in any way. However if any risk (e.g. evidence of elder abuse, inadequate care, acute health need) is
disclosed, procedures are in place to address this that reflect the care home, PCT and university guidance
and procedures The study relies on close collaboration with the participating sites. Part of the recruitment
process involves how the study will address incidents where the participants may become distressed,
or there is evidence of need for support or review from health and social care services. The researchers
will have a protocol describing who to consult and how, which they will follow in all such cases (see
EVIDEM-EoL Bad Practice Protocol V2 260608.)
All interviews will be structured so that they minimise the distress caused by the discussion of sensitive
issues and focus on collecting data which is essential to each participant. However, the main participants
are older people with complex health and social care needs, so it is possible that the older people may
become upset. The researchers will treat all participants with respect and dignity. Moreover, the research
fellows who are responsible for data collection have extensive experience in interviewing vulnerable older
people about sensitive topics.
If the participants express any sensitivity, embarrassment or upset at any point during the interview,
the researcher will remind them that they are free to stop the interview at any time. In this situation, the
researcher will switch off the recorder immediately. The research team work closely with each of the care
homes involved and the key workers. If a resident becomes distressed in the course of an interview the
researcher will ask their permission to ensure that their key worker and other appropriate staff members
are aware of this.
There is a small risk of disclosure in the study, as the core participant group includes older people with
complex health and social care needs. At the beginning of each interview participants will be reminded
that anything they say is confidential but that it will not be possible to keep information confidential if
there is any indication that they or any other participant is at risk, or if their care services are deficient
or there is evidence of abuse or an acute health need.
The procedures for situations where there is evidence of abuse, neglect or criminal disclosure are:
l if the person is at immediate risk the care home manager will be contacted
l if there is suspicion of abuse, what the participant reported or was observed will be documented by
the researcher, the care home manager or appropriate line manager will be informed and the agreed
procedure for reporting suspicion of abuse will be adhered to. The Principal Investigators for the study
will also be informed
l if there is evidence of negligence in the provision of care or significant shortcomings in the care
provided to the older person, the research fellow will document the concerns/issues and notify the care
home manager or other appropriate line manager and the procedures for registering and addressing a
complaint about the standard of care will be followed
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l if during the data collection it becomes apparent that the participant needs medical attention, the
researcher will contact a member of the care home staff urgently.
With regards to the NHS professionals and care staff, there is likely to be an increased workload as part of
participating in Phase 2. Researchers will make clear what commitments could be involved when
explaining the study to potential participants and throughout the recruitment process. Researchers will
reiterate that all participants are free to withdraw from the study at any point, without giving a reason.
In addition, there is a risk that the study may highlight areas of tension and disagreement between care
home staff and NHS professionals. The researcher designated as the facilitator for the group discussions
and meetings has extensive experience in facilitating and managing focus groups and potentially difficult
discussions in a range of settings. A semi-structured prompt guide will also be used in aiding the
discussions and ensuring they maintain focus.
Interviewing vulnerable older people may be stressful and emotionally demanding.
All researchers will meet with the Principal Investigators regularly to debrief and identify any issues or
needs they have for ongoing support.
Conducting interviews with relatives in their own homes incurs a degree of risk to the researcher
conducting the interviews. The research team will adhere to the Centre for Research in Primary and
Community Care (CRIPACC) lone worker policy.
Vulnerable patient group
This research will be conducted with a diverse group of people who are ill, easily tired and who may be
vulnerable for a number of reasons. All participants will be treated with dignity and respect at all times.
The researchers are experienced in working with older people who have problems of this nature. Data
collection procedures and participant responses will be monitored carefully and reviewed by the research
team throughout the study. The wellbeing and support of participants are study priorities.
The research team
The multidisciplinary research team brings together academics and practitioners from nursing, social work,
general practice and health economics. The team has worked on a series of research studies, both
together and independently, that focus on older people with complex needs living in care homes and
community settings. These have included funded work on inter-professional working in: care homes,
activity promotion, team working across health and social care, the use of new technologies, case
management and shared assessment processes across health and social care to improve care to older
people, multi professional networks for the delivery of care to people with long term and disease specific
conditions. The Public Involvement in Research Group (PIR Group) has strong links with the voluntary
sector and is working closely with INVOLVE. The PIR Group will be contributors to the research design and
execution. Members from this group will be involved in the Steering Group for this project and bring to
the proposal experience of having been recipients of health and social care services, working with older
people’s groups, and involvement in other studies that focused on older people including care homes and
project management. The PIR Group comprises users, carers, patients, patient and public involvement links,
and representatives from the voluntary sector.
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Dissemination
The findings from this study will inform commissioners and providers of services in their decision-making
about commissioning and providing end-of-life care services to care homes. It will make explicit the
managerial processes and tools that enable better integration of care delivery between health-care
professionals and care homes, and demonstrate the ongoing support and training required to achieve
meaningful outcomes for the older person and the service.
Dissemination of preliminary findings for consultation and the final report will initially be through the
participating study sites, following a report to the NIHR and the organisations of the different practitioners,
teams and agencies that are involved in the study. This will be done through workshop events, e-alerts and
network meetings.
The research team and Steering Group will disseminate findings nationally through their involvement with
bodies such as Age UK, Alzheimer’s Society, National Care Home Research and Development Forum,
DeNDroN, PCRN, Better Government for Older People and relevant research networks. Findings will
be presented in professional and peer reviewed journals and at conference events across the
relevant disciplines.
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Appendix 37 Chapter 4: Care home manager
topic guide
REC REF: 08/H0502/74 
 
 
Topic guide: CH manager 
 
 
Date:  
Care home ID: 
Participant ID: 
 
Sex [ ] Male [ ] Female Age___years  F/T   P/T 
Qualifications: e.g. NVQ  
Length of time in current care home? 
Total time working in care homes? 
Current home In total 
Training:  
Dementia care 
End of life care 
Details 
 
Residents: 
Number of residents when full? 
 
Number of residents currently?  
Staff : (not including auxillary staff?) Full Time Part-Time 
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Number of Care staff? Total________ 
Day staff 
Night staff 
Senior grades  
Junior grades 
Full-time/Part-Time 
Agency staff 
Other 
  
  
  
  
  
  
  
Staff training: 
How many staff hold an NVQ2? 
State number: 
Staff turn over:  
How many new appointments in the 
last 3 months?  
6 months? 
3 months 6 months 
 
Organisation of care 
· How do you organise the care in your care home? 
· Could we sketch a diagram?  
o Teams with a senior care worker 
o Named care workers for the older person 
o Formal handover /report 
· Probe:  
o Do you have a key worker system? Y/N 
o How many residents does each key worker have? 
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o Does that key worker stay with a resident all the time they are in the care 
home or change over time? 
 
· Do you have volunteers with the care home? 
o What to they do? 
o Details? (hrs a week) 
· Do any family members contribute to care? 
o What do they do? 
o Details? (hrs a week) 
 
Other Health Services 
Can you tell me about how much contact do you have with health professionals who visit the 
care home?  
· GPs:  
o How many GPs do you work with? 
o Do you pay a GP retainer? Yes/No  
· District nurses 
o How many district nursing teams visit your care home? 
o Can you tell me about what sort of activities they undertake in the care home? 
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I would now like to discuss different groups of people who may provide services to older 
people within your care home. Can you tell me about….(each individual in turn) 
___________________________________________________________________ 
 Reason/type of care On 
req. 
Once 
a 
week 
Every 
two 
weeks 
Once  
a 
month 
Never In-house 
trained 
GP        
GP: out of hours 
service 
       
District Nurse        
Night nurse        
Specialist nurses:        
Community mental 
health nurses 
       
Admiral nurse        
Palliative care nurse, 
(Macmillan, Marie 
Curie) 
       
Continence nurse        
Stoma nurse        
Dietician         
Chiropodist        
Hairdresser        
Dentist        
APPENDIX 37
NIHR Journals Library www.journalslibrary.nihr.ac.uk
474
Optician        
Occupational 
Therapist 
       
Physiotherapist        
SALT        
Social worker        
Counsellor         
Any others not 
discussed? 
       
 
I would now like to talk a little more about end of life care for people with dementia in 
your care home 
 
o Can you tell me about when you would consider an older person with dementia was 
nearing the end of their life?  
o How do you define end of life care? 
o Who do you feel is responsible for supporting people with dementia as they near the end 
of their life? 
o Who decides at what stage an older person with dementia requires end of life 
care, or palliative care?  
o How are GPs involved? 
o What other services are you involved with in connection with end of life care in this 
care home? 
o Probe:  
o Macmillan 
o Marie Curie 
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o District Nursing 
o Hospice support 
o Hospice at Home 
o Night sitter service 
o Charitable support  
o Geriatrician 
o Psychogeriatrician 
o Equipment loan 
o Which services do you find helpful? 
o What is it that they do? 
o Which services do you find not so helpful? 
o Do you have any private services coming in? Yes/No 
o Can you tell me a little more about these 
 
Care home and end of life  
o What end of life care planning procedures are in place in your care home? 
Probe: 
o Advance Care Planning in your home? 
 
o The Gold Standard Framework? Yes/No 
 
o The Liverpool Care Pathway? Yes/No 
 
o Preferred Place/Priorities of Care (PPC)? Yes/No 
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o How do you feel your care home supports older people with dementia at the end of 
life? 
Probe: 
o Are things planned in advance?  
o Are things dealt with as and when they arise? 
o What do you think works well? 
o What things could be improved? 
o Do you have any religious/spiritual services offered here in the home? 
 
o How do you know if someone with dementia is dying? 
Probe: 
o Can you tell me what is a usual pattern, for someone in their last 48 hours of life?  
o What services are usually involved? 
o What constraints the care that you would like to provide? 
o When someone dies what happens?  
o What it is like when someone dies? 
o How do you feel? 
o Tell me about someone who had a good death?  
o Tell me about someone who died here where you felt it could have been better? 
o How many people died in the last 6 months? Last year? Of those, how many had 
dementia? 
 
o What do you think are the most important aspects when someone with dementia is dying 
in a care home? 
 
o Is there anything else you would like to say about caring for someone with dementia 
towards the end of their life in a care home? 
 
 
DOI: 10.3310/pgfar03030 PROGRAMME GRANTS FOR APPLIED RESEARCH 2015 VOL. 3 NO. 3
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Iliffe et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
477
Return Questionnaire  
Any changes since last visit (date)  
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Appendix 38 Chapter 4: Care worker topic guide
REC Ref: 08/H0502/74 
 
 
 
 
Topic guide: Care Home Staff 
 
 
Date: 
Care Home ID 
Participant ID 
Age 
 
Sex [ ] Male [ ] Female 
 
Length of time working in care home 
____months 
Total time working in care homes?_____ 
Full time/part-time (hours) 
Qualifications (NVQ) 
 
Job Title 
Have you had any training in: 
Dementia care 
End of Life care  
 
Details:  
Other Health Services 
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How much contact do you have with outside health professionals?  
 
 Reason/type of care On 
req. 
Once 
a 
week 
Every 
two 
weeks 
Once  
a 
month 
Never In-house 
trained 
GP 
GP out of hours 
service 
       
District Nurse         
Nurse specialists:        
Mental health: 
CMHN 
Admiral nurse () 
       
Palliative care: 
Macmillan  
Hospice 
Marie Curie 
       
Continence Nurse        
Stoma nurse        
Dietician         
Chiropodist        
Hairdresser        
Dentist        
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Optician        
Occupational 
Therapist 
       
Physiotherapist        
SALT        
Social worker 
Care manager 
       
Counsellor         
Any others not 
mentioned? 
 
       
 
· How much are they involved in supporting older people with dementia at the end of their 
life? 
· Who do you feel is responsible for providing care to an older person with dementia at the 
end of life? 
o Who decides when someone is dying 
o What stage does this occur?  
o How are GPs involved?) 
Dementia and end of life 
· How do you know when someone with dementia is dying? 
· Tell me about someone with dementia who had a good death?  
· Tell me about someone who died here where you felt it could have been better? 
· What is the ideal team structure for caring for someone with dementia at the end of life? 
(in-house staff and outside agencies) 
· What constrains you from providing the care you would like to give? 
· How many deaths occurred in the care home in the last 6 months? Last year? Of these 
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how many did you consider had dementia 
 
End of Life Planning  
· Tell me a little more about what you define as end of life care for people with dementia? 
Probe:  
· Are you aware of any end of life care planning procedures in place in your care home? 
· Explore each in turn probing for how used within the care home, for whom and when. 
· Advance Care Planning  
· The Gold Standard Framework? (the seven Cs) 
· The Liverpool Care Pathway? 
· Preferred Place/Priorities of Care (PPC)?  
· Do you have any religious/spiritual services offered here in the home? 
 
Care Home and End of Life 
· How do you feel your care home supports residents with dementia and the care they 
require at the end of life? 
Probe: 
o Are things planned in advance?  
o Are things dealt with as and when they arise? 
o What do you think works well? 
o What do you think could be improved? 
o What do you find particularly challenging when caring for someone with dementia 
who is thought to be dying? 
 
What do you think are the most important aspects of care when supporting an older person 
with dementia who is dying in a care home? 
 
Is there anything else you would like to say about caring for someone with dementia 
towards the end of their life? 
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Appendix 39 Chapter 4: NHS and social services
staff topic guide
REC REF: 08/H0502/74 
 
 
 
 
 
 
Topic guide: NHS & SS staff 
 
 
Date 
Participant ID 
Associated CH ID:        
Sex [ ] Male [ ] Female Age: 
Professional qualifications:  
 
Length of time present post: 
Time since qualified (eg DN/GP/SW) 
 
______years ______months 
______years ______months 
Specialist training: 
Dementia care 
End of Life Care 
 
Details: 
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How long worked with care home 
[state name]  
On average how often do you go into 
the care home? 
______years ______months 
 
[ ] Every day 
[ ] Regular arrangement (Ward round) 
[ ] More than once a week 
[ ] About once a week  
[ ] Once a fortnight 
[ ] Once a month 
[ ] Less than once a month 
 
 
Recognition and assessment of end of life care for people with dementia 
 
o Can you tell me about when you may consider an older person with dementia as 
nearing the end of his/her life?  
o Who decides at what stage an older person with dementia requires end of life care?  
o What is your involvement in this process 
o How are GPs involved?  
o How are you informed about one of your patients dying? 
o How do you define end of life care? 
o Tell me about someone who had a good death in this home? 
 
o Tell me about someone who died here where you felt it could have been better? 
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o In what way do you think older people with dementia nearing the end of their life 
could be better supported within a care home?  
 
Health service provision 
o Who do you feel is responsible for supporting people with dementia as they near the end 
of their life? 
o What other services do you draw upon to support older people’s needs with dementia 
when they are dying?  
o Probe:  
o Macmillan 
o Marie Curie 
o District Nursing 
o Hospice support 
o Hospice at Home 
o Night sitter service 
o Charitable support  
o Geriatrician 
o Psychogeriatrician 
o Equipment loan 
o Which services do you find helpful? 
o What is it that they do? 
o Which services do you find not so helpful? 
 
Specifically care home identified as working closely with  
 
o How would you describe your working relationship with care home [state name]? 
Probe: 
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o How do you initiate contact with the care home? 
o Visit regularly to review residents, wait for them to call and respond to a 
referral – pro-active or reactive? 
o How have you been involved in providing end of life care to older people with 
dementia in care home [state name] 
o How do you work with the care home staff to meet a resident’s health needs who has 
dementia? 
o In the past year, how many residents have you provided care to who died in the care 
home? Of these how many did you consider had dementia? 
 
End of Life Planning 
o Are you aware of any end of life care planning procedures in place in the care home? 
Probe: Ask re each procedure and explore how used and involvement in use 
o Advance Care Planning  
 
o Gold Standard Framework 
 
o Liverpool Care Pathway 
 
o Preferred Place/Priorities of Care (PPC)?  
 
o What do you think are the most important aspects when someone with dementia is dying 
in a care home? 
 
o Is there anything else you would like to say about caring for someone with dementia 
towards the end of their life in a care home? 
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Appendix 40 Chapter 4: Emergency services
topic guide
REC REF: 08/H0502/74 
 
 
 
 
 
Topic guide: Paramedic and Ambulance staff 
 
 
Date 
Participant ID 
Associated CH ID:        
Sex [ ] Male [ ] Female Age: 
Professional qualifications:  
 
Length of time present post: 
Time since qualified  
Geographical area covered? 
______years ______months 
______years ______months 
Specialist training: 
Dementia  
Mental Capacity Act (MCA) 
Details: 
 
 
On average how often do you go into 
a care home? 
[ ] Every day 
[ ] Regular arrangement  
[ ] More than once a week 
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[ ] About once a week  
[ ] Once a fortnight 
[ ] Once a month 
[ ] Less than once a month 
 
Emergency treatment for people with dementia 
1.  In your experience, what are the most common reasons for an emergency ambulance 
being called to people with dementia in residential care homes? 
 
2. How does somebody having dementia impact on the treatment you give? 
 
Working with residential care homes 
o How would you describe your working relationship with residential care homes? 
o Do you feel calls to people with dementia in care homes are usually justified? 
o Why/ Why not? 
 
o Who is responsible for contacting you? 
o Do you find some residential care homes call for 999 ambulances more than others?  
o In the past year, how many times do you think you’ve been called out to a residential 
care home?  
o Are you aware you’ll be seeing a patient with dementia? 
o At which point are you informed? (i.e at arrival, receipt of the call) 
o Can you think of a visit to a residential care home where you felt that things could 
have gone better?  
 
End of life planning and protocols 
o Are there any protocols in your ambulance trust regarding older people and 
resuscitation? 
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o If somebody has written instructions about DNR, are you obliged to follow these? 
o How often do these need to be updated? 
o If there are verbal or informal written instructions how far are you able to follow 
these? 
o What is your legal position? 
o Is it a difficult decision not to transport to hospital? 
o Are you under any pressure to convey to hospital, or not to convey? 
o Does a resident having dementia, or not, have an influence on commencing or 
withdrawing CPR? 
o What do you think are the most important aspects when you are called out to someone 
with dementia that is very poorly or dying in a residential care home? 
o Are there any changes you would like to see with regard to emergency ambulance 
calls to care homes for people with dementia towards end of life?  
o Is there anything else you would like to say about being called out to someone with 
dementia towards the end of their life in a residential care home? 
 
Finally, we would like to give you two scenarios to consider? 
 
1. Ben, 81 years old. Admitted to a residential care home approximately 2 years ago.  
Pre-existing conditions include a diagnosis of dementia (type unspecified) and 
heart failure (CCF). 
 
The care staff feel he has been deteriorating over the last 3 weeks, and saw his GP 
2 days ago with a chest infection, for which Ben was prescribed a course of 
antibiotics. The care home staff report, as directed by the GP, Ben is now 
receiving tlc.  
 
At around 9pm a care worker dialled 999 for an ambulance because Ben was 
becoming more and more breathless and was ‘struggling’. 
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In the care notes, there is a DNaR order and a wish to die in the care home 
informally recorded, dated 2 years ago. 
 
How would you respond and why? 
 
2. Doris, 93 years old. Admitted to a residential care home approximately 6 months 
ago.  
Has memory problems, particularly with short term memory and gets confused, 
but does not have a formal diagnosis of dementia. She has osteoarthritis and is 
generally very frail and most of time she is cared for in bed.  
 
At around 4.30pm, Doris suffered a brief loss of consciousness and was then very 
sleepy, so the care staff dialled 999 for an ambulance.  
 
Doris has stated she would like to die in the care home, and this was recorded in 
her care notes at point of admission. There is nothing recorded about resuscitation. 
 
How would you respond and why? 
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Appendix 41 Chapter 4: Care notes data
extraction form
REC REF: 08/H0502/74 
 
EVIDEM EoL Resident’s Data Extraction Form-  
 
1. Please give the resident ID number 
 
 
2. Please give the Care Home ID number 
  
 
 A. TIMEPOINT (There will be a different form for each extraction point) 
3. Baseline Data  
 
                         
 
       d d   m m     y y   y y  
3. Data Extraction 1 
 
                         
 
      d d   m m     y y   y y 
3. Data Extraction 2 
 
                         
 
      d d   m m      y y   yy 
 
B. HEALTH STATUS 
13. Long Term Conditions (Please circle all that are documented)  
 
1 Diabetes 
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2 COPD 
3 High blood pressure 
4 Stroke 
5 Heart disease 
6 Dementia 
7 Parkinson’s disease 
8 Cancer 
9 Arthritis 
10 Epilepsy 
11 Other (Please specify)_________________________________ 
 
C. ADMISSION INFORMATION 
 
10 a. Is there a documented diagnosis of dementia? Yes/No 
 
If yes, please give details: 
    b. Type_________________________________________ 
 
    c. Source of diagnosis______________________________ 
 
    d. Date of diagnosis_______________________________ 
     
 
D. Current Health Problems 
      
14. Acute Conditions in last 2 weeks (Please circle all that are documented) 
 
1. Upper respiratory tract infection 
2. Chest infection 
3. Flu-like illness 
4. Urinary tract infection 
5. Gastro-enteritis 
6. Other (Please specify) ________________________________ 
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15a. Any Falls in the last 2 weeks? Yes/No 
 If yes: 
  b. Number of falls_____________ 
E. ASSESSMENTS 
16. Please give details of recorded assessments  
 
Type of 
Assessment 
 
 Scales or Measures Used Date Conducted 
 
Score/Other Details 
i. Pain Assessment 
 
Y/N 
(Free text: To code when entered into SPSS)  
 
 
 
Score ______  
Not Assessed 
ii. Cognitive 
assessment 
 
 
(Free text: To code when entered into SPSS)  
Eg MMSE  
 
 
Score ______  
 
Not Assessed 
iii. Depression 
 
 
(Free text: To code when entered into SPSS)  
Eg GDS  
 
  
Score ______  
Not Assessed 
iv. Dependency 
 
 
(Free text: To code when entered into SPSS)  
Eg Barthel  
 
  
Score ______  
Not Assessed 
v. Activities of 
Daily Living 
(ADL)  
 
 
Breathing   1 No problems 
2 Some problems 
3 Immobile due to breathing problems 
4 Needs Oxygen 
5 Not recorded 
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Maintaining a safe environment  1 No problems 
2 Walks with aid 
3 Needs supervision to mobilise 
4 Safety rail in use 
5 History of falls 
6 Other _______________________ 
7 Not recorded 
Expressing Sexuality  
 
 1 No problems 
2 Needs assistance with privacy and 
dignity 
3 Other _______________________ 
4 Not recorded 
Eating and Drinking   1 Self caring 
2 Needs assistance of one person 
3 Needs assistance of two people 
4 Other _______________________ 
5 Not recorded 
Elimination  1 Self caring 
2 Needs regular reminding  
3 Needs assistance of one person 
4 Needs assistance of two people 
5 Incontinent 
6 Not recorded 
Personal Care  1 Self caring 
2 Needs assistance of one person 
3 Needs assistance of two people 
4 Variable assistance 
5 Not recorded 
Sleeping  1 No problems 
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 2 Takes night sedation 
3 Has disturbed sleep 
4 Sleeps during day 
5 Walks in their sleep 
6 Not recorded 
Death and dying  
(wishes, hopes, fears) 
 1 Has been discussed with person  
2.Not discussed  
3. Not resorded 
 
Consultee involvement? Y/N 
 
 
vi. Pressure ulcer 
assessment  
 
 
(Free text: To code when entered into SPSS)  
Eg Waterlow 
 
 
 
vii. Falls Risk 
Assessment 
 
 
(Free text: To code when entered into SPSS)  
Eg Fall Risk and Fracture Assessment Tool 
 
 
viii. Manual 
Handling Risk 
Score 
 
 
(Free text: To code when entered into SPSS)  
 
 
 
 
ix. Nutrition 
Assessment 
 
 
Weight__ (Kg)  
 Date_______ 
   
 
 
 
 
 
Not assessed  
x. Other    
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Assessments  
xi. Other 
Assessments 
 
 
 
 
xii. Other 
Assessments 
 
 
 
 
xiii. Other 
Assessments 
 
 
 
 
 
 
F. Preparation for End-of-Life-Care  
 
15. Evidence of Physical Decline towards the End-of-Life 
              (Please tick one box)     Yes      No  
 
If Yes please circle all codes that apply:  
 
1 Falling         10 Eating and Drinking  
2 Infections  
   a chest infection/pneumonia        a loss of appetite 
     b urinary tract infection     b weight loss 
     c septicaemia      c difficulty in swallowing 
     d skin infections      d supplementary feeds 
     e other please state___________________   e unable to eat 
 3 Chair bound             f unable to drink  
 4 Bed bound               
 5 Incontinence: a urine; b faeces      11 Contractures   
   6 Diarrhoea              12 Other (please specify) ________________  
   7 Vomiting        13 Not recorded 
   8 Pressure areas: skin breakdown         
9 Increased confusion             
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16. Is there evidence of the resident being actively involved in advanced planning or in the assessment, care planning and 
evaluation process for end-of-life care?  
(Please tick all that apply)    
 
Resident         Yes      No  
 
 
 
Consultee involvement?   Yes     No 
 
Family involvement     Yes     No 
 
Please give details________________________________________________ 
 
 
17. Preferred place for end-of-life care  
(Please circle code that applies) 
 
1 Care home 
2 Hospice 
3 Hospital  
4 Other (please specify)______________________________ 
5 Not recorded 
 
 
18. Use of Protocols for End-of–Life Care 
 (Please circle codes that apply) 
1. Care home specific 
2. Organisation specific (please specify)__________________ 
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National Palliative Care Guidelines 
 
3. Gold Standard Framework (Care Home) GSFCH 
4. Liverpool Care Pathway LCP 
   5. Preferred Place of Care PPC 
   6. Other (please specify)____________________________ 
   7. Not documented 
 
G. TOTAL SCORE OF ALL ASSESSMENTS 
 
ASSESSMENT TOTAL 
SCORE 
 
DATE and COMMENTS 
Disability Assessment for Dementia  
(DAD) 
 
 
Cornell Scale for Depression in Dementia 
(CSDD) 
 
 
Cohen-Mansfield Agitation Inventory (CMAI) 
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CLIENT SERVICE RECEIPT INVENTORY 
 
     
A 
1. Please state the name of the organisation that manages the facility and tick whether 
 this is local authority social services, an NHS organisation, private (for-profit) 
 organisation, voluntary (non-profit) organisation or other. 
  
 ________________________________________________________________ 
   (social services)   (NHS) 
   (private)   (voluntary)  (other) 
 
2.  What is the total weekly charge per week for the resident? 
  
       £  
 
 
3. Who contributes towards the cost of this placement? (Circle all codes that apply) 
 
 1 DSS     5 Resident 
  2 National health service   6 Resident’s family 
  3 Local authority    7 Insurance policy 
  4 Voluntary organisation   8 Other (please specify)______________________ 
 
 
 
If no, go 
to 
question 6   
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4. Has the service user lived anywhere else during the last three months? 
 (excluding hospital stays) 
 
 
5. If yes to Question 4, what type of accommodation was this? 
 
Accommodation type 
 
Approximate number of nights spent in this 
accommodation in last 3 months 
  
Nursing home  
Other  
(please specify)__________________________________ 
 
 
B.  SERVICE RECEIPT 
 
6. Please list any use of the following hospital services over the last 3 months 
 
Service Name of ward, clinic, hospital, 
centre 
Reason for 
using service 
 
Number of contacts  
Accident & Emergency   _________ visits     
Hospital inpatient ward 
in an acute hospital 
  
_______inpatient days 
Community Hospital 
ward 
  _____inpatient days 
Day hospital   _____attendances 
Outpatient services (list 
all) 
 
  _____appointments 
  _____appointments 
Yes No 
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  _____appointments 
  _____appointments 
Other  
(Please specify): 
 
  
 
 
  
7. Please list any use the service user has made of community-based services over the last 3 months. *Code outpatient 
services at Q8 above 
 
Primary Care, Community Health and 
Emergency Services* 
Tick if yes Total number of contacts  
 
Typical duration of contact (mins)  
Paramedic (ambulance service)  
  
Community Matron 
 
 
 
  
Community/District Nurse 
 
 
 
  
Practice Nurse   
  
Night Nurse 
 
 
 
  
Specialist nurse e.g.palliative care, 
continence, diabetes  
 
 
 
__________________home 
__________________office 
______________home 
______________office 
Occupational Therapist  
  
Speech and language therapist  
__________________home ______________home 
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__________________office ______________office 
Physiotherapist  
__________________home 
__________________office 
______________home 
______________office 
General practitioner  
__________________home 
__________________office 
__________________phone 
 
______________home 
______________office 
______________________phone 
Other community doctor, describe: 
 
 
__________________home 
__________________office 
__________________phone 
 
______________home 
______________office 
______________________phone 
Palliative care services e.g. Marie Curie 
nurse, hospice outreach 
 
  
 
Social Care Tick if yes Total number of contacts  Typical duration 
 of contact (mins)  
Social worker or Care manager  
__________________home 
__________________office 
__________________phone 
 
______________home 
______________office 
______________phone 
 
Sitting scheme (e.g. Crossroads, Marie 
Curie) 
 
  
 Voluntary sector e,g, Age Concern 
befriending service, ‘pet a dog’ 
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Community Mental Health Services Tick if yes Total number of contacts  Typical duration 
 of contact (mins)  
Psychiatrist 
 
__________________home 
__________________office 
______________home 
______________office 
Psychogeriatrician  
 
__________________home 
__________________office 
______________home 
______________office 
Psychologist 
 
__________________home 
__________________office 
______________home 
______________office 
Counsellor 
__________________home 
__________________office 
______________home 
______________office 
Community psychiatric nurse/ Community 
mental health nurse 
 
__________________home 
__________________office 
______________home 
______________office 
Other mental health professional, describe:  
 
 
__________________home 
__________________office 
______________home 
______________office 
Other mental health professional, describe:  
 
 
__________________home 
__________________office 
______________home 
______________office 
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 Adaptations, Equipment and 
products 
Tick if 
yes 
Type of adaptation or equipment (list 
all) 
Who supplied this? Who/what organisation 
paid for this? 
Special equipment (e.g. for 
mobility, pressure area care, 
safe moving and handling, pain 
management (syringe driver).  
  Equipment provided by NHS and those 
by CH included in fees? 
 
Continence products (e,g., 
pads, pull up pants)  
  Supplied NHS or in CH fees?  
Aids to getting to and using the 
toilet or protecting 
bedding/furniture(e.g. raised 
toilet, urinal bottles) 
    
 
 
Other services: e.g. dentist, optician, 
chiropodist, other social care 
Tick if yes Total number of contacts  Typical duration 
 of contact (mins)  
Who/what 
organisation paid for 
this? (eg NHS, 
purchased by 
individual, included in 
CH fees) 
1.     
2.     
3.     
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8. Please list any use of the following day services over the last 3 months  
 
Day Services Tick if 
yes 
Name of centre/ 
service 
Number of contacts per 
week 
Total number of  
contacts over 
last 3 months 
Day care – local authority social services 
department 
  
__________Days 
 
Day care – voluntary organisation   __________Days  
Day care – NHS (community-based)   __________DaYs  
Social activities (Include activities inside care 
home, or external activities) 
  
_________Visits 
 
Patient education/Expert Patient group - Please 
describe: 
 
  
_________Visits 
 
Exercise class (Include activities inside care 
home, or external activities) 
 
  
_______Sessions 
 
Other   
 
 
 
9. Please list below use of any medications taken over the last 3 months (write additional on separate sheet) 
 
Name of medication Dosage  
(if known) (mg) 
Dose frequency 
(e.g. daily) 
For how long has service user 
taken this drug? 
1. 
 
    
2. 
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3. 
 
   
4. 
 
   
5. 
 
   
6. 
 
   
7. 
 
   
8.    
9.    
10.    
11.    
12.    
 
C. BENEFITS (Difficult to obtain from residents in CHs, only likely receive state pension and, for the minority, a private pension. Not 
entitled other payments if LA funding CH placement) 
11. Over the past 3 months have you received any of the following payments? (include payments made jointly to others in household)  
 Service user (tick as 
many as apply) 
Other member of 
household  
(describe which) 
How long has service user 
received this benefit (in weeks, 
over the last 3 months) 
State Retirement (old age) Pension    
A Widow's or War Widow's Pension    
Pension Credit    
War disablement Pension    
Any other state benefit not listed 
(please state) 
 
   
APPENDIX 41
NIHR Journals Library www.journalslibrary.nihr.ac.uk
506
Any other state benefit not listed 
(please state) 
 
   
Any other state benefit not listed 
(please state) 
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Appendix 42 Chapter 4: Care home manager/
senior carer topic guide
REC REF: 10/H0502/5 
 
Topic guide: Care home 
manager/Senior carer 
Date  
Participant  
Associated CH  
Sex [ ] Male [ x ] Female  
Professional qualifications:  
Length of time present post: 
Time since qualified (eg 
DN/GP/SW) 
 
______years ______months  
______years ______months 
Specialist training: 
Dementia care 
End of Life Care 
 
 
How long worked with care 
home [state name]  
__years Total 
[ ] Every day 
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Recognition and assessment of end of life care for people with dementia 
 
o Can you tell me about when you may consider an older person with dementia as 
nearing the end of his/her life? Assessment, generalise about? 
 
AI intervention 
 
o Since we had the Appreciative Enquiry meetings with Caroline, do you think that care 
for pwd at EoL in the care home has changed at all?  
o If yes - In what way? 
o If no – why not do you think?  
 
o What are your thoughts about the AI as a process to improve client care? 
o What worked well? 
o What were the challenges? 
 
o Have your views about EoL care changed at all as a result of the AI meetings? 
 
 
o How would you judge good EoL care now? 
 
 
o Who decides at what stage an older person with dementia requires end of life care?        
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o Has this changed with AI? 
o What is your involvement in this process 
o How are GPs involved? (any different because of meeting) 
o How are DNs involved?  
o  
 
o Has the AI process influenced you as a CH manager at all? 
 
o Overall, what sort of impact would you say AI has had on the CH, if any?  
 
o If there has been an impact/change in practice, do you think this will be sustained? 
Why/ why not?  
 
o Is there anything else you would like to say about AI? 
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Appendix 43 Chapter 4: Care home staff
topic guide
REC REF: 10/H0502/5 
 
 
Topic guide: Care staff 
 
Date  
Participant  
Associated CH  
Sex [ ] Male [ x ] Female  
Professional qualifications:  
Length of time present post: 
Time since qualified (eg 
DN/GP/SW) 
 
______years ______months  
______years ______months 
Specialist training: 
Dementia care 
End of Life Care 
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How long worked with care 
home [state name]  
 
__years Total 
[ ] Every day 
 
 
Recognition and assessment of end of life care for people with dementia 
 
o Can you tell me about when you may consider an older person with dementia as 
nearing the end of his/her life? Assessment, generalise about? 
o How are you informed that someone with dementia is nearing EoL? 
 
DNACPR 
o Do any of the residents have DNACPR forms? How recent? Where stored? Etc. 
o Will ambulance staff be satisfied to see a copy of the original form? 
 
Do any residents have DNACPR forms? How recent? Where stored etc?  
 
Will ambulance staff be satisfied to see a copy of the original form?  
 
AI intervention 
o Have you been made aware of the intervention that has been introduced by the care 
home through taking part in the research? 
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Appendix 44 Chapter 4: NHS staff topic guide
REC REF: 10/H0502/5 
 
 
 
 
 
Topic guide: NHS staff 
 
Date  
Participant  
Associated CH  
Sex [ ] Male [ x ] Female  
Professional qualifications:  
Length of time present post: 
Time since qualified (eg 
DN/GP/SW) 
 
______years ______months  
______years ______months 
Specialist training: 
Dementia care 
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End of Life Care 
 
How long worked with care 
home [state name]  
 
__years Total 
[ ] Every day 
 
 
Recognition and assessment of end of life care for people with dementia 
 
o Can you tell me about when you may consider an older person with dementia as 
nearing the end of his/her life? Assessment, generalise about? 
 
AI intervention 
 
o Since we had the Appreciative Enquiry meetings with Caroline, do you think that care 
for pwd at EoL with the care home has changed at all?  
o If yes - In what way? 
o If no – why not do you think?  
 
o What are your thoughts about the AI as a process to improve client care? 
o What worked well? 
o What were the challenges? 
 
o Have your views about EoL care changed at all as a result of the AI meetings? 
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o How would you judge good EoL care now? 
 
 
o This care home; who decides at what stage an older person with dementia requires 
end of life care? Do care staff ring you or do you regularly review patients?  
 
o Anyone on the palliative care register?  
 
o Has this changed with AI? 
o What is your involvement in this process 
o How are you involved? (any different because of meeting) 
o How are DNs involved?  
 
o Has the AI process influenced you as a GP at all? 
 
o Overall, what sort of impact would you say AI has had on the CH, if any?  
Do you see any changes with the OOHs checklist? Has it been used? 
When they ring have you noticed any differences? 
Less inappropriate calls? 
 
· If there has been an impact/change in practice, do you think this will be sustained? 
Why/ why not?  
· DN working together with care staff 
 
· Is there anything else you would like to say about AI? 
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Appendix 45 Chapter 4: Relatives prompt guide
REC REF: 10/H0502/5 
 
 
Relatives Prompt Guide 
 
Date of Interview  
Participant ID  
Associated PWD ID  
Associated Care Home ID  
 
Thank you for being willing to talk to us about your relative. 
1. Looking back over the time leading up to when your relative died, is there anything 
that you particularly remember? 
 
 
2. How effectively do you feel the NHS staff and the care home worked together to 
provide good end of life care? 
 
 
3. How well do you feel decisions about your relative’s care were communicated with 
you? 
 
 
4. When your relative died did it come as surprise? 
Probe: 
i. If no what prepared you for the death? 
 
OR 
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ii. If yes, can you explain why? 
 
5. Can you remember who was involved when your relative died e.g. GP, district nurse, 
hospital staff 
 
6. What did you find helpful? 
a. For your relative 
b. For you 
 
7. Was there anything you think could have been done differently? 
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Appendix 46 Chapter 4: Emergency services
prompt guide
REC REF: 10/H0502/5 
 
 
 
Topic guide: Paramedic and 
Ambulance staff 
 
 
Date 
Participant ID 
Associated CH ID:        
Sex [ ] Male [ ] Female Age: 
Professional qualifications:  
 
Length of time present post: 
Time since qualified  
Geographical area covered? 
______years ______months 
______years ______months 
Specialist training: 
Dementia  
Mental Capacity Act (MCA) 
Details: 
 
 
On average how often do you go into 
a care home? 
[ ] Every day 
[ ] Regular arrangement  
[ ] More than once a week 
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[ ] About once a week  
[ ] Once a fortnight 
[ ] Once a month 
[ ] Less than once a month 
 
 
Emergency treatment for people with dementia 
1.  In your experience, what are the most common reasons for an emergency ambulance 
being called to people with dementia in residential care homes? 
 
2. How does somebody having dementia impact on the treatment you give? 
 
 
Working with residential care homes 
o How would you describe your working relationship with residential care homes? 
o Do you feel calls to people with dementia in care homes are usually justified? 
o Why/ Why not? 
 
o Who is responsible for contacting you? 
o Do you find some residential care homes call for 999 ambulances more than others?  
o In the past year, how many times do you think you’ve been called out to a residential 
care home?  
o Are you aware you’ll be seeing a patient with dementia? 
o At which point are you informed? (i.e at arrival, receipt of the call) 
o Can you think of a visit to a residential care home where you felt that things could 
have gone better?  
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End of life planning and protocols 
o Are there any protocols in your ambulance trust regarding older people and 
resuscitation? 
o If somebody has written instructions about DNR, are you obliged to follow these? 
o How often do these need to be updated? 
o If there are verbal or informal written instructions how far are you able to follow 
these? 
o What is your legal position? 
o Is it a difficult decision not to transport to hospital? 
o Are you under any pressure to convey to hospital, or not to convey? 
o Does a resident having dementia, or not, have an influence on commencing or 
withdrawing CPR? 
o What do you think are the most important aspects when you are called out to someone 
with dementia that is very poorly or dying in a residential care home? 
o Are there any changes you would like to see with regard to emergency ambulance 
calls to care homes for people with dementia towards end of life?  
o Is there anything else you would like to say about being called out to someone with 
dementia towards the end of their life in a residential care home? 
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Appendix 47 Chapter 4: Intervention design,
Phase 2
Appreciative Inquiry
Devised in the USA as a complement to conventional forms of action research, AI is a research approach,
method and philosophy for promoting positive personal or organisational change and development. AI
seeks to discover those things that ‘give life’ to people, organisations and human systems when they are
most effective and healthy. It is founded on the assumption that inquiry into, and conversation about,
strengths, successes, values and hopes triggers change. It assumes that in every situation or organisation
something works well and change can be leveraged through discovering, sustaining and spreading these
moments of excellence within the wider system. Widely used in public and corporate institutions to
develop organisations, the central tenet within AI is that in order to understand a person or situation
(necessary for change and development) one needs to appreciate and openly inquire. Thus at the centre of
AI participatory research is a subtle but fundamental shift from ‘diagnosis’ (determining why something is
like it is) to ‘inquiry’ (questioning to understand another person’s view and thus seeing new perspectives
and possibilities within a situation). AI argues that the way people talk about an organisation or situation is
important and affects the way people view their work and their role. Furthermore, AI assumes that an
organisation is dynamic – with a past, present and future. People within an organisation will have more
confidence to move towards the future (the unknown) if they carry forward within their working practices
the best parts of their past (the known). The exploration and enhancement of what is going well in a
system is often framed as a four-dimensional (4-D) cycle (Figure 31).
Modified Appreciative Inquiry for care homes
Appreciative Inquiry Light
Typically, AI interventions work intensely over a period of 2–5 days and assume a stable unitary
organisation. In the EVIDEM-EoL study, care home and health-care staff were spread over different
locations and with limited time resources. The AI method was modified (Figure 32). Hour-long sessions,
were held three times over a period of 6 months in the three care homes. There was a focus on creating a
‘team in the moment’, whose members carried ideas generated back into their own professional place
of work.
Appreciative
topic
What do
we want
more of?
Discovery:
appreciating the best of
what is
Dream:
envisioning what might be
Design:
together finding innovative
ways to make it happen
Destiny:
sustaining the change
FIGURE 31 The AI 4-D model of positive change.
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••
•
Stories of excellence around
joint working in end-of-life 
care for residents with 
dementia
Being together and valuing
each others roles
Shared goals of future end-of-life 
care for residents with dementia 
v m
e
6  months 
Session 1
Appreciation/stories 
Generous listening and
development of interventions
from post-death case reviews
Seeing the world from 
another's point of view
Working out next steps around
specific interventions
•
•
•
Session 2
Positive development
of practice
Sustaining and expanding
circles of dialogue
What small things can we do to
spread the changes?
Who else needs to be involved?
Stories of the process from
different perpectives
Session 3
Sustaining change
•
•
•
•
FIGURE 32 Modified AI for care homes.
Appreciative Inquiry sessions
All sessions were facilitated by a nurse researcher (‘facilitator’) and attended by at least two other
researchers (‘researchers’) from the EVIDEM-EoL team. Sessions brought together care home staff and
visiting health-care practitioners with the expressed intent of discussing end-of-life practice. There was
considerable preparation before the sessions and follow-up by the research team in between the meetings.
The researchers’ role was to ground sessions in actual practice by providing participants with evidence of
end-of-life care gathered in Phase 1, as well as evidence from Phase 2, as it became available. Researchers
gave absent stakeholders (i.e. residents and relatives, emergency services) a voice over the course of the
sessions using interview data collected over the course of the study. Researchers also summarised key
themes and points for participants in between sessions, and provided updates in newsletters. Initiatives
arising from the intervention were linked to practice development within the wider system by providing
care homes with current and up-to-date resources in end-of-life care (Dying Matters leaflets, East of
England DNACPR forms) and links to the care homes’ local support networks (local hospices, end-of-life
facilitators, Hertfordshire Partnerships).
Session one: appreciation/stories
Prior to session one, participants were sent a letter introducing AI and encouraging reflection and sharing
of stories of good practice (see intervention information). This introduction to ‘good gossip’ enabled some
familiarity with AI and the emphasis on positive experiences before the structured sessions. Session one
used the principles of the Discovery and Destiny phases of AI to reveal current excellent practice, value the
shared capacity among participants and together create a shared intent about the future of end of life
within that care home. Following a brief introduction participants were paired and invited to tell each
other a story of ‘a positive memorable moment of working with others to provide end-of-life care for a
resident dying with dementia’. Each pair recounted and listened to experiences of working well and then
spent time comparing their stories for > 15 minutes. Each pair reported back to the wider group, and
participants were invited to respond to what they had heard. This enabled participants to notice and value
the role of each group member. Participants were encouraged to comment on any similarities they had
noticed in the stories and together the group constructed a number of key attributes, values, skills and
abilities they identified around shared working which were written down, for example ‘families are really
APPENDIX 47
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important and we value keeping them involved’. The whole group were then asked to imagine the
care home 5 years on, and together to think about their best ideal for end-of-life care for people with
dementia. Several questions were used to help direct this thinking: i.e. What is different? What is going
on in the home? Who is here? How have residents benefited? These future-directed statements were
recorded, and the session ended by each participant reflecting on their own practice and shared working.
Session two: positive development of practice
The second round of AI session across care homes built on session one and used the principles of the AI
design phase to focus on prioritising and choosing a particular innovation for participants to co-design
together. Session two used reflections on real-life practice and end-of-life care within the care home to
reflect on collaborative working and tease out the specifics of each innovation.
The meeting began with a check in about session one and anything participants wanted to share. An after
death analysis of a care home resident was presented to the group (see Appendix 51) by the research
team, using data from care notes, interview with key staff members and the time line of death. The
emphasis on using these after-death analyses was on the process of care giving, and the alignment of
strengths and adjustment of practice, where necessary, to move towards the future-directed statements.
This emphasis on moving care forward to the intended ideal allowed for the telling of real-life/nuanced
stories within a framework of generous listening, in which problem talk is framed in appreciation and
possibilities, and forward thinking reflection. The tension between reflection on, and judging, specific
practices was held by asking each participant to see the case from a variety of different perspectives.
Thus, the discussions of the end-of-life pathway within the cases were looked at first from the point
of the primary care doctor/district nurse, second from the care home staff perspective and then from the
resident and family viewpoint. This proved a powerful tool in keeping participants open to the point of
view of others and valuing difference, but with enough detail to enable realistic plans to develop the
future-directed statements about the organisation and quality of end of life within the care home.
For example, one GP was able to imagine himself as a member of care staff confronted with a collapsed
resident, calling OOH for urgent medical advice. He acknowledged the inevitability of calling paramedics
when the OOH response was slow, which often ends with a resident being transferred to hospital and
possibly dying there. The remainder of session two was given over to the participants prioritising an
innovation, and working within the groups to allocate responsibilities as to what needed to happen next,
with whom and how to work with wider systems, for example OOH doctors.
Session three: sustaining change
The final session built on the previous two phases and the AI Destiny phase to concentrate on
sustainability and embedding the practice innovation into the wider care home system. Although the
emphasis throughout the Phase 2 study has been on a specific innovation in each care home, participants
has taken the principles of AI into wider everyday practices. Thus, although session three reflected on the
particular innovation of each care home and spreading, there was also an emphasis on reflecting on
collaborative working and end-of-life care and how this can continue to be developed within each case
study site. Also throughout the 6 months the participants had become a stronger group and more
self-directing and in this last session the facilitator’s role was more supporter than coach.
Thus the facilitator asked questions of the group to enhance their own learning and capacity to sustain
and spread the processes, for example ‘Where are we now compared with where we hoped we would
be?’ ‘What more needs to happen?’. Essentially, this allowed each group to negotiate with each other
about what realistic sustainability might look like rather than taking on imposed targets from outside.
Using this context-based approach, three different structures emerged based on the strengths and interests
of participants. One care home is using an existing GP visit as a strategic overview meeting to attend to
the development of end-of-life care in the home. Another is creating structures to involve the other GP
practice and spread their learning. The third is using AI principles to collaborate more with the district
nurses who were unable to continue to attend the facilitated meetings. Participants reflected on the
positives but also the challenges of the AI intervention, and set their own plans for furthering the work.
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Appendix 48 Chapter 4: Intervention information –
general
Appreciative conversations
Part of the EVIDEM project is about acknowledging and sharing what experiences and skills we already
have in caring for people with dementia dying in care homes. We know from research that people
work best when they work from a place of strength acknowledging what they do well and having
conversations with others. These conversations create a shared understanding of what is good practice
and what needs to be in place so it can happen more of the time. Usually we ask about things that are
broken – the problems – so that we can fix them. In this case, we are trying to look at things at their
best – the successes – so that we can find out what works and do more of it.
In January we will be doing this through ‘appreciative conversations’, asking you to tell your stories to
other care home staff and the primary care team staff about times when you saw things working at their
best in relation to people dying of dementia in your care home.
So, in preparation for this, we would like you to think about a situation where you felt you or the team
you were working with, delivered care that allowed a resident to die well?
This may be in relation to symptom control, how you worked with the NHS professionals, or perhaps were
able to carry out the wishes of the resident or their family.
Think about
What made the situation really special?
What was your contribution?
How did it feel?
Has it changed you in any way, if so how?
How did the care home or primary care team help you in this?
What were other people doing that helped?
What do you think was really making it work?
Talk about
Find a colleague and talk about it together – are your experiences similar?
We call this Good Gossip and can happen over a tea break, coming on and off a shift, as well as
structured meeting times in the course of work.
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Appendix 49 Chapter 4: Intervention information –
care home staff
Information for care home staff
We are really pleased that you are joining with us in Phase 2 of the EVIDEM project and excited about
working with yourselves and the Primary Health Care Team.
What we want to do in January
Our aim is to help you use your experiences and knowledge of what works well to create shared
interventions to support and enhance practice. We all want the care of people dying with dementia to be
as good as it can possibly be.
What we have asked you to do
We have asked you to tell stories of times when you felt you and the team have delivered care that
allowed a resident with dementia to die really well. Although you may have remembered a difficult
experience was there a moment when you remembered something good that came out of it? Perhaps you
felt proud about how you or your care home handled the difficulty? We are not denying that there are lots
of challenges in your work but we are interested in your capacity with your colleagues to overcome these.
The idea of talking about the good things with other colleagues we call Good Gossip because:
l Good Gossip not only makes you feel better, but also your listener and the organisation in which you
are working.
l You can only gossip by talking to others, no one gossips on their own.
l Good Gossip is ongoing conversation when you talk and listen to colleagues in your organisation,
about what you are proud of, what you do well, what you have seen others do that makes you
feel good.
What we want you to do now . . .
Experience and Practice Good Gossip . . . For many of us we need others to help us practice and talk
about what we do well. Here are some ways to do that:
1. Think about your wishes for your care home and residents dying of dementia, what you would love to
see happening or in place . . .
2. Go tell someone else and ask them to tell you their wishes. If that feels hard then what would things
look like if it were a little better in your care home?
3. What would be the smallest thing you could do to bring your wishes into being . . . it may start with
saying good morning to someone or learning someone’s name.
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Appendix 50 Chapter 4: Intervention information –
district nurses/general practitioners
Information for district nurses and general practitioners
The EVIDEM-EoL Phase 1 tracked over 1 year the care received by people with dementia in six care homes.
The findings suggested that fundamental to good care is the way of working together of NHS care home
staff, family members and, where possible, people with dementia.
Phase 2 is an intervention-based study with three care homes, underpinned by collaborative working.
Care home and primary care staff identify an area for improvement around the care of a person dying with
dementia, and develop strategies to implement this. To facilitate this we are using an AI approach. The
originator David Cooperrider first worked with physicians in USA and noted that when he asked doctors
about success rather than failure their energy, enthusiasm and motivation shifted.
Appreciative Intervention is both a philosophy and process that has been widely applied to change in
health care. Fundamentally, it is the search for the best in people and their organisations and the
assumption that within a system there is always something that is working. This strength-based change
uses enquiry, positive questions, and good experiences to explore, discover and open up new possibilities
with others who are important in the system.
In January we will begin this through ‘appreciative conversations’, asking you when you saw things
working at their best in relation to people dying of dementia in care homes. So in preparation we would
like you to think about a situation where you felt you or the team you were working with, delivered care
that allowed a resident to die well. This may be in relation to symptom control, how you worked with the
care home or were able to carry out the wishes of the resident or their family.
Think about
What made the situation really special?
What was your contribution?
How did it feel?
Has it changed you in any way, if so how?
How did the care home or other primary care team members help you in this?
What do you think was really making it work?
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Talk about
Find a colleague and talk about it together, are your experiences similar? We call this Good Gossip and
can happen over a break, as well as structured meeting times in the course of work.
Cooperrider D. Appreciative Inquiry: towards a methodology for understanding and enhancing
organizational innovation. Doctoral Dissertation. Cleveland, OH: Western Reserve University; 1986.
Reed J. Older people maintaining wellbeing: implications for future developments. Int J Older People
Nurs 2008;3:76–8.
Alfred R, Shohet R. ‘What’s the best day you’ve ever had at work?’ Appreciative Inquiry at the Manchester
Heart Centre. In Edmonstone J, editor. Building on the Best: An Introduction to Appreciative Inquiry in
Health Care. Chichester: Kingsham Press; 2006.
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Appendix 51 Chapter 4: Intervention material –
post-death analysis
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Appendix 52 Chapter 4: Participant developed
tools – prompt sheet
Starting to have conversations about dying with residents
and relatives
There is something about looking for clues from residents or relatives as to when they might be ready to
talk about their wishes and being able to respond outside of a need to fill in a form, for example:
l when they have received news of a death, may be a friend, family, pet . . .
l when someone else in the home has died . . .
l when they have just been through a time of change or something out of the ordinary routine, e.g. a
hospital admission/not feeling so well/family member has visited . . .
Sometimes an open question, e.g. ‘How are you today?’ can open up a lot and often it is allowing yourself
to not close this down. In one care home, passing by a resident, I said ‘How are you?’ and she said ‘I’m
past my sell by date just waiting now to go . . .’ It could be a start of a conversation. My neighbour said to
me yesterday, ‘I shouldn’t be here any longer.’ These are openings for us to listen.
Some ways of asking
l I wondered if you minded thinking about the care you want for the future, for instance when you
become unwell or your health starts to deteriorate.
l I am not bringing this up because you/your relative is ill at the moment but just so that we can plan for
the future and provide the best care for you/your relative in the coming months.
l Some people have very definite views about how they want to be cared for at end of life and others
do not want to think about it. We understand everyone is an individual.
l It has been shown that it is sometimes easier to think about these things while you/residents are well,
rather than have to make decisions at short notice.
l You might not want to talk about this with me at the moment, or ever and that is absolutely fine.
We just wanted to ask and hope you don’t mind. Or I can give you a form to take away and we can
talk again. You might want to talk to other relatives, chat together or talk to your GP. There are
some leaflets.
You (the resident or relative) are welcome to discuss the issues at any time they feel prompted to do so
and for whatever reason.
l We sometimes ask our residents if they have any anxieties about dying when the time comes. Is this
something you would like to talk about?’
l None of us know what the future holds but sometimes it helps to talk about our hopes and fears.
Is there is anything you would like to talk about with me or your relative, a GP a spiritual or religious
person? Please let me know and we will make some time for a conversation.
From research findings
Residents/relatives may talk informally with carers about their wishes (or what they don’t want, or what
happened to a close relative that was good or bad), ask them if this can be recorded in the care notes.
Follow up those conversations. It is not just the manager who has the conversations – in one care home
the woman who worked in the laundry had the most open discussions with residents and relatives.
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Possible times to talk with resident/relative – after a hospital admission, after a death of a fellow resident,
when a resident’s health declines.
Advice from another care home manager: start the subject at the initial assessment (6 weeks), give them
the form to take away and then review in another few months’ time. Keep offering the opportunity to
follow up, especially as health deteriorates. It is easier to have the difficult conversations, if you have
already had some earlier.
Some specific questions
Any wishes for your last days?
Where would you like to be cared for in the future? (care home or hospital?) ‘Care home as long
as possible?’
Would you want any more hospital admissions? Resuscitation? Transfer to a nursing home?
Examples from other documents/care homes
A Preferred Priorities of Care (final wishes) document can help you/us prepare for the future. It gives you
an opportunity to think about, talk about and write down your preferences and priorities for care at the
end of life. You do not need to do this unless you want to . . .
l Remember your views may change over time and you can change what you have written whenever
you wish to.
l What are your preferences and priorities for your future care?
l Where would you like to be cared for in the future?
A final wishes plan is designed to inform people around me of my ‘wishes’ regarding the atmosphere and
environment I would like to be in as my life draws to a close – and any specific requests I have. Please note
this is for guidance and not legally binding.
l Resident Have you spoken to anyone about your wishes? Would you like help to do so?
l Relative Has your relative ever spoken to you about what they might like?
l When you (or your relative) comes towards the end of your/their life, what would you/they like around
you/them?
¢ favourite flowers, music, pictures, favourite perfume, prayers, physical contact, massage,
personal care
¢ relatives/someone with you
¢ any spiritual/religious needs
¢ if the condition is prolonged I would/would not like to venture out of my room.
l Subjects you might need to talk about:
¢ the type of care someone would like towards the end of their life
¢ where they’d like to die
¢ whether they have any particular worries they’d like to discuss about being ill and dying
¢ how long you would like doctors to keep treating you
¢ resuscitation.
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Some questions about funeral arrangements
(Not the key for advanced planning but sometimes a way to start a conversation; some people may feel
more comfortable talking about funeral plans.)
l I would like my death and funeral to be announced in the following ways
l My preferred funeral director is
l The person I would like to deal with my funeral arrangements is
l The type of funeral I would like is (traditional, less traditional, hymns, music, readings, poems)
l Buried or cremated
l Flowers and or donations at the funeral
l I would like to take with me (leave from); to wear (clothes, jewellery) to take with me (photo, book)
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Appendix 53 Chapter 4: Participant developed
tools – out-of-hours information sheet
Information out-of-hours services need to know about
a resident
Prompt guide for care staff – out-of-hours services information sheet
These are questions for care home staff to think about before ringing OOH services. Please try and have
answers ready for as many of these questions as you can.
_________________________Date
Resident’s name Answers
Medical history/background
Symptoms (what is wrong?)
How long has this been going on?
Is this:
l an expected palliative situation (i.e. when someone is approaching end of life or not for
further active treatment is being considered by their usual doctor)
or
l person getting acutely unwell all of a sudden?
What were they like before this problem arose?
What are they usually like?
What is normal for them/what has changed?
How has the problem altered/what are they normally like?
Wishes of the residents
Wishes of the family/relative
Preferred place of care?
(anything else known – resus.?)
Any more hospital admissions?
Would resident want to go to hospital?
What do you want OOH to do?
Why is OOH being called?
Are they acutely unwell now?
Do they need an ambulance (999)? Is it an emergency situation?
Can their symptoms be managed?
Further treatment for infection?
Other
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Appendix 54 Chapter 4: EVIDEM-EoL advisory
group members
Marion Cowe Member of the Public Involvement Group for CRIPACC (University of Hertfordshire). Lay perspective,
former carer of brother with dementia
Jaleh von Wagner Lay perspective. United Carers for Dementia. Carer for 8 years (24/7) of mother, who died from
vascular dementia/Alzheimer’s disease then cared for elderly, disabled blind father for further
2.5 years (24/7); with both at the death
Rachel Dutton Member of Housing 21 Association. Specialist area is social care provision for people with dementia
towards end of life
Catherine Evans Former EVIDEM-EoL lead researcher; research specialises in older people; background in nursing
Hillary Speller
(attended one
meeting)
Lay perspective. Father died with dementia in distressing circumstances
Jane Wilcock Senior Research Fellow, University College London and EVIDEM Programme Manager
Allan Kellehear Professor of Sociology, University of Bath. Specialist areas include dying, public health and end of life
Derek Baker Lay perspective, wife has dementia and is living in a care home. Chairman of the Mid Essex Branch
Committee, Alzheimer’s Society
Nicole Jackman Senior doctor at St Francis Hospice – specialist interest in palliative care for the elderly
Louise Robinson GP academic, University of Newcastle. Specialist areas include dementia (diagnosis, quality of life, end
of life), promoting older people’s health
Sheila Peace Professor of Gerontology, The Open University. Specialises in sociology, care homes, end of life and
older people
Clive Evers Director of Education and Information, Alzheimer’s Society
Ram Awatar Director of Clinical Services, Nightingale House. Specialist areas include care homes, dementia and
older people
Karen Harrison
Dening
Specialises in research for OPWD and is a consultant Admiral Nurse
Priya Jain Assistant Research Manager, EVIDEM Early Diagnosis
Kalpa Kharicha Senior Research Fellow and EVIDEM Programme Manager (covering Jane Wilcock’s maternity leave)
Jan Dewing Professor at University of Kent at Canterbury and Visiting Professor at the University of Wollongong,
Australia. Holds extensive national and international experience, particularly in the field of dementia
and care for the elderly, and has made a great contribution to consenting with people who lack
capacity
Heather Maggs Member of the Public Involvement Group for CRIPACC (University of Hertfordshire). Lay perspective.
Father had dementia. Member of Alzheimer’s Society Quality Research in Dementia
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Appendix 55 Chapter 4: Care home characteristics
TABLE 106 Organisation of care, dementia training, palliative care traininga
Care
home Organisation of care Dementia training Palliative training or other
CH1 Dedicated Dementia Unit; staff
allocation by duty manager night
before shift on basis of experience –
less experienced placed with more
experienced; high level of continuity;
key worker
Need to have completed basic
dementia training to work on
Dementia Unit. Can do further
training BTEC diploma over
2.5 days or 1-year course –
Champion in Dementia. Yearly
update given to staff regarding use
of antipsychotics
Informal in-house training
provided by district nurses
dependent on needs (e.g. stoma
care, catheter care). Informal
in-house training on mouth care,
pressure area care, basics of pain
relief and constipation management
CH2 Team of workers; key worker system;
key worker for two to three residents,
may change if poor rapport with
resident. At beginning of shift,
three staff members decide how to
allocate work. Duty manager gives
handover to all staff for morning shift
and again for afternoon shift, which
starts at 3.30 pm
On dementia unit all staff will have
undertaken basic dementia training
District nurses advise CH staff on
mouth care, request turning
charts, fluid/food intake charts,
monitoring passing of urine
CH3 Three staff per shift on dementia
unit; allocated on daily basis at
beginning of shift by senior staff.
Communication – verbal and
written, notes in diary, district nurse
book and GP book
On dementia unit all staff will have
undertaken basic dementia training
CH4 Dedicated dementia unit; 6- and
12-hour shifts; separate night staff
(12-hour shifts). Verbal handover
through notes. Verbal to senior who
transfers information to team
Training compulsory for all care
staff run by organisation – 3 days
over 3 weeks, including some
homework
CH5 Key worker system; hierarchical
system; not clear how work
organised; night staff entirely
separate – not same support system
available to them, fewer staff, no
senior, theoretically home manager
contactable
Training (information on office wall)
but not clear what is involved
Informal in-house training
provided by district nurses
(nursing sisters) in the past,
e.g. diabetic training
CH6 Senior carer on each unit, on each
shift. Seniors handover to everybody
but anything more specific to do
with staff it would be senior to
senior
Unclear
BTEC, Business and Technology Education Council; CH, care home.
a Source: care home manager and district nurse interviews.
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Appendix 56 Chapter 4: Care home resident
needs and deaths in year prior to study
TABLE 108 Care home residents’ significant areas of needa
Areas of need
CH1 (N= 44):
n (%)
CH2 (N= 58):
n (%)
CH3 (N= 57):
n (%)
CH4 (N= 62):
n (%)
CH5 (N= 66):
n (%)
CH6 (N= 54):
n (%)
Bedfast 0 0 3 (5.3) 0 0 0
Help with
dressing/undressing
41 (93.2) 46 (79.3) 50 (87.7) 42 (67.7) 52 (78.8) 38 (70.4)
Help with
washing/bathing
44 (100.0) 56 (96.6) 57 (100.0) 59 (95.2) 63 (95.5) 51 (94.4)
Help going to the toilet 33 (75.0) 32 (55.2) 42 (73.7) 32 (51.6) 30 (45.5) 21 (38.9)
Singly incontinent 34 (77.3) 15 (25.9) 7 (12.3) 39 (62.9) 16 (24.2) 13 (24.1)
Doubly incontinent 18 (40.9) 22 (37.9) 18 (31.6) 9 (14.5) 21 (31.8) 3 (5.6)
Dementia 31 (70.5) 34 (58.6) 29 (50.9) 30 (48.4) 55 (83.3) 23 (42.6)
Other mental health
needs
1 (2.3) 6 (10.3) 1 (1.8) 0 4 (6.1) 0
Learning disabilities 1 (2.3) 1 (1.7) 2 (3.5) 0 0 0
Physical disabilities 19 (43.2) 17 (29.3) 0 0 0 1 (1.9)
Two or more staff to help
with their care
14 (31.8) 11 (19.0) 8 (14.0) 14 (22.6) 13 (19.7) 4 (7.4)
Help/supervision/prompts
to eat meals
23 (52.3) 17 (29.3) 11 (19.3) 23 (37.1) 29 (43.9) 4 (7.4)
Impaired vision 24 (54.5) 13 (22.4) 25 (43.9) 37 (59.7) 42 (63.6) 2 (3.7)
Impaired hearing 2 (4.5) 8 (13.8) 16 (28.1) 20 (32.3) 19 (28.8) 2 (3.7)
English not first language 1 (2.3) 2 (3.4) 0 0 0 0
Specialist communication
needs
4 (9.1) 0 0 0 3 (4.5) 0
Alcohol dependence 0 1 (1.7) 0 0 0 1 (1.9)
Drug dependence 0 0 0 0 0 0
a Source: AQAA data.
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Appendix 57 Chapter 4: Care homes’ access to
primary and specialist services
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Appendix 58 Chapter 4: Resident baseline
characteristics
TABLE 112 Admission routea
Place of previous residence (N= 120) n %
Own home 52 43.3
Relative’s home 7 5.8
Hospital 35 29.2
Care home 13 10.8
Sheltered housing – warden controlled 13 10.8
Total 120 100.0
Reason for admission (N = 91)
Following death of spouse 3 3.30
Resident isolated 5 5.50
Concerns about safety 8 8.80
Deterioration of health 16 17.60
continued
TABLE 110 Phase 1: recruitment and retention rates
Care home Recruitment (n) Recruitment rate (%) Retention (n) Retention (%) at end of Phase 1
CH1 20 71.4 15 75.0
CH2 25 62.5 19 76.0
CH3 16 50.0 12 75.0
CH4 23 76.7 19 82.6
CH5 34 54.0 25 73.5
CH6 15 71.4 10 66.7
Total 133 62.2 100 75.2
TABLE 111 Resident age, length of staya
Care home CH1 CH2 CH3 CH4 CH5 CH6
Median age at admission,
years (mean, SD)
84.4
(84.4, 6.15)
87.3
(86.3, 8.55)
87.5
(86.0, 4.63)
86.5
(83.7, 5.61)
82.7
(82.0, 6.56)
83.7
(82.8, 7.06)
Median age at baseline,
years (mean, SD)
88.7
(87.4, 6.16)
90.4
(89.51, 8.33)
89.7
(88.7, 5.77)
88.1
(85.7, 5.85)
84.9
(83.5, 6.22)
84.3
(83.7, 7.41)
Median length of residency,
years (mean, SD)
2.5
(3.0, 2.16)
3.4
(3.2, 1.84)
2.0
(2.8, 2.13)
1.6
(2.0, 1.77)
1.3
(1.5, 1.00)
0.2
(1.0, 2.20)
a Source: care notes.
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Reason for admission (N = 91)
Resident unable to cope living independently 31 34.10
Carers no longer able to cope 11 12.10
Short-term stay into long-term placement 7 7.70
Needs unmet in previous accommodation 4 4.40
Other 6 6.60
Total 91 100.0
a Source: care notes.
TABLE 112 Admission routea (continued)
TABLE 113 Dementia diagnosisa
Recorded diagnosis of dementia (N= 98)
Type n %
Alzheimer’s disease 38 38.80
Vascular dementia 16 16.30
Mixed 5 5.10
Lewy body 2 2.00
Korsakoff syndrome 1 1.00
Other 1 1.00
Not recorded 35 35.70
No recorded diagnosis 35 26.30
Source
Neurologist 1 1.00
Social worker 2 2.00
Consultant psychiatrist 12 12.30
Assessment 4 4.10
Brain scan 1 1.00
SMHT 7 7.20
CPN report 1 1.00
Memory clinic 2 2.00
Not recorded 68 69.40
No recorded diagnosis 35 26.30
CPN, community psychiatric nurse; SMHT, Specialist Mental Health Team.
a Source: care notes.
APPENDIX 58
NIHR Journals Library www.journalslibrary.nihr.ac.uk
552
TABLE 114 Activities of daily living record in care notes
ADL Recorded (N, %) No record (N, %) Total (N, %)
(In)continence 131 (100) 0 (0.0) 131 (100)
Personal care 131 (99.2) 1 (0.8) 132 (100)
Maintaining a safe environment 128 (97.7) 3 (2.3) 131 (100)
Eating and drinking 128 (97.0) 4 (3.0) 132 (100)
Toilet use 92 (70.2) 39 (29.8) 131 (100)
Sleeping 61 (47.7) 67 (52.3) 128 (100)
Expressing sexuality 19 (14.5) 112 (85.5) 131 (100)
Breathing 13 (9.8) 119 (90.2) 132 (100)
TABLE 115 Function within care homes (ADL; N= 133)
Function CH1 CH2 CH3 CH4 CH5 CH6 Total
ADLa
(In)continence, n (%)
Incontinent 13 (68.4) 5 (20.8) 7 (43.8) 11 (47.8) 13 (38.2) 4 (26.7) 53 (40.5)
Occasional accident 0 (0) 2 (8.3) 1 (6.3) 0 (0) 2 (5.9) 1 (6.7) 6 (4.6)
Continent 6 (31.6) 17 (70.8) 8 (50.0) 12 (52.2) 19 (55.9) 10 (66.7) 72 (55.0)
Personal care, n (%)
Needs assistance of up to two people 4 (21.1) 8 (33.3) 7 (43.8) 18 (78.3) 7 (20.6) 6 (40) 50 (38.2)
Needs assistance of one person 15 (78.9) 16 (66.7) 7 (43.8) 4 (17.4) 26 (76.5) 5 (33.3) 73 (55.7)
Independent 0 (0) 0 (0) 2 (12.5) 1 (4.3) 1 (2.9) 4 (26.7) 8 (6.1)
Maintaining a safe environment, n (%)
Immobile 3 (15.8) 2 (8.7) 1 (6.7) 2 (8.7) 3 (9.1) 0 (0.0) 11 (8.6)
Needs supervision 5 (26.3) 7 (30.4) 4 (26.7) 2 (8.7) 11 (33.3) 5 (33.3) 34 (26.6)
Independent (with or without
mobility aid)
11 (57.9) 14 (60.9) 10 (66.7) 19 (82.6) 19 (57.6) 10 (66.7) 83 (64.8)
Eating and drinking, n (%)
Full assistance 7 (35) 6 (28.6) 4 (25) 4 (17.4) 8 (24.2) 2 (13.3) 31 (24.2)
Minimal assistance 3 (15) 2 (9.5) 1 (6.3) 2 (8.7) 3 (9.1) 1 (6.7) 12 (9.4)
Independent 10 (50) 13 (61.9) 11 (68.8) 17 (73.9) 22 (66.7) 12 (80) 85 (66.4)
Toilet use, n (%)
Needs assistance of up to two people 2 (15.4) 3 (15) 3 (25) 0 (0) 4 (21.1) 2 (15.4) 14 (15.2)
Needs assistance of one person 7 (53.8) 7 (35) 2 (16.7) 2 (13.3) 2 (10.5) 3 (23.1) 23 (25)
Independent 4 (30.8) 10 (50) 7 (58.3) 13 (86.7) 13 (68.4) 8 (61.5) 55 (59.8)
a Source: care notes.
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TABLE 116 Event categories
Event category Detail as recorded in care notes
Infection Upper respiratory tract, chest, urinary tract, eye, thrush, catheter-induced penile tear, discharge
(anal, penile), raised temperature
Gastrointestinal Vomiting, diarrhoea, constipation
Pain Increased pain, headache
Stroke/transient
ischaemic attack
Suspected stroke or transient ischaemic attack
Carcinoma Suspected or spreading carcinoma
Leg/ankle swelling Leg and/or ankle swelling
Tissue viability Pressure ulcer, blister, tear, soreness
Confusion Increased confusion, absence
General deterioration General ill health, general deterioration, generally unwell, increased frailty, increased weakness
Fallsa Falls
Eating and drinking Loss of appetite, difficulty swallowing, supplementary feeds, unable to eat, unable to drink,
weight loss
Sleepiness Increased sleepiness
Withdrawal Increasingly withdrawn, no longer enjoys activities as s/he used to
Skin colour Pale, skin colour change
Decreased mobility Reduced mobility, increased stiffness
Incontinence Urine, faeces
Refusing personal care Repeatedly refusing personal care
Breathing Laboured breathing, breathlessness
Agitation Increased agitation, aggressive behaviour towards other residents
Distress Low mood, tearfulness, ‘wants to die’
Other Muscle spasms, ‘floppiness’, not his or herself, lethargy, altered level of consciousness,
increased difficulty in communicating, disturbed sleep, dehydration, mouth sores, seizure,
unsteadiness, nausea, drowsiness, weight gain, shaking, rectal prolapse, renal and heart failure,
dizziness, fainting, bleeding (penile, vaginal, nose, blood in stools), lip swelling, face swelling,
unresponsive
a Falls as recorded in care notes up to 3 months preceding baseline extraction or up to the previous date of extraction at
time point 2 and time point 3.
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TABLE 117 Events at baseline, time point 2, and time point 3a
Type of eventb
Baseline (N= 133) Time point 2 (N= 127) Time point 3 (N= 112)
n % n % n %
Infection 31 23.30 20 15.70 29 25.90
Gastrointestinal 9 6.80 16 12.60 27 24.10
Pain 3 2.30 5 3.90 3 2.70
Stroke/transient ischaemic attack 2 1.50 2 1.60 2 1.80
Carcinoma 1 0.80 2 1.60 4 3.60
Leg/ankle swelling 4 3.00 3 2.40 4 3.60
Tissue viability 10 7.50 15 11.80 11 9.80
Confusion 11 8.30 13 10.20 15 13.40
General deterioration 1 0.80 8 6.30 4 3.60
Fallsc 29 21.80 39 30.70 33 29.50
Eating and drinking 36 27.10 45 35.40 37 33.00
Sleepiness 11 8.30 22 17.30 36 32.10
Withdrawal 0 0.00 4 3.10 8 7.10
Skin colour 0 0.00 2 1.60 2 1.80
Decreased mobility 0 0.00 2 1.60 4 3.60
Incontinence 15 11.30 36 28.30 38 33.60
Refusing personal care 0 0.00 1 0.80 3 2.70
Other 8 6.00 10 7.90 19 17.00
Breathing 1 0.80 1 0.80 3 2.70
Agitation 2 1.50 9 7.10 12 10.70
Distress 0 0.00 2 1.60 5 4.50
a Source: care notes.
b See Table 116 for detail of event categories.
c Falls as recorded in care notes up to 3 months preceding baseline extraction or up to the previous date of extraction.
TABLE 118 Falls at baseline, time point 2 and time point 3
Time period CH1 CH2 CH3 CH4 CH5 CH6 Total
At least one fall up to 3 months preceding baseline or up to the previous date of extraction
Baseline (N= 133), n (%) 5 (25.0) 6 (24.0) 2 (12.5) 4 (17.4) 9 (26.5) 3 (20.0) 29 (21.8)
Time point 2 (N= 127), n (%) 8 (40.0) 9 (37.5) 4 (26.7) 5 (22.7) 10 (32.3) 3 (20.0) 39 (30.7)
Time point 3 (N= 112), n (%) 9 (47.4) 2 (10.0) 2 (14.3) 9 (42.9) 6 (23.1) 5 (41.7) 33 (29.5)
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TABLE 119 Level of involvement in end-of-life discussions (n, %)
Resident, consultee and family 8 (6.0)
Resident and consultee 3 (2.3)
Resident and family 7 (5.3)
Consultee and family 10 (7.5)
Family 18 (13.5)
Consultee 14 (10.5)
Resident 10 (7.5)
No evidence of discussions on end-of-life wishes 53 (39.8)
Unclear 10 (7.5)
TABLE 120 Phase 1 attrition
Attrition CH1 CH2 CH3 CH4 CH5 CH6 Total
Baseline
Deceased: care
home
EoL0201064 EoL0301074 2
Deceased:
hospital
EoL0501171 1
Transferred EoL0501165 1
Time point 2
Deceased: care
home
EoL0101015 EoL0401148a 2
Deceased:
hospital
EoL0501154 4
EoL0501156 EoL0601223
EoL0501209
Transferred EoL0301083 EoL0501181 EoL0601215 3
Time point 3
Deceased: care
home
EoL0101013 EoL0301090 EoL0401127 EoL0601217 6
EoL0101021 EoL0401133a
Deceased:
hospital
EoL0101023 EoL0201044a EoL0501192 EoL0601233 7
EoL0201062a EoL0501206
EoL0201067a
Transferred EoL0501199a EoL0601221 2
End of Phase 1
Deceased: care
home
EoL0101022 EoL0201056 EoL0301091 EoL0401130 5
EoL0201068
Total deaths (%) 5 6 3 4 6 3 27 (20.3)
Total transfers (%) 0 0 1 0 3 2 6 (4.5)
Total (%) 5 (25) 6 (24) 4 (25) 4 (17.4) 9 (26.5) 5 (33.3) 33 (24.8)
a Care notes unavailable for review at time point (post-death analysis interview only, where appropriate).
Italicised resident identifiers denote inclusion in survival analysis.
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Appendix 59 Chapter 4: Service utilisation and
associated costs
TABLE 121 Distribution of service use (per month): median (IQRa)
Type of visit Overall (n= 122) Alive (n= 105) Dead (n= 17) Wilcoxon test p-value
Primary care 0.9 (0.5–1.3) 0.8 (0.5–1.2) 2.0 (1.0–3.0) 0.0006
Hospital 0.3 (0–0.8) 0.2 (0–0.7) 0.8 (0.4–13.8) 0.002
Community health 0.4 (0.2–1.1) 0.4 (0.2–0.7) 1.1 (0.6–1.6) 0.008
IQR, interquartile range.
a IQR, i.e. 25th percentile to 75th percentile.
TABLE 122 Phase 1: distribution of costs (£ per month): median (IQR)
Costs Overall (n= 133) Alive (n= 116) Dead (n= 17) Wilcoxon test p-value
Primary care 76 (45–123) 67 (39–107) 127 (106–279) 0.0003
Hospital 39 (0–199) 34 (0–111) 273 (96–6984) 0.0018
Community health
care
45 (21–92) 44 (20–83) 89 (29–167) 0.0401
Accommodation 2243 (0–2473) 2243 (0–2447) 2243 (1754–2473) 0.4958
Total care and
accommodation
2488 (413–2890) 2438 (194–2834) 2917 (2226–9867) 0.0152
Medication 57 (31–92) 57 (30–95) 43 (38–66) 0.4015
Total (including
accommodation
and medication)
2549 (463–2974) 2490 (251–2927) 2964 (2253–9925) 0.0168
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Appendix 60 Chapter 4: Sample information –
interviews
TABLE 125 NHS staff: sample information
Staff GPs (n= 5) District nurses (n= 5) Emergency services (n= 3)
Length of time in post: range, years 7–18 0.5–7 6–7
Length of time working with
care home: range, years
4–11 0.5–7 N/A
Dementia training 2/5 2/5 No (MCA only)
End-of-life training No 4/5 No
N/A, not applicable.
TABLE 123 Care home managerial staff interviews
Staff CH1 CH2 CH3 CH4 CH5 CH6
Care home manager ✗ ✗ ✗ ✗ ✗
Care home deputy manager ✗ ✗ ✗ ✗
TABLE 124 Care home staff focus groups (female): sample information
Participant
information CH1 (N= 5) CH2 (N= 5)
CH3
(N= 3)
CH4
(N= 3)
CH5
(N= 4)
CH6
(N= 4)
Age, years: age range,
median (n)
41–56,
48.7 (3)
27–58,
41.0 (4)
46–68,
57.0 (2)
20–47,
30.0 (3)
31–46,
40.25 (4)
18–39,
27.0 (4)
FT spread; PT (n) 1 FT;
4 PT (5)
3 FT;
2 PT (5)
1 FT;
2 PT (3)
3 FT;
0 PT (3)
3 FT;
0 PT (3)
2 FT;
1 PT (3)
Length of time working
in care home, months:
range (n)
1–240 (4) 11–36 (3) 50–178 (2) 30–36 (3) 24–48 (4) 3–27 (3)
Qualifications: received
detail (n)
4 NVQ2 (4)
2 BTEC (4)
2 NVQ2 (4) 1 NVQ2 (2) 3 NVQ2 (3) 2 NVQ2 (3) 2 NVQ3 (3)
Dementia training:
received (n)
5 in-house (5) 5 (5) 3 (3) 3 (3) 4 in-house (4) 3 (4)
End-of-life training:
received (n)
2 (5) 5 (5) included in
general training
2 (3) 0 (3) 0 (4) 1 (4)
BTEC, Business and Technology Education Council; CH, care home; FT, full time; PT, part time.
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Appendix 61 Chapter 4: Phase 2 – documentation
changes
TABLE 126 Evidence of end-of-life discussions and involvement (N= 74)
Time point Baseline (n= 74) Time point 2 (n= 73)
Evidence of end-of-life discussions: n (%) 54 (73) 58 (79.5)
Involvement in end-of-life discussions: n (%)
Resident involvement 7 (13.0) 7 (12.1)
Family involvement 34 (63.0) 44 (75.9)
POA 4 (7.4) 6 (10.3)
Care home staff involvement 9 (16.7) 19 (32.8)
GP involvement 4 (7.4) 10 (17.2)
Other (i.e. witness to living will, minister) 4 (7.4) 4 (6.9)
District nurse involvement – 2 (3.4)
Hospital Medical Assessment Unit – 2 (3.4)
a Source: care notes.
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Appendix 62 Chapter 5: EVIDEM-MCA protocol
Introduction
EVIDEM-MCA is a part of the NIHR-funded EVIDEM programme of research (Principal Investigator Professor
Steve Iliffe) and has the ultimate goal of developing an evidence-based resource to enhance practitioners’
awareness of the MCA to the benefit of people with dementia and to develop new knowledge about the
interaction between the MCA and adult safeguarding systems and practice. This study will evaluate
the impact of the Mental Capacity Act (MCA) 2005 over time, how it affects people with dementia
and carers, and develop educational outputs in support of the Act. Based on an investigation into the
implementation of the Act at practice level, the study will produce practice guidance on the use of
the MCA, with a special focus on its use in adult safeguarding work. The study will take place in the
North West London area as part of the EVIDEM programme and will connect to other parts of the
programme. Specifically the study will evaluate the impact of the MCA on people with dementia, carers,
professionals and the culture of the health and social care organisations. It will produce case series to
inform adult protection approaches in the context of the MCA at Trust, local authority and national level.
Background
The Mental Capacity Act 2005 (MCA) in England and Wales, implemented 2007, enshrines much of the
practice established under case law to safeguard people who lack ability to make specific decisions, to
enhance personal autonomy and to enable people to make advance decisions to refuse treatment. It
introduced new proxy decision-making roles to address health, welfare and financial matters and specialist
advocacy for people who do not have family or friends where major health and welfare decisions are to be
made. The implications of the MCA for health and social care practitioners around the areas of planning
and working with others in new roles remain unclear.250,251
It has been estimated that over two million people in England and Wales may be personally affected by
the provisions of the Act.252 These include many people with dementia and those who are carers, their
representatives or service provider.253 The MCA provides a statutory framework to empower and protect
people, notably those who fear cognitive impairment or those who have received a diagnosis of a
dementia, or those who have early and advancing symptoms who may not be able to make specific
decisions at specific times (www.dca.gov.uk) currently or in the future.254 It clarifies who can make
decisions, in which situations, and the steps that should be taken. It also enables people to plan ahead in
the event of loss of capacity to make particular decisions.256
The procedures and the ability to make choices about future care and treatment decisions mean that the
MCA has potential to enhance practice and user empowerment, and thus contribute to better outcomes
for service users and carers.257 People with dementia may require specialist advice sensitive to their
particular values and networks to make valid and applicable advance decisions to refuse treatment and to
formulate and communicate their wishes and preferences about care and treatment. However, there are
likely to be key transitions or times when this type of advice and assistance may be most pertinent. These
include encounters, such as the communication of a diagnosis of dementia, transitional periods when
planning and setting up care packages or facing end of life. Professionals may need to devote time to
assist people with dementia and their carers to benefit from the Act, and to make sure that they are ready
to explain and debate its implications within teams and across agencies.259 Whilst savings of professional
time may emerge if people with dementia and carers are better informed and more confident,
practitioners may feel compromised by work pressures and unable to provide the necessary support.
Furthermore, proactive promotion of the Act on the part of managers and professionals in a range of local
settings may be required if people with dementia are to maximise their opportunities for planning their
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care and making their wishes known. In these respects, the Act offers people with dementia a crucial
opportunity to influence professional-decision-making so that capacity is presumed unless proven
otherwise, that best interests should be the basis for decisions if a person is not able to make a specific
decision, and provides people with a dementia with greater confidence that they are able to shape their
future social care and treatment.209 Lastly, the new criminal offences of ill-treatment and wilful neglect
under the Act offer new means of adult protection that may be of benefit to people with dementia.
The full implementation of this Act in late 2007 has provided a unique opportunity to explore the early
operation of the Act and its incorporation into practice and service cultures.
Rationale for the study
Implemented in 2007, the Mental Capacity Act (2005) has a number of implications for the practice and
governance of research, most of which reflect existing good research practice. The specific implications for
the responsibilities of local authority social care research governance procedures are given here. More
general issues for research involving people who lack capacity are given in the Mental Capacity Act Code
of Practice.446
Section 1 of the MCA establishes some basic principles: that a person must be assumed to have capacity
unless it is established that he lacks capacity; that a person is not to be treated as unable to make a
decision unless all practicable steps to help him to do so have been taken without success; that a person is
not to be treated as unable to make a decision merely because he makes an unwise decision; that an act
done, or decision made, under this Act for or on behalf of a person who lacks capacity must be done, or
made, in his best interests; that before the act is done, or the decision is made, regard must be had to
whether the purpose for which it is needed can be as effectively achieved in a way that is less restrictive of
the person’s rights and freedom of action.249 (Please note that ‘he’ also refers to ‘she’.)
Someone is thought to lack capacity because of ‘impairment or particular problems with the functioning of
the mind or brain’ (Section 2 Sub section 1). A person is thought to be unable to make specific decisions
if he or she is unable:
l to understand the information relevant to the decision
l to retain that information
l to use or weigh that information as part of the process of making the decision, or
l to communicate his decision (whether by talking, using sign language or any other means) (Section 3
sub section 1).
However, if a person can understand information with appropriate explanations they are seen as capable
of making that decision. Further, a person’s inability to recall information for long periods does not make
them incapable under the MCA.
The MCA requires that decisions taken on behalf of people who are deemed to lack capacity are taken
explicitly in their best interests. Such decisions should be made after considering all relevant features and
not simply on the person’s age, appearance, condition(s) or known behaviour patterns. In particular, those
making such decisions should take into account views expressed when the person did have capacity and
the possibility he or she might regain capacity in the future.
A person judged to be unable to make decisions or consent under the MCA should be involved as much
as possible in making choices and their known or suspected feelings and beliefs need to be taken into
account in making any decisions on their behalf. Those acting for someone deemed not to be capable
under the MCA should also consult any individual named by the person to consult on such matters and
the person’s carers (unpaid or paid). Such individuals include someone granted lasting powers of attorney
by the person or a deputy appointed by the Court of Protection to manage his or her affairs (i.e. welfare).
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In addition to these requirements, the individual making the decision must reasonably believe the course of
action is in the best interests of the incapable person.
Study aim and research approach
This study aims to:
l identify the implementation issues arising from the introduction of the MCA in the services and
practices of staff working with people with dementia and their carers over a 5-year period
l explore and make recommendations about continued professional development programmes around
the MCA for staff and their links to adult safeguarding training and practice.
There are five main research questions:
1. In 2007 what challenges face staff when they come across issues of mental capacity in their practice
with people with dementia?
2. What are the expectations of professionals working with people with dementia about the MCA?
3. What are the expectations of older people and carers about the MCA?
4. What is revealed by a study of professional records about practitioners’ work in passing information
about the MCA to people with dementia and their carers and how does this change over the period of
5 years?
5. What links between the MCA and adult protection arise in practice and is the MCA assisting the
safeguarding of people with dementia?
This study has two main phases. Phase 1 involves an audit of staff perceptions of issues arising in
decision-making and assessment of capacity among people with dementia, collection of data about
training received on the MCA and information provided. Phase 2 will build on this audit to continue to
engage with staff about their work in assessing capacity and implementing the provisions of the MCA, will
undertake a review of case records, and will seek information from staff and people with dementia and
carers about their contact with professionals over issues of mental capacity and decisions about care
and treatment.
The results from Phase 1 will thus be used to develop tools for data collection about advice and
recommendations (Phase 2). Details of Phase 2 will be submitted for peer and ethical review.
The development of this protocol has been informed by the main EVIDEM advisory group and the
EVIDEM-MCA study advisory group, which involve people with experience of using services, carers,
practitioners, advocates and managers. The latter has commented in particular on the draft interview
schedule and the proposed list of participants.
Phase 1
Methodology
Qualitative research methodology, using individual in-depth interviews will be used over time to obtain a
range of perspectives from practitioners working with people with dementia and carers. Interviews will be
conducted at baseline and follow-up will be conducted 12–18 months after baseline interviews.
Practitioner sample and recruitment
Participants will be recruited through contact with employers. Interviews will be semi-structured and
will start through an audit of training and experiences in the management of issues surrounding
decision-making and mental capacity. Those interviewed will also be asked about adult protection
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connections with the MCA. Interviews with the new IMCA will explore the nature of these roles in the
Trust area and their expectations about the size and type of work with people with dementia as the service
becomes established.
These first interviews will provide a baseline for the main interviews in 2009, 2010 and 2011 as
participants will be asked if we can return to them in future years as part of the study. The interviews will
be semi-structured.
The interviews will target specific individuals in specific settings in North London as being likely to have
particularly pivotal experiences:
l community-based mental health nurses whose practice involves the day to day support of carers of
people with dementia (Admiral Nurses, n= 15)
l adult protection staff (n= 10)
l medical staff with experience of clinical work with people with dementia at times of transition (n= 6)
l carers, former and current, of people with dementia who have volunteered to assist dementia related
studies through the voluntary sector (n= 15)
l senior social workers/approved social workers/care managers working with people with dementia at
times of transition or change in care packages (n= 20)
l voluntary sector staff supporting people with dementia and carers (n= 30) (Age Concern, Alzheimer
Society and Carers Groups)
l independent mental capacity advocates (IMCAs) (n= 5)
l care home staff, ranging from managers and deputies (n= 10) to care assistants (n= 15)
l home care staff (n= 15)
l older people attending a science interest group; a multicultural social group and an advocacy group
(a set of groups chosen for their diversity of memberships) (n= 30).
Staff from a range of agencies will be invited to participate as well as a small number of carers and older
people (Phase 2 will be the opportunity to focus on the research questions with people using services for
support with dementia or caregiving). Key agencies will include the local authorities, independent sector
providers of health and social care services, and support groups for older people and people with dementia
and their carers. The community and voluntary sector have been interested in this area for a long time447
and Phase 1 will include interviews with groups that advise older people as well as older people.
Data collection and analysis
Data will be gathered through individual interviews (face to face or by telephone) using a semi-structured
interview schedule to ensure key themes are explored. Interviews will focus on the training practitioners
had, their experience of the Act and their expectations of it as it was implemented. An attempt to obtain
case examples will be made. Interviews will be taped, with permission, transcribed and the tapes deleted
and telephone interviews will be recorded in note form. Each transcription will only be known by an
identifying number not the person’s name and all items that might identify the informant, such as names
or care homes, will be made anonymous. Data will be coded using the Framework qualitative method of
data analysis261,262 to draw out issues, concepts and themes. Data analysis will be an iterative process of
identifying, organising, refining and re-organising the data into themes and sub-themes to describe the
key elements of practice, including describing similarities and differences in training, knowledge and
confidence. Background literature will be used to establish consistencies and inconsistencies between the
reports of knowledge and practice and to identify the general issues and research questions raised by
the data.
APPENDIX 62
NIHR Journals Library www.journalslibrary.nihr.ac.uk
566
Ethical considerations
People will be approached following contact with their employer. This person would explain about the
research and pass on an information leaflet which has been adapted to provide key points in straight
forward language. After consent to approach the person has been gained the researcher will repeat the
explanations and check consent at that point in time. A consent form for signing will be offered, although
if the informant is unwilling to sign this will not be pursued and verbal consent will be noted. The
researcher will thank the person for their time and involvement and offer to send them a summary of the
study’s findings and to leave a short leaflet of information sources about the MCA.
All participants will be assured of anonymity and confidentiality in the transcription, analysis and reporting
of their interview. Any direct quotations used in the report will be non-attributable.
Approximate timescale
Development of topic guide – Winter 2007
Phase 1 baseline interviews – Spring to Winter 2008
Analysis and writing up of baseline interviews – Spring 2009
Concurrent Phase 1 follow-up interviews – Spring to Winter 2009
Analysis and writing up of Phase 1 follow-up interviews – Spring 2010 and ongoing
Feedback to participants – ongoing according to their convenience
Reports and dissemination
The findings will be written up as a brief report for circulation to participants. A full report will be used as
the basis for papers and articles to be submitted to professional journals and local and national voluntary
organisations’ newsletters. An abstract will be submitted for presentation at a service users’ and
professional conference, such as the Dementia Congress.
Phase 2
Methodology
This study adopts a longitudinal qualitative, exploratory approach and people with dementia and carers will be
interviewed at three or four time points over the course of 2 years. Issues explored will include day-to-day
decision-making issues, whether plans and decisions have changed, whether certain individuals or
groups have been particularly helpful and to identify whether the MCA 2005 has been helpful or useful in
the formalising of these plans and decisions. We are aware that individuals and their carers may choose
not to continue for the full duration of the study, and there may be people who die through the course
of the study. However, following people with dementia and their carers prospectively will give a more
accurate picture of their experiences, as well as facilitate identification of when assistance might have been
most beneficial.
Sample and recruitment of people with dementia and carers
This study mainly includes interviews with people with dementia and their family carers. In a small number
of cases, professionals involved in care will be approached with permission of the person with dementia
and carer. The research team is working closely with local specialist agencies, such as the Alzheimer’s
Society and other carers groups in order to recruit people with dementia and carers who will be willing to
speak to us. The moderator or the organiser at each of these groups will approach suitable participants
and inform them of the research study. Only after both the person with dementia and the carer consent to
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being approached by the research team will contact details be passed to the research team. A researcher
will arrange to meet both of them at a mutually convenient time and location.
In accordance with the principles of the MCA, people with dementia will not be thought to lack capacity
and everyone referred for the study will be approached to participate. The procedure for establishing a
person’s ability to decide whether or not they want to participate will proceed in accordance with the
guidance for the Mental Capacity Act 2005; this will include the following four steps:
1. The Information Sheet will be explained to the person with dementia by the researcher, with any
necessary assistance from the carer.
2. The ability to retain the information will be determined by asking the person with dementia to repeat to
the researcher the salient points of the Information Sheet, namely what participation will involve, that it
is entirely voluntary and that follow-up interviews may be conducted.
3. The researcher will ask the person with dementia whether they are happy with taking part, followed by
querying the reason for this; this will again determine that they recognise that participation is voluntary.
4. Finally, all participants will be asked to sign the Consent Form as the means to communicate their
decision. If they are unable to sign the form due to any other physical or cognitive problems, their
relative or carer will be approached to sign for them, after obtaining verbal assent from the person with
dementia. Any sign (verbally or in body language) that the individual is not happy about taking part
or continuing to take part in the research will be interpreted as withholding consent, or a desire
to withdraw. The researcher will end the conversation, thanking the person for their time and
involvement. The researcher will check throughout the discussion that the participant is willing to
continue and cease if the person indicates they wish the discussion to end.
Carers will also be asked to participate in the interview. They will be provided with an Information Sheet
and the study explained to them by the researcher. Carers willing to participate will be interviewed either
before or after the interview with their relative with dementia, depending on their preference. Consent
will be obtained from carers prior to interviews and the same procedure for obtaining consent will be
followed. However, we are not expecting carers to lack capacity. In total, we are hoping to interview
10 people with dementia and 10 carers and we estimate that moderators of groups that are involved in
working with this client group may need to approach around 15 to 20 people for this.
We will also ask people with dementia and carers if it possible for us to speak to their wider social and
professional network, such as friends, lawyers, bank managers, in order to obtain a more holistic picture of
the role of external sources of support in the making of plans and decisions by people with dementia and
carers. If both parties are willing for this contact to be initiated, we will ask for relevant contact details and
they will be approached and invited to take part in the study. An Invitation Letter, an Information Sheet
and a Consent Form will be sent to all such parties. Similar procedures for obtaining consent will be
followed. Interview with this group will be conducted depending on the professional or social role they
have played in the life of the person with dementia and carer, based on the anecdotal information
supplied by them.
At each subsequent contact, consent to participate will be again obtained, following the same procedure.
At subsequent contacts over the 2 years, the person with dementia may have lost the capacity to make a
decision to consent i.e. understand information about the decision to be made, retain that information in
their mind, use or weigh that information as part of the decision-making process, or communicate their
decision (by talking, using sign language or any other means). In these instances, these will be excluded
from the study and the researcher will conduct the interview with carer. Consent will be obtained from
them prior to conducting the interview. Once again, we are not expecting carers to lack capacity.
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Data collection
Making plans and decisions for the future is a sensitive, personal topic for people with dementia as well as
carers and supporters. All interviews will be conducted by empathic researchers aware of the potential
problematic nature of the issues being discussed and with experience of working with both groups of
participants. Interviewers will use language understandable and acceptable to the interviewee. Should an
individual become distressed during the interview, the interviewer will pause, offer sympathy and check
whether the person wishes to discontinue the interview. All interviewers carry relevant contact information
on key support agencies to leave with participants. All participants will be reassured of confidentiality and
anonymity in the transcription, analysis and reporting of interviews. Any direct quotations used in the
report will be non-attributable.
Participants will be made aware that if any information is shared that suggests that a vulnerable older
adult is suffering neglect or abuse then the researcher has a responsibility to share that information with
the service manager (in case of abuse or neglect from a service provider) or in the case of individuals, gain
their consent to share that information with the named Local Authority Officer for safeguarding adults. In
extreme cases, where a crime appears to be suspected, then the researcher will discuss with the Principal
Investigator or call the police.
Data analysis
Data will be coded using the Framework Analysis method (Pope et al., 2000;262 Ritchie and Spencer,
1993261) to draw out issues, concepts and themes. Data analysis will be an iterative process of identifying,
organising, refining and re-organising the data into themes and sub-themes to describe the key elements
of practice, including day to day support, decision-making and formal and informal sources of support and
information with formalising plans. We will use NVivo™, a qualitative data analysis software package that
can manage pooled data. The trustworthiness of the data and analysis will be framed in terms of its
credibility to others with experience of the topic, transferability to other settings, dependability (depth of
description of methods, peer analysis of data, third party evaluation of data gathering) and if possible,
confirmability (by independent review of the data). The advisory group (consisting of professionals, carers
and people with dementia) will also be consulted during this process in order to refine developing codes.
Data will be anonymised before presenting or discussing with any member outside the research team.
Approximate timescale
This project is contracted to end in September 2012. The following are the timescales that have been
generated for this phase (Phase 2) of the study:
Development of Phase 2 topic guide – Spring 2010.
Phase 2 baseline interviews – Spring to Winter 2010.
Concurrent Phase 2 follow-up interviews – Winter 2010 to Summer 2011.
Analysis and writing up of Phase 2 interviews – Winter 2011 and ongoing.
Feedback to participants – from Winter 2011 onwards.
Report writing – Spring 2012.
Completion of project: September 2012.
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Reports and dissemination
The study will be disseminated in five main ways:
1. A brief report presenting the salient findings in an easy-to-read style will be generated and circulated
to participants.
2. A full report to the study funders.
3. This report will serve as the basis for papers and articles which will be submitted to professional journals
and local and national voluntary organisations’ newsletters.
4. Abstracts will be regularly submitted for presentation at service users’ and professionals conferences,
such as the Dementia Congress, British Society of Gerontology Conference and Alzheimer’s Disease
International Conference.
5. The groups and moderators who have helped us with recruitment will be offered presentation days
when the researcher will go down and present the study findings either to volunteers and staff who
work there or to clients at these centres.
APPENDIX 62
NIHR Journals Library www.journalslibrary.nihr.ac.uk
570
Appendix 63 Chapter 5: Details of the four phases
of study design
Phase 1 This phase explored the needs, wishes, experiences and challenges facing ‘‘well’ older people’(with no reported suspicions of declining mental capacity or dementia) many of whom have little or no
contact with health or social care services. The MCA potentially affects this group, as it does us all, by
enabling a person to set out their choices, and for these to be respected even if decision-making capacity
eventually deteriorates. By setting up a LPA, for example, people may nominate trusted family member(s)
(or others) to make decisions on their behalf should they lose the capacity to do so themselves. Our
research questions were:
1. RQ1: How do ‘well’ older people conceptualise and consider future care needs? How do they plan for
their future within the remit of the MCA?
2. RQ2: What are the knowledge, views, experiences and expectations of the MCA among staff working
with ‘well’ older people living in the community who may be interested in making plans for their futures?
We conducted semi-structured qualitative interviews with a diverse population of ‘well’ older people and
with information and advice staff working in local Age Concern (now Age UK) offices to answer these
research questions.
Phase 2 This phase investigated the needs and experiences of people who had recently been diagnosed
with dementia (and their carers) in order to explore their views of short- and longer-term planning.
Although decision-making capacity is likely to not be severely impaired in this group, the MCA offers
options for planning in such circumstances that may seem more personally relevant. We also wanted to
explore the experiences and attitudes of people newly diagnosed with dementia and the practitioners who
support them about decision-making. We sought to understand the possible impact of the MCA on
everyday decision-making for people living in the community (an under-researched area compared with
decision-making at end of life or when major medical options are under consideration). Research questions
for Phase 2 were:
1. RQ3: What are the knowledge, views, experiences and expectations of the MCA among staff
supporting people in the early stages of dementia? Has this changed over time and how?
2. RQ4: What advice, information and support are available about decision-making after receiving
a diagnosis?
3. RQ5: What framework, if any, does the MCA provide people with dementia and carers living in their
own homes who make decisions on an everyday basis?
We conducted semi-structured qualitative interviews with four groups: (1) people with dementia and
carers; (2) staff at Alzheimer’s Society branches; (3) staff at Carers’ Centres; and (4) SACs, often at the
forefront of implementing the MCA.
Phase 3 This phase investigated the needs and experiences of those whose capacity may be impaired, and
who as a result of this, need help with decision-making and possibly safeguarding against abuse. As the
MCA incorporates provisions for this group, we wanted to explore the training, experiences, attitudes and
expectations of practitioners who work with people with dementia and their carers. Research questions for
Phase 3 were:
1. RQ6: What are the knowledge, views, experiences and expectations of the MCA among staff
supporting people in the later stages of dementia, when capacity may be impaired? Has this changed
over time and how?
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2. RQ7: What advice, information and support are available to those who are caring for relatives with
dementia whose capacity is impaired?
3. RQ8: What arrangements can be put in place so that people with dementia with and without capacity
are safeguarded against abuse? Does the MCA help?
Semi-structured qualitative interviews were carried out with four groups: (1) social workers, (2) Admiral
Nurses (specialist dementia nurses), (3) people with dementia and carers living in the community, and
(4) SACs. An online survey of Alzheimer’s Society staff was also conducted through the Society.
We further undertook specific consultations about an issue that emerged across many of the interviews
from this and earlier phases; practitioners’ knowledge of and practice experience with the two new
offences of wilful neglect and ill-treatment created by the MCA. Our first consultation event included
practitioners from NHS, social care and criminal justice backgrounds on 10 March 2011. Our second
sought the views of older people about what type of information they would find helpful, without being
alarmist. We met with this group on 15 November 2011 and recorded this discussion. Following these
consultations and analysis of the interview data we produced a preliminary paper for the Journal of
Dementia Care (Manthorpe and Samsi, 2012)448 and will be writing another paper for an academic journal.
We will also be liaising with the SCIE to encourage them to host a version of these on their website.
Phase 4 This final phase of the research study explored the potential relevance of the MCA for people
with severe dementia who may be at the end of life. Capacity at this stage is likely to be consistently
impaired, proxy decision-making is likely to be needed on a regular basis, and advance care plans may be
in place. We sought to elicit the attitudes of staff working in care homes about the practice of decision-
making on behalf of or by their residents, and the possible impacts of the MCA on their work more
generally. The research questions for this phase were:
1. RQ9: What are the knowledge, views, experiences and expectations of the MCA among staff who
work with people with dementia at the end of their lives and their carers regarding advance care plans
or other similar plans?
2. RQ10: How does MCA proxy decision-making work in practice?
Semi-structured confidential interviews were conducted with staff in a variety of care homes (small single
owner to part of a large chain of care homes) at two time points to ascertain their training, experiences
and attitudes towards the MCA.
Nested within Phase 4 was a substudy of an NHS acute hospital trust where several untoward incidents
involving patients lacking capacity had indicated that use and knowledge of the MCA were partial among
the hospital staff. This substudy engaged with the author of an audit commissioned by the hospital trust
to produce a report with lessons for the wider NHS and health-care providers that was made available to
the wider public.274
APPENDIX 63
NIHR Journals Library www.journalslibrary.nihr.ac.uk
572
Appendix 64 Chapter 5: Semi-structured
interview schedules
1. Interviews for Practitioners’ Audit Time 1.
2. Interviews for Practitioners’ Audit Time 2.
3. Interviews with ‘well’ older people.
4. Interviews with people with dementia.
5. Interviews with carers.
EVIDEM – Mental Capacity Act 2005
Interviews for Practitioners’ Audit Time 1
Revised according to practitioner group being interviewed
Introductions
l Explain purpose of this audit, no right or wrong answers but interest in hearing about practitioners’
experiences. Explain part of EVIDEM (info provided).
l Assurances of confidentiality (draw attention to Consent Form).
l Seek permission to tape.
Brief details of interviewee
l Job title.
l Role (key activities).
l Qualifications (including registrations/NVQ).
l Number of years since qualified.
l Place of work (employer/department/team).
l Time in present post.
Section 1: training
1. Have you heard of the MCA 2005?
2. If yes, please tell me what you have heard/if you have been involved in implementation.
3. Have you had any training on the Act? If yes, please outline when, where and who supplied it, content.
4. Was this helpful in terms of information? If yes, what in particular? – If no, why not?
5. Has the training proved useful in practice? If yes, please give some examples of how, if no, why do you
think this is? e.g. prompts, not my line of work, no one has heard of it . . .
6. Have you explained the MCA to anyone (colleagues or patients/carers)? If yes please outline, with
some examples.
7. Have you delivered training yourself? If yes please outline when, where, to whom, how did you do this?
8. Specifically, how confident are you in your own knowledge of the Act, say, if 0 is not at all confident
and 5 is very confident, where would you place yourself?
9. And where do you think you should be (0–5)?
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Section 2: roles and activity
10. Is the MCA affecting your work? Please outline if yes, and explain which areas or no and why?
11. Where would you seek advice from about mental capacity/making decisions matters if you had
any problems?
12. Is there any new paperwork/guidance in place? If yes, where and are you using it?
13. In your opinion, do you think that people with suspected or early dementia will use the MCA to make
plans for their future?
14. Is discussion about this something that you might get involved in, in your work?
i. If yes, please outline the possible areas of MCA that are raised in your work e.g. advance decisions
about treatment, lasting powers of attorney, assessment of capacity.
ii. If no, where do you advise people with early/suspected dementia and their families to go if they
have queries or want advice? Would this be within your team/organisation/or elsewhere?
15. What do you think might be the advantages of the MCA? (prompt to whom, people with dementia,
carers, professionals)
16. And what about any disadvantages (and to whom, why)?
Section 3: looking ahead
17. Have you any predictions about the MCA? (e.g. lots of interest, no real help)
18. Do you think it will be useful in adult protection/safeguarding people with dementia? If yes, please
explain. If no, why not?
19. Just briefly, and this is not an exam, but we are trying to find out how familiar these new terms are –
have you heard of the following:
i. Independent Mental Capacity Advocates (IMCAs) – if yes, what do they do?
ii. Lasting Powers of Attorney – if yes, what can the LPAs do?
iii. Deprivation of Liberty or Bournewood safeguards?
iv. The new offences of mistreatment and wilful neglect under the MCA?
v. And how would you define ‘capacity’?
Section 4: personal perspectives
20. Would you say you have had experiences of looking after someone with dementia in your own family
or network, e.g. partner/friend? Could you briefly outline if you think this has affected any of the
matters we have been talking about?
21. Finally, have you been thinking of making any plans yourself or for a person you know (e.g. discussion
with parents or partner) about this area? If yes, please outline.
End of interview
Demographic details
l Male/female
l Age
l Are you a carer? Or recent experience?
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l Ethnicity (Census categories):
Ethnic group
Choose ONE from A to E, then indicate cultural background.
¢ A. White Options of British; Irish or any other White background (please describe).
¢ B. Mixed Options of White and Black Caribbean; White and Black African; White and Asian or any
other Mixed background (please describe).
¢ C. Asian or Asian British Options of Indian; Pakistani; Bangladeshi; any other Asian background
(please describe).
¢ D. Black or Black British Options of Caribbean; African; any other Black background
(please describe).
¢ E. Chinese or other ethnic group Options of Chinese; any other (please describe).
Conclusion
Thanks and assurances of anonymity
Ask permission to get back in touch over the course of the project to ask for updates/Best
method of making contact again? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [phone number]
Offer to leave information sheet about MCA training materials and contacts
Interviews for Practitioners’ Audit Time 2
Revised according to practitioner group being interviewed
Thank participant for allowing us to talk to them last year about the MCA. We interviewed over a hundred
practitioners and have found it really useful to learn what their initial experiences and expectations were.
We’d like to ask you a few (five) follow-up questions – is that convenient?
1. When we talked last time, you said that X was happening – is this still the case? (e.g. revised
policy/procedures)
2. What are your main experiences of the MCA – now it’s bedded in?
3. Last time you had experience of/did not have experience of . . .
i. Has anything changed? If yes, what?
4. Last time you predicted . . .
i. Were you right?
ii. What’s happened since?
5. In what ways has the Act changed your practice or that of staff team colleagues – if at all? Is there
anything you would like to add?
6. Any developments/experiences around the new offences under the Act – wilful neglect or ill-treatment?
7. Any other observations around the links between adult safeguarding and the MCA?
8. Have you made any plans yourself or for your family?
Many thanks for your help – we would be happy to send you a copy of our findings. Would you like this?
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Interviews with ‘well’ older people
1. Please can you tell me if you have made any plans for managing your money and so on for now and
in the future and what these are?
i. What about a will/any advanced decisions, a LPA.
ii. Have you told people any wishes you might have?
iii. Why is it that you have this (all aspects) (Why not?)
2. What about any plans for your future care if you needed to be looked after?
i. What about where you want to live?
ii. Why is it that you have this (all aspects) (Why not?)
3. What about any medical plans or decisions?
4. Do you think you might think about making plans in the future (what circumstances/events?)
For example:
i. if you got a diagnosis of something serious
ii. if you felt you were having memory problems
iii. if your family/friends change/move
iv. if suggested by family and friends and so on
v. (Why/why not?)
5. Have any professionals talked to you about making plans? Explore if HSC or if lawyer/accountant, etc.
6. We would just like to ask if you have heard of any of the following and what they mean to you:
i. The Mental Capacity Act?
ii. LPA or Enduring Power of Attorney (EPOA)?
iii. Advance decisions? (sometimes termed Living Wills)
7. If you have made/will make any plans, do you think that professionals (e.g. doctors, nurses, social
workers, care workers) will take any notice of them?
i. Why do you think this? – Do you have any experiences?
8. Have you made any decisions on behalf of other people (adults), like relatives when they are
poorly, confused?
i. What happened here?
ii. Who encouraged you?
iii. (Why/why not?)
iv. How has this affected how you feel about making plans for your own future?
9. Have you ever discussed any of these issues with your friends/family?
10. If you decided to make plans or had a friend who wanted to make plans, whom do you think you
would you seek advice from?
11. Is there anything we have not covered that you would like to add?
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Demographic details
l Male/female
l Age
l Are you a carer? Or recent experience?
l Ethnicity (Census categories):
Ethnic group
Choose ONE from A to E, then indicate cultural background.
¢ A. White Options of British; Irish or any other White background (please describe).
¢ B. Mixed Options of White and Black Caribbean; White and Black African; White and Asian or any
other Mixed background (please describe).
¢ C. Asian or Asian British Options of Indian; Pakistani; Bangladeshi; any other Asian background
(please describe).
¢ D. Black or Black British Options of Caribbean; African; any other Black background
(please describe).
¢ E. Chinese or other ethnic group Options of Chinese; any other (please describe).
End of interview
l Permission to get back in touch over the course of the project to ask for updates.
l Best method of making contact again? . . . . . . . . . . . . . . . . . . . . . . . [phone number]
Interviews with people with dementia
Introduction and assurance of confidentiality: explain pilot process, informed consent, seek permission
to record.
1. Could you tell me what an ordinary day for you is like?
l Does anyone support or help you in any way? (Who is the main person?)
¢ Establish relationship, co-residency, frequency of contact.
l What, if anything, does X (main person) help you with?
l On an average day, do you have to make a lot of decisions?
¢ Explore what these are.
¢ Prompts:
¢ what time to get up
¢ what to wear
¢ paying bills
¢ going shopping
¢ cleaning the house.
2. Do you make all of your own decisions?
l Does anyone help you with some of them?
¢ For example, banking, bills.
¢ Has this always been the case?
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l Do you choose who makes decisions for you?
l Are you happy with decisions you have made recently?
¢ Can you tell me about any decisions that you have been happy with?
¢ Have you give away responsibility to someone else to make a decision for you that you were
unhappy with?
l Can you tell me any specific instances when you might need the help of someone to make a decision
for or with you?
l What about things like managing finances?
¢ Paying bills, investments, savings.
l What about things like your health, such as taking medicines, going to the doctor, etc.?
¢ Having dental treatment, getting new glasses, hearing aids, etc.
l What about just everyday decisions, like shopping for clothes or deciding what groceries to buy?
l Lifestyle issues:
¢ Driving and car-related items, such as car repairs.
¢ Repairs and major household items/decorating.
¢ Valued activities and hobbies.
l Looking after yourself (dressing, hairdressing, toileting, washing and so on)
¢ Choice about type of care.
¢ What about having paid people to help around the house or to help with other things?
3. Did you have any plans about what to do in retirement?
l Did you have any wishes for retired life?
¢ Like staying in this house/flat.
l What were these?
l Did you talk to anyone about this?
l Have you had to change any plans recently?
4. Did you have any formal or written plans for this time or period of your life?
l Such as a will.
l Joint bank accounts/utilities.
l Insurance policies.
l An enduring power of attorney or LPA.
l Statements of wishes.
l Advance decisions about care and treatment (sometimes called Living Wills).
l Any other written wishes or plans?
¢ When did you set these out and why?
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5. Has anyone been involved in helping you make any decisions or plans?
l Family/relatives?
l Professionals?
¢ Medics/nurses/etc.
¢ Bank managers/solicitors/accountants/etc.
¢ Alzheimer’s Society/Age Concern (now Age UK)/Carers’ centres, etc.
l Friends?
l How did you feel about this?
l Do you wish they had?
6. We would like to learn more about how people make everyday decisions. How do you think we might
be able to do this best?
l Prompts:
¢ Could you see yourself writing a diary?
¢ Telephone calls at regular intervals?
¢ Visiting for a talk?
¢ Other?
¢ How often could we contact you?
¢ How can we find the times when people are ‘wondering what to do’, ‘thinking’, ‘pondering’?
¢ Using vignettes (think aloud around imaginary case studies).
7. Do you think there is anything we have not covered?
8. Would it be possible for us to speak to the main people involved in helping you? Such as your GP/social
services person/Community Psychiatric Nurse (CPN)/Alzheimer’s Society? Is there anyone you would
particularly recommend?
Thank you for your time today. Offer reassurances of confidentiality and anonymity.
Interviews with carers
Introduction and assurance of confidentiality: explain pilot process, informed consent, seek permission
to record.
1. Could you tell me about your role as a person supporting/looking after x.
l How did it begin?
l How long have you been involved in caregiving?
l What do you do for X?
¢ Has it changed from when you first started helping him/her?
l (Flesh out relationships and carer role/responsibility).
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2. Could you tell me about any decisions you make or think about together with or on behalf of X?
l Could you tell me who was involved, why they were involved, in what capacity they were involved and
how they contributed.
l Expand around finance (managing money, accounts, bills, etc.).
l Law.
l Health (medical, physical, medication, dentist and so on).
l Consumer decisions, like shopping and deciding what groceries to buy.
l What about issues of everyday life, such as driving.
l What about decisions to do with care, such as toileting, washing and so on.
¢ What about whether or not they need help?
l Family contact and relationships with others (family, services, etc.)
¢ What works well and not so well?
¢ What is comfortable for you?
¢ What is troubling or tricky?
l Do you tend to give X a chance to make the decision first, even if it’s not something you agree on?
¢ Why/why not?
3. Could you describe a ‘tricky’ day or ‘tricky event’?
l How do you deal with making decisions for X?
4. What guides how you make decisions for X?
l Previous discussions?
¢ Can you tell me about the kinds of discussions you have.
¢ Context and content of discussions.
5. Does what you do come from any plans made by X?
l Enduring power of attorney.
l LPA.
l Statements of wishes.
l Advance decisions about care and treatment (sometimes called Living Will).
l Your knowledge of X as a person.
6. Is anyone else involved (professionals, relatives, etc) in helping you making such decisions?
l Family/relatives?
l Professionals?
l Friends?
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7. We would like to learn more about how people make decisions and are thinking about decisions on an
every day basis, as well as major ones, over a period of time. How do you think we might be able to do
this best?
l Prompts:
¢ Diary format?
¢ Telephone calls at regular intervals?
¢ Visiting for a talk or interview?
¢ Other?
¢ What intervals would be best to balance the detail of everyday life and yet not being a bother?
¢ How can we capture times when people are ‘wondering what to do’, ‘thinking’, ‘pondering’?
¢ Using vignettes (think aloud around imaginary case studies).
8. Do you think there is anything we have not covered?
Thank you for your time today. Offer reassurances of confidentiality and anonymity.
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Appendix 65 Chapter 5: Five main stages in
framework analysis
Familiarisation
This early stage is for the researchers to get familiarised with the data and sensitised to early themes.
It encourages the research to see the individual differences inherent in transcripts that can sometimes
get lost when coding begins. The process of sensitisation to these individual differences also enables the
researcher to better identify within- and between-participant differences. In a few cases, the researcher felt
the need to revert to the original recorded interview to get a better feel for the data. Any emergent early
impressions were noted, relating to reactions to transcript/participant, how they felt as they listened to the
participant, and any specifics that they wanted to remember for later. These were jotted on one side of
the paper transcript.
Identifying a thematic framework
This stage of framework analysis is commonly referred to as ‘coding’ in other qualitative methodologies.
This principally involves identifying key themes, issues or discussion points embedded in the transcript.
These are delineated and assigned a ‘code’ or a name that best captures the essence of the theme or issue
identified. In framework analysis, ‘a priori issues’ questions can form the basis of the themes – we
therefore used the interview topic guide as a starting point for creating overarching categories and any
emergent themes from transcripts were coded as responses to each question. As Pope and colleagues
describe,262 the outcome of this stage is a ‘detailed index’ of the data into ‘manageable chunks for
subsequent retrieval and exploration’, which is what we achieved.
Example
l We were keen to ascertain the training on the MCA practitioners had been offered. We therefore
labelled ‘Training’ as one of our a priori categories and coded (1) ‘no training’, (2) ‘1-day training
course’, (3) ‘1+ day training programme’, and (4) ‘MCA training as part of other activities’. We were
able to identify and make inferences regarding the amount of training one participant group had had
compared with another.
Indexing
Indexing refers to the process of numerically annotating transcripts in order to identify consistencies,
which then go on to develop the coding framework. However, we followed this process slightly differently.
All of the word codes (as opposed to numerical) that had been generated during stage 2 were listed on a
separate sheet of paper. We then grouped together all codes that shared commonalities or consistencies.
These clusters were given an appropriate name.
Example
l One of our interview questions referred to ‘Practice experiences’ – we named this as an overarching
category, incorporating (1) ‘intrinsic impact’, (2) ‘community role of X’, (3) ‘role of safeguarding’, and
(4) ’change and extension to job role’ as separate codes under it.269
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l This also helped us to identify and be mindful of individual participant differences. For example, while
community nurses saw safeguarding as less of a priority in their jobs during time 1 interviews258 SACs
talked about the significant impact of the MCA on their practice experiences.264
Charting
Framework analysis describes this stage as a process of rearranging the data and thematic framework to
create order, not dissimilar to the iterative principle of grounded theory.449 We applied this stage as a
principle for synthesising and developing our final coding framework through a process of abstraction, in
order to derive all the detail from the data and ensure that we were coding elements that may have been
missed with simply an a priori approach.
Example
l The question asking all participants about their personal experiences of caregiving (family caring) was
asked as a final question to round off the interview. Family caring experiences were commonly reported
and participants offered examples of how these had contributed to their professional understanding of
dementia and caring. In relation to this, five main codes were developed: (1) ‘informing the professional
role’, (2) ‘insight into services’, (3) ‘professional influences on caring’, (4) ‘planning’, and (5) ‘no apparent
effect of MCA’.
Mapping and interpretation
Mapping and interpreting essentially are ways of representing pictorially or graphically all of the themes
and investigating how each of the themes relates to each other. This detailed exploration of the iteratively
developed and revised thematic framework enabled us to gain a clearer understanding and explanation of
the ‘bigger picture’. For instance, we examined the association between three categories: (1) ‘training’,
(2) ‘(self-reported) knowledge of the MCA’, and (3) ‘self-reported confidence’; and we were able to
identify and offer explanations for individual discrepancies between these three categories.
Example
l In Manthorpe et al.268 we describe how some participants, with no training and limited self-reported
knowledge, reported high levels of confidence in abiding by the Act. We questioned the reliability of
some self-reported knowledge about the MCA, and have considered the adequacy of training now the
Act is no longer ‘new’ and the potential for mandatory training for all staff.
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Appendix 66 Chapter 5: Narrative account of
findings
Universal appeal of the Mental Capacity Act
3.2.1.1. Beneficial Practitioners across the range of professional groups felt that the MCA was
beneficial as it clarified and consolidated a previously confusing legal system that
had baffled older people, and sometimes practitioners. Most thought it enhanced
the autonomy of people with impaired cognition, by assuming that people are able
to make decisions unless proved otherwise; encouraging professionals to better
consider ability to make decisions, and ‘giving a voice to older people at risk’
(Manager 02)
3.2.1.2. Dignity and rights
protected
While recognising that individual decision-making was supported (even unwise or
‘eccentric’ decisions), many participants believed that the Act provided better
safeguards for people who might be particularly vulnerable to neglect and abuse.
Overall, the Act was seen as supporting the rights and dignity and decisions of
people with dementia
3.2.1.3. Details not widespread
but growing
Alongside the universal appeal of the MCA, however, it was evident that awareness
of details and experience of using the Act were still not widespread, but these were
steadily growing.294 Those who had direct contact with people with dementia and
carers said that the Act made them more aware of questions related to capacity,
and one intrinsic impact was the more common practice of now routinely
questioning whether a capacity assessment had been done. Understanding of the
MCA was seen as increasing overall, and there appeared to be steady advances of
understanding, confidence and experience when time 1 and time 2 interviews
were compared
Training
3.2.2.1. Frequency and format of
training offered
Training appeared to have been available to nearly all practitioners who participated
in our study. However, not all had undertaken it for various reasons. There was also
variability in the level and type of training each participant had received. Although
some participants had undertaken in-house training, others had attended more
detailed training provided by external consultants, geared towards professional
HSC workers. Some training had lasted for less than an hour, or half a day, whereas
others attended day-long sessions. Formats varied too, ranging from conferences,
‘awareness-raising’ sessions, specific to the MCA (e.g. through an employer) or as
general updating (part of Continuing Professional Development)
Most who had received training deemed it useful, providing a good overview, being
informative and helpful in outlining a job-defined formalised code of working and
‘crystallising what [I] do’ (AN13). However, in terms of day-to-day work, some
perceived minimal change and reported little benefit from training. Other accounts
varied according to participants’ experiences. Although some felt that senior staff
were responsible for cascading the information to more junior levels, this did not
seem to happen systematically, but occurred instead during staff meetings or by
putting items on a notice board to convey the ‘basics’. A number of junior care
home workers tended to rely on paperwork and care plans to come from ‘head
office’ and demonstrated little knowledge of the MCA. Few professionals had
received training that incorporated safeguarding practice and the MCA
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3.2.2.2. Challenge of translating
training into practice
Training sometimes appeared to be over-didactic, with limited use of case studies
and examples. High-level information was imparted at these events, which often
resulted in most participants knowing about the general principles of the MCA but
not its specifics. Many appeared to use guesswork when asked about specific
points, suggesting that they had gleaned overviews of the MCA rather than
acquired detailed understanding
Ongoing training was considered important, as these provided opportunities to
share emerging challenges. A minority of practitioners across all professional groups
said they had missed the training offered or had not been able to attend owing to
work commitments. Two participants talked of having recently started at a particular
organisation and, therefore, had missed training at their old place of work as well as
at their new one
Given the high turnover of staff and frequent changes to staff and organisational
structures, the need for training to be a continuous process was identified.
Renewing and refreshing training at local levels could also incorporate new
information and developments. Following the Act’s initial implementation, there
have been many changes to procedures and structures, as well as results of early
evaluations and research findings, all of which could be incorporated into regular
training. Use of the Mental Health Foundation’s Assessment of Mental Capacity
Audit Tool (AMCAT) (easily accessible and free: URL: www.amcat.org.uk/
audit_your_assessment/) material could be enhanced (Mental Health Foundation
2010)450
Implementation
3.2.3.1. Quick and easy
incorporation into safeguarding
practices and procedures
Practitioners working in adult safeguarding were especially positive about the Act
and considered that it had enhanced their everyday practice. They felt that much of
their work was already guided by the principles of the MCA, but considered that the
MCA had reinforced these principles. Many of these participants particularly
appreciated that the MCA provided a framework for mental capacity assessments.
They welcomed the focus on specific rather than global capacity (is the person able
to make a specific decision and does it need to be made now?) and the provisions
for planning, either by appointment of a LPA or by greater encouragement for
people to make their wishes known about future care and treatment.451 Over the
different time points, these participants were enthusiastic in extolling the Act’s
potential to support defensible decision-making for professionals and carers,
protecting people’s rights from abuse, and achieving good outcomes for those who
lacked capacity
However, all practitioners considered that it would be some time before the MCA
was completely embedded in practice. Given that HSC policy and commissioning are
increasingly driven by the policy of personalisation, greater clarity will be needed
around challenges arising from concerns about safeguarding risks (e.g. of
exploitation, abuse and neglect). We were able to witness this major change to
adult social care services in the course of the study and have produced some of the
first findings about the MCA and its link to personalisation and safeguarding267
3.2.3.2. Confidence and expertise We explored practitioners’ level of professional confidence in implementing the
MCA. In order to encourage discussion and to avoid the uncertainties of language
(e.g. differences between ‘much’, ‘a little’, ‘somewhat’), we used a five-point scale
as a means to get practitioners to state how confident they felt, where ‘1’ was ‘not
confident’ and ‘5’ was ‘very confident
APPENDIX 66
NIHR Journals Library www.journalslibrary.nihr.ac.uk
586
We noted some lack of association between confidence and knowledge. Participants
who said they were very knowledgeable about the MCA did not always feel
confident about implementing it. Perhaps more worryingly, those who indicated that
they did not feel knowledgeable about the MCA sometimes indicated higher than
expected levels of confidence. A majority of participants, however, talked of feeling
confident about other sources if they needed more information
Confidence seems likely to accumulate with familiarity and experience in using the
Act. Confidence was also related to whether practitioners felt able to access advice
and expertise locally
There was limited confidence about conducting assessments of capacity, with some
practitioners stating their belief that only medical professionals were able to ‘verify’
whether or not a client with dementia had capacity. Although most practitioners
were aware in principle that capacity had to be understood and assessed by the
person closest to the specific decision, many suggested that, for a formal report of
capacity, a medical practitioner was needed. Others held the erroneous view that
next-of-kin status granted family members the rights to make decisions for their
relatives
3.2.3.3. Risk of information
‘merry-go-round’
An information ‘merry-go-round’ was evident, by which practitioners appeared to be
signposting queries on to other practitioners or agencies who then passed these
queries back to them in a potential loop of confusion. There was not always a
central point of expertise locally that could deal with queries, signpost appropriately
and answer questions that practitioners encountered. Where this was available, it
was highly valued
An additional challenge was a lack of clarity about the specific content of
information and advice and consequently the roles of advice and information
agencies. This also led in part to the information
‘merry go-round’ when staff in agencies that provided information were approached
for advice that they did not feel equipped to supply. For example, making a LPA
involves completing a lengthy form with which some professionals said they did not
feel able to assist269
Although some third-sector groups were keen to describe themselves as
safeguarding agents and champions of older people, they often perceived their roles
as gatekeepers to more detailed sources of information and routes to intervention,
rather than providing these themselves. For instance, groups that traditionally
provided information and advice, such as Age Concern (now Age UK), felt rightly
not able to respond to specialist legal queries falling outside their competence258
Signposting to other services was becoming an expanding task. Although many
information-providing agencies were responding to basic enquiries from older
people, as well as those closely involved with decision-making, and encouraging
drawing up of LPAs, they also suggested other sources of help. When responding to
enquiries related to a dementia, many of those providing basic information and
advice turned to health practitioners or solicitors as specialists, sometimes to
supplement their own in-house national resources, such as telephone helplines. This
suggests that sources of information and advice were not clearly mapped at local
levels. There is the potential for people to be passed on from agency to agency.
Commissioners may wish to satisfy themselves that the local map of information and
advice has linear pathways and is not circular
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3.2.3.4. MCA expertise at all levels
unlikely, but central expertise
required
A striking conclusion from interviews held with staff at all levels in care homes was
the need for a single authoritative lead on the MCA. Most junior care workers
(generally termed ‘care assistants’) and some senior care workers had rudimentary, if
any, understanding of the Act and indicated that they would rely on care home
managers or senior staff to identify or answer any complex questions.268 Although
some care home managers were well informed, others indicated that they too had
fairly rudimentary understanding of the Act themselves and would turn to other
specialist sources if the need arose. However, there was little consistency in
nominations made. They included the home’s regional manager or other
headquarter’s staff (in homes that were part of large chains), local social workers,
community mental health nurses, the local mental health team, an IMCA helpline,
Age Concern (now Age UK) (local voluntary sector) advocates, a GP and solicitors.
Each manager’s choices were different and a minority were uncertain of any source
of authority, advice or expertise. For example, some managers emphasised the role
of the family in making decisions, whereas others emphasised the role of social
workers or mental health professionals
There appears to be scope for the principles of the Act to be more explicit in
everyday practice and record keeping in care homes. Although in most homes
participating in this study, there was anecdotal evidence of this (i.e. making best-
interests decisions based on a resident’s past preferences), there was little formal
record of these procedures which could stand up to legal challenge or regulatory
scrutiny. Moreover, some care home staff themselves confessed to a lack of
confidence in dealing with more complex cases when quick decisions may need to
be made, e.g. about whether a resident lacking capacity could lawfully be moved
from a care home to another setting for treatment or assessment or who could
consent to treatment. By time 2 some homes had clarified these matters, often
through the making of advance care plans or similar decisions being recorded on a
person’s move to the care home. Nonetheless, at time 2 there were still care home
staff who were unfamiliar with the MCA, largely because they were new in post and
new to the work. Some were not familiar with English law and their level of English
was basic
Everyday decision-making
3.2.4.1. Everyday negotiation Analysis revealed a significant theme around the number of everyday decisions
people with dementia and carers who lived together made jointly, including what
to do, what to wear, what to eat and what holidays to plan. Both people with
dementia and carers talked of the potential of making decisions as important to
individual autonomy. Most, however, acknowledged that, since the diagnosis of
dementia, things had changed and almost half the participants with dementia said
they now found it difficult to make decisions
Many carers reported trying to actively involve their relative with dementia in
decision-making; some provided them with cues or reduced possible stress, for
example, by offering fewer options. Some carers revealed that, over time, shared
decision-making had given way to them making decisions unilaterally. While some
tried to involve their relative with dementia in general or domestic decisions, four
carers described deliberately not doing so in order to protect or ‘save’ them from the
stress of minor decision-making, in order to better participate in more important
decisions. Spousal carers were more likely to make joint decisions through the
interchange of everyday conversation
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Such changes can be seen as part of a life course of changes to family decision-
making and so need to be contextualised within biographies and gendered
relationships. For example, retirement appeared to have been the point at which
many participants’ lifestyles and routines had changed and when joint domestic
decision-making often seemed to have started. One man with dementia talked of
how, when he was working, he left decision-making about meals to his wife, but
since retirement, they had made such decisions together. Similarly, deciding how to
spend the day was a joint enterprise for some, another change since retirement
3.2.4.2. Past preferences and best-
interest decisions key to making
proxy decisions
Many carers were making decisions on behalf of their relative with dementia
without reference to the MCA but in line with its values of acting in a person’s best
interests and in the least restrictive way. Although most recognised the reasons for
having to make such decisions, there were some expressions of frustration when
carers felt responsible, strained and confused. Mostly they used their knowledge of
their relative’s past habits, preferences, likes and dislikes to help them make
decisions. In some cases, however, they confessed to resorting to doing what suited
them best. For instance, one carer talked of his wife with dementia never liked
having sugar in her tea, although lately this had changed. However, when he ran
out of sugar, he reasoned that his wife would not mind as it was in keeping with
her past preferences
3.2.4.3. Weighing best-interest
decisions
The principle of making decisions in the PWD’s best interests appeared to underlie
many carers’ interactions with their relatives with dementia, albeit in different ways.
There appeared to be a divide between two groups of carers. One group described
their relative’s well-being or best interests being at the heart of decisions that they
made on their behalf. A second group described making decisions in terms of what
might be beneficial to them both. In many cases, this constituted what was least
stressful to carers. Carers in this group felt that maintaining their health was
important in being able to support their relative with dementia and, therefore, they
adopted the most pragmatic solution they judged necessary for the long term
3.2.4.4. Inequalities in access to
information
We asked participants whom they had approached, if anyone, for information and
advice when facing major or difficult decisions. Their responses indicated that such
decisions rarely occurred in isolation. A range of support was accessed, from friends
and family to solicitors and members of support groups. Many of the participants
had family members upon whom they felt they could rely, relatives who were
sufficiently knowledgeable and whom they felt had their best interests at heart. In
most cases, this ‘family’ was adult children; in one case, it was a sister and her
family. Adult children were more likely to use the internet and seek other sources of
information, and many of our participants felt happy to leave any complex decisions
to their children whom they felt were able to access advice and expertise. Although
there were no apparent gender differences, adult daughters were more often
involved in supporting day-to-day practicalities, whereas adult sons were involved in
more long-term care planning. However, from such a small number of participants,
it would be premature to make any generalisations. What emerges is a lack of
evidence about effective support for older people who have no social support
networks that they trust or who are not able to access local support services. This is
an area in which research may have much to offer practitioners about how to meet
specific needs and how to sustain resourcefulness
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Long-term planning
3.2.5.1. Planning influenced by personal
factors
A significant theme that emerged was that participants had individual and
personal approaches to planning.272 A range of predisposing factors was
identified, including disposition, belief systems and spirituality, participants’
living situations, the current (2010–11) uncertain state of the economy, and
their confidence and trust in medical practitioners. Some participants declared
their personal tendencies and preferences were to avoid planning for the
future. They described beliefs such as ‘living for today’, enjoy life to the
maximum, not thinking much about the future, and not letting worries and
problems affect their life. Making detailed plans for the future had, therefore,
not featured in their lives prior to dementia or old age
Some participants discussed this disinclination in the context of spiritual beliefs.
Illustrating this, apart from funeral arrangements and despite being concerned
about finances, one older person had not drawn up a will nor any made health
or social care plans. She did not feel that it was appropriate for her to interfere
in ‘God’s work’
A significant subtheme was identified from discussions with people living alone
and with no relatives. This group spoke about being unable to appoint anyone
to hold a LPA or to ensure their wishes and preferences were carried out
because they had no direct or even distant next of kin. They highlighted that
their friends, being elderly themselves, were compromised in their ability to act
as effective attorneys. This particular group indicated the strongest intentions to
plan but it was difficult for some to find members of their social networks who
could take on the responsibility
A small group of participants said that they did not have any finances or valuable
personal effects to leave their children and hence viewed planning as irrelevant to
their situation. They conceptualised plans in terms of financial transactions or for
functions of inheritance and appeared to find it difficult to think about planning
for health and personal welfare decisions as matters that might affect them
3.2.5.2. Financial and funeral plans
commons, less so HSC plans
Of the arrangements that had been made, the most common were financial.
Making a will was frequently mentioned, followed by granting EPOA
(the earlier Power that applied to financial decisions alone and not health and
welfare decisions), setting up joint bank accounts, taking out health insurance,
and consolidating investments and bank accounts. A tendency to plan for
financial security did not necessarily mean that individuals also planned for
other aspects of their future. For example, one participant talked of her
household insurance, health insurance, income protection plans and financial
arrangements. Despite having made difficult decisions for her late mother
through final stages of cancer, this participant had not considered making plans
of this nature for herself although she expressed interest in these when the
subject was raised during the interview
Funeral arrangements were also discussed, ranging from having a separate
bank account for funeral costs, to more elaborately planned procedures,
including hymns participants would like to have sung at the ceremony
Housing and residential care appeared to be significant discussion points (rather
than explicit planning measures) for participants. Most had spoken to partners,
family members and close friends about these subjects. Some described how
much their home meant to them emotionally and that they hoped to stay in it
until the end; others spoke of their willingness to move into residential care in
order to relieve their children of caring responsibilities. It appeared, however,
that few were aware of the complexities of the social care system in England
and did not understand how they could state their preferences or how the
MCA could support these
There was an absence of HSC plans in the formats permitted under the MCA
(Advance Decisions and LPAs) and most participants admitted not having
thought about these. They seemed interested in the provisions of the MCA
when they were introduced during the interviews and asked for information
afterwards. This was in contrast with the many financial arrangements that they
had already put in place around joint accounts, direct debit for bills, Powers of
Attorney, and wills
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3.2.5.3. Limited support with knowing
where to turn
Most participants did not know where to turn if they were interested in taking
forward plans for the future. The interviews conceptualised possible serious
debilitating conditions as a way to start these exploratory discussions
about planning. Participants were asked about their familiarity with and
understanding of key terms and phrases, such as the MCA, LPAs and Living
Wills (the legal term being Advance Decisions but this term was not widely
understood). None of the participants had heard of the MCA specifically,
despite some understanding that principles of the Act were respected in health
and care settings. Some appeared to have an understanding of LPAs, knowing
that this involved appointment of a trusted person to manage one’s affairs
when one is unable to do so. However, few appeared aware of the change in
terms since the introduction of the Act and assumed that the EPOA meant the
same as the LPA. Living Wills/Advance Decisions were rarely understood, and,
in some cases, associated with what participants called ‘clinics in Switzerland’
and euthanasia. Many participants assumed that Living Wills could not be
honoured by medical professionals because assisted suicide is illegal in the UK
Participants on the whole appeared unsure where to turn for support with
planning. Financial advice appeared easier to come by and participants knew
where this could be accessed. Having reliable financial advisers to give sound
advice was described positively and participants appeared reassured by them
The role of the GP appeared to be crucial. Some participants were unsure if
they could rely on their GP, reporting not always seeing the same GP and not
feeling particularly supported by the primary health-care team. Others felt
they could rely on their GP for advice about making plans and that these
would be honoured. These were confident in the GP’s information and advice
regarding Living Wills/Advance Decisions. When asked whether any local
information and advice agencies would be helpful, white British participants
said that they were likely to visit local branches of Age Concern (now Age UK),
whereas black Caribbean participants appeared reluctant to share personal
information with these voluntary agencies. The latter group felt that if they
wanted to make plans they were more likely to consult family members and
friends who would direct them to appropriate agencies and people rather
than talking to strangers. These findings are indicative but may suggest that
professionals should explore people’s confidence in voluntary sector groups as
sources of advice when advising people to contact them
One reason for making plans was the onset of a debilitating illness. The current
high profile of dementia in the media may explain why this condition was
generally known about by almost all participants. Dementia was discussed as
one of these conditions, when participants speculated that there might be
little chance of recovery and the prospect of losing capacity to make decisions
was heightened
Safeguarding
3.2.6.1. Inherent safeguarding value Most participants, including practitioners and some people with dementia and
carers, felt that the principles of the MCA provided safeguards to protect the
autonomy and well-being of the person with dementia, through respecting
capacity, enabling the setting up of LPAs and best-interests decision-making.
Most were optimistic about its use and value, and some highlighted that its
greatest benefit was in providing safeguards against false allegations of abuse
for practitioners and carers as well.451 Many practitioners also considered that
carers would benefit from knowing details of the Act, as it would provide them
with knowledge of when and how they would be able to make decisions for
their relatives if the need arose or to act on their behalves
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The principles and procedures of the MCA were perceived as placing the
individual at the heart of the safeguarding process by those with local
responsibilities for adult safeguarding (formerly adult protection, also known as
elder abuse) in local authorities (SACs). Rights to draw up a LPA were, in several
instances, described as part of ‘protection plans’ (SAC04) and could be one
outcome of a safeguarding investigation (SAC07). Access to the IMCA
(paid advocacy) service in cases of suspected abuse was universally valued.
The Deprivation of Liberty Safeguards (introduced later than the MCA) were
providing another layer of protection. In one example, a person’s wish to remain
in a care home against family pressure had been supported (SAC05). In another,
a case of neglect had emerged (SAC11). (This study did not focus on
Deprivation of Liberty Safeguards as there are other major research studies on
this subject in progress.) The Act’s potential to shift the boundaries of traditional
relationships and to empower vulnerable adults was observed, but a new
emphasis on its role in reducing victimisation and positive risk-taking also
emerged
However, some raised criticisms that there was insufficient publicity about the
Act and that written material was not always readily available (most of it is
online). One SAC was particularly concerned that there were limited
opportunities for people to find out about the Act and considered that at the
time of its introduction: ‘a bigger national drive would have been better’
3.2.6.2. Financial management and
safeguarding
Safeguarding Adult Coordinators felt that the MCA might potentially address
one significant area of concern for them – money management and financial
abuse. They discussed the safeguarding potential (but limited current use) of the
MCA in these areas and the hazards that might be faced by carers and people
with dementia who had not yet set out prespecified plans, but when the latter
had deteriorating capacity. Most SACs interviewed described this area as a
major element of their work
Current data collection systems make it hard to be specific about the prevalence
of actual abuse or the even the composition of formal referrals to SACs. One
participant noted that although financial abuse featured in about 12% of local
investigations, they lacked information about whether alleged victims had
dementia or cognitive impairment. Some described situations as common place
in which family care was insufficient, yet services were declined because their
cost would reduce the family inheritance. Within families, unusual interest in a
person’s financial affairs could be suspicious, with some relatives described as
being financially motivated. One SAC reflected ‘having money does not protect
you from abuse in old age; it can make you more vulnerable’. Other examples of
the abuse of people with dementia encountered following referrals included
valuables missing without explanation; undue influence and theft; misuse of
direct payments (cash for care); taking the ‘free’ item under a ‘buy one get one
free’ supermarket offer; or ‘borrowing’ money from an older vulnerable person
Although having dementia in itself was acknowledged as problematic when
raising safeguarding alerts (because people might not realise the risk or danger),
most practitioners reported using strategies to engage a person with dementia
to find out what was happening or of concern. These included face-to-face
interviews, involving advocates, liaison with partner agencies (e.g. the police and
the Department of Work and Pensions) and exploring legal options. However,
they deemed the highest priority was remaining vigilant about the risks of
financial abuse
In a modified form of data triangulation, interviews with SACs were compared
with responses from a survey of staff of the Alzheimer’s Society to see if they
considered that money management was a problem for people with dementia.
These staff similarly thought that risks of financial abuse were widespread. The
MCA and financial systems were reported to be not always sufficiently sensitive
to the needs of people with declining, rather than greatly impaired, capacity to
make fine judgements and to take account of their changing circumstances
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3.2.6.3. Warning signs of financial
abuse should be publicised
Participants from the Alzheimer’s Society suggested that there should be greater
publicity about the warning signs of financial abuse to raise awareness among
practitioners, community support networks such as shops, banks, and post
offices, and society in general. In their experience, discussions about managing
money were not easy and this suggests that skills may need to be developed in
this area of practice. We worked with the Alzheimer’s Society to develop a series
of evidence-based policy recommendations to promote the safeguarding and
rights of people with dementia, pointing to the provisions of the MCA as helpful
for some people lacking decision-making capacity and as part of a prevention or
protection plan.287 This study attracted substantial media publicity
In addition to individual planning to minimise abuse or to minimise common
confusions over money management, SACs referred to other preventative
measures including:
l Setting up direct debits to pay bills from a person’s bank account
l Restricting access to bank details and Personal-Identification-Number
l Prohibiting junk mail or ‘cold calling’
l Reducing unsolicited (scam) telephone calls by barring ‘number withheld’
calls
The SACs considered that the risks of exploitation of people with dementia are
not always identified by NHS professionals. Greater recognition of such risks and
preventative measures may be needed among community support teams and
memory clinic staff. However, one problem in their experience was that many of
those at risk still retain decision-making capacity and are not yet under the
protection of an attorney (under the LPA provisions) or other appointments
under the Office of the Public Guardian
Almost all SACs highlighted the potential for people with decision-making
capacity to draw up a LPA under the MCA. This was widely regarded as the
most significant means of prevention of abuse once mental capacity was
severely affected. Allied to these positive views of LPAs, and acknowledging that
they had to be drawn up while a person was still able to make this decision,
SACs generally expressed confidence in the system of deputies appointed for
people without LPAs. One also reported that the Office of the Public Guardian
was proving extremely helpful in managing an errant attorney in complex and
difficult circumstances. There seems greater scope for professionals who inform
people with dementia and their carers about the MCA to highlight the Office of
the Public Guardian’s potential role in prevention of exploitation
For people with minimal income and savings, the Department of Work and
Pensions system of appointeeship (appointment of a suitable person to collect
pension or benefits on behalf of another person, typically a relative) was viewed
positively but not to the same extent. SACs made criticisms of the lack of
checking of those who took on the role of an appointee although even drawing
up a LPA, where greater checks and monitoring are required, could not ensure
protection, as this example indicated
3.2.6.4. Role of banks and community
support networks
The procedures and rules of banks reportedly presented significant barriers to
safeguarding people with dementia from financial abuse. Most participants
raised this problem and alluded to the impersonal nature of high street banks,
bank staff’s reluctance to question suspicious activity and defensiveness about
information sharing, even when MCA arrangements had been made. Memory
clinic staff and others may wish to suggest that people with a new diagnosis
should consider current and future financial arrangements when they are ready
to do so. At policy level, as noted above, the Alzheimer’s Society report Short
Changed: Protecting People with Dementia from Financial Abuse,287 to which
this research contributed, has been a springboard for the Alzheimer’s Society to
take forward discussions with the financial services industry
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Appendix 67 Chapter 6: Proposed data capture
fields with definitions for primary care
Date of data
extraction
GP name and
contact details
Search register for:
Dementia syndrome Suspected (see below) Allows mild cognitve impairment capture
Diagnosed Diagnosis of dementia
Subtype diagnosed Subtype diagnosed under ‘organic brain disorders’, i.e. Alzheimer’s
disease, vascular, mixed, Lewy body, frontotemporal dementia,
Parkinson’s disease dementia, other
or Dementia
symptoms
Presence of possible
dementia symptoms
Presence of possible dementia indicators such as: st memory loss,
memory loss, forgetfulness, behavioural change, disorientation,
confusion, personality change, speech problems, deterioration, global
deterioration, wandering
or Cognitive
impairment indicator
MMSE score Where MMSE score is not available from within the electronic medical
record other psychometric tests indicative of cognitive impairment will
be captured, e.g. 6CIT, AMTS, ADAS-cog, etc.
Then exclude:
Alcohol dependency Alcohol dependency Record of alcohol dependency is required as ‘alcohol problem’ may be
insufficient as an exclusion criterion
and Opioid
dependency
Opioid dependency
and Diagnosis of
psychiatric disorder
Diagnosis of major
psychiatric disorder
Any diagnosis of major psychiatric disorder would be an exclusion
criterion
From this modified subpopulation audit and report on:
Patient gender Automatic
Patient age Automatic
Patient contact
details
Residential status Ideally we could like to capture residential status, i.e. own home,
sheltered accommodation, care home. However, we will be able to
capture only the patient’s address
Carer details Ideally it would be preferable to capture presence of a carer, marital status
and carer strain score as a dependency indicator. However, we are unlikely
to be able to routinely capture this data and a follow-up call for these
details after initial selection criteria have been applied may be required
Comorbidities Capture all active
comorbidities
Automatically identified from active problem list
Medication Capture all medications The whole medication record can be extracted, this will allow checking
for prescription of cholinesterase inhibitors and concomitant
medications, such as antidepressants, psychotropics, etc.
Contact with
secondary care
Professional contacts List other professional contacts, such as memory clinics. This information
will allow a quality assessment of secondary care databases and also
give contact details if further information is required; reports may need
to be followed up manually
Medical imaging Indication of whether CT scans/MRI scans have been performed, date of scan
and results where possible; reports may need to be followed up manually
ADAS-cog, Alzheimer’s Disease Assessment Scale-cognitive subscale.
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